e10vk
UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
Form 10-K
|
|
|
(Mark One)
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
For the fiscal
year ended December 31,
2010
|
or
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
|
For the transition period
from to
|
Commission file number
001-15787
MetLife, Inc.
(Exact name of registrant as
specified in its charter)
|
|
|
Delaware
|
|
13-4075851
|
(State or other jurisdiction
of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
200 Park Avenue, New York, N.Y.
|
|
10166-0188
|
(Address of principal
executive offices)
|
|
(Zip Code)
|
(212) 578-2211
(Registrants telephone
number, including area code)
|
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
Title of each class
|
|
Name of each exchange on which registered
|
Common Stock, par value $0.01
|
|
New York Stock Exchange
|
Floating Rate Non-Cumulative Preferred Stock, Series A, par
value $0.01
|
|
New York Stock Exchange
|
6.50% Non-Cumulative Preferred Stock, Series B, par value
$0.01
|
|
New York Stock Exchange
|
5.875% Senior Notes
|
|
New York Stock Exchange
|
5.375% Senior Notes
|
|
Irish Stock Exchange
|
5.25% Senior Notes
|
|
Irish Stock Exchange
|
Securities registered pursuant to Section 12(g) of the
Act: None
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act. Yes þ No o
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or 15(d) of the
Act. Yes o No þ
Indicate by check mark whether the registrant: (1) has
filed all reports required to be filed by Section 13 or
15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any,
every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of
Regulation S-T
(§ 232.405 of this chapter) during the preceding
12 months (or for such shorter period that the registrant
was required to submit and post such
files). Yes þ No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
(§ 229.405 of this chapter) is not contained herein,
and will not be contained, to the best of registrants
knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this
Form 10-K
or any amendment to this
Form 10-K. þ
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in
Rule 12b-2
of the Exchange Act. (Check one):
|
|
|
Large accelerated
filer þ
|
|
Accelerated
filer o
|
Non-accelerated
filer o (Do
not check if a smaller reporting company)
|
|
Smaller reporting
company o
|
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the Exchange
Act). Yes o No þ
The aggregate market value of the voting and non-voting common
equity held by non-affiliates of the registrant at June 30,
2010 was approximately $31 billion. At February 18,
2011, 986,585,463 shares of the registrants common
stock were outstanding.
DOCUMENTS
INCORPORATED BY REFERENCE
Part III of this
Form 10-K
incorporates by reference certain information from the
registrants definitive proxy statement for the Annual
Meeting of Shareholders to be held on April 26, 2011, to be
filed by the registrant with the Securities and Exchange
Commission pursuant to Regulation 14A not later than
120 days after the year ended December 31, 2010.
As used in this
Form 10-K,
MetLife, the Company, we,
our and us refer to MetLife, Inc., a
Delaware corporation incorporated in 1999 (the Holding
Company), its subsidiaries and affiliates.
Note
Regarding Forward-Looking Statements
This Annual Report on
Form 10-K,
including Managements Discussion and Analysis of Financial
Condition and Results of Operations, may contain or incorporate
by reference information that includes or is based upon
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements give expectations or forecasts of future events.
These statements can be identified by the fact that they do not
relate strictly to historical or current facts. They use words
such as anticipate, estimate,
expect, project, intend,
plan, believe and other words and terms
of similar meaning in connection with a discussion of future
operating or financial performance. In particular, these include
statements relating to future actions, prospective services or
products, future performance or results of current and
anticipated services or products, sales efforts, expenses, the
outcome of contingencies such as legal proceedings, trends in
operations and financial results.
Any or all forward-looking statements may turn out to be wrong.
They can be affected by inaccurate assumptions or by known or
unknown risks and uncertainties. Many such factors will be
important in determining the actual future results of MetLife,
Inc., its subsidiaries and affiliates. These statements are
based on current expectations and the current economic
environment. They involve a number of risks and uncertainties
that are difficult to predict. These statements are not
guarantees of future performance. Actual results could differ
materially from those expressed or implied in the
forward-looking statements. Risks, uncertainties, and other
factors that might cause such differences include the risks,
uncertainties and other factors identified in MetLife,
Inc.s filings with the U.S. Securities and Exchange
Commission (the SEC). These factors include:
(1) difficult conditions in the global capital markets;
(2) increased volatility and disruption of the capital and
credit markets, which may affect our ability to seek financing
or access our credit facilities; (3) uncertainty about the
effectiveness of the U.S. governments programs to
stabilize the financial system, the imposition of fees relating
thereto, or the promulgation of additional regulations;
(4) impact of comprehensive financial services regulation
reform on us; (5) exposure to financial and capital market
risk; (6) changes in general economic conditions, including
the performance of financial markets and interest rates, which
may affect our ability to raise capital, generate fee income and
market-related revenue and finance statutory reserve
requirements and may require us to pledge collateral or make
payments related to declines in value of specified assets;
(7) potential liquidity and other risks resulting from our
participation in a securities lending program and other
transactions; (8) investment losses and defaults, and
changes to investment valuations; (9) impairments of
goodwill and realized losses or market value impairments to
illiquid assets; (10) defaults on our mortgage loans;
(11) the impairment of other financial institutions that
could adversely affect our investments or business;
(12) our ability to address unforeseen liabilities, asset
impairments, loss of key contractual relationships, or rating
actions arising from acquisitions or dispositions, including our
acquisition of American Life Insurance Company (American
Life), a subsidiary of ALICO Holdings LLC (ALICO
Holdings), and Delaware American Life Insurance Company
(DelAm, together with American Life, collectively,
ALICO) (the Acquisition) and to
successfully integrate and manage the growth of acquired
businesses with minimal disruption; (13) uncertainty with
respect to the outcome of the closing agreement entered into
between American Life and the United States Internal Revenue
Service in connection with the Acquisition;
(14) uncertainty with respect to any incremental tax
benefits resulting from the planned elections for ALICO and
certain of its subsidiaries under Section 338 of the
U.S. Internal Revenue Code of 1986, as amended (the
Section 338 Elections); (15) the dilutive
impact on our stockholders resulting from the issuance of equity
securities to ALICO Holdings in connection with the Acquisition;
(16) downward pressure on our stock price as a result of
ALICO Holdings ability to sell its equity securities;
(17) the conditional payment obligation of approximately
$300 million to ALICO Holdings if the conversion of the
preferred stock issued to ALICO Holdings in connection with the
Acquisition into our common stock is not approved;
(18) economic, political, currency and other risks relating
to our international operations, including with respect to
fluctuations of exchange rates; (19) our primary reliance,
as a holding company, on dividends from our subsidiaries to meet
debt payment obligations and the applicable regulatory
restrictions on the ability of the subsidiaries to pay such
dividends; (20) downgrades in our claims paying ability,
financial strength or credit ratings; (21) ineffectiveness
of risk management policies and procedures;
(22) availability and effectiveness of reinsurance or
indemnification arrangements, as well as default or failure of
counterparties to perform; (23) discrepancies between
actual
2
claims experience and assumptions used in setting prices for our
products and establishing the liabilities for our obligations
for future policy benefits and claims; (24) catastrophe
losses; (25) heightened competition, including with respect
to pricing, entry of new competitors, consolidation of
distributors, the development of new products by new and
existing competitors, distribution of amounts available under
U.S. government programs, and for personnel;
(26) unanticipated changes in industry trends;
(27) changes in accounting standards, practices
and/or
policies; (28) changes in assumptions related to deferred
policy acquisition costs, deferred sales inducements, value of
business acquired or goodwill; (29) increased expenses
relating to pension and postretirement benefit plans, as well as
health care and other employee benefits; (30) exposure to
losses related to variable annuity guarantee benefits, including
from significant and sustained downturns or extreme volatility
in equity markets, reduced interest rates, unanticipated
policyholder behavior, mortality or longevity, and the
adjustment for nonperformance risk; (31) deterioration in
the experience of the closed block established in
connection with the reorganization of Metropolitan Life
Insurance Company (MLIC); (32) adverse results
or other consequences from litigation, arbitration or regulatory
investigations; (33) inability to protect our intellectual
property rights or claims of infringement of the intellectual
property rights of others, (34) discrepancies between
actual experience and assumptions used in establishing
liabilities related to other contingencies or obligations;
(35) regulatory, legislative or tax changes relating to our
insurance, banking, international, or other operations that may
affect the cost of, or demand for, our products or services,
impair our ability to attract and retain talented and
experienced management and other employees, or increase the cost
or administrative burdens of providing benefits to employees;
(36) the effects of business disruption or economic
contraction due to terrorism, other hostilities, or natural
catastrophes, including any related impact on our disaster
recovery systems and management continuity planning which could
impair our ability to conduct business effectively;
(37) the effectiveness of our programs and practices in
avoiding giving our associates incentives to take excessive
risks; and (38) other risks and uncertainties described
from time to time in MetLife, Inc.s filings with the SEC.
We do not undertake any obligation to publicly correct or update
any forward-looking statement if we later become aware that such
statement is not likely to be achieved. Please consult any
further disclosures MetLife, Inc. makes on related subjects in
reports to the SEC.
Note
Regarding Reliance on Statements in Our Contracts
In reviewing the agreements included as exhibits to this Annual
Report on
Form 10-K,
please remember that they are included to provide you with
information regarding their terms and are not intended to
provide any other factual or disclosure information about
MetLife, Inc., its subsidiaries or affiliates, or the other
parties to the agreements. The agreements contain
representations and warranties by each of the parties to the
applicable agreement. These representations and warranties have
been made solely for the benefit of the other parties to the
applicable agreement and:
|
|
|
|
|
should not in all instances be treated as categorical statements
of fact, but rather as a way of allocating the risk to one of
the parties if those statements prove to be inaccurate;
|
|
|
|
have been qualified by disclosures that were made to the other
party in connection with the negotiation of the applicable
agreement, which disclosures are not necessarily reflected in
the agreement;
|
|
|
|
may apply standards of materiality in a way that is different
from what may be viewed as material to investors; and
|
|
|
|
were made only as of the date of the applicable agreement or
such other date or dates as may be specified in the agreement
and are subject to more recent developments.
|
Accordingly, these representations and warranties may not
describe the actual state of affairs as of the date they were
made or at any other time. Additional information about us may
be found elsewhere in this Annual Report on
Form 10-K
and MetLife, Inc.s other public filings, which are
available without charge through the SEC website at www.sec.gov.
3
Part I
As used in this
Form 10-K,
MetLife, the Company, we,
our and us refer to MetLife, Inc., a
Delaware corporation incorporated in 1999 (the Holding
Company), its subsidiaries and affiliates.
With a more than
140-year
history, we have grown to become a leading global provider of
insurance, annuities and employee benefit programs, serving
90 million customers in over 60 countries. Through our
subsidiaries and affiliates, MetLife holds leading market
positions in the United States (U.S.), Japan, Latin
America, Asia Pacific, Europe and the Middle East. Over the past
several years, we have grown our core businesses, as well as
successfully executed on our growth strategy. This has included
completing a number of transactions that have resulted in the
acquisition and, in some cases, divestiture of certain
businesses while also further strengthening our balance sheet to
position MetLife for continued growth.
On November 1, 2010 (the Acquisition Date),
MetLife, Inc. completed the acquisition of American Life
Insurance Company (American Life), from ALICO
Holdings LLC (ALICO Holdings), a subsidiary of
American International Group, Inc. (AIG), and
Delaware American Life Insurance Company (DelAm,)
from AIG, (American Life, together with DelAm, collectively,
ALICO) (the Acquisition) for a total
purchase price of $16.4 billion. The business acquired in
the Acquisition provides consumers and businesses with products
and services, life insurance, accident and health insurance,
retirement and wealth management solutions. This transaction
delivers on our global growth strategies, adding significant
scale and reach to MetLifes international footprint,
furthering our diversification in geographic mix and product
offerings, as well as increasing our distribution strength. See
Note 2 of the Notes to the Consolidated Financial
Statements.
MetLife is organized into five segments: Insurance Products,
Retirement Products, Corporate Benefit Funding and
Auto & Home (collectively,
U.S. Business) and International. The assets
and liabilities of ALICO as of November 30, 2010 and the
operating results of ALICO from the Acquisition Date through
November 30, 2010 are included in the International
segment. In addition, the Company reports certain of its results
of operations in Banking, Corporate & Other, which
includes MetLife Bank, National Association (MetLife
Bank) and other business activities. For reporting periods
beginning in 2011, our
non-U.S. Business
results will be presented within two separate segments: Japan
and Other International Regions. MetLifes management
continues to evaluate the Companys segment performance and
allocated resources and may adjust such measurements in the
future to better reflect segment profitability.
U.S. Business provides a variety of insurance and financial
services products including life, dental,
disability, auto and homeowner insurance, guaranteed interest
and stable value products, and annuities through
both proprietary and independent retail distribution channels,
as well as at the workplace. This business serves over 60,000
group customers, including over 90 of the top one hundred
FORTUNE
500®
companies, and provides protection and retirement solutions to
millions of individuals.
International operates in Japan and 64 countries within Latin
America, Asia Pacific, Europe and the Middle East. MetLife is
the largest life insurer in Mexico and also holds leading market
positions in Japan, Poland, Chile and South Korea. This business
provides life insurance, accident and health insurance, credit
insurance, annuities, endowment and retirement &
savings products to both individuals and groups. International
is the fastest-growing of MetLifes businesses, and we
believe it will be one of the largest future growth areas.
Within the U.S., we also provide a variety of mortgage and
deposit products through MetLife Bank. Results of our banking
operation are reported in Banking, Corporate & Other.
Operating revenues derived from any customer did not exceed 10%
of consolidated operating revenues in any of the last three
years. Financial information, including revenues, expenses,
operating earnings, and total assets by segment, is provided in
Note 22 of the Notes to the Consolidated Financial
Statements. Operating revenues and operating earnings are
performance measures that are not based on accounting principles
generally accepted in the United States of America
(GAAP). See Managements Discussion and
Analysis of Financial Condition and Results of Operations
for definitions of such measures.
4
We are one of the largest institutional investors in the
U.S. with a $476 billion general account portfolio
invested primarily in investment grade corporate bonds,
structured finance securities, commercial and agricultural
mortgage loans, U.S. Treasury, agency and government
guaranteed securities, as well as real estate and corporate
equity. Over the past several years, we have taken a number of
actions to further diversify and strengthen our general account
portfolio.
Our well-recognized brand, leading market positions, competitive
and innovative product offerings and financial strength and
expertise should help drive future growth and enhance
shareholder value, building on a long history of fairness,
honesty and integrity. Over the course of the next several
years, we will pursue the following objectives to achieve our
goals:
|
|
|
|
|
Strengthen our growth platform
|
Focus on targeted, disciplined global growth of
our businesses
Build on our widely recognized brand name
Capitalize on our large base of institutional and
individual customers
|
|
|
|
|
Optimize our delivery and operations
|
Expand and leverage our broad, diverse
distribution channels
Focus on margin improvement and return on equity
expansion
|
|
|
|
|
Protect and extend our risk management
|
Build on our strong risk management and
investment expertise
Maintain a balanced focus on income and
protection products
|
|
|
|
|
Enhance organizational effectiveness
|
Further our commitment to a diverse, high
performance workplace
|
|
|
|
|
Capitalize on innovation
|
Continue to introduce innovative and competitive
products
U.S.
Business
Overview
Insurance
Products
Our Insurance Products segment offers a broad range of
protection products and services aimed at serving the financial
needs of our customers throughout their lives. These products
are sold to individuals and corporations, as well as other
institutions and their respective employees. We have built a
leading position in the U.S. group insurance market through
long-standing relationships with many of the largest corporate
employers in the U.S., and are one of the largest issuers of
individual life insurance products in the U.S. We are
organized into three businesses: Group Life, Individual Life and
Non-Medical Health.
Our Group Life insurance products and services include variable
life, universal life, and term life products. We offer group
insurance products as employer-paid benefits or as voluntary
benefits where all or a portion of the premiums are paid by the
employee. These group products and services also include
employee paid supplemental life and are offered as standard
products or may be tailored to meet specific customer needs.
Our Individual Life insurance products and services include
variable life, universal life, term life and whole life
products. Additionally, through our broker-dealer affiliates, we
offer a full range of mutual funds and other securities
products. The elimination of transactions from activity between
the segments within U.S. Business occurs within Individual
Life.
5
The major products within both Group Life and Individual Life
are as follows:
Variable Life. Variable life products provide
insurance coverage through a contract that gives the
policyholder flexibility in investment choices and, depending on
the product, in premium payments and coverage amounts, with
certain guarantees. Most importantly, with variable life
products, premiums and account balances can be directed by the
policyholder into a variety of separate account investment
options or directed to the Companys general account. In
the separate account investment options, the policyholder bears
the entire risk of the investment results. We collect specified
fees for the management of the investment options. The
policyholders cash value reflects the investment return of
the selected investment options, net of management fees and
insurance-related and other charges. In some instances,
third-party money management firms manage these investment
options. With some products, by maintaining a certain premium
level, policyholders may have the advantage of various
guarantees that may protect the death benefit from adverse
investment experience.
Universal Life. Universal life products
provide insurance coverage on the same basis as variable life,
except that premiums, and the resulting accumulated balances,
are allocated only to the Companys general account.
Universal life products may allow the insured to increase or
decrease the amount of death benefit coverage over the term of
the contract and the owner to adjust the frequency and amount of
premium payments. We credit premiums to an account maintained
for the policyholder. Premiums are credited net of specified
expenses. Interest is credited to the policyholders
account at interest rates we determine, subject to specified
minimums. Specific charges are made against the
policyholders account for the cost of insurance protection
and for expenses. With some products, by maintaining a certain
premium level, policyholders may have the advantage of various
guarantees that may protect the death benefit from adverse
investment experience.
Term Life. Term life products provide a
guaranteed benefit upon the death of the insured for a specified
time period in return for the periodic payment of premiums.
Specified coverage periods range from one year to 30 years,
but in no event are they longer than the period over which
premiums are paid. Death benefits may be level over the period
or decreasing. Decreasing coverage is used principally to
provide for loan repayment in the event of death. Premiums may
be guaranteed at a level amount for the coverage period or may
be non-level and non-guaranteed. Term insurance products are
sometimes referred to as pure protection products, in that there
are typically no savings or investment elements. Term contracts
expire without value at the end of the coverage period when the
insured party is still living.
Whole Life. Whole life products provide a
guaranteed benefit upon the death of the insured in return for
the periodic payment of a fixed premium over a predetermined
period. Premium payments may be required for the entire life of
the contract period, to a specified age or period, and may be
level or change in accordance with a predetermined schedule.
Whole life insurance includes policies that provide a
participation feature in the form of dividends. Policyholders
may receive dividends in cash or apply them to increase death
benefits, increase cash values available upon surrender or
reduce the premiums required to maintain the contract in-force.
Because the use of dividends is specified by the policyholder,
this group of products provides significant flexibility to
individuals to tailor the product to suit their specific needs
and circumstances, while at the same time providing guaranteed
benefits.
Our Non-Medical Health products and services include dental
insurance, group short- and long-term disability, individual
disability income, long-term care (LTC), critical
illness and accidental death & dismemberment
coverages. Other products and services include
employer-sponsored auto and homeowners insurance provided
through the Auto & Home segment and prepaid legal
plans. We also sell administrative services-only
(ASO) arrangements to some employers. The major
products in this area are:
Dental. Dental products provide insurance and
ASO plans that assist employees, retirees and their families in
maintaining oral health while reducing
out-of-pocket
expenses and providing superior customer service. Dental plans
include the Preferred Dentist Program and the Dental Health
Maintenance Organization.
Disability. Disability products provide a
benefit in the event of the disability of the insured. In most
instances, this benefit is in the form of monthly income paid
until the insured reaches age 65. In addition to
6
income replacement, the product may be used to provide for the
payment of business overhead expenses for disabled business
owners or mortgage payment protection. This is offered on both a
group and individual basis.
Long-term Care. LTC products provide
protection against the potentially high costs of LTC services.
They generally pay benefits to insureds who need assistance with
activities of daily living or have a cognitive impairment. In
November 2010, we announced our decision to discontinue all new
sales of individual and employer group LTC products, as well as
our intent to file for an in-force rate increase on our employer
group business. We remain committed to our existing LTC insureds
and will ensure that they continue to receive the same high
level of service.
Retirement
Products
Our Retirement products segment includes a variety of variable
and fixed annuities that are primarily sold to individuals and
employees of corporations and other institutions. The major
products in this area are:
Variable Annuities. Variable annuities provide
for both asset accumulation and asset distribution needs.
Variable annuities allow the contractholder to make deposits
into various investment options in a separate account, as
determined by the contractholder. The risks associated with such
investment options are borne entirely by the contractholder,
except where guaranteed minimum benefits are involved. In
certain variable annuity products, contractholders may also
choose to allocate all or a portion of their account to the
Companys general account and are credited with interest at
rates we determine, subject to certain minimums. In addition,
contractholders may also elect certain minimum death benefit and
minimum living benefit guarantees for which additional fees are
charged.
Fixed Annuities. Fixed annuities provide for
both asset accumulation and asset distribution needs. Fixed
annuities do not allow the same investment flexibility provided
by variable annuities, but provide guarantees related to the
preservation of principal and interest credited. Deposits made
into deferred annuity contracts are allocated to the
Companys general account and are credited with interest at
rates we determine, subject to certain minimums. Credited
interest rates are guaranteed not to change for certain limited
periods of time, ranging from one to ten years. Fixed income
annuities provide a guaranteed monthly income for a specified
period of years
and/or for
the life of the annuitant.
In the fourth quarter of 2010, management realigned certain
income annuity products within the Companys segments to
better conform to the way it manages and assesses its business
and began reporting such product results in the Retirement
Products segment previously reported in the Corporate Benefit
Funding segment. Accordingly, prior period segment results have
been adjusted to reflect such product reclassifications. See
Note 1 and Note 22 of the Notes to the Consolidated
Financial Statements for further information.
Corporate
Benefit Funding
Our Corporate Benefit Funding segment includes an array of
annuity and investment products, including, guaranteed interest
products and other stable value products, income annuities, and
separate account contracts for the investment management of
defined benefit and defined contribution plan assets. This
segment also includes certain products to fund postretirement
benefits and company, bank or trust owned life insurance used to
finance non-qualified benefit programs for executives. The major
products in this area are:
Stable Value Products. We offer general
account guaranteed interest contracts, separate account
guaranteed interest contracts, and similar products used to
support the stable value option of defined contribution plans.
We also offer private floating rate funding agreements that are
used for money market funds, securities lending cash collateral
portfolios and short-term investment funds.
Pensions Closeouts. We offer general account
and separate account annuity products, generally in connection
with the termination of defined benefit pension plans, both in
the U.S. and the United Kingdom (U.K.). We also
offer partial risk transfer solutions that allow for partial
transfers of pension liabilities and annuity products that
include single premium buyouts.
7
Torts and Settlements. We offer innovative
strategies for complex litigation settlements, primarily
structured settlement annuities.
Capital Markets Investment Products. Products
offered include funding agreements, Federal Home Loan Bank
advances and funding agreement-backed commercial paper.
Other Corporate Benefit Funding Products and
Services. We offer specialized life insurance
products designed specifically to provide solutions for
non-qualified benefit and retiree benefit funding purposes.
Auto &
Home
Our Auto & Home segment includes personal lines
property and casualty insurance offered directly to employees at
their employers worksite, as well as to individuals
through a variety of retail distribution channels, including
independent agents, property and casualty specialists, direct
response marketing and the individual distribution sales group.
Auto & Home primarily sells auto insurance, which
represented 68% of Auto & Homes total net earned
premiums in 2010. Homeowners and other insurance represented 32%
of Auto & Homes total net earned premiums in
2010. The major products in this area are:
Auto Coverages. Auto insurance policies
provide coverage for private passenger automobiles, utility
automobiles and vans, motorcycles, motor homes, antique or
classic automobiles and trailers. Auto & Home offers
traditional coverage such as liability, uninsured motorist, no
fault or personal injury protection, as well as collision and
comprehensive.
Homeowners and Other
Coverages. Homeowners insurance policies
provide protection for homeowners, renters, condominium owners
and residential landlords against losses arising out of damage
to dwellings and contents from a wide variety of perils, as well
as coverage for liability arising from ownership or occupancy.
Other insurance includes personal excess liability (protection
against losses in excess of amounts covered by other liability
insurance policies), and coverage for recreational vehicles and
boat owners. Most of Auto & Homes
homeowners policies are traditional insurance policies for
dwellings, providing protection for loss on a replacement
cost basis. These policies also provide additional
coverage for reasonable, normal living expenses incurred by
policyholders that have been displaced from their homes.
Sales
Distribution
U.S. Business markets our products and services through
various distribution groups. Our life insurance and retirement
products targeted to individuals are sold via sales forces,
comprised of MetLife employees, in addition to third-party
organizations. Our group life, non-medical health and corporate
benefit funding products are sold via sales forces primarily
comprised of MetLife employees. Personal lines property and
casualty insurance products are directly marketed to employees
at their employers worksite. Auto & Home
products are also marketed and sold to individuals by
independent agents and property and casualty specialists through
a direct response channel and the individual distribution sales
group. MetLife sales employees work with all distribution groups
to better reach and service customers, brokers, consultants and
other intermediaries.
Individual
Distribution
Our individual distribution sales group targets the large
middle-income market, as well as affluent individuals, owners of
small businesses and executives of small- to medium-sized
companies. We have also been successful in selling our products
in various multi-cultural markets.
Insurance Products are sold through our individual distribution
sales group and also through various third-party organizations
utilizing two models. In the coverage model, wholesalers sell to
high net worth individuals and small- to medium-sized businesses
through independent general agencies, financial advisors,
consultants, brokerage general agencies and other independent
marketing organizations under contractual arrangements. In the
point of sale model, wholesalers sell through financial
intermediaries, including regional broker-dealers, brokerage
firms, financial planners and banks.
8
Retirement Products are sold through our individual distribution
sales group and also through various third-party organizations
such as regional broker-dealers, New York Stock Exchange
(NYSE) brokerage firms, financial planners and banks.
The individual distribution sales group is comprised of three
channels: the MetLife distribution channel, a career agency
system, the New England financial distribution channel, a
general agency system, and MetLife Resources, a career agency
system.
The MetLife distribution channel had 5,053 MetLife agents under
contract in 54 agencies at December 31, 2010. The career
agency sales force focuses on the large middle-income and
affluent markets, including multi-cultural markets. We support
our efforts in multi-cultural markets through targeted
advertising, specially trained agents and sales literature
written in various languages.
The New England financial distribution channel included 33
general agencies providing support to 2,102 general agents and a
network of independent brokers throughout the U.S. at
December 31, 2010. The New England financial distribution
channel targets high net worth individuals, owners of small
businesses and executives of small- to medium-sized companies.
MetLife Resources, a focused distribution channel of MetLife,
markets retirement, annuity and other financial products on a
national basis through 547 MetLife agents and independent
brokers at December 31, 2010. MetLife Resources targets the
nonprofit, educational and healthcare markets.
We market and sell Auto & Home products through
independent agents, property and casualty specialists, a direct
response channel and the direct distribution group. In recent
years, we have increased the number of independent agents
appointed to sell these products.
In 2010, Auto & Homes business was concentrated
in the following states, as measured by amount and percentage of
total direct earned premiums:
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2010
|
|
|
(In millions)
|
|
Percent
|
|
New York
|
|
$
|
391
|
|
|
|
13
|
%
|
Massachusetts
|
|
$
|
258
|
|
|
|
9
|
%
|
Illinois
|
|
$
|
203
|
|
|
|
7
|
%
|
Florida
|
|
$
|
164
|
|
|
|
5
|
%
|
Connecticut
|
|
$
|
153
|
|
|
|
5
|
%
|
Texas
|
|
$
|
142
|
|
|
|
5
|
%
|
Group
Distribution
Insurance Products distributes its group life and non-medical
health products and services through a sales force that is
segmented by the size of the target customer. Marketing
representatives sell either directly to corporate and other
group customers or through an intermediary, such as a broker or
consultant. Voluntary products are sold through the same sales
channels, as well as by specialists for these products.
Employers have been emphasizing such voluntary products and, as
a result, we have increased our focus on communicating and
marketing to such employees in order to further foster sales of
those products. At December 31, 2010, the group life and
non-medical health sales channels had 356 marketing
representatives.
Retirement Products markets its retirement, savings, investment
and payout annuity products and services to sponsors and
advisors of benefit plans of all sizes. These products and
services are offered to private and public pension plans,
collective bargaining units, nonprofit organizations, recipients
of structured settlements and the current and retired members of
these and other institutions.
Corporate Benefit Funding products and services are distributed
through dedicated sales teams and relationship managers located
in 12 offices around the country. In addition, the
retirement & benefits funding organization works with
individual distribution and group life and non-medical health
distribution areas to better reach and service customers,
brokers, consultants and other intermediaries.
9
Auto & Home is a leading provider of personal lines
property and casualty insurance products offered to employees at
their employers worksite. At December 31, 2010, 2,215
employers offered MetLife Auto & Home products to
their employees.
Group marketing representatives market personal lines property
and casualty insurance products to employers through a variety
of means, including broker referrals and cross-selling to group
customers. Once permitted by the employer, MetLife commences
marketing efforts to employees. Employees who are interested in
the auto and homeowners products can call a toll-free number to
request a quote to purchase coverage and to request payroll
deduction over the telephone. Auto & Home has also
developed a proprietary software that permits an employee in
most states to obtain a quote for auto insurance through
Auto & Homes internet website.
We have entered into several joint ventures and other
arrangements with third parties to expand the marketing and
distribution opportunities of group products and services. We
also seek to sell our group products and services through
sponsoring organizations and affinity groups. In addition, we
also provide life and dental coverage to federal employees.
International
Overview
International provides life insurance, accident and health
insurance, credit insurance, annuities, endowment and
retirement & savings products to both individuals and
groups. We focus on markets primarily within Japan, Latin
America, Asia Pacific, Europe and the Middle East. We operate in
international markets through subsidiaries and affiliates. See
Risk Factors Fluctuations in Foreign Currency
Exchange Rates Could Negatively Affect Our Profitability,
and Risk Factors Our International Operations
Face Political, Legal, Operational and Other Risks, Including
Exposure to Local and Regional Economic Conditions, That Could
Negatively Affect Those Operations or Our Profitability,
and Quantitative and Qualitative Disclosures About Market
Risk.
Japan
Our Japan operation (excluding our Japan joint venture, as
described below under Asia Pacific) is
comprised of the business acquired in the Acquisition. Our Japan
operation is among the largest foreign life insurers in Japan
and ranks 6th in the Japanese life insurance industry
measured by total premiums according to the Statistics of Life
Insurance in Japan 2009. It provides life insurance, accident
and health insurance, annuities and endowment products to both
individuals and groups. Its products are distributed through a
multi-distribution platform consisting of captive agents,
independent agents, brokers, bancassurance, and direct
marketing (DM).
Latin
America
We operate in 20 countries in Latin America, with the largest
operations in Mexico, Chile and Argentina. The Mexican operation
is the largest life insurance company in both the individual and
group businesses in Mexico according to Asociación Mexicana
de Instituciones de Seguro, a Mexican industry trade group which
provides rankings for insurance companies. Our Chilean operation
is the largest annuity company in Chile, based on market share
according to Superintendencia Valores y Seguros, the Chilean
insurance regulator. The Chilean operation also offers
individual life insurance and group insurance products. We also
actively market individual life insurance, group insurance
products and credit life coverage in Argentina, but the
nationalization of the pension system substantially reduced our
presence in Argentina. The business environment in Argentina has
been, and may continue to be, affected by governmental and legal
actions which impact our results of operations.
Asia
Pacific
We operate in 5 countries in Asia Pacific with the largest
operations in South Korea, Hong Kong and Australia. Our South
Korean operation has significant sales of variable universal
life and annuity products. Our Hong Kong operation has
significant sales of variable universal life and endowment
products. Our Australia operation has significant sales of
credit insurance and group life products. We also operate
through joint ventures in Japan and China, the results of which
are reflected in net investment income and are not consolidated
in the financial results.
10
We have a quota share reinsurance agreement with the joint
venture in Japan, whereby we assume 100% of the living and death
guarantee benefits associated with the variable annuity business
written after April 2005 by the joint venture. As discussed in
Note 2 of the Notes to the Consolidated Financial
Statements, the Company reached an agreement to sell its 50%
interest in the joint venture in Japan.
Europe
and the Middle East
We operate in 39 countries in Europe and the Middle East with
our largest operations in Poland, the U.K., France, and the
United Arab Emirates, as well as through a consolidated joint
venture in India. Our Poland operation is a leading provider of
life insurance, accident and health insurance, and credit
insurance. It is consistently ranked as a top 3 company in
net profits according to Rzeczpospolita financial
daily. Our U.K. operation provides life insurance, accident and
health insurance and variable annuities in its home market and
throughout Europe. Our operation in France provides life
insurance, accident and health insurance and credit insurance.
In the Middle East, we provide life insurance, accident and
health insurance, credit insurance, annuities, endowment and
retirement & savings products.
Sales
Distribution
International markets its products and services through a
multi-distribution strategy which varies by geographic region.
The various distribution channels include: agency,
bancassurance, DM, brokerage and
e-commerce.
In developing countries, agency covers the needs of the emerging
middle class with primarily traditional products (e.g.,
endowment and accident and health). In more developed and mature
markets, agents, while continuing to serve their existing
customers to keep pace with their developing financial needs,
also target upper middle class and high net worth customer bases
with a more sophisticated product set including more
investment-sensitive products, such as universal life, mutual
fund and single premium deposits.
In the bancassurance channel, International leverages
partnerships that span all regions. In addition, DM has
extensive and far reaching capabilities in all regions. The DM
operations deploy both broadcast marketing approaches (e.g.
direct response TV, web-based lead generation) and traditional
DM techniques such as telemarketing. Japan represents the
largest DM market.
Japan
Japans multi-channel distribution strategy consists of
captive agents, independent agents, bancassurance and DM. While
face-to-face
channels continue to be core to Japans business, other
channels, including bancassurance and DM, have become a critical
part of Japans distribution strategy. Our Japan operation
has maintained its position in bancassurance due to its strong
distribution relationship with Japans mega banks, trust
banks and various regional banks, as well as with the Japan
Post. The DM channel is supported by an industry-leading
marketing platform,
state-of-the-art
call center infrastructure and its own campaign management
system.
Japan has 5,397 captive agents, 10,642 independent agents, 96
bancassurance relationships, including Japan Post, and 195
DM sponsors.
Latin
America
Latin Americas key distribution channels include captive
agents, large multinational brokers and small-and medium-sized
brokers, direct and group sales forces (mostly for group
policies without broker intermediation), DM, bancassurance and
worksite marketing. The region has an exclusive and captive
agency distribution network with more than 3,000 agents also
selling a variety of individual life, accident and health, and
pension products (AFORE), as well as small- and
medium-sized group life and medical solutions products. We
currently work with over 3,300 active brokers with registered
sales of group and individual life, accident and health, group
medical, dental and pension products. Worksite marketing has
over 2,300 agents.
11
Asia
Pacific
In Asia Pacific, distribution strategies differ by country but
generally utilize a combination of captive agents, bancassurance
relationships and DM. Agency sales are achieved through a force
of approximately 7,500 agents and a growing force of independent
general agents. Bancassurance sales are currently reliant upon a
significant regional strategic partnership along with a number
of smaller partnerships in each market. Throughout the region,
our Asia Pacific operation leverages its expertise in DM
operations management to conduct its own campaigns and provide
those DM capabilities to third-party sponsors.
While not a significant part of the regions overall
business, sales of group life and pension business are primarily
achieved through independent brokers and an employee sales force.
Europe
and the Middle East
Our operation in Central and Eastern Europe (CEE)
has a multi-channel distribution strategy, which includes
significant face to face channels, built on a strong captive
agency force of more than 3,450 agents, and relationships with
more than 150 independent brokers and third-party multi-level
agency networks. Our CEE operation also has a group/corporate
business direct sales force of more than 70 and distribution
relationships with more than 90 banks, other financial and non
financial institutions, as well as a fast growing DM channel.
The primary method of distribution is captive and third party
agency and captive direct sales forces, with a growing presence
in bank, other financial and non financial institutions,
and DM.
Our operation in Continental Western Europe (CWE)
also has a multi-channel distribution strategy, including DM,
brokerage, banks and financial institutions. Our U.K. operation
has built a strong position in the U.K. independent financial
advisor sector through its strong distribution relationships
with Britains leading advisory networks, serving the
mainstream markets specializing particularly in guaranteed
products. Recent arrangements with two U.K. banks should enhance
our distribution capability going forward. Our U.K. operation
also has an agency force which focuses on the protection market.
In the Middle East, our products are distributed via a variety
of channels including approximately 16,400 agents,
bancassurance, brokers and DM. Agency distribution is the
primary channel, with MetLife having the largest captive network
in the Middle East. Bancassurance is a growing channel with
approximately 100 relationships, and approximately 250
programs providing access to millions of bank customers.
Banking,
Corporate & Other
Banking, Corporate & Other contains the excess capital
not allocated to the segments, which is invested to optimize
investment spread and to fund company initiatives and various
start-up and
run-off entities. Banking, Corporate & Other also
includes interest expense related to the majority of our
outstanding debt and expenses associated with certain legal
proceedings, as well as the financial results of MetLife Bank,
which offers a variety of mortgage and deposit products. The
elimination of transactions from activity between
U.S. Business, International, and Banking,
Corporate & Other occurs within Banking,
Corporate & Other.
Mortgage products offered by MetLife Bank include forward and
reverse residential mortgage loans. Residential mortgage loans
are originated through MetLife Banks national sales force,
mortgage brokers and mortgage correspondents.
The residential mortgage banking activities include the
origination and servicing of mortgage loans. Mortgage loans are
held-for-investment
or sold primarily into Federal National Mortgage Association
(FNMA), Federal Home Loan Mortgage Corporation
(FHLMC) or Government National Mortgage Association
(GNMA) securities. MetLife Bank also leverages
MetLifes investment platform to source commercial and
agriculture loans as investments on its balance sheet. MetLife
Bank is a member of the Federal Reserve System and the Federal
Home Loan Bank of New York (FHLB of NY) and is
subject to regulation, examination and supervision by the Office
of the Comptroller of the Currency (OCC) and
secondarily by the Federal Deposit Insurance Corporation
(FDIC) and the Federal Reserve.
12
The origination of forward and reverse mortgage single family
loans include both variable and fixed rate products. MetLife
Bank does not originate
sub-prime or
alternative residential mortgage loans (Alt-A) and
the funding for the mortgage banking activities is provided by
deposits and borrowings.
Deposit products include traditional savings accounts, money
market savings accounts, certificates of deposit
(CDs) and individual retirement accounts. MetLife
Bank participates in the Certificate of Deposit Account Registry
Service program through which certain customer CDs are exchanged
for CDs of similar amounts from participating banks. The deposit
products provide a relatively stable source of funding and
liquidity and are used to fund securities and loans. In
addition, MetLife Bank principally seeks deposits from direct
customers via the Internet and postal mail, and takes advantage
of cross-marketing opportunities, including through voluntary
benefits platforms of its affiliates customers.
Policyholder
Liabilities
We establish, and carry as liabilities, actuarially determined
amounts that are calculated to meet our policy obligations when
a policy matures or is surrendered, an insured dies or becomes
disabled or upon the occurrence of other covered events, or to
provide for future annuity payments. We compute the amounts for
actuarial liabilities reported in our consolidated financial
statements in conformity with GAAP. For more details on
Policyholder Liabilities see Managements Discussion
and Analysis of Financial Condition and Results of
Operations Summary of Critical Accounting
Estimates Liability for Future Policy Benefits
and Managements Discussion and Analysis of Financial
Condition and Results of Operations Policyholder
Liabilities.
Pursuant to state insurance laws and country regulators, the
Holding Companys insurance subsidiaries establish
statutory reserves, reported as liabilities, to meet their
obligations on their respective policies. These statutory
reserves are established in amounts sufficient to meet policy
and contract obligations, when taken together with expected
future premiums and interest at assumed rates. Statutory
reserves generally differ from actuarial liabilities for future
policy benefits determined using GAAP.
The New York Insurance Law and regulations require certain
MetLife entities to submit to the New York Superintendent of
Insurance or other state insurance departments, with each annual
report, an opinion and memorandum of a qualified
actuary that the statutory reserves and related actuarial
amounts recorded in support of specified policies and contracts,
and the assets supporting such statutory reserves and related
actuarial amounts, make adequate provision for their statutory
liabilities with respect to these obligations. See
U.S. Regulation Insurance
Regulation Policy and Contract Reserve Sufficiency
Analysis.
Underwriting
and Pricing
Underwriting
Underwriting generally involves an evaluation of applications
for Insurance Products, Retirement Products, Corporate Benefit
Funding, and Auto & Home by a professional staff of
underwriters and actuaries, who determine the type and the
amount of risk that we are willing to accept. In addition to the
products described above, with the exception of Auto &
Home, International also offers credit insurance, accident and
health, and medical products. We employ detailed underwriting
policies, guidelines and procedures designed to assist the
underwriter to properly assess and quantify risks before issuing
policies to qualified applicants or groups.
Insurance underwriting considers not only an applicants
medical history, but also other factors such as financial
profile, foreign travel, vocations and alcohol, drug and tobacco
use. Group underwriting generally evaluates the risk
characteristics of each prospective insured group, although with
certain voluntary products and for certain coverages, members of
a group may be underwritten on an individual basis. We generally
perform our own underwriting; however, certain policies are
reviewed by intermediaries under guidelines established by us.
Generally, we are not obligated to accept any risk or group of
risks from, or to issue a policy or group of policies to, any
employer or intermediary. Requests for coverage are reviewed on
their merits and generally a policy is not issued unless the
particular risk or group has been examined and approved by our
underwriters.
13
Our remote underwriting offices, intermediaries, as well as our
corporate underwriting office, are periodically reviewed via
continuous on-going internal underwriting audits to maintain
high-standards of underwriting and consistency. Such offices are
also subject to periodic external audits by reinsurers with whom
we do business.
We have established senior level oversight of the underwriting
process that facilitates quality sales and serves the needs of
our customers, while supporting our financial strength and
business objectives. Our goal is to achieve the underwriting,
mortality and morbidity levels reflected in the assumptions in
our product pricing. This is accomplished by determining and
establishing underwriting policies, guidelines, philosophies and
strategies that are competitive and suitable for the customer,
the agent and us.
Auto & Homes underwriting function has six
principal aspects: evaluating potential worksite marketing
employer accounts and independent agencies; establishing
guidelines for the binding of risks; reviewing coverage bound by
agents; underwriting potential insureds, on a case by case
basis, presented by agents outside the scope of their binding
authority; pursuing information necessary in certain cases to
enable Auto & Home to issue a policy within our
guidelines; and ensuring that renewal policies continue to be
written at rates commensurate with risk.
Subject to very few exceptions, agents in each of the
U.S. Business distribution channels have binding authority
for risks which fall within its published underwriting
guidelines. Risks falling outside the underwriting guidelines
may be submitted for approval to the underwriting department;
alternatively, agents in such a situation may call the
underwriting department to obtain authorization to bind the risk
themselves. In most states, we generally have the right within a
specified period (usually the first 60 days) to cancel any
policy.
Pricing
Pricing has traditionally reflected our corporate underwriting
standards. Product pricing is based on the expected payout of
benefits calculated through the use of assumptions for
mortality, morbidity, expenses, persistency and investment
returns, as well as certain macroeconomic factors, such as
inflation. Investment-oriented products are priced based on
various factors, which may include investment return, expenses,
persistency and optionality. For certain investment oriented
products in the U.S. and certain business sold
internationally, pricing may include prospective and
retrospective experience rating features. Prospective experience
rating involves the evaluation of past experience for the
purpose of determining future premium rates and all prior year
gains and losses are borne by us. Retrospective experience
rating also involves the evaluation of past experience for the
purpose of determining the actual cost of providing insurance
for the customer, however, the contract includes certain
features that allow us to recoup certain losses or distribute
certain gains back to the policyholder based on actual prior
years experience.
Rates for group life, non-medical health, and medical health
products are based on anticipated results for the book of
business being underwritten. Renewals are generally reevaluated
annually or biannually and are repriced to reflect actual
experience on such products. Products offered by Corporate
Benefit Funding are priced frequently and are very responsive to
bond yields, and such prices include additional margin in
periods of market uncertainty. This business is predominantly
illiquid, because a majority of the policyholders have no
contractual rights to cash values and no options to change the
form of the products benefits.
Rates for individual life insurance products are highly
regulated and must be approved by the regulators of the
jurisdictions in which the product is sold. Generally such
products are renewed annually and may include pricing terms that
are guaranteed for a certain period of time. Fixed and variable
annuity products are also highly regulated and approved by the
respective regulators. Such products generally include penalties
for early withdrawals and policyholder benefit elections to
tailor the form of the products benefits to the needs of
the opting policyholder. We periodically reevaluate the costs
associated with such options and will periodically adjust
pricing levels on our guarantees. Further, from time to time, we
may also reevaluate the type and level of guarantee features
currently being offered.
Rates for Auto & Homes major lines of insurance
are based on its proprietary database, rather than relying on
rating bureaus. Auto & Home determines prices in part
from a number of variables specific to each risk. The pricing of
personal lines insurance products takes into account, among
other things, the expected frequency and severity of losses, the
costs of providing coverage (including the costs of acquiring
policyholders and administering policy
14
benefits and other administrative and overhead costs),
competitive factors and profit considerations. The major pricing
variables for personal lines insurance include characteristics
of the insured property, such as age, make and model or
construction type, as well as characteristics of the insureds,
such as driving record and loss experience, and the
insureds personal financial management. Auto &
Homes ability to set and change rates is subject to
regulatory oversight.
As a condition of our license to do business in each state,
Auto & Home, like all other automobile insurers, is
required to write or share the cost of private passenger
automobile insurance for higher risk individuals who would
otherwise be unable to obtain such insurance. This
involuntary market, also called the shared
market, is governed by the applicable laws and regulations
of each state, and policies written in this market are generally
written at rates higher than standard rates.
We continually review our underwriting and pricing guidelines so
that our policies remain competitive and supportive of our
marketing strategies and profitability goals. The current
economic environment, with its volatility and uncertainty is not
expected to materially impact the pricing of our products.
Reinsurance
Activity
We participate in reinsurance activities in order to limit
losses, minimize exposure to significant risks, and provide
additional capacity for future growth. We enter into various
agreements with reinsurers that cover individual risks, group
risks or defined blocks of business, primarily on a coinsurance,
yearly renewable term, excess or catastrophe excess basis. These
reinsurance agreements spread risk and minimize the effect of
losses. The extent of each risk retained by us depends on our
evaluation of the specific risk, subject, in certain
circumstances, to maximum retention limits based on the
characteristics of coverages. We also cede first dollar
mortality risk under certain contracts. In addition to
reinsuring mortality risk, we reinsure other risks, as well as
specific coverages. We obtain reinsurance for capital
requirement purposes and also when the economic impact of the
reinsurance agreement makes it appropriate to do so.
Under the terms of the reinsurance agreements, the reinsurer
agrees to reimburse us for the ceded amount in the event a claim
is paid. Cessions under reinsurance arrangements do not
discharge our obligations as the primary insurer. In the event
that reinsurers do not meet their obligations under the terms of
the reinsurance agreements, reinsurance balances recoverable
could become uncollectible.
We reinsure our business through a diversified group of
well-capitalized, highly rated reinsurers. We analyze recent
trends in arbitration and litigation outcomes in disputes, if
any, with our reinsurers. We monitor ratings and evaluate the
financial strength of our reinsurers by analyzing their
financial statements. In addition, the reinsurance recoverable
balance due from each reinsurer is evaluated as part of the
overall monitoring process. Recoverability of reinsurance
recoverable balances is evaluated based on these analyses. We
generally secure large reinsurance recoverable balances with
various forms of collateral, including secured trusts, funds
withheld accounts and irrevocable letters of credit.
U.S.
Business
For our individual life insurance products, we have historically
reinsured the mortality risk primarily on an excess of retention
basis or a quota share basis. We currently reinsure 90% of the
mortality risk in excess of $1 million for most products
and reinsure up to 90% of the mortality risk for certain other
products. In addition to reinsuring mortality risk as described
above, we reinsure other risks, as well as specific coverages.
Placement of reinsurance is done primarily on an automatic basis
and also on a facultative basis for risks with specified
characteristics. On a case by case basis, we may retain up to
$20 million per life and reinsure 100% of amounts in excess
of the amount we retain. We evaluate our reinsurance programs
routinely and may increase or decrease our retention at any time.
For other policies within the Insurance Products segment, we
generally retain most of the risk and only cede particular risks
on certain client arrangements.
Our Retirement Products segment reinsures a portion of the
living and death benefit guarantees issued in connection with
our variable annuities. Under these reinsurance agreements, we
pay a reinsurance premium
15
generally based on fees associated with the guarantees collected
from policyholders, and receive reimbursement for benefits paid
or accrued in excess of account values, subject to certain
limitations.
Our Corporate Benefit Funding segment has periodically engaged
in reinsurance activities, as considered appropriate.
Our Auto & Home segment purchases reinsurance to
manage its exposure to large losses (primarily catastrophe
losses) and to protect statutory surplus. We cede to reinsurers
a portion of losses and premiums based upon the exposure of the
policies subject to reinsurance. To manage exposure to large
property and casualty losses, we utilize property catastrophe,
casualty and property per risk excess of loss agreements.
International
For certain of our life insurance products, we reinsure risks
above the corporate retention limit of up to $5 million to
external reinsurers on a yearly renewable term basis. We may
also reinsure certain risks with external reinsurers depending
upon the nature of the risk and local regulatory requirements.
For selected large corporate clients, our International segment
reinsures group employee benefits or credit insurance business
with various client-affiliated reinsurance companies, covering
policies issued to the employees or customers of the clients.
Additionally, we cede and assume risk with other insurance
companies when either company requires a business partner with
the appropriate local licensing to issue certain types of
policies in certain countries. In these cases, the assuming
company typically underwrites the risks, develops the products
and assumes most or all of the risk.
Our International segment also has reinsurance agreements in
force that reinsure a portion of the living and death benefit
guarantees issued in connection with our variable annuities.
Under these agreements, we pay reinsurance fees associated with
the guarantees collected from policyholders, and receive
reimbursement for benefits paid or accrued in excess of account
values, subject to certain limitations.
Banking,
Corporate & Other
We also reinsure through 100% quota share reinsurance agreements
certain run-off LTC and workers compensation business
written by MetLife Insurance Company of Connecticut
(MICC), a subsidiary of the Company.
Catastrophe
Coverage
We have exposure to catastrophes, which could contribute to
significant fluctuations in our results of operations. We also
use excess of retention and quota share reinsurance arrangements
to provide greater diversification of risk and minimize exposure
to larger risks. For our International segment, we currently
purchase catastrophe coverage to insure risks within certain
countries deemed by management to be exposed to the greatest
catastrophic risks.
Reinsurance
Recoverables
For information regarding ceded reinsurance recoverable
balances, included in premiums, reinsurance and other
receivables in the consolidated balance sheets, see Note 9
of the Notes to the Consolidated Financial Statements.
U.S.
Regulation
Insurance
Regulation
Metropolitan Life Insurance Company (MLIC) is
licensed to transact insurance business in, and is subject to
regulation and supervision by, all 50 states, the District
of Columbia, Guam, Puerto Rico, Canada, the U.S. Virgin
Islands and Northern Mariana Islands. Each of MetLifes
insurance subsidiaries is licensed and regulated in each
U.S. and international jurisdiction where it conducts
insurance business. The extent of such regulation varies, but
most jurisdictions have laws and regulations governing the
financial aspects of insurers, including standards of
16
solvency, statutory reserves, reinsurance and capital adequacy,
and the business conduct of insurers. In addition, statutes and
regulations usually require the licensing of insurers and their
agents, the approval of policy forms and certain other related
materials and, for certain lines of insurance, the approval of
rates. Such statutes and regulations also prescribe the
permitted types and concentration of investments. New York
Insurance Law limits the amount of compensation that insurers
doing business in New York may pay to their agents, as well as
the amount of total expenses, including sales commissions and
marketing expenses, that such insurers may incur in connection
with the sale of life insurance policies and annuity contracts
throughout the U.S.
Each insurance subsidiary is required to file reports, generally
including detailed annual financial statements, with insurance
regulatory authorities in each of the jurisdictions in which it
does business, and its operations and accounts are subject to
periodic examination by such authorities. These subsidiaries
must also file, and in many jurisdictions and in some lines of
insurance obtain regulatory approval for, rules, rates and forms
relating to the insurance written in the jurisdictions in which
they operate.
The National Association of Insurance Commissioners
(NAIC) has established a program of accrediting
state insurance departments. NAIC accreditation contemplates
that accredited states will conduct periodic examinations of
insurers domiciled in such states. NAIC-accredited states will
not accept reports of examination of insurers from unaccredited
states, except under limited circumstances. As a direct result,
insurers domiciled in unaccredited states may be subject to
financial examination by accredited states in which they are
licensed, in addition to any examinations conducted by their
domiciliary states. In 2009, the New York State Department of
Insurance (the Department), MLICs principal
insurance regulator, received accreditation from the NAIC.
Previously, the Department was not accredited by the NAIC, but
the absence of this accreditation did not have a significant
impact upon our ability to conduct our insurance businesses.
State and federal insurance and securities regulatory
authorities and other state law enforcement agencies and
attorneys general from time to time make inquiries regarding
compliance by the Holding Company and its insurance subsidiaries
with insurance, securities and other laws and regulations
regarding the conduct of our insurance and securities
businesses. We cooperate with such inquiries and take corrective
action when warranted. See Note 16 of the Notes to the
Consolidated Financial Statements.
Holding Company Regulation. The Holding
Company and its U.S. insurance subsidiaries are subject to
regulation under the insurance holding company laws of various
jurisdictions. The insurance holding company laws and
regulations vary from jurisdiction to jurisdiction, but
generally require a controlled insurance company (insurers that
are subsidiaries of insurance holding companies) to register
with state regulatory authorities and to file with those
authorities certain reports, including information concerning
its capital structure, ownership, financial condition, certain
intercompany transactions and general business operations.
State insurance statutes also typically place restrictions and
limitations on the amount of dividends or other distributions
payable by insurance company subsidiaries to their parent
companies, as well as on transactions between an insurer and its
affiliates. See Managements Discussion and Analysis
of Financial Condition and Results of Operations
Liquidity and Capital Resources The Holding
Company Liquidity and Capital Sources
Dividends from Subsidiaries.
Guaranty Associations and Similar
Arrangements. Most of the jurisdictions in which
our U.S. insurance subsidiaries are admitted to transact
business require life and property and casualty insurers doing
business within the jurisdiction to participate in guaranty
associations, which are organized to pay certain contractual
insurance benefits owed pursuant to insurance policies issued by
impaired, insolvent or failed insurers. These associations levy
assessments, up to prescribed limits, on all member insurers in
a particular state on the basis of the proportionate share of
the premiums written by member insurers in the lines of business
in which the impaired, insolvent or failed insurer is engaged.
Some states permit member insurers to recover assessments paid
through full or partial premium tax offsets.
In the past five years, the aggregate assessments levied against
MetLife have not been material. We have established liabilities
for guaranty fund assessments that we consider adequate for
assessments with respect to insurers that are currently subject
to insolvency proceedings. See Note 16 of the Notes to the
Consolidated Financial Statements for additional information on
the insolvency assessments.
17
Statutory Insurance Examination. As part of
their regulatory oversight process, state insurance departments
conduct periodic detailed examinations of the books, records,
accounts, and business practices of insurers domiciled in their
states. State insurance departments also have the authority to
conduct examinations of non-domiciliary insurers that are
licensed in their states. During the three-year period ended
December 31, 2010, MetLife has not received any material
adverse findings resulting from state insurance department
examinations of its insurance subsidiaries conducted during this
three-year period.
Regulatory authorities in a small number of states, Financial
Industry Regulatory Authority (FINRA) and,
occasionally, the SEC, have had investigations or inquiries
relating to sales of individual life insurance policies or
annuities or other products by MLIC, MetLife Securities, Inc.,
New England Life Insurance Company, New England Securities
Corporation, General American Life Insurance Company, Walnut
Street Securities, Inc., MICC and Tower Square Securities, Inc.
These investigations often focus on the conduct of particular
financial services representatives and the sale of unregistered
or unsuitable products or the misuse of client assets. Over the
past several years, these and a number of investigations by
other regulatory authorities were resolved for monetary payments
and certain other relief, including restitution payments. We may
continue to resolve investigations in a similar manner.
Policy and Contract Reserve Sufficiency
Analysis. Annually, our U.S. insurance
subsidiaries are required to conduct an analysis of the
sufficiency of all statutory reserves. In each case, a qualified
actuary must submit an opinion which states that the statutory
reserves, when considered in light of the assets held with
respect to such reserves, make good and sufficient provision for
the associated contractual obligations and related expenses of
the insurer. If such an opinion cannot be provided, the insurer
must set up additional reserves by moving funds from surplus.
Since inception of this requirement, our U.S. insurance
subsidiaries which are required by their states of domicile to
provide these opinions have provided such opinions without
qualifications.
Surplus and Capital. Our U.S. insurance
subsidiaries are subject to the supervision of the regulators in
each jurisdiction in which they are licensed to transact
business. Regulators have discretionary authority, in connection
with the continued licensing of these insurance subsidiaries, to
limit or prohibit sales to policyholders if, in their judgment,
the regulators determine that such insurer has not maintained
the minimum surplus or capital or that the further transaction
of business will be hazardous to policyholders. See
Risk-Based Capital.
Risk-Based Capital
(RBC). Each of our
U.S. insurance subsidiaries that is subject to RBC
requirements reports its RBC based on a formula calculated by
applying factors to various asset, premium and statutory reserve
items, as well as taking into account the risk characteristics
of the insurer. The major categories of risk involved are asset
risk, insurance risk, interest rate risk, market risk and
business risk. The formula is used as an early warning
regulatory tool to identify possible inadequately capitalized
insurers for purposes of initiating regulatory action, and not
as a means to rank insurers generally. State insurance laws
provide insurance regulators the authority to require various
actions by, or take various actions against, insurers whose RBC
ratio does not meet or exceed certain RBC levels. As of the date
of the most recent annual statutory financial statements filed
with insurance regulators, the RBC of each of these subsidiaries
was in excess of each of those RBC levels. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations Liquidity and
Capital Resources The Company
Capital.
Statutory Accounting Principles. The NAIC
provides standardized insurance industry accounting and
reporting guidance through its Accounting Practices and
Procedures Manual (the Manual). However, statutory
accounting principles continue to be established by individual
state laws, regulations and permitted practices. The Department
has adopted the Manual with certain modifications for the
preparation of statutory financial statements of insurance
companies domiciled in New York. Changes to the Manual or
modifications by the various state insurance departments may
impact the statutory capital and surplus of the Companys
U.S. insurance subsidiaries.
Regulation of Investments. Each of our
U.S. insurance subsidiaries are subject to state laws and
regulations that require diversification of our investment
portfolios and limit the amount of investments in certain asset
categories, such as below investment grade fixed income
securities, equity real estate, other equity investments, and
derivatives. Failure to comply with these laws and regulations
would cause investments exceeding regulatory limitations to be
treated as non-admitted assets for purposes of measuring surplus
and, in some instances, would
18
require divestiture of such non-qualifying investments. We
believe that the investments made by each of the Companys
insurance subsidiaries complied, in all material respects, with
such regulations at December 31, 2010.
Until various studies are completed and final regulations are
promulgated pursuant to the Dodd-Frank Wall Street Reform and
Consumer Protection Act (Dodd-Frank), the full
impact of Dodd-Frank on the investments, investment activities
and insurance and annuity products of the Company remain
unclear. See Risk Factors Various Aspects of
Dodd-Frank Could Impact Our Business Operations, Capital
Requirements and Profitability and Limit Our Growth.
Federal Initiatives. Although the federal
government generally does not directly regulate the insurance
business, federal initiatives often have an impact on our
business in a variety of ways. See Risk
Factors Various Aspects of Dodd-Frank Could Impact
Our Business Operations, Capital Requirements and Profitability
and Limit Our Growth. From time to time, federal measures
are proposed which may significantly affect the insurance
business. These areas include financial services regulation,
securities regulation, pension regulation, health care
regulation, privacy, tort reform legislation and taxation. In
addition, various forms of direct and indirect federal
regulation of insurance have been proposed from time to time,
including proposals for the establishment of an optional federal
charter for insurance companies. Dodd-Frank established the
Federal Insurance Office within the Department of Treasury to
collect information about the insurance industry, recommend
prudential standards, and represent the U.S. in dealings
with foreign insurance regulators. See Risk
Factors Our Insurance, Brokerage and Banking
Businesses Are Heavily Regulated, and Changes in
Regulation May Reduce Our Profitability and Limit Our
Growth.
Financial
Holding Company Regulation
Regulatory Agencies. As the owner of a
federally-chartered bank, MetLife, Inc. is a bank holding
company and financial holding company. As such, the Holding
Company is subject to regulation under the Bank Holding Company
Act of 1956, as amended (the BHC Act), and to
inspection, examination, and supervision by the Board of
Governors of the Federal Reserve Bank of New York. In addition,
MetLife Bank is subject to regulation and examination primarily
by the OCC and secondarily by the Federal Reserve Bank of New
York and the FDIC, as described below under Banking
Regulation.
Financial Holding Company Activities. As a
financial holding company, MetLife, Inc.s activities and
investments are restricted by the BHC Act, as amended by the
Gramm-Leach-Bliley Act of 1999 (the GLB Act), to
those that are financial in nature or
incidental or complementary to such
financial activities. Activities that are financial in nature
include securities underwriting, dealing and market making,
sponsoring mutual funds and investment companies, insurance
underwriting and agency, merchant banking and activities that
the Federal Reserve Board has determined to be closely related
to banking. In addition, under the insurance company investment
portfolio provision of the GLB Act, financial holding companies
are authorized to make investments in other financial and
non-financial companies, through their insurance subsidiaries,
that are in the ordinary course of business and in accordance
with state insurance law, provided the financial holding company
does not routinely manage or operate such companies except as
may be necessary to obtain a reasonable return on investment.
Under Dodd-Frank, as a large, interconnected bank holding
company with assets of $50 billion or more, or possibly as
an otherwise systemically important financial company, MetLife,
Inc. will be subject to enhanced prudential standards imposed on
systemically significant financial companies. Enhanced standards
will be applied to RBC, liquidity, leverage (unless another,
similar standard is appropriate for the Company), resolution
plan and credit exposure reporting, concentration limits, and
risk management. The so-called Volcker Rule
provisions of Dodd-Frank restrict the ability of affiliates of
insured depository institutions (such as MetLife Bank) to engage
in proprietary trading or sponsor or invest in hedge funds or
private equity funds. See Risk Factors Various
Aspects of Dodd-Frank Could Impact Our Business Operations,
Capital Requirements and Profitability and Limit Our
Growth.
Capital. MetLife, Inc. and MetLife Bank are
subject to risk-based and leverage capital guidelines issued by
the federal banking regulatory agencies for banks and financial
holding companies. The federal banking regulatory agencies are
required by law to take specific prompt corrective actions with
respect to institutions that do not meet minimum capital
standards. MetLife, Inc. may become required to comply with
further requirements relating to the
19
calculation of capital, commonly referred to as Basel
II, which could require significant investment by the
Company, including software. In addition, in December 2010, the
Basel Committee on Banking Supervision published its final rules
for increased capital and liquidity requirements (commonly
referred to as Basel III) for bank holding
companies, such as MetLife, Inc. Assuming these requirements are
endorsed and adopted by the U.S., they are to be phased in
beginning January 1, 2013. It is possible that even more
stringent capital and liquidity requirements could be imposed
under Dodd-Frank if MetLife, Inc. is determined to be a
systemically important company. The ability of MetLife Bank and
MetLife, Inc. to pay dividends could be reduced by any
additional capital requirements that might be imposed as a
result of the enactment of Dodd-Frank
and/or the
endorsement and adoption by the U.S. of Basel III. See
Risk Factors Various Aspects of Dodd-Frank
Could Impact Our Business Operations, Capital Requirements and
Profitability and Limit Our Growth and Risk
Factors Our Insurance, Brokerage and Banking
Businesses Are Heavily Regulated, and Changes in
Regulation May Reduce Our Profitability and Limit Our
Growth. At December 31, 2010, MetLife, Inc. and
MetLife Bank were in compliance with applicable requirements
currently in effect.
Consumer Protection Laws. Numerous other
federal and state laws also affect the Holding Companys
and MetLife Banks earnings and activities, including
federal and state consumer protection laws. The GLB Act included
consumer privacy provisions that, among other things, require
disclosure of a financial institutions privacy policy to
customers. In addition, these provisions permit states to adopt
more extensive privacy protections through legislation or
regulation. As part of Dodd-Frank, Congress established the
Bureau of Consumer Financial Protection to supervise and
regulate institutions that provide certain financial products
and services to consumers. Although the consumer financial
services subject to the Bureaus jurisdiction generally
exclude insurance business of the kind in which we engage, the
Bureau does have authority to regulate consumer services
provided by MetLife Bank.
Change of Control and Restrictions on Mergers and
Acquisitions. Because MetLife, Inc. is a
financial holding company and bank holding company, no person
may acquire control of MetLife, Inc. without the prior approval
of the Federal Reserve Board. A change of control is
conclusively presumed upon acquisition of 25% or more of any
class of voting securities and rebuttably presumed upon
acquisition of 10% or more of any class of voting securities.
Further, as a result of MetLife, Inc.s ownership of
MetLife Bank, approval from the OCC would be required in
connection with a change of control (generally presumed upon the
acquisition of 10% or more of any class of voting securities) of
MetLife, Inc. As a result of Dodd-Frank, Federal Reserve
approval would be required after July 21, 2011, for any
acquisition of a non-bank firm by a bank holding company having
more than $10 billion of assets, such as MetLife, Inc. As a
bank holding company with assets of $50 billion or more,
MetLife, Inc. will be required to provide prior notice to the
Federal Reserve before acquiring control of voting shares of a
company engaged in financial activities that has
$10 billion or more of consolidated assets. MetLife, Inc.
received the approval of the Federal Reserve prior to
consummating the Acquisition.
Banking
Regulation
As a federally chartered national association, MetLife Bank is
subject to a wide variety of banking laws, regulations and
guidelines. Federal banking laws regulate most aspects of the
business of MetLife Bank, but certain state laws may apply as
well. MetLife Bank is principally regulated by the OCC and
secondarily by the Federal Reserve Bank of New York and the
FDIC. Federal banking laws and regulations address various
aspects of MetLife Banks business and operations with
respect to, among other things, chartering to carry on business
as a bank; maintaining minimum capital ratios; capital
management in relation to the banks assets; safety and
soundness standards; loan loss and other statutory reserves;
liquidity; financial reporting and disclosure standards;
counterparty credit concentration; restrictions on related party
and affiliate transactions; lending limits; payment of interest;
unfair or deceptive acts or practices; privacy; and bank holding
company and bank change of control. MetLife Bank is also subject
to the jurisdiction of the Bureau of Consumer Financial
Protection created by Dodd-Frank to promulgate and enforce
consumer protection rules for certain kinds of financial
products.
Dodd-Frank
established a statutory standard for Federal preemption of state
consumer financial protection laws, which standard will require
national banks to comply with many state consumer financial
protection laws that previously were considered preempted by
Federal law. The FDIC has the right to assess FDIC-insured banks
for funds to help pay the obligations of insolvent banks to
depositors. Federal and state banking regulators regularly
20
re-examine
existing laws and regulations applicable to banks and their
products. Changes in these laws and regulations, or in
interpretations thereof, are often made for the benefit of the
consumer at the expense of the bank.
Securities,
Broker-Dealer and Investment Adviser Regulation
Some of our subsidiaries and their activities in offering and
selling variable insurance products are subject to extensive
regulation under the federal securities laws administered by the
U.S. Securities and Exchange Commission (SEC).
These subsidiaries issue variable annuity contracts and variable
life insurance policies through separate accounts that are
registered with the SEC as investment companies under the
Investment Company Act of 1940, as amended (the Investment
Company Act). Each registered separate account is
generally divided into
sub-accounts,
each of which invests in an underlying mutual fund which is
itself a registered investment company under the Investment
Company Act. In addition, the variable annuity contracts and
variable life insurance policies issued by the separate accounts
are registered with the SEC under the Securities Act of 1933, as
amended (the Securities Act). Other subsidiaries are
registered with the SEC as broker-dealers under the Securities
Exchange Act of 1934, as amended (the Exchange Act),
and are members of, and subject to, regulation by FINRA.
Further, some of our subsidiaries are registered as investment
advisers with the SEC under the Investment Advisers Act of 1940,
as amended (the Investment Advisers Act), and are
also registered as investment advisers in various states, as
applicable. Certain variable contract separate accounts
sponsored by our subsidiaries are exempt from registration, but
may be subject to other provisions of the federal securities
laws.
Federal and state securities regulatory authorities and FINRA
from time to time make inquiries and conduct examinations
regarding compliance by the Holding Company and its subsidiaries
with securities and other laws and regulations. We cooperate
with such inquiries and examinations and take corrective action
when warranted.
Federal and state securities laws and regulations are primarily
intended to protect investors in the securities markets and
generally grant regulatory agencies broad rulemaking and
enforcement powers, including the power to limit or restrict the
conduct of business for failure to comply with such laws and
regulations. We may also be subject to similar laws and
regulations in the foreign countries in which we provide
investment advisory services, offer products similar to those
described above, or conduct other activities.
Environmental
Considerations
As an owner and operator of real property, we are subject to
extensive federal, state and local environmental laws and
regulations. Inherent in such ownership and operation is also
the risk that there may be potential environmental liabilities
and costs in connection with any required remediation of such
properties. In addition, we hold equity interests in companies
that could potentially be subject to environmental liabilities.
We routinely have environmental assessments performed with
respect to real estate being acquired for investment and real
property to be acquired through foreclosure. We cannot provide
assurance that unexpected environmental liabilities will not
arise. However, based on information currently available to us,
we believe that any costs associated with compliance with
environmental laws and regulations or any remediation of such
properties will not have a material adverse effect on our
business, results of operations or financial condition.
Employee
Retirement Income Security Act of 1974 (ERISA)
Considerations
We provide products and services to certain employee benefit
plans that are subject to ERISA, or the Internal Revenue Code of
1986, as amended (the Code). As such, our activities
are subject to the restrictions imposed by ERISA and the Code,
including the requirement under ERISA that fiduciaries must
perform their duties solely in the interests of ERISA plan
participants and beneficiaries and the requirement under ERISA
and the Code that fiduciaries may not cause a covered plan to
engage in prohibited transactions with persons who have certain
relationships with respect to such plans. The applicable
provisions of ERISA and the Code are subject to enforcement by
the Department of Labor (DOL), the Internal Revenue
Service (IRS) and the Pension Benefit Guaranty
Corporation.
In John Hancock Mutual Life Insurance Company v. Harris Trust
and Savings Bank (1993), the U.S. Supreme Court held
that certain assets in excess of amounts necessary to satisfy
guaranteed obligations under a participating group annuity
general account contract are plan assets. Therefore,
these assets are subject to certain fiduciary
21
obligations under ERISA, which requires fiduciaries to perform
their duties solely in the interest of ERISA plan participants
and beneficiaries. On January 5, 2000, the Secretary of
Labor issued final regulations indicating, in cases where an
insurer has issued a policy backed by the insurers general
account to or for an employee benefit plan, the extent to which
assets of the insurer constitute plan assets for purposes of
ERISA and the Code. The regulations apply only with respect to a
policy issued by an insurer on or before December 31, 1998
(Transition Policy). No person will generally be
liable under ERISA or the Code for conduct occurring prior to
July 5, 2001, where the basis of a claim is that insurance
company general account assets constitute plan assets. An
insurer issuing a new policy that is backed by its general
account and is issued to or for an employee benefit plan after
December 31, 1998 will generally be subject to fiduciary
obligations under ERISA, unless the policy is a guaranteed
benefit policy.
The regulations indicate the requirements that must be met so
that assets supporting a Transition Policy will not be
considered plan assets for purposes of ERISA and the Code. These
requirements include detailed disclosures to be made to the
employee benefits plan and the requirement that the insurer must
permit the policyholder to terminate the policy on 90 day
notice and receive without penalty, at the policyholders
option, either (i) the unallocated accumulated fund balance
(which may be subject to market value adjustment) or (ii) a
book value payment of such amount in annual installments with
interest. We have taken and continue to take steps designed to
ensure compliance with these regulations.
Legislative
and Regulatory Developments
Dodd-Frank, enacted in July 2010, effected the most far-reaching
overhaul of financial regulation in the U.S. in decades.
Dodd-Frank also establishes the framework for new regulations
relating to prudential standards for systemically significant
financial companies, certain investment activities, consumer
protection, the liquidation of bank holding companies,
derivative transitions, corporate governance and executive
compensation. These changes are particularly relevant to the
Company as an insurer, public company and bank holding company.
The potential impact of these changes on the Company are more
fully discussed under Risk Factors Various
Aspects of Dodd-Frank Could Impact Our Business Operations,
Capital Requirements and Profitability and Limit Our
Growth, Risk Factors Our Insurance,
Brokerage and Banking Businesses Are Heavily Regulated, and
Changes in Regulation May Reduce Our Profitability and
Limit Our Growth and Risk Factors New
and Impending Compensation and Corporate Governance Regulations
Could Hinder or Prevent Us From Attracting and Retaining
Management and Other Employees with the Talent and Experience to
Manage and Conduct Our Business Effectively. The full
impact of Dodd-Frank on us will depend on the numerous
rulemaking initiatives required or permitted by Dodd-Frank and
the various studies mandated by Dodd-Frank, which are scheduled
to be completed over the next few years.
We cannot predict what other proposals may be made, what
legislation may be introduced or enacted or the impact of any
such legislation on our business, results of operations and
financial condition.
International
Regulation
With the acquisition of ALICO, the Company has significantly
expanded its scope of operations in foreign jurisdictions. The
Companys international operations are regulated in the
jurisdictions in which they are located or operate. The
Companys international insurance operations are subject to
minimum capital, solvency and operational requirements. The
authority of the Companys international operations to
conduct business is subject to licensing requirements, permits
and approvals, and these authorizations are subject to
modification and revocation. Periodic examinations of insurance
company books and records, financial reporting requirements,
market conduct examinations and policy filing requirements are
among the techniques used by regulators to supervise our
non-U.S. insurance
businesses. The Company also has investment and pension
companies in certain foreign jurisdictions that provide mutual
fund, pension and other financial products and services. Those
entities are subject to securities, investment, pension and
other laws and regulations, and oversight by the relevant
securities, pension and other authorities of the countries in
which the companies operate.
The Companys international operations are exposed to
increased political, legal, financial, operational and other
risks. Our international operations may be materially adversely
affected by the actions and decisions of foreign authorities and
regulators, such as through nationalization or expropriation of
assets, the imposition of limits
22
on foreign ownership of local companies, changes in laws
(including tax laws and regulations), their application or
interpretation, political instability, dividend limitations,
price controls, currency exchange controls or other restrictions
that prevent us from transferring funds from these operations
out of the countries in which they operate or converting local
currencies we hold into U.S. dollars or other currencies,
as well as other adverse actions by foreign governmental
authorities and regulators. Such actions may negatively affect
our business in these jurisdictions. See Risk
Factors Our International Operations Face Political,
Legal, Operational and Other Risks, Including Exposure to Local
and Regional Economic Conditions, That Could Negatively Affect
Those Operations or Our Profitability.
Certain of the Companys international insurance
operations, including Japan, may be subject to assessments,
generally based on their proportionate share of business written
in the relevant jurisdiction, for certain obligations to
policyholders and claimants resulting from the insolvency of
insurance companies. Under the Japanese Insurance Business Law,
all licensed life insurers in Japan are assessed on a pre-funded
basis by the Life Insurance Policyholders Protection Corporation
of Japan. These assessments are aggregated across all licensed
life insurers in Japan and used to satisfy certain obligations
to policyholders and claimants of insolvent life insurance
companies. As we cannot predict the timing and scope of future
assessments, they may materially affect the results of
operations of the Companys international insurance
operations in particular quarterly or annual periods. In
addition, in some jurisdictions, some of the Companys
insurance products are considered securities under
local law and may be subject to local securities regulations and
oversight by local securities regulators.
Our operations in Japan are subject to regulation and
examination by Japans Financial Services Agency
(FSA). Our operations in Japan are required to file
with the FSA annual reports which include financial statements.
Similar to the U.S., Japanese law provides that insurers in
Japan must maintain specified solvency standards for the
protection of policyholders and to support the financial
strength of licensed insurers. As of September 30, 2010,
the date of our most recent regulatory filing in Japan, the
solvency margin ratio of our Japan operations was 1,466%, which
is significantly in excess of the legally mandated solvency
margin in Japan. The FSA has issued a proposal to revise the
current method of calculating the solvency margin ratio. The FSA
intends to apply the revised method to life insurance companies
for the fiscal year-end 2011 (March 31, 2012) for life
insurance companies in Japan, and require the disclosure of the
ratio as reference information for fiscal year-end 2010
(March 31, 2011).
A portion of the annual earnings of our Japan operations may be
repatriated each year, and may further be distributed to the
Holding Company as a dividend. We may determine not to
repatriate profits from the Japan operations or to repatriate a
reduced amount in order to maintain or improve the solvency
margin of the Japan operations or for other reasons. In
addition, the FSA may limit or not permit profit repatriations
or other transfers of funds to the U.S. if such transfers would
be detrimental to the solvency or financial strength of our
Japan operations or for other reasons.
In addition, the European Commission has established
Solvency II as a new capital adequacy regime for the
European insurance industry, which will become effective
beginning in 2013. Solvency II sets capital standards for
insurers on a risk basis and has a three-pillar structure
covering quantitative requirements, supervisory review, and
market disclosure. Regulators in certain other countries, such
as Mexico, are also establishing new capital regimes similar to
Solvency II. Compliance with these new capital standards
may impact the level of capital required to be held at
individual legal entities. Further, the efforts required to
comply with these regulations may increase operating costs at
these entities.
We expect the scope and extent of regulation outside of the
U.S., as well as regulatory oversight, generally to continue to
increase. That oversight, and the legal and regulatory
environment in the countries in which the Company operates,
could have a material adverse effect on the Companys
results of operations.
Governmental
Responses to Extraordinary Market Conditions
U.S.
Federal Governmental Responses
Dodd-Frank was enacted in response to the recent economic
crisis. See Legislative and Regulatory
Developments. Actions taken by Congress, the Federal
Reserve Bank of New York, the U.S. Treasury and other
23
agencies of the U.S. Federal government prior to the
enactment of Dodd-Frank were increasingly aggressive and,
together with a series of interest rate reductions that began in
the second half of 2007, intended to provide liquidity to
financial institutions and markets, to avert a loss of investor
confidence in particular troubled institutions and to prevent or
contain the spread of the financial crisis. These measures
included:
|
|
|
|
|
expanding the types of institutions that have access to the
Federal Reserve Bank of New Yorks discount window;
|
|
|
|
providing asset guarantees and emergency loans to particular
distressed companies;
|
|
|
|
a temporary ban on short selling of shares of certain financial
institutions (including, for a period, MetLife);
|
|
|
|
programs intended to reduce the volume of mortgage foreclosures
by modifying the terms of mortgage loans for distressed
borrowers;
|
|
|
|
temporarily guaranteeing money market funds; and
|
|
|
|
programs to support the mortgage-backed securities market and
mortgage lending.
|
Many of the actions outlined above expired or terminated by
mid-2010 or earlier.
In addition to these actions, pursuant to the Emergency Economic
Stabilization Act of 2008 (EESA), enacted in October
2008, the U.S. Treasury injected capital into selected
financial institutions and their holding companies. EESA also
authorized the U.S. Treasury to purchase mortgage-backed
and other securities from financial institutions as part of the
overall $700 billion available for the purpose of
stabilizing the financial markets; this authority expired in
October 2010. The Federal government, the Federal Reserve Bank
of New York, FDIC and other governmental and regulatory bodies
also took other actions to address the financial crisis. For
example, the Federal Reserve Bank of New York made funds
available to commercial and financial companies under a number
of programs, including the Commercial Paper Funding Facility
(the CPFF), and the FDIC established the Temporary
Liquidity Guarantee Program (the FDIC Program). In
March 2009, MetLife, Inc. issued $397 million of senior
notes guaranteed by the FDIC under the FDIC Program. The FDIC
Program and the CPFF expired in late 2009 and early 2010,
respectively. During the period of its existence, the Company
made limited use of the CPFF, and no amounts were outstanding
under the CPFF at December 31, 2009.
In February 2009, the Treasury Department outlined a financial
stability plan with additional measures to provide capital
relief to institutions holding troubled assets, including a
capital assistance program for banks that have undergone a
stress test (the Capital Assistance
Program) and a public-private investment fund to purchase
troubled assets from financial institutions. MetLife was
eligible to participate in the U.S. Treasurys Capital
Purchase Program, a voluntary capital infusion program
established under EESA, but elected not to participate in that
program. MetLife took part in the stress test and
was advised by the Federal Reserve in May 2009 that, based on
the stress tests economic scenarios and methodology,
MetLife had adequate capital to sustain a further deterioration
in the economy. In January 2011, MetLife submitted to the
Federal Reserve a comprehensive capital plan, as mandated by the
Federal Reserve for the same bank holding companies that
completed the 2009 stress test. The capital plan projects
MetLifes capital levels to the end of 2012 under baseline
and stress scenarios. The Federal Reserve has stated that it
will consider the results of the capital plan exercise in
evaluating proposed capital actions by participating bank
holding companies, such as common stock dividend increases and
stock repurchases. The Federal Reserve has indicated that it
will provide its assessment of participating institutions
capital plans in late March 2011.
State
Insurance Regulatory Responses
The NAIC adopted a number of reserve and capital relief
proposals during 2009. The NAIC revisited many of those
adoptions and studied related and additional topics for
potential adoption during 2010.
The NAIC revisited the mortgage experience adjustment factor
(the MEAF) which is utilized in calculating RBC
charges that are assigned to commercial and agricultural
mortgages held by our domestic insurers. The MEAF calculation
includes the ratio of an insurers commercial and
agricultural mortgage default experience to the industry average
commercial and agricultural mortgage default experience and, in
2009, a cap of 125% and a floor
24
of 75% were adopted. The NAIC adopted during 2010 a cap of 175%
and a floor of 80%. As a result of this revision in MEAF for
2010, the RBC impact on our U.S. insurance subsidiaries is
not likely to be material.
In late 2009, the NAIC issued Statement of Statutory Accounting
Principles (SSAP) 10R (SSAP 10R). SSAP
10R increased the amount of deferred tax assets that may be
admitted on a statutory basis. The admission criteria for
realizing the value of deferred tax assets was increased from a
one year to a three year period. Further, the aggregate cap on
deferred tax assets that may be admitted was increased from 10%
to 15% of surplus. These changes increased the capital and
surplus of our U.S. insurance subsidiaries, thereby
positively impacting RBC at December 31, 2009. To temper
this positive RBC impact, and as a temporary measure at
December 31, 2009 only, a 5% pre-tax RBC charge must be
applied to the additional admitted deferred tax assets generated
by SSAP 10R. The adoption for 2009 had a December 31, 2009
sunset; however, during 2010, the 2009 adoption, including the
5% pre-tax RBC charge, was extended through December 31,
2011.
In late 2009, following rating agency downgrades of virtually
all residential mortgage-backed securities (RMBS)
from certain vintages, the NAIC engaged PIMCO Advisory
(PIMCO), a provider of investment advisory services,
to analyze approximately 20,000 RMBS held by insurers and
evaluate the likely loss that holders of those securities would
suffer in the event of a default. PIMCOs analysis showed
that the severity of expected losses on those securities
evaluated that are held by our U.S. insurance companies was
significantly less than would be implied by the rating
agencies ratings of such securities. The NAIC incorporated
the results of PIMCOs analysis into the RBC charges
assigned to the evaluated securities, with a beneficial impact
on the RBC of our U.S. insurance subsidiaries. The NAIC
utilized the solution again for 2010. The NAIC adopted a similar
solution for 2010 for commercial mortgage-backed securities
(CMBS) by selecting BlackRock Solutions, a provider
of investment advisory services, to assist in the RBC
determination process. BlackRock Solutions will serve as a
third-party modeler of the 7,000 CMBS holdings of
U.S. insurance companies, including MetLifes
U.S. insurance subsidiaries. The impact of the
implementation for 2010 of the modeling solution for CMBS is not
known at the current time but the RBC impact on our
U.S. insurance subsidiaries is not expected to be material.
Foreign
Governmental and Intergovernmental Responses
In an effort to strengthen the financial condition of key
financial institutions or avert their collapse, and to forestall
or reduce the effects of reduced lending activity, a number of
foreign governments and intergovernmental entities have taken
action to enhance stability and liquidity, reduce risk and
increase regulatory controls and oversight. Foreign government
and intergovernmental responses have been similar to some of
those taken by the U.S. Federal government, including
injecting capital into domestic financial institutions in
exchange for ownership stakes and, in the case of certain
European Union member states such as Greece, Spain, Portugal and
Ireland, providing or making available certain funds and rescue
packages to support the solvency of such countries or financial
institutions, and such responses are intended to achieve similar
goals. We cannot predict whether foreign government
and/or
intergovernmental actions will achieve their intended purpose or
how such actions will impact competition in the financial
services industry. We expect the scope and extent of regulation
outside the U.S., as well as regulatory oversight, generally to
continue to increase. That oversight, and the legal and
regulatory environment in the countries in which the Company
operates, could have a material adverse effect on the
Companys results of operations.
Competition
We believe that competition faced by our segments is based on a
number of factors, including service, product features, scale,
price, financial strength, claims-paying ratings, credit
ratings,
e-business
capabilities and name recognition. We compete with a large
number of other insurance companies, as well as non-insurance
financial services companies, such as banks, broker-dealers and
asset managers, for individual consumers, employer and other
group customers as well as agents and other distributors of
insurance and investment products. Some of these companies offer
a broader array of products, have more competitive pricing or,
with respect to other insurance companies, have higher claims
paying ability ratings. Many of our insurance products are
underwritten annually and, accordingly, there is a risk that
group purchasers may be able to obtain more favorable terms from
competitors rather than renewing coverage with us.
25
We believe that the turbulence in financial markets that began
in the second half of 2007, its impact on the capital position
of many competitors, and subsequent actions by regulators and
rating agencies have altered the competitive environment. In
particular, we believe that these factors have highlighted
financial strength as the most significant differentiator from
the perspective of some customers and certain distributors. We
believe the Company is well positioned to compete in this
environment. In particular, the Company distributes many of its
individual products through other financial institutions such as
banks and broker-dealers. These distribution partners are
currently placing greater emphasis on the financial strength of
the company whose products they sell. In addition, the financial
market turbulence has highlighted the extent of the risk
associated with certain variable annuity products and has led
many companies in our industry to re-examine the pricing and
features of the products they offer. The effects of current
market conditions may also lead to consolidation in the life
insurance industry. Although we cannot predict the ultimate
impact of these conditions, we believe that the strongest
companies will enjoy a competitive advantage as a result of the
current circumstances.
We must attract and retain productive sales representatives to
sell our insurance, annuities and investment products. Strong
competition exists among insurance companies for sales
representatives with demonstrated ability. We compete with other
insurance companies for sales representatives primarily on the
basis of our financial position, support services and
compensation and product features. See
U.S. Business Sales
Distribution. In the U.S. and selected international
markets, we continue to undertake several initiatives to grow
our career agency force, while continuing to enhance the
efficiency and production of our existing sales force. We cannot
provide assurance that these initiatives will succeed in
attracting and retaining new agents. Sales of individual
insurance, annuities and investment products and our results of
operations and financial position could be materially adversely
affected if we are unsuccessful in attracting and retaining
agents. See Risk Factors We May Be Unable to
Attract and Retain Sales Representatives for Our Products.
Numerous aspects of our business are subject to regulation.
Legislative and other changes affecting the regulatory
environment can affect our competitive position within the life
insurance industry and within the broader financial services
industry. See U.S. Regulation,
International Regulation, Risk
Factors Our Insurance, Brokerage and Banking
Businesses Are Heavily Regulated, and Changes in
Regulation May Reduce Our Profitability and Limit Our
Growth and Risk Factors Changes in
U.S. Federal and State Securities Laws and Regulations, and
State Insurance Regulations Regarding Suitability of Annuity
Product Sales, May Affect Our Operations and Our
Profitability.
Employees
At December 31, 2010, we had approximately
66,000 employees. We believe that our relations with our
employees are satisfactory.
Executive
Officers of the Registrant
Set forth below is information regarding the executive officers
of MetLife, Inc.:
C. Robert Henrikson, age 63, has been Chairman,
President and Chief Executive Officer of MetLife, Inc. and MLIC
since April 25, 2006. Previously, he was President and
Chief Executive Officer of MetLife, Inc. and MLIC from
March 1, 2006, President and Chief Operating Officer of
MetLife, Inc. from June 2004, and President of the
U.S. Insurance and Financial Services businesses of
MetLife, Inc. and MLIC from July 2002 to June 2004. He served as
President of Institutional Business of MetLife, Inc. from
September 1999 to July 2002 and President of Institutional
Business of MLIC from May 1999 through June 2002. He was Senior
Executive Vice President, Institutional Business, of MLIC from
December 1997 to May 1999, Executive Vice President,
Institutional Business, from January 1996 to December 1997, and
Senior Vice President, Pensions, from January 1991 to January
1995. He is a director of MetLife, Inc. and MLIC.
Gwenn L. Carr, age 65, has been Executive Vice
President and Chief of Staff to the Chairman and Chief Executive
Officer of MetLife, Inc. and MLIC since August 2009. Previously,
she was Senior Vice President and Chief of Staff to the Chairman
and Chief Executive Officer of MetLife, Inc. and MLIC from June
2009, Senior Vice President, Secretary and Chief of Staff to the
Chairman and Chief Executive Officer of MetLife, Inc, and MLIC
from 2007, Senior Vice President and Secretary of MetLife, Inc.
and MLIC from October 2004, and Vice President
26
and Secretary of MetLife, Inc. and MLIC from August 1999.
Ms. Carr was Vice President and Secretary of
ITT Corporation from 1990 to 1999.
Kathleen A. Henkel, age 62, has been Executive Vice
President, Human Resources, of MetLife, Inc. and MLIC since
March 2010. Previously, she was Senior Vice President, Human
Resources, of MLIC from July 2008 to March 2010 and Senior Vice
President, Institutional Business, of MLIC from December 2005 to
July 2008. Ms. Henkel was promoted to Senior Vice President
of MLIC after serving as a Vice President of MLIC from 1992 to
2004. Ms. Henkel joined the Company in 1966 and has served
in various senior management positions since that time.
Steven A. Kandarian, age 58, has been Executive Vice
President and Chief Investment Officer of MetLife, Inc. and MLIC
since April 2005. Previously, he was the executive director of
the Pension Benefit Guaranty Corporation from 2001 to 2004.
Before joining the Pension Benefit Guaranty Corporation,
Mr. Kandarian was founder and managing partner of Orion
Capital Partners, LP, where he managed a private equity fund
specializing in venture capital and corporate acquisitions for
eight years. He is a director of MetLife Bank.
Nicholas D. Latrenta, age 59, has been Executive
Vice President of MetLife, Inc. and MLIC since August 2010 and
General Counsel of MetLife, Inc. and MLIC since May 2010.
Previously, he was Senior Chief Counsel of MLIC supporting the
Insurance Group from March 2007 to April 2010, Chief Counsel of
MLIC supporting Institutional Business, ERISA and the Product
Tax Legal Group from April 2006 to February 2007, Chief Counsel
of MLIC supporting MetLife Business-Legal from July 2004 to
March 2006, and Senior Vice President of MLIC Institutional
Business from October 2000 to June 2004. Mr. Latrenta was
promoted to Senior Vice President of MLIC in 1997 after serving
as a Vice President of MLIC from 1986 to 1997. Mr. Latrenta
joined the Company in 1969 and has served in various senior
management positions since that time. Mr. Latrenta is a
director of American Life Insurance Company.
Maria R. Morris, age 48, has been Executive Vice
President, Technology and Operations, of MetLife, Inc. and MLIC
since January 2008. Previously, she was Executive Vice President
of MLIC from December 2005 to January 2008, Senior Vice
President of MLIC from July 2003 to December 2005, and Vice
President of MLIC from March 1997 to July 2003. Ms. Morris
is a director of MetLife Insurance Company of Connecticut.
William J. Mullaney, age 51, has been President,
U.S. Business of MetLife, Inc. and MLIC since August 2009.
Previously, he was President, Institutional Business, of
MetLife, Inc. and MLIC from January 2007 to July 2009, President
of Metropolitan Property and Casualty Insurance Company from
January 2005 to January 2007, Senior Vice President of
Metropolitan Property and Casualty Insurance Company from July
2002 to December 2004, Senior Vice President, Institutional
Business, of MLIC from August 2001 to July 2002, and a Vice
President of MLIC for more than five years. He is a director of
MetLife Bank.
William J. Toppeta, age 62, has been President,
International, of MetLife, Inc. and MLIC since June 2001. He was
President of Client Services and Chief Administrative Officer of
MetLife, Inc. from September 1999 to June 2001 and President of
Client Services and Chief Administrative Officer of MLIC from
May 1999 to June 2001. He was Senior Executive Vice President,
Head of Client Services, of MLIC from March 1999 to May 1999,
Senior Executive Vice President, Individual, from February 1998
to March 1999, Executive Vice President, Individual Business,
from July 1996 to February 1998, Senior Vice President from
October 1995 to July 1996 and President and Chief Executive
Officer of its Canadian Operations from July 1993 to October
1995. Mr. Toppeta is a director of American Life Insurance
Company.
William J. Wheeler, age 49, has been Executive Vice
President and Chief Financial Officer of MetLife, Inc. and MLIC
since December 2003, prior to which he was a Senior Vice
President of MLIC from 1997 to December 2003. Previously, he was
a Senior Vice President of Donaldson, Lufkin &
Jenrette for more than five years. Mr. Wheeler is a
director of MetLife Bank.
Trademarks
We have a worldwide trademark portfolio that we consider
important in the marketing of our products and services,
including, among others, the trademark MetLife. We
also have the exclusive license to use the
Peanuts®
characters in the area of financial services and healthcare
benefit services in the U.S. and internationally under an
27
advertising and premium agreement with Peanuts Worldwide, LLC
until December 31, 2014. We also have a non-exclusive
license to use certain Citigroup-owned trademarks in connection
with the marketing, distribution or sale of life insurance and
annuity products under a licensing agreement with Citigroup
until June 30, 2015. Furthermore, as result of the recent
Acquisition, we acquired American Life Insurance Company and its
trademarks, including the Alico trademark. We
believe that our rights in our trademarks and under our
Peanuts®
characters license and our Citigroup license are well protected.
Available
Information
MetLife files periodic reports, proxy statements and other
information with the SEC. Such reports, proxy statements and
other information may be obtained by visiting the Public
Reference Room of the SEC at its Headquarters Office,
100 F Street, N.E., Washington D.C. 20549 or by
calling the SEC at
1-202-551-8090
or
1-800-SEC-0330
(Office of Investor Education and Advocacy). In addition, the
SEC maintains an internet website (www.sec.gov) that contains
reports, proxy statements, and other information regarding
issuers that file electronically with the SEC, including
MetLife, Inc.
MetLife makes available, free of charge, on its website
(www.metlife.com) through the Investor Relations page, its
annual reports on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K,
and amendments to all those reports, as soon as reasonably
practicable after filing (furnishing) such reports to the SEC.
Other information found on the website is not part of this or
any other report filed with or furnished to the SEC.
Difficult
Conditions in the Global Capital Markets and the Economy
Generally May Materially Adversely Affect Our Business and
Results of Operations and These Conditions May Not Improve in
the Near Future
Our business and results of operations are materially affected
by conditions in the global capital markets and the economy
generally, both in the U.S. and elsewhere around the world.
Stressed conditions, volatility and disruptions in global
capital markets or in particular markets or financial asset
classes can have an adverse effect on us, in part because we
have a large investment portfolio and our insurance liabilities
are sensitive to changing market factors. Disruptions in one
market or asset class can also spread to other markets or asset
classes. Although the disruption in the global financial markets
that began in late 2007 has moderated, not all global financial
markets are functioning normally, and some remain reliant upon
government intervention and liquidity. Upheavals in the
financial markets can also affect our business through their
effects on general levels of economic activity, employment and
customer behavior. Although the recent recession in the U.S.
ended in June of 2009, the recovery from the recession has been
below historic averages and the unemployment rate is expected to
remain high for some time. In addition, inflation is expected to
remain at low levels for some time. Some economists believe that
some level of disinflation and deflation risk remains in the
U.S. economy. The global recession and disruption of the
financial markets has led to concerns over capital markets
access and the solvency of certain European Union member states,
including Portugal, Ireland, Italy, Greece and Spain. The
Japanese economy, to which we face increased exposure as a
result of the Acquisition, continues to experience low nominal
growth, a deflationary environment, and weak consumer spending.
Our revenues and net investment income are likely to remain
under pressure in such circumstances and our profit margins
could erode. Also, in the event of extreme prolonged market
events, such as the recent global credit crisis, we could incur
significant capital
and/or
operating losses. Even in the absence of a market downturn, we
are exposed to substantial risk of loss due to market volatility.
We are a significant writer of variable annuity products. The
account values of these products decrease as a result of
downturns in capital markets. Decreases in account values reduce
the fees generated by our variable annuity products, cause the
amortization of deferred policy acquisition costs
(DAC) to accelerate and could increase the level of
insurance liabilities we must carry to support those variable
annuities issued with any associated guarantees.
Factors such as consumer spending, business investment,
government spending, the volatility and strength of the capital
markets, and inflation all affect the business and economic
environment and, ultimately, the amount and
28
profitability of our business. In an economic downturn
characterized by higher unemployment, lower family income, lower
corporate earnings, lower business investment and lower consumer
spending, the demand for our financial and insurance products
could be adversely affected. Group insurance, in particular, is
affected by the higher unemployment rate. In addition, we may
experience an elevated incidence of claims and lapses or
surrenders of policies. Our policyholders may choose to defer
paying insurance premiums or stop paying insurance premiums
altogether. Adverse changes in the economy could affect earnings
negatively and could have a material adverse effect on our
business, results of operations and financial condition. The
recent market turmoil has precipitated, and may continue to
raise the possibility of, legislative, regulatory and
governmental actions. We cannot predict whether or when such
actions may occur, or what impact, if any, such actions could
have on our business, results of operations and financial
condition. See Actions of the
U.S. Government, Federal Reserve Bank of New York and Other
Governmental and Regulatory Bodies for the Purpose of
Stabilizing and Revitalizing the Financial Markets and
Protecting Investors and Consumers May Not Achieve the Intended
Effect or Could Adversely Affect MetLifes Competitive
Position, Various Aspects of Dodd-Frank
Could Impact Our Business Operations, Capital Requirements and
Profitability and Limit Our Growth, Our
Insurance, Brokerage and Banking Businesses Are Heavily
Regulated, and Changes in Regulation May Reduce Our
Profitability and Limit Our Growth and
Competitive Factors May Adversely Affect Our
Market Share and Profitability.
Adverse
Capital and Credit Market Conditions May Significantly Affect
Our Ability to Meet Liquidity Needs, Access to Capital and Cost
of Capital
The capital and credit markets are sometimes subject to periods
of extreme volatility and disruption. Such volatility and
disruption could cause liquidity and credit capacity for certain
issuers to be limited.
We need liquidity to pay our operating expenses, interest on our
debt and dividends on our capital stock, maintain our securities
lending activities and replace certain maturing liabilities.
Without sufficient liquidity, we will be forced to curtail our
operations, and our business will suffer. The principal sources
of our liquidity are insurance premiums, annuity considerations,
deposit funds, and cash flow from our investment portfolio and
assets, consisting mainly of cash or assets that are readily
convertible into cash. Sources of liquidity in normal markets
also include short-term instruments such as funding agreements
and commercial paper. Sources of capital in normal markets
include long-term instruments, medium- and long-term debt,
junior subordinated debt securities, capital securities and
equity securities.
In the event market or other conditions have an adverse impact
on our capital and liquidity beyond expectations and our current
resources do not satisfy our needs, we may have to seek
additional financing. The availability of additional financing
will depend on a variety of factors such as market conditions,
regulatory considerations, the general availability of credit,
the volume of trading activities, the overall availability of
credit to the financial services industry, our credit ratings
and credit capacity, as well as the possibility that customers
or lenders could develop a negative perception of our long- or
short-term financial prospects if we incur large investment
losses or if the level of our business activity decreases due to
a market downturn. Similarly, our access to funds may be
impaired if regulatory authorities or rating agencies take
negative actions against us. Our internal sources of liquidity
may prove to be insufficient and, in such case, we may not be
able to successfully obtain additional financing on favorable
terms, or at all.
Our liquidity requirements may change if, among other things, we
are required to return significant amounts of cash collateral on
short notice under securities lending agreements.
Disruptions, uncertainty or volatility in the capital and credit
markets may also limit our access to capital required to operate
our business, most significantly our insurance operations. Such
market conditions may limit our ability to replace, in a timely
manner, maturing liabilities; satisfy regulatory capital
requirements (under both insurance and banking laws); and access
the capital necessary to grow our business. See
Business U.S. Regulation
Financial Holding Company Regulation for information
relating to the possible impact of Basel II and
Basel III on the Company. As such, we may be forced to
delay raising capital, issue different types of securities than
we would otherwise, less effectively deploy such capital, issue
shorter tenor securities than we prefer, or bear an unattractive
cost of capital which could decrease our profitability and
significantly reduce our financial flexibility. Our results of
operations, financial condition, cash flows and statutory
capital position could be materially adversely affected by
disruptions in the financial markets.
29
Actions
of the U.S. Government, Federal Reserve Bank of New York and
Other Governmental and Regulatory Bodies for the Purpose of
Stabilizing and Revitalizing the Financial Markets and
Protecting Investors and Consumers May Not Achieve the Intended
Effect or Could Adversely Affect MetLifes Competitive
Position
In recent years, Congress, the Federal Reserve Bank of New York,
the FDIC, the U.S. Treasury and other agencies of the
U.S. federal government took a number of increasingly
aggressive actions (in addition to continuing a series of
interest rate reductions that began in the second half of
2007) intended to provide liquidity to financial
institutions and markets, to avert a loss of investor confidence
in particular troubled institutions, to prevent or contain the
spread of the financial crisis and to spur economic growth. Most
of these programs have largely run their course or been
discontinued. More likely to be relevant to MetLife, Inc. is the
monetary policy implemented by the Federal Reserve Board, as
well as Dodd-Frank, which will significantly change financial
regulation in the U.S. in a number of areas that could
affect MetLife. Given the large number of provisions that must
be implemented through regulatory action, we cannot predict what
impact this could have on our business, results of operations
and financial condition.
It is not certain what effect the enactment of Dodd-Frank will
have on the financial markets, the availability of credit, asset
prices and MetLifes operations. See
Various Aspects of Dodd-Frank Could Impact Our
Business Operations, Capital Requirements and Profitability and
Limit Our Growth. In addition, the U.S. federal
government (including the FDIC) and private lenders have
instituted programs to reduce the monthly payment obligations of
mortgagors
and/or
reduce the principal payable on residential mortgage loans. As a
result of such programs or of any legislation requiring loan
modifications, we may need to maintain or increase our
engagement in similar activities in order to comply with program
or statutory requirements and to remain competitive. We cannot
predict whether the funds made available by the
U.S. federal government and its agencies will be enough to
continue stabilizing or to further revive the financial markets
or, if additional amounts are necessary, whether the Federal
Reserve Board will make funds available, whether Congress will
be willing to make the necessary appropriations, what the
publics sentiment would be towards any such
appropriations, or what additional requirements or conditions
might be imposed on the use of any such additional funds.
The choices made by the U.S. Treasury, the Federal Reserve
Board and the FDIC in their distribution of funds under EESA and
any future asset purchase programs, as well as any decisions
made regarding the imposition of additional regulation on large
financial institutions may have, over time, the effect of
supporting or burdening some aspects of the financial services
industry more than others. Some of our competitors have
received, or may in the future receive, benefits under one or
more of the federal governments programs. This could
adversely affect our competitive position. See
Competitive Factors May Adversely Affect Our
Market Share and Profitability. See also
New and Impending Compensation and Corporate
Governance Regulations Could Hinder or Prevent Us From
Attracting and Retaining Management and Other Employees with the
Talent and Experience to Manage and Conduct Our Business
Effectively and Our Insurance, Brokerage
and Banking Businesses Are Heavily Regulated, and Changes in
Regulation May Reduce Our Profitability and Limit Our
Growth.
Our
Insurance, Brokerage and Banking Businesses Are Heavily
Regulated, and Changes in Regulation May Reduce Our
Profitability and Limit Our Growth
Our insurance operations are subject to a wide variety of
insurance and other laws and regulations. See
Business U.S. Regulation
Insurance Regulation. State insurance laws regulate most
aspects of our U.S. insurance businesses, and our insurance
subsidiaries are regulated by the insurance departments of the
states in which they are domiciled and the states in which they
are licensed. Our
non-U.S. insurance
operations are principally regulated by insurance regulatory
authorities in the jurisdictions in which they are domiciled or
operate. See Business International
Regulation.
State laws in the U.S. grant insurance regulatory authorities
broad administrative powers with respect to, among other things:
|
|
|
|
|
licensing companies and agents to transact business;
|
|
|
|
calculating the value of assets to determine compliance with
statutory requirements;
|
|
|
|
mandating certain insurance benefits;
|
30
|
|
|
|
|
regulating certain premium rates;
|
|
|
|
reviewing and approving policy forms;
|
|
|
|
regulating unfair trade and claims practices, including through
the imposition of restrictions on marketing and sales practices,
distribution arrangements and payment of inducements;
|
|
|
|
regulating advertising;
|
|
|
|
protecting privacy;
|
|
|
|
establishing statutory capital and reserve requirements and
solvency standards;
|
|
|
|
fixing maximum interest rates on insurance policy loans and
minimum rates for guaranteed crediting rates on life insurance
policies and annuity contracts;
|
|
|
|
approving changes in control of insurance companies;
|
|
|
|
restricting the payment of dividends and other transactions
between affiliates; and
|
|
|
|
regulating the types, amounts and valuation of investments.
|
State insurance guaranty associations have the right to assess
insurance companies doing business in their state for funds to
help pay the obligations of insolvent insurance companies to
policyholders and claimants. Because the amount and timing of an
assessment is beyond our control, the liabilities that we have
currently established for these potential liabilities may not be
adequate. See Business
U.S. Regulation Insurance
Regulation Guaranty Associations and Similar
Arrangements.
State insurance regulators and the NAIC regularly reexamine
existing laws and regulations applicable to insurance companies
and their products. Changes in these laws and regulations, or in
interpretations thereof, are often made for the benefit of the
consumer at the expense of the insurer and, thus, could have a
material adverse effect on our financial condition and results
of operations.
Currently, the U.S. federal government does not directly
regulate the business of insurance. However,
Dodd-Frank
allows federal regulators to compel state insurance regulators
to liquidate an insolvent insurer under some circumstances if
the state regulators have not acted within a specific period. It
also establishes the Federal Insurance Office which has the
authority to participate in the negotiations of international
insurance agreements with foreign regulators for the U.S. The
Federal Insurance Office also is authorized to collect
information about the insurance industry and recommend
prudential standards.
Federal legislation and administrative policies in several areas
can significantly and adversely affect insurance companies.
These areas include financial services regulation, securities
regulation, pension regulation, health care regulation, privacy,
tort reform legislation and taxation. In addition, various forms
of direct and indirect federal regulation of insurance have been
proposed from time to time, including proposals for the
establishment of an optional federal charter for insurance
companies. Other aspects of our insurance operations could also
be affected by Dodd-Frank. For example, Dodd-Frank imposes new
restrictions on the ability of affiliates of insured depository
institutions (such as MetLife Bank) to engage in proprietary
trading or sponsor or invest in hedge funds or private equity
funds. See Various Aspects of Dodd-Frank Could
Impact Our Business Operations, Capital Requirements and
Profitability and Limit Our Growth.
As a federally chartered national association, MetLife Bank is
subject to a wide variety of banking laws, regulations and
guidelines. Federal banking laws regulate most aspects of the
business of MetLife Bank, but certain state laws may apply as
well. MetLife Bank is principally regulated by the OCC, the
Federal Reserve and the FDIC.
Federal banking laws and regulations address various aspects of
MetLife Banks business and operations with respect to,
among other things:
|
|
|
|
|
chartering to carry on business as a bank;
|
|
|
|
the permissibility of certain activities;
|
|
|
|
maintaining minimum capital ratios;
|
31
|
|
|
|
|
capital management in relation to the banks assets;
|
|
|
|
dividend payments;
|
|
|
|
safety and soundness standards;
|
|
|
|
loan loss and other related liabilities;
|
|
|
|
liquidity;
|
|
|
|
financial reporting and disclosure standards;
|
|
|
|
counterparty credit concentration;
|
|
|
|
restrictions on related party and affiliate transactions;
|
|
|
|
lending limits (and, in addition, Dodd-Frank includes the credit
exposures arising from securities lending by MetLife Bank within
lending limits otherwise applicable to loans);
|
|
|
|
payment of interest;
|
|
|
|
unfair or deceptive acts or practices;
|
|
|
|
privacy; and
|
|
|
|
bank holding company and bank change of control.
|
Federal and state banking regulators regularly re-examine
existing laws and regulations applicable to banks and their
products. Changes in these laws and regulations, or in
interpretations thereof, are often made for the benefit of the
consumer at the expense of the bank and, thus, could have a
material adverse effect on the financial condition and results
of operations of MetLife Bank.
In addition, Dodd-Frank establishes a new Bureau of Consumer
Financial Protection that supervises and regulates institutions
providing certain financial products and services to consumers.
Although the consumer financial services to which this
legislation applies exclude insurance business of the kind in
which we engage, the new Bureau has authority to regulate
consumer services provided by MetLife Bank and non-insurance
consumer services provided elsewhere throughout MetLife.
Dodd-Frank established a statutory standard for Federal
pre-emption of state consumer financial protection laws, which
standard will require national banks to comply with many state
consumer financial protection laws that previously were
considered preempted by Federal law. As a result, the regulatory
and compliance burden on MetLife Bank may increase and could
adversely affect its business and results of operations.
Dodd-Frank also includes provisions on mortgage lending,
anti-predatory lending and other regulatory and supervisory
provisions that could impact the business and operations of
MetLife Bank.
Dodd-Frank also authorizes the SEC to establish a standard of
conduct applicable to brokers and dealers when providing
personalized investment advice to retail and other customers.
This standard of conduct would be to act in the best interest of
the customer without regard to the financial or other interest
of the broker or dealer providing the advice. See
Business U.S. Regulation
Banking Regulation and Changes in
U.S. Federal and State Securities Laws and Regulations, and
State Insurance Regulations Regarding Suitability of Annuity
Product Sales, May Affect Our Operations and Our
Profitability.
In December 2010, the Basel Committee on Banking Supervision
published Basel III for banks and bank holding companies,
such as MetLife, Inc. Assuming regulators in the U.S. endorse
and adopt Basel III, it will require banks and bank holding
companies to hold greater amounts of capital, to comply with
requirements for short-term liquidity and to reduce reliance on
short-term funding sources. See Business
U.S. Regulation Financial Holding Company
Regulation Capital and Managements
Discussion and Analysis of Financial Condition and Results of
Operations Industry Trends Financial and
Economic Environment. It is not clear how these new
requirements will compare to the enhanced prudential standards
that may apply to us under Dodd-Frank. See
Various Aspects of Dodd-Frank Could Impact Our
Business Operations, Capital Requirements and Profitability and
Limit Our Growth.
32
As a bank holding company, MetLife, Inc.s ability to pay
dividends may be restricted by the Federal Reserve Bank of
New York. In addition, the ability of MetLife Bank and
MetLife, Inc. to pay dividends could be restricted by any
additional capital requirements that might be imposed as a
result of the enactment of Dodd-Frank
and/or the
endorsement and adoption by the U.S. of Basel III.
The FDIC has the right to assess FDIC-insured banks for funds to
help pay the obligations of insolvent banks to depositors.
Because the amount and timing of an assessment is beyond our
control, the liabilities that we have currently established for
these potential liabilities may not be adequate. In addition,
Dodd-Frank will result in increased assessment for banks with
assets of $10.0 billion or more, which includes MetLife
Bank.
Our international operations are subject to regulation in the
jurisdictions in which they operate, as described further under
Business International Regulation. A
significant portion of our revenues are generated through
operations in foreign jurisdictions, including many countries in
early stages of economic and political development. Our
international operations may be materially adversely affected by
foreign authorities and regulators, such as through
nationalization or expropriation of assets, the imposition of
limits on foreign ownership, changes in laws or their
interpretation or application, political instability, dividend
limitations, price controls, currency exchange controls or other
restrictions that prevent us from transferring funds from these
operations out of the countries in which they operate or
converting local currencies we hold to U.S. dollars or
other currencies, as well as adverse actions by foreign
governmental authorities and regulators. This may also impact
many of our customers and independent sales intermediaries.
Changes in the regulations that affect their operations also may
affect our business relationships with them and their ability to
purchase or distribute our products. Accordingly, these changes
could have a material adverse effect on our financial condition
and results of operations.
Our international operations are subject to local laws and
regulations, and we expect the scope and extent of regulation
outside of the U.S., as well as regulatory oversight, generally
to continue to increase. The authority of our international
operations to conduct business is subject to licensing
requirements, permits and approvals, and these authorizations
are subject to modification and revocation. The regulatory
environment in the countries in which we operate and changes in
laws could have a material adverse effect on us and our foreign
operations. See Our International Operations
Face Political, Legal, Operational and Other Risks, Including
Exposure to Local and Regional Economic Conditions, that Could
Negatively Affect Those Operations or Our Profitability
and Business International Regulation.
Furthermore, the increase in our international operations as a
result of the acquisition of ALICO may also subject us to
increased supervision by the Federal Reserve Board, since the
size of a bank holding companys foreign activities is
taken as an indication of the holding companys complexity.
It may also have an effect on the manner in which MetLife, Inc.
is required to calculate its RBC.
Compliance with applicable laws and regulations is time
consuming and personnel-intensive, and changes in these laws and
regulations may materially increase our direct and indirect
compliance and other expenses of doing business, thus having a
material adverse effect on our financial condition and results
of operations.
From time to time, regulators raise issues during examinations
or audits of MetLife, Inc.s regulated subsidiaries that
could, if determined adversely, have a material impact on us. We
cannot predict whether or when regulatory actions may be taken
that could adversely affect our operations. In addition, the
interpretations of regulations by regulators may change and
statutes may be enacted with retroactive impact, particularly in
areas such as accounting or statutory reserve requirements.
We are also subject to other regulations and may in the future
become subject to additional regulations. See
Business U.S. Regulation and
Business International Regulation.
33
Various
Aspects of Dodd-Frank Could Impact Our Business Operations,
Capital Requirements and Profitability and Limit Our
Growth
On July 21, 2010, President Obama signed Dodd-Frank.
Various provisions of Dodd-Frank could affect our business
operations and our profitability and limit our growth. For
example:
|
|
|
|
|
As a large, interconnected bank holding company with assets of
$50 billion or more, or possibly as an otherwise
systemically important financial company, MetLife, Inc. will be
subject to enhanced prudential standards imposed on systemically
significant financial companies. Enhanced standards will be
applied to RBC, liquidity, leverage (unless another, similar,
standard is appropriate), resolution plan and credit exposure
reporting, concentration limits, and risk management.
Off-balance sheet activities are required to be accounted for in
meeting capital requirements. In addition, if it were determined
that MetLife posed a substantial threat to U.S. financial
stability, the applicable federal regulators would have the
right to require it to take one or more other mitigating actions
to reduce that risk, including limiting its ability to merge
with or acquire another company, terminating activities,
restricting its ability to offer financial products or requiring
it to sell assets or off-balance sheet items to unaffiliated
entities. Enhanced standards would also permit, but not require,
regulators to establish requirements with respect to contingent
capital, enhanced public disclosures and short-term debt limits.
These standards are described as being more stringent than those
otherwise imposed on bank holding companies; however, the
Federal Reserve Board is permitted to apply them on an
institution-by-institution
basis, depending on its determination of the institutions
riskiness. In addition, under Dodd-Frank, all bank holding
companies that have elected to be treated as financial holding
companies, such as MetLife, Inc. will be required to be
well capitalized and well managed as
defined by the Federal Reserve Board, on a consolidated basis
and not just at their depository institution(s), a higher
standard than was applicable to financial holding companies
before
Dodd-Frank.
|
|
|
|
MetLife, Inc., as a bank holding company, will have to meet
minimum leverage ratio and RBC requirements on a consolidated
basis to be established by the Federal Reserve Board that are
not less than those applicable to insured depository
institutions under so-called prompt corrective action
regulations as in effect on the date of the enactment of
Dodd-Frank. One consequence of these new rules will ultimately
be the inability of bank holding companies to include
trust-preferred securities as part of their Tier 1 capital.
Because of the phase-in period for these new rules, they should
have little practical effect on MetLifes ability to treat
its currently outstanding trust-preferred securities as part of
its Tier 1 capital, but they do prevent MetLife, Inc. from
treating the common equity units issued as part of the
consideration for the Acquisition as Tier I capital, since
the new rules apply immediately to instruments issued after
May 19, 2010.
|
|
|
|
Under the provisions of Dodd-Frank relating to the resolution or
liquidation of certain types of financial institutions,
including bank holding companies, if MetLife, Inc. were to
become insolvent or were in danger of defaulting on its
obligations, it could be compelled to undergo liquidation with
the FDIC as receiver. For this new regime to be applicable, a
number of determinations would have to be made, including that a
default by the affected company would have serious adverse
effects on financial stability in the U.S. If the FDIC were to
be appointed as the receiver for such a company, the liquidation
of that company would occur under the provisions of the new
liquidation authority, and not under the Bankruptcy Code. In
such a liquidation, the holders of such companys debt
could in certain a respects be treated differently than under
the Bankruptcy Code. In particular, unsecured creditors and
shareholders are intended to bear the losses of the company
being liquidated. The FDIC is authorized to establish rules for
the priority of creditors claims and, under certain
circumstances, to treat similarly situated creditors
differently. These provisions could apply to some financial
institutions whose outstanding debt securities we hold in our
investment portfolios. Dodd-Frank also provides for the
assessment of bank holding companies with assets of
$50.0 billion or more, non-bank financial companies
supervised by the Federal Reserve Bank, and other financial
companies with assets of $50.0 billion or more to cover the
costs of liquidating any financial company subject to the new
liquidation authority. Although it is not possible to assess the
full impact of the liquidation authority at this time, it could
affect the funding costs of large bank holding companies or
financial companies that might be viewed as systemically
significant. It could also lead to an increase in secured
financings.
|
|
|
|
Dodd-Frank also includes a new framework of regulation of the
OTC derivatives markets which will require clearing of certain
types of transactions currently traded OTC and could potentially
impose additional costs,
|
34
|
|
|
|
|
including new capital, reporting and margin requirements and
additional regulation on the Company. Increased margin
requirements on MetLife, Inc.s part and a smaller universe
of securities that will qualify as eligible collateral could
reduce its liquidity and require an increase in its holdings of
cash and government securities with lower yields causing a
reduction in income. However, increased margin requirements and
the expanded ability to transfer trades between MetLife,
Inc.s counterparties could reduce MetLife, Inc.s
exposure to its counterparties default. MetLife, Inc. uses
derivatives to mitigate a wide range of risks in connection with
its businesses, including the impact of increased benefit
exposures from our annuity products that offer guaranteed
benefits. The derivative clearing requirements of
Dodd-Frank
could increase the cost of our risk mitigation and expose us to
the risk of a default by a clearinghouse or one of its members.
In addition, we are subject to the risk that hedging and other
management procedures prove ineffective in reducing the risks to
which insurance policies expose us or that unanticipated
policyholder behavior or mortality, combined with adverse market
events, produces economic losses beyond the scope of the risk
management techniques employed. Any such losses could be
increased by any higher costs of writing derivatives (including
customized derivatives) that might result from the enactment of
Dodd-Frank.
|
|
|
|
|
|
Dodd-Frank restricts the ability of insured depository
institutions and of companies, such as MetLife, Inc., that
control an insured depository institution and their affiliates,
to engage in proprietary trading and to sponsor or invest in
funds (hedge funds and private equity funds) that rely on
certain exemptions from the Investment Company Act. Dodd-Frank
provides an exemption for investment activity by a regulated
insurance company or its affiliate solely for the general
account of such insurance company if such activity is in
compliance with the insurance company investments laws of the
state or jurisdiction in which such company is domiciled and the
appropriate Federal regulators after consultation with relevant
insurance commissioners have not jointly determined such laws to
be insufficient to protect the safety and soundness of the
institution or the financial stability of the U.S.
Notwithstanding the foregoing, the appropriate Federal
regulatory authorities are permitted under the legislation to
impose, as part of rulemaking, additional capital requirements
and other restrictions on any exempted activity. Dodd-Frank
provides for a period of study and rule making during which the
effects of the statutory language may be clarified. Among other
considerations, the study is to assess and include
recommendations so as to appropriately accommodate the business
of insurance within an insurance company subject to regulation
in accordance with relevant insurance company investments laws.
While these provisions of Dodd-Frank are supposed to accommodate
the business of insurance, until the related study and
rulemaking are complete, it is unclear whether MetLife, Inc. may
have to alter any of its future investment activities to comply.
|
|
|
|
Until various studies are completed and final regulations are
promulgated pursuant to Dodd-Frank, the full impact of
Dodd-Frank on the investments and investment activities and
insurance and annuity products of MetLife, Inc. and its
subsidiaries remains unclear. For example, besides directly
limiting our future investment activities, Dodd-Frank could
potentially negatively impact the market for, the returns from,
or liquidity in, primary and secondary investments in private
equity funds and hedge funds that are connected to (either
through a fund sponsorship or investor relationship) an insured
depository institution. The number of sponsors of such funds
going forward may diminish, which may impact our available fund
investment opportunities. Although Dodd-Frank provides for
various transition periods for coming into compliance, fund
sponsors that are subject to Dodd-Frank, and whose funds we have
invested in, may have to spin off their funds business or reduce
their ownership stakes in their funds, thereby potentially
impacting our related investments in such funds. In addition,
should such funds be required or choose to liquidate or sell
their underlying assets, the market value and liquidity of such
assets or the broader related asset classes could negatively be
affected, including securities and real estate assets that
MetLife, Inc. and its subsidiaries hold or may plan to sell.
Secondary sales of fund interests at significant discounts by
banking institutions and their affiliates, which are not fund
sponsors but nevertheless are subject to the divestment
requirements of
Dodd-Frank,
could reduce the returns realized by investors such as MetLife,
Inc. and its subsidiaries seeking to access liquidity by selling
their fund interests. In addition, our existing derivatives
counterparties and the financial institutions subject to
Dodd-Frank in which we have invested also could be negatively
impacted by Dodd-Frank. See also New and
Impending Compensation and Corporate Governance Regulations
Could Hinder or Prevent Us From Attracting and Retaining
Management and Other Employees with the Talent and Experience to
Manage and Conduct Our Business Effectively.
|
35
|
|
|
|
|
In addition, Dodd-Frank statutorily imposes the requirement that
MetLife, Inc. serve as a source of strength for MetLife Bank.
|
The addition of a new regulatory regime over MetLife, Inc. and
its subsidiaries, the likelihood of additional regulations, and
the other changes discussed above could require changes to
MetLife, Inc.s operations. Whether such changes would
affect our competitiveness in comparison to other institutions
is uncertain, since it is possible that at least some of our
competitors, for example insurance holding companies that
control thrifts, rather than banks, will be similarly affected.
Competitive effects are possible, however, if MetLife, Inc. were
required to pay any new or increased assessments and capital
requirements are imposed, and to the extent any new prudential
supervisory standards are imposed on MetLife, Inc. but not on
its competitors. We cannot predict whether other proposals will
be adopted, or what impact, if any, the adoption of Dodd-Frank
or other proposals and the resulting studies and regulations
could have on our business, financial condition or results of
operations or on our dealings with other financial companies.
See also Our Insurance, Brokerage and Banking
Businesses are Heavily Regulated, and Changes in Regulation May
Reduce Our Profitability and Limit Our Growth and
New and Impending Compensation and Corporate
Governance Regulations Could Hinder or Prevent Us From
Attracting and Retaining Management and Other Employees with the
Talent and Experience to Manage and Conduct Our Business
Effectively.
Moreover, Dodd-Frank potentially affects such a wide range of
the activities and markets in which MetLife, Inc. and its
subsidiaries engage and participate that it may not be possible
to anticipate all of the ways in which it could affect us. For
example, many of our methods for managing risk and exposures are
based upon the use of observed historical market behavior or
statistics based on historical models. Historical market
behavior may be altered by the enactment of Dodd-Frank. As a
result of this enactment and otherwise, these methods may not
fully predict future exposures, which could be significantly
greater than our historical measures indicate.
The
Resolution of Several Issues Affecting the Financial Services
Industry Could Have a Negative Impact on Our Reported Results or
on Our Relations with Current and Potential
Customers
We will continue to be subject to legal and regulatory actions
in the ordinary course of our business, both in the U.S. and
internationally. This could result in a review of business sold
in the past under previously acceptable market practices at the
time. Regulators are increasingly interested in the approach
that product providers use to select third-party distributors
and to monitor the appropriateness of sales made by them. In
some cases, product providers can be held responsible for the
deficiencies of third-party distributors.
As a result of publicity relating to widespread perceptions of
industry abuses, there have been numerous regulatory inquiries
and proposals for legislative and regulatory reforms.
In Asia, where MetLife derives and will continue to derive a
significant portion of its income, regulatory regimes are
developing at different speeds, driven by a combination of
global factors and local considerations. New requirements may be
introduced that are retrospectively applied to sales made prior
to their introduction.
We Are
Exposed to Significant Financial and Capital Markets Risk Which
May Adversely Affect Our Results of Operations, Financial
Condition and Liquidity, and May Cause Our Net Investment Income
to Vary from Period to Period
We are exposed to significant financial and capital markets
risk, including changes in interest rates, credit spreads,
equity prices, real estate markets, foreign currency exchange
rates, market volatility, the performance of the global economy
in general, the performance of the specific obligors, including
governments, included in our portfolio and other factors outside
our control.
Our exposure to interest rate risk relates primarily to the
market price and cash flow variability associated with changes
in interest rates. Changes in interest rates will impact the net
unrealized gain or loss position of our fixed income investment
portfolio. If long-term interest rates rise dramatically within
a six to twelve month time period, certain of our life insurance
businesses and fixed annuity business may be exposed to
disintermediation risk. Disintermediation risk refers to the
risk that our policyholders may surrender their contracts in a
rising interest rate environment, requiring us to liquidate
fixed income investments in an unrealized loss position. Due to
the long-term
36
nature of the liabilities associated with certain of our life
insurance businesses, guaranteed benefits on variable annuities,
and structured settlements, sustained declines in long-term
interest rates may subject us to reinvestment risks and
increased hedging costs. In other situations, declines in
interest rates may result in increasing the duration of certain
life insurance liabilities, creating asset-liability duration
mismatches.
Our investment portfolio also contains interest rate sensitive
instruments, such as fixed income securities, which may be
adversely affected by changes in interest rates from
governmental monetary policies, domestic and international
economic and political conditions and other factors beyond our
control. Changes in interest rates will impact both the net
unrealized gain or loss position of our fixed income portfolio
and the rates of return we receive on funds invested. Our
mitigation efforts with respect to interest rate risk are
primarily focused towards maintaining an investment portfolio
with diversified maturities that has a weighted average duration
that is approximately equal to the duration of our estimated
liability cash flow profile. However, our estimate of the
liability cash flow profile may be inaccurate and we may be
forced to liquidate fixed income investments prior to maturity
at a loss in order to cover the cash flow profile of the
liability. Although we take measures to manage the economic
risks of investing in a changing interest rate environment, we
may not be able to mitigate the interest rate risk of our fixed
income investments relative to our liabilities. See also
Changes in Market Interest Rates May
Significantly Affect Our Profitability.
Our exposure to credit spreads primarily relates to market price
volatility and cash flow variability associated with changes in
credit spreads. A widening of credit spreads will adversely
impact both the net unrealized gain or loss position of the
fixed-income investment portfolio, will increase losses
associated with credit-based non-qualifying derivatives where we
assume credit exposure, and, if issuer credit spreads increase
significantly or for an extended period of time, will likely
result in higher
other-than-temporary
impairments. Credit spread tightening will reduce net investment
income associated with new purchases of fixed maturity
securities. In addition, market volatility can make it difficult
to value certain of our securities if trading becomes less
frequent. As such, valuations may include assumptions or
estimates that may have significant period to period changes
which could have a material adverse effect on our results of
operations or financial condition. Credit spreads on both
corporate and structured securities widened significantly during
2008, resulting in continuing depressed pricing. As a result of
improved conditions, credit spreads narrowed in 2009 and changed
to a lesser extent in 2010. If there is a resumption of
significant volatility in the markets, it could cause changes in
credit spreads and defaults and a lack of pricing transparency
which, individually or in tandem, could have a material adverse
effect on our results of operations, financial condition,
liquidity or cash flows through realized investment losses,
impairments, and changes in unrealized loss positions.
Our primary exposure to equity risk relates to the potential for
lower earnings associated with certain of our insurance
businesses where fee income is earned based upon the estimated
fair value of the assets under management. Downturns and
volatility in equity markets can have a material adverse effect
on the revenues and investment returns from our savings and
investment products and services. Because these products and
services generate fees related primarily to the value of assets
under management, a decline in the equity markets could reduce
our revenues from the reduction in the value of the investments
we manage. The retail variable annuity business in particular is
highly sensitive to equity markets, and a sustained weakness in
the equity markets could decrease revenues and earnings in
variable annuity products. Furthermore, certain of our variable
annuity products offer guaranteed benefits which increase our
potential benefit exposure should equity markets decline.
MetLife, Inc. uses derivatives and reinsurance to mitigate the
impact of such increased potential benefit exposures. We are
also exposed to interest rate and equity risk based upon the
discount rate and expected long-term rate of return assumptions
associated with our pension and other postretirement benefit
obligations. Sustained declines in long-term interest rates or
equity returns likely would have a negative effect on the funded
status of these plans. Lastly, we invest a portion of our
investments in public and private equity securities, leveraged
buy-out funds, hedge funds and other private equity funds and
the estimated fair value of such investments may be impacted by
downturns or volatility in equity markets.
Our primary exposure to real estate risk relates to commercial
and agricultural real estate. Our exposure to commercial and
agricultural real estate risk stems from various factors. These
factors include, but are not limited to, market conditions
including the demand and supply of leasable commercial space,
creditworthiness of tenants and partners, capital markets
volatility and the inherent interest rate movement. In addition,
our real estate joint venture development program is subject to
risks, including, but not limited to, reduced property sales and
decreased availability of financing which could adversely impact
the joint venture developments
and/or
operations. The state of the economy
37
and speed of recovery in fundamental and capital market
conditions in the commercial and agricultural real estate
sectors will continue to influence the performance of our
investments in these sectors. These factors and others beyond
our control could have a material adverse effect on our results
of operations, financial condition, liquidity or cash flows
through net investment income, realized investment losses and
levels of valuation allowances.
Our investment portfolio contains investments in government
bonds issued by European nations. Recently, the European Union
member states have experienced above average public debt,
inflation and unemployment as the global economic downturn has
developed. A number of member states are significantly impacted
by the economies of their more influential neighbors, such as
Germany. In addition, financial troubles of one nation can
trigger a domino effect on others. In particular, a number of
large European banks hold significant amounts of sovereign
financial institution debt of other European nations and could
experience difficulties as a result of defaults or declines in
the value of such debt. Our investment portfolio also contains
investments in revenue bonds issued under the auspices of
U.S. states and municipalities and a limited amount of
general obligation bonds of U.S. states and municipalities
(collectively, Municipal Bonds). Recently, certain
U.S. states and municipalities have faced budget deficits
and financial difficulties. There can be no assurance that the
financial difficulties of such U.S. states and
municipalities would not have an adverse impact on our Municipal
Bond portfolio.
Our primary foreign currency exchange risks are described under
Fluctuations in Foreign Currency Exchange
Rates Could Negatively Affect Our Profitability. Changes
in these factors, which are significant risks to us, can affect
our net investment income in any period, and such changes can be
substantial.
A portion of our investments are made in leveraged buy-out
funds, hedge funds and other private equity funds, many of which
make private equity investments. The amount and timing of net
investment income from such investment funds tends to be uneven
as a result of the performance of the underlying investments,
including private equity investments. The timing of
distributions from the funds, which depends on particular events
relating to the underlying investments, as well as the
funds schedules for making distributions and their needs
for cash, can be difficult to predict. As a result, the amount
of net investment income that we record from these investments
can vary substantially from quarter to quarter. Recovering
private equity markets and stabilizing credit and real estate
markets during 2010 had a positive impact on returns and net
investment income on private equity funds, hedge funds and real
estate joint ventures, which are included within other limited
partnership interests and real estate and real estate joint
venture portfolios. Although volatility in most global financial
markets has moderated, if there is a resumption of significant
volatility, it could adversely impact returns and net investment
income on these alternative investment classes.
Continuing challenges include continued weakness in the
U.S. real estate market and increased residential mortgage
loan and other consumer loan delinquencies, investor anxiety
over the U.S. and European economies, rating agency
downgrades of various structured products and financial issuers,
unresolved issues with structured investment vehicles and
monoline financial guarantee insurers, deleveraging of financial
institutions and hedge funds and the continuing recovery in the
inter-bank market. If there is a resumption of significant
volatility in the markets, it could cause changes in interest
rates, declines in equity prices, and the strengthening or
weakening of foreign currencies against the U.S. dollar
which, individually or in tandem, could have a material adverse
effect on our results of operations, financial condition,
liquidity or cash flows through realized investment losses,
impairments, increased valuation allowances and changes in
unrealized gain or loss positions.
Changes
in Market Interest Rates May Significantly Affect Our
Profitability
Some of our products, principally traditional whole life
insurance, fixed annuities and guaranteed interest contracts,
expose us to the risk that changes in interest rates will reduce
our investment margin or spread, or the difference
between the amounts that we are required to pay under the
contracts in our general account and the rate of return we are
able to earn on general account investments intended to support
obligations under the contracts. Our spread is a key component
of our net income.
As interest rates decrease or remain at low levels, we may be
forced to reinvest proceeds from investments that have matured
or have been prepaid or sold at lower yields, reducing our
investment margin. Moreover, borrowers may prepay or redeem the
fixed income securities, commercial or agricultural mortgage
loans and mortgage-backed securities in our investment portfolio
with greater frequency in order to borrow at lower market rates,
which exacerbates this risk.
38
Lowering interest crediting rates can help offset decreases in
investment margins on some products. However, our ability to
lower these rates could be limited by competition or
contractually guaranteed minimum rates and may not match the
timing or magnitude of changes in asset yields. As a result, our
spread could decrease or potentially become negative. Our
expectation for future spreads is an important component in the
amortization of DAC and value of business acquired
(VOBA), and significantly lower spreads may cause us
to accelerate amortization, thereby reducing net income in the
affected reporting period. In addition, during periods of
declining interest rates, life insurance and annuity products
may be relatively more attractive investments to consumers,
resulting in increased premium payments on products with
flexible premium features, repayment of policy loans and
increased persistency, or a higher percentage of insurance
policies remaining in force from year to year, during a period
when our new investments carry lower returns. A decline in
market interest rates could also reduce our return on
investments that do not support particular policy obligations.
Accordingly, declining interest rates may materially affect our
results of operations, financial position and cash flows and
significantly reduce our profitability. We recognize that a low
interest rate environment will adversely affect our earnings,
but we do not believe any such impact will be material in 2011.
The sufficiency of our life insurance statutory reserves in
Taiwan is highly sensitive to interest rates and other related
assumptions. This is due to the sustained low interest rate
environment in Taiwan coupled with long-term interest rate
guarantees of approximately 6% embedded in the life and health
contracts sold prior to 2003 and the lack of availability of
long-duration investments in the Taiwanese capital markets to
match such long-duration liabilities. The key assumptions
include current Taiwan government bond yield rates increasing
approximately 1% from current levels over the next ten years,
lapse rates, mortality and morbidity levels remaining consistent
with recent experience, and U.S. dollar-denominated
investments making up to 35% of total assets backing life
insurance statutory reserves. Current reserve adequacy analysis
shows that provisions are adequate; however, adverse changes in
key assumptions for interest rates, lapse experience and
mortality and morbidity levels could lead to a need to
strengthen reserves.
Increases in market interest rates could also negatively affect
our profitability. In periods of rapidly increasing interest
rates, we may not be able to replace, in a timely manner, the
investments in MetLifes general account with higher
yielding investments needed to fund the higher crediting rates
necessary to keep interest sensitive products competitive. We,
therefore, may have to accept a lower spread and, thus, lower
profitability or face a decline in sales and greater loss of
existing contracts and related assets. In addition, policy
loans, surrenders and withdrawals may tend to increase as
policyholders seek investments with higher perceived returns as
interest rates rise. This process may result in cash outflows
requiring that we sell investments at a time when the prices of
those investments are adversely affected by the increase in
market interest rates, which may result in realized investment
losses. Unanticipated withdrawals and terminations may cause us
to accelerate the amortization of DAC, VOBA and negative VOBA,
which reduces net income. An increase in market interest rates
could also have a material adverse effect on the value of our
investment portfolio, for example, by decreasing the estimated
fair values of the fixed income securities that comprise a
substantial portion of our investment portfolio. Lastly, an
increase in interest rates could result in decreased fee income
associated with a decline in the value of variable annuity
account balances invested in fixed income funds.
Some
of Our Investments Are Relatively Illiquid and Are in Asset
Classes That Have Been Experiencing Significant Market
Valuation Fluctuations
We hold certain investments that may lack liquidity, such as
privately-placed fixed maturity securities; mortgage loans;
policy loans and leveraged leases; equity real estate, including
real estate joint ventures and funds; and other limited
partnership interests. These asset classes represented 26.6% of
the carrying value of our total cash and investments at
December 31, 2010. In recent years, even some of our very
high quality investments experienced reduced liquidity during
periods of market volatility or disruption. If we require
significant amounts of cash on short notice in excess of normal
cash requirements or are required to post or return cash
collateral in connection with our investment portfolio,
derivatives transactions or securities lending program, we may
have difficulty selling these investments in a timely manner, be
forced to sell them for less than we otherwise would have been
able to realize, or both. The reported value of our relatively
illiquid types of investments, our investments in the asset
classes described above and, at times, our high quality,
generally liquid asset classes, do not necessarily reflect the
lowest current market price for the asset. If we were forced to
sell certain of our investments in the global market, there can
be no assurance that we will be able to sell them for the prices
at which we have recorded them and we could be forced to sell
them at significantly lower prices.
39
Our
Participation in a Securities Lending Program Subjects Us to
Potential Liquidity and Other Risks
We participate in a securities lending program whereby blocks of
securities, which are included in fixed maturity securities and
short-term investments, are loaned to third parties, primarily
brokerage firms and commercial banks. We generally obtain
collateral in an amount equal to 102% of the estimated fair
value of the loaned securities, which is obtained at the
inception of a loan and maintained at a level greater than or
equal to 100% for the duration of the loan. Returns of loaned
securities by the third parties would require us to return the
collateral associated with such loaned securities. In addition,
in some cases, the maturity of the securities held as invested
collateral (i.e., securities that we have purchased with cash
collateral received from the third parties) may exceed the term
of the related securities on loan and the estimated fair value
may fall below the amount of cash received as collateral and
invested. If we are required to return significant amounts of
cash collateral on short notice and we are forced to sell
securities to meet the return obligation, we may have difficulty
selling such collateral that is invested in securities in a
timely manner, be forced to sell securities in a volatile or
illiquid market for less than we otherwise would have been able
to realize under normal market conditions, or both. In addition,
under stressful capital market and economic conditions,
liquidity broadly deteriorates, which may further restrict our
ability to sell securities. If we decrease the amount of our
securities lending activities over time, the amount of net
investment income generated by these activities will also likely
decline. See Managements Discussion and Analysis of
Financial Condition and Results of Operations
Investments Securities Lending.
Our
Requirements to Pledge Collateral or Make Payments Related to
Declines in Estimated Fair Value of Specified Assets May
Adversely Affect Our Liquidity and Expose Us to Counterparty
Credit Risk
Some of our transactions with financial and other institutions
specify the circumstances under which the parties are required
to pledge collateral related to any decline in the estimated
fair value of the specified assets. In addition, under the terms
of some of our transactions, we may be required to make payments
to our counterparties related to any decline in the estimated
fair value of the specified assets. The amount of collateral we
may be required to pledge and the payments we may be required to
make under these agreements may increase under certain
circumstances, which could adversely affect our liquidity. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations Liquidity and
Capital Resources The Company Liquidity
and Capital Sources Collateral Financing
Arrangements and Note 12 of the Notes to the
Consolidated Financial Statements.
Gross
Unrealized Losses on Fixed Maturity and Equity Securities May Be
Realized or Result in Future Impairments, Resulting in a
Reduction in Our Net Income
Fixed maturity and equity securities classified as
available-for-sale
are reported at their estimated fair value. Unrealized gains or
losses on
available-for-sale
securities are recognized as a component of other comprehensive
income (loss) and are, therefore, excluded from net income. Our
gross unrealized losses on fixed maturity and equity securities
available for sale at December 31, 2010 were
$6.9 billion. The portion of the $6.9 billion of gross
unrealized losses for fixed maturity and equity securities where
the estimated fair value has declined and remained below
amortized cost or cost by 20% or more for six months or greater
was $2.1 billion at December 31, 2010. The accumulated
change in estimated fair value of these
available-for-sale
securities is recognized in net income when the gain or loss is
realized upon the sale of the security or in the event that the
decline in estimated fair value is determined to be
other-than-temporary
and an impairment charge to earnings is taken. Realized losses
or impairments may have a material adverse effect on our net
income in a particular quarterly or annual period.
The
Determination of the Amount of Allowances and Impairments Taken
on Our Investments is Highly Subjective and Could Materially
Impact Our Results of Operations or Financial
Position
The determination of the amount of allowances and impairments
varies by investment type and is based upon our periodic
evaluation and assessment of known and inherent risks associated
with the respective asset class. Such evaluations and
assessments are revised as conditions change and new information
becomes available. We update our evaluations regularly and
reflect changes in allowances and impairments in net investment
losses as such evaluations are revised. Additional impairments
may need to be taken or allowances provided for in the future.
Furthermore, historical trends may not be indicative of future
impairments or allowances.
40
For example, the cost of our fixed maturity and equity
securities is adjusted for impairments deemed to be
other-than-temporary.
The assessment of whether impairments have occurred is based on
our
case-by-case
evaluation of the underlying reasons for the decline in
estimated fair value. The review of our fixed maturity and
equity securities for impairments includes an analysis of the
total gross unrealized losses by three categories of securities:
(i) securities where the estimated fair value has declined
and remained below cost or amortized cost by less than 20%;
(ii) securities where the estimated fair value has declined
and remained below cost or amortized cost by 20% or more for
less than six months; and (iii) securities where the
estimated fair value has declined and remained below cost or
amortized cost by 20% or more for six months or greater.
Additionally, we consider a wide range of factors about the
security issuer and use our best judgment in evaluating the
cause of the decline in the estimated fair value of the security
and in assessing the prospects for near term recovery. Inherent
in our evaluation of the security are assumptions and estimates
about the operations of the issuer and its future earnings
potential. Considerations in the impairment evaluation process
include, but are not limited to: (i) the length of time and
the extent to which the estimated fair value has been below cost
or amortized cost; (ii) the potential for impairments of
securities when the issuer is experiencing significant financial
difficulties; (iii) the potential for impairments in an
entire industry sector or
sub-sector;
(iv) the potential for impairments in certain economically
depressed geographic locations; (v) the potential for
impairments of securities where the issuer, series of issuers or
industry has suffered a catastrophic type of loss or has
exhausted natural resources; (vi) with respect to fixed
maturity securities, whether we have the intent to sell or will
more likely than not be required to sell a particular security
before recovery of the decline in estimated fair value below
amortized cost; (vii) with respect to equity securities,
whether we have the ability and intent to hold a particular
security for a period of time sufficient to allow for the
recovery of its estimated fair value to an amount at least equal
to its cost; (viii) unfavorable changes in forecasted cash
flows on mortgage-backed and asset-backed securities
(ABS); and (ix) other subjective factors,
including concentrations and information obtained from
regulators and rating agencies.
Defaults
on Our Mortgage Loans and Volatility in Performance May
Adversely Affect Our Profitability
Our mortgage loans face default risk and are principally
collateralized by commercial, agricultural and residential
properties. We establish valuation allowances for estimated
impairments at the balance sheet date. Such valuation allowances
are based on the excess carrying value of the loan over the
present value of expected future cash flows discounted at the
loans original effective interest rate, the estimated fair
value of the loans collateral if the loan is in the
process of foreclosure or otherwise collateral dependent, or the
loans observable market price. We also establish valuation
allowances for loan losses for pools of loans with similar risk
characteristics, such as property types, or loans having similar
loan-to-value
ratios and debt service coverage ratios, when based on past
experience, it is probable that a credit event has occurred and
the amount of the loss can be reasonably estimated. These
valuation allowances are based on loan risk characteristics,
historical default rates and loss severities, real estate market
fundamentals and outlook as well as other relevant factors. At
December 31, 2010, mortgage loans that were either
delinquent or in the process of foreclosure totaled less than
0.6% of our mortgage loan investments. The performance of our
mortgage loan investments, however, may fluctuate in the future.
In addition, substantially all of our mortgage loans
held-for-investment
have balloon payment maturities. An increase in the default rate
of our mortgage loan investments could have a material adverse
effect on our business, results of operations and financial
condition through realized investment losses or increases in our
valuation allowances.
Further, any geographic or sector concentration of our mortgage
loans may have adverse effects on our investment portfolios and
consequently on our results of operations or financial
condition. While we seek to mitigate this risk by having a
broadly diversified portfolio, events or developments that have
a negative effect on any particular geographic region or sector
may have a greater adverse effect on the investment portfolios
to the extent that the portfolios are concentrated. Moreover,
our ability to sell assets relating to such particular groups of
related assets may be limited if other market participants are
seeking to sell at the same time. In addition, legislative
proposals that would allow or require modifications to the terms
of mortgage loans could be enacted. We cannot predict whether
these proposals will be adopted, or what impact, if any, such
proposals or, if enacted, such laws, could have on our business
or investments. See Managements Discussion and
Analysis of Financial Condition and Results of
Operations Investments Mortgage
Loans.
41
The
Impairment of Other Financial Institutions Could Adversely
Affect Us
We have exposure to many different industries and
counterparties, and routinely execute transactions with
counterparties in the financial services industry, including
brokers and dealers, commercial banks, investment banks, hedge
funds and other investment funds and other institutions. Many of
these transactions expose us to credit risk in the event of
default of our counterparty. In addition, with respect to
secured transactions, our credit risk may be exacerbated when
the collateral held by us cannot be realized or is liquidated at
prices not sufficient to recover the full amount of the loan or
derivative exposure due to us. We also have exposure to these
financial institutions in the form of unsecured debt
instruments, non-redeemable and redeemable preferred securities,
derivative transactions, joint venture, hedge fund and equity
investments. Further, potential action by governments and
regulatory bodies in response to the financial crisis affecting
the global banking system and financial markets, such as
investment, nationalization, conservatorship, receivership and
other intervention, whether under existing legal authority or
any new authority that may be created, could negatively impact
these instruments, securities, transactions and investments.
There can be no assurance that any such losses or impairments to
the carrying value of these investments would not materially and
adversely affect our business and results of operations.
We
Face Unforeseen Liabilities, Asset Impairments or Rating Actions
Arising from Acquisitions, Including ALICO, and Dispositions of
Businesses or Difficulties Integrating and Managing Growth of
Such Businesses
We have engaged in dispositions and acquisitions of businesses
in the past, and expect to continue to do so in the future.
Acquisition and disposition activity exposes us to a number of
risks.
There could be unforeseen liabilities or asset impairments,
including goodwill impairments, that arise in connection with
the businesses that we may sell or the businesses that we may
acquire in the future.
In addition, there may be liabilities or asset impairments that
we fail, or are unable, to discover in the course of performing
due diligence investigations on each business that we have
acquired or may acquire. Furthermore, even for obligations and
liabilities that we do discover during the due diligence
process, neither the valuation adjustment nor the contractual
protections we negotiate may be sufficient to fully protect us
from losses. For example, in connection with the acquisition of
ALICO, we may be exposed to obligations and liabilities of ALICO
that are not adequately covered, in amount, scope or duration,
by the indemnification provisions in the Stock Purchase
Agreement or reflected or reserved for in ALICOs
historical financial statements. Although we have rights to
indemnification from ALICO Holdings under the Stock Purchase
Agreement for certain losses, our rights are limited by survival
periods for bringing claims and monetary limitations on the
amount we may recover, and we cannot be certain that
indemnification will be, among other things, collectible or
sufficient in amount, scope or duration to fully offset any loss
we may suffer.
Furthermore, the use of our own funds as consideration in any
acquisition would consume capital resources that would no longer
be available for other corporate purposes. We also may not be
able to raise sufficient funds to consummate an acquisition if,
for example, we are unable to sell our securities or close
related bridge credit facilities. Moreover, as a result of
uncertainty and risks associated with potential acquisitions and
dispositions of businesses, rating agencies may take certain
actions with respect to the ratings assigned to MetLife, Inc.
and/or its
subsidiaries.
Our ability to achieve certain benefits we anticipate from any
acquisitions of businesses will depend in large part upon our
ability to successfully integrate such businesses in an
efficient and effective manner. We may not be able to integrate
such businesses smoothly or successfully, and the process may
take longer than expected. The integration of operations and
differences in operational culture may require the dedication of
significant management resources, which may distract
managements attention from
day-to-day
business. If we are unable to successfully integrate the
operations of such acquired businesses, we may be unable to
realize the benefits we expect to achieve as a result of such
acquisitions and our business and results of operations may be
less than expected.
42
The success with which we are able to integrate acquired
operations, will depend on our ability to manage a variety of
issues, including the following:
|
|
|
|
|
Loss of key personnel or higher than expected employee attrition
rates could adversely affect the performance of the acquired
business and our ability to integrate it successfully.
|
|
|
|
Customers of the acquired business may reduce, delay or defer
decisions concerning their use of its products and services as a
result of the acquisition or uncertainty related to the
consummation of the acquisition, including, for example,
potential unfamiliarity with the MetLife brand in regions where
MetLife did not have a market presence prior to the acquisition.
|
|
|
|
If the acquired business relies upon independent distributors to
distribute its products, these distributors may not continue to
generate the same volume of business for MetLife after the
acquisition. Independent distributors may reexamine the scope of
their relationship with the acquired business or MetLife as a
result of the acquisition and decide to curtail or eliminate
distribution of our products.
|
|
|
|
Integrating acquired operations with our existing operations may
require us to coordinate geographically separated organizations,
address possible differences in corporate culture and management
philosophies, merge financial processes and risk and compliance
procedures, combine separate information technology platforms
and integrate operations that were previously closely tied to
the former parent of the acquired business or other service
providers.
|
|
|
|
In cases where we or an acquired business operates in certain
markets through joint ventures, the acquisition may affect the
continued success and prospects of the joint venture. Our
ability to exercise management control or influence over these
joint venture operations and our investment in them will depend
on the continued cooperation between the joint venture
participants and on the terms of the joint venture agreements,
which allocate control among the joint venture participants. We
may face financial or other exposure in the event that any of
these joint venture partners fail to meet their obligations
under the joint venture, encounter financial difficulty or elect
to alter, modify or terminate the relationship.
|
|
|
|
We may incur significant costs in connection with any
acquisition and the related integration. The costs and
liabilities actually incurred in connection with an acquisition
and subsequent integration process may exceed those anticipated.
|
All of these challenges are present in our integration of ALICO,
which we expect to extend over a substantial period.
The prospects of our business also may be materially and
adversely affected if we are not able to manage the growth of
any acquired business successfully. For example, the life
insurance markets in many of the international markets in which
ALICO operates have experienced significant growth in recent
years. Management of ALICOs growth to date has required
significant management and operational resources and is likely
to continue to do so. Future growth of our combined business
will require, among other things, the continued development of
adequate underwriting and claim handling capabilities and
skills, sufficient capital base, increased marketing and sales
activities, and the hiring and training of new personnel.
There can be no assurance that we will be successful in managing
future growth of any acquired business, including ALICO. In
particular, there may be difficulties in hiring and training
sufficient numbers of customer service personnel and agents to
keep pace with any future growth in the number of customers in
our developing or developed markets. In addition, we may
experience difficulties in upgrading, developing and expanding
information technology systems quickly enough to accommodate any
future growth. If we are unable to manage future growth, our
prospects may be materially and adversely affected.
There
Can Be No Assurance That the Closing Agreement American Life
Entered Into With the IRS Will Achieve Its Intended Effect, or
That American Life Will Be Able to Comply with the Related
Agreed Upon Plan
On March 4, 2010, American Life entered into a closing
agreement with the Commissioner of the IRS with respect to a
U.S. withholding tax issue arising from payments by foreign
branches of a life insurance company
43
incorporated under U.S. law. IRS Revenue Ruling
2004-75,
effective January 1, 2005, requires foreign branches of
U.S. life insurance companies in certain circumstances to
withhold U.S. income taxes on payments of taxable income
made with respect to certain insurance and annuity products paid
to customers resident in a foreign country. The closing
agreement provides transitional relief under
Section 7805(b) of the Code to American Life, such that
American Lifes foreign branches will not be required to
withhold U.S. income tax on the income portion of payments
made pursuant to American Lifes life insurance and annuity
contracts (Covered Payments) under IRS Revenue
Ruling
2004-75 for
any tax periods beginning on January 1, 2005 and ending on
December 31, 2013 (the Deferral Period). In
accordance with the closing agreement, American Life submitted a
plan to the IRS indicating the steps American Life will take (on
a country by country basis) to ensure that no substantial amount
of U.S. withholding tax will arise from Covered Payments
made by American Lifes foreign branches to foreign
customers after the Deferral Period. In addition, the closing
agreement requires that such plan be updated in quarterly
filings with the IRS. The closing agreement is final and binding
upon American Life and the IRS; provided, however,
that the agreement can be reopened in the event of malfeasance,
fraud or a misrepresentation of a material fact, and is subject
to change of law risk that occurs after the effective date of
the closing agreement (with certain exceptions). In addition,
the closing agreement provides that no legislative amendment to
Section 861(a)(1)(A) of the Code shall shorten the Deferral
Period, regardless of when such amendment is enacted. The plan
American Life delivered to the IRS involves the transfer of
businesses from certain of the foreign branches of American Life
to one or more existing or newly-formed foreign affiliates of
American Life; however, the plan is subject to change pursuant
to the quarterly updates that American Life will provide to the
IRS. An estimate of the costs to comply with the plan has been
recorded in the financial statements. Also the achievement of
the plan presented to the IRS within the required time frame of
December 31, 2013 is contingent upon regulatory approvals
and other requirements. Failure to achieve the plan in a timely
manner could cause American Life to be required to withhold
U.S. income taxes on the taxable portion of payments made
by American Lifes foreign branches after December 31,
2013 to customers resident in a foreign country, which could put
American Life at a competitive disadvantage with its competitors
that sell similar products through foreign entities and could
have a material adverse effect on American Lifes future
revenues or expenses or both.
There
Can Be No Assurance That Any Incremental Tax Benefit Will Result
From the Currently Planned Elections Under Section 338 of
the Code
MetLife, Inc. currently plans to make Section 338 Elections
with respect to ALICO and certain of its subsidiaries, and
MetLife, Inc. believes that ALICO and such subsidiaries should
have additional amortizable basis in their assets for
U.S. tax purposes as a result of such elections. No
assurance can be given, however, as to the incremental tax
benefit, if any, that will result from any such elections,
if made.
The
Issuance of Certain Equity Securities to ALICO Holdings in
Connection with the Acquisition Will Have a Dilutive Impact on
MetLife, Inc.s Stockholders
As part of the consideration paid to ALICO Holdings pursuant to
the terms of the Stock Purchase Agreement, MetLife, Inc. issued
to ALICO Holdings (A) 78,239,712 shares of its common
stock, (B) 6,857,000 shares of the Series B
Contingent Convertible Junior Participating Non-Cumulative
Perpetual Preferred Stock (the Convertible Preferred
Stock), which will be convertible into approximately
68,570,000 shares of MetLife, Inc.s common stock
(subject to anti-dilution adjustments) upon a favorable vote of
MetLife, Inc.s common stockholders, and
(C) $3.0 billion aggregate stated amount of MetLife,
Inc.s common equity units, which initially consist of
(x) purchase contracts obligating the holder to purchase a
variable number of shares of MetLife, Inc.s common stock
on each of three specified future settlement dates
(approximately two, three and four years after the closing of
the Acquisition, subject to deferral under certain
circumstances) for a fixed amount per purchase contract (an
aggregate of $1.0 billion on each settlement date) (the
Stock Purchase Contracts) and (y) an interest
in each of three series of debt securities of MetLife, Inc. The
aggregate amount of MetLife, Inc.s common stock expected
to be issued to ALICO Holdings in connection with the
Acquisition (including shares of common stock issuable upon
conversion of the Convertible Preferred Stock and shares of
common stock issuable upon settlement of the Stock Purchase
Contracts) is expected to be approximately 214,600,000 to
231,500,000 shares.
44
As a result of the issuance of these securities, more shares of
common stock will be outstanding and each existing stockholder
will own a smaller percentage of our common stock then
outstanding.
Subject
to Certain Limitations, ALICO Holdings Will Be Able to Sell
MetLife, Inc.s Equity Securities at Any Time From and
After the Date 270 Days After the Closing of the Acquisition,
Which Could Cause MetLife, Inc.s Stock Price to
Decrease
ALICO Holdings agreed in the Investor Rights Agreement entered
into in connection with the Acquisition, not to transfer any of
MetLife, Inc.s securities received pursuant to the terms
of the Stock Purchase Agreement, at any time up to the date
270 days after the closing of the Acquisition, without the
consent of MetLife, Inc. However, from and after such date,
ALICO Holdings will be able to transfer up to half of such
equity securities, and from and after the first anniversary of
the closing of the Acquisition, ALICO Holdings will be able to
transfer all of such securities, subject in each case to certain
limited volume and timing restrictions set forth in the Investor
Rights Agreement. Moreover, ALICO Holdings will agree to use
commercially reasonable efforts to transfer, and it will cause
its affiliates to so transfer, all of MetLife, Inc.s
securities received in connection with the Acquisition prior to
the later of (i) the fifth anniversary of the closing of
the Acquisition, and (ii) the first anniversary of the
third stock purchase date under the Stock Purchase Contracts.
Subject to certain conditions, we have agreed to register the
resale of MetLife, Inc.s equity and other securities to be
issued to ALICO Holdings under the Securities Act. The sale or
transfer of a substantial number of these securities within a
short period of time could cause MetLife, Inc.s stock
price to decrease, make it more difficult for us to raise funds
through future offerings of MetLife, Inc.s common stock or
acquire other businesses using MetLife, Inc.s common stock
as consideration.
If
MetLife, Inc.s Stockholders Do Not Vote to Approve the
Conversion of the Convertible Preferred Stock Into Common Stock,
MetLife, Inc. Will Be Required to Pay Approximately $300 Million
to ALICO Holdings
ALICO Holdings received shares of the Convertible Preferred
Stock upon completion of the Acquisition. Each share of
Convertible Preferred Stock will convert into 10 shares of
MetLife, Inc.s common stock (subject to anti-dilution
adjustments) if conversion is approved by MetLife, Inc.s
common stockholders. If we fail to obtain such approval prior to
the first anniversary of the closing of the Acquisition,
November 1, 2011, MetLife, Inc. will be required to pay
approximately $300 million to ALICO Holdings, assuming no
purchase price adjustments, and, upon request, register the
Convertible Preferred Stock for sale by ALICO Holdings in a
public offering and list the Convertible Preferred Stock on the
NYSE.
Fluctuations
in Foreign Currency Exchange Rates Could Negatively Affect Our
Profitability
We are exposed to risks associated with fluctuations in foreign
currency exchange rates against the U.S. dollar resulting
from our holdings of
non-U.S. dollar
denominated investments, investments in foreign subsidiaries and
net income from foreign operations and issuance of
non-U.S. dollar
denominated instruments, including guaranteed interest contracts
and funding agreements. These risks relate to potential
decreases in estimated fair value and income resulting from a
strengthening or weakening in foreign exchange rates versus the
U.S. dollar. In general, the weakening of foreign
currencies versus the U.S. dollar will adversely affect the
estimated fair value of our
non-U.S. dollar
denominated investments, our investments in foreign
subsidiaries, and our net income from foreign operations.
Although we use foreign currency swaps and forward contracts to
mitigate foreign currency exchange rate risk, we cannot provide
assurance that these methods will be effective or that our
counterparties will perform their obligations. See
Quantitative and Qualitative Disclosures About Market
Risk.
From time to time, various emerging market countries have
experienced severe economic and financial disruptions, including
significant devaluations of their currencies. Our exposure to
foreign exchange rate risk is exacerbated by our investments in
certain emerging markets.
Historically, we have matched substantially all of our foreign
currency liabilities in our foreign subsidiaries with
investments denominated in their respective foreign currency,
which limits the effect of currency exchange rate fluctuation on
local operating results; however, fluctuations in such rates
affect the translation of these results into our
U.S. dollar basis consolidated financial statements.
Although we take certain actions to address this risk, foreign
45
currency exchange rate fluctuation could materially adversely
affect our reported results due to unhedged positions or the
failure of hedges to effectively offset the impact of the
foreign currency exchange rate fluctuation. See
Quantitative and Qualitative Disclosures About Market
Risk.
The Acquisition has increased our exposure to risks associated
with fluctuations in foreign currency exchange rates against the
U.S. dollar and increased our exposure to emerging markets.
Fluctuations in the yen/ U.S. dollar exchange rate can have
a significant effect on our reported financial position and
results of operations because ALICO has substantial operations
in Japan and a significant portion of its premiums and
investment income are received in yen. Claims and expenses are
also paid in yen and ALICO primarily purchases yen-denominated
assets to support yen-denominated policy liabilities. These and
other yen-denominated financial statement items are, however,
translated into U.S. dollars for financial reporting
purposes. Accordingly, fluctuations in the yen/U.S. dollar
exchange rate can have a significant effect on our reported
financial position and results of operations.
Due to our significant international operations, during periods
when any foreign currency in which we derive our revenues (such
as the Japanese yen) weakens, translating amounts expressed in
that currency into U.S. dollars causes fewer
U.S. dollars to be reported. When the relevant foreign
currency strengthens, translating such currency into
U.S. dollars causes more U.S. dollars to be reported.
Between September 30, 2010 and December 31, 2010, the
Japanese yen has strengthened against the U.S. dollar,
which fluctuated from a low point of ¥80.40 to the
U.S. dollar on October 29, 2010 to a high point of
¥84.26 to the U.S. dollar on November 29, 2010,
which has been somewhat offset by the weakening of the euro,
which fluctuated from a high point of 0.7702 euro to the
U.S. dollar on November 30, 2010, to 0.7039 euro to
the U.S. dollar on November 4, 2010. Any unrealized
foreign currency translation adjustments are reported in
accumulated other comprehensive income (loss). The weakening of
a foreign currency relative to the U.S. dollar will
generally adversely affect the value of investments in
U.S. dollar terms and reduce the level of reserves
denominated in that currency.
Our
International Operations Face Political, Legal, Operational and
Other Risks, Including Exposure to Local and Regional Economic
Conditions, That Could Negatively Affect Those Operations or Our
Profitability
Our international operations face political, legal, operational
and other risks that we do not face in our domestic operations.
We face the risk of discriminatory regulation, nationalization
or expropriation of assets, price controls and exchange controls
or other restrictions that prevent us from transferring funds
from these operations out of the countries in which they operate
or converting local currencies we hold into U.S. dollars or
other currencies. Some of our foreign insurance operations are,
and are likely to continue to be, in emerging markets where
these risks are heightened. See Quantitative and
Qualitative Disclosures About Market Risk. In addition, we
rely on local sales forces in these countries and may encounter
labor problems resulting from workers associations and
trade unions in some countries. In several countries, including
Japan, China and India, we operate with local business partners
with the resulting risk of managing partner relationships to the
business objectives. If our business model is not successful in
a particular country, we may lose all or most of our investment
in building and training the sales force in that country. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations Executive
Summary and Note 2 of the Notes to the Consolidated
Financial Statements.
We are expanding our international operations in certain markets
where we operate and in selected new markets. This may require
considerable management time, as well as
start-up
expenses for market development before any significant revenues
and earnings are generated. Operations in new foreign markets
may achieve low margins or may be unprofitable, and expansion in
existing markets may be affected by local economic and market
conditions. Therefore, as we expand internationally, we may not
achieve expected operating margins and our results of operations
may be negatively impacted.
In addition, in recent years, the operating environment in
Argentina has been very challenging. In Argentina, we were
formerly principally engaged in the pension business. In
December 2008, the Argentine government nationalized private
pensions and seized the pension funds investments,
eliminating the private pensions business in Argentina. As a
result, we have experienced and will continue to experience
reductions in the operations revenues and cash flows. The
Argentine government now controls all assets which previously
were managed by our
46
Argentine pension operations. Further governmental or legal
actions related to our operations in Argentina could negatively
impact our operations in Argentina and result in future losses.
We have market presence in over 60 different countries and
increased exposure to risks posed by local and regional economic
conditions. Europe has recently experienced a deep recession and
countries such as Italy, Spain, Portugal and, in particular,
Greece and Ireland, have been particularly affected by the
recession, resulting in increased national debts and depressed
economic activity. We have significant operations and
investments in these countries which could be adversely affected
by economic developments such as higher taxes, growing
inflation, decreasing government spending, rising unemployment
and currency instability.
In addition to fluctuations in the yen/U.S. dollar exchange
rate discussed above, we face increased exposure to the Japanese
markets as a result of ALICOs considerable presence there.
Deterioration in Japans economic recovery could have an
adverse effect on our results of operations and financial
condition.
We also have operations in the Middle East where the legal and
political systems and regulatory frameworks are subject to
instability and disruptions. Lack of legal certainty and
stability in the region exposes our operations to increased risk
of disruption and to adverse or unpredictable actions by
regulators and may make it more difficult for us to enforce our
contracts, which may negatively impact our business in this
region. See also Changes in Market Interest
Rates May Significantly Affect Our Profitability regarding
the impact of low interest rates on our Taiwanese operations.
As a
Holding Company, MetLife, Inc. Depends on the Ability of Its
Subsidiaries to Transfer Funds to It to Meet Its Obligations and
Pay Dividends
MetLife, Inc. is a holding company for its insurance and
financial subsidiaries and does not have any significant
operations of its own. Dividends from its subsidiaries and
permitted payments to it under its tax sharing arrangements with
its subsidiaries are its principal sources of cash to meet its
obligations and to pay preferred and common stock dividends. If
the cash MetLife, Inc. receives from its subsidiaries is
insufficient for it to fund its debt service and other holding
company obligations, MetLife, Inc. may be required to raise cash
through the incurrence of debt, the issuance of additional
equity or the sale of assets.
The payment of dividends and other distributions to MetLife,
Inc. by its insurance subsidiaries is regulated by insurance
laws and regulations. In general, dividends in excess of
prescribed limits require insurance regulatory approval. In
addition, insurance regulators may prohibit the payment of
dividends or other payments by its insurance subsidiaries to
MetLife, Inc. if they determine that the payment could be
adverse to our policyholders or contractholders. The payment of
dividends and other distributions by insurance companies is also
influenced by business conditions and rating agency
considerations. See Business
U.S. Regulation Insurance Regulation and
Managements Discussion and Analysis of Financial
Condition and Results of Operations Liquidity and
Capital Resources The Holding Company
Liquidity and Capital Sources Dividends from
Subsidiaries. The ability of MetLife Bank to pay dividends
is also subject to regulation by the OCC.
Any payment of interest, dividends, distributions, loans or
advances by our foreign subsidiaries and branches to MetLife,
Inc. could be subject to taxation or other restrictions on
dividends or repatriation of earnings under applicable law,
monetary transfer restrictions and foreign currency exchange
regulations in the jurisdiction in which such foreign
subsidiaries operate. See Business
International Regulation and Our
International Operations Face Political, Legal, Operational and
Other Risks, Including Exposure to Local and Regional Economic
Conditions, That Could Negatively Affect Those Operations or Our
Profitability.
A
Downgrade or a Potential Downgrade in Our Financial Strength or
Credit Ratings Could Result in a Loss of Business and Materially
Adversely Affect Our Financial Condition and Results of
Operations
Financial strength ratings, which various Nationally Recognized
Statistical Rating Organizations (NRSRO) publish as
indicators of an insurance companys ability to meet
contractholder and policyholder obligations, are important to
maintaining public confidence in our products, our ability to
market our products and our competitive position.
47
Downgrades in our financial strength ratings could have a
material adverse effect on our financial condition and results
of operations in many ways, including:
|
|
|
|
|
reducing new sales of insurance products, annuities and other
investment products;
|
|
|
|
adversely affecting our relationships with our sales force and
independent sales intermediaries;
|
|
|
|
materially increasing the number or amount of policy surrenders
and withdrawals by contractholders and policyholders;
|
|
|
|
requiring us to reduce prices for many of our products and
services to remain competitive; and
|
|
|
|
adversely affecting our ability to obtain reinsurance at
reasonable prices or at all.
|
In addition to the financial strength ratings of our insurance
subsidiaries, various NRSROs also publish credit ratings for
MetLife, Inc. and several of its subsidiaries. Credit ratings
are indicators of a debt issuers ability to meet the terms
of debt obligations in a timely manner and are important factors
in our overall funding profile and ability to access certain
types of liquidity. Downgrades in our credit ratings could have
a material adverse effect on our financial condition and results
of operations in many ways, including adversely limiting our
access to capital markets, potentially increasing the cost of
debt, and requiring us to post collateral. For example, with
respect to derivative transactions with credit ratings downgrade
triggers, a one-notch downgrade would have increased our
derivative collateral requirements by $99 million at
December 31, 2010. Also, $375 million of liabilities
associated with funding agreements and other capital market
products were subject to credit ratings downgrade triggers that
permit early termination subject to a notice period of
90 days.
In view of the difficulties experienced during 2008 and 2009 by
many financial institutions, including our competitors in the
insurance industry, we believe it is possible that the NRSROs
will continue to heighten the level of scrutiny that they apply
to such institutions, will continue to increase the frequency
and scope of their credit reviews, will continue to request
additional information from the companies that they rate, and
may adjust upward the capital and other requirements employed in
the NRSRO models for maintenance of certain ratings levels.
Rating agencies use an outlook statement of
positive, stable, negative
or developing to indicate a medium- or long-term
trend in credit fundamentals which, if continued, may lead to a
ratings change. A rating may have a stable outlook
to indicate that the rating is not expected to change; however,
a stable rating does not preclude a rating agency
from changing a rating at any time, without notice. Certain
rating agencies assign rating modifiers such as
CreditWatch or Under Review to indicate
their opinion regarding the potential direction of a rating.
These ratings modifiers are generally assigned in connection
with certain events such as potential mergers and acquisitions,
or material changes in a companys results, in order for
the rating agencies to perform their analyses to fully determine
the rating implications of the event. Certain rating agencies
have recently implemented rating actions, including downgrades,
outlook changes and modifiers, for MetLife, Inc.s and
certain of its subsidiaries insurer financial strength and
credit ratings.
Based on the announcement in February 2010 that MetLife was in
discussions to acquire ALICO, in February 2010, S&P and
A.M. Best placed the ratings of MetLife, Inc. and its
subsidiaries on CreditWatch with negative
implications and under review with negative
implications, respectively. Also in connection with the
announcement, in March 2010, Moodys changed the ratings
outlook of MetLife, Inc. and its subsidiaries from
stable to negative outlook. Upon
completion of the public financing transactions related to the
Acquisition, in August 2010, S&P affirmed the ratings of
MetLife, Inc. and subsidiaries with a negative
outlook, and removed them from CreditWatch. On
November 1, 2010, upon closing of the Acquisition, S&P
changed the rating outlook of ALICO to positive from
negative and affirmed its financial strength rating;
the ratings of MetLife, Inc. and its other subsidiaries were
unaffected by this ratings action. Also on November 1,
2010, Fitch Ratings upgraded by one notch (and changed the
rating outlook from Rating Watch Positive to
stable) the financial strength rating of American
Life and affirmed all existing ratings for MetLife, Inc. and its
other subsidiaries. On November 4, 2010, A.M. Best
upgraded by one notch the financial strength rating of American
Life and changed the rating outlook from under review with
positive implications to negative.
A.M. Best also changed the outlook for MetLife, Inc. and
certain of its other subsidiaries to negative from
under review with negative implications. Effective
as of January in 2011, MetLife withdrew the American Life
financial strength ratings by A.M. Best and Fitch Ratings
as once it became a subsidiary of MetLife it was not deemed
necessary to maintain stand-alone ratings.
48
On July 1, 2010, Moodys published revised guidance
called Revisions to Moodys Hybrid Tool Kit
(the Guidance) for assigning equity credit to
so-called hybrid securities, i.e., securities with both debt and
equity characteristics (Hybrids). Moodys
evaluates Hybrids using certain specified criteria and then
places each such security into a basket, with a
specific percentage of debt and equity being associated with
each basket, which is then used to adjust full sets of financial
statements for purposes of, among other things, calculating the
issuing companys financial leverage. Under the Guidance,
Hybrids are one element that Moodys considers within the
context of an issuers overall credit profile. As of
December 31, 2010, we have approximately $11.1 billion
of Hybrids outstanding, which includes approximately
$6.2 billion of debt securities and $4.9 billion of
equity securities. Application of the Guidance has resulted in
Moodys significantly reducing the amount of equity credit
it assigns to these securities, including the common equity
units issued to ALICO Holdings in connection with the
Acquisition. We do not expect at this time, as a result of the
Guidance, that a reduction in Moodys equity treatment of
our Hybrids, including the common equity units, would result in
any material negative impact on MetLife, Inc.s credit
rating or the financial strength ratings of its insurance
company subsidiaries. However, if we decided to increase our
adjusted capital as a result of the application of the Guidance,
we may seek to (i) issue additional common equity or higher
equity content Hybrids satisfying the Guidances revised
rating criteria,
and/or
(ii) redeem, repurchase or restructure existing Hybrids.
Any sale of additional common equity would have a dilutive
effect on our common stockholders.
We cannot predict what actions rating agencies may take, or what
actions we may take in response to the actions of rating
agencies, which could adversely affect our business. As with
other companies in the financial services industry, our ratings
could be downgraded at any time and without any notice by any
NRSRO.
An
Inability to Access Our Credit Facilities Could Result in a
Reduction in Our Liquidity and Lead to Downgrades in Our Credit
and Financial Strength Ratings
In October 2010, we entered into two senior unsecured credit
facilities: a three-year $3 billion facility and a
364-day
$1 billion facility. We also have other facilities which we
enter into in the ordinary course of business. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations Liquidity and
Capital Resources The Company Liquidity
and Capital Sources Credit and Committed
Facilities and Notes 11 and 24 of the Notes to the
Consolidated Financial Statements.
We rely on our credit facilities as a potential source of
liquidity. The availability of these facilities could be
critical to our credit and financial strength ratings and our
ability to meet our obligations as they come due in a market
when alternative sources of credit are tight. The credit
facilities contain certain administrative, reporting, legal and
financial covenants. We must comply with covenants under our
credit facilities, including a requirement to maintain a
specified minimum consolidated net worth.
Our right to make borrowings under these facilities is subject
to the fulfillment of certain important conditions, including
our compliance with all covenants, and our ability to borrow
under these facilities is also subject to the continued
willingness and ability of the lenders that are parties to the
facilities to provide funds. Our failure to comply with the
covenants in the credit facilities or fulfill the conditions to
borrowings, or the failure of lenders to fund their lending
commitments (whether due to insolvency, illiquidity or other
reasons) in the amounts provided for under the terms of the
facilities, would restrict our ability to access these credit
facilities when needed and, consequently, could have a material
adverse effect on our financial condition and results of
operations.
Defaults,
Downgrades or Other Events Impairing the Carrying Value of Our
Fixed Maturity or Equity Securities Portfolio May Reduce Our
Earnings
We are subject to the risk that the issuers, or guarantors, of
fixed maturity securities we own may default on principal and
interest payments they owe us. We are also subject to the risk
that the underlying collateral within loan-backed securities,
including mortgage-backed securities, may default on principal
and interest payments causing an adverse change in cash flows.
Fixed maturity securities represent a significant portion of our
investment portfolio. The occurrence of a major economic
downturn, acts of corporate malfeasance, widening risk spreads,
or other events that adversely affect the issuers, guarantors or
underlying collateral of these securities could cause the
estimated fair value of our fixed maturity securities portfolio
and our earnings to decline and the default rate of the
49
fixed maturity securities in our investment portfolio to
increase. A ratings downgrade affecting issuers or guarantors of
particular securities, or similar trends that could worsen the
credit quality of issuers, such as the corporate issuers of
securities in our investment portfolio, could also have a
similar effect. With economic uncertainty, credit quality of
issuers or guarantors could be adversely affected. Similarly, a
ratings downgrade affecting a security we hold could indicate
the credit quality of that security has deteriorated and could
increase the capital we must hold to support that security to
maintain our RBC levels. Any event reducing the estimated fair
value of these securities other than on a temporary basis could
have a material adverse effect on our business, results of
operations and financial condition. Levels of writedowns or
impairments are impacted by our assessment of intent to sell, or
whether it is more likely than not that we will be required to
sell, fixed maturity securities and the intent and ability to
hold equity securities which have declined in value until
recovery. If we determine to reposition or realign portions of
the portfolio so as not to hold certain equity securities, or
intend to sell or determine that it is more likely than not that
we will be required to sell, certain fixed maturity securities
in an unrealized loss position prior to recovery, then we will
incur an
other-than-temporary
impairment charge in the period that the decision was made not
to hold the equity security to recovery, or to sell, or the
determination was made it is more likely than not that we will
be required to sell the fixed maturity security.
Our
Risk Management Policies and Procedures May Leave Us Exposed to
Unidentified or Unanticipated Risk, Which Could Negatively
Affect Our Business
Management of risk requires, among other things, policies and
procedures to record properly and verify a large number of
transactions and events. We have devoted significant resources
to develop our risk management policies and procedures and
expect to continue to do so in the future. Nonetheless, our
policies and procedures may not be comprehensive. Many of our
methods for managing risk and exposures are based upon the use
of observed historical market behavior or statistics based on
historical models. As a result, these methods may not fully
predict future exposures, which can be significantly greater
than our historical measures indicate. Other risk management
methods depend upon the evaluation of information regarding
markets, clients, catastrophe occurrence or other matters that
is publicly available or otherwise accessible to us. This
information may not always be accurate, complete,
up-to-date
or properly evaluated. See Quantitative and Qualitative
Disclosures About Market Risk.
Reinsurance
May Not Be Available, Affordable or Adequate to Protect Us
Against Losses
As part of our overall risk management strategy, we purchase
reinsurance for certain risks underwritten by our various
business segments. See Business Reinsurance
Activity. While reinsurance agreements generally bind the
reinsurer for the life of the business reinsured at generally
fixed pricing, market conditions beyond our control determine
the availability and cost of the reinsurance protection for new
business. In certain circumstances, the price of reinsurance for
business already reinsured may also increase. Any decrease in
the amount of reinsurance will increase our risk of loss and any
increase in the cost of reinsurance will, absent a decrease in
the amount of reinsurance, reduce our earnings. Accordingly, we
may be forced to incur additional expenses for reinsurance or
may not be able to obtain sufficient reinsurance on acceptable
terms, which could adversely affect our ability to write future
business or result in the assumption of more risk with respect
to those policies we issue.
If the
Counterparties to Our Reinsurance or Indemnification
Arrangements or to the Derivative Instruments We Use to Hedge
Our Business Risks Default or Fail to Perform, We May Be Exposed
to Risks We Had Sought to Mitigate, Which Could Materially
Adversely Affect Our Financial Condition and Results of
Operations
We use reinsurance, indemnification and derivative instruments
to mitigate our risks in various circumstances. In general,
reinsurance does not relieve us of our direct liability to our
policyholders, even when the reinsurer is liable to us.
Accordingly, we bear credit risk with respect to our reinsurers
and indemnitors. We cannot provide assurance that our reinsurers
will pay the reinsurance recoverables owed to us or that
indemnitors will honor their obligations now or in the future or
that they will pay these recoverables on a timely basis. A
reinsurers or indemnitors insolvency, inability or
unwillingness to make payments under the terms of reinsurance
agreements or indemnity agreements with us could have a material
adverse effect on our financial condition and results of
operations.
50
In addition, we use derivative instruments to hedge various
business risks. We enter into a variety of derivative
instruments, including options, forwards, interest rate, credit
default and currency swaps with a number of counterparties. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations
Investments. If our counterparties fail or refuse to honor
their obligations under these derivative instruments, our hedges
of the related risk will be ineffective. This is a more
pronounced risk to us in view of the stresses suffered by
financial institutions over the past few years. Such failure
could have a material adverse effect on our financial condition
and results of operations.
Differences
Between Actual Claims Experience and Underwriting and Reserving
Assumptions May Adversely Affect Our Financial
Results
Our earnings significantly depend upon the extent to which our
actual claims experience is consistent with the assumptions we
use in setting prices for our products and establishing
liabilities for future policy benefits and claims. Our
liabilities for future policy benefits and claims are
established based on estimates by actuaries of how much we will
need to pay for future benefits and claims. For life insurance
and annuity products, we calculate these liabilities based on
many assumptions and estimates, including estimated premiums to
be received over the assumed life of the policy, the timing of
the event covered by the insurance policy, the amount of
benefits or claims to be paid and the investment returns on the
investments we make with the premiums we receive. We establish
liabilities for property and casualty claims and benefits based
on assumptions and estimates of damages and liabilities
incurred. To the extent that actual claims experience is less
favorable than the underlying assumptions we used in
establishing such liabilities, we could be required to increase
our liabilities.
Due to the nature of the underlying risks and the high degree of
uncertainty associated with the determination of liabilities for
future policy benefits and claims, we cannot determine precisely
the amounts which we will ultimately pay to settle our
liabilities. Such amounts may vary from the estimated amounts,
particularly when those payments may not occur until well into
the future. We evaluate our liabilities periodically based on
accounting requirements, which change from time to time, the
assumptions used to establish the liabilities, as well as our
actual experience. We charge or credit changes in our
liabilities to expenses in the period the liabilities are
established or re-estimated. If the liabilities originally
established for future benefit payments prove inadequate, we
must increase them. Such increases could affect earnings
negatively and have a material adverse effect on our business,
results of operations and financial condition.
Catastrophes
May Adversely Impact Liabilities for Policyholder Claims and
Reinsurance Availability
Our life insurance operations are exposed to the risk of
catastrophic mortality, such as a pandemic or other event that
causes a large number of deaths. Significant influenza pandemics
have occurred three times in the last century, but neither the
likelihood, timing, nor the severity of a future pandemic can be
predicted. A significant pandemic could have a major impact on
the global economy or the economies of particular countries or
regions, including travel, trade, tourism, the health system,
food supply, consumption, overall economic output and,
eventually, on the financial markets. In addition, a pandemic
that affected our employees or the employees of our distributors
or of other companies with which we do business could disrupt
our business operations. The effectiveness of external parties,
including governmental and non-governmental organizations, in
combating the spread and severity of such a pandemic could have
a material impact on the losses experienced by us. In our group
insurance operations, a localized event that affects the
workplace of one or more of our group insurance customers could
cause a significant loss due to mortality or morbidity claims.
These events could cause a material adverse effect on our
results of operations in any period and, depending on their
severity, could also materially and adversely affect our
financial condition.
Our Auto & Home business has experienced, and will
likely in the future experience, catastrophe losses that may
have a material adverse impact on the business, results of
operations and financial condition of the Auto & Home
segment. Although Auto & Home makes every effort to
manage our exposure to catastrophic risks through volatility
management and reinsurance programs, these efforts do not
eliminate all risk. Catastrophes can be caused by various
events, including hurricanes, windstorms, earthquakes, hail,
tornadoes, explosions, severe winter weather (including snow,
freezing water, ice storms and blizzards), fires and man-made
events such as terrorist attacks. Historically, substantially
all of our catastrophe-related claims have related to homeowners
coverages.
51
However, catastrophes may also affect other Auto &
Home coverages. Due to their nature, we cannot predict the
incidence, timing and severity of catastrophes. In addition,
changing climate conditions, primarily rising global
temperatures, may be increasing, or may in the future increase,
the frequency and severity of natural catastrophes such as
hurricanes.
Hurricanes and earthquakes are of particular note for our
homeowners coverages. Areas of major hurricane exposure include
coastal sections of the northeastern U.S. (including lower New
York, Connecticut, Rhode Island and Massachusetts), the Gulf
Coast (including Alabama, Mississippi, Louisiana and Texas) and
Florida. We also have some earthquake exposure, primarily along
the New Madrid fault line in the central U.S. and in the Pacific
Northwest.
The extent of losses from a catastrophe is a function of both
the total amount of insured exposure in the area affected by the
event and the severity of the event. Most catastrophes are
restricted to small geographic areas; however, hurricanes,
earthquakes and man-made catastrophes may produce significant
damage or loss of life in larger areas, especially those that
are heavily populated. Claims resulting from natural or man-made
catastrophic events could cause substantial volatility in our
financial results for any fiscal quarter or year and could
materially reduce our profitability or harm our financial
condition. Also, catastrophic events could harm the financial
condition of our reinsurers and thereby increase the probability
of default on reinsurance recoveries. Our ability to write new
business could also be affected. It is possible that increases
in the value, caused by the effects of inflation or other
factors, and geographic concentration of insured property, could
increase the severity of claims from catastrophic events in the
future.
Most of the jurisdictions in which our insurance subsidiaries
are admitted to transact business require life and property and
casualty insurers doing business within the jurisdiction to
participate in guaranty associations, which are organized to pay
contractual benefits owed pursuant to insurance policies issued
by impaired, insolvent or failed insurers. These associations
levy assessments, up to prescribed limits, on all member
insurers in a particular state on the basis of the proportionate
share of the premiums written by member insurers in the lines of
business in which the impaired, insolvent or failed insurer is
engaged. In addition, certain states have government owned or
controlled organizations providing life and property and
casualty insurance to their citizens. The activities of such
organizations could also place additional stress on the adequacy
of guaranty fund assessments. Many of these organizations also
have the power to levy assessments similar to those of the
guaranty associations described above. Some states permit member
insurers to recover assessments paid through full or partial
premium tax offsets. See Business
U.S. Regulation Insurance
Regulation Guaranty Associations and Similar
Arrangements and Business International
Regulation.
While in the past five years, the aggregate assessments levied
against MetLife, Inc.s insurance subsidiaries have not
been material, it is possible that a large catastrophic event
could render such guaranty funds inadequate and we may be called
upon to contribute additional amounts, which may have a material
impact on our financial condition or results of operations in a
particular period. We have established liabilities for guaranty
fund assessments that we consider adequate for assessments with
respect to insurers that are currently subject to insolvency
proceedings, but additional liabilities may be necessary. See
Note 16 of the Notes to the Consolidated Financial
Statements.
Consistent with industry practice and accounting standards, we
establish liabilities for claims arising from a catastrophe only
after assessing the probable losses arising from the event. We
cannot be certain that the liabilities we have established will
be adequate to cover actual claim liabilities. From time to
time, states have passed legislation that has the effect of
limiting the ability of insurers to manage risk, such as
legislation restricting an insurers ability to withdraw
from catastrophe-prone areas. While we attempt to limit our
exposure to acceptable levels, subject to restrictions imposed
by insurance regulatory authorities, a catastrophic event or
multiple catastrophic events could have a material adverse
effect on our business, results of operations and financial
condition.
Our ability to manage this risk and the profitability of our
property and casualty and life insurance businesses depends in
part on our ability to obtain catastrophe reinsurance, which may
not be available at commercially acceptable rates in the future.
See Reinsurance May Not Be Available,
Affordable or Adequate to Protect Us Against Losses.
52
Our
Statutory Reserve Financings May Be Subject to Cost Increases
and New Financings May Be Subject to Limited Market
Capacity
To support statutory reserves for several products, including,
but not limited to, our level premium term life and universal
life with secondary guarantees and MLICs closed block, we
currently utilize capital markets solutions for financing a
portion of our statutory reserve requirements. While we have
financing facilities in place for our previously written
business and have remaining capacity in existing facilities to
support writings through the end of 2010 or later, certain of
these facilities are subject to cost increases upon the
occurrence of specified ratings downgrades of MetLife or are
subject to periodic repricing. Any resulting cost increases
could negatively impact our financial results.
Future capacity for these statutory reserve funding structures
in the marketplace is not guaranteed. If capacity becomes
unavailable for a prolonged period of time, hindering our
ability to obtain funding for these new structures, our ability
to write additional business in a cost effective manner may be
impacted.
Competitive
Factors May Adversely Affect Our Market Share and
Profitability
Our segments are subject to intense competition. We believe that
this competition is based on a number of factors, including
service, product features, scale, price, financial strength,
claims-paying ratings, credit ratings,
e-business
capabilities and name recognition. We compete with a large
number of other insurers, as well as non-insurance financial
services companies, such as banks, broker-dealers and asset
managers, for individual consumers, employers and other group
customers and agents and other distributors of insurance and
investment products. Some of these companies offer a broader
array of products, have more competitive pricing or more
attractive features in their products or, with respect to other
insurers, have higher claims paying ability ratings. Some may
also have greater financial resources with which to compete.
National banks, which may sell annuity products of life insurers
in some circumstances, also have pre-existing customer bases for
financial services products. Many of our group insurance
products are underwritten annually, and, accordingly, there is a
risk that group purchasers may be able to obtain more favorable
terms from competitors rather than renewing coverage with us.
The effect of competition may, as a result, adversely affect the
persistency of these and other products, as well as our ability
to sell products in the future.
In addition, the investment management and securities brokerage
businesses have relatively few barriers to entry and continually
attract new entrants. See Business
Competition.
Finally, the new requirements imposed on the financial industry
by Dodd-Frank could similarly have differential effects. See
Various Aspects of Dodd-Frank Could Impact Our
Business Operations, Capital Requirements and Profitability and
Limit Our Growth.
Industry
Trends Could Adversely Affect the Profitability of Our
Businesses
Our segments continue to be influenced by a variety of trends
that affect the insurance industry, including competition with
respect to product features, price, distribution capability,
customer service and information technology. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations Industry
Trends. The impact on our business and on the life
insurance industry generally of the volatility and instability
of the financial markets is difficult to predict, and our
business plans, financial condition and results of operations
may be negatively impacted or affected in other unexpected ways.
In addition, the life insurance industry is subject to state
regulation, and, as complex products are introduced, regulators
may refine capital requirements and introduce new reserving
standards. Dodd-Frank, Basel III and the market environment
in general may also lead to changes in regulation that may
benefit or disadvantage us relative to some of our competitors.
See Business Competition,
Our Insurance, Brokerage and Banking
Businesses Are Heavily Regulated, and Changes in Regulation May
Reduce Our Profitability and Limit Our Growth and
Competitive Factors May Adversely Affect Our
Market Share and Profitability.
53
Consolidation
of Distributors of Insurance Products May Adversely Affect the
Insurance Industry and the Profitability of Our
Business
The insurance industry distributes many of its individual
products through other financial institutions such as banks and
broker-dealers. An increase in bank and broker-dealer
consolidation activity may negatively impact the industrys
sales, and such consolidation could increase competition for
access to distributors, result in greater distribution expenses
and impair our ability to market insurance products to our
current customer base or to expand our customer base.
Consolidation of distributors
and/or other
industry changes may also increase the likelihood that
distributors will try to renegotiate the terms of any existing
selling agreements to terms less favorable to us.
Our
Valuation of Fixed Maturity, Equity and Trading and Other
Securities and Short-Term Investments May Include Methodologies,
Estimations and Assumptions Which Are Subject to Differing
Interpretations and Could Result in Changes to Investment
Valuations That May Materially Adversely Affect Our Results of
Operations or Financial Condition
Fixed maturity, equity, and trading and other securities and
short-term investments which are reported at estimated fair
value on the consolidated balance sheets represent the majority
of our total cash and investments. We have categorized these
securities into a three-level hierarchy, based on the priority
of the inputs to the respective valuation technique.
The fair value hierarchy gives the highest priority to quoted
prices in active markets for identical assets or liabilities
(Level 1) and the lowest priority to unobservable
inputs (Level 3). An asset or liabilitys
classification within the fair value hierarchy is based on the
lowest level of significant input to its valuation. The input
levels are as follows:
|
|
|
|
Level 1
|
Unadjusted quoted prices in active markets for identical assets
or liabilities. We define active markets based on average
trading volume for equity securities. The size of the bid/ask
spread is used as an indicator of market activity for fixed
maturity securities.
|
|
|
Level 2
|
Quoted prices in markets that are not active or inputs that are
observable either directly or indirectly. Level 2 inputs
include quoted prices for similar assets or liabilities other
than quoted prices in Level 1; quoted prices in markets
that are not active; or other significant inputs that are
observable or can be derived principally from or corroborated by
observable market data for substantially the full term of the
assets or liabilities.
|
|
|
Level 3
|
Unobservable inputs that are supported by little or no market
activity and are significant to the estimated fair value of the
assets or liabilities. Unobservable inputs reflect the reporting
entitys own assumptions about the assumptions that market
participants would use in pricing the asset or liability.
Level 3 assets and liabilities include financial
instruments whose values are determined using pricing models,
discounted cash flow methodologies, or similar techniques, as
well as instruments for which the determination of the estimated
fair value requires significant management judgment or
estimation.
|
At December 31, 2010, 7.0%, 85.8% and 7.2% of these
securities represented Level 1, Level 2 and
Level 3, respectively. The Level 1 securities
primarily consist of certain U.S. Treasury, agency and
government guaranteed fixed maturity securities; certain foreign
government fixed maturity securities; exchange-traded common
stock; certain trading securities; certain fair value option
securities and certain short-term investments. The Level 2
assets include fixed maturity and equity securities priced
principally through independent pricing services using
observable inputs. These fixed maturity securities include most
U.S. Treasury, agency and government guaranteed securities,
as well as the majority of U.S. and foreign corporate
securities, RMBS, CMBS, state and political subdivision
securities, foreign government securities, and ABS. Equity
securities classified as Level 2 primarily consist of
non-redeemable preferred securities and certain equity
securities where market quotes are available but are not
considered actively traded and are priced by independent pricing
services. We review the valuation methodologies used by the
independent pricing services on an ongoing basis and ensure that
any changes to valuation methodologies are justified.
Level 3 assets include fixed maturity securities priced
principally through independent non-binding broker quotations or
market standard valuation methodologies using inputs that are
not
54
market observable or cannot be derived principally from or
corroborated by observable market data. Level 3 consists of
less liquid fixed maturity securities with very limited trading
activity or where less price transparency exists around the
inputs to the valuation methodologies including: U.S. and
foreign corporate securities including below
investment grade private placements; RMBS; CMBS; and
ABS including all of those supported by
sub-prime
mortgage loans. Equity securities classified as Level 3
securities consist principally of nonredeemable preferred stock
and common stock of companies that are privately held or
companies for which there has been very limited trading activity
or where less price transparency exists around the inputs to the
valuation.
Prices provided by independent pricing services and independent
non-binding broker quotations can vary widely even for the same
security.
The determination of estimated fair values by management in the
absence of quoted market prices is based on: (i) valuation
methodologies; (ii) securities we deem to be comparable;
and (iii) assumptions deemed appropriate given the
circumstances. The fair value estimates are made at a specific
point in time, based on available market information and
judgments about financial instruments, including estimates of
the timing and amounts of expected future cash flows and the
credit standing of the issuer or counterparty. Factors
considered in estimating fair value include: coupon rate,
maturity, estimated duration, call provisions, sinking fund
requirements, credit rating, industry sector of the issuer, and
quoted market prices of comparable securities. The use of
different methodologies and assumptions may have a material
effect on the estimated fair value amounts. During periods of
market disruption including periods of significantly rising or
high interest rates, rapidly widening credit spreads or
illiquidity, it may be difficult to value certain of our
securities, for example
sub-prime
mortgage-backed securities, mortgage-backed securities where the
underlying loans are Alt-A and CMBS, if trading becomes less
frequent
and/or
market data becomes less observable. In times of financial
market disruption, certain asset classes that were in active
markets with significant observable data may become illiquid. In
such cases, more securities may fall to Level 3 and thus
require more subjectivity and management judgment. As such,
valuations may include inputs and assumptions that are less
observable or require greater estimation, as well as valuation
methods which are more sophisticated or require greater
estimation thereby resulting in estimated fair values which may
be greater or less than the amount at which the investments may
be ultimately sold. Further, rapidly changing and unprecedented
credit and equity market conditions could materially impact the
valuation of securities as reported within our consolidated
financial statements and the
period-to-period
changes in estimated fair value could vary significantly.
Decreases in value may have a material adverse effect on our
results of operations or financial condition.
If Our
Business Does Not Perform Well, We May Be Required to Recognize
an Impairment of Our Goodwill or Other Long-Lived Assets or to
Establish a Valuation Allowance Against the Deferred Income Tax
Asset, Which Could Adversely Affect Our Results of Operations or
Financial Condition
Goodwill represents the excess of the amounts we paid to acquire
subsidiaries and other businesses over the estimated fair value
of their net assets at the date of acquisition. As of
December 31, 2010, our goodwill was $11,781, of which
$6,959 of goodwill was established in connection with the
acquisition of ALICO. We test goodwill at least annually for
impairment. Impairment testing is performed based upon estimates
of the estimated fair value of the reporting unit to
which the goodwill relates. The reporting unit is the operating
segment or a business one level below that operating segment if
discrete financial information is prepared and regularly
reviewed by management at that level. The estimated fair value
of the reporting unit is impacted by the performance of the
business. The performance of our businesses may be adversely
impacted by prolonged market declines. If it is determined that
the goodwill has been impaired, we must write down the goodwill
by the amount of the impairment, with a corresponding charge to
net income. Such writedowns could have an adverse effect on our
results of operation or financial position. For example, our
goodwill has increased substantially as a result of the
Acquisition. Market factors, the failure of ALICO to perform
well, or issues relating to the integration of ALICO could
result in the reporting units containing parts of ALICO having
fair values lower than their respective carrying values, which
would result in a writedown of goodwill and, consequently, it
could have a material adverse effect on our results of
operations. See Managements Discussion and Analysis
of Financial Condition and Results of Operations
Summary of Critical Accounting Estimates
Goodwill.
Long-lived assets, including assets such as real estate, also
require impairment testing to determine whether changes in
circumstances indicate that MetLife will be unable to recover
the carrying amount of the asset group
55
through future operations of that asset group or market
conditions that will impact the estimated fair value of those
assets. Such writedowns could have a material adverse effect on
our results of operations or financial position.
Deferred income tax represents the tax effect of the differences
between the book and tax basis of assets and liabilities.
Deferred tax assets are assessed periodically by management to
determine if they are realizable. Factors in managements
determination include the performance of the business including
the ability to generate future taxable income. If based on
available information, it is more likely than not that the
deferred income tax asset will not be realized then a valuation
allowance must be established with a corresponding charge to net
income. Such charges could have a material adverse effect on our
results of operations or financial position.
If Our
Business Does Not Perform Well or if Actual Experience Versus
Estimates Used in Valuing and Amortizing DAC, Deferred Sales
Inducements (DSI) and VOBA Vary Significantly, We
May Be Required to Accelerate the Amortization and/or Impair the
DAC, DSI and VOBA Which Could Adversely Affect Our Results of
Operations or Financial Condition
We incur significant costs in connection with acquiring new and
renewal business. Those costs that vary with and are primarily
related to the production of new and renewal business are
deferred and referred to as DAC. Bonus amounts credited to
certain policyholders, either immediately upon receiving a
deposit or as excess interest credits for a period of time, are
referred to as DSI. The recovery of DAC and DSI is dependent
upon the future profitability of the related business. The
amount of future profit or margin is dependent principally on
investment returns in excess of the amounts credited to
policyholders, mortality, morbidity, persistency, interest
crediting rates, dividends paid to policyholders, expenses to
administer the business, creditworthiness of reinsurance
counterparties and certain economic variables, such as
inflation. Of these factors, we anticipate that investment
returns are most likely to impact the rate of amortization of
such costs. The aforementioned factors enter into
managements estimates of gross profits or margins, which
generally are used to amortize such costs.
If the estimates of gross profits or margins were overstated,
then the amortization of such costs would be accelerated in the
period the actual experience is known and would result in a
charge to income. Significant or sustained equity market
declines could result in an acceleration of amortization of the
DAC and DSI related to variable annuity and variable universal
life contracts, resulting in a charge to income. Such
adjustments could have a material adverse effect on our results
of operations or financial condition.
VOBA is an intangible asset that represents the excess of book
value over the estimated fair value of acquired insurance,
annuity, and investment-type contracts in-force at the
acquisition date. The estimated fair value of the acquired
liabilities is based on actuarially determined projections, by
each block of business, of future policy and contract charges,
premiums, mortality and morbidity, separate account performance,
surrenders, operating expenses, investment returns,
nonperformance risk adjustment and other factors. Actual
experience on the purchased business may vary from these
projections. Revisions to estimates result in changes to the
amounts expensed in the reporting period in which the revisions
are made and could result in a charge to income. Also, as VOBA
is amortized similarly to DAC and DSI, an acceleration of the
amortization of VOBA would occur if the estimates of gross
profits or margins were overstated. Accordingly, the
amortization of such costs would be accelerated in the period in
which the actual experience is known and would result in a
charge to net income. Significant or sustained equity market
declines could result in an acceleration of amortization of the
VOBA related to variable annuity and variable universal life
contracts, resulting in a charge to income. Such adjustments
could have a material adverse effect on our results of
operations or financial condition. See Managements
Discussion and Analysis of Financial Condition and Results of
Operations Summary of Critical Accounting
Estimates Deferred Policy Acquisition Costs and
Value of Business Acquired for further consideration of
DAC and VOBA.
Changes
in Accounting Standards Issued by the Financial Accounting
Standards Board or Other Standard- Setting Bodies May Adversely
Affect Our Financial Statements
Our financial statements are subject to the application of GAAP,
which is periodically revised
and/or
expanded. Accordingly, from time to time we are required to
adopt new or revised accounting standards issued by recognized
authoritative bodies, including the Financial Accounting
Standards Board. Market conditions have prompted accounting
standard setters to expose new guidance which further interprets
or seeks to revise accounting
56
pronouncements related to financial instruments, structures or
transactions, as well as to issue new standards expanding
disclosures. The impact of accounting pronouncements that have
been issued but not yet implemented is disclosed in this annual
and quarterly reports on
Form 10-K
and
Form 10-Q.
An assessment of proposed standards is not provided as such
proposals are subject to change through the exposure process
and, therefore, the effects on our financial statements cannot
be meaningfully assessed. It is possible that future accounting
standards we are required to adopt could change the current
accounting treatment that we apply to our consolidated financial
statements and that such changes could have a material adverse
effect on our financial condition and results of operations.
Changes
in Our Discount Rate, Expected Rate of Return and Expected
Compensation Increase Assumptions for Our Pension and Other
Postretirement Benefit Plans May Result in Increased Expenses
and Reduce Our Profitability
We determine our pension and other postretirement benefit plan
costs based on our best estimates of future plan experience.
These assumptions are reviewed regularly and include discount
rates, expected rates of return on plan assets and expected
increases in compensation levels and expected medical inflation.
Changes in these assumptions may result in increased expenses
and reduce our profitability. See Note 17 of the Notes to
the Consolidated Financial Statements for details on how changes
in these assumptions would affect plan costs.
Guarantees
Within Certain of Our Products that Protect Policyholders
Against Significant Downturns in Equity Markets May Decrease Our
Earnings, Increase the Volatility of Our Results if Hedging or
Risk Management Strategies Prove Ineffective, Result in Higher
Hedging Costs and Expose Us to Increased Counterparty
Risk
Certain of our variable annuity products include guaranteed
benefits. These include guaranteed death benefits, guaranteed
withdrawal benefits, lifetime withdrawal guarantees, guaranteed
minimum accumulation benefits, and guaranteed minimum income
benefits. Periods of significant and sustained downturns in
equity markets, increased equity volatility, or reduced interest
rates could result in an increase in the valuation of the future
policy benefit or policyholder account balance liabilities
associated with such products, resulting in a reduction to net
income. We use reinsurance in combination with derivative
instruments to mitigate the liability exposure and the
volatility of net income associated with these liabilities, and
while we believe that these and other actions have mitigated the
risks related to these benefits, we remain liable for the
guaranteed benefits in the event that reinsurers or derivative
counterparties are unable or unwilling to pay. In addition, we
are subject to the risk that hedging and other management
procedures prove ineffective or that unanticipated policyholder
behavior or mortality, combined with adverse market events,
produces economic losses beyond the scope of the risk management
techniques employed. These, individually or collectively, may
have a material adverse effect on net income, financial
condition or liquidity. We are also subject to the risk that the
cost of hedging these guaranteed minimum benefits increases as
implied volatilities increase
and/or
interest rates decrease, resulting in a reduction to net income.
The valuation of certain of the foregoing liabilities (carried
at fair value) includes an adjustment for nonperformance risk
that reflects the credit standing of the issuing entity. This
adjustment, which is not hedged, is based in part on publicly
available information regarding credit spreads related to the
Holding Companys debt, including credit default swaps. In
periods of extreme market volatility, movements in these credit
spreads can have a significant impact on net income.
Guarantees
Within Certain of Our Life and Annuity Products May Increase Our
Exposure to Foreign Exchange Risk, and Decrease Our
Earnings
Certain of our life and annuity products are exposed to foreign
exchange risk. Payments under these contracts may be required to
be made in different currencies, depending on the circumstances.
Therefore, payments may be required in a different currency than
the currency upon which the liability valuation is based. If the
currency upon which expected future payments are made
strengthens relative to the currency upon which the liability
valuation is based, the liability valuation may increase,
resulting in a reduction of net income.
57
We May
Need to Fund Deficiencies in Our Closed Block; Assets
Allocated to the Closed Block Benefit Only the Holders of Closed
Block Policies
MLICs plan of reorganization, as amended (the
Plan), required that we establish and operate an
accounting mechanism, known as a closed block, to ensure that
the reasonable dividend expectations of policyholders who own
certain individual insurance policies of MLIC are met. See
Note 10 of the Notes to the Consolidated Financial
Statements. We allocated assets to the closed block in an amount
that will produce cash flows which, together with anticipated
revenue from the policies included in the closed block, are
reasonably expected to be sufficient to support obligations and
liabilities relating to these policies, including, but not
limited to, provisions for the payment of claims and certain
expenses and tax, and to provide for the continuation of the
policyholder dividend scales in effect for 1999, if the
experience underlying such scales continues, and for appropriate
adjustments in such scales if the experience changes. We cannot
provide assurance that the closed block assets, the cash flows
generated by the closed block assets and the anticipated revenue
from the policies included in the closed block will be
sufficient to provide for the benefits guaranteed under these
policies. If they are not sufficient, we must fund the
shortfall. Even if they are sufficient, we may choose, for
competitive reasons, to support policyholder dividend payments
with our general account funds.
The closed block assets, the cash flows generated by the closed
block assets and the anticipated revenue from the policies in
the closed block will benefit only the holders of those
policies. In addition, to the extent that these amounts are
greater than the amounts estimated at the time the closed block
was funded, dividends payable in respect of the policies
included in the closed block may be greater than they would be
in the absence of a closed block. Any excess earnings will be
available for distribution over time only to closed block
policyholders.
Litigation
and Regulatory Investigations Are Increasingly Common in Our
Businesses and May Result in Significant Financial Losses and/or
Harm to Our Reputation
We face a significant risk of litigation and regulatory
investigations and actions in the ordinary course of operating
our businesses, including the risk of class action lawsuits. Our
pending legal and regulatory actions include proceedings
specific to us and others generally applicable to business
practices in the industries in which we operate. In connection
with our insurance operations, plaintiffs lawyers may
bring or are bringing class actions and individual suits
alleging, among other things, issues relating to sales or
underwriting practices, claims payments and procedures, product
design, disclosure, administration, denial or delay of benefits
and breaches of fiduciary or other duties to customers.
Plaintiffs in class action and other lawsuits against us may
seek very large or indeterminate amounts, including punitive and
treble damages, and the damages claimed and the amount of any
probable and estimable liability, if any, may remain unknown for
substantial periods of time. See Note 16 of the Notes to
the Consolidated Financial Statements.
Due to the vagaries of litigation, the outcome of a litigation
matter and the amount or range of potential loss at particular
points in time may normally be difficult to ascertain.
Uncertainties can include how fact finders will evaluate
documentary evidence and the credibility and effectiveness of
witness testimony, and how trial and appellate courts will apply
the law in the context of the pleadings or evidence presented,
whether by motion practice, or at trial or on appeal.
Disposition valuations are also subject to the uncertainty of
how opposing parties and their counsel will themselves view the
relevant evidence and applicable law.
On a quarterly and annual basis, we review relevant information
with respect to litigation and contingencies to be reflected in
our consolidated financial statements. The review includes
senior legal and financial personnel. Estimates of possible
losses or ranges of loss for particular matters cannot in the
ordinary course be made with a reasonable degree of certainty.
Liabilities are established when it is probable that a loss has
been incurred and the amount of the loss can be reasonably
estimated.
Liabilities have been established for a number of matters noted
in Note 16 of the Notes to the Consolidated Financial
Statements. It is possible that some of the matters could
require us to pay damages or make other expenditures or
establish accruals in amounts that could not be estimated at
December 31, 2010.
58
MLIC and its affiliates are currently defendants in numerous
lawsuits including class actions and individual suits, alleging
improper marketing or sales of individual life insurance
policies, annuities, mutual funds or other products.
In addition, MLIC is a defendant in a large number of lawsuits
seeking compensatory and punitive damages for personal injuries
allegedly caused by exposure to asbestos or asbestos-containing
products. These lawsuits principally have focused on allegations
with respect to certain research, publication and other
activities of one or more of MLICs employees during the
period from the 1920s through approximately the
1950s and have alleged that MLIC learned or should have
learned of certain health risks posed by asbestos and, among
other things, improperly publicized or failed to disclose those
health risks. Additional litigation relating to these matters
may be commenced in the future. The ability of MLIC to estimate
its ultimate asbestos exposure is subject to considerable
uncertainty, and the conditions impacting its liability can be
dynamic and subject to change. The availability of reliable data
is limited and it is difficult to predict with any certainty the
numerous variables that can affect liability estimates,
including the number of future claims, the cost to resolve
claims, the disease mix and severity of disease in pending and
future claims, the impact of the number of new claims filed in a
particular jurisdiction and variations in the law in the
jurisdictions in which claims are filed, the possible impact of
tort reform efforts, the willingness of courts to allow
plaintiffs to pursue claims against MLIC when exposure took
place after the dangers of asbestos exposure were well known,
and the impact of any possible future adverse verdicts and their
amounts. The number of asbestos cases that may be brought or the
aggregate amount of any liability that MLIC may incur, and the
total amount paid in settlements in any given year are uncertain
and may vary significantly from year to year. Accordingly, it is
reasonably possible that our total exposure to asbestos claims
may be materially greater than the liability recorded by us in
our consolidated financial statements and that future charges to
income may be necessary. The potential future charges could be
material in the particular quarterly or annual periods in which
they are recorded.
We are also subject to various regulatory inquiries, such as
information requests, subpoenas and books and record
examinations, from state and federal regulators and other
authorities. A substantial legal liability or a significant
regulatory action against us could have a material adverse
effect on our business, financial condition and results of
operations. Moreover, even if we ultimately prevail in the
litigation, regulatory action or investigation, we could suffer
significant reputational harm, which could have a material
adverse effect on our business, financial condition and results
of operations, including our ability to attract new customers,
retain our current customers and recruit and retain employees.
Regulatory inquiries and litigation may cause volatility in the
price of stocks of companies in our industry.
The New York Attorney General announced on July 29, 2010
that his office had launched a major fraud investigation into
the life insurance industry for practices related to the use of
retained asset accounts as a settlement option for death
benefits and that subpoenas requesting comprehensive data
related to retained asset accounts have been served on MetLife
and other insurance carriers. We received the subpoena on
July 30, 2010. We also have received requests for documents
and information from U.S. congressional committees and
members as well as various state regulatory bodies, including
the New York Insurance Department. It is possible that other
state and federal regulators or legislative bodies may pursue
similar investigations or make related inquiries. We cannot
predict what effect any such investigations might have on our
earnings or the availability of our retained asset account known
as the Total Control Account (TCA), but we believe
that our financial statements taken as a whole would not be
materially affected. We believe that any allegations that
information about the TCA is not adequately disclosed or that
the accounts are fraudulent or violate state or federal laws are
without merit.
We cannot give assurance that current claims, litigation,
unasserted claims probable of assertion, investigations and
other proceedings against us will not have a material adverse
effect on our business, financial condition or results of
operations. It is also possible that related or unrelated
claims, litigation, unasserted claims probable of assertion,
investigations and proceedings may be commenced in the future,
and we could become subject to further investigations and have
lawsuits filed or enforcement actions initiated against us. In
addition, increased regulatory
59
scrutiny and any resulting investigations or proceedings could
result in new legal actions and precedents and industry-wide
regulations that could adversely affect our business, financial
condition and results of operations.
We May
Not be Able to Protect Our Intellectual Property and May be
Subject to Infringement Claims
We rely on a combination of contractual rights with third
parties and copyright, trademark, patent and trade secret laws
to establish and protect our intellectual property. Although we
endeavor to protect our rights, third parties may infringe or
misappropriate our intellectual property. We may have to
litigate to enforce and protect our copyrights, trademarks,
patents, trade secrets and know-how or to determine their scope,
validity or enforceability. This would represent a diversion of
resources that may be significant and our efforts may not prove
successful. The inability to secure or protect our intellectual
property assets could have a material adverse effect on our
business and our ability to compete.
We may be subject to claims by third parties for
(i) patent, trademark or copyright infringement,
(ii) breach of copyright, trademark or license usage
rights, or (iii) misappropriation of trade secrets. Any
such claims and any resulting litigation could result in
significant expense and liability for damages. If we were found
to have infringed or misappropriated a third-party patent or
other intellectual property right, we could in some
circumstances be enjoined from providing certain products or
services to our customers or from utilizing and benefiting from
certain methods, processes, copyrights, trademarks, trade
secrets or licenses. Alternatively, we could be required to
enter into costly licensing arrangements with third parties or
implement a costly work around. Any of these scenarios could
have a material adverse effect on our business and results of
operations.
New
and Impending Compensation and Corporate Governance Regulations
Could Hinder or Prevent Us From Attracting and Retaining
Management and Other Employees with the Talent and Experience to
Manage and Conduct Our Business Effectively
The compensation and corporate governance practices of financial
institutions have become and will continue to be subject to
increasing regulation and scrutiny. Dodd-Frank includes new
requirements that will affect our corporate governance and
compensation practices, including some that have resulted in (or
are likely to lead to) shareholders having the limited right to
use MetLife, Inc.s proxy statement to solicit proxies to
vote for their own candidates for director, impose additional
requirements for membership on Board committees, requirements
for additional shareholder votes on compensation matters,
requirements for policies to recover compensation previously
paid to certain executives under certain circumstances,
elimination of broker discretionary voting on compensation
matters, requirements for additional performance and
compensation disclosure, and other requirements. See
Various Aspects of Dodd-Frank Could Impact Our
Business Operations, Capital Requirements and Profitability and
Limit Our Growth. In addition, the Federal Reserve Board,
the FDIC and other U.S. bank regulators have released
guidelines on incentive compensation that may apply to or impact
MetLife, Inc. as a bank holding company. These requirements and
restrictions, and others Congress or regulators may propose or
implement, could hinder or prevent us from attracting and
retaining management and other employees with the talent and
experience to manage and conduct our business effectively.
Although AIG has received assurances from the Troubled Asset
Relief Program Special Master for Executive Compensation that
neither we nor ALICO will be subject to compensation related
requirements and restrictions under programs established in
whole or in part under EESA, there can be no assurance that the
Acquisition will not lead to greater public or governmental
scrutiny, regulation, or restrictions on our compensation
practices as a result of the Acquisition and expansion into new
markets outside the U.S., whether in connection with AIGs
having received U.S. government funding or as a result of
other factors.
Legislative
and Regulatory Activity in Health Care and Other Employee
Benefits Could Increase the Costs or Administrative Burdens of
Providing Benefits to Our Employees or Hinder or Prevent Us From
Attracting and Retaining Employees, or Affect our Profitability
As a Provider of Life Insurance, Annuities, and Non-Medical
Health Insurance Benefit Products
The Patient Protection and Affordable Care Act, signed into law
on March 23, 2010, and The Health Care and Education
Reconciliation Act of 2010, signed into law on March 30,
2010 (together, the Health Care Act), may
60
lead to fundamental changes in the way that employers, including
us, provide health care benefits, other benefits, and other
forms of compensation to their employees and former employees.
Among other changes, and subject to various effective dates, the
Health Care Act generally restricts certain limits on benefits,
mandates coverage for certain kinds of care, extends the
required coverage of dependent children through age 26,
eliminates pre-existing condition exclusions or limitations,
requires cost reporting and, in some cases, requires premium
rebates to participants under certain circumstances, limits
coverage waiting periods, establishes several penalties on
employers who fail to offer sufficient coverage to their
full-time employees, and requires employers under certain
circumstances to provide employees with vouchers to purchase
their own health care coverage. The Health Care Act also
provides for increased taxation of high cost
coverage, restricts the tax deductibility of certain
compensation paid by health insurers, reduces the tax
deductibility of retiree health care costs to the extent of any
retiree prescription drug benefit subsidy provided to the
employer by the federal government, increases Medicare taxes on
certain high earners, and establishes health insurance
exchanges for individual purchases of health
insurance.
The impact of the Health Care Act on us as an employer and on
the benefit plans we sponsor for employees or retirees and their
dependents, whether those benefits remain competitive or
effective in meeting their business objectives, and our costs to
provide such benefits and our tax liabilities in connection with
benefits or compensation, cannot be predicted. Furthermore, we
cannot predict the impact of choices that will be made by
various regulators, including the U.S. Treasury, the IRS, the
U.S. Department of Health and Human Services, and state
regulators, to promulgate regulations or guidance, or to make
determinations under or related to the Health Care Act. Either
the Health Care Act or any of these regulatory actions could
adversely affect our ability to attract, retain, and motivate
talented associates. They could also result in increased or
unpredictable costs to provide employee benefits, and could harm
our competitive position if we are subject to fees, penalties,
tax provisions or other limitations in the Health Care Act and
our competitors are not.
The Health Care Act also imposes requirements on us as a
provider of non-medical health insurance benefit products,
subject to various effective dates. It also imposes requirements
on the purchasers of certain of these products and has
implications for certain other MLIC products, such as annuities.
We cannot predict the impact of the Act or of regulations,
guidance or determinations made by various regulators, on the
various products that we offer. Either the Health Care Act or
any of these regulatory actions could adversely affect our
ability to offer certain of these products in the same manner as
we do today. They could also result in increased or
unpredictable costs to provide certain products, and could harm
our competitive position if the Health Care Act has a disparate
impact on our products compared to products offered by our
competitors.
The Preservation of Access to Care for Medicare Beneficiaries
and Pension Relief Act of 2010 also includes certain provisions
for defined benefit pension plan funding relief. These
provisions may impact the likelihood
and/or
timing of corporate plan sponsors terminating their plans
and/or
engaging in transactions to partially or fully transfer pension
obligations to an insurance company. As part of our Corporate
Benefit Funding segment, we offer general account and separate
account group annuity products that enable a plan sponsor to
transfer these risks, often in connection with the termination
of defined benefit pension plans. Consequently, this legislation
could indirectly affect the mix of our business, with fewer
closeouts and more non-guaranteed funding products, and
adversely impact our results of operations.
Changes
in U.S. Federal and State Securities Laws and Regulations, and
State Insurance Regulations Regarding Suitability of Annuity
Product Sales, May Affect Our Operations and Our
Profitability
Federal and state securities laws and regulations apply to
insurance products that are also securities,
including variable annuity contracts and variable life insurance
policies. As a result, some of MetLife, Inc.s subsidiaries
and their activities in offering and selling variable insurance
contracts and policies are subject to extensive regulation under
these securities laws. These subsidiaries issue variable annuity
contracts and variable life insurance policies through separate
accounts that are registered with the SEC as investment
companies under the Investment Company Act. Each registered
separate account is generally divided into
sub-accounts,
each of which invests in an underlying mutual fund which is
itself a registered investment company under the Investment
Company Act. In addition, the variable annuity contracts and
variable life insurance policies issued by the separate accounts
are registered with the SEC under the Securities Act. Other
subsidiaries are registered with the SEC as
61
broker-dealers under the Exchange Act, and are members of and
subject to regulation by FINRA. Further, some of our
subsidiaries are registered as investment advisers with the SEC
under the Investment Advisers Act of 1940, and are also
registered as investment advisers in various states, as
applicable.
Federal and state securities laws and regulations are primarily
intended to ensure the integrity of the financial markets and to
protect investors in the securities markets, as well as protect
investment advisory or brokerage clients. These laws and
regulations generally grant regulatory agencies broad rulemaking
and enforcement powers, including the power to limit or restrict
the conduct of business for failure to comply with the
securities laws and regulations. A number of changes have
recently been suggested to the laws and regulations that govern
the conduct of our variable insurance products business and our
distributors that could have a material adverse effect on our
financial condition and results of operations. For example,
Dodd-Frank authorizes the SEC to establish a standard of conduct
applicable to brokers and dealers when providing personalized
investment advice to retail and other customers. This standard
of conduct would be to act in the best interest of the customer
without regard to the financial or other interest of the broker
or dealer providing the advice. Further, proposals have been
made that the SEC establish a self-regulatory organization with
respect to registered investment advisers, which could increase
the level of regulatory oversight over such investment advisers.
In addition, state insurance regulators are becoming more active
in adopting and enforcing suitability standards with respect to
sales of annuities, both fixed and variable. In particular, the
NAIC has adopted a revised Suitability in Annuity Transactions
Model Regulation (SAT), that will, if enacted by the
states, place new responsibilities upon issuing insurance
companies with respect to the suitability of annuity sales,
including responsibilities for training agents. Several states
have already enacted laws based on the SAT.
We also may be subject to similar laws and regulations in the
foreign countries in which we offer products or conduct other
activities similar to those described above. See
Business International Regulation.
Changes
in Tax Laws, Tax Regulations, or Interpretations of Such Laws or
Regulations Could Increase Our Corporate Taxes; Changes in Tax
Laws Could Make Some of Our Products Less Attractive to
Consumers
Changes in tax laws, Treasury and other regulations promulgated
thereunder, or interpretations of such laws or regulations could
increase our corporate taxes. The Obama Administration has
proposed corporate tax changes. Changes in corporate tax rates
could affect the value of deferred tax assets and deferred tax
liabilities. Furthermore, the value of deferred tax assets could
be impacted by future earnings levels.
Changes in tax laws could make some of our products less
attractive to consumers. A shift away from life insurance and
annuity contracts and other tax-deferred products would reduce
our income from sales of these products, as well as the assets
upon which we earn investment income. The Obama Administration
has proposed certain changes to individual income tax rates and
rules applicable to certain policies.
We cannot predict whether any tax legislation impacting
corporate taxes or insurance products will be enacted, what the
specific terms of any such legislation will be or whether, if at
all, any legislation would have a material adverse effect on our
financial condition and results of operations.
Changes
to Regulations Under the Employee Retirement Income Security Act
of 1974 Could Adversely Affect Our Distribution Model by
Restricting Our Ability to Provide Customers With
Advice
The prohibited transaction rules of ERISA and the Internal
Revenue Code generally restrict the provision of investment
advice to ERISA plans and participants and Individual Retirement
Accounts (IRAs) if the investment recommendation
results in fees paid to the individual advisor, his or her firm
or their affiliates that vary according to the investment
recommendation chosen. In March 2010, the DOL issued proposed
regulations which provide limited relief from these investment
advice restrictions. If the proposed rules are issued in final
form and no additional relief is provided regarding these
investment advice restrictions, the ability of our affiliated
broker-dealers and their registered representatives to provide
investment advice to ERISA plans and participants, and with
respect to IRAs, would likely be significantly restricted. Also,
the fee and revenue arrangements of certain advisory
62
programs may be required to be revenue neutral, resulting in
potential lost revenues for these broker-dealers and their
affiliates.
Other proposed regulatory initiatives under ERISA also may
negatively impact the current business model of our
broker-dealers. In particular, the DOL issued a proposed
regulation in October 2010 that would, if adopted as proposed,
significantly broaden the circumstances under which a person or
entity providing investment advice with respect to ERISA plans
or IRAs would be deemed a fiduciary under ERISA or the Internal
Revenue Code. If adopted, the proposed regulations may make it
easier for the DOL in enforcement actions, and for
plaintiffs attorneys in ERISA litigation, to attempt to
extend fiduciary status to advisors who would not be deemed
fiduciaries under current regulations.
In addition, the DOL has issued a number of regulations recently
that increase the level of disclosure that must be provided to
plan sponsors and participants, and may issue additional such
regulations in 2011. These ERISA disclosure requirements will
likely increase the regulatory and compliance burden upon
MetLife, resulting in increased costs.
We May
Be Unable to Attract and Retain Sales Representatives for Our
Products
We must attract and retain productive sales representatives to
sell our insurance, annuities and investment products. Strong
competition exists among insurers for sales representatives with
demonstrated ability. In addition, there is competition for
representatives with other types of financial services firms,
such as independent broker-dealers.
We compete with other insurers for sales representatives
primarily on the basis of our financial position, support
services and compensation and product features. We continue to
undertake several initiatives to grow our career agency force
while continuing to enhance the efficiency and production of our
existing sales force. We cannot provide assurance that these
initiatives will succeed in attracting and retaining new agents.
Sales of individual insurance, annuities and investment products
and our results of operations and financial condition could be
materially adversely affected if we are unsuccessful in
attracting and retaining agents. See Business
Competition.
MetLife,
Inc.s Board of Directors May Control the Outcome of
Stockholder Votes on Many Matters Due to the Voting Provisions
of the MetLife Policyholder Trust
Under the Plan, we established the MetLife Policyholder Trust
(the Trust) to hold the shares of MetLife, Inc.
common stock allocated to eligible policyholders not receiving
cash or policy credits under the plan. As of February 18,
2011, the Trust held 220,255,199 shares, or 22.3%, of the
outstanding shares of MetLife, Inc. common stock. Because of the
number of shares held in the Trust and the voting provisions of
the Trust, the Trust may affect the outcome of matters brought
to a stockholder vote.
Except on votes regarding certain fundamental corporate actions
described below, the trustee will vote all of the shares of
common stock held in the Trust in accordance with the
recommendations given by MetLife, Inc.s Board of Directors
to its stockholders or, if the Board gives no such
recommendations, as directed by the Board. As a result of the
voting provisions of the Trust, the Board of Directors may be
able to control votes on matters submitted to a vote of
stockholders, excluding those fundamental corporate actions, so
long as the Trust holds a substantial number of shares of common
stock.
If the vote relates to fundamental corporate actions specified
in the Trust, the trustee will solicit instructions from the
Trust beneficiaries and vote all shares held in the Trust in
proportion to the instructions it receives. These actions
include:
|
|
|
|
|
an election or removal of directors in which a stockholder has
properly nominated one or more candidates in opposition to a
nominee or nominees of MetLife, Inc.s Board of Directors
or a vote on a stockholders proposal to oppose a Board
nominee for director, remove a director for cause or fill a
vacancy caused by the removal of a director by stockholders,
subject to certain conditions;
|
63
|
|
|
|
|
a merger or consolidation, a sale, lease or exchange of all or
substantially all of the assets, or a recapitalization or
dissolution, of MetLife, Inc., in each case requiring a vote of
stockholders under applicable Delaware law;
|
|
|
|
any transaction that would result in an exchange or conversion
of shares of common stock held by the Trust for cash, securities
or other property; and
|
|
|
|
any proposal requiring MetLife, Inc.s Board of Directors
to amend or redeem the rights under MetLife, Inc.s
stockholder rights plan, other than a proposal with respect to
which we have received advice of nationally-recognized legal
counsel to the effect that the proposal is not a proper subject
for stockholder action under Delaware law. MetLife, Inc. does
not currently have a stockholder rights plan.
|
If a vote concerns any of these fundamental corporate actions,
the trustee will vote all of the shares of common stock held by
the Trust in proportion to the instructions it received, which
will give disproportionate weight to the instructions actually
given by Trust beneficiaries.
ALICO Holdings has agreed to vote all shares of MetLife, Inc.
common stock acquired by it in connection with the Acquisition
in proportion to the votes cast by all other stockholders of
MetLife, Inc., including the Trust.
State
Laws, Federal Laws, Our Certificate of Incorporation and Our
By-Laws May Delay, Deter or Prevent Takeovers and Business
Combinations that Stockholders Might Consider in Their Best
Interests
State laws and our certificate of incorporation and by-laws may
delay, deter or prevent a takeover attempt that stockholders
might consider in their best interests. For instance, they may
prevent stockholders from receiving the benefit from any premium
over the market price of MetLife, Inc.s common stock
offered by a bidder in a takeover context. Even in the absence
of a takeover attempt, the existence of these provisions may
adversely affect the prevailing market price of MetLife,
Inc.s common stock if they are viewed as discouraging
takeover attempts in the future.
Any person seeking to acquire a controlling interest in us would
face various regulatory obstacles which may delay, deter or
prevent a takeover attempt that stockholders of MetLife, Inc.
might consider in their best interests. First, the insurance
laws and regulations of the various states in which MetLife,
Inc.s insurance subsidiaries are organized may delay or
impede a business combination involving us. State insurance laws
prohibit an entity from acquiring control of an insurance
company without the prior approval of the domestic insurance
regulator. Under most states statutes, an entity is
presumed to have control of an insurance company if it owns,
directly or indirectly, 10% or more of the voting stock of that
insurance company or its parent company. We are also subject to
banking regulations, and may in the future become subject to
additional regulations. Dodd-Frank contains provisions that
could restrict or impede consolidation, mergers and acquisitions
by systemically significant firms
and/or large
bank holding companies. See Business U.S.
Regulation Financial Holding Company
Regulation Change of Control and Restrictions on
Mergers and Acquisitions. In addition, the Investment
Company Act would require approval by the contract owners of our
variable contracts in order to effectuate a change of control of
any affiliated investment adviser to a mutual fund underlying
our variable contracts. Finally, FINRA approval would be
necessary for a change of control of any FINRA registered
broker-dealer that is a direct or indirect subsidiary of
MetLife, Inc.
In addition, Section 203 of the Delaware General
Corporation Law may affect the ability of an interested
stockholder to engage in certain business combinations,
including mergers, consolidations or acquisitions of additional
shares, for a period of three years following the time that the
stockholder becomes an interested stockholder. An
interested stockholder is defined to include persons
owning, directly or indirectly, 15% or more of the outstanding
voting stock of a corporation.
MetLife, Inc.s certificate of incorporation and by-laws
also contain provisions that may delay, deter or prevent a
takeover attempt that stockholders might consider in their best
interests. These provisions may adversely affect prevailing
market prices for MetLife, Inc.s common stock and include:
classification of MetLife, Inc.s Board of Directors into
three classes; a prohibition on the calling of special meetings
by stockholders; advance notice procedures for the nomination of
candidates to the Board of Directors and stockholder proposals
to be considered at stockholder meetings; and supermajority
voting requirements for the amendment of certain provisions of
the certificate of incorporation and by-laws.
64
The
Continued Threat of Terrorism and Ongoing Military Actions May
Adversely Affect the Level of Claim Losses We Incur and the
Value of Our Investment Portfolio
The continued threat of terrorism, both within the U.S. and
abroad, ongoing military and other actions and heightened
security measures in response to these types of threats may
cause significant volatility in global financial markets and
result in loss of life, property damage, additional disruptions
to commerce and reduced economic activity. Some of the assets in
our investment portfolio may be adversely affected by declines
in the credit and equity markets and reduced economic activity
caused by the continued threat of terrorism. We cannot predict
whether, and the extent to which, companies in which we maintain
investments may suffer losses as a result of financial,
commercial or economic disruptions, or how any such disruptions
might affect the ability of those companies to pay interest or
principal on their securities or mortgage loans. The continued
threat of terrorism also could result in increased reinsurance
prices and reduced insurance coverage and potentially cause us
to retain more risk than we otherwise would retain if we were
able to obtain reinsurance at lower prices. Terrorist actions
also could disrupt our operations centers in the U.S. or abroad.
In addition, the occurrence of terrorist actions could result in
higher claims under our insurance policies than anticipated. See
Difficult Conditions in the Global Capital
Markets and the Economy Generally May Materially Adversely
Affect Our Business and Results of Operations and These
Conditions May Not Improve in the Near Future.
The
Occurrence of Events Unanticipated in Our Disaster Recovery
Systems and Management Continuity Planning Could Impair Our
Ability to Conduct Business Effectively
In the event of a disaster such as a natural catastrophe, an
epidemic, an industrial accident, a blackout, a computer virus,
a terrorist attack or war, unanticipated problems with our
disaster recovery systems could have a material adverse impact
on our ability to conduct business and on our results of
operations and financial position, particularly if those
problems affect our computer-based data processing,
transmission, storage and retrieval systems and destroy valuable
data. We depend heavily upon computer systems to provide
reliable service. Despite our implementation of a variety of
security measures, our computer systems could be subject to
physical and electronic break-ins, and similar disruptions from
unauthorized tampering. In addition, in the event that a
significant number of our managers were unavailable in the event
of a disaster, our ability to effectively conduct business could
be severely compromised. These interruptions also may interfere
with our suppliers ability to provide goods and services
and our employees ability to perform their job
responsibilities.
Our
Associates May Take Excessive Risks Which Could Negatively
Affect Our Financial Condition and Business
As an insurance enterprise, we are in the business of being paid
to accept certain risks. The associates who conduct our
business, including executive officers and other members of
management, sales managers, investment professionals, product
managers, sales agents, and other associates, do so in part by
making decisions and choices that involve exposing us to risk.
These include decisions such as setting underwriting guidelines
and standards, product design and pricing, determining what
assets to purchase for investment and when to sell them, which
business opportunities to pursue, and other decisions. Although
we endeavor, in the design and implementation of our
compensation programs and practices, to avoid giving our
associates incentives to take excessive risks, associates may
take such risks regardless of the structure of our compensation
programs and practices. Similarly, although we employ controls
and procedures designed to monitor associates business
decisions and prevent us from taking excessive risks, there can
be no assurance that these controls and procedures are or may be
effective. If our associates take excessive risks, the impact of
those risks could have a material adverse effect on our
financial condition or business operations.
|
|
Item 1B.
|
Unresolved
Staff Comments
|
MetLife has no unresolved comments from the SEC staff regarding
its periodic or current reports under the Exchange Act.
65
In 2006, we signed a lease for approximately
410,000 rentable square feet on 12 floors in an office
building in Manhattan, New York. The term of that lease
commenced during 2008 and continues for 21 years. In August
2009, we subleased 32,000 rentable square feet of that
space to a subtenant, which has met our standards of review with
respect to creditworthiness, and we currently have approximately
34,000 rentable square feet of space available for
sublease. We moved certain operations from our Long Island City,
Queens facility, to the Manhattan space in late 2008, but
continue to maintain an on-going presence in Long Island City.
Our lease in Long Island City covers 686,000 rentable
square feet under a long-term lease arrangement that commenced
during 2003 and continues for 20 years. In connection with
the move of certain operations to Manhattan, in late 2008, we
subleased 330,000 rentable square feet to four subtenants,
each of which has met our standards of review with respect to
creditworthiness. To date, with our occupancy and the four
subtenants we have secured, we are fully subscribed at the Long
Island City location.
In connection with the 2005 sale of the 200 Park Avenue
property, we have retained rights to existing signage and are
leasing space for associates in the property for 20 years
with optional renewal periods through 2205.
We continue to own 15 other buildings in the U.S. that we
use in the operation of our business. These buildings contain
approximately four million rentable square feet and are located
in the following states: Connecticut, Florida, Illinois,
Missouri, New Jersey, New York, Ohio, Oklahoma, Pennsylvania and
Rhode Island. Our computer center in Rensselaer, New York is not
owned in fee but rather is occupied pursuant to a long-term
ground lease. We lease space in approximately 700 other
locations throughout the U.S., and these leased facilities
consist of 8.9 million rentable square feet. Approximately
50% of these leases are occupied as sales offices for the
U.S. Business operations. The balance of space is utilized
for MetLife Bank and other corporate functions supporting
business activities. We also own over 70 properties outside the
U.S., comprised of 10 significant properties and the balance of
condominium units. We lease approximately 1,200 sites in various
locations outside the U.S. Of the aforementioned
international locations, approximately 70 owned sites and
approximately 700 leased sites were acquired recently in
connection with the Acquisition. We believe that these
properties are suitable and adequate for our current and
anticipated business operations.
We arrange for property and casualty coverage on our properties,
taking into consideration our risk exposures and the cost and
availability of commercial coverages, including deductible loss
levels. In connection with the renewal of those coverages, we
have arranged $700 million of property insurance, including
coverage for terrorism, on our real estate portfolio through
May 15, 2011, its renewal date.
|
|
Item 3.
|
Legal
Proceedings
|
See Note 16 of the Notes to the Consolidated Financial
Statements.
|
|
Item 4.
|
(Removed
and Reserved)
|
66
Part II
|
|
Item 5.
|
Market
for Registrants Common Equity, Related Stockholder Matters
and Issuer Purchases of Equity Securities
|
Issuer
Common Equity
MetLife, Inc.s common stock, par value $0.01 per share,
began trading on the NYSE under the symbol MET on
April 5, 2000.
The following table presents high and low closing prices for the
common stock on the NYSE for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
1st Quarter
|
|
2nd Quarter
|
|
3rd Quarter
|
|
4th Quarter
|
|
Common Stock Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
High
|
|
$
|
43.34
|
|
|
$
|
47.10
|
|
|
$
|
42.73
|
|
|
$
|
44.92
|
|
Low
|
|
$
|
33.64
|
|
|
$
|
37.76
|
|
|
$
|
36.49
|
|
|
$
|
37.74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
1st Quarter
|
|
2nd Quarter
|
|
3rd Quarter
|
|
4th Quarter
|
|
Common Stock Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
High
|
|
$
|
35.97
|
|
|
$
|
35.50
|
|
|
$
|
40.83
|
|
|
$
|
38.35
|
|
Low
|
|
$
|
12.10
|
|
|
$
|
23.43
|
|
|
$
|
26.90
|
|
|
$
|
33.22
|
|
At February 18, 2011, there were 90,250 stockholders of record
of common stock.
The table below presents dividend declaration, record and
payment dates, as well as per share and aggregate dividend
amounts, for the common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend
|
Declaration Date
|
|
Record Date
|
|
Payment Date
|
|
Per Share
|
|
Aggregate
|
|
|
|
|
|
|
(In millions,
|
|
|
|
|
|
|
except per share data)
|
|
October 26, 2010
|
|
November 9, 2010
|
|
|
December 14, 2010
|
|
|
$
|
0.74
|
|
|
$
|
784
|
(1)
|
October 29, 2009
|
|
November 9, 2009
|
|
|
December 14, 2009
|
|
|
$
|
0.74
|
|
|
$
|
610
|
|
|
|
|
(1) |
|
Includes dividends paid on Series B Contingent Convertible
Junior Participating Non-Cumulative Perpetual Preferred Stock
(the Convertible Preferred Stock). |
Future common stock dividend decisions will be determined by the
Companys Board of Directors after taking into
consideration factors such as our current earnings, expected
medium-term and long-term earnings, financial condition,
regulatory capital position, and applicable governmental
regulations and policies. Furthermore, the payment of dividends
and other distributions to the Company by its insurance
subsidiaries is regulated by insurance laws and regulations. See
Business U.S. Regulation
Insurance Regulation, Managements Discussion
and Analysis of Financial Condition and Results of
Operations Liquidity and Capital
Resources The Holding Company Liquidity
and Capital Sources Dividends from
Subsidiaries and Note 18 of the Notes to the
Consolidated Financial Statements.
67
Issuer
Purchases of Equity Securities
Purchases of common stock made by or on behalf of the Company or
its affiliates during the quarter ended December 31, 2010
are set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c) Total Number
|
|
(d) Maximum Number
|
|
|
|
|
|
|
of Shares
|
|
(or Approximate
|
|
|
|
|
|
|
Purchased as Part
|
|
Dollar Value) of
|
|
|
(a) Total Number
|
|
|
|
of Publicly
|
|
Shares that May Yet
|
|
|
of Shares
|
|
(b) Average Price
|
|
Announced Plans
|
|
Be Purchased Under the
|
Period
|
|
Purchased (1)
|
|
Paid per Share
|
|
or Programs
|
|
Plans or Programs (2)
|
|
October 1- October 31, 2010
|
|
|
1,241
|
|
|
$
|
38.92
|
|
|
|
|
|
|
$
|
1,260,735,127
|
|
November 1- November 30, 2010
|
|
|
160
|
|
|
$
|
42.90
|
|
|
|
|
|
|
$
|
1,260,735,127
|
|
December 1- December 31, 2010
|
|
|
987
|
|
|
$
|
43.90
|
|
|
|
|
|
|
$
|
1,260,735,127
|
|
|
|
|
(1) |
|
During the periods October 1 through October 31, 2010,
November 1 through November 30, 2010 and December 1 through
December 31, 2010, separate account affiliates of the
Company purchased 1,241 shares, 160 shares and
987 shares, respectively, of common stock on the open
market in nondiscretionary transactions to rebalance index
funds. Except as disclosed above, no shares of common stock were
repurchased by the Company. |
|
(2) |
|
At December 31, 2010, the Company had $1,261 million
remaining under its common stock repurchase program
authorizations. In April 2008, the Companys Board of
Directors authorized an additional $1.0 billion common
stock repurchase program, which will begin after the completion
of the January 2008 $1.0 billion common stock repurchase
program, of which $261 million remained outstanding at
December 31, 2010. Under these authorizations, the Company
may purchase its common stock from the MetLife Policyholder
Trust, in the open market (including pursuant to the terms of a
pre-set trading plan meeting the requirements of
Rule 10b5-1
under the Exchange Act) and in privately negotiated
transactions. Whether or not to purchase any common stock and
the size and timing of any such purchases will be determined in
the Companys complete discretion. |
See also Managements Discussion and Analysis of
Financial Condition and Results of Operations
Liquidity and Capital Resources The
Company Liquidity and Capital Uses Share
Repurchases for further information relating to common
stock repurchases.
68
|
|
Item 6.
|
Selected
Financial Data
|
The following selected financial data has been derived from the
Companys audited consolidated financial statements. The
statement of operations data for the years ended
December 31, 2010, 2009 and 2008, and the balance sheet
data at December 31, 2010 and 2009 have been derived from
the Companys audited financial statements included
elsewhere herein. The statement of operations data for the years
ended December 31, 2007 and 2006, and the balance sheet
data at December 31, 2008, 2007 and 2006 have been derived
from the Companys audited financial statements not
included herein. The selected financial data set forth below
should be read in conjunction with Managements
Discussion and Analysis of Financial Condition and Results of
Operations and the consolidated financial statements and
related notes included elsewhere herein.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Statement of Operations Data (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
27,394
|
|
|
$
|
26,460
|
|
|
$
|
25,914
|
|
|
$
|
22,970
|
|
|
$
|
22,052
|
|
Universal life and investment-type product policy fees
|
|
|
6,037
|
|
|
|
5,203
|
|
|
|
5,381
|
|
|
|
5,238
|
|
|
|
4,711
|
|
Net investment income
|
|
|
17,615
|
|
|
|
14,837
|
|
|
|
16,289
|
|
|
|
18,055
|
|
|
|
16,239
|
|
Other revenues
|
|
|
2,328
|
|
|
|
2,329
|
|
|
|
1,586
|
|
|
|
1,465
|
|
|
|
1,301
|
|
Net investment gains (losses)
|
|
|
(392
|
)
|
|
|
(2,906
|
)
|
|
|
(2,098
|
)
|
|
|
(318
|
)
|
|
|
(1,174
|
)
|
Net derivative gains (losses)
|
|
|
(265
|
)
|
|
|
(4,866
|
)
|
|
|
3,910
|
|
|
|
(260
|
)
|
|
|
(208
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
52,717
|
|
|
|
41,057
|
|
|
|
50,982
|
|
|
|
47,150
|
|
|
|
42,921
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
29,545
|
|
|
|
28,336
|
|
|
|
27,437
|
|
|
|
23,783
|
|
|
|
22,869
|
|
Interest credited to policyholder account balances
|
|
|
4,925
|
|
|
|
4,849
|
|
|
|
4,788
|
|
|
|
5,461
|
|
|
|
4,899
|
|
Policyholder dividends
|
|
|
1,486
|
|
|
|
1,650
|
|
|
|
1,751
|
|
|
|
1,723
|
|
|
|
1,698
|
|
Other expenses
|
|
|
12,803
|
|
|
|
10,556
|
|
|
|
11,947
|
|
|
|
10,405
|
|
|
|
9,514
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
48,759
|
|
|
|
45,391
|
|
|
|
45,923
|
|
|
|
41,372
|
|
|
|
38,980
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before provision for
income tax
|
|
|
3,958
|
|
|
|
(4,334
|
)
|
|
|
5,059
|
|
|
|
5,778
|
|
|
|
3,941
|
|
Provision for income tax expense (benefit)
|
|
|
1,181
|
|
|
|
(2,015
|
)
|
|
|
1,580
|
|
|
|
1,675
|
|
|
|
1,027
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income tax
|
|
|
2,777
|
|
|
|
(2,319
|
)
|
|
|
3,479
|
|
|
|
4,103
|
|
|
|
2,914
|
|
Income (loss) from discontinued operations, net of income tax
|
|
|
9
|
|
|
|
41
|
|
|
|
(201
|
)
|
|
|
362
|
|
|
|
3,526
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
2,786
|
|
|
|
(2,278
|
)
|
|
|
3,278
|
|
|
|
4,465
|
|
|
|
6,440
|
|
Less: Net income (loss) attributable to noncontrolling interests
|
|
|
(4
|
)
|
|
|
(32
|
)
|
|
|
69
|
|
|
|
148
|
|
|
|
147
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to MetLife, Inc.
|
|
|
2,790
|
|
|
|
(2,246
|
)
|
|
|
3,209
|
|
|
|
4,317
|
|
|
|
6,293
|
|
Less: Preferred stock dividends
|
|
|
122
|
|
|
|
122
|
|
|
|
125
|
|
|
|
137
|
|
|
|
134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.s common
shareholders
|
|
$
|
2,668
|
|
|
$
|
(2,368
|
)
|
|
$
|
3,084
|
|
|
$
|
4,180
|
|
|
$
|
6,159
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Balance Sheet Data (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General account assets (2)
|
|
$
|
547,569
|
|
|
$
|
390,273
|
|
|
$
|
380,839
|
|
|
$
|
399,007
|
|
|
$
|
383,758
|
|
Separate account assets
|
|
|
183,337
|
|
|
|
149,041
|
|
|
|
120,839
|
|
|
|
160,142
|
|
|
|
144,349
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
730,906
|
|
|
$
|
539,314
|
|
|
$
|
501,678
|
|
|
$
|
559,149
|
|
|
$
|
528,107
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder liabilities and other policy-related balances (3)
|
|
$
|
401,905
|
|
|
$
|
283,759
|
|
|
$
|
282,261
|
|
|
$
|
261,442
|
|
|
$
|
252,099
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
27,272
|
|
|
|
24,196
|
|
|
|
31,059
|
|
|
|
44,136
|
|
|
|
45,846
|
|
Bank deposits
|
|
|
10,316
|
|
|
|
10,211
|
|
|
|
6,884
|
|
|
|
4,534
|
|
|
|
4,638
|
|
Short-term debt
|
|
|
306
|
|
|
|
912
|
|
|
|
2,659
|
|
|
|
667
|
|
|
|
1,449
|
|
Long-term debt (2)
|
|
|
27,586
|
|
|
|
13,220
|
|
|
|
9,667
|
|
|
|
9,100
|
|
|
|
8,822
|
|
Collateral financing arrangements
|
|
|
5,297
|
|
|
|
5,297
|
|
|
|
5,192
|
|
|
|
4,882
|
|
|
|
|
|
Junior subordinated debt securities
|
|
|
3,191
|
|
|
|
3,191
|
|
|
|
3,758
|
|
|
|
4,075
|
|
|
|
3,381
|
|
Other (2)
|
|
|
22,583
|
|
|
|
15,989
|
|
|
|
15,374
|
|
|
|
33,186
|
|
|
|
32,277
|
|
Separate account liabilities
|
|
|
183,337
|
|
|
|
149,041
|
|
|
|
120,839
|
|
|
|
160,142
|
|
|
|
144,349
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
681,793
|
|
|
|
505,816
|
|
|
|
477,693
|
|
|
|
522,164
|
|
|
|
492,861
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable noncontrolling interests in partially owned
consolidated securities
|
|
|
117
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MetLife, Inc.s stockholders equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, at par value
|
|
|
1
|
|
|
|
1
|
|
|
|
1
|
|
|
|
1
|
|
|
|
1
|
|
Convertible preferred stock, at par value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, at par value
|
|
|
10
|
|
|
|
8
|
|
|
|
8
|
|
|
|
8
|
|
|
|
8
|
|
Additional paid-in capital
|
|
|
26,423
|
|
|
|
16,859
|
|
|
|
15,811
|
|
|
|
17,098
|
|
|
|
17,454
|
|
Retained earnings
|
|
|
21,363
|
|
|
|
19,501
|
|
|
|
22,403
|
|
|
|
19,884
|
|
|
|
16,574
|
|
Treasury stock, at cost
|
|
|
(172
|
)
|
|
|
(190
|
)
|
|
|
(236
|
)
|
|
|
(2,890
|
)
|
|
|
(1,357
|
)
|
Accumulated other comprehensive income (loss)
|
|
|
1,000
|
|
|
|
(3,058
|
)
|
|
|
(14,253
|
)
|
|
|
1,078
|
|
|
|
1,118
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total MetLife, Inc.s stockholders equity
|
|
|
48,625
|
|
|
|
33,121
|
|
|
|
23,734
|
|
|
|
35,179
|
|
|
|
33,798
|
|
Noncontrolling interests
|
|
|
371
|
|
|
|
377
|
|
|
|
251
|
|
|
|
1,806
|
|
|
|
1,448
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity
|
|
|
48,996
|
|
|
|
33,498
|
|
|
|
23,985
|
|
|
|
36,985
|
|
|
|
35,246
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and equity
|
|
$
|
730,906
|
|
|
$
|
539,314
|
|
|
$
|
501,678
|
|
|
$
|
559,149
|
|
|
$
|
528,107
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2010
|
|
2009
|
|
2008
|
|
2007
|
|
2006
|
|
|
(In millions, except per share data)
|
|
Other Data (1), (4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.s common
shareholders
|
|
$
|
2,668
|
|
$
|
(2,368)
|
|
$
|
3,084
|
|
$
|
4,180
|
|
$
|
6,159
|
Return on MetLife, Inc.s common equity
|
|
|
6.9%
|
|
|
(9.0)%
|
|
|
11.2%
|
|
|
12.9%
|
|
|
20.9%
|
Return on MetLife, Inc.s common equity, excluding
accumulated other comprehensive income (loss)
|
|
|
7.0%
|
|
|
(6.8)%
|
|
|
9.1%
|
|
|
13.3%
|
|
|
22.1%
|
EPS Data (1), (5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (Loss) from Continuing Operations Available to MetLife,
Inc.s Common Shareholders Per Common Share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
3.01
|
|
$
|
(2.94)
|
|
$
|
4.60
|
|
$
|
5.32
|
|
$
|
3.64
|
Diluted
|
|
$
|
2.99
|
|
$
|
(2.94)
|
|
$
|
4.54
|
|
$
|
5.19
|
|
$
|
3.59
|
Income (Loss) from Discontinued Operations Per Common Share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.01
|
|
$
|
0.05
|
|
$
|
(0.41)
|
|
$
|
0.30
|
|
$
|
4.45
|
Diluted
|
|
$
|
0.01
|
|
$
|
0.05
|
|
$
|
(0.40)
|
|
$
|
0.29
|
|
$
|
4.40
|
Net Income (Loss) Available to MetLife, Inc.s Common
Shareholders Per Common Share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
3.02
|
|
$
|
(2.89)
|
|
$
|
4.19
|
|
$
|
5.62
|
|
$
|
8.09
|
Diluted
|
|
$
|
3.00
|
|
$
|
(2.89)
|
|
$
|
4.14
|
|
$
|
5.48
|
|
$
|
7.99
|
Cash Dividends Declared Per Common Share
|
|
$
|
0.74
|
|
$
|
0.74
|
|
$
|
0.74
|
|
$
|
0.74
|
|
$
|
0.59
|
|
|
|
(1) |
|
On November 1, 2010, the Holding Company acquired ALICO.
The results of the Acquisition are reflected in the 2010
selected financial data. See Note 2 of the Notes to the
Consolidated Financial Statements. |
|
(2) |
|
At December 31, 2010, general account assets, long-term
debt and other liabilities include amounts relating to variable
interest entities of $11,080 million, $6,902 million
and $93 million, respectively. |
|
(3) |
|
Policyholder liabilities and other policy-related balances
include future policy benefits, policyholder account balances,
other policy-related balances, policyholder dividends payable
and the policyholder dividend obligation. |
|
(4) |
|
Return on MetLife, Inc.s common equity is defined as net
income (loss) available to MetLife, Inc.s common
shareholders divided by MetLife, Inc.s average common
stockholders equity. |
|
(5) |
|
For the year ended December 31, 2009, shares related to the
assumed exercise or issuance of stock-based awards have been
excluded from the calculation of diluted earnings per common
share as these assumed shares are anti-dilutive. |
|
|
Item 7.
|
Managements
Discussion and Analysis of Financial Condition and Results of
Operations
|
For purposes of this discussion, MetLife, the
Company, we, our and
us refer to MetLife, Inc., a Delaware corporation
incorporated in 1999 (the Holding Company), its
subsidiaries and affiliates. Following this summary is a
discussion addressing the consolidated results of operations and
financial condition of the Company for the periods indicated.
This discussion should be read in conjunction with Note
Regarding Forward Looking Statements, Risk
Factors, Selected Financial Data and the
Companys consolidated financial statements included
elsewhere herein.
This Managements Discussion and Analysis of Financial
Condition and Results of Operations may contain or incorporate
by reference information that includes or is based upon
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements give expectations or forecasts of future events.
These statements can be identified by the fact that they do not
relate strictly to historical or current facts. They use words
such as anticipate, estimate,
expect, project, intend,
plan, believe and other words and terms
of similar meaning in connection with a discussion of future
operating or financial performance. In particular, these include
statements relating to future actions, prospective services or
products, future performance
71
or results of current and anticipated services or products,
sales efforts, expenses, the outcome of contingencies such as
legal proceedings, trends in operations and financial results.
Any or all forward-looking statements may turn out to be wrong.
Actual results could differ materially from those expressed or
implied in the forward-looking statements. See Note
Regarding Forward-Looking Statements.
The following discussion includes references to our performance
measures operating earnings and operating earnings available to
common shareholders, that are not based on accounting principles
generally accepted in the United States of America
(GAAP). Operating earnings is the measure of segment
profit or loss we use to evaluate segment performance and
allocate resources and, consistent with GAAP accounting guidance
for segment reporting, is our measure of segment performance.
Operating earnings is also a measure by which our senior
managements and many other employees performance is
evaluated for the purposes of determining their compensation
under applicable compensation plans. Operating earnings is
defined as operating revenues less operating expenses, net of
income tax. Operating earnings available to common shareholders,
which is used to evaluate the performance of Banking,
Corporate & Other, as well as MetLife, is defined as
operating earnings less preferred stock dividends.
Operating revenues is defined as GAAP revenues (i) less net
investment gains (losses) and net derivative gains (losses);
(ii) less amortization of unearned revenue related to net
investment gains (losses) and net derivative gains (losses);
(iii) plus scheduled periodic settlement payments on
derivatives that are hedges of investments but do not qualify
for hedge accounting treatment; (iv) plus income from
discontinued real estate operations; (v) less net
investment income related to contractholder-directed unit-linked
investments; and (vi) plus, for operating joint ventures
reported under the equity method of accounting, the
aforementioned adjustments, those identified in the definition
of operating expenses and changes in the fair value of hedges of
operating joint venture liabilities, all net of income tax.
Operating expenses is defined as GAAP expenses (i) less
changes in policyholder benefits associated with asset value
fluctuations related to experience-rated contractholder
liabilities and certain inflation-indexed liabilities;
(ii) less costs related to business combinations (since
January 1, 2009) and noncontrolling interests;
(iii) less amortization of deferred policy acquisition
costs (DAC) and value of business acquired
(VOBA) and changes in the policyholder dividend
obligation related to net investment gains (losses) and net
derivative gains (losses); (iv) less interest credited to
policyholder account balances (PABs) related to
contractholder-directed unit-linked investments; and
(v) plus scheduled periodic settlement payments on
derivatives that are hedges of PABs but do not qualify for hedge
accounting treatment.
In addition, operating revenues and operating expenses do not
reflect the consolidation of certain securitization entities
that are variable interest entities (VIEs) as
required under GAAP.
We believe the presentation of operating earnings and operating
earnings available to common shareholders as we measure it for
management purposes enhances the understanding of our
performance by highlighting the results of operations and the
underlying profitability drivers of our businesses. Operating
earnings and operating earnings available to common shareholders
should not be viewed as substitutes for GAAP income (loss) from
continuing operations, net of income tax. Reconciliations of
operating earnings and operating earnings available to common
shareholders to GAAP income (loss) from continuing operations,
net of income tax, the most directly comparable GAAP measure,
are included in Results of Operations.
In this discussion, we sometimes refer to sales activity for
various products. These sales statistics do not correspond to
revenues under GAAP, but are used as relevant measures of
business activity.
Executive
Summary
MetLife is a leading global provider of insurance, annuities and
employee benefit programs throughout the United States
(U.S.), Japan, Latin America, Asia Pacific, Europe
and the Middle East. Through its subsidiaries and affiliates,
MetLife offers life insurance, annuities, auto and homeowners
insurance, retail banking and other financial services to
individuals, as well as group insurance and
retirement & savings products and services to
corporations and other institutions. MetLife is organized into
five segments: Insurance Products, Retirement Products,
Corporate Benefit Funding and Auto & Home
(collectively, U.S. Business) and
International. The assets and liabilities of American Life
Insurance Company (American Life) and Delaware
American Life Insurance Company (DelAm, together
with American Life, collectively, ALICO) as of
November 30, 2010 and
72
the operating results of ALICO from November 1, 2010 (the
Acquisition Date) through November 30, 2010 are
included in the International segment. In addition, the Company
reports certain of its results of operations in Banking,
Corporate & Other, which is comprised of MetLife Bank,
National Association (MetLife Bank) and other
business activities. For reporting periods beginning in 2011,
our
non-U.S. Business
results will be presented within two separate segments: Japan
and Other International Regions.
On the Acquisition Date, the Holding Company completed the
acquisition of American Life from ALICO Holdings LLC
(ALICO Holdings), a subsidiary of American
International Group, Inc. (AIG), and DelAm from AIG,
(the Acquisition) for a total purchase price of
$16.4 billion. The business acquired in the Acquisition
provides consumers and businesses with life insurance, accident
and health insurance, retirement and wealth management
solutions. This transaction delivers on our global growth
strategies, adding significant scale and reach to MetLifes
international footprint, furthering our diversification in
geographic mix and product offerings, as well as increasing our
distribution strength. See Note 2 of the Notes to the
Consolidated Financial Statements.
As the U.S. and global financial markets continue to
recover, we have experienced a significant improvement in net
investment income and favorable changes in net investment and
net derivative gains (losses). We also continue to experience an
increase in market share and sales in some of our businesses, in
part, from a flight to quality in the industry. These positive
factors were somewhat dampened by the negative impact of general
economic conditions, including high levels of unemployment, on
the demand for certain of our products.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Income (loss) from continuing operations, net of income tax
|
|
$
|
2,777
|
|
|
$
|
(2,319
|
)
|
|
$
|
3,479
|
|
Less: Net investment gains (losses)
|
|
|
(392
|
)
|
|
|
(2,906
|
)
|
|
|
(2,098
|
)
|
Less: Net derivative gains (losses)
|
|
|
(265
|
)
|
|
|
(4,866
|
)
|
|
|
3,910
|
|
Less: Adjustments to continuing operations (1)
|
|
|
(981
|
)
|
|
|
283
|
|
|
|
(664
|
)
|
Less: Provision for income tax (expense) benefit
|
|
|
401
|
|
|
|
2,683
|
|
|
|
(488
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
|
4,014
|
|
|
|
2,487
|
|
|
|
2,819
|
|
Less: Preferred stock dividends
|
|
|
122
|
|
|
|
122
|
|
|
|
125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings available to common shareholders
|
|
$
|
3,892
|
|
|
$
|
2,365
|
|
|
$
|
2,694
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
See definitions of operating revenues and operating expenses for
the components of such adjustments. |
Year
Ended December 31, 2010 compared with the Year Ended
December 31, 2009
Unless otherwise stated, all amounts discussed below are net of
income tax.
During the year ended December 31, 2010, MetLifes
income (loss) from continuing operations, net of income tax
increased $5.1 billion to a gain of $2.8 billion from
a loss of $2.3 billion in 2009, of which $2 million in
losses is from the inclusion of ALICO results for one month in
2010 and the impact of financing costs for the Acquisition. The
change was predominantly due to a $4.6 billion favorable
change in net derivative gains (losses), before income tax, and
a $2.5 billion favorable change in net investment gains
(losses), before income tax. Offsetting these favorable
variances were unfavorable changes in adjustments related to
continuing operations of $1.3 billion, before income tax,
and $2.2 billion of income tax, resulting in a total
favorable variance of $3.6 billion. In addition, operating
earnings available to common shareholders increased
$1.5 billion to $3.9 billion in the current year from
$2.4 billion in the prior year.
The favorable change in net derivative gains (losses) of
$3.0 billion was primarily driven by net gains on
freestanding derivatives in the current year compared to net
losses in the prior year, partially offset by an unfavorable
change in embedded derivatives from gains in the prior year to
losses in the current year. The favorable change in freestanding
derivatives was primarily attributable to market factors,
including falling long-term and mid-term interest rates, a
stronger recovery in equity markets in the prior year than the
current year, equity volatility, which decreased more in the
prior year as compared to the current year, a strengthening
U.S. dollar and widening corporate credit spreads in the
financial services sector. The favorable change in net
investment gains (losses) of
73
$1.6 billion was primarily driven by a decrease in
impairments and a decrease in the provision for credit losses on
mortgage loans. These favorable changes in net derivative and
net investment gains (losses) were partially offset by an
unfavorable change of $514 million in related adjustments.
The improvement in the financial markets, which began in the
second quarter of 2009 and continued into 2010, was a key driver
of the $1.5 billion increase in operating earnings
available to common shareholders. Such market improvement was
most evident in higher net investment income and policy fees, as
well as a decrease in variable annuity guarantee benefit costs.
These increases were partially offset by an increase in
amortization of DAC, VOBA and deferred sales inducements
(DSI) as a result of an increase in average separate
account balances and higher current year gross margins in the
closed block driven by increased investment yields and the
impact of dividend scale reductions. The 2010 period also
includes one month of ALICO results, contributing
$114 million to the increase in operating earnings. The
favorable impact of a reduction in discretionary spending
associated with our enterprise-wide cost reduction and revenue
enhancement initiative was more than offset by an increase in
other expenses related to our International business. This
increase primarily stemmed from the impact of a benefit recorded
in the prior year related to the pesification in Argentina, as
well as current year business growth in the segment.
Year
Ended December 31, 2009 compared with the Year Ended
December 31, 2008
Unless otherwise stated, all amounts discussed below are net of
income tax.
During the year ended December 31, 2009, MetLifes
income (loss) from continuing operations, net of income tax,
decreased $5.8 billion to a loss of $2.3 billion from
income of $3.5 billion in the comparable 2008 period. The
year over year change is predominantly due to an
$8.8 billion unfavorable change in net derivative gains
(losses), before income tax, to losses of $4.9 billion in
2009 from gains of $3.9 billion in 2008. In addition, there
was an $808 million unfavorable change in net investment
gains (losses), before income tax. Offsetting these variances
were favorable changes in adjustments related to continuing
operations of $947 million, before income tax, and
$3.2 billion of income tax, resulting in a total
unfavorable variance of $5.5 billion. In addition,
operating earnings available to common shareholders decreased by
$329 million to $2.4 billion in 2009 from
$2.7 billion in 2008.
The unfavorable change in net derivative gains (losses) of
$8.8 billion was primarily driven by losses on freestanding
derivatives, partially offset by gains on embedded derivatives,
most of which were associated with variable annuity minimum
benefit guarantees, and lower losses on fixed maturity
securities. The unfavorable change in net investment gains
(losses) of $808 million was primarily driven by an
increase in impairments. These unfavorable changes in gains
(losses) were partially offset by a favorable change of
$947 million in related adjustments.
The positive impact of business growth and favorable mortality
in several of our businesses was more than offset by a decline
in net investment income, resulting in a decrease in operating
earnings of $329 million. The decrease in net investment
income caused significant declines in the operating earnings of
many of our businesses, especially the interest spread
businesses. Also contributing to the decline in operating
earnings was an increase in net guaranteed annuity benefit costs
and a charge related to our closed block of business, a specific
group of participating life policies that were segregated in
connection with the demutualization of Metropolitan Life
Insurance Company (MLIC). The favorable impact of
our enterprise-wide cost reduction and revenue enhancement
initiative, was more than offset by higher pension and
postretirement benefit costs, driving the increase in other
expenses. The declines in operating earnings were partially
offset by a change in amortization related to DAC, DSI and
unearned revenue.
Consolidated
Company Outlook
As a result of the Acquisition, operations outside the
U.S. are expected to contribute approximately 30% of the
premiums, fees and other revenues and approximately 40% of
MetLifes operating earnings in 2011.
74
In 2010, general economic conditions improved and interest rates
remained low throughout the year. In 2011, we expect a
significant improvement in the operating earnings of the
Company, driven primarily by the following:
|
|
|
|
|
Premiums, fees and other revenues growth in 2011 of
approximately 30%, of which 27% is directly attributable to the
Acquisition. The remaining 3% increase is driven by:
|
|
|
|
|
|
Increases in our
non-U.S. businesses
from continuing organic growth throughout our various geographic
regions;
|
|
|
|
Higher fees earned on separate accounts, as the equity markets
continue to improve, thereby increasing the value of those
separate accounts. In addition, net flows of variable annuities
are expected to continue to be strong in 2011, which also
increases the account values upon which these fees are earned;
|
|
|
|
Increased sales in the pension closeout business, both in the
U.S. and the United Kingdom (U.K.), as we
expect the demand for these products to return to a more normal
level in 2011.
|
|
|
|
|
|
Focus on disciplined underwriting. We see no significant changes
to the underlying trends that drive underwriting results and
anticipate solid results in 2011.
|
|
|
|
Focus on expense management. We continue to focus on expense
control throughout the Company, specifically managing the costs
associated with the integration of ALICO. We also expect to
begin realizing cost synergies later in 2011.
|
|
|
|
Returns on investment portfolio. Although the market
environment remains challenging, we expect the returns on our
investment portfolio in 2011, with respect to both income and
realized gains and losses, will be in line with the results
achieved in 2010.
|
More difficult to predict is the impact of potential changes in
fair value of freestanding and embedded derivatives as even
relatively small movements in market variables, including
interest rates, equity levels and volatility, can have a large
impact on the fair value of derivatives and net derivative gains
(losses). Additionally, changes in fair value of embedded
derivatives within certain insurance liabilities may have a
material impact on net derivative gains (losses) related to the
inclusion of an adjustment for nonperformance risk.
Industry
Trends
Despite improvement in general economic conditions in 2010, we
continue to be impacted by the unstable global financial and
economic environment that has been affecting the industry.
Financial and Economic Environment. Our
business and results of operations are materially affected by
conditions in the global capital markets and the economy,
generally, both in the U.S. and elsewhere around the world.
The global economy and markets are now recovering from a period
of significant stress that began in the second half of 2007 and
substantially increased through the first quarter of 2009. This
disruption adversely affected the financial services industry,
in particular. The U.S. economy entered a recession in late
2007. This recession ended in mid-2009, but the recovery from
the recession has been below historic averages and the
unemployment rate is expected to remain high for some time. In
addition, inflation has fallen over the last several years and
is expected to remain at low levels for some time. Some
economists believe that some level of disinflation and deflation
risk remains in the economy.
Throughout 2008 and continuing in 2009, Congress, the Federal
Reserve Bank of New York, the Federal Deposit Insurance
Corporation (FDIC), the U.S. Treasury and other
agencies of the Federal government took a number of increasingly
aggressive actions (in addition to continuing a series of
interest rate reductions that began in the second half of
2007) intended to provide liquidity to financial
institutions and markets, to avert a loss of investor confidence
in particular troubled institutions, to prevent or contain the
spread of the financial crisis and to spur economic growth. Most
of these programs have run their course or have been
discontinued. The monetary policy by the Federal Reserve Board
and the Dodd-Frank Wall Street Reform and Consumer Protection
Act (Dodd-Frank), which was signed by President
Obama in July 2010, are more likely to be relevant to MetLife,
Inc. and will significantly change financial regulation in the
U.S. See Regulatory Changes. In
addition, the oversight body of the Basel Committee on Banking
Supervision announced in December 2010 increased capital and
liquidity requirements (commonly referred
75
to as Basel III) for bank holding companies, such as
MetLife, Inc. Assuming these requirements are endorsed and
adopted by the U.S., they are to be phased in beginning
January 1, 2013. It is possible that even more stringent
capital and liquidity requirements could be imposed under
Dodd-Frank and Basel III.
It is not certain what effect the enactment of Dodd-Frank or
Basel III will have on the financial markets, the
availability of credit, asset prices and MetLifes
operations. We cannot predict whether the funds made available
by the U.S. Federal government and its agencies will be
enough to continue stabilizing or to further revive the
financial markets or, if additional amounts are necessary,
whether Congress will be willing to make the necessary
appropriations, what the publics sentiment would be
towards any such appropriations, or what additional requirements
or conditions might be imposed on the use of any such additional
funds.
The imposition of additional regulation on large financial
institutions may have, over time, the effect of supporting some
aspects of the financial services industry more than others.
This could adversely affect our competitive position.
Although the disruption in the global financial markets has
moderated, not all such markets are functioning normally, and
some remain reliant upon government intervention and liquidity.
The global recession and disruption of the financial markets has
also led to concerns over capital markets access and the
solvency of certain European Union member states, including
Portugal, Ireland, Italy, Greece and Spain. In response, on
May 10, 2010, the European Union, the European Central Bank
and the International Monetary Fund announced a rescue package
of up to 750 billion, or approximately $1 trillion,
for European nations in the Eurozone. This rescue package is
intended to stabilize these economies. The Japanese economy, to
which we face increased exposure as a result of the Acquisition,
continues to experience low nominal growth, a deflationary
environment, and weak consumer spending.
Recent global economic conditions have had and could continue to
have an adverse effect on the financial results of companies in
the financial services industry, including MetLife. Such global
economic conditions, as well as the global financial markets,
continue to impact our net investment income, our net investment
and net derivative gains (losses), and the demand for and the
cost and profitability of certain of our products, including
variable annuities and guarantee benefits. See
Results of Operations and
Liquidity and Capital Resources.
Competitive Pressures. The life insurance
industry remains highly competitive. The product development and
product life-cycles have shortened in many product segments,
leading to more intense competition with respect to product
features. Larger companies have the ability to invest in brand
equity, product development, technology and risk management,
which are among the fundamentals for sustained profitable growth
in the life insurance industry. In addition, several of the
industrys products can be quite homogeneous and subject to
intense price competition. Sufficient scale, financial strength
and financial flexibility are becoming prerequisites for
sustainable growth in the life insurance industry. Larger market
participants tend to have the capacity to invest in additional
distribution capability and the information technology needed to
offer the superior customer service demanded by an increasingly
sophisticated industry client base. We believe that the
turbulence in financial markets that began in the second half of
2007, its impact on the capital position of many competitors,
and subsequent actions by regulators and rating agencies have
highlighted financial strength as a significant differentiator
from the perspective of customers and certain distributors. In
addition, the financial market turbulence and the economic
recession have led many companies in our industry to re-examine
the pricing and features of the products they offer and may lead
to consolidation in the life insurance industry.
Regulatory Changes. The U.S. life
insurance industry is regulated at the state level, with some
products and services also subject to Federal regulation. As
life insurers introduce new and often more complex products,
regulators refine capital requirements and introduce new
reserving standards for the life insurance industry. Regulations
recently adopted or currently under review can potentially
impact the statutory reserve and capital requirements of the
industry. In addition, regulators have undertaken market and
sales practices reviews of several markets or products,
including equity-indexed annuities, variable annuities and group
products. The regulation of the financial services industry in
the U.S. and internationally has received renewed scrutiny
as a result of the disruptions in the financial markets in 2008
and 2009. Significant regulatory reforms have been proposed and
these or other reforms could be implemented. See
Business U.S. Regulation and
Business International Regulation. We
cannot predict whether any such reforms will be adopted, the
form they will take or their effect upon us. We also cannot
predict how the various government responses to the recent
financial and economic difficulties will affect the financial
services and insurance industries or the standing of particular
companies, including us, within those industries. See
Business Governmental
76
Responses to Extraordinary Market Conditions, Risk
Factors Our Insurance, Brokerage and Banking
Businesses Are Heavily Regulated, and Changes in
Regulation May Reduce Our Profitability and Limit Our
Growth and Risk Factors Changes in
U.S. Federal and State Securities Laws and Regulations, and
State Insurance Regulations Regarding Suitability of Annuity
Product Sales, May Affect Our Operations and Our
Profitability. Until various studies are completed and
final regulations are promulgated pursuant to Dodd-Frank, the
full impact of Dodd-Frank on the investments, investment
activities and insurance and annuity products of the Company
remain unclear. See Risk Factors Various
Aspects of Dodd-Frank Could Impact Our Business Operations,
Capital Requirements and Profitability and Limit Our
Growth. Under Dodd-Frank, as a large, interconnected bank
holding company with assets of $50 billion or more, or
possibly as an otherwise systemically important financial
company, MetLife, Inc. will be subject to enhanced prudential
standards imposed on systemically significant financial
companies. Enhanced standards will be applied to Tier 1 and
total risk-based capital (RBC), liquidity, leverage
(unless another, similar standard is appropriate for the
Company), resolution plan and credit exposure reporting,
concentration limits, and risk management. The so-called
Volcker Rule provisions of Dodd-Frank restrict the
ability of affiliates of insured depository institutions (such
as MetLife Bank) to engage in proprietary trading or sponsor or
invest in hedge funds or private equity funds. See Risk
Factors Various Aspects of
Dodd-Frank
Could Impact Our Business Operations, Capital Requirements and
Profitability and Limit Our Growth.
Mortgage and Foreclosure-Related Exposures. In
2008 MetLife Bank acquired certain assets to enter the forward
and reverse residential mortgage origination and servicing
business, including rights to service residential mortgage
loans. At various times since then, including most recently in
the third quarter of 2010, MetLife Bank has acquired additional
residential mortgage loan servicing rights. As an originator and
servicer of mortgage loans, which are usually sold to an
investor shortly after origination, MetLife Bank has obligations
to repurchase loans upon demand by the investor due to
(i) a determination that material representations made in
connection with the sale of the loans (relating, for example, to
the underwriting and origination of the loans) are incorrect or
(ii) defects in servicing of the loan. MetLife Bank is
indemnified by the sellers of the acquired assets, for various
periods depending on the transaction and the nature of the
claim, for origination and servicing deficiencies that occurred
prior to MetLife Banks acquisition, including
indemnification for any repurchase claims made from investors
who purchased mortgage loans from the sellers. Substantially all
mortgage servicing rights (MSRs) that were acquired
by MetLife Bank relate to loans sold to Federal National
Mortgage Association (FNMA) or Federal Home Loan
Mortgage Corporation (FHLMC). Since the 2008
acquisitions, MetLife Bank has originated and sold mortgages
primarily to FNMA, FHLMC and Government National Mortgage
Association (GNMA) (collectively, the Agency
Investors) and, to a limited extent, a small number of
private investors. Currently 99% of MetLife Banks
$83 billion servicing portfolio is comprised of products
sold to Agency Investors. Other than repurchase obligations
which are subject to indemnification by sellers of acquired
assets as described above, MetLife Banks exposure to
repurchase obligations and losses related to origination
deficiencies is limited to the approximately $52 billion of
loans originated by MetLife Bank (all of which have been
originated since August 2008) and to servicing deficiencies
after the date of acquisition, and management is satisfied that
adequate provision has been made in the Companys
consolidated financial statements for all probable and
reasonably estimable repurchase obligations and losses.
In light of recent events concerning foreclosure proceedings
within the industry, MetLife Bank has undertaken a close review
of its procedures. MetLife Bank verifies the accuracy of
borrower information included in affidavits filed in foreclosure
proceedings. We do not believe that MetLife Bank has material
exposure to potential losses arising from challenges to its
foreclosure procedures. Like other mortgage servicers, MetLife
Bank has been the subject of recent inquiries and investigations
from state attorneys general and banking regulators. See
Note 16 of the Notes to the Consolidated Financial
Statements.
Summary
of Critical Accounting Estimates
The preparation of financial statements in conformity with GAAP
requires management to adopt accounting policies and make
estimates and assumptions that affect amounts reported in the
consolidated financial statements. The most critical estimates
include those used in determining:
|
|
|
|
(i)
|
the estimated fair value of investments in the absence of quoted
market values;
|
|
|
(ii)
|
investment impairments;
|
77
|
|
|
|
(iii)
|
the recognition of income on certain investment entities and the
application of the consolidation rules to certain investments;
|
|
|
(iv)
|
the estimated fair value of and accounting for freestanding
derivatives and the existence and estimated fair value of
embedded derivatives requiring bifurcation;
|
|
|
(v)
|
the capitalization and amortization of DAC and the establishment
and amortization of VOBA;
|
|
|
(vi)
|
the measurement of goodwill and related impairment, if any;
|
|
|
(vii)
|
the liability for future policyholder benefits and the
accounting for reinsurance contracts;
|
|
|
(viii)
|
accounting for income taxes and the valuation of deferred tax
assets;
|
|
|
(ix)
|
accounting for employee benefit plans; and
|
|
|
(x)
|
the liability for litigation and regulatory matters.
|
The application of purchase accounting requires the use of
estimation techniques in determining the estimated fair values
of assets acquired and liabilities assumed the most
significant of which relate to aforementioned critical
accounting estimates. In applying the Companys accounting
policies, we make subjective and complex judgments that
frequently require estimates about matters that are inherently
uncertain. Many of these policies, estimates and related
judgments are common in the insurance and financial services
industries; others are specific to the Companys businesses
and operations. Actual results could differ from these estimates.
Fair
Value
The Company defines fair value as the price that would be
received to sell an asset or paid to transfer a liability (an
exit price) in the principal or most advantageous market for the
asset or liability in an orderly transaction between market
participants on the measurement date. In many cases, the exit
price and the transaction (or entry) price will be the same at
initial recognition. However, in certain cases, the transaction
price may not represent fair value. The fair value of a
liability is based on the amount that would be paid to transfer
a liability to a third party with the same credit standing. It
requires that fair value be a market-based measurement in which
the fair value is determined based on a hypothetical transaction
at the measurement date, considered from the perspective of a
market participant. When quoted prices are not used to determine
fair value of an asset, the Company considers three broad
valuation techniques: (i) the market approach,
(ii) the income approach, and (iii) the cost approach.
The Company determines the most appropriate valuation technique
to use, given what is being measured and the availability of
sufficient inputs. The Company prioritizes the inputs to fair
valuation techniques and allows for the use of unobservable
inputs to the extent that observable inputs are not available.
The Company categorizes its assets and liabilities measured at
estimated fair value into a three-level hierarchy, based on the
priority of the inputs to the respective valuation technique.
The fair value hierarchy gives the highest priority to quoted
prices in active markets for identical assets or liabilities
(Level 1) and the lowest priority to unobservable
inputs (Level 3). An asset or liabilitys
classification within the fair value hierarchy is based on the
lowest level of input to its valuation. The input levels are as
follows:
|
|
|
|
Level 1
|
Unadjusted quoted prices in active markets for identical assets
or liabilities. The Company defines active markets based on
average trading volume for equity securities. The size of the
bid/ask spread is used as an indicator of market activity for
fixed maturity securities.
|
|
|
Level 2
|
Quoted prices in markets that are not active or inputs that are
observable either directly or indirectly. Level 2 inputs
include quoted prices for similar assets or liabilities other
than quoted prices in Level 1; quoted prices in markets
that are not active; or other significant inputs that are
observable or can be derived principally from or corroborated by
observable market data for substantially the full term of the
assets or liabilities.
|
|
|
Level 3
|
Unobservable inputs that are supported by little or no market
activity and are significant to the estimated fair value of the
assets or liabilities. Unobservable inputs reflect the reporting
entitys own assumptions about the assumptions that market
participants would use in pricing the asset or liability.
Level 3 assets and liabilities include financial
instruments whose values are determined using pricing models,
discounted cash flow methodologies, or similar techniques, as
well as
|
78
|
|
|
|
|
instruments for which the determination of estimated fair value
requires significant management judgment or estimation.
|
Prior to January 1, 2009, the measurement and disclosures
of fair value based on exit price excluded certain items such as
nonfinancial assets and nonfinancial liabilities initially
measured at estimated fair value in a business combination,
reporting units measured at estimated fair value in the first
step of a goodwill impairment test and indefinite-lived
intangible assets measured at estimated fair value for
impairment assessment.
In addition, the Company elected the fair value option
(FVO) for certain of its financial instruments to
better match measurement of assets and liabilities in the
consolidated statements of operations.
Estimated
Fair Value of Investments
The Companys investments in fixed maturity and equity
securities, investments in trading and other securities, certain
short-term investments, most mortgage loans
held-for-sale,
and MSRs are reported at their estimated fair value. In
determining the estimated fair value of these investments,
various methodologies, assumptions and inputs are utilized, as
described further below.
When available, the estimated fair value of securities is based
on quoted prices in active markets that are readily and
regularly obtainable. Generally, these are the most liquid of
the Companys securities holdings and valuation of these
securities does not involve management judgment.
When quoted prices in active markets are not available, the
determination of estimated fair value is based on market
standard valuation methodologies. The market standard valuation
methodologies utilized include: discounted cash flow
methodologies, matrix pricing or other similar techniques. The
inputs to these market standard valuation methodologies include,
but are not limited to: interest rates, credit standing of the
issuer or counterparty, industry sector of the issuer, coupon
rate, call provisions, sinking fund requirements, maturity,
estimated duration and managements assumptions regarding
liquidity and estimated future cash flows. Accordingly, the
estimated fair values are based on available market information
and managements judgments about financial instruments.
The significant inputs to the market standard valuation
methodologies for certain types of securities with reasonable
levels of price transparency are inputs that are observable in
the market or can be derived principally from or corroborated by
observable market data. Such observable inputs include
benchmarking prices for similar assets in active, liquid
markets, quoted prices in markets that are not active and
observable yields and spreads in the market.
When observable inputs are not available, the market standard
valuation methodologies for determining the estimated fair value
of certain types of securities that trade infrequently, and
therefore have little or no price transparency, rely on inputs
that are significant to the estimated fair value that are not
observable in the market or cannot be derived principally from
or corroborated by observable market data. These unobservable
inputs can be based in large part on management judgment or
estimation, and cannot be supported by reference to market
activity. Even though unobservable, these inputs are based on
assumptions deemed appropriate given the circumstances and
consistent with what other market participants would use when
pricing such securities.
The estimated fair value of residential mortgage loans
held-for-sale
is determined based on observable pricing of residential
mortgage loans
held-for-sale
with similar characteristics, or observable pricing for
securities backed by similar types of loans, adjusted to convert
the securities prices to loan prices. Generally, quoted market
prices are not available. When observable pricing for similar
loans or securities that are backed by similar loans are not
available, the estimated fair values of residential mortgage
loans
held-for-sale
are determined using independent broker quotations, which is
intended to approximate the amounts that would be received from
third parties. Certain other mortgage loans have also been
designated as
held-for-sale
which are recorded at the lower of amortized cost or estimated
fair value less expected disposition costs determined on an
individual loan basis. For these loans, estimated fair value is
determined using independent broker quotations or, when the loan
is in foreclosure or otherwise determined to be collateral
dependent, the estimated fair value of the underlying collateral
estimated using internal models.
79
MSRs, which are recorded in other invested assets, are measured
at estimated fair value and are either acquired or are generated
from the sale of originated residential mortgage loans where the
servicing rights are retained by the Company. The estimated fair
value of MSRs is principally determined through the use of
internal discounted cash flow models which utilize various
assumptions. Valuation inputs and assumptions include generally
observable items such as type and age of loan, loan interest
rates, current market interest rates, and certain unobservable
inputs, including assumptions regarding estimates of discount
rates, loan prepayments and servicing costs, all of which are
sensitive to changing markets conditions. The use of different
valuation assumptions and inputs, as well as assumptions
relating to the collection of expected cash flows, may have a
material effect on the estimated fair values of MSRs.
Financial markets are susceptible to severe events evidenced by
rapid depreciation in asset values accompanied by a reduction in
asset liquidity. The Companys ability to sell securities,
or the price ultimately realized for these securities, depends
upon the demand and liquidity in the market and increases the
use of judgment in determining the estimated fair value of
certain securities.
Investment
Impairments
One of the significant estimates related to
available-for-sale
securities is the evaluation of investments for impairments. The
assessment of whether impairments have occurred is based on our
case-by-case
evaluation of the underlying reasons for the decline in
estimated fair value. The Companys review of its fixed
maturity and equity securities for impairments includes an
analysis of the total gross unrealized losses by three
categories of severity
and/or age
of the gross unrealized loss, as described more fully in
Note 3 of the Notes to the Consolidated Financial
Statements. An extended and severe unrealized loss position on a
fixed maturity security may not have any impact on the ability
of the issuer to service all scheduled interest and principal
payments and the Companys evaluation of recoverability of
all contractual cash flows or the ability to recover an amount
at least equal to its amortized cost based on the present value
of the expected future cash flows to be collected. In contrast,
for certain equity securities, greater weight and consideration
are given by the Company to a decline in estimated fair value
and the likelihood such estimated fair value decline will
recover.
Additionally, we consider a wide range of factors about the
security issuer and use our best judgment in evaluating the
cause of the decline in the estimated fair value of the security
and in assessing the prospects for near-term recovery. Inherent
in our evaluation of the security are assumptions and estimates
about the operations of the issuer and its future earnings
potential. Considerations used by the Company in the impairment
evaluation process include, but are not limited to:
|
|
|
|
(i)
|
the length of time and the extent to which the estimated fair
value has been below cost or amortized cost;
|
|
|
(ii)
|
the potential for impairments of securities when the issuer is
experiencing significant financial difficulties;
|
|
|
(iii)
|
the potential for impairments in an entire industry sector or
sub-sector;
|
|
|
(iv)
|
the potential for impairments in certain economically depressed
geographic locations;
|
|
|
(v)
|
the potential for impairments of securities where the issuer,
series of issuers or industry has suffered a catastrophic type
of loss or has exhausted natural resources;
|
|
|
(vi)
|
with respect to fixed maturity securities, whether the Company
has the intent to sell or will more likely than not be required
to sell a particular security before recovery of the decline in
estimated fair value below cost or amortized cost;
|
|
|
(vii)
|
with respect to equity securities, whether the Companys
ability and intent to hold the security for a period of time
sufficient to allow for the recovery of its value to an amount
equal to or greater than cost;
|
|
|
(viii)
|
unfavorable changes in projected cash flows on mortgage-backed
and asset-backed securities (ABS); and
|
|
|
(ix)
|
other subjective factors, including concentrations and
information obtained from regulators and rating agencies.
|
80
The cost of fixed maturity and equity securities is adjusted for
the credit loss component of
Other-Than-Temporary
Impairment (OTTI) in the period in which the
determination is made. When an OTTI of a fixed maturity security
has occurred, the amount of the OTTI recognized in earnings
depends on whether the Company intends to sell the security or
more likely than not will be required to sell the security
before recovery of the decline in estimated fair value below
amortized cost. If the fixed maturity security meets either of
these two criteria, the OTTI recognized in earnings is equal to
the entire difference between the securitys amortized cost
and its estimated fair value at the impairment measurement date.
For OTTI of fixed maturity securities that do not meet either of
these two criteria, the net amount recognized in earnings is
equal to the difference between the amortized cost of the fixed
maturity security and the present value of projected future cash
flows expected to be collected from this security (credit
loss). If the estimated fair value is less than the
present value of projected future cash flows expected to be
collected, this portion of OTTI related to other than credit
factors (noncredit loss) is recorded as other
comprehensive income (loss). For equity securities, the carrying
value of the equity security is impaired to its estimated fair
value, with a corresponding charge to earnings. The Company does
not make any adjustments for subsequent recoveries in value.
The determination of the amount of allowances and impairments on
other invested asset classes is highly subjective and is based
upon the Companys periodic evaluation and assessment of
known and inherent risks associated with the respective asset
class. Such evaluations and assessments are revised as
conditions change and new information becomes available.
Recognition
of Income on Certain Investment Entities
The recognition of income on certain investments (e.g.
loan-backed securities, including mortgage-backed and ABS,
certain structured investment transactions, trading and other
securities) is dependent upon market conditions, which could
result in prepayments and changes in amounts to be earned.
Application
of the Consolidation Rules to Certain Investments
The Company has invested in certain structured transactions that
are VIEs. These structured transactions include reinsurance
trusts, asset-backed securitizations, hybrid securities, real
estate joint ventures, other limited partnership interests and
limited liability companies. The Company is required to
consolidate those VIEs for which it is deemed to be the primary
beneficiary. The accounting rules for the determination of when
an entity is a VIE and when to consolidate a VIE are complex.
The determination of the VIEs primary beneficiary requires
an evaluation of the contractual and implied rights and
obligations associated with each partys relationship with
or involvement in the entity, an estimate of the entitys
expected losses and expected residual returns and the allocation
of such estimates to each party involved in the entity. The
Company generally uses a qualitative approach to determine
whether it is the primary beneficiary.
For most VIEs, the entity that has both the ability to direct
the most significant activities of the VIE and the obligation to
absorb losses or receive benefits that could be significant to
the VIE is considered the primary beneficiary. However, for VIEs
that are investment companies or apply measurement principles
consistent with those utilized by investment companies, the
primary beneficiary is based on a risks and rewards model and is
defined as the entity that will absorb a majority of a
VIEs expected losses, receive a majority of a VIEs
expected residual returns if no single entity absorbs a majority
of expected losses, or both. The Company reassesses its
involvement with VIEs on a quarterly basis. The use of different
methodologies, assumptions and inputs in the determination of
the primary beneficiary could have a material effect on the
amounts presented within the consolidated financial statements.
Derivative
Financial Instruments
The Company enters into freestanding derivative transactions
including swaps, forwards, futures and option contracts to
manage various risks relating to its ongoing business
operations. To a lesser extent, the Company uses credit
derivatives, such as credit default swaps, to synthetically
replicate investment risks and returns which are not readily
available in the cash market.
81
The estimated fair value of derivatives is determined through
the use of quoted market prices for exchange-traded derivatives
and interest forwards to sell certain to-be-announced securities
or through the use of pricing models for
over-the-counter
(OTC) derivatives. The determination of estimated
fair value, when quoted market values are not available, is
based on market standard valuation methodologies and inputs that
are assumed to be consistent with what other market participants
would use when pricing the instruments. Derivative valuations
can be affected by changes in interest rates, foreign currency
exchange rates, financial indices, credit spreads, default risk
(including the counterparties to the contract), volatility,
liquidity and changes in estimates and assumptions used in the
pricing models. See Note 5 of the Notes to the Consolidated
Financial Statements for additional details on significant
inputs into the OTC derivative pricing models and credit risk
adjustment.
The accounting for derivatives is complex and interpretations of
the primary accounting guidance continue to evolve in practice.
Judgment is applied in determining the availability and
application of hedge accounting designations and the appropriate
accounting treatment under such accounting guidance. If it was
determined that hedge accounting designations were not
appropriately applied, reported net income could be materially
affected. Differences in judgment as to the availability and
application of hedge accounting designations and the appropriate
accounting treatment may result in a differing impact on the
consolidated financial statements of the Company from that
previously reported. Assessments of hedge effectiveness and
measurements of ineffectiveness of hedging relationships are
also subject to interpretations and estimations and different
interpretations or estimates may have a material effect on the
amount reported in net income.
Embedded
Derivatives
The Company issues certain variable annuity products with
guaranteed minimum benefits. These include guaranteed minimum
withdrawal benefits (GMWB), guaranteed minimum
accumulation benefits (GMAB), and certain guaranteed
minimum income benefits (GMIB). GMWB, GMAB and
certain GMIB are embedded derivatives, which are measured at
estimated fair value separately from the host variable annuity
product, with changes in estimated fair value reported in net
derivative gains (losses).
The estimated fair values of these embedded derivatives are
determined based on the present value of projected future
benefits minus the present value of projected future fees. The
projections of future benefits and future fees require capital
market and actuarial assumptions including expectations
concerning policyholder behavior. A risk neutral valuation
methodology is used under which the cash flows from the
guarantees are projected under multiple capital market scenarios
using observable risk free rates. The valuation of these
embedded derivatives also includes an adjustment for the
Companys nonperformance risk and risk margins for
non-capital market inputs. The nonperformance risk adjustment is
determined by taking into consideration publicly available
information relating to spreads in the secondary market for the
Holding Companys debt, including related credit default
swaps. These observable spreads are then adjusted, as necessary,
to reflect the priority of these liabilities and the claims
paying ability of the issuing insurance subsidiaries compared to
the Holding Company. Risk margins are established to capture the
non-capital market risks of the instrument which represent the
additional compensation a market participant would require to
assume the risks related to the uncertainties of such actuarial
assumptions as annuitization, premium persistency, partial
withdrawal and surrenders. The establishment of risk margins
requires the use of significant management judgment.
The accounting for embedded derivatives is complex and
interpretations of the primary accounting standards continue to
evolve in practice. If interpretations change, there is a risk
that features previously not bifurcated may require bifurcation
and reporting at estimated fair value in the consolidated
financial statements and respective changes in estimated fair
value could materially affect net income.
These guaranteed minimum benefits may be more costly than
expected in volatile or declining equity markets. Market
conditions including, but not limited to, changes in interest
rates, equity indices, market volatility and foreign currency
exchange rates, changes in the Companys nonperformance
risk, variations in actuarial assumptions regarding policyholder
behavior, mortality and risk margins related to non-capital
market inputs may result in significant fluctuations in the
estimated fair value of the guarantees that could materially
affect net income.
82
The Company ceded the risk associated with certain of the GMIB
and GMAB described in the preceding paragraphs. The value of the
embedded derivatives on the ceded risk is determined using a
methodology consistent with that described previously for the
guarantees directly written by the Company.
As part of its regular review of critical accounting estimates,
the Company periodically assesses inputs for estimating
nonperformance risk in fair value measurements. During the
second quarter of 2010, the Company completed a study that
aggregated and evaluated data, including historical recovery
rates of insurance companies as well as policyholder behavior
observed over the past two years as the recent financial crisis
evolved. As a result, at the end of the second quarter of 2010,
the Company refined the manner in which its insurance
subsidiaries incorporate expected recovery rates into the
nonperformance risk adjustment for purposes of estimating the
fair value of investment-type contracts and embedded derivatives
within insurance contracts. The refinement impacted the
Companys income from continuing operations, net of income
tax, with no effect on operating earnings.
As described above, the valuation of variable annuity guarantees
accounted for as embedded derivatives includes an adjustment for
the Companys nonperformance risk, which is subject to
variability. The table below illustrates the impact that a range
of reasonably likely variances in credit spreads would have on
the Companys consolidated balance sheet, excluding the
effect of income tax. Changes in the carrying values of PABs
would be reported in net investment gains (losses) and changes
in the carrying value of DAC and VOBA would be reported in other
expenses. However, these estimated effects do not take into
account potential changes in other variables, such as equity
price levels and market volatility, that can also contribute
significantly to changes in carrying values. Therefore, the
table does not necessarily reflect the ultimate impact on the
consolidated financial statements under the credit spread
variance scenarios presented below.
In determining the ranges, the Company has considered current
market conditions as well as the market level of spreads that
can reasonably be anticipated over the near term. The ranges do
not reflect extreme market conditions experienced during the
2008 and 2009 economic crisis as the Company does not consider
those to be reasonably likely events in the near future.
|
|
|
|
|
|
|
|
|
|
|
Carrying Value
|
|
|
|
At December 31, 2010
|
|
|
|
|
|
|
DAC and
|
|
|
|
PABs
|
|
|
VOBA
|
|
|
|
(In millions)
|
|
|
100% increase in the Companys credit spread
|
|
$
|
1,551
|
|
|
$
|
79
|
|
As reported
|
|
$
|
2,357
|
|
|
$
|
110
|
|
50% decrease in the Companys credit spread
|
|
$
|
2,852
|
|
|
$
|
130
|
|
The estimated fair value of the embedded equity and bond indexed
derivatives contained in certain funding agreements is
determined using market standard swap valuation models and
observable market inputs, including an adjustment for the
Companys nonperformance risk that takes into consideration
publicly available information relating to the Companys
debt, as well as its claims paying ability. Changes in equity
and bond indices, interest rates and the Companys credit
standing may result in significant fluctuations in estimated the
fair value of these embedded derivatives that could materially
affect net income.
Deferred
Policy Acquisition Costs and Value of Business
Acquired
The Company incurs significant costs in connection with
acquiring new and renewal insurance business. Costs that vary
with and relate to the production of new business are deferred
as DAC. Such costs consist principally of commissions and agency
and policy issuance expenses. VOBA is an intangible asset that
represents the excess of book value over the estimated fair
value of acquired insurance, annuity, and investment-type
contracts in-force at the acquisition date. The estimated fair
value of the acquired liabilities is based on actuarially
determined projections, by each block of business, of future
policy and contract charges, premiums, mortality and morbidity,
separate account performance, surrenders, operating expenses,
investment returns, nonperformance risk adjustment and other
factors. Actual experience on the purchased business may vary
from these projections. The recovery of DAC and VOBA is
dependent upon the future profitability of the related business.
DAC and VOBA are aggregated in the consolidated financial
statements for reporting purposes.
83
Note 1 of the Notes to the Consolidated Financial
Statements describes the Companys accounting policy
relating to DAC and VOBA amortization for various types of
contracts.
Separate account rates of return on variable universal life
contracts and variable deferred annuity contracts affect
in-force account balances on such contracts each reporting
period which can result in significant fluctuations in
amortization of DAC and VOBA. The Companys practice to
determine the impact of gross profits resulting from returns on
separate accounts assumes that long-term appreciation in equity
markets is not changed by short-term market fluctuations, but is
only changed when sustained interim deviations are expected. The
Company monitors these events and only changes the assumption
when its long-term expectation changes. The effect of an
increase/(decrease) by 100 basis points in the assumed
future rate of return is reasonably likely to result in a
decrease/(increase) in the DAC and VOBA amortization of
approximately $128 million with an offset to the
Companys unearned revenue liability of approximately
$19 million for this factor.
The Company also periodically reviews other long-term
assumptions underlying the projections of estimated gross
margins and profits. These include investment returns,
policyholder dividend scales, interest crediting rates,
mortality, persistency, and expenses to administer business. We
annually update assumptions used in the calculation of estimated
gross margins and profits which may have significantly changed.
If the update of assumptions causes expected future gross
margins and profits to increase, DAC and VOBA amortization will
decrease, resulting in a current period increase to earnings.
The opposite result occurs when the assumption update causes
expected future gross margins and profits to decrease.
The Companys most significant assumption updates resulting
in a change to expected future gross margins and profits and the
amortization of DAC and VOBA were due to revisions to expected
future investment returns, expenses, in-force or persistency
assumptions and policyholder dividends on contracts included
within the Insurance Products and Retirement Products segments.
The Company expects these assumptions to be the ones most
reasonably likely to cause significant changes in the future.
Changes in these assumptions can be offsetting and the Company
is unable to predict their movement or offsetting impact over
time.
Note 6 of the Notes to the Consolidated Financial
Statements provides a rollforward of DAC and VOBA for the
Company for each of the years ended December 31, 2010, 2009
and 2008, as well as a breakdown of DAC and VOBA by segment and
reporting unit at December 31, 2010 and 2009.
At December 31, 2010, 2009 and 2008, DAC and VOBA for the
Company was $27.3 billion, $19.3 billion and
$20.1 million, respectively. The DAC and VOBA balance
increased significantly as a result of the Acquisition, which
contributed $8.9 billion to the balance at
December 31, 2010. Approximately 55%, of the Companys
DAC and VOBA was associated with the Insurance Products and
Retirement Products segments at December 31, 2010. At
December 31, 2010, 2009 and 2008, DAC and VOBA for these
segments was $14.9 billion, $16.1 billion and
$17.4 billion, respectively. Amortization of DAC and VOBA
associated with the variable and universal life and the
annuities contracts within the Insurance Products and Retirement
Products segments is significantly impacted by movements in
equity markets. The following chart illustrates the effect on
DAC and VOBA within the Companys U.S. Business of
changing each of the respective assumptions, as well as updating
estimated gross margins or profits with actual gross margins or
profits during the years ended December 31, 2010, 2009 and
2008. Increases (decreases) in DAC and VOBA balances, as
presented below, resulted in a corresponding decrease (increase)
in amortization.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Investment return
|
|
$
|
3
|
|
|
$
|
141
|
|
|
$
|
70
|
|
Separate account balances
|
|
|
21
|
|
|
|
(32
|
)
|
|
|
(708
|
)
|
Net investment gain (loss)
|
|
|
(124
|
)
|
|
|
712
|
|
|
|
(521
|
)
|
Expense
|
|
|
89
|
|
|
|
60
|
|
|
|
61
|
|
In-force/Persistency
|
|
|
17
|
|
|
|
(87
|
)
|
|
|
(159
|
)
|
Policyholder dividends and other
|
|
|
(192
|
)
|
|
|
174
|
|
|
|
(30
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
(186
|
)
|
|
$
|
968
|
|
|
$
|
(1,287
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
84
The following represents significant items contributing to the
changes to DAC and VOBA amortization in 2010:
|
|
|
|
|
Changes in net investment gains (losses) resulted in the
following changes in DAC and VOBA amortization:
|
|
|
|
|
|
Actual gross profits increased as a result of a decrease in
liabilities associated with guarantee obligations on variable
annuities, resulting in an increase of DAC and VOBA amortization
of $197 million, excluding the impact from the
Companys nonperformance risk and risk margins, which are
described below. This increase in actual gross profits was
partially offset by freestanding derivative losses associated
with the hedging of such guarantee obligations, which resulted
in a decrease in DAC and VOBA amortization of $88 million.
|
|
|
|
The narrowing of the Companys nonperformance risk
adjustment increased the valuation of guarantee liabilities,
decreased actual gross profits and decreased DAC and VOBA
amortization by $96 million. In addition, higher risk
margins which increased the guarantee liability valuations,
decreased actual gross profits and decreased DAC and VOBA
amortization by $18 million.
|
|
|
|
The remainder of the impact of net investment gains (losses),
which increased DAC amortization by $129 million, was
primarily attributable to current period investment activities.
|
|
|
|
|
|
Included in policyholder dividends and other was an increase in
DAC and VOBA amortization of $42 million as a result of
changes to long-term assumptions. In addition, amortization
increased by $39 million as a result of favorable gross
margin variances. The remainder of the increase was due to
various immaterial items.
|
The following represents significant items contributing to the
changes to DAC and VOBA amortization in 2009:
|
|
|
|
|
Actual gross profits decreased as a result of increased
investment losses from the portfolios associated with the
hedging of guaranteed insurance obligations on variable
annuities, resulting in a decrease of DAC and VOBA amortization
of $141 million.
|
|
|
|
Changes in net investment gains (losses) resulted in the
following changes in DAC and VOBA amortization:
|
|
|
|
|
|
Actual gross profits increased as a result of a decrease in
liabilities associated with guarantee obligations on variable
annuities, resulting in an increase of DAC and VOBA amortization
of $995 million, excluding the impact from the
Companys nonperformance risk and risk margins, which are
described below. This increase in actual gross profits was
partially offset by freestanding derivative losses associated
with the hedging of such guarantee obligations, which resulted
in a decrease in DAC and VOBA amortization of $636 million.
|
|
|
|
The narrowing of the Companys nonperformance risk
adjustment increased the valuation of guarantee liabilities,
decreased actual gross profits and decreased DAC and VOBA
amortization by $607 million. This was partially offset by
lower risk margins which decreased the guarantee liability
valuations, increased actual gross profits and increased DAC and
VOBA amortization by $20 million.
|
|
|
|
The remainder of the impact of net investment gains (losses),
which decreased DAC amortization by $484 million, was
primarily attributable to current period investment activities.
|
|
|
|
|
|
Included in policyholder dividends and other was a decrease in
DAC and VOBA amortization of $90 million as a result of
changes to long-term assumptions. The remainder of the decrease
was due to various immaterial items.
|
The following represents significant items contributing to the
changes in DAC and VOBA amortization in 2008:
|
|
|
|
|
The decrease in equity markets during the year significantly
lowered separate account balances which led to a significant
reduction in expected future gross profits on variable universal
life contracts and variable deferred annuity contracts resulting
in an increase of $708 million in DAC and VOBA amortization.
|
85
|
|
|
|
|
Changes in net investment gains (losses) resulted in the
following changes in DAC and VOBA amortization:
|
|
|
|
|
|
Actual gross profits decreased as a result of an increase in
liabilities associated with guarantee obligations on variable
annuities resulting in a reduction of DAC and VOBA amortization
of $1,047 million. This decrease in actual gross profits
was mitigated by freestanding derivative gains associated with
the hedging of such guarantee obligations which resulted in an
increase in actual gross profits and an increase in DAC and VOBA
amortization of $625 million.
|
|
|
|
The widening of the Companys nonperformance risk
adjustment decreased the valuation of guarantee liabilities,
increased actual gross profits and increased DAC and VOBA
amortization by $739 million. This was partially offset by
higher risk margins which increased the guarantee liability
valuations, decreased actual gross profits and decreased DAC and
VOBA amortization by $100 million.
|
|
|
|
Reductions in both actual and expected cumulative earnings of
the closed block resulting from recent experience in the closed
block combined with changes in expected dividend scales resulted
in an increase in closed block DAC amortization of
$195 million, $175 million of which was related to net
investment gains (losses).
|
|
|
|
The remainder of the impact of net investment gains (losses) on
DAC amortization of $129 million was attributable to
numerous immaterial items.
|
|
|
|
|
|
Increases in DAC and VOBA amortization in 2008 resulting from
changes in assumptions related to in-force/persistency of
$159 million were driven by higher than anticipated
mortality and lower than anticipated premium persistency during
2008.
|
The Companys DAC and VOBA balance is also impacted by
unrealized investment gains (losses) and the amount of
amortization which would have been recognized if such gains and
losses had been recognized. The increase in unrealized
investment gains decreased the DAC and VOBA balance by
$1.4 billion in 2010. The decrease in unrealized investment
losses decreased the DAC and VOBA balance by $2.8 billion
in 2009, whereas the increase in unrealized investment losses
increased the DAC and VOBA balance by $3.4 billion in 2008.
Notes 3 and 6 of the Notes to the Consolidated Financial
Statements include the DAC and VOBA offset to unrealized
investment losses.
Goodwill
Goodwill is the excess of cost over the estimated fair value of
net assets acquired. Goodwill is not amortized but is tested for
impairment at least annually or more frequently if events or
circumstances, such as adverse changes in the business climate,
indicate that there may be justification for conducting an
interim test.
Impairment testing is performed using the fair value approach,
which requires the use of estimates and judgment, at the
reporting unit level. A reporting unit is the
operating segment or a business one level below the operating
segment, if discrete financial information is prepared and
regularly reviewed by management at that level.
For purposes of goodwill impairment testing, if the carrying
value of a reporting unit exceeds its estimated fair value,
there might be an indication of impairment. In such instances,
the implied fair value of the goodwill is determined in the same
manner as the amount of goodwill that would be determined in a
business acquisition. The excess of the carrying value of
goodwill over the implied fair value of goodwill would be
recognized as an impairment and recorded as a charge against net
income.
The key inputs, judgments and assumptions necessary in
determining estimated fair value of the reporting units include
projected operating earnings, current book value (with and
without accumulated other comprehensive income), the level of
economic capital required to support the mix of business,
long-term growth rates, comparative market multiples, the
account value of in-force business, projections of new and
renewal business, as well as margins on such business, the level
of interest rates, credit spreads, equity market levels, and the
discount rate that we believe is appropriate for the respective
reporting unit. The estimated fair values of the retirement
products and individual life reporting units are particularly
sensitive to the equity market levels.
86
We apply significant judgment when determining the estimated
fair value of our reporting units and when assessing the
relationship of market capitalization to the aggregate estimated
fair value of our reporting units. The valuation methodologies
utilized are subject to key judgments and assumptions that are
sensitive to change. Estimates of fair value are inherently
uncertain and represent only managements reasonable
expectation regarding future developments. These estimates and
the judgments and assumptions upon which the estimates are based
will, in all likelihood, differ in some respects from actual
future results. Declines in the estimated fair value of our
reporting units could result in goodwill impairments in future
periods which could materially adversely affect our results of
operations or financial position.
On an ongoing basis, we evaluate potential triggering events
that may affect the estimated fair value of our reporting units
to assess whether any goodwill impairment exists. Deteriorating
or adverse market conditions for certain reporting units may
have a significant impact on the estimated fair value of these
reporting units and could result in future impairments of
goodwill.
Liability
for Future Policy Benefits
The Company establishes liabilities for amounts payable under
insurance policies, including traditional life insurance,
traditional annuities, certain accident and health, and
non-medical health insurance. Generally, amounts are payable
over an extended period of time and related liabilities are
calculated as the present value of future expected benefits to
be paid reduced by the present value of future expected
premiums. Such liabilities are established based on methods and
underlying assumptions in accordance with GAAP and applicable
actuarial standards. Principal assumptions used in the
establishment of liabilities for future policy benefits are
mortality, morbidity, policy lapse, renewal, retirement,
disability incidence, disability terminations, investment
returns, inflation, expenses and other contingent events as
appropriate to the respective product type and geographical
area. These assumptions are established at the time the policy
is issued and are intended to estimate the experience for the
period the policy benefits are payable. Utilizing these
assumptions, liabilities are established on a block of business
basis. If experience is less favorable than assumptions,
additional liabilities may be required, resulting in a charge to
policyholder benefits and claims.
Future policy benefit liabilities for disabled lives are
estimated using the present value of benefits method and
experience assumptions as to claim terminations, expenses and
interest.
Liabilities for unpaid claims and claim expenses for property
and casualty insurance are included in future policyholder
benefits and represent the amount estimated for claims that have
been reported but not settled and claims incurred but not
reported. Other policy-related balances include claims that have
been reported but not settled and claims incurred but not
reported on life and non-medical health insurance. Liabilities
for unpaid claims are estimated based upon the Companys
historical experience and other actuarial assumptions that
consider the effects of current developments, anticipated trends
and risk management programs, reduced for anticipated salvage
and subrogation.
Future policy benefit liabilities for minimum death and income
benefit guarantees relating to certain annuity contracts and
secondary and
paid-up
guarantees relating to certain life policies are based on
estimates of the expected value of benefits in excess of the
projected account balance and recognizing the excess ratably
over the accumulation period based on total expected
assessments. Liabilities for universal and variable life
secondary guarantees and
paid-up
guarantees are determined by estimating the expected value of
death benefits payable when the account balance is projected to
be zero and recognizing those benefits ratably over the
accumulation period based on total expected assessments. The
assumptions used in estimating these liabilities are consistent
with those used for amortizing DAC, and are thus subject to the
same variability and risk. The assumptions of investment
performance and volatility for variable products are consistent
with historical experience of the appropriate underlying equity
index, such as the Standard & Poors Ratings
Services (S&P) 500 Index.
The Company periodically reviews its estimates of actuarial
liabilities for future policy benefits and compares them with
its actual experience. Differences between actual experience and
the assumptions used in pricing of these policies and guarantees
and in the establishment of the related liabilities result in
variances in profit and could result in losses.
87
Reinsurance
The Company enters into reinsurance agreements primarily as a
purchaser of reinsurance for its various insurance products and
also as a provider of reinsurance for some insurance products
issued by third parties. Accounting for reinsurance requires
extensive use of assumptions and estimates, particularly related
to the future performance of the underlying business and the
potential impact of counterparty credit risks. The Company
periodically reviews actual and anticipated experience compared
to the aforementioned assumptions used to establish assets and
liabilities relating to ceded and assumed reinsurance and
evaluates the financial strength of counterparties to its
reinsurance agreements using criteria similar to that evaluated
in the security impairment process discussed previously.
Additionally, for each of its reinsurance agreements, the
Company determines whether the agreement provides
indemnification against loss or liability relating to insurance
risk, in accordance with applicable accounting standards. The
Company reviews all contractual features, particularly those
that may limit the amount of insurance risk to which the
reinsurer is subject or features that delay the timely
reimbursement of claims. If the Company determines that a
reinsurance agreement does not expose the reinsurer to a
reasonable possibility of a significant loss from insurance
risk, the Company records the agreement using the deposit method
of accounting.
Income
Taxes
Income taxes represent the net amount of income taxes that the
Company expects to pay to or receive from various taxing
jurisdictions in connection with its operations. The Company
provides for federal, state and foreign income taxes currently
payable, as well as those deferred due to temporary differences
between the financial reporting and tax bases of assets and
liabilities. The Companys accounting for income taxes
represents managements best estimate of various events and
transactions.
Deferred tax assets and liabilities resulting from temporary
differences between the financial reporting and tax bases of
assets and liabilities are measured at the balance sheet date
using enacted tax rates expected to apply to taxable income in
the years the temporary differences are expected to reverse.
For U.S. federal income tax purposes, the Company
anticipates making an election under the Internal Revenue Code
Section 338 as it relates to the Acquisition. As such, the
tax basis in the acquired assets and liabilities is adjusted as
of the Acquisition Date resulting in a change to the related
deferred income taxes.
The realization of deferred tax assets depends upon the
existence of sufficient taxable income within the carryback or
carryforward periods under the tax law in the applicable tax
jurisdiction. Valuation allowances are established when
management determines, based on available information, that it
is more likely than not that deferred income tax assets will not
be realized. Factors in managements determination consider
the performance of the business including the ability to
generate capital gains. Significant judgment is required in
determining whether valuation allowances should be established,
as well as the amount of such allowances. When making such
determination, consideration is given to, among other things,
the following:
|
|
|
|
(i)
|
future taxable income exclusive of reversing temporary
differences and carryforwards;
|
|
|
(ii)
|
future reversals of existing taxable temporary differences;
|
|
|
(iii)
|
taxable income in prior carryback years; and
|
|
|
(iv)
|
tax planning strategies.
|
The Company determines whether it is more likely than not that a
tax position will be sustained upon examination by the
appropriate taxing authorities before any part of the benefit is
recorded in the financial statements. A tax position is measured
at the largest amount of benefit that is greater than
50 percent likely of being realized upon settlement. The
Company may be required to change its provision for income taxes
when the ultimate deductibility of certain items is challenged
by taxing authorities or when estimates used in determining
valuation allowances on deferred tax assets significantly
change, or when receipt of new information indicates the need
for adjustment in valuation allowances. Additionally, future
events, such as changes in tax laws, tax regulations, or
interpretations of such laws or regulations, could have an
impact on the provision for income tax and the effective tax
rate. Any such changes could significantly affect the amounts
reported in the consolidated financial statements in the year
these changes occur.
88
Employee
Benefit Plans
Certain subsidiaries of the Holding Company sponsor
and/or
administer pension and other postretirement benefit plans
covering employees who meet specified eligibility requirements.
The obligations and expenses associated with these plans require
an extensive use of assumptions such as the discount rate,
expected rate of return on plan assets, rate of future
compensation increases, healthcare cost trend rates, as well as
assumptions regarding participant demographics such as rate and
age of retirements, withdrawal rates and mortality. In
consultation with our external consulting actuarial firms, we
determine these assumptions based upon a variety of factors such
as historical performance of the plan and its assets, currently
available market and industry data, and expected benefit payout
streams. The assumptions used may differ materially from actual
results due to, among other factors, changing market and
economic conditions and changes in participant demographics.
These differences may have a significant effect on the
Companys consolidated financial statements and liquidity.
Litigation
Contingencies
The Company is a party to a number of legal actions and is
involved in a number of regulatory investigations. Given the
inherent unpredictability of these matters, it is difficult to
estimate the impact on the Companys financial position.
Liabilities are established when it is probable that a loss has
been incurred and the amount of the loss can be reasonably
estimated. Liabilities related to certain lawsuits, including
the Companys asbestos-related liability, are especially
difficult to estimate due to the limitation of available data
and uncertainty regarding numerous variables that can affect
liability estimates. The data and variables that impact the
assumptions used to estimate the Companys asbestos-related
liability include the number of future claims, the cost to
resolve claims, the disease mix and severity of disease in
pending and future claims, the impact of the number of new
claims filed in a particular jurisdiction and variations in the
law in the jurisdictions in which claims are filed, the possible
impact of tort reform efforts, the willingness of courts to
allow plaintiffs to pursue claims against the Company when
exposure to asbestos took place after the dangers of asbestos
exposure were well known, and the impact of any possible future
adverse verdicts and their amounts. On a quarterly and annual
basis, the Company reviews relevant information with respect to
liabilities for litigation, regulatory investigations and
litigation-related contingencies to be reflected in the
Companys consolidated financial statements. It is possible
that an adverse outcome in certain of the Companys
litigation and regulatory investigations, including
asbestos-related cases, or the use of different assumptions in
the determination of amounts recorded could have a material
effect upon the Companys consolidated net income or cash
flows in particular quarterly or annual periods.
Economic
Capital
Economic capital is an internally developed risk capital model,
the purpose of which is to measure the risk in the business and
to provide a basis upon which capital is deployed. The economic
capital model accounts for the unique and specific nature of the
risks inherent in our businesses. As a part of the economic
capital process, a portion of net investment income is credited
to the segments based on the level of allocated equity. This is
in contrast to the standardized regulatory RBC formula, which is
not as refined in its risk calculations with respect to the
nuances of our businesses.
Acquisitions
and Dispositions
See Note 2 of the Notes to the Consolidated Financial
Statements.
Results
of Operations
Year
Ended December 31, 2010 compared with the Year Ended
December 31, 2009
We have experienced growth and an increase in market share in
several of our businesses, which, together with improved overall
market conditions compared to conditions a year ago, positively
impacted our results most significantly through increased net
cash flows, improved yields on our investment portfolio and
increased policy fee income. Sales of our domestic annuity
products were up 14%, driven by an increase in variable annuity
sales compared with the prior year. We benefited in 2010 from
strong sales of structured settlement products. Market
penetration continues in our pension closeout business in the
U.K.; however, although improving, our domestic
89
pension closeout business has been adversely impacted by a
combination of poor equity returns and lower interest rates.
High levels of unemployment continue to depress growth across
our group insurance businesses due to lower covered payrolls.
While we experienced growth in our group life business, sales of
non-medical health and individual life products declined. Sales
of new homeowner and auto policies increased 11% and 4%,
respectively, as the housing and automobile markets have
improved. We experienced a 30% increase in sales of retirement
and savings products abroad. During 2010, mortgage refinancing
activity continued to return to more moderate levels compared to
the unusually high levels experienced in 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Change
|
|
|
% Change
|
|
|
|
(In millions)
|
|
|
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
27,394
|
|
|
$
|
26,460
|
|
|
$
|
934
|
|
|
|
3.5
|
%
|
Universal life and investment-type product policy fees
|
|
|
6,037
|
|
|
|
5,203
|
|
|
|
834
|
|
|
|
16.0
|
%
|
Net investment income
|
|
|
17,615
|
|
|
|
14,837
|
|
|
|
2,778
|
|
|
|
18.7
|
%
|
Other revenues
|
|
|
2,328
|
|
|
|
2,329
|
|
|
|
(1
|
)
|
|
|
|
%
|
Net investment gains (losses)
|
|
|
(392
|
)
|
|
|
(2,906
|
)
|
|
|
2,514
|
|
|
|
86.5
|
%
|
Net derivative gains (losses)
|
|
|
(265
|
)
|
|
|
(4,866
|
)
|
|
|
4,601
|
|
|
|
94.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
52,717
|
|
|
|
41,057
|
|
|
|
11,660
|
|
|
|
28.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims and policyholder dividends
|
|
|
31,031
|
|
|
|
29,986
|
|
|
|
1,045
|
|
|
|
3.5
|
%
|
Interest credited to policyholder account balances
|
|
|
4,925
|
|
|
|
4,849
|
|
|
|
76
|
|
|
|
1.6
|
%
|
Interest credited to bank deposits
|
|
|
137
|
|
|
|
163
|
|
|
|
(26
|
)
|
|
|
(16.0
|
)%
|
Capitalization of DAC
|
|
|
(3,343
|
)
|
|
|
(3,019
|
)
|
|
|
(324
|
)
|
|
|
(10.7
|
)%
|
Amortization of DAC and VOBA
|
|
|
2,801
|
|
|
|
1,307
|
|
|
|
1,494
|
|
|
|
114.3
|
%
|
Interest expense on debt
|
|
|
1,550
|
|
|
|
1,044
|
|
|
|
506
|
|
|
|
48.5
|
%
|
Other expenses
|
|
|
11,658
|
|
|
|
11,061
|
|
|
|
597
|
|
|
|
5.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
48,759
|
|
|
|
45,391
|
|
|
|
3,368
|
|
|
|
7.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before provision for
income tax
|
|
|
3,958
|
|
|
|
(4,334
|
)
|
|
|
8,292
|
|
|
|
191.3
|
%
|
Provision for income tax expense (benefit)
|
|
|
1,181
|
|
|
|
(2,015
|
)
|
|
|
3,196
|
|
|
|
158.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income tax
|
|
|
2,777
|
|
|
|
(2,319
|
)
|
|
|
5,096
|
|
|
|
219.7
|
%
|
Income (loss) from discontinued operations, net of income tax
|
|
|
9
|
|
|
|
41
|
|
|
|
(32
|
)
|
|
|
(78.0
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
2,786
|
|
|
|
(2,278
|
)
|
|
|
5,064
|
|
|
|
222.3
|
%
|
Less: Net income (loss) attributable to noncontrolling interests
|
|
|
(4
|
)
|
|
|
(32
|
)
|
|
|
28
|
|
|
|
87.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to MetLife, Inc.
|
|
|
2,790
|
|
|
|
(2,246
|
)
|
|
|
5,036
|
|
|
|
224.2
|
%
|
Less: Preferred stock dividends
|
|
|
122
|
|
|
|
122
|
|
|
|
|
|
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.s common
shareholders
|
|
$
|
2,668
|
|
|
$
|
(2,368
|
)
|
|
$
|
5,036
|
|
|
|
212.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unless otherwise stated, all amounts discussed below are net of
income tax.
During the year ended December 31, 2010, income (loss) from
continuing operations, net of income tax increased
$5.1 billion to a gain of $2.8 billion from a loss of
$2.3 billion in 2009, of which $2 million in losses
was from the inclusion of one month of ALICO results in 2010.
The change was predominantly due to a $3.0 billion
favorable change in net derivative gains (losses) and a
$1.6 billion favorable change in net investment gains
(losses). Offsetting these favorable variances totaling
$4.6 billion were unfavorable changes in adjustments
related to net derivative and net investment gains (losses) of
$514 million, net of income tax, principally associated
with DAC and
90
VOBA amortization, resulting in a total favorable variance
related to net derivative and net investment gains (losses), net
of related adjustments and income tax, of $4.1 billion.
We manage our investment portfolio using disciplined
Asset/Liability Management (ALM) principles,
focusing on cash flow and duration to support our current and
future liabilities. Our intent is to match the timing and amount
of liability cash outflows with invested assets that have cash
inflows of comparable timing and amount, while optimizing, net
of income tax, risk-adjusted net investment income and
risk-adjusted total return. Our investment portfolio is heavily
weighted toward fixed income investments, with over 80% of our
portfolio invested in fixed maturity securities and mortgage
loans. These securities and loans have varying maturities and
other characteristics which cause them to be generally well
suited for matching the cash flow and duration of insurance
liabilities. Other invested asset classes including, but not
limited to, equity securities, other limited partnership
interests and real estate and real estate joint ventures,
provide additional diversification and opportunity for long-term
yield enhancement in addition to supporting the cash flow and
duration objectives of our investment portfolio. We also use
derivatives as an integral part of our management of the
investment portfolio to hedge certain risks, including changes
in interest rates, foreign currencies, credit spreads and equity
market levels. Additional considerations for our investment
portfolio include current and expected market conditions and
expectations for changes within our specific mix of products and
business segments. In addition, the general account investment
portfolio includes within trading and other securities,
contractholder-directed investments supporting unit-linked
variable annuity type liabilities, which do not qualify for
reporting and presentation as separate account assets. The
returns on these investments, which can vary significantly
period to period include changes in estimated fair value
subsequent to purchase, inure to contractholders and are offset
in earnings by a corresponding change in policyholder account
balances through interest credited to policyholder account
balances.
The composition of the investment portfolio of each business
segment is tailored to the specific characteristics of its
insurance liabilities, causing certain portfolios to be shorter
in duration and others to be longer in duration. Accordingly,
certain portfolios are more heavily weighted in longer duration,
higher yielding fixed maturity securities, or certain
sub-sectors
of fixed maturity securities, than other portfolios.
Investments are purchased to support our insurance liabilities
and not to generate net investment gains and losses. However,
net investment gains and losses are generated and can change
significantly from period to period, due to changes in external
influences, including movements in interest rates, foreign
currencies, credit spreads and equity markets, counterparty
specific factors such as financial performance, credit rating
and collateral valuation, and internal factors such as portfolio
rebalancing, that can generate gains and losses. As an investor
in the fixed income, equity security, mortgage loan and certain
other invested asset classes, we are exposed to the above stated
risks, which can lead to both impairments and credit-related
losses.
Freestanding derivatives are used to hedge certain investments
and liabilities. For those hedges not designated as accounting
hedges, changes in these market risks can lead to the
recognition of fair value changes in net derivative gains
(losses) without an offsetting gain or loss recognized in
earnings for the item being hedged even though these are
effective economic hedges. Additionally, we issue liabilities
and purchase assets that contain embedded derivatives whose
changes in estimated fair value are sensitive to changes in
market risks and are also recognized in net derivative gains
(losses).
The favorable variance in net derivative gains (losses) of
$3.0 billion, from losses of $3.2 billion in 2009 to
losses of $172 million in 2010 was primarily driven by a
favorable change in freestanding derivatives of
$4.4 billion, comprised of a $4.5 billion favorable
change from losses in the prior year of $4.3 billion to
gains in the current year of $203 million and
$123 million in ALICO freestanding derivative losses. This
favorable variance was partially offset by an unfavorable change
in embedded derivatives primarily associated with variable
annuity minimum benefit guarantees of $1.4 billion from
gains in the prior year of $1.1 billion to losses in the
current year of $257 million, net of $5 million in
ALICO embedded derivative gains.
We use freestanding interest rate, currency, credit and equity
derivatives to provide economic hedges of certain invested
assets and insurance liabilities, including embedded
derivatives, within certain of our variable annuity minimum
benefit guarantees. The $4.5 billion favorable variance in
freestanding derivatives was primarily attributable to market
factors, including falling long-term and mid-term interest
rates, a stronger recovery in equity markets in the prior year
than the current year, a greater decrease in equity volatility
in the prior year as
91
compared to the current year, a strengthening U.S. dollar
and widening corporate credit spreads in the financial services
sector. Falling long-term and mid-term interest rates in the
current year compared to rising long-term and mid-term interest
rates in the prior year had a positive impact of
$2.6 billion on our interest rate derivatives,
$931 million of which is attributable to hedges of variable
annuity minimum benefit guarantee liabilities, which are
accounted for as embedded derivatives. In addition, stronger
equity market recovery and lower equity market volatility in the
prior year as compared to the current year had a positive impact
of $1.1 billion on our equity derivatives, which we use to
hedge variable annuity minimum benefit guarantees.
U.S. dollar strengthening had a positive impact of
$554 million on certain of our foreign currency
derivatives, which are used to hedge foreign-denominated asset
and liability exposures. Finally, widening corporate credit
spreads in the financial services sector had a positive impact
of $221 million on our purchased protection credit
derivatives.
Certain variable annuity products with minimum benefit
guarantees contain embedded derivatives that are measured at
estimated fair value separately from the host variable annuity
contract, with changes in estimated fair value reported in net
derivative gains (losses). These embedded derivatives also
include an adjustment for nonperformance risk of the related
liabilities carried at estimated fair value. The
$1.4 billion unfavorable change in embedded derivatives was
primarily attributable to the impact of market factors,
including falling long-term and mid-term interest rates, changes
in foreign currency exchange rates, equity volatility and equity
market movements. Falling long-term and mid-term interest rates
in the current year compared to rising long-term and mid-term
interest rates in the prior year had a negative impact of
$1.4 billion. Changes in foreign currency exchange rates
had a negative impact of $468 million. Equity volatility
decreased more in the prior year than in the current year
causing a negative impact of $284 million, and a stronger
recovery in the equity markets in the prior year than in the
current year had a negative impact of $228 million. The
unfavorable impact from these hedged risks was partially offset
by a favorable change related to the adjustment for
nonperformance risk of $1.2 billion, from losses of
$1.3 billion in 2009 to losses of $62 million in 2010.
This $62 million loss was net of a $621 million loss
related to a refinement in estimating the spreads used in the
adjustment for nonperformance risk made in the second quarter of
2010. Gains on the freestanding derivatives that hedged these
embedded derivative risks largely offset the change in
liabilities attributable to market factors, excluding the
adjustment for nonperformance risk, which does not have an
economic impact on the Company.
Improved or stabilizing market conditions across several
invested asset classes and sectors as compared to the prior year
resulted in decreases in impairments and in net realized losses
from sales and disposals of investments in most components of
our investment portfolio. These decreases, coupled with a
decrease in the provision for credit losses on mortgage loans
due to improved market conditions, resulted in a
$1.6 billion improvement in net investment gains (losses).
Income from continuing operations, net of income tax for 2010
includes $138 million of expenses related to the
acquisition and integration of ALICO. These expenses, which
primarily consisted of investment banking and legal fees, are
recorded in Banking, Corporate & Other and are not a
component of operating earnings.
As more fully described in the discussion of performance
measures above, we use operating earnings, which does not equate
to income (loss) from continuing operations as determined in
accordance with GAAP, to analyze our performance, evaluate
segment performance, and allocate resources. Operating earnings
is also a measure by which senior managements and many
other employees performance is evaluated for the purpose
of determining their compensation under applicable compensation
plans. We believe that the presentation of operating earnings,
as we measure it for management purposes, enhances the
understanding of our performance by highlighting the results of
operations and the underlying profitability drivers of the
business. Operating earnings should not be viewed as a
substitute for GAAP income (loss) from continuing operations,
net of income tax. Operating earnings available to common
shareholders increased by $1.5 billion to $3.9 billion
in 2010 from $2.4 billion in 2009.
92
Reconciliation
of income (loss) from continuing operations, net of income tax,
to operating earnings available to common
shareholders
Year
Ended December 31, 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
Banking,
|
|
|
|
|
|
|
Insurance
|
|
|
Retirement
|
|
|
Benefit
|
|
|
Auto &
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
Products
|
|
|
Products
|
|
|
Funding
|
|
|
Home
|
|
|
International
|
|
|
& Other
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income tax
|
|
$
|
1,371
|
|
|
$
|
813
|
|
|
$
|
1,002
|
|
|
$
|
295
|
|
|
$
|
(131
|
)
|
|
$
|
(573
|
)
|
|
$
|
2,777
|
|
Less: Net investment gains (losses)
|
|
|
103
|
|
|
|
139
|
|
|
|
176
|
|
|
|
(7
|
)
|
|
|
(273
|
)
|
|
|
(530
|
)
|
|
|
(392
|
)
|
Less: Net derivative gains (losses)
|
|
|
215
|
|
|
|
266
|
|
|
|
(193
|
)
|
|
|
(1
|
)
|
|
|
(491
|
)
|
|
|
(61
|
)
|
|
|
(265
|
)
|
Less: Adjustments to continuing operations (1)
|
|
|
(237
|
)
|
|
|
(282
|
)
|
|
|
143
|
|
|
|
|
|
|
|
(427
|
)
|
|
|
(178
|
)
|
|
|
(981
|
)
|
Less: Provision for income tax (expense) benefit
|
|
|
(31
|
)
|
|
|
(49
|
)
|
|
|
(44
|
)
|
|
|
3
|
|
|
|
268
|
|
|
|
254
|
|
|
|
401
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
1,321
|
|
|
$
|
739
|
|
|
$
|
920
|
|
|
$
|
300
|
|
|
$
|
792
|
|
|
|
(58
|
)
|
|
|
4,014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Preferred stock dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
122
|
|
|
|
122
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings available to common shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(180
|
)
|
|
$
|
3,892
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
Ended December 31, 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
Banking,
|
|
|
|
|
|
|
Insurance
|
|
|
Retirement
|
|
|
Benefit
|
|
|
Auto &
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
Products
|
|
|
Products
|
|
|
Funding
|
|
|
Home
|
|
|
International
|
|
|
& Other
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income tax
|
|
$
|
(418
|
)
|
|
$
|
(628
|
)
|
|
$
|
(581
|
)
|
|
$
|
321
|
|
|
$
|
(280
|
)
|
|
$
|
(733
|
)
|
|
$
|
(2,319
|
)
|
Less: Net investment gains (losses)
|
|
|
(472
|
)
|
|
|
(533
|
)
|
|
|
(1,486
|
)
|
|
|
(41
|
)
|
|
|
(105
|
)
|
|
|
(269
|
)
|
|
|
(2,906
|
)
|
Less: Net derivative gains (losses)
|
|
|
(1,786
|
)
|
|
|
(1,426
|
)
|
|
|
(421
|
)
|
|
|
39
|
|
|
|
(798
|
)
|
|
|
(474
|
)
|
|
|
(4,866
|
)
|
Less: Adjustments to continuing operations (1)
|
|
|
(139
|
)
|
|
|
519
|
|
|
|
125
|
|
|
|
|
|
|
|
(206
|
)
|
|
|
(16
|
)
|
|
|
283
|
|
Less: Provision for income
tax (expense) benefit
|
|
|
837
|
|
|
|
504
|
|
|
|
621
|
|
|
|
1
|
|
|
|
366
|
|
|
|
354
|
|
|
|
2,683
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
1,142
|
|
|
$
|
308
|
|
|
$
|
580
|
|
|
$
|
322
|
|
|
$
|
463
|
|
|
|
(328
|
)
|
|
|
2,487
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Preferred stock dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
122
|
|
|
|
122
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings available to common shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(450
|
)
|
|
$
|
2,365
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
See definitions of operating revenues and operating expenses for
the components of such adjustments. |
93
Reconciliation
of GAAP revenues to operating revenues and GAAP expenses to
operating expenses
Year
Ended December 31, 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
Banking,
|
|
|
|
|
|
|
Insurance
|
|
|
Retirement
|
|
|
Benefit
|
|
|
Auto &
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
Products
|
|
|
Products
|
|
|
Funding
|
|
|
Home
|
|
|
International
|
|
|
& Other
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
$
|
26,451
|
|
|
$
|
6,881
|
|
|
$
|
7,540
|
|
|
$
|
3,146
|
|
|
$
|
6,794
|
|
|
$
|
1,905
|
|
|
$
|
52,717
|
|
Less: Net investment gains (losses)
|
|
|
103
|
|
|
|
139
|
|
|
|
176
|
|
|
|
(7
|
)
|
|
|
(273
|
)
|
|
|
(530
|
)
|
|
|
(392
|
)
|
Less: Net derivative gains (losses)
|
|
|
215
|
|
|
|
266
|
|
|
|
(193
|
)
|
|
|
(1
|
)
|
|
|
(491
|
)
|
|
|
(61
|
)
|
|
|
(265
|
)
|
Less: Adjustments related to net investment gains (losses) and
net derivative gains (losses)
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
Less: Other adjustments to revenues (1)
|
|
|
(144
|
)
|
|
|
(248
|
)
|
|
|
193
|
|
|
|
|
|
|
|
44
|
|
|
|
449
|
|
|
|
294
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
$
|
26,276
|
|
|
$
|
6,724
|
|
|
$
|
7,364
|
|
|
$
|
3,154
|
|
|
$
|
7,514
|
|
|
$
|
2,047
|
|
|
$
|
53,079
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
$
|
24,338
|
|
|
$
|
5,622
|
|
|
$
|
5,999
|
|
|
$
|
2,781
|
|
|
$
|
6,987
|
|
|
$
|
3,032
|
|
|
$
|
48,759
|
|
Less: Adjustments related to net investment gains (losses) and
net derivative gains (losses)
|
|
|
90
|
|
|
|
35
|
|
|
|
|
|
|
|
|
|
|
|
(7
|
)
|
|
|
|
|
|
|
118
|
|
Less: Other adjustments to expenses (1)
|
|
|
4
|
|
|
|
(1
|
)
|
|
|
50
|
|
|
|
|
|
|
|
478
|
|
|
|
627
|
|
|
|
1,158
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
$
|
24,244
|
|
|
$
|
5,588
|
|
|
$
|
5,949
|
|
|
$
|
2,781
|
|
|
$
|
6,516
|
|
|
$
|
2,405
|
|
|
$
|
47,483
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
Ended December 31, 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
Banking,
|
|
|
|
|
|
|
Insurance
|
|
|
Retirement
|
|
|
Benefit
|
|
|
Auto &
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
Products
|
|
|
Products
|
|
|
Funding
|
|
|
Home
|
|
|
International
|
|
|
& Other
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
$
|
23,483
|
|
|
$
|
3,725
|
|
|
$
|
5,486
|
|
|
$
|
3,113
|
|
|
$
|
4,383
|
|
|
$
|
867
|
|
|
$
|
41,057
|
|
Less: Net investment gains (losses)
|
|
|
(472
|
)
|
|
|
(533
|
)
|
|
|
(1,486
|
)
|
|
|
(41
|
)
|
|
|
(105
|
)
|
|
|
(269
|
)
|
|
|
(2,906
|
)
|
Less: Net derivative gains (losses)
|
|
|
(1,786
|
)
|
|
|
(1,426
|
)
|
|
|
(421
|
)
|
|
|
39
|
|
|
|
(798
|
)
|
|
|
(474
|
)
|
|
|
(4,866
|
)
|
Less: Adjustments related to net investment gains (losses) and
net derivative gains (losses)
|
|
|
(27
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(27
|
)
|
Less: Other adjustments to revenues (1)
|
|
|
(74
|
)
|
|
|
(219
|
)
|
|
|
188
|
|
|
|
|
|
|
|
(169
|
)
|
|
|
22
|
|
|
|
(252
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
$
|
25,842
|
|
|
$
|
5,903
|
|
|
$
|
7,205
|
|
|
$
|
3,115
|
|
|
$
|
5,455
|
|
|
$
|
1,588
|
|
|
$
|
49,108
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
$
|
24,165
|
|
|
$
|
4,690
|
|
|
$
|
6,400
|
|
|
$
|
2,697
|
|
|
$
|
4,868
|
|
|
$
|
2,571
|
|
|
$
|
45,391
|
|
Less: Adjustments related to net investment gains (losses) and
net derivative gains (losses)
|
|
|
39
|
|
|
|
(739
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(700
|
)
|
Less: Other adjustments to expenses (1)
|
|
|
(1
|
)
|
|
|
1
|
|
|
|
63
|
|
|
|
|
|
|
|
37
|
|
|
|
38
|
|
|
|
138
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
$
|
24,127
|
|
|
$
|
5,428
|
|
|
$
|
6,337
|
|
|
$
|
2,697
|
|
|
$
|
4,831
|
|
|
$
|
2,533
|
|
|
$
|
45,953
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
See definitions of operating revenues and operating expenses for
the components of such adjustments. |
94
Unless otherwise stated, all amounts discussed below are net of
income tax and are on a constant currency basis. The constant
currency basis amounts for both periods are calculated using the
average foreign currency exchange rates of 2010.
The improvement in the financial markets was the primary driver
of the increase in operating earnings as evidenced by higher net
investment income and an increase in average separate account
balances, which resulted in an increase in policy fee income.
Interest rate and equity market changes resulted in a decrease
in variable annuity guarantee benefit costs. Partially
offsetting this improvement was an increase in amortization of
DAC, VOBA and DSI. The increase in operating earnings also
includes the positive impact of changes in foreign currency
exchange rates in 2010. This improved reported operating
earnings by $38 million for 2010 compared to 2009.
Excluding the impact of changes in foreign currency exchange
rates, operating earnings increased $1.5 billion from the
prior period. Furthermore, the 2010 period also includes one
month of ALICO results, contributing $114 million to the
increase in operating earnings. The current period also
benefited from the dividend scale reduction in the fourth
quarter of 2009. The improvement in 2010 results compared to
2009 was partially offset by a decline in residential mortgage
loan production and the prior period impact of pesification in
Argentina.
In addition to a $133 million increase due to the inclusion
of ALICO results, net investment income increased by
$792 million from higher yields and $515 million from
growth in average invested assets. Yields were positively
impacted by the effects of stabilizing real estate markets and
recovering private equity markets year over year on real estate
joint ventures and other limited partnership interests, and by
the effects of continued repositioning of the accumulated
liquidity in our portfolio to longer duration and higher
yielding investments, including investment grade corporate fixed
maturity securities. Growth in our investment portfolio was
primarily due to positive net cash flows from growth in our
domestic individual and group life businesses, as well as
certain international businesses; increased bank deposits,
higher cash collateral balances received from our derivative
counterparties, as well as the temporary investment of proceeds
from the debt and common stock issuances in anticipation of the
Acquisition. With the exception of the cash flows from such
securities issuances, which were temporarily invested in lower
yielding liquid investments, we continued to reposition the
accumulated liquidity in our portfolio to longer duration and
higher yielding investments.
Since many of our products are interest spread-based, higher net
investment income is typically offset by higher interest
credited expense. However, interest credited expense, including
amounts reflected in policyholder benefits and claims, decreased
$147 million, primarily in our domestic funding agreement
business, which experienced lower average crediting rates
combined with lower average account balances. Our fixed
annuities business also experienced lower crediting rates.
Certain crediting rates can move consistently with the
underlying market indices, primarily the London Inter-Bank Offer
Rate (LIBOR), which were lower than the prior year.
The impact from the growth in our structured settlement,
long-term care and disability businesses partially offset those
decreases in interest credited expense.
A significant increase in average separate account balances is
largely attributable to favorable market performance resulting
from improved market conditions since the second quarter of 2009
and positive net cash flows from the annuity business. This
resulted in higher policy fees and other revenues of
$471 million, most notably in our Retirement Products
segment. The improvement in fees is partially offset by greater
DAC, VOBA and DSI amortization of $377 million. Policy fees
are typically calculated as a percentage of the average assets
in the separate accounts. DAC, VOBA and DSI amortization is
based on the earnings of the business, which in the retirement
business are derived, in part, from fees earned on separate
account balances. A portion of the increase in amortization was
due to the impact of higher current year gross margins, a
primary component in the determination of the amount of
amortization for our Insurance Products segment, mostly in the
closed block resulting from increased investment yields and the
impact of dividend scale reductions.
There was a $59 million decrease in variable annuity
guaranteed benefit costs. Costs associated with our annuity
guaranteed benefit liabilities, hedge programs and reinsurance
programs are impacted by equity markets and interest rate levels
to varying degrees. While 2010 and 2009 both experienced equity
market improvements, the improvement in 2009 was greater.
Interest rate levels declined in the current year and increased
in the prior year. Annuity guaranteed benefit liabilities, net
of a decrease in paid claims, increased benefits by
$93 million primarily from our annual unlocking of
assumptions related to these liabilities. The hedge and
reinsurance programs which are used to mitigate the risk
associated with these guarantees produced losses in both
periods, but the losses in the
95
prior period were more significant due to the 2009 equity market
recovery. The change in hedge and reinsurance program costs
decreased by $152 million. These hedge and reinsurance
programs, which are a key part of our risk management strategy,
performed as anticipated.
The reduction in the dividend scale in the fourth quarter of
2009 resulted in a $109 million decrease in policyholder
dividends in the traditional life business in the current period.
Claims experience varied amongst our businesses with a net
unfavorable impact of $153 million to operating earnings
compared to the prior year. We had unfavorable claims experience
in our Auto & Home segment, primarily due to increased
catastrophes. Our Insurance Products segment experienced mixed
claims experience with a net unfavorable impact. We experienced
less favorable mortality experience in our Corporate Benefit
Funding segment despite favorable experience in our structured
settlements business.
A $15.2 billion decline in residential mortgage loan
production resulted in a $131 million decrease in operating
earnings, $32 million of which is reflected in net
investment income from lower investment levels with the
remainder largely attributable to a reduction in fee income. The
increase in the serviced residential mortgage loan portfolio
improved operating earnings by $41 million, including
$23 million of costs associated with investment and growth
in our banking business as discussed below.
Interest expense increased $64 million primarily as a
result of the full year impact of debt issuances in 2009 and of
senior notes and debt securities issued in anticipation of the
Acquisition, partially offset by the impact of lower interest
rates on variable rate collateral financing arrangements.
In addition to a $269 million increase associated with the
Acquisition, operating expenses increased due to the impact of a
$95 million benefit recorded in the prior period related to
the pesification in Argentina, as well as an $83 million
increase related to the investment and growth in our
international and banking businesses. In addition, the current
period includes a $14 million increase in charitable
contributions and $13 million of costs associated with the
integration of ALICO. Offsetting these increases was a
$76 million reduction in discretionary spending, such as
consulting, rent and postemployment related costs. In addition,
we experienced a $47 million decline in market driven
expenses, primarily pension and post retirement benefit costs.
Also contributing to the decrease was a $35 million
reduction in real estate-related charges and $15 million of
lower legal costs.
Income tax expense for the year ended December 31, 2010 was
$1,181 million, or 30% of income from continuing operations
before provision for income tax, compared with income tax
benefit of $2,015 million, or 47% of the loss from
continuing operations before benefit for income tax, for the
comparable 2009 period. The Companys 2010 and 2009
effective tax rates differ from the U.S. statutory rate of
35% primarily due to the impact of certain permanent tax
differences, including non-taxable investment income and tax
credits for investments in low income housing, in relation to
income (loss) from continuing operations before income tax, as
well as certain foreign permanent tax differences.
The 2010 period includes $75 million of charges related to
the Patient Protection and Affordable Care Act and the Health
Care and Education Reconciliation Act of 2010 (together, the
Health Care Act). The Federal government currently
provides a Medicare Part D subsidy. The Health Care Act
reduced the tax deductibility of retiree health care costs to
the extent of any Medicare Part D subsidy received
beginning in 2013. Because the deductibility of future retiree
health care costs is reflected in our financial statements, the
entire future impact of this change in law was required to be
recorded as a charge in the period in which the legislation was
enacted. Changes to the provision for income taxes in both
periods contributed to an increase in operating earnings of
$86 million for our International segment, resulting from a
$34 million unfavorable impact in 2009 due to a change in
assumption regarding the repatriation of earnings and a benefit
of $52 million in the current year from additional
permanent reinvestment of earnings, the reversal of tax
provisions and favorable changes in liabilities for tax
uncertainties. In addition, in 2009 we had a larger benefit of
$71 million as compared to 2010 related to the utilization
of tax preferenced investments which provide tax credits and
deductions.
96
Insurance
Products
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Change
|
|
|
% Change
|
|
|
|
(In millions)
|
|
|
|
|
|
OPERATING REVENUES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
17,200
|
|
|
$
|
17,168
|
|
|
$
|
32
|
|
|
|
0.2
|
%
|
Universal life and investment-type product policy fees
|
|
|
2,247
|
|
|
|
2,281
|
|
|
|
(34
|
)
|
|
|
(1.5
|
)%
|
Net investment income
|
|
|
6,068
|
|
|
|
5,614
|
|
|
|
454
|
|
|
|
8.1
|
%
|
Other revenues
|
|
|
761
|
|
|
|
779
|
|
|
|
(18
|
)
|
|
|
(2.3
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
|
26,276
|
|
|
|
25,842
|
|
|
|
434
|
|
|
|
1.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and dividends
|
|
|
19,075
|
|
|
|
19,111
|
|
|
|
(36
|
)
|
|
|
(0.2
|
)%
|
Interest credited to policyholder account balances
|
|
|
963
|
|
|
|
952
|
|
|
|
11
|
|
|
|
1.2
|
%
|
Capitalization of DAC
|
|
|
(841
|
)
|
|
|
(873
|
)
|
|
|
32
|
|
|
|
3.7
|
%
|
Amortization of DAC and VOBA
|
|
|
966
|
|
|
|
725
|
|
|
|
241
|
|
|
|
33.2
|
%
|
Interest expense on debt
|
|
|
1
|
|
|
|
6
|
|
|
|
(5
|
)
|
|
|
(83.3
|
)%
|
Other expenses
|
|
|
4,080
|
|
|
|
4,206
|
|
|
|
(126
|
)
|
|
|
(3.0
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
24,244
|
|
|
|
24,127
|
|
|
|
117
|
|
|
|
0.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
711
|
|
|
|
573
|
|
|
|
138
|
|
|
|
24.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
1,321
|
|
|
$
|
1,142
|
|
|
$
|
179
|
|
|
|
15.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unless otherwise stated, all amounts discussed below are net of
income tax.
The improvement in the global financial markets had a positive
impact on net investment income, which contributed to the
increase in Insurance Products operating earnings. In
addition, we experienced overall modest revenue growth in
several of our businesses despite this challenging environment.
High levels of unemployment continue to depress growth across
most of our group insurance businesses due to lower covered
payrolls. Growth in our group life business was dampened by a
decline in our non-medical health and individual life
businesses. However, our dental business benefited from higher
enrollment and pricing actions, partially offset by lower
persistency and the loss of existing subscribers, driven by high
unemployment. This business also experienced more stable
utilization and benefits costs in the current year. The revenue
growth from our dental business was more than offset by a
decline in revenues from our disability business, mainly due to
net customer cancellations, changes in benefit levels and lower
covered lives. Our long-term care revenues were flat year over
year, concurrent with the discontinuance of the sale of this
coverage at the end of 2010. In our individual life business,
the change in revenues was suppressed by the impact of a benefit
recorded in the prior year related to the positive resolution of
certain legal matters. Excluding this impact, the traditional
life business experienced 8% growth in our open block of
business. The expected run-off of our closed block more than
offset this growth.
The significant components of the $179 million increase in
operating earnings were an improvement in net investment income
and the impact of a reduction in dividends to certain
policyholders, coupled with lower expenses. These improvements
were partially offset by an increase in DAC amortization, as
well as net unfavorable claims experience across several of our
businesses.
Higher net investment income of $295 million was due to a
$202 million increase from growth in average invested
assets and a $93 million increase from higher yields.
Growth in the investment portfolio was attributed to an increase
in net cash flows from the majority of our businesses. The
increase in yields was largely due to the positive effects of
recovering private equity markets and stabilizing real estate
markets on other limited partnership interests and real estate
joint ventures. To manage the needs of our intermediate to
longer-term liabilities, our portfolio consists primarily of
investment grade corporate fixed maturity securities, mortgage
loans, structured finance securities (comprised of mortgage and
asset-backed securities) and U.S. Treasury, agency and
government guaranteed fixed maturity securities and, to a lesser
extent, certain other invested asset classes, including other
97
limited partnership interests, real estate joint ventures and
other invested assets which provide additional diversification
and opportunity for long-term yield enhancement.
The increase in net investment income was partially offset by a
$36 million increase in interest credited on long duration
contracts, which is reflected in the change in policyholder
benefits and dividends, primarily due to growth in future
policyholder benefits in our long-term care and disability
businesses.
Other expenses decreased by $82 million, largely due to a
decrease of $40 million from the impact of market
conditions on certain expenses, such as pension and
post-retirement benefit costs. In addition, a decrease in
information technology expenses of $29 million contributed
to the improvement in operating earnings. A decrease in variable
expenses, such as commissions and premium taxes, further reduced
expenses by $11 million, a portion of which is offset by
DAC capitalization.
The reduction in the dividend scale in the fourth quarter of
2009 resulted in a $109 million decrease in policyholder
dividends in the traditional life business in the current year.
Claims experience varied amongst Insurance Products
businesses with a net unfavorable impact of $42 million to
operating earnings. We experienced excellent mortality results
in our group life business due to a decrease in severity, as
well as favorable reserve refinements in the current year. In
addition, an improvement in our long-term care results was
driven by favorable claim experience mainly due to higher
terminations and less claimants in the current year, coupled
with the impact of unfavorable reserve refinements in the prior
year. Our improved dental results were driven by higher
enrollment and pricing actions, as well as improved claim
experience in the current year. The impact of this positive
experience was surpassed by solid, but less favorable mortality,
in our individual life business combined with higher incidence
and severity of group disability claims in the current year, and
the impact of a gain from the recapture of a reinsurance
arrangement in the prior year.
Higher DAC amortization of $157 million was primarily
driven by the impact of higher gross margins, a primary
component in the determination of the amount of amortization,
mostly in the closed block resulting from increased investment
yields and the impact of dividend scale reductions. In addition,
the net impact of various model refinements in both the prior
and current year increased DAC amortization.
Certain events reduced operating earnings, including the impact
of a benefit being recorded in the prior year of
$17 million related to the positive resolution of certain
legal matters and an increase in current income tax expense of
$27 million, resulting from an increase in our effective
tax rate.
98
Retirement
Products
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Change
|
|
|
% Change
|
|
|
|
(In millions)
|
|
|
|
|
|
OPERATING REVENUES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
875
|
|
|
$
|
920
|
|
|
$
|
(45
|
)
|
|
|
(4.9
|
)%
|
Universal life and investment-type product policy fees
|
|
|
2,234
|
|
|
|
1,712
|
|
|
|
522
|
|
|
|
30.5
|
%
|
Net investment income
|
|
|
3,395
|
|
|
|
3,098
|
|
|
|
297
|
|
|
|
9.6
|
%
|
Other revenues
|
|
|
220
|
|
|
|
173
|
|
|
|
47
|
|
|
|
27.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
|
6,724
|
|
|
|
5,903
|
|
|
|
821
|
|
|
|
13.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and dividends
|
|
|
1,879
|
|
|
|
1,950
|
|
|
|
(71
|
)
|
|
|
(3.6
|
)%
|
Interest credited to policyholder account balances
|
|
|
1,612
|
|
|
|
1,688
|
|
|
|
(76
|
)
|
|
|
(4.5
|
)%
|
Capitalization of DAC
|
|
|
(1,067
|
)
|
|
|
(1,067
|
)
|
|
|
|
|
|
|
|
%
|
Amortization of DAC and VOBA
|
|
|
724
|
|
|
|
424
|
|
|
|
300
|
|
|
|
70.8
|
%
|
Interest expense on debt
|
|
|
3
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
Other expenses
|
|
|
2,437
|
|
|
|
2,433
|
|
|
|
4
|
|
|
|
0.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
5,588
|
|
|
|
5,428
|
|
|
|
160
|
|
|
|
2.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
397
|
|
|
|
167
|
|
|
|
230
|
|
|
|
137.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
739
|
|
|
$
|
308
|
|
|
$
|
431
|
|
|
|
139.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unless otherwise stated, all amounts discussed below are net of
income tax.
During 2010, overall annuity sales decreased 5% compared to 2009
as declines in fixed annuity sales were partially offset by
increased sales of our variable annuity products. The financial
market turmoil in early 2009 resulted in extraordinarily high
sales of fixed annuity products in 2009. The high sales level
was not expected to continue after the financial markets
returned to more stable levels. Variable annuity product sales
increased primarily due to the expansion of alternative
distribution channels and fewer competitors in the market place.
Surrender rates for both our variable and fixed annuities
remained low during the current period as we believe our
customers continue to value our products compared to other
alternatives in the marketplace.
Interest rate and equity market changes were the primary driver
of the $431 million increase in operating earnings, with
the largest impact resulting from a $370 million increase
in policy fees and other revenues, a $193 million increase
in net investment income, and a $59 million decrease in
variable annuity guarantee benefit costs, offset by a
$204 million increase in DAC, VOBA and DSI amortization and
a $39 million increase in commission expense resulting from
growth in annuity contract balances.
A significant increase in average separate account balances was
largely attributable to favorable market performance resulting
from improved market conditions since the second quarter of 2009
and positive net cash flows from the annuity business. This
resulted in higher policy fees and other revenues of
$370 million, partially offset by greater DAC, VOBA and DSI
amortization. Policy fees are typically calculated as a
percentage of the average assets in the separate account. DAC,
VOBA and DSI amortization is based on the earnings of the
business, which in the retirement business are derived, in part,
from fees earned on separate account balances.
Financial market improvements also resulted in the increase in
net investment income of $193 million as a
$291 million increase from higher yields was partially
offset by a $98 million decrease from a decline in average
invested assets. Yields were positively impacted by the effects
of the continued repositioning of the accumulated liquidity in
our investment portfolio to longer duration and higher yielding
assets, including investment grade corporate fixed maturity
securities. Yields were also positively impacted by the effects
of recovering private equity markets and stabilizing real estate
markets on other limited partnership interests and real estate
joint ventures. Despite positive net cash flows, a reduction in
the general account investment portfolio was due to the impact
of
99
more customers gaining confidence in the equity markets and, as
a result, electing to transfer funds into our separate account
investment options as market conditions improved. To manage the
needs of our intermediate to longer-term liabilities, our
investment portfolio consists primarily of investment grade
corporate fixed maturity securities, structured finance
securities, mortgage loans and U.S. Treasury, agency and
government guaranteed fixed maturity securities and, to a lesser
extent, certain other invested asset classes, including other
limited partnership interests, real estate joint ventures and
other invested assets, in order to provide additional
diversification and opportunity for long-term yield enhancement.
There was a $59 million decrease in variable annuity
guaranteed benefit costs in 2010 compared to 2009. Costs
associated with our annuity guaranteed benefit liabilities,
hedge programs and reinsurance programs are impacted by equity
markets and interest rate levels to varying degrees. While the
equity market improved in both 2010 and 2009, the improvement in
2009 was greater. Interest rate levels declined in the current
year and increased in the prior year. Annuity guaranteed benefit
liabilities, net of a decrease in paid claims, increased
benefits by $93 million primarily from our annual unlocking
of assumptions related to these liabilities. The hedge and
reinsurance programs which are used to mitigate the risk
associated with these guarantees produced losses in both
periods, but the losses in the prior period were more
significant due to the 2009 equity market recovery. The costs
related to our hedge and reinsurance programs decreased by
$152 million in 2010 compared to 2009. These hedge and
reinsurance programs, which are a key part of our risk
management strategy, performed as anticipated.
Interest credited expense decreased $49 million driven by
lower average crediting rates on fixed annuities and higher
amortization of excess interest reserve due to one large case
surrender in 2010, partially offset by growth in our fixed
annuity policyholder account balances.
Corporate
Benefit Funding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Change
|
|
|
% Change
|
|
|
|
(In millions)
|
|
|
|
|
|
OPERATING REVENUES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
1,938
|
|
|
$
|
2,264
|
|
|
$
|
(326
|
)
|
|
|
(14.4
|
)%
|
Universal life and investment-type product policy fees
|
|
|
226
|
|
|
|
176
|
|
|
|
50
|
|
|
|
28.4
|
%
|
Net investment income
|
|
|
4,954
|
|
|
|
4,527
|
|
|
|
427
|
|
|
|
9.4
|
%
|
Other revenues
|
|
|
246
|
|
|
|
238
|
|
|
|
8
|
|
|
|
3.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
|
7,364
|
|
|
|
7,205
|
|
|
|
159
|
|
|
|
2.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and dividends
|
|
|
4,041
|
|
|
|
4,245
|
|
|
|
(204
|
)
|
|
|
(4.8
|
)%
|
Interest credited to policyholder account balances
|
|
|
1,445
|
|
|
|
1,632
|
|
|
|
(187
|
)
|
|
|
(11.5
|
)%
|
Capitalization of DAC
|
|
|
(19
|
)
|
|
|
(14
|
)
|
|
|
(5
|
)
|
|
|
(35.7
|
)%
|
Amortization of DAC and VOBA
|
|
|
16
|
|
|
|
15
|
|
|
|
1
|
|
|
|
6.7
|
%
|
Interest expense on debt
|
|
|
6
|
|
|
|
3
|
|
|
|
3
|
|
|
|
100.0
|
%
|
Other expenses
|
|
|
460
|
|
|
|
456
|
|
|
|
4
|
|
|
|
0.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
5,949
|
|
|
|
6,337
|
|
|
|
(388
|
)
|
|
|
(6.1
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
495
|
|
|
|
288
|
|
|
|
207
|
|
|
|
71.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
920
|
|
|
$
|
580
|
|
|
$
|
340
|
|
|
|
58.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unless otherwise stated, all amounts discussed below are net of
income tax.
Corporate Benefit Funding benefited in 2010 from strong sales of
structured settlement products and continued market penetration
of our pension closeout business in the U.K. However, structured
settlement premiums have declined $174 million, before
income tax, from 2009 reflecting extraordinary sales in the
fourth quarter of 2009. While market penetration continued in
our pension closeout business in the U.K. as the number of sold
cases
100
increased, the average premium has declined, resulting in a
decrease in premiums of $216 million, before income tax.
Although improving, a combination of poor equity returns and
lower interest rates have contributed to pension plans remaining
underfunded, both in the U.S. and in the U.K., which
reduces our customers flexibility to engage in
transactions such as pension closeouts. For each of these
businesses, the movement in premiums is almost entirely offset
by the related change in policyholder benefits. The insurance
liability that is established at the time we assume the risk
under these contracts is typically equivalent to the premium
recognized.
The $340 million increase in operating earnings was
primarily driven by an improvement in net investment income and
the impact of lower crediting rates, partially offset by the
impact of prior period favorable liability refinements and less
favorable mortality.
The primary driver of the $340 million increase in
operating earnings was higher net investment income of
$278 million, reflecting a $187 million increase from
higher yields and a $91 million increase in average
invested assets. Yields were positively impacted by the effects
of stabilizing real estate markets and recovering private equity
markets on real estate joint ventures and other limited
partnership interests. These improvements in yields were
partially offset by decreased yields on fixed maturity
securities due to the reinvestment of proceeds from maturities
and sales during this lower interest rate environment. Growth in
the investment portfolio is due to an increase in average
policyholder account balances and growth in the securities
lending program. To manage the needs of our longer-term
liabilities, our portfolio consists primarily of investment
grade corporate fixed maturity securities, structured finance
securities, mortgage loans and U.S. Treasury, agency and
government guaranteed securities, and, to a lesser extent,
certain other invested asset classes including other limited
partnership interests, real estate joint ventures and other
invested assets in order to provide additional diversification
and opportunity for long-term yield enhancement. For our
short-term obligations, we invest primarily in structured
finance securities, mortgage loans and investment grade
corporate fixed maturity securities. The yields on these
short-term investments have moved consistently with the
underlying market indices, primarily LIBOR and
U.S. Treasury, on which they are based.
As many of our products are interest spread-based, changes in
net investment income are typically offset by a corresponding
change in interest credited expense. However, interest credited
expense decreased $122 million, primarily related to our
funding agreement business as a result of lower average
crediting rates combined with lower average account balances.
Certain crediting rates can move consistently with the
underlying market indices, primarily LIBOR, which were lower
than the prior year. Interest credited expense related to the
structured settlement businesses increased $40 million as a
result of the increase in the average policyholder liabilities.
Mortality experience was mixed and reduced operating earnings in
2010 by $26 million. Less favorable mortality in our
pension closeouts and corporate owned life insurance businesses
compared to 2009 was only slightly offset by favorable mortality
experience in our structured settlements business.
Liability refinements in both the current and prior year
resulted in a $28 million decrease to operating earnings.
These were largely offset by the impact of a charge in the 2009
period related to a refinement of a reinsurance recoverable in
the small business recordkeeping business which increased
operating earnings by $20 million.
101
Auto &
Home
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Change
|
|
|
% Change
|
|
|
|
(In millions)
|
|
|
|
|
|
OPERATING REVENUES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
2,923
|
|
|
$
|
2,902
|
|
|
$
|
21
|
|
|
|
0.7
|
%
|
Net investment income
|
|
|
209
|
|
|
|
180
|
|
|
|
29
|
|
|
|
16.1
|
%
|
Other revenues
|
|
|
22
|
|
|
|
33
|
|
|
|
(11
|
)
|
|
|
(33.3
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
|
3,154
|
|
|
|
3,115
|
|
|
|
39
|
|
|
|
1.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and dividends
|
|
|
2,021
|
|
|
|
1,932
|
|
|
|
89
|
|
|
|
4.6
|
%
|
Capitalization of DAC
|
|
|
(448
|
)
|
|
|
(435
|
)
|
|
|
(13
|
)
|
|
|
(3.0
|
)%
|
Amortization of DAC and VOBA
|
|
|
439
|
|
|
|
436
|
|
|
|
3
|
|
|
|
0.7
|
%
|
Other expenses
|
|
|
769
|
|
|
|
764
|
|
|
|
5
|
|
|
|
0.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
2,781
|
|
|
|
2,697
|
|
|
|
84
|
|
|
|
3.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
73
|
|
|
|
96
|
|
|
|
(23
|
)
|
|
|
(24.0
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
300
|
|
|
$
|
322
|
|
|
$
|
(22
|
)
|
|
|
(6.8
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unless otherwise stated, all amounts discussed below are net of
income tax.
The improving housing and automobile markets have provided
opportunities that led to increased new business sales for both
homeowners and auto policies in 2010. Sales of new policies
increased 11% for our homeowners business and 4% for our auto
business in 2010 compared to 2009. Average premium per policy
also improved in 2010 over 2009 in our homeowners businesses but
remained flat in our auto business.
The primary driver of the $22 million decrease in operating
earnings was unfavorable claims experience, partially offset by
higher net investment income and increased premiums.
Catastrophe-related losses increased by $58 million
compared to 2009 due to increases in both the number and
severity of storms. Current period claim costs decreased
$19 million as a result of lower frequencies in both our
auto and homeowners businesses; however, this was partially
offset by a $13 million increase in claims due to higher
severity in our homeowners business. Also contributing to the
decline in operating earnings was an increase of $7 million
in loss adjusting expenses, primarily related to a decrease in
our unallocated loss adjusting expense liabilities at the end of
2009.
The impact of the items discussed above can be seen in the
unfavorable change in the combined ratio, including
catastrophes, increasing to 94.6% in 2010 from 92.3% in 2009 and
the favorable change in the combined ratio, excluding
catastrophes, decreasing to 88.1% in 2010 from 88.9% in 2009.
A $19 million increase in net investment income partially
offset the declines in operating earnings discussed above. Net
investment income was higher primarily as a result of an
increase in average invested assets, including changes in
allocated equity, partially offset by a decrease in yields. This
portfolio is comprised primarily of high quality municipal bonds.
The increase in average premium per policy in our homeowners
businesses improved operating earnings by $10 million as
did an increase in exposures which improved operating earnings
by $1 million. Exposures are primarily each automobile for
the auto line of business and each residence for the property
line of business. Also improving operating earnings, through an
increase in premiums, was a $5 million reduction in
reinsurance costs.
The slight increase in other expenses was more than offset by an
$8 million increase in DAC capitalization, resulting
primarily from increased premiums written.
In addition, a first quarter 2010 write-off of an equity
interest in a mandatory state underwriting pool required by a
change in legislation and a decrease in income from a
retroactive reinsurance contract in run-off, both of which
102
were recorded in other revenues, drove a $7 million
decrease in operating earnings. Auto & Home also
benefited from a lower effective tax rate which improved
operating earnings by $8 million primarily as a result of
tax free interest income representing a larger portion of
pre-tax income.
International
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Change
|
|
|
% Change
|
|
|
|
(In millions)
|
|
|
|
|
|
OPERATING REVENUES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
4,447
|
|
|
$
|
3,187
|
|
|
$
|
1,260
|
|
|
|
39.5
|
%
|
Universal life and investment-type product policy fees
|
|
|
1,329
|
|
|
|
1,061
|
|
|
|
268
|
|
|
|
25.3
|
%
|
Net investment income
|
|
|
1,703
|
|
|
|
1,193
|
|
|
|
510
|
|
|
|
42.7
|
%
|
Other revenues
|
|
|
35
|
|
|
|
14
|
|
|
|
21
|
|
|
|
150.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
|
7,514
|
|
|
|
5,455
|
|
|
|
2,059
|
|
|
|
37.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and dividends
|
|
|
3,723
|
|
|
|
2,660
|
|
|
|
1,063
|
|
|
|
40.0
|
%
|
Interest credited to policyholder account balances
|
|
|
683
|
|
|
|
581
|
|
|
|
102
|
|
|
|
17.6
|
%
|
Capitalization of DAC
|
|
|
(968
|
)
|
|
|
(630
|
)
|
|
|
(338
|
)
|
|
|
(53.7
|
)%
|
Amortization of DAC and VOBA
|
|
|
537
|
|
|
|
415
|
|
|
|
122
|
|
|
|
29.4
|
%
|
Interest expense on debt
|
|
|
3
|
|
|
|
8
|
|
|
|
(5
|
)
|
|
|
(62.5
|
)%
|
Other expenses
|
|
|
2,538
|
|
|
|
1,797
|
|
|
|
741
|
|
|
|
41.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
6,516
|
|
|
|
4,831
|
|
|
|
1,685
|
|
|
|
34.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
206
|
|
|
|
161
|
|
|
|
45
|
|
|
|
28.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
792
|
|
|
$
|
463
|
|
|
$
|
329
|
|
|
|
71.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unless otherwise stated, all amounts discussed below are net of
income tax and are on a constant currency basis. The constant
currency basis amounts for both periods are calculated using the
average foreign currency exchange rates for 2010.
The improvement in the global financial markets has resulted in
continued growth, with a 24% increase in sales in the current
period compared to the prior period excluding the results of our
Japan joint venture. Retirement and savings sales increased 30%
driven by strong annuity, universal life and pension sales in
Europe, Mexico, Chile, South Korea and China. In our Europe and
the Middle East operations, sales of annuities and universal
life products remained strong, more than doubling from the prior
year, partially offset by lower pension and variable universal
life sales in India due to the loss of a major distributor, as
well as lower credit life sales. Our Latin America operation
experienced an overall increase in sales resulting from solid
growth in pension and universal life sales in Mexico and an
increase in fixed annuity sales in Chile due to market recovery,
slightly offset by lower bank sales in Brazil resulting from
incentives offered in the prior year. Sales in our Asia Pacific
operation, excluding the results of our Japan joint venture,
increased primarily due to higher variable universal life sales
in South Korea, slightly offset by the decline in annuity sales
and strong bank channel sales in China. We have experienced
lower sales in Taiwan following the announcement of the planned
sale of this business. While the third partys application
for approval of the sale of our Taiwan affiliate was rejected by
the Taiwan Financial Supervising Commission, the Company
continues to explore strategic options with respect to this
affiliate.
Reported operating earnings increased by $329 million over
the prior year. The positive impact of changes in foreign
currency exchange rates improved reported earnings by
$38 million for 2010 compared to 2009. Excluding the impact
of changes in foreign currency exchange rates, operating
earnings increased $291 million, or 58%. Reported operating
earnings reflect the operating results of ALICO from the
Acquisition Date through November 30, 2010, which
contributed $114 million to our 2010 operating earnings. As
previously noted,
103
ALICOs accounting year-end is November 30; therefore,
Internationals results for the year include one month of
ALICO results.
Changes in assumptions for measuring the impact of inflation on
certain inflation-indexed fixed maturity securities increased
operating earnings by $124 million. Changes to the
provision for income taxes in both periods contributed to an
increase in operating earnings of $86 million, resulting
from a $34 million unfavorable impact in 2009 from a change
in assumption regarding the repatriation of earnings and a
benefit $52 million in the current year from additional
permanent reinvestment of earnings, the reversal of tax
provisions and favorable changes in liabilities for tax
uncertainties. Business growth in our Latin America operation
contributed to an increase in operating earnings. Operating
earnings in Mexico increased $56 million from growth in our
institutional and individual businesses, partially offset by the
impact of unfavorable claims experience of $26 million.
Higher investment yields resulting from portfolio restructuring
was the primary driver in Argentina contributing
$23 million to the improvement in operating earnings.
Indias results benefited by $10 million primarily due
to lower expenses resulting from the loss of a major distributor
and slower growth resulting from market conditions.
Partially offsetting these increases is the impact of
pesification in Argentina, which favorably impacted 2009
reported earnings by $95 million. This prior period benefit
was due to a liability release resulting from a reassessment of
our approach in managing existing and potential future claims
related to certain social security pension annuity
contractholders in Argentina. In addition, operating earnings in
Australia were lower by $9 million, which was primarily due
to a write-off of DAC attributable to a change in a product
feature in the current period.
In addition to a $133 million increase due to the inclusion
of ALICO results, net investment income increased
$102 million from growth in average invested assets and
$88 million from improved yields. Growth in average
invested assets reflects growth in our businesses. Improved
yields reflects the impact of increased inflation, primarily in
Chile, as well as the impact of changes in assumptions for
measuring the effects of inflation on certain inflation-indexed
fixed maturity securities. The increase in net investment income
from higher inflation was offset by an increase in the related
insurance liabilities due to higher inflation. Although
diversification into higher yielding investments had a positive
impact on yields, this was partially offset by decreased trading
and other securities results driven by a stronger recovery in
equity markets in 2009 compared to 2010, primarily in Hong Kong,
and by a decrease in the results of our operating joint
ventures. The reduction in net investment income from our
trading portfolio is entirely offset by a corresponding decrease
in the interest credited on the related contractholder account
balances and therefore had no impact on operating earnings.
In addition to a $269 million increase associated with the
Acquisition, operating expenses increased due to the impact of
the pesification in Argentina noted above, as well as current
period business growth in South Korea, Brazil and Mexico, which
resulted in $93 million of increased commissions and
compensation. These increases were partially offset by
$33 million of lower commissions and business expenses in
India.
104
Banking,
Corporate & Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Change
|
|
|
% Change
|
|
|
|
(In millions)
|
|
|
|
|
|
OPERATING REVENUES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
11
|
|
|
$
|
19
|
|
|
$
|
(8
|
)
|
|
|
(42.1
|
)%
|
Net investment income
|
|
|
992
|
|
|
|
477
|
|
|
|
515
|
|
|
|
108.0
|
%
|
Other revenues
|
|
|
1,044
|
|
|
|
1,092
|
|
|
|
(48
|
)
|
|
|
(4.4
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
|
2,047
|
|
|
|
1,588
|
|
|
|
459
|
|
|
|
28.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and dividends
|
|
|
(14
|
)
|
|
|
4
|
|
|
|
(18
|
)
|
|
|
(450.0
|
)%
|
Interest credited to bank deposits
|
|
|
137
|
|
|
|
163
|
|
|
|
(26
|
)
|
|
|
(16.0
|
)%
|
Amortization of DAC and VOBA
|
|
|
1
|
|
|
|
3
|
|
|
|
(2
|
)
|
|
|
(66.7
|
)%
|
Interest expense on debt
|
|
|
1,126
|
|
|
|
1,027
|
|
|
|
99
|
|
|
|
9.6
|
%
|
Other expenses
|
|
|
1,155
|
|
|
|
1,336
|
|
|
|
(181
|
)
|
|
|
(13.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
2,405
|
|
|
|
2,533
|
|
|
|
(128
|
)
|
|
|
(5.1
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
(300
|
)
|
|
|
(617
|
)
|
|
|
317
|
|
|
|
51.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
|
(58
|
)
|
|
|
(328
|
)
|
|
|
270
|
|
|
|
82.3
|
%
|
Less: Preferred stock dividends
|
|
|
122
|
|
|
|
122
|
|
|
|
|
|
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings available to common shareholders
|
|
$
|
(180
|
)
|
|
$
|
(450
|
)
|
|
$
|
270
|
|
|
|
60.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unless otherwise stated, all amounts discussed below are net of
income tax.
During 2010, mortgage refinancing activity continued to return
to more moderate levels compared to the unusually high levels
experienced in 2009. Consistent with these market conditions, we
experienced a $15.2 billion decline in residential mortgage
production during 2010, while our serviced residential mortgage
loans increased $20.1 billion, which includes a
$16.5 billion purchase from a FDIC receivership bank in the
third quarter of 2010 and a net sale of $4.8 billion to
FNMA in the second quarter of 2010. Servicing run-off of
existing business slowed to 18.2% in 2010 compared with 19.6% in
2009.
The Holding Company completed four debt financings in August
2010 in anticipation of the Acquisition, issuing
$1.0 billion of 2.375% senior notes, $1.0 billion
of 4.75% senior notes, $750 million of
5.875% senior notes, and $250 million of floating rate
senior notes. The Holding Company also issued debt securities,
which are part of the $3.0 billion stated value of common
equity units. The proceeds from these debt issuances were used
to finance the Acquisition. The Holding Company completed three
debt issuances in 2009 in response to the economic crisis,
issuing $397 million of floating rate senior notes in March
2009, $1.3 billion of senior notes in May 2009, and
$500 million of junior subordinated debt securities in July
2009. The proceeds from these debt issuances were used for
general corporate purposes.
Operating earnings available to common shareholders and
operating earnings, which excludes preferred stock dividends,
each increased $270 million, primarily due to an increase
in net investment income and a reduction in operating expenses,
partially offset by a decline in mortgage banking revenues, a
decrease in tax benefit and an increase in interest expense
resulting from the debt issuances noted above.
Net investment income increased $335 million reflecting an
increase of $189 million due to higher yields and an
increase of $146 million from growth in average invested
assets. Yields were positively impacted by the effects of
recovering private equity markets and stabilizing real estate
markets on other limited partnership interests and real estate
joint ventures. This was partially offset by lower fixed
maturities yields which were adversely impacted by the
reinvestment of proceeds from maturities and sales during this
lower interest rate environment and from decreased trading and
other securities results due to a stronger recovery in equity
markets in 2009 as compared to 2010. In addition, due to the
lower interest rate environment in the current year, less net
investment income was credited to the segments in 2010 compared
to 2009. Growth in average invested assets was primarily due to
an
105
increase in bank deposits, higher cash collateral balances
received from our derivative counterparties and the temporary
investment of the proceeds from the debt and common stock
issuances in anticipation of the Acquisition. Our investments
primarily include structured finance securities, investment
grade corporate fixed maturities, mortgage loans and
U.S. Treasury, agency and government guaranteed fixed
maturity securities. In addition, our investment portfolio
includes the excess capital not allocated to the segments.
Accordingly, it includes a higher allocation of certain other
invested asset classes to provide additional diversification and
opportunity for long-term yield enhancement, including leveraged
leases, other limited partnership interests, real estate, real
estate joint ventures, trading securities and equity securities.
Banking, Corporate & Other benefited in 2010 from a
$76 million reduction in discretionary spending, such as
consulting and postemployment related costs, a $35 million
decrease in real estate-related charges and $15 million of
lower legal costs. Other expenses also include a
$48 million decrease in commissions as a result of the
decline in residential mortgage loan production discussed below.
These savings were partially offset by a $14 million
increase in charitable contributions. The current year also
included $44 million of internal resource costs for
associates committed to the Acquisition and a $23 million
increase in expenses associated with expanding the
infrastructure of our banking business. Additionally, the
positive resolution of certain legal matters increased operating
earnings by $27 million.
The $15.2 billion decline in residential mortgage loan
production resulted in a $131 million decrease in operating
earnings, $32 million of which is reflected in net
investment income with the remainder largely attributable to a
reduction in fee income. The increase in the serviced
residential mortgage loan portfolio improved operating earnings
by $41 million despite the increased infrastructure
expenses discussed above.
Maturing time deposits and the need for liquidity in the lower
interest rate environment of 2010 resulted in a $17 million
decrease in interest credited to bank deposits, despite growth
of $1.7 billion in deposits.
Interest expense increased $64 million primarily as a
result of the debt issuances in 2009 and the senior notes and
debt securities issued in anticipation of the Acquisition,
partially offset by the impact of lower interest rates on
variable rate collateral financing arrangements.
The 2010 period includes $75 million of charges related to
the Health Care Act. The Federal government currently provides a
Medicare Part D subsidy. The Health Care Act reduced the
tax deductibility of retiree health care costs to the extent of
any Medicare Part D subsidy received beginning in 2013.
Because the deductibility of future retiree health care costs is
reflected in our financial statements, the entire future impact
of this change in law was required to be recorded as a charge in
the period in which the legislation was enacted. As a result, we
incurred a $75 million charge in the first quarter of 2010.
The Health Care Act also amended Internal Revenue Code
Section 162(m) as a result of which MetLife was initially
considered a healthcare provider, as defined, and would be
subject to limits on tax deductibility of certain types of
compensation. In December 2010, the Internal Revenue Service
issued Notice
2011-2 which
clarified that the executive compensation deduction limitation
included in the Health Care Act did not apply to insurers like
MetLife selling de minimis amounts of health care coverage. As a
result, in the fourth quarter of 2010, we reversed
$18 million of previously recorded taxes for 2010. In 2009,
Banking, Corporate & Other received a larger benefit
of $36 million as compared to 2010 related to the
utilization of tax preferenced investments which provide tax
credits and deductions.
Results
of Operations
Year
Ended December 31, 2009 compared with the Year Ended
December 31, 2008
Unfavorable market conditions continued through 2009, providing
a challenging business environment. The largest and most
significant impact continued to be on our investment portfolio
as declining yields resulted in lower net investment income.
Market sensitive expenses were also negatively impacted by the
market conditions as evidenced by an increase in pension and
postretirement benefit costs. Higher levels of unemployment
continued to impact certain group businesses as a decrease in
covered payrolls reduced growth. Our auto and homeowners
business was impacted by a declining housing market, the
deterioration of the new auto sales market and the continuation
of credit availability issues, all of which contributed to a
decrease in insured exposures. Despite the challenging business
environment, revenue growth remained solid in the majority of
our businesses. A flight to
106
quality during the year contributed to an improvement in sales
in both our domestic fixed and variable annuity products. We
also saw an increase in market share, especially in the
structured settlement business, where we experienced an increase
of 53% in premiums. An improvement in the global financial
markets contributed to a recovery of sales in most of our
international regions and resulted in improved investment
performance in some regions during the second half of 2009. We
also benefited domestically from a strong residential mortgage
refinance market and healthy growth in the reverse mortgage
arena.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
2008
|
|
|
Change
|
|
|
% Change
|
|
|
|
(In millions)
|
|
|
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
26,460
|
|
|
$
|
25,914
|
|
|
$
|
546
|
|
|
|
2.1
|
%
|
Universal life and investment-type product policy fees
|
|
|
5,203
|
|
|
|
5,381
|
|
|
|
(178
|
)
|
|
|
(3.3
|
)%
|
Net investment income
|
|
|
14,837
|
|
|
|
16,289
|
|
|
|
(1,452
|
)
|
|
|
(8.9
|
)%
|
Other revenues
|
|
|
2,329
|
|
|
|
1,586
|
|
|
|
743
|
|
|
|
46.8
|
%
|
Net investment gains (losses)
|
|
|
(2,906
|
)
|
|
|
(2,098
|
)
|
|
|
(808
|
)
|
|
|
(38.5
|
)%
|
Net derivative gains (losses)
|
|
|
(4,866
|
)
|
|
|
3,910
|
|
|
|
(8,776
|
)
|
|
|
(224.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
41,057
|
|
|
|
50,982
|
|
|
|
(9,925
|
)
|
|
|
(19.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims and policyholder dividends
|
|
|
29,986
|
|
|
|
29,188
|
|
|
|
798
|
|
|
|
2.7
|
%
|
Interest credited to policyholder account balances
|
|
|
4,849
|
|
|
|
4,788
|
|
|
|
61
|
|
|
|
1.3
|
%
|
Interest credited to bank deposits
|
|
|
163
|
|
|
|
166
|
|
|
|
(3
|
)
|
|
|
(1.8
|
)%
|
Capitalization of DAC
|
|
|
(3,019
|
)
|
|
|
(3,092
|
)
|
|
|
73
|
|
|
|
2.4
|
%
|
Amortization of DAC and VOBA
|
|
|
1,307
|
|
|
|
3,489
|
|
|
|
(2,182
|
)
|
|
|
(62.5
|
)%
|
Interest expense on debt
|
|
|
1,044
|
|
|
|
1,051
|
|
|
|
(7
|
)
|
|
|
(0.7
|
)%
|
Other expenses
|
|
|
11,061
|
|
|
|
10,333
|
|
|
|
728
|
|
|
|
7.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
45,391
|
|
|
|
45,923
|
|
|
|
(532
|
)
|
|
|
(1.2
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before provision for
income tax
|
|
|
(4,334
|
)
|
|
|
5,059
|
|
|
|
(9,393
|
)
|
|
|
(185.7
|
)%
|
Provision for income tax expense (benefit)
|
|
|
(2,015
|
)
|
|
|
1,580
|
|
|
|
(3,595
|
)
|
|
|
(227.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income tax
|
|
|
(2,319
|
)
|
|
|
3,479
|
|
|
|
(5,798
|
)
|
|
|
(166.7
|
)%
|
Income (loss) from discontinued operations, net of income tax
|
|
|
41
|
|
|
|
(201
|
)
|
|
|
242
|
|
|
|
120.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
(2,278
|
)
|
|
|
3,278
|
|
|
|
(5,556
|
)
|
|
|
(169.5
|
)%
|
Less: Net income (loss) attributable to noncontrolling interests
|
|
|
(32
|
)
|
|
|
69
|
|
|
|
(101
|
)
|
|
|
(146.4
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to MetLife, Inc.
|
|
|
(2,246
|
)
|
|
|
3,209
|
|
|
|
(5,455
|
)
|
|
|
(170.0
|
)%
|
Less: Preferred stock dividends
|
|
|
122
|
|
|
|
125
|
|
|
|
(3
|
)
|
|
|
(2.4
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.s common
shareholders
|
|
$
|
(2,368
|
)
|
|
$
|
3,084
|
|
|
$
|
(5,452
|
)
|
|
|
(176.8
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unless otherwise stated, all amounts are net of income tax.
During the year ended December 31, 2009, MetLifes
income (loss) from continuing operations, net of income tax
decreased $5.8 billion to a loss of $2.3 billion from
income of $3.5 billion in the comparable 2008 period. The
year over year change was predominantly due to a
$5.7 billion unfavorable change in net derivative gains
(losses) to losses of $3.2 billion in 2009 from gains of
$2.5 billion in 2008, and a $525 million unfavorable
change in net investment gains (losses). Offsetting these
unfavorable variances totaling $6.2 billion were favorable
changes in adjustments related to net derivative and net
investment gains (losses) of $972 million, net of income
tax, principally associated with DAC and VOBA amortization,
resulting in a total unfavorable variance related to net
derivative and net investment gains (losses), net of related
adjustments and income tax, of $5.2 billion.
We manage our investment portfolio using disciplined ALM
principles, focusing on cash flow and duration to support our
current and future liabilities. Our intent is to match the
timing and amount of liability cash outflows with invested
assets that have cash inflows of comparable timing and amount,
while optimizing, net of income tax, risk-adjusted net
investment income and risk-adjusted total return. Our investment
portfolio is heavily weighted toward fixed income investments,
with over 80% of our portfolio invested in fixed maturity
securities and mortgage loans.
107
These securities and loans have varying maturities and other
characteristics which cause them to be generally well suited for
matching the cash flow and duration of insurance liabilities.
Other invested asset classes including, but not limited to
equity securities, other limited partnership interests and real
estate and real estate joint ventures provide additional
diversification and opportunity for long-term yield enhancement
in addition to supporting the cash flow and duration objectives
of our investment portfolio. We also use derivatives as an
integral part of our management of the investment portfolio to
hedge certain risks, including changes in interest rates,
foreign currencies, credit spreads and equity market levels.
Additional considerations for our investment portfolio include
current and expected market conditions and expectations for
changes within our unique mix of products and business segments.
The composition of the investment portfolio of each business
segment is tailored to the unique characteristics of its
insurance liabilities, causing certain portfolios to be shorter
in duration and others to be longer in duration. Accordingly,
certain portfolios are more heavily weighted in fixed maturity
securities, or certain
sub-sectors
of fixed maturity securities, than other portfolios.
Investments are purchased to support our insurance liabilities
and not to generate net investment gains and losses. However,
net investment gains and losses are generated and can change
significantly from period to period, due to changes in external
influences including movements in interest rates, foreign
currencies and credit spreads, counterparty specific factors
such as financial performance, credit rating and collateral
valuation, and internal factors such as portfolio rebalancing
that can generate gains and losses. As an investor in the fixed
income, equity security, mortgage loan and certain other
invested asset classes, we are exposed to the above stated
risks, which can lead to both impairments and credit-related
losses.
In addition to the above risk management strategies, as an
integral part of our management of the investment portfolio, we
use freestanding derivatives to hedge market risks including
changes in interest rates, foreign currencies, credit spreads
and the equity market. We also use freestanding derivatives to
hedge these same risks in certain of our liabilities, including
variable annuity minimum benefit guarantees. For those hedges
not designated as an accounting hedge, changes in these market
risks can lead to the recognition of fair value changes in net
derivative gains (losses) without an offsetting gain or loss
recognized in earnings for the item being hedged even though
these are effective economic hedges. Additionally, we issue
liabilities and purchase assets that contain embedded
derivatives whose changes in estimated fair value are sensitive
to changes in market risks and are also recognized in net
derivative gains (losses).
The unfavorable variance in net derivative gains (losses) of
$5.7 billion, from gains of $2.5 billion in 2008 to
losses of $3.2 billion in 2009 was primarily driven by an
unfavorable change in freestanding derivatives of
$8.6 billion from gains in the prior period of
$4.3 billion to losses in the current period of
$4.3 billion. This unfavorable variance was partially
offset by a favorable change in embedded derivatives primarily
associated with variable annuity minimum benefit guarantees of
$2.9 billion from losses in the prior period of
$1.7 billion to gains in the current period of
$1.2 billion.
The $8.6 billion unfavorable variance in freestanding
derivatives was primarily attributable to market factors,
including rising interest rates, improving equity markets on
equity options and futures, decreased equity volatility,
weakening U.S. dollar, and narrowing credit spreads.
Long-term and mid-term interest rates increased in the current
period which caused a negative impact of $4.4 billion on
our interest rate derivatives, $1.2 billion of which is
attributable to hedges of variable annuity minimum benefit
guarantees. Equity markets improved while equity volatility
decreased in the current period, which had a net negative impact
of $3.1 billion on our equity derivatives, which we use to
hedge variable annuity minimum benefit guarantees. Weakening of
the U.S. dollar in the current period had a negative impact
of $646 million on certain foreign currency derivatives
that are used to hedge foreign-denominated asset and liability
exposures. Narrowing corporate credit spreads had a negative
impact of $453 million on our purchased protection credit
derivatives.
The variable annuity products with minimum benefit guarantees
containing embedded derivatives are measured at fair value
separately from the host variable annuity contract, with changes
in estimated fair value reported in net derivative gains
(losses). The estimated fair value of these embedded derivatives
also includes an adjustment for nonperformance risk of the
related liabilities carried at estimated fair value. The
$2.9 billion favorable change in embedded derivatives was
primarily attributable to rising interest rates, improving
equity market performance, a decrease in equity volatility, and
weakening of the U.S. dollar, which was offset by the
108
unfavorable change in the adjustment for nonperformance risk.
Both long-term and mid-term interest rates increased in the
current period which had a positive impact of $2.2 billion.
Improving equity markets in the current period had a positive
impact of $1.5 billion. Lower equity market volatility in
the current period compared to the prior period had a positive
impact of $817 million, and the weakening U.S. dollar
had a positive impact of $456 million. The favorable
results from these hedged risks was partially offset by an
unfavorable change related to the adjustment for nonperformance
risk of $3.2 billion, from gains of $1.9 billion in
2008 to losses of $1.3 billion in 2009. Gains on the
freestanding derivatives that hedged these embedded derivative
risks more than offset the change in liabilities attributable to
market factors, excluding the adjustment for nonperformance
risk. Finally, there was a favorable change of $1.1 billion
for all other unhedged risks on the variable annuity minimum
benefit guarantee liabilities.
The $525 million unfavorable change in net investment gains
(losses) was primarily attributable to higher net losses on
mortgage loans and other limited partnership interests. The
increase in losses on mortgage loans was principally due to
increases in mortgage valuation allowances resulting from
weakening of the real estate market and other economic
fundamentals. The increase in losses on other limited
partnership interests was principally due to higher impairments
on certain cost method investments which experienced a reduction
in net asset values of the underlying portfolio companies. The
underlying valuations of the portfolio companies have decreased
due to the current economic environment.
As more fully described in the discussion of performance
measures above, operating earnings is the measure of segment
profit or loss we use to evaluate performance and allocate
resources. Consistent with GAAP accounting guidance for segment
reporting, it is our measure of performance, as reported below.
Operating earnings is not determined in accordance with GAAP and
should not be viewed as a substitute for GAAP income (loss) from
continuing operations, net of income tax. We believe that the
presentation of operating earnings enhances the understanding of
our performance by highlighting the results of operations and
the underlying profitability drivers of the business. Operating
earnings available to common shareholders decreased by
$329 million to $2.4 billion in 2009 from
$2.7 billion in 2008.
Reconciliation
of income (loss) from continuing operations, net of income tax,
to operating earnings available to common
shareholders
Year
Ended December 31, 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
Banking,
|
|
|
|
|
|
|
Insurance
|
|
|
Retirement
|
|
|
Benefit
|
|
|
Auto &
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
Products
|
|
|
Products
|
|
|
Funding
|
|
|
Home
|
|
|
International
|
|
|
& Other
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Income (loss) from continuing operations, net of income tax
|
|
$
|
(418
|
)
|
|
$
|
(628
|
)
|
|
$
|
(581
|
)
|
|
$
|
321
|
|
|
$
|
(280
|
)
|
|
$
|
(733
|
)
|
|
$
|
(2,319
|
)
|
Less: Net investment gains (losses)
|
|
|
(472
|
)
|
|
|
(533
|
)
|
|
|
(1,486
|
)
|
|
|
(41
|
)
|
|
|
(105
|
)
|
|
|
(269
|
)
|
|
|
(2,906
|
)
|
Less: Net derivative gains (losses)
|
|
|
(1,786
|
)
|
|
|
(1,426
|
)
|
|
|
(421
|
)
|
|
|
39
|
|
|
|
(798
|
)
|
|
|
(474
|
)
|
|
|
(4,866
|
)
|
Less: Adjustments to continuing operations (1)
|
|
|
(139
|
)
|
|
|
519
|
|
|
|
125
|
|
|
|
|
|
|
|
(206
|
)
|
|
|
(16
|
)
|
|
|
283
|
|
Less: Provision for income tax (expense) benefit
|
|
|
837
|
|
|
|
504
|
|
|
|
621
|
|
|
|
1
|
|
|
|
366
|
|
|
|
354
|
|
|
|
2,683
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
1,142
|
|
|
$
|
308
|
|
|
$
|
580
|
|
|
$
|
322
|
|
|
$
|
463
|
|
|
|
(328
|
)
|
|
|
2,487
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Preferred stock dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
122
|
|
|
|
122
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings available to common shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(450
|
)
|
|
$
|
2,365
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
109
Year
Ended December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
Banking,
|
|
|
|
|
|
|
Insurance
|
|
|
Retirement
|
|
|
Benefit
|
|
|
Auto &
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
Products
|
|
|
Products
|
|
|
Funding
|
|
|
Home
|
|
|
International
|
|
|
& Other
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Income (loss) from continuing operations, net of income tax
|
|
$
|
2,195
|
|
|
$
|
539
|
|
|
$
|
(256
|
)
|
|
$
|
275
|
|
|
$
|
553
|
|
|
$
|
173
|
|
|
$
|
3,479
|
|
Less: Net investment gains (losses)
|
|
|
(1,219
|
)
|
|
|
(669
|
)
|
|
|
(1,682
|
)
|
|
|
(89
|
)
|
|
|
(91
|
)
|
|
|
1,652
|
|
|
|
(2,098
|
)
|
Less: Net derivative gains (losses)
|
|
|
2,777
|
|
|
|
1,842
|
|
|
|
(219
|
)
|
|
|
(45
|
)
|
|
|
260
|
|
|
|
(705
|
)
|
|
|
3,910
|
|
Less: Adjustments to continuing operations (1)
|
|
|
(193
|
)
|
|
|
(622
|
)
|
|
|
82
|
|
|
|
|
|
|
|
52
|
|
|
|
17
|
|
|
|
(664
|
)
|
Less: Provision for income tax (expense) benefit
|
|
|
(480
|
)
|
|
|
(192
|
)
|
|
|
637
|
|
|
|
46
|
|
|
|
(147
|
)
|
|
|
(352
|
)
|
|
|
(488
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
1,310
|
|
|
$
|
180
|
|
|
$
|
926
|
|
|
$
|
363
|
|
|
$
|
479
|
|
|
|
(439
|
)
|
|
|
2,819
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Preferred stock dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
125
|
|
|
|
125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings available to common shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(564
|
)
|
|
$
|
2,694
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
See definitions of operating revenues and operating expenses for
the components of such adjustments. |
Reconciliation
of GAAP revenues to operating revenues and GAAP expenses to
operating expenses
Year
Ended December 31, 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
Banking,
|
|
|
|
|
|
|
Insurance
|
|
|
Retirement
|
|
|
Benefit
|
|
|
Auto &
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
Products
|
|
|
Products
|
|
|
Funding
|
|
|
Home
|
|
|
International
|
|
|
& Other
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Total revenues
|
|
$
|
23,483
|
|
|
$
|
3,725
|
|
|
$
|
5,486
|
|
|
$
|
3,113
|
|
|
$
|
4,383
|
|
|
$
|
867
|
|
|
$
|
41,057
|
|
Less: Net investment gains (losses)
|
|
|
(472
|
)
|
|
|
(533
|
)
|
|
|
(1,486
|
)
|
|
|
(41
|
)
|
|
|
(105
|
)
|
|
|
(269
|
)
|
|
|
(2,906
|
)
|
Less: Net derivative gains (losses)
|
|
|
(1,786
|
)
|
|
|
(1,426
|
)
|
|
|
(421
|
)
|
|
|
39
|
|
|
|
(798
|
)
|
|
|
(474
|
)
|
|
|
(4,866
|
)
|
Less: Adjustments related to net investment gains (losses) and
net derivative gains (losses)
|
|
|
(27
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(27
|
)
|
Less: Other adjustments to revenues (1)
|
|
|
(74
|
)
|
|
|
(219
|
)
|
|
|
188
|
|
|
|
|
|
|
|
(169
|
)
|
|
|
22
|
|
|
|
(252
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
$
|
25,842
|
|
|
$
|
5,903
|
|
|
$
|
7,205
|
|
|
$
|
3,115
|
|
|
$
|
5,455
|
|
|
$
|
1,588
|
|
|
$
|
49,108
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
$
|
24,165
|
|
|
$
|
4,690
|
|
|
$
|
6,400
|
|
|
$
|
2,697
|
|
|
$
|
4,868
|
|
|
$
|
2,571
|
|
|
$
|
45,391
|
|
Less: Adjustments related to net investment gains (losses) and
net derivative gains (losses)
|
|
|
39
|
|
|
|
(739
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(700
|
)
|
Less: Other adjustments to expenses (1)
|
|
|
(1
|
)
|
|
|
1
|
|
|
|
63
|
|
|
|
|
|
|
|
37
|
|
|
|
38
|
|
|
|
138
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
$
|
24,127
|
|
|
$
|
5,428
|
|
|
$
|
6,337
|
|
|
$
|
2,697
|
|
|
$
|
4,831
|
|
|
$
|
2,533
|
|
|
$
|
45,953
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
110
Year
Ended December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
Banking,
|
|
|
|
|
|
|
Insurance
|
|
|
Retirement
|
|
|
Benefit
|
|
|
Auto &
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
Products
|
|
|
Products
|
|
|
Funding
|
|
|
Home
|
|
|
International
|
|
|
& Other
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Total revenues
|
|
$
|
26,754
|
|
|
$
|
6,487
|
|
|
$
|
6,700
|
|
|
$
|
3,061
|
|
|
$
|
6,001
|
|
|
$
|
1,979
|
|
|
$
|
50,982
|
|
Less: Net investment gains (losses)
|
|
|
(1,219
|
)
|
|
|
(669
|
)
|
|
|
(1,682
|
)
|
|
|
(89
|
)
|
|
|
(91
|
)
|
|
|
1,652
|
|
|
|
(2,098
|
)
|
Less: Net derivative gains (losses)
|
|
|
2,777
|
|
|
|
1,842
|
|
|
|
(219
|
)
|
|
|
(45
|
)
|
|
|
260
|
|
|
|
(705
|
)
|
|
|
3,910
|
|
Less: Adjustments related to net investment gains (losses) and
net derivative gains (losses)
|
|
|
18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18
|
|
Less: Other adjustments to revenues (1)
|
|
|
(1
|
)
|
|
|
(45
|
)
|
|
|
53
|
|
|
|
|
|
|
|
69
|
|
|
|
13
|
|
|
|
89
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
$
|
25,179
|
|
|
$
|
5,359
|
|
|
$
|
8,548
|
|
|
$
|
3,195
|
|
|
$
|
5,763
|
|
|
$
|
1,019
|
|
|
$
|
49,063
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
$
|
23,418
|
|
|
$
|
5,665
|
|
|
$
|
7,119
|
|
|
$
|
2,728
|
|
|
$
|
5,044
|
|
|
$
|
1,949
|
|
|
$
|
45,923
|
|
Less: Adjustments related to net investment gains (losses) and
net derivative gains (losses)
|
|
|
262
|
|
|
|
577
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
839
|
|
Less: Other adjustments to expenses (1)
|
|
|
(52
|
)
|
|
|
|
|
|
|
(29
|
)
|
|
|
|
|
|
|
17
|
|
|
|
(4
|
)
|
|
|
(68
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
$
|
23,208
|
|
|
$
|
5,088
|
|
|
$
|
7,148
|
|
|
$
|
2,728
|
|
|
$
|
5,027
|
|
|
$
|
1,953
|
|
|
$
|
45,152
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
See definitions of operating revenues and operating expenses for
the components of such adjustments. |
The volatile market conditions that began in 2008 and continued
into 2009 impacted several key components of our operating
earnings available to common shareholders including net
investment income, hedging costs, and certain market sensitive
expenses. The markets also positively impacted our operating
earnings available to common shareholders as conditions began to
improve during 2009, resulting in lower DAC and DSI amortization.
A $722 million decline in net investment income was the
result of decreasing yields, including the effects of our higher
quality, more liquid, but lower yielding investment position in
response to the extraordinary market conditions. The impact of
declining yields caused a $1.6 billion decrease in net
investment income, which was partially offset by an increase of
$846 million due to growth in average invested assets
calculated excluding unrealized gains and losses. The decrease
in yields resulted from the disruption and dislocation in the
global financial markets experienced in 2008, which continued,
but moderated, in 2009. The adverse yield impact was
concentrated in the following four invested asset classes:
|
|
|
|
|
Fixed maturity securities primarily due to lower
yields on floating rate securities from declines in short-term
interest rates and an increased allocation to lower yielding,
higher quality, U.S. Treasury, agency and government
guaranteed securities, to increase liquidity in response to the
extraordinary market conditions, as well as decreased income on
our securities lending program, primarily due to the smaller
size of the program in the current year. These adverse impacts
were offset slightly as conditions improved late in 2009 and we
began to reallocate our portfolio to higher-yielding assets;
|
|
|
|
Real estate joint ventures primarily due to
declining property valuations on certain investment funds that
carry their real estate at estimated fair value and operating
losses incurred on properties that were developed for sale by
development joint ventures;
|
|
|
|
Cash, cash equivalents and short-term investments
primarily due to declines in short-term interest rates; and
|
|
|
|
Mortgage loans primarily due to lower prepayments on
commercial mortgage loans and lower yields on variable rate
loans reflecting declines in short-term interest rates.
|
111
Equity markets experienced some recovery in 2009, which led to
improved yields on other limited partnership interests. As many
of our products are interest spread-based, the lower net
investment income was significantly offset by lower interest
credited expense on our investment and insurance products.
The financial market conditions also resulted in a
$348 million increase in net guaranteed annuity benefit
costs in our Retirement Products segment, as increased hedging
losses were only partially offset by lower guaranteed benefit
costs.
The key driver of the increase in other expenses stemmed from
the impact of market conditions on certain expenses, primarily
pension and postretirement benefit costs, reinsurance expenses
and letter of credit fees. These increases coupled with higher
variable costs, such as commissions and premium taxes, some of
which have been capitalized, more than offset the favorable
impact of lower information technology, travel, professional
services and advertising expenses, which include the impact of
our enterprise-wide cost reduction and revenue enhancement
initiative.
The market improvement which began in the second quarter of 2009
was a key factor in the determination of our expected future
gross profits, the increase of which triggered a decrease in DAC
and DSI amortization, most significantly in the Retirement
Products segment. The increase in our expected future gross
profits stemmed primarily from an increase in the market value
of our separate account balances, which is attributable, in
part, to the improving financial markets. Our Insurance Products
segment benefited, in the current year, from an increase in
amortization of unearned revenue, primarily as a result of our
annual review of assumptions that are used in the determination
of the amount of amortization recognized. These collective
changes in amortization resulted in a $720 million benefit,
partially offsetting the declines in operating earnings
available to common shareholders discussed above.
A portion of the decline in operating earnings available to
common shareholders was caused by a $200 million reduction
in the results of our closed block of business, a specific group
of participating life policies that were segregated in
connection with the demutualization of MLIC. Until early 2009,
the operating earnings of the closed block did not have a full
impact on operating earnings as the operating earnings or loss
was partially offset by a change in the policyholder dividend
obligation, a liability established at the time of
demutualization. However, in early 2009 the policyholder
dividend obligation was depleted and, as a result, the total
operating earnings or loss related to the closed block for the
year ended December 31, 2009 was, and in the future may be
a component of operating earnings.
Business growth, from the majority of our businesses, along with
net favorable mortality experience, had a positive impact on
operating earnings available to common shareholders. These
impacts were somewhat dampened by higher benefit utilization in
our dental business and mixed claim activity in our
Auto & Home segment. In addition, our forward and
reverse residential mortgage platform acquisitions in late 2008
benefited Banking, Corporate & Others 2009
results.
112
Insurance
Products
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
2008
|
|
|
Change
|
|
|
% Change
|
|
|
|
(In millions)
|
|
|
|
|
|
OPERATING REVENUES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
17,168
|
|
|
$
|
16,402
|
|
|
$
|
766
|
|
|
|
4.7
|
%
|
Universal life and investment-type product policy fees
|
|
|
2,281
|
|
|
|
2,171
|
|
|
|
110
|
|
|
|
5.1
|
%
|
Net investment income
|
|
|
5,614
|
|
|
|
5,787
|
|
|
|
(173
|
)
|
|
|
(3.0
|
)%
|
Other revenues
|
|
|
779
|
|
|
|
819
|
|
|
|
(40
|
)
|
|
|
(4.9
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
|
25,842
|
|
|
|
25,179
|
|
|
|
663
|
|
|
|
2.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and dividends
|
|
|
19,111
|
|
|
|
18,183
|
|
|
|
928
|
|
|
|
5.1
|
%
|
Interest credited to policyholder account balances
|
|
|
952
|
|
|
|
930
|
|
|
|
22
|
|
|
|
2.4
|
%
|
Capitalization of DAC
|
|
|
(873
|
)
|
|
|
(849
|
)
|
|
|
(24
|
)
|
|
|
(2.8
|
)%
|
Amortization of DAC and VOBA
|
|
|
725
|
|
|
|
743
|
|
|
|
(18
|
)
|
|
|
(2.4
|
)%
|
Interest expense on debt
|
|
|
6
|
|
|
|
5
|
|
|
|
1
|
|
|
|
20.0
|
%
|
Other expenses
|
|
|
4,206
|
|
|
|
4,196
|
|
|
|
10
|
|
|
|
0.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
24,127
|
|
|
|
23,208
|
|
|
|
919
|
|
|
|
4.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
573
|
|
|
|
661
|
|
|
|
(88
|
)
|
|
|
(13.3
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
1,142
|
|
|
$
|
1,310
|
|
|
$
|
(168
|
)
|
|
|
(12.8
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unfavorable market conditions, which continued through 2009,
provided a challenging business environment for our Insurance
Products segment. This resulted in lower net investment income
and an increase in market sensitive expenses, primarily pension
and postretirement benefit costs. We also experienced higher
utilization of dental benefits along with a lower number of
recoveries in our disability business. Higher levels of
unemployment continued to impact certain group businesses as a
decrease in covered payrolls reduced growth. However, revenue
growth remained solid in all of our businesses. Revenue growth
in our dental and individual life businesses reflected strong
sales and renewals.
The significant components of the $168 million decline in
operating earnings were the aforementioned decline in net
investment income, especially in the closed block business,
partially offset by an increase in the amortization of unearned
revenue, the impact of a reduction in dividends to certain
policyholders and favorable mortality in the individual life
business.
Until early 2009, the earnings of the closed block did not have
a full impact on operating earnings as the earnings or loss was
partially offset by a change in the policyholder dividend
obligation. However, in early 2009 the policyholder dividend
obligation was depleted and, as a result, the total operating
earnings or loss related to the closed block for the year ended
December 31, 2009 was, and in the future may be, a
component of operating earnings. This resulted in a
$200 million decline in operating earnings in 2009.
The decrease in net investment income of $112 million was
primarily due to a $317 million decrease from lower yields,
partially offset by a $205 million increase from growth in
average invested assets. Yields were adversely impacted by the
severe downturn in the global financial markets, which primarily
impacted other invested assets, real estate joint ventures and
fixed maturity securities. In addition, income from our
securities lending program decreased primarily due to the
smaller size of the program in 2009. The growth in the average
invested asset base was primarily from an increase in net flows
from our individual life, non-medical health, and group life
businesses. The moderate recovery in equity markets in 2009 led
to improved yields on other limited partnership interests, which
partially offset the overall reduction in yields. To manage the
needs of our intermediate to longer-term liabilities, our
portfolio consists primarily of investment grade corporate fixed
maturity securities, structured finance securities (comprised of
mortgage and asset-backed securities), mortgage loans, and
U.S. Treasury, agency and government guaranteed fixed
maturity securities and, to a lesser extent, certain other
invested asset classes
113
including real estate joint ventures and other invested assets
to provide additional diversification and opportunity for
long-term yield enhancement.
Other expenses were essentially flat despite an increase of
$137 million from the impact of market conditions on
certain expenses, primarily pension and postretirement benefit
costs. This increase was partially offset by a decrease of
$85 million, predominantly from declines in information
technology, travel, and professional services, including the
positive impact of our enterprise-wide cost reduction and
revenue enhancement initiative. A further reduction of expenses
was achieved through a decrease in variable expenses, such as
commissions and premium taxes of $46 million, a portion of
which is offset by DAC capitalization.
The aforementioned declines in operating earnings were partially
offset by the favorable impact of a $63 million decrease in
policyholder dividends in the traditional life business, the
result of a dividend scale reduction in the fourth quarter of
2009. In addition, favorable mortality in the individual life
business was partially offset by higher benefit utilization in
the dental business during 2009, reflecting the negative
employment trends in the marketplace. The net impact of these
two items benefited operating earnings by $36 million. The
2009 results were also favorably impacted by our review of
assumptions used to determine estimated gross profits and
margins, which in turn are factors in determining the
amortization for DAC and unearned revenue. This review resulted
in an unlocking event related to unearned revenue and, coupled
with the impact from the prior years review, generated an
increase in operating earnings of $82 million. This
increase was recorded in universal life and investment-type
product policy fees. Partially offsetting these increases was
the impact of lower separate account balances, which resulted in
lower fee income of $25 million.
DAC amortization reflects lower current year amortization of
$108 million, stemming from the impact of the improvement
in the financial markets in 2009, which increased our expected
future gross profits, as well as lower current year gross
margins in the closed block. This decrease was partially offset
by the net impact of refinements in both the prior and current
years of $98 million, the majority of which was recorded in
the prior year as a result of the 2008 review of certain DAC
related assumptions.
Retirement
Products
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
2008
|
|
|
Change
|
|
|
% Change
|
|
|
|
(In millions)
|
|
|
|
|
|
OPERATING REVENUES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
920
|
|
|
$
|
696
|
|
|
$
|
224
|
|
|
|
32.2
|
%
|
Universal life and investment-type product policy fees
|
|
|
1,712
|
|
|
|
1,870
|
|
|
|
(158
|
)
|
|
|
(8.4
|
)%
|
Net investment income
|
|
|
3,098
|
|
|
|
2,624
|
|
|
|
474
|
|
|
|
18.1
|
%
|
Other revenues
|
|
|
173
|
|
|
|
169
|
|
|
|
4
|
|
|
|
2.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
|
5,903
|
|
|
|
5,359
|
|
|
|
544
|
|
|
|
10.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and dividends
|
|
|
1,950
|
|
|
|
1,271
|
|
|
|
679
|
|
|
|
53.4
|
%
|
Interest credited to policyholder account balances
|
|
|
1,688
|
|
|
|
1,338
|
|
|
|
350
|
|
|
|
26.2
|
%
|
Capitalization of DAC
|
|
|
(1,067
|
)
|
|
|
(980
|
)
|
|
|
(87
|
)
|
|
|
(8.9
|
)%
|
Amortization of DAC and VOBA
|
|
|
424
|
|
|
|
1,356
|
|
|
|
(932
|
)
|
|
|
(68.7
|
)%
|
Interest expense on debt
|
|
|
|
|
|
|
2
|
|
|
|
(2
|
)
|
|
|
(100.0
|
)%
|
Other expenses
|
|
|
2,433
|
|
|
|
2,101
|
|
|
|
332
|
|
|
|
15.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
5,428
|
|
|
|
5,088
|
|
|
|
340
|
|
|
|
6.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
167
|
|
|
|
91
|
|
|
|
76
|
|
|
|
83.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
308
|
|
|
$
|
180
|
|
|
$
|
128
|
|
|
|
71.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In 2009, Retirement Products benefited from a flight to quality,
which contributed to a 10% improvement in combined sales of our
fixed and variable products and a 28% reduction in surrenders
and withdrawals. Our variable
114
annuity sales have outpaced the industry, increasing our market
share. Fixed annuity sales benefited from enhanced marketing on
our income annuity with life contingency products, which
increased our premium revenues by $224 million, or 32%,
before income taxes. In the annuity business, the movement in
premiums is almost entirely offset by the related change in
policyholder benefits, as the insurance liability that we
establish at the time we assume the risk under these contracts
is typically equivalent to the premium earned less the amount of
acquisition expenses. Our average PAB grew by $7.2 billion
in 2009, primarily due to an increase in sales of fixed annuity
products and more customers electing the fixed option on
variable annuity sales. This has a favorable impact on earnings
by increasing net investment income, which is somewhat offset by
higher interest credited expense. Unfavorable market conditions
resulted in poor investment performance, which outweighed the
impact of higher variable annuity sales on our separate account
balances causing the average separate account balance to remain
lower than the previous year. This resulted in lower policy fees
and other revenues which are based on daily asset balances in
the policyholder separate accounts.
The improvement in the financial markets was the primary driver
of the $128 million increase in operating earnings, with
the largest impact resulting in a decrease in DAC, VOBA and DSI
amortization of $655 million. The 2008 results reflected
increased, or accelerated, amortization primarily stemming from
a decline in the market value of our separate account balances.
A factor that determines the amount of amortization is expected
future earnings, which in the annuity business are derived, in
part, from fees earned on separate account balances. The market
value of our separate account balances declined significantly in
2008, resulting in a decrease in the expected future gross
profits, triggering an acceleration of amortization in 2008.
Beginning in the second quarter of 2009, the market conditions
began to improve and the market value of our separate account
balances began to increase, resulting in an increase in the
expected future gross profits and a corresponding lower level of
amortization in 2009.
Also contributing to the increase in operating earnings was an
increase in net investment income of $308 million, which
was primarily due to a $286 million increase from growth in
average invested assets and a $22 million increase in
yields. The increase in average invested assets was due to
increased cash flows from the sales of fixed annuity products
and more customers electing the fixed option on variable annuity
sales, which were reinvested primarily in fixed maturity
securities, other invested assets and mortgage loans. The
increase in yields was due to moderate improvement in the equity
markets in 2009 which led to an increase in yields principally
for other limited partnership interests and certain other
invested assets, which was partially offset by a decrease in
yields on real estate joint ventures, reflecting the severe
downturn in the global financial markets. To manage the needs of
our intermediate to longer-term liabilities, our portfolio
consists primarily of investment grade corporate fixed maturity
securities, structured finance securities, mortgage loans and
U.S. Treasury, agency and government guaranteed fixed
maturity securities and, to a lesser extent, certain other
invested asset classes, including real estate joint ventures in
order to provide additional diversification and opportunity for
long-term yield enhancement. As is typically the case with fixed
annuity products, higher net investment income was somewhat
offset by higher interest credited expense. Growth in our fixed
annuity policyholder account balances increased interest
credited expense by $186 million in 2009 and higher average
crediting rates on fixed annuities increased interest credited
expense by $27 million.
Operating earnings were negatively impacted by $348 million
of operating losses related to the hedging programs for variable
annuity minimum death and income benefit guarantees, which are
not embedded derivatives, partially offset by a decrease in the
liability established for these variable annuity guarantees. The
various hedging strategies in place to offset the risk
associated with these variable annuity guarantee benefits were
more sensitive to market movements than the liability for the
guaranteed benefit. Market volatility, improvements in the
equity markets, and higher interest rates produced operating
losses on these hedging strategies in the current year. Our
hedging strategies, which are a key part of our risk management,
performed as anticipated. The decrease in annuity guarantee
benefit liabilities was due to the improvement in the equity
markets, higher interest rates and the annual unlocking of
future market expectations.
Other expenses increased by $216 million primarily due to
an increase of $123 million from the impact of market
conditions on certain expenses. These expenses are largely
comprised of reinsurance costs, pension and postretirement
benefit expenses, and letter of credit fees. In addition,
variable expenses, such as commissions and premium taxes,
increased $77 million, the majority of which have been
offset by DAC capitalization. The positive impact of our
enterprise-wide cost reduction and revenue enhancement
initiative was reflected in lower travel,
115
professional services and advertising expenses, but was more
than offset by increases largely due to business growth.
Finally, policy fees and other revenues decreased by
$100 million, mainly due to lower average separate account
balances in the current year versus prior year.
Corporate
Benefit Funding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
2008
|
|
|
Change
|
|
|
% Change
|
|
|
|
(In millions)
|
|
|
|
|
|
OPERATING REVENUES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
2,264
|
|
|
$
|
2,348
|
|
|
$
|
(84
|
)
|
|
|
(3.6
|
)%
|
Universal life and investment-type product policy fees
|
|
|
176
|
|
|
|
227
|
|
|
|
(51
|
)
|
|
|
(22.5
|
)%
|
Net investment income
|
|
|
4,527
|
|
|
|
5,615
|
|
|
|
(1,088
|
)
|
|
|
(19.4
|
)%
|
Other revenues
|
|
|
238
|
|
|
|
358
|
|
|
|
(120
|
)
|
|
|
(33.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
|
7,205
|
|
|
|
8,548
|
|
|
|
(1,343
|
)
|
|
|
(15.7
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and dividends
|
|
|
4,245
|
|
|
|
4,398
|
|
|
|
(153
|
)
|
|
|
(3.5
|
)%
|
Interest credited to policyholder account balances
|
|
|
1,632
|
|
|
|
2,297
|
|
|
|
(665
|
)
|
|
|
(29.0
|
)%
|
Capitalization of DAC
|
|
|
(14
|
)
|
|
|
(18
|
)
|
|
|
4
|
|
|
|
22.2
|
%
|
Amortization of DAC and VOBA
|
|
|
15
|
|
|
|
29
|
|
|
|
(14
|
)
|
|
|
(48.3
|
)%
|
Interest expense on debt
|
|
|
3
|
|
|
|
2
|
|
|
|
1
|
|
|
|
50.0
|
%
|
Other expenses
|
|
|
456
|
|
|
|
440
|
|
|
|
16
|
|
|
|
3.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
6,337
|
|
|
|
7,148
|
|
|
|
(811
|
)
|
|
|
(11.3
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
288
|
|
|
|
474
|
|
|
|
(186
|
)
|
|
|
(39.2
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
580
|
|
|
$
|
926
|
|
|
$
|
(346
|
)
|
|
|
(37.4
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Benefit Funding benefited in certain markets in 2009
as a flight to quality helped drive our increase in market
share, especially in the structured settlement business, where
we experienced a 53% increase in premiums. Our pension closeout
business in the U.K .continues to expand and experienced premium
growth during 2009 of almost $400 million, or 105% before
income taxes. However, this growth was more than offset by a
decline in our domestic pension closeout business driven by
unfavorable market conditions and regulatory changes. A
combination of poor equity returns and lower interest rates have
contributed to pension plans being under funded, which reduces
our customers flexibility to engage in transactions such
as pension closeouts. Our customers plans funded status
may be affected by a variety of factors, including the ongoing
phased implementation of the Pension Protection Act of 2006, a
comprehensive reform of defined benefit and defined contribution
plan rules. For each of these businesses, the movement in
premiums is almost entirely offset by the related change in
policyholder benefits. The insurance liability that is
established at the time we assume the risk under these contracts
is typically equivalent to the premium earned.
Market conditions also contributed to a lower demand for several
of our investment-type products. The decrease in sales of these
investment-type products is not necessarily evident in our
results of operations as the transactions related to these
products are recorded through the balance sheet. Our funding
agreement products, primarily the LIBOR based contracts,
experienced the most significant impact from the volatile market
conditions. As companies seek greater liquidity, investment
managers are refraining from repurchasing the contracts when
they mature and are opting for more liquid investments. In
addition, unfavorable market conditions continued to impact the
demand for global guaranteed interest contracts, a type of
funding agreement.
Policyholder account balances for our investment-type products
were down by approximately $10 billion during 2009, as
issuances were more than offset by scheduled maturities.
However, due to the timing of issuances and maturities, the
average policyholder account balances and liabilities increased
from 2008 to 2009. The impact
116
of the decrease in policyholder account balances resulted in
lower net investment income, which was somewhat offset by lower
interest credited expense.
The primary driver of the $346 million decrease in
operating earnings was lower net investment income of
$707 million reflecting a $682 million decrease from
lower yields and a $25 million increase due to growth in
average invested assets. Yields were adversely impacted by the
severe downturn in the global financial markets which impacted
real estate joint ventures, fixed maturity securities, other
invested assets and mortgage loans. In addition, income from our
securities lending program decreased, primarily due to the
smaller size of the program during the year. To manage the needs
of our longer-term liabilities, our portfolio consists primarily
of investment grade corporate fixed maturity securities,
mortgage loans, U.S. Treasury, agency and government
guaranteed securities and, to a lesser extent, certain other
invested asset classes including real estate joint ventures in
order to provide additional diversification and opportunity for
long-term yield enhancement. For our shorter-term obligations,
we invest primarily in structured finance securities, mortgage
loans and investment grade corporate fixed maturity securities.
The yields on these investments have moved consistent with the
underlying market indices, primarily LIBOR and Treasury, on
which they are based. The growth in the average invested asset
base is consistent with the increase in the average policyholder
account balances and liabilities.
As many of our products are interest spread-based, the lower net
investment income was somewhat offset by lower net interest
credited expense of $380 million. The decrease in interest
credited expense is attributed to $431 million from lower
crediting rates. Crediting rates have moved consistent with the
underlying market indices, primarily LIBOR, on which they are
based. The increase in the average policyholder account balances
resulted in a $51 million increase in interest credited
expense.
The year over year decline in operating earnings was also due in
part to lower other revenues as the prior year benefited by
$44 million in fees for the cancellation of a bank owned
life insurance stable value wrap policy combined with the
surrender of a global guaranteed interest contract. In addition,
a refinement to a reinsurance recoverable in the small business
record keeping line of business in the latter part of 2009 also
contributed $20 million to the decrease in operating
earnings.
Current year results benefited from favorable liability
refinements as compared to unfavorable liability refinements in
2008, as well as improved mortality experience in the current
year, all in the pension closeouts business. These items
improved 2009 operating earnings by approximately
$90 million. Other products generated mortality gains or
losses; however, the net change did not have a material impact
on our year over year results.
Although our other expenses only increased marginally and are
not a significant driver of the decrease in operating earnings,
the general themes associated with the increase are consistent
with those factors discussed above in the discussion of our
consolidated results of operations. Market conditions triggered
an increase in our pension and postretirement benefit expenses
of $26 million. In addition, variable expenses, such as
commissions and premium taxes, have increased $20 million.
These increases were partially offset by a decrease of
$36 million, primarily in information technology, travel
and professional services expenses, all of which were largely
due to our enterprise-wide cost reduction and revenue
enhancement initiative.
117
Auto &
Home
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
2008
|
|
|
Change
|
|
|
% Change
|
|
|
|
(In millions)
|
|
|
|
|
|
OPERATING REVENUES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
2,902
|
|
|
$
|
2,971
|
|
|
$
|
(69
|
)
|
|
|
(2.3
|
)%
|
Net investment income
|
|
|
180
|
|
|
|
186
|
|
|
|
(6
|
)
|
|
|
(3.2
|
)%
|
Other revenues
|
|
|
33
|
|
|
|
38
|
|
|
|
(5
|
)
|
|
|
(13.2
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
|
3,115
|
|
|
|
3,195
|
|
|
|
(80
|
)
|
|
|
(2.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and dividends
|
|
|
1,932
|
|
|
|
1,924
|
|
|
|
8
|
|
|
|
0.4
|
%
|
Capitalization of DAC
|
|
|
(435
|
)
|
|
|
(444
|
)
|
|
|
9
|
|
|
|
2.0
|
%
|
Amortization of DAC and VOBA
|
|
|
436
|
|
|
|
454
|
|
|
|
(18
|
)
|
|
|
(4.0
|
)%
|
Other expenses
|
|
|
764
|
|
|
|
794
|
|
|
|
(30
|
)
|
|
|
(3.8
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
2,697
|
|
|
|
2,728
|
|
|
|
(31
|
)
|
|
|
(1.1
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
96
|
|
|
|
104
|
|
|
|
(8
|
)
|
|
|
(7.7
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
322
|
|
|
$
|
363
|
|
|
$
|
(41
|
)
|
|
|
(11.3
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auto & Home was negatively impacted in 2009 by a
declining housing market, the deterioration of the new auto
sales market and the continuation of credit availability issues,
all of which contributed to a decrease in insured exposures in
2009. Average premiums per policy increased slightly for our
homeowners policies but decreased for auto policies,
primarily as a result of a business shift in insured exposures
by state. In particular, we experienced a large decrease in
earned exposures in Massachusetts, whose market was impacted by
a regulatory change, which resulted in a marked increase in
competition.
A return to more normal weather conditions in 2009 resulted in
fewer, and less severe, catastrophe events than in 2008. This
was more than offset by an increase in both non-catastrophe
claim frequencies and non-catastrophe claim severities in 2009.
Mixed claim experience and the impact of lower exposures were
the primary drivers of the $41 million decrease in
operating earnings. While we had a $90 million decrease in
catastrophe-related losses compared to the prior year, we also
recorded $68 million less of a benefit in 2009 from
favorable development of prior year non-catastrophe losses.
Current year claim costs rose primarily as a result of a
$29 million increase in claim frequency from both our auto
and homeowners products. In addition, we had a $15 million
net increase in claim severity, stemming from higher severity in
our auto line of business that was partially offset by lower
severity in our homeowners line of business. In 2009, we
experienced a decline in insured exposures, which contributed
approximately $16 million to the decrease in operating
earnings. While this decrease in exposures had a positive impact
on the amount of claims, it was more than offset by the negative
impact on premiums. The decrease in exposures is largely
attributable to slightly higher non-renewal rates, partially
offset by greater sales of new policies. Also contributing to
the decline in earnings was a decrease of $9 million in the
average premium per policy, which is primarily due to a shift in
earned exposures to lower average premium states and an increase
of $10 million in loss adjustment expenses, primarily
related to a decrease in unallocated loss adjusting expense
liabilities at the end of 2008.
The impact of the items discussed above can be seen in the
unfavorable change in the combined ratio, excluding
catastrophes, to 88.9% in 2009 from 83.1% in 2008 and the
unfavorable change in the combined ratio, including
catastrophes, to 92.3% in 2009 from 91.2% in 2008.
A $25 million decrease in other expenses, including the net
change in DAC, partially offset the declines in operating
earnings discussed above. This improvement resulted from
decreases in sales-related expenses and from minor fluctuations
in a number of expense categories, a portion of which is due to
our enterprise-wide cost reduction and revenue enhancement
initiative.
118
Also contributing to the decrease in operating earnings was a
decline in net investment income of $4 million which was
primarily due to a $9 million decrease from a decline in
average invested assets, partially offset by an increase of
$5 million due to improved yields.
International
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
2008
|
|
|
Change
|
|
|
% Change
|
|
|
|
(In millions)
|
|
|
|
|
|
OPERATING REVENUES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
3,187
|
|
|
$
|
3,470
|
|
|
$
|
(283
|
)
|
|
|
(8.2
|
)%
|
Universal life and investment-type product policy fees
|
|
|
1,061
|
|
|
|
1,095
|
|
|
|
(34
|
)
|
|
|
(3.1
|
)%
|
Net investment income
|
|
|
1,193
|
|
|
|
1,180
|
|
|
|
13
|
|
|
|
1.1
|
%
|
Other revenues
|
|
|
14
|
|
|
|
18
|
|
|
|
(4
|
)
|
|
|
(22.2
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
|
5,455
|
|
|
|
5,763
|
|
|
|
(308
|
)
|
|
|
(5.3
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and dividends
|
|
|
2,660
|
|
|
|
3,185
|
|
|
|
(525
|
)
|
|
|
(16.5
|
)%
|
Interest credited to policyholder account balances
|
|
|
581
|
|
|
|
171
|
|
|
|
410
|
|
|
|
239.8
|
%
|
Capitalization of DAC
|
|
|
(630
|
)
|
|
|
(798
|
)
|
|
|
168
|
|
|
|
21.1
|
%
|
Amortization of DAC and VOBA
|
|
|
415
|
|
|
|
381
|
|
|
|
34
|
|
|
|
8.9
|
%
|
Interest expense on debt
|
|
|
8
|
|
|
|
9
|
|
|
|
(1
|
)
|
|
|
(11.1
|
)%
|
Other expenses
|
|
|
1,797
|
|
|
|
2,079
|
|
|
|
(282
|
)
|
|
|
(13.6
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
4,831
|
|
|
|
5,027
|
|
|
|
(196
|
)
|
|
|
(3.9
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
161
|
|
|
|
257
|
|
|
|
(96
|
)
|
|
|
(37.4
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
463
|
|
|
$
|
479
|
|
|
$
|
(16
|
)
|
|
|
(3.3
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
An improvement in the global financial markets contributed to a
recovery of sales in the majority of our International regions
and resulted in improved investment performance in some regions
during the second half of 2009. Sales in Asia Pacific were down
primarily from a decrease in variable annuity sales in Japan,
primarily as a result of pricing actions we took during the
latter half of 2009. This decline was somewhat offset by growth
in South Koreas fixed annuities product and an increase of
variable universal life sales, which are indications that
markets are beginning to recover. We experienced growth in the
pension, group life, and medical businesses of our Latin America
region, specifically in Mexico. Our operations in Europe and the
Middle East continue to have strong growth in the European
variable annuity business.
The reduction in operating earnings includes the adverse impact
of changes in foreign currency exchange rates in 2009 as the
U.S. dollar strengthened against the various foreign
currencies. This decreased operating earnings by
$99 million in 2009 relative to 2008. Excluding the impact
of changes in foreign currency exchange rates, operating
earnings increased $83 million, or 22%, from the prior
year. This increase was primarily driven by higher operating
earnings of $184 million in our Asia Pacific region, while
operating earnings from our Latin America and Europe and Middle
East decreased by $83 million and $18 million,
respectively.
Asia Pacific. Improving financial market
conditions was the primary driver of the increase in operating
earnings. net investment income in the region increased by
$422 million due to an increase of $278 million from
improved yields on our investment portfolio, $111 million
from the change in results of operating joint ventures, and
$33 million from an increase in average invested assets.
The increase in yields was primarily due to higher income of
$277 million on the trading and other securities portfolio,
stemming from equity markets experiencing some recovery in 2009.
As our trading and other securities portfolio backs unit-linked
policyholder liabilities, this increase in income was entirely
offset by a corresponding increase in interest credited expense.
The income of the Japan joint venture improved by
$103 million due to favorable investment results and lower
amortization of DAC and VOBA. The decrease in DAC and VOBA
amortization was primarily due to an increase in the market
value of
119
the joint ventures separate account balances, which is
directly tied to the improving financial markets. A factor that
determines the amount of DAC and VOBA amortization is expected
future fees earned on separate account balances. Since the
market value of separate account balances have increased, it is
expected that future earnings on this block of business will be
higher than previously anticipated. As a result, the
amortization of DAC and VOBA was less in the current year.
Operating earnings in this region also benefited from higher
surrender charges of $16 million. Difficult economic
conditions in South Korea during the first half of the year
resulted in a higher level of surrenders. Growth in our Japan
reinsurance business and an increase in reinsurance rates
contributed $21 million to the increase in operating
earnings. In addition, the favorable impact of a reduction in
the liability for our variable annuity guarantees contributed
$22 million to operating earnings. The change in the
liability was primarily due to an increase in separate account
balances in the Japan joint venture. These liabilities are
accrued over the life of the contract in proportion to actual
and future expected policy assessments based on the level of
guaranteed minimum benefits generated using multiple scenarios
of separate account returns. The scenarios use best estimate
assumptions consistent with those used to amortize DAC. Because
separate account balances have had positive returns relative to
the prior year, current estimates of future benefits are lower
than that previously projected which resulted in a decrease in
this liability in the current period. Partially offsetting these
increases, higher DAC amortization of $49 million resulted
from business growth and favorable investment results.
Latin America. The decrease in operating
earnings was primarily driven by lower net investment income.
Net investment income decreased by $297 million due to a
decrease of $383 million from lower yields, partially
offset by an increase of $86 million due to an increase in
average invested assets. The decrease in yields was due, in
part, to the impact of changes in assumptions for measuring the
effects of inflation on certain inflation-indexed fixed maturity
securities. This decrease was partially offset by a reduction of
$221 million in the related insurance liability primarily
due to lower inflation. The increase in net investment income
attributable to an increase in average invested assets was
primarily due to business growth and, as such, was largely
offset by increases in policyholder benefits and interest
credited expense.
Higher claims experience in Mexico resulted in a
$45 million decline in operating earnings. The
nationalization and reform of the pension business in Argentina
impacted both years earnings, resulting in a net
$36 million decline in operating earnings. In addition,
operating earnings decreased due to a net income tax increase of
$8 million in Mexico, resulting from a change in assumption
regarding the repatriation of earnings, partially offset by the
favorable impact of a lower effective tax rate in 2009.
Partially offsetting these decreases in operating earnings was
the combination of growth in Mexicos individual and
institutional businesses and higher premium rates in its
institutional business, which increased operating earnings by
$51 million. Pesification in Argentina impacted both the
current year and prior year earnings, resulting in a net
$73 million increase in operating earnings. This benefit
was largely due to a reassessment of our approach in managing
existing and potential future claims related to certain social
security pension annuity contract holders in Argentina resulting
in a liability release. Lower expenses of $8 million
resulted primarily from the impact of operational efficiencies
achieved through our enterprise-wide cost reduction and revenue
enhancement initiative.
Europe and Middle East. The impact of foreign
currency transaction gains and a tax benefit, both of which
occurred in the prior year, contributed $12 million to the
decline in operating earnings. Our investment of $9 million
in our distribution capability and growth initiatives in 2009
also reduced operating earnings. There was an increase in net
investment income of $76 million, which was due to an
increase of $65 million from an improvement in yields and
$11 million from an increase in average invested assets.
The increase in yields was primarily due to favorable results on
the trading and other securities portfolio, stemming from the
equity markets experiencing some recovery in 2009. As our
trading and other securities portfolio backs unit-linked
policyholder liabilities, the trading and other securities
portfolio results were entirely offset by a corresponding
increase in interest credited expense. The increase in net
investment income attributable to an increase in average
invested assets was primarily due to business growth and was
largely offset by increases in policyholder benefits and
interest credited expense, also due to business growth.
120
Banking,
Corporate & Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
2008
|
|
|
Change
|
|
|
% Change
|
|
|
|
(In millions)
|
|
|
|
|
|
OPERATING REVENUES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
19
|
|
|
$
|
27
|
|
|
$
|
(8
|
)
|
|
|
(29.6
|
)%
|
Net investment income
|
|
|
477
|
|
|
|
808
|
|
|
|
(331
|
)
|
|
|
(41.0
|
)%
|
Other revenues
|
|
|
1,092
|
|
|
|
184
|
|
|
|
908
|
|
|
|
493.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues
|
|
|
1,588
|
|
|
|
1,019
|
|
|
|
569
|
|
|
|
55.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and dividends
|
|
|
4
|
|
|
|
46
|
|
|
|
(42
|
)
|
|
|
(91.3
|
)%
|
Interest credited to policyholder account balances
|
|
|
|
|
|
|
7
|
|
|
|
(7
|
)
|
|
|
(100.0
|
)%
|
Interest credited to bank deposits
|
|
|
163
|
|
|
|
166
|
|
|
|
(3
|
)
|
|
|
(1.8
|
)%
|
Capitalization of DAC
|
|
|
|
|
|
|
(3
|
)
|
|
|
3
|
|
|
|
100.0
|
%
|
Amortization of DAC and VOBA
|
|
|
3
|
|
|
|
5
|
|
|
|
(2
|
)
|
|
|
(40.0
|
)%
|
Interest expense on debt
|
|
|
1,027
|
|
|
|
1,033
|
|
|
|
(6
|
)
|
|
|
(0.6
|
)%
|
Other expenses
|
|
|
1,336
|
|
|
|
699
|
|
|
|
637
|
|
|
|
91.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
2,533
|
|
|
|
1,953
|
|
|
|
580
|
|
|
|
29.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
(617
|
)
|
|
|
(495
|
)
|
|
|
(122
|
)
|
|
|
(24.6
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
|
(328
|
)
|
|
|
(439
|
)
|
|
|
111
|
|
|
|
25.3
|
%
|
Less: Preferred stock dividends
|
|
|
122
|
|
|
|
125
|
|
|
|
(3
|
)
|
|
|
(2.4
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings available to common shareholders
|
|
$
|
(450
|
)
|
|
$
|
(564
|
)
|
|
$
|
114
|
|
|
|
20.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Banking, Corporate & Other recognized the full year
impact of our forward and reverse residential mortgage platform
acquisitions, a strong residential mortgage refinance market,
healthy growth in the reverse mortgage arena, and a favorable
interest spread environment. Our forward and reverse residential
mortgage production of $37.4 billion in 2009 was up 484%
compared to 2008 production. The increase in mortgage production
drove higher investments in residential mortgage loans
held-for-sale
and MSRs. At December 31, 2009, our residential mortgage
loans servicing portfolio was $64.1 billion comprised of
agency (FNMA, FHLMC, and GNMA) portfolios. Transaction and time
deposits, which provide a relatively stable source of funding
and liquidity and are used to fund loans and fixed income
securities purchases, grew 48% in 2009 to $10.2 billion.
Borrowings decreased 10% in 2009 to $2.4 billion. During
2009, we participated in the Federal Reserve Bank of New York
Term Auction Facility, which provided short term liquidity with
low funding costs.
In response to the economic crisis and unusual financial market
events that occurred in 2008 and continued into 2009, we decided
to utilize excess debt capacity. The Holding Company completed
three debt issuances in 2009. The Holding Company issued
$397 million of floating rate senior notes in March 2009,
$1.3 billion of senior notes in May 2009, and
$500 million of junior subordinated debt securities in July
2009. In February 2009, in connection with the initial
settlement of the stock purchase contracts issued as part of the
common equity units sold in June 2005, the Holding Company
issued common stock for $1.0 billion. The proceeds from
these equity and debt issuances were used for general corporate
purposes and have resulted in increased investments and cash and
cash equivalents held within Banking, Corporate &
Other.
Operating earnings available to common shareholders improved by
$114 million, of which $254 million was due to MetLife
Bank and its acquisitions of a residential mortgage origination
and servicing business and a reverse mortgage business, both
during 2008. Excluding the impact of MetLife Bank, our operating
earnings available to common shareholders decreased
$140 million, primarily due to lower net investment income,
partially offset by the impact of a lower effective tax rate.
The lower effective tax rate provided an increased benefit of
$139 million from the prior year. This benefit was the
result of a partial settlement of certain prior year tax audit
issues and increased utilization of tax preferenced investments,
which provide tax credits and deductions.
121
Excluding a $68 million increase from MetLife Bank, net
investment income decreased $283 million, which was
primarily due a decrease of $287 million due to lower
yields, partially offset by an increase of $4 million due
to an increase in average invested assets. Consistent with the
consolidated results of operations discussion above, yields were
adversely impacted by the severe downturn in the global
financial markets, which primarily impacted fixed maturity
securities and real estate joint ventures. The increased average
invested asset base was due to cash flows from debt issuances
during 2009. Our investments primarily include structured
finance securities, investment grade corporate fixed maturity
securities, U.S. Treasury, agency and government guaranteed
fixed maturity securities and mortgage loans. In addition, our
investment portfolio includes the excess capital not allocated
to the segments. Accordingly, it includes a higher allocation of
certain other invested asset classes to provide additional
diversification and opportunity for long-term yield enhancement
including leveraged leases, other limited partnership interests,
real estate, real estate joint ventures and equity securities.
After excluding the impact of a $394 million increase from
MetLife Bank, other expenses increased by $20 million.
Deferred compensation costs, which are tied to equity market
performance, were higher due to a significant market rebound. We
also had an increase in costs associated with the implementation
of our enterprise-wide cost reduction and revenue enhancement
initiative. These increases were partially offset by lower
postemployment related costs and corporate-related expenses,
specifically legal costs. Legal costs were lower largely due to
the prior year commutation of asbestos policies. In addition,
interest expense declined slightly as a result of rate
reductions on variable rate collateral financing arrangements
offset by debt issuances in 2009 and 2008.
Effects
of Inflation
The Company does not believe that inflation has had a material
effect on its consolidated results of operations, except insofar
as inflation may affect interest rates.
Inflation in the U.S. has remained contained and been in a
general downward trend for an extended period. However, in light
of recent and ongoing aggressive fiscal and monetary stimulus
measures by the U.S. federal government and foreign
governments, it is possible that inflation could increase in the
future. Globally, inflation trends can vary by region and
between developed and emerging markets. The Japanese economy, to
which we face increased exposure as a result of the Acquisition,
continues to experience low nominal growth and a deflationary
environment. As the global economy improves, inflation trends
are increasing in other regions, particularly in emerging
markets like China and India. In the more developed Eurozone
countries, inflation rates, while not as high, have trended
upward at a greater pace than in the U.S.
An increase in inflation could affect our business in several
ways. During inflationary periods, the value of fixed income
investments falls which could increase realized and unrealized
losses. Inflation also increases expenses for labor and other
materials, potentially putting pressure on profitability if such
costs can not be passed through in our product prices. Inflation
could also lead to increased costs for losses and loss
adjustment expenses in certain of our businesses, which could
require us to adjust our pricing to reflect our expectations for
future inflation. Prolonged and elevated inflation could
adversely affect the financial markets and the economy
generally, and dispelling it may require governments to pursue a
restrictive fiscal and monetary policy, which could constrain
overall economic activity, inhibit revenue growth and reduce the
number of attractive investment opportunities.
Investments
Investment Risks. The Companys primary
investment objective is to optimize, net of income tax,
risk-adjusted investment income and risk-adjusted total return
while ensuring that assets and liabilities are managed on a cash
flow and duration basis. The Company is exposed to four primary
sources of investment risk:
|
|
|
|
|
credit risk, relating to the uncertainty associated with the
continued ability of a given obligor to make timely payments of
principal and interest;
|
|
|
|
interest rate risk, relating to the market price and cash flow
variability associated with changes in market interest rates;
|
122
|
|
|
|
|
liquidity risk, relating to the diminished ability to sell
certain investments in times of strained market
conditions; and
|
|
|
|
market valuation risk, relating to the variability in the
estimated fair value of investments associated with changes in
market factors such as credit spreads.
|
The Company manages risk through in-house fundamental analysis
of the underlying obligors, issuers, transaction structures and
real estate properties. The Company also manages credit risk,
market valuation risk and liquidity risk through industry and
issuer diversification and asset allocation. For real estate and
agricultural assets, the Company manages credit risk and market
valuation risk through geographic, property type and product
type diversification and asset allocation. The Company manages
interest rate risk as part of its asset and liability management
strategies; product design, such as the use of market value
adjustment features and surrender charges; and proactive
monitoring and management of certain non-guaranteed elements of
its products, such as the resetting of credited interest and
dividend rates for policies that permit such adjustments. The
Company also uses certain derivative instruments in the
management of credit, interest rate, currency and equity market
risks.
Current Environment. The global economy and
markets are now recovering from a period of significant stress
that began in the second half of 2007 and substantially
increased through the first quarter of 2009. This disruption
adversely affected the financial services industry, in
particular. The U.S. economy entered a recession in late
2007. This recession ended in mid-2009, but the recovery from
the recession has been below historic averages and the
unemployment rate is expected to remain high for some time. In
addition, inflation has fallen over the last several years and
is expected to remain at low levels for some time. Some
economists believe that some level of disinflation and deflation
risk remains in the U.S. economy.
Although the disruption in the global financial markets has
moderated, not all such markets are functioning normally, and
some remain reliant upon government intervention and liquidity.
The global recession and disruption of the financial markets has
also led to concerns over capital markets access and the
solvency of certain European Union member states, including
Portugal, Ireland, Italy, Greece and Spain. The Japanese
economy, to which we face increased exposure to as a result of
the Acquisition, continues to experience low nominal growth, a
deflationary environment, and weak consumer spending. See
Industry Trends. See also
Investments Fixed Maturity and Equity
Securities
Available-for-Sale
Concentrations of Credit Risk (Fixed Maturity
Securities) Summary in Note 3 of the
Notes to Consolidated Financial Statements for information about
exposure to sovereign fixed maturity securities of Portugal,
Ireland, Italy, Greece and Spain.
During the year ended December 31, 2010, the net unrealized
loss position on fixed maturity and equity securities improved
from a net unrealized loss of $2.2 billion at
December 31, 2009 to a net unrealized gain of
$7.3 billion at December 31, 2010, as a result of a
decrease in interest rates, and to a lesser extent, a decrease
in credit spreads.
Investment Outlook. Recovering private equity
markets and stabilizing credit and real estate markets during
2010 had a positive impact on returns and net investment income
on private equity funds, hedge funds and real estate funds,
which are included within other limited partnership interests
and real estate and real estate joint venture portfolios.
Although the disruption in the global financial markets has
moderated, if there is a resumption of significant disruption,
it could adversely impact returns and net investment income on
these alternative investment classes. Net cash flows arising
from our business and our investment portfolio will be
reinvested in a prudent manner and according to our ALM
discipline in appropriate assets over time. We will maintain a
sufficient level of liquidity to meet business needs. Net
investment income may be adversely affected if excess liquidity
is required over an extended period of time to meet changing
business needs.
123
Composition
of Investment Portfolio and Investment Portfolio
Results
The following yield table presents the investment income,
investment portfolio gains (losses), annualized yields on
average ending assets and ending carrying value for each of the
asset classes within the Companys investment portfolio, as
well as investment income and investment portfolio gains
(losses) for the investment portfolio as a whole. The yield
table also presents gains (losses) on derivative instruments
which are used to manage risk for certain invested assets and
certain insurance liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At and for the Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Fixed Maturity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Yield (1)
|
|
|
5.53
|
%
|
|
|
5.77
|
%
|
|
|
6.40
|
%
|
Investment income (2), (3), (4)
|
|
$
|
12,650
|
|
|
$
|
11,899
|
|
|
$
|
12,403
|
|
Investment gains (losses) (3)
|
|
$
|
(255
|
)
|
|
$
|
(1,663
|
)
|
|
$
|
(1,953
|
)
|
Ending carrying value (2), (3)
|
|
$
|
327,878
|
|
|
$
|
230,026
|
|
|
$
|
189,197
|
|
Mortgage Loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
Yield (1)
|
|
|
5.51
|
%
|
|
|
5.38
|
%
|
|
|
6.08
|
%
|
Investment income (3), (4)
|
|
$
|
2,823
|
|
|
$
|
2,735
|
|
|
$
|
2,774
|
|
Investment gains (losses) (3)
|
|
$
|
22
|
|
|
$
|
(442
|
)
|
|
$
|
(136
|
)
|
Ending carrying value (3)
|
|
$
|
55,536
|
|
|
$
|
50,909
|
|
|
$
|
51,364
|
|
Real Estate and Real Estate Joint Ventures:
|
|
|
|
|
|
|
|
|
|
|
|
|
Yield (1)
|
|
|
1.10
|
%
|
|
|
(7.47
|
)%
|
|
|
2.98
|
%
|
Investment income
|
|
$
|
77
|
|
|
$
|
(541
|
)
|
|
$
|
217
|
|
Investment gains (losses)
|
|
$
|
(40
|
)
|
|
$
|
(156
|
)
|
|
$
|
(9
|
)
|
Ending carrying value
|
|
$
|
8,030
|
|
|
$
|
6,896
|
|
|
$
|
7,586
|
|
Policy Loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
Yield (1)
|
|
|
6.37
|
%
|
|
|
6.54
|
%
|
|
|
6.22
|
%
|
Investment income
|
|
$
|
657
|
|
|
$
|
648
|
|
|
$
|
601
|
|
Ending carrying value
|
|
$
|
11,914
|
|
|
$
|
10,061
|
|
|
$
|
9,802
|
|
Equity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Yield (1)
|
|
|
4.39
|
%
|
|
|
5.12
|
%
|
|
|
5.25
|
%
|
Investment income
|
|
$
|
128
|
|
|
$
|
175
|
|
|
$
|
249
|
|
Investment gains (losses)
|
|
$
|
104
|
|
|
$
|
(399
|
)
|
|
$
|
(253
|
)
|
Ending carrying value
|
|
$
|
3,606
|
|
|
$
|
3,084
|
|
|
$
|
3,197
|
|
Other Limited Partnership Interests:
|
|
|
|
|
|
|
|
|
|
|
|
|
Yield (1)
|
|
|
14.99
|
%
|
|
|
3.22
|
%
|
|
|
(2.77
|
)%
|
Investment income
|
|
$
|
879
|
|
|
$
|
173
|
|
|
$
|
(170
|
)
|
Investment gains (losses)
|
|
$
|
(18
|
)
|
|
$
|
(356
|
)
|
|
$
|
(140
|
)
|
Ending carrying value
|
|
$
|
6,416
|
|
|
$
|
5,508
|
|
|
$
|
6,039
|
|
Cash and Short-Term Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Yield (1)
|
|
|
0.46
|
%
|
|
|
0.44
|
%
|
|
|
1.62
|
%
|
Investment income
|
|
$
|
81
|
|
|
$
|
94
|
|
|
$
|
307
|
|
Investment gains (losses)
|
|
$
|
2
|
|
|
$
|
6
|
|
|
$
|
3
|
|
Ending carrying value (3)
|
|
$
|
22,394
|
|
|
$
|
18,486
|
|
|
$
|
38,085
|
|
Other Invested Assets: (5)
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment income
|
|
$
|
491
|
|
|
$
|
339
|
|
|
$
|
279
|
|
Investment gains (losses)
|
|
$
|
(8
|
)
|
|
$
|
(32
|
)
|
|
$
|
313
|
|
Ending carrying value
|
|
$
|
15,430
|
|
|
$
|
12,709
|
|
|
$
|
17,248
|
|
Total Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross investment income yield (1)
|
|
|
5.29
|
%
|
|
|
4.90
|
%
|
|
|
5.68
|
%
|
Investment fees and expenses yield
|
|
|
(0.14
|
)
|
|
|
(0.14
|
)
|
|
|
(0.16
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Income Yield (3)
|
|
|
5.15
|
%
|
|
|
4.76
|
%
|
|
|
5.52
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross investment income
|
|
$
|
17,786
|
|
|
$
|
15,522
|
|
|
$
|
16,660
|
|
Investment fees and expenses
|
|
|
(465
|
)
|
|
|
(433
|
)
|
|
|
(460
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Income (3), (6)
|
|
$
|
17,321
|
|
|
$
|
15,089
|
|
|
$
|
16,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending Carrying Value (3)
|
|
$
|
451,204
|
|
|
$
|
337,679
|
|
|
$
|
322,518
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross investment gains (3)
|
|
$
|
1,200
|
|
|
$
|
1,232
|
|
|
$
|
1,802
|
|
Gross investment losses (3)
|
|
|
(848
|
)
|
|
|
(1,429
|
)
|
|
|
(1,935
|
)
|
Writedowns
|
|
|
(545
|
)
|
|
|
(2,845
|
)
|
|
|
(2,042
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Portfolio Gains (Losses) (3), (6)
|
|
$
|
(193
|
)
|
|
$
|
(3,042
|
)
|
|
$
|
(2,175
|
)
|
Investment portfolio gains (losses) income tax (expense) benefit
|
|
|
53
|
|
|
|
1,121
|
|
|
|
795
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Portfolio Gains (Losses), Net of Income Tax
|
|
$
|
(140
|
)
|
|
$
|
(1,921
|
)
|
|
$
|
(1,380
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Gains (Losses) (6)
|
|
$
|
(614
|
)
|
|
$
|
(5,106
|
)
|
|
$
|
3,782
|
|
Derivative gains (losses) income tax (expense) benefit
|
|
$
|
160
|
|
|
$
|
1,803
|
|
|
$
|
(1,438
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Gains (Losses), Net of Income Tax
|
|
$
|
(454
|
)
|
|
$
|
(3,303
|
)
|
|
$
|
2,344
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
|
|
|
As described in the footnotes below, the yield table reflects
certain differences from the presentation of invested assets,
net investment income, net investment gains (losses) and net
derivative gains (losses) as presented in the consolidated
balance sheets and consolidated statements of operations,
including the exclusion of contractholder-directed unit-linked
investments classified within trading and other securities, as
the contractholder, not the Company, directs the investment of
the funds; and the exclusion of the effects of consolidating
under GAAP certain VIEs that are consolidated securitization
entities (CSEs). We believe this yield table
presentation is consistent with how we measure our investment
performance for management purposes enhances understanding. |
|
|
|
|
(1)
|
Yields are based on average of quarterly average asset carrying
values, excluding recognized and unrealized investment gains
(losses), collateral received from counterparties associated
with our securities lending program, the effects of
consolidating under GAAP certain VIEs that are treated as CSEs
and, effective October 1, 2010, contractholder-directed
unit-linked investments. Yields also exclude investment income
recognized on mortgage loans and securities held by CSEs and,
effective October 1, 2010, contractholder-directed
unit-linked investments.
|
|
|
(2)
|
Fixed maturity securities include $594 million,
$2,384 million and $946 million at estimated fair
value of trading and other securities at December 31, 2010,
2009 and 2008, respectively. Fixed maturity securities include
$234 million, $400 million and ($193) million of
investment income related to trading and other securities for
the years ended December 31, 2010, 2009 and 2008,
respectively.
|
|
|
(3)
|
(a) Fixed maturity securities ending carrying values as
presented herein, exclude (i) contractholder-directed
unit-linked investments reported within trading and
other securities of $17,794 million, and
(ii) securities held by CSEs that are consolidated under
GAAP reported within trading and other securities of
$201 million at December 31, 2010. Net investment
income as presented herein, excludes investment income on
contractholder-directed unit-linked investments
reported within trading and other securities effective
October 1, 2010 as shown in footnote (6) to this yield
table.
|
|
|
|
|
|
(b) Ending carrying values, investment income and
investment gains (losses) as presented herein, exclude the
effects of consolidating under GAAP certain VIEs that are
treated as CSEs. The adjustment to investment income and
investment gains (losses) in the aggregate are as shown in
footnote (6) to this yield table. The adjustments to ending
carrying value, investment income and investment gains (losses)
by invested asset class are presented below. Both the invested
assets and long-term debt of the CSEs are accounted for under
the FVO. The adjustment to investment gains (losses) presented
below and in footnote (6) to this yield table includes the
effects of remeasuring both the invested assets and long-term
debt in accordance with the FVO.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At or for the Year Ended December 31, 2010
|
|
|
|
|
Impact of Excluding
|
|
Total With all
|
|
|
As Reported in the
|
|
Trading and Other
|
|
Trading and Other
|
|
|
Yield Table
|
|
Securities and CSEs
|
|
Securities and CSEs
|
|
|
(In millions)
|
|
Trading and Other Securities (included within Fixed Maturity
Securities):
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending carrying value
|
|
$
|
594
|
|
|
$
|
17,995
|
|
|
$
|
18,589
|
|
Investment income
|
|
$
|
234
|
|
|
$
|
226
|
|
|
$
|
460
|
|
Investment gains (losses)
|
|
$
|
|
|
|
$
|
(30
|
)
|
|
$
|
(30
|
)
|
Mortgage Loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending carrying value
|
|
$
|
55,536
|
|
|
$
|
6,840
|
|
|
$
|
62,376
|
|
Investment income
|
|
$
|
2,823
|
|
|
$
|
396
|
|
|
$
|
3,219
|
|
Investment gains (losses)
|
|
$
|
22
|
|
|
$
|
36
|
|
|
$
|
58
|
|
Cash and Short-Term Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending carrying value
|
|
$
|
22,394
|
|
|
$
|
39
|
|
|
$
|
22,433
|
|
Total Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending carrying value
|
|
$
|
451,204
|
|
|
$
|
24,874
|
|
|
$
|
476,078
|
|
125
|
|
|
|
(4)
|
Investment income from fixed maturity securities and mortgage
loans includes prepayment fees.
|
|
|
(5)
|
Other invested assets are principally comprised of freestanding
derivatives with positive estimated fair values and leveraged
leases. Freestanding derivatives with negative estimated fair
values are included within other liabilities. However, the
accruals of settlement payments in other liabilities are
included in net investment income as shown in Note 4 of the
Notes to the Consolidated Financial Statements. As yield is not
considered a meaningful measure of performance for other
invested assets, it has been excluded from the yield table.
|
|
|
(6)
|
Investment income, investment portfolio gains (losses) and
derivative gains (losses) presented in this yield table vary
from the most directly comparable measures presented in the GAAP
consolidated statements of operations due to certain
reclassifications affecting net investment income, net
investment gains (losses), net derivative gains (losses), and
interest credited to PABs and to exclude the effects of
consolidating under GAAP certain VIEs that are treated as CSEs.
Such reclassifications are presented in the tables below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Investment income in the above yield table
|
|
$
|
17,321
|
|
|
$
|
15,089
|
|
|
$
|
16,200
|
|
Real estate discontinued operations deduct from net
investment income
|
|
|
10
|
|
|
|
(8
|
)
|
|
|
(11
|
)
|
Scheduled periodic settlement payments on derivatives not
qualifying for hedge accounting deduct from net
investment income, add to net derivative gains (losses)
|
|
|
(208
|
)
|
|
|
(88
|
)
|
|
|
(5
|
)
|
Equity method operating joint ventures add to net
investment income, deduct from net derivative gains (losses)
|
|
|
(130
|
)
|
|
|
(156
|
)
|
|
|
105
|
|
Net investment income on contractholder-directed unit-linked
investments reported within trading and other
securities add to net investment income
|
|
|
211
|
|
|
|
|
|
|
|
|
|
Incremental net investment income from CSEs add to
net investment income
|
|
|
411
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income GAAP consolidated statements
of operations
|
|
$
|
17,615
|
|
|
$
|
14,837
|
|
|
$
|
16,289
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment portfolio gains (losses) in the above
yield table
|
|
$
|
(193
|
)
|
|
$
|
(3,042
|
)
|
|
$
|
(2,175
|
)
|
Real estate discontinued operations deduct from net
investment gains (losses)
|
|
|
(14
|
)
|
|
|
(8
|
)
|
|
|
(8
|
)
|
Investment gains (losses) related to CSEs add to net
investment gains (losses)
|
|
|
6
|
|
|
|
|
|
|
|
|
|
Purchased credit default swaps that offset losses incurred on
certain fixed maturity securities deduct from net
investment gains (losses)
|
|
|
|
|
|
|
|
|
|
|
(183
|
)
|
Other gains (losses) add to net investment gains
(losses)
|
|
|
(191
|
)
|
|
|
144
|
|
|
|
268
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment gains (losses) GAAP consolidated
statements of operations
|
|
$
|
(392
|
)
|
|
$
|
(2,906
|
)
|
|
$
|
(2,098
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative gains (losses) in the above yield table
|
|
$
|
(614
|
)
|
|
$
|
(5,106
|
)
|
|
$
|
3,782
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Scheduled periodic settlement payments on derivatives not
qualifying for hedge accounting add to net
derivative gains (losses), deduct from net investment income
|
|
|
208
|
|
|
|
88
|
|
|
|
5
|
|
Scheduled periodic settlement payments on derivatives not
qualifying for hedge accounting add to net
derivative gains (losses), deduct from interest credited to PABs
|
|
|
11
|
|
|
|
(4
|
)
|
|
|
45
|
|
Purchased credit default swaps that offset losses incurred on
certain fixed maturity securities add to net
derivative gains (losses)
|
|
|
|
|
|
|
|
|
|
|
183
|
|
Equity method operating joint ventures add to net
investment income, deduct from net derivative gains (losses)
|
|
|
130
|
|
|
|
156
|
|
|
|
(105
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net derivative gains (losses) GAAP consolidated
statements of operations
|
|
$
|
(265
|
)
|
|
$
|
(4,866
|
)
|
|
$
|
3,910
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
126
See Results of Operations Year
Ended December 31, 2010 compared with the Year Ended
December 31, 2009 and Year Ended December 31, 2009
compared with the Year Ended December 31, 2008, for
an analysis of the year over year changes in net investment
income and net investment gains (losses) and net derivative
gains (losses).
Fixed
Maturity and Equity Securities
Available-for-Sale
Fixed maturity securities, which consisted principally of
publicly-traded and privately placed fixed maturity securities,
were $327.3 billion and $227.6 billion, or 69% and 67%
of total cash and invested assets at estimated fair value, at
December 31, 2010 and 2009, respectively. Publicly-traded
fixed maturity securities represented $286.5 billion and
$191.4 billion, or 88% and 84% of total fixed maturity
securities at estimated fair value, at December 31, 2010
and 2009, respectively. Privately placed fixed maturity
securities represented $40.8 billion and
$36.2 billion, or 12% and 16% of total fixed maturity
securities at estimated fair value, at December 31, 2010
and 2009, respectively.
Equity securities, which consisted principally of
publicly-traded and privately-held common and preferred stocks,
including certain perpetual hybrid securities and mutual fund
interests, were $3.6 billion and $3.1 billion, or 0.8%
and 0.9% of total cash and invested assets at estimated fair
value, at December 31, 2010 and 2009, respectively.
Publicly-traded equity securities represented $2.3 billion
and $2.1 billion, or 64% and 68% of total equity securities
at estimated fair value, at December 31, 2010 and 2009,
respectively. Privately-held equity securities represented
$1.3 billion and $1.0 billion, or 36% and 32% of total
equity securities at estimated fair value, at December 31,
2010 and 2009, respectively.
Valuation of Securities. We are responsible
for the determination of estimated fair value. The estimated
fair value of publicly-traded fixed maturity, equity and trading
and other securities, as well as short-term securities is
determined by management after considering one of three primary
sources of information: quoted market prices in active markets,
independent pricing services, or independent broker quotations.
The number of quotes obtained varies by instrument and depends
on the liquidity of the particular instrument. Generally, we
obtain prices from multiple pricing services to cover all asset
classes and obtain multiple prices for certain securities, but
ultimately utilize the price with the highest placement in the
fair value hierarchy. Independent pricing services that value
these instruments use market standard valuation methodologies
based on inputs that are market observable or can be derived
principally from or corroborated by observable market data. Such
observable inputs include benchmarking prices for similar assets
in active, liquid markets, quoted prices in markets that are not
active and observable yields and spreads in the market. The
market standard valuation methodologies utilized include:
discounted cash flow methodologies, matrix pricing or similar
techniques. The assumptions and inputs in applying these market
standard valuation methodologies include, but are not limited
to, interest rates, credit standing of the issuer or
counterparty, industry sector of the issuer, coupon rate, call
provisions, sinking fund requirements, maturity, estimated
duration, and managements assumptions regarding liquidity
and estimated future cash flows. When a price is not available
in the active market or through an independent pricing service,
management will value the security primarily using independent
non-binding broker quotations. Independent non-binding broker
quotations utilize inputs that are not market observable or
cannot be derived principally from or corroborated by observable
market data.
Senior management, independent of the trading and investing
functions, is responsible for the oversight of control systems
and valuation policies, including reviewing and approving new
transaction types and markets, for ensuring that observable
market prices and market-based parameters are used for
valuation, wherever possible, and for determining that
judgmental valuation adjustments, if any, are based upon
established policies and are applied consistently over time. We
review our valuation methodologies on an ongoing basis and
ensure that any changes to valuation methodologies are
justified. We gain assurance on the overall reasonableness and
consistent application of input assumptions, valuation
methodologies and compliance with accounting standards for fair
value determination through various controls designed to ensure
that the financial assets and financial liabilities are
appropriately valued and represent an exit price. The control
systems and procedures include, but are not limited to, analysis
of portfolio returns to corresponding benchmark returns,
comparing a sample of executed prices of securities sold to the
fair value estimates, comparing fair value estimates to
managements knowledge of the current market, reviewing the
bid/ask spreads to assess activity and ongoing confirmation that
independent pricing services use, wherever possible,
market-based parameters for valuation. We determine the
observability of inputs used in
127
estimated fair values received from independent pricing services
or brokers by assessing whether these inputs can be corroborated
by observable market data. The Company also follows a formal
process to challenge any prices received from independent
pricing services that are not considered representative of
estimated fair value. If we conclude that prices received from
independent pricing services are not reflective of market
activity or representative of estimated fair value, we will seek
independent non-binding broker quotes or use an internally
developed valuation to override these prices. Such overrides are
classified as Level 3. Despite the credit events prevalent
since the second half of 2007 described above, including market
dislocation, volatility in valuation of certain investments, and
reduced levels of liquidity, which has since moderated but is
still present in certain portions of the global financial
markets and in certain asset sectors, our internally developed
valuations of current estimated fair value, which reflect our
estimates of liquidity and non-performance risks, compared with
pricing received from the independent pricing services, did not
produce material differences for the vast majority of our fixed
maturity securities portfolio. Our estimates of liquidity and
non-performance risks are generally based on available market
evidence and on what other market participants would use. In the
absence of such evidence, managements best estimate is
used. As a result, we generally continued to use the price
provided by the independent pricing service under our normal
pricing protocol and pricing overrides were not material. The
Company uses the results of this analysis for classifying the
estimated fair value of these instruments in Level 1, 2 or
3. For example, we will review the estimated fair values
received to determine whether corroborating evidence (i.e.,
similar observable positions and actual trades) will support a
Level 2 classification in the fair value hierarchy.
Security prices which cannot be corroborated due to relatively
less pricing transparency and diminished liquidity will be
classified as Level 3. Even some of our very high quality
invested assets have been more illiquid for periods of time as a
result of the market conditions described above.
For privately placed fixed maturity securities, the Company
determines the estimated fair value generally through matrix
pricing, discounted cash flow techniques or from independent
pricing services after assessing that the observability of
inputs used can be corroborated with observable market data. The
discounted cash flow valuations rely upon the estimated future
cash flows of the security, credit spreads of comparable public
securities and secondary transactions, as well as taking into
account, among other factors, the credit quality of the issuer
and the reduced liquidity associated with privately placed debt
securities.
The Company has reviewed the significance and observability of
inputs used in the valuation methodologies to determine the
appropriate fair value hierarchy level for each of its
securities. Based on the results of this review and investment
class analyses, each instrument is categorized as Level 1,
2 or 3 based on the priority of the inputs to the respective
valuation methodologies. Certain U.S. Treasury, agency and
government guaranteed fixed maturity securities, certain foreign
government fixed maturity securities, residential
mortgage-backed securities (RMBS), principally
to-be-announced securities, exchange-traded common stock and
mutual fund interests, registered mutual fund interests priced
using daily net asset value provided by fund managers included
within trading and other securities, certain other securities
classified as trading and other securities which are similar to
the above described fixed maturity and equity securities and
certain short-term money market securities, including
U.S. Treasury bills, have been classified into Level 1
because of high volumes of trading activity and narrow bid/ask
spreads. Most securities valued by independent pricing services
have been classified into Level 2 because the significant
inputs used in pricing these securities are market observable or
can be corroborated using market observable information. Most
investment grade privately placed fixed maturity securities and
certain below investment grade privately placed fixed maturity
securities priced by independent pricing services that use
observable inputs have been classified within Level 2.
Distressed privately placed fixed maturity securities have been
classified within Level 3. Below investment grade privately
placed fixed maturity securities and less liquid securities with
very limited trading activity where estimated fair values are
determined by independent pricing services or by independent
non-binding broker quotations that use unobservable inputs or
cannot be derived principally from or corroborated by observable
market data, are classified as Level 3. Use of independent
non-binding broker quotations generally indicates there is a
lack of liquidity or the general lack of transparency in the
process to develop these price estimates causing them to be
considered Level 3.
Effective April 1, 2009, the Company adopted accounting
guidance that clarified existing guidance regarding
(1) estimating the estimated fair value of an asset or
liability if there was a significant decrease in the volume and
level of trading activity for these assets or liabilities and
(2) identifying transactions that are not orderly. The
128
Companys valuation policies as described above and in
Summary of Critical Accounting
Estimates Estimated Fair Values of Investments
already incorporated the key concepts from this additional
guidance, accordingly, this guidance results in no material
changes in our valuation policies. At April 1, 2009 and at
each subsequent quarterly period in 2009 and 2010, we evaluated
the markets that our fixed maturity and equity securities trade
in and in our judgment, despite the increased illiquidity
discussed above, believe none of these fixed maturity and equity
securities trading markets should be characterized as distressed
and disorderly. We will continue to re-evaluate and monitor such
fixed maturity and equity securities trading markets on an
ongoing basis.
Fair Value Hierarchy. Fixed maturity
securities and equity securities
available-for-sale
measured at estimated fair value on a recurring basis and their
corresponding fair value pricing sources and fair value
hierarchy are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
Fixed Maturity
|
|
|
Equity
|
|
|
|
Securities
|
|
|
Securities
|
|
|
|
(In millions)
|
|
|
Level 1:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted prices in active markets for identical assets
|
|
$
|
15,025
|
|
|
|
4.6
|
%
|
|
$
|
832
|
|
|
|
23.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 2:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Independent pricing source
|
|
|
257,625
|
|
|
|
78.7
|
|
|
|
616
|
|
|
|
17.1
|
|
Internal matrix pricing or discounted cash flow techniques
|
|
|
31,839
|
|
|
|
9.8
|
|
|
|
985
|
|
|
|
27.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Significant other observable inputs
|
|
|
289,464
|
|
|
|
88.5
|
|
|
|
1,601
|
|
|
|
44.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 3:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Independent pricing source
|
|
|
10,481
|
|
|
|
3.2
|
|
|
|
1,011
|
|
|
|
28.0
|
|
Internal matrix pricing or discounted cash flow techniques
|
|
|
9,872
|
|
|
|
3.0
|
|
|
|
149
|
|
|
|
4.1
|
|
Independent broker quotations
|
|
|
2,442
|
|
|
|
0.7
|
|
|
|
13
|
|
|
|
0.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Significant unobservable inputs
|
|
|
22,795
|
|
|
|
6.9
|
|
|
|
1,173
|
|
|
|
32.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total estimated fair value
|
|
$
|
327,284
|
|
|
|
100.0
|
%
|
|
$
|
3,606
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
129
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
Fair Value Measurements Using
|
|
|
|
Quoted Prices
|
|
|
Significant
|
|
|
|
|
|
|
|
|
|
in Active
|
|
|
Other
|
|
|
Significant
|
|
|
|
|
|
|
Markets for
|
|
|
Observable
|
|
|
Unobservable
|
|
|
Total
|
|
|
|
Identical Assets
|
|
|
Inputs
|
|
|
Inputs
|
|
|
Estimated
|
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
Fair Value
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Fixed Maturity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
|
|
|
$
|
85,419
|
|
|
$
|
7,149
|
|
|
$
|
92,568
|
|
Foreign corporate securities
|
|
|
|
|
|
|
62,401
|
|
|
|
5,777
|
|
|
|
68,178
|
|
Residential mortgage-backed securities
|
|
|
274
|
|
|
|
43,037
|
|
|
|
1,422
|
|
|
|
44,733
|
|
Foreign government securities
|
|
|
149
|
|
|
|
40,092
|
|
|
|
3,159
|
|
|
|
43,400
|
|
U.S. Treasury, agency and government guaranteed securities
|
|
|
14,602
|
|
|
|
18,623
|
|
|
|
79
|
|
|
|
33,304
|
|
Commercial mortgage-backed securities (CMBS)
|
|
|
|
|
|
|
19,664
|
|
|
|
1,011
|
|
|
|
20,675
|
|
Asset-backed securities
|
|
|
|
|
|
|
10,142
|
|
|
|
4,148
|
|
|
|
14,290
|
|
State and political subdivision securities
|
|
|
|
|
|
|
10,083
|
|
|
|
46
|
|
|
|
10,129
|
|
Other fixed maturity securities
|
|
|
|
|
|
|
3
|
|
|
|
4
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
15,025
|
|
|
$
|
289,464
|
|
|
$
|
22,795
|
|
|
$
|
327,284
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
832
|
|
|
$
|
1,094
|
|
|
$
|
268
|
|
|
$
|
2,194
|
|
Non-redeemable preferred stock
|
|
|
|
|
|
|
507
|
|
|
|
905
|
|
|
|
1,412
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
832
|
|
|
$
|
1,601
|
|
|
$
|
1,173
|
|
|
$
|
3,606
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The composition of fair value pricing sources for and
significant changes in Level 3 securities at
December 31, 2010 are as follows:
|
|
|
|
|
The majority of the Level 3 fixed maturity and equity
securities (84%, as presented above) were concentrated in four
sectors: U.S. and foreign corporate securities, ABS and
foreign government securities.
|
|
|
|
Level 3 fixed maturity securities are priced principally
through market standard valuation methodologies, independent
pricing services and independent non-binding broker quotations
using inputs that are not market observable or cannot be derived
principally from or corroborated by observable market data.
Level 3 fixed maturity securities consists of less liquid
fixed maturity securities with very limited trading activity or
where less price transparency exists around the inputs to the
valuation methodologies including alternative residential
mortgage loan RMBS and less liquid prime RMBS, certain below
investment grade private placements and less liquid investment
grade corporate securities (included in U.S. and foreign
corporate securities) and less liquid ABS including securities
supported by
sub-prime
mortgage loans (included in ABS).
|
|
|
|
During the year ended December 31, 2010, Level 3 fixed
maturity securities increased by $371 million, or 2%,
excluding the impact of the Acquisition, and
$5,605 million, or 33%, including the impact of the
Acquisition. The Level 3 fixed maturity securities acquired
from ALICO of $5,435 million have been included in
purchases, sales, issuances and settlements in the table below.
The increase was driven by net purchases in excess of sales and
increases in estimated fair value recognized in other
comprehensive income (loss). Net purchases in excess of sales of
fixed maturity securities were concentrated in foreign
government and ABS. The increase in estimated fair value in
fixed maturity securities was concentrated in U.S. and
foreign corporate securities and ABS (including RMBS backed by
sub-prime
mortgage loans) due to improving or stabilizing market
conditions including an improvement in liquidity coupled with
the effect of decreased interest rates on such securities.
|
130
A rollforward of the fair value measurements for fixed maturity
securities and equity securities
available-for-sale
measured at estimated fair value on a recurring basis using
significant unobservable (Level 3) inputs is as
follows:
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2010
|
|
|
|
Fixed Maturity
|
|
|
Equity
|
|
|
|
Securities
|
|
|
Securities
|
|
|
|
(In millions)
|
|
|
Balance, beginning of year
|
|
$
|
17,190
|
|
|
$
|
1,240
|
|
Total realized/unrealized gains (losses) included in:
|
|
|
|
|
|
|
|
|
Earnings
|
|
|
(39
|
)
|
|
|
51
|
|
Other comprehensive income (loss)
|
|
|
1,072
|
|
|
|
19
|
|
Purchases, sales, issuances and settlements (1)
|
|
|
4,519
|
|
|
|
(122
|
)
|
Transfers into and/or out of Level 3
|
|
|
53
|
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
Balance, end of year
|
|
$
|
22,795
|
|
|
$
|
1,173
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes securities acquired from ALICO of $5,435 million
for fixed maturity securities and $68 million for equity
securities. |
An analysis of transfers into
and/or out
of Level 3 for the year ended December 31, 2010 is as
follows:
|
|
|
|
|
Total gains and losses in earnings and other comprehensive
income (loss) are calculated assuming transfers in or out of
Level 3 occurred at the beginning of the period. Items
transferred in and out for the same period are excluded from the
rollforward.
|
|
|
|
Total gains and losses for fixed maturity securities included in
earnings of ($2) million and other comprehensive income
(loss) of $19 million respectively, were incurred for
transfers subsequent to their transfer to Level 3, for the
year ended December 31, 2010.
|
|
|
|
Net transfers into
and/or out
of Level 3 for fixed maturity securities were
$53 million for the year ended December 31, 2010, and
were comprised of transfers in of $1,736 million and
transfers out of ($1,683) million, respectively.
|
Overall, transfers into
and/or out
of Level 3 are attributable to a change in the
observability of inputs. Assets and liabilities are transferred
into Level 3 when a significant input cannot be
corroborated with market observable data. This occurs when
market activity decreases significantly and underlying inputs
cannot be observed, current prices are not available, and when
there are significant variances in quoted prices, thereby
affecting transparency. Assets and liabilities are transferred
out of Level 3 when circumstances change such that a
significant input can be corroborated with market observable
data. This may be due to a significant increase in market
activity, a specific event, or one or more significant input(s)
becoming observable. Transfers into
and/or out
of any level are assumed to occur at the beginning of the
period. Significant transfers in
and/or out
of Level 3 assets and liabilities for the year ended
December 31, 2010 are summarized below.
|
|
|
|
|
During the year ended December 31, 2010, fixed maturity
securities transfers into Level 3 of $1,736 million
resulted primarily from current market conditions characterized
by a lack of trading activity, decreased liquidity and credit
ratings downgrades (e.g., from investment grade to below
investment grade). These current market conditions have resulted
in decreased transparency of valuations and an increased use of
broker quotations and unobservable inputs to determine estimated
fair value principally for certain private placements included
in U.S. and foreign corporate securities and certain CMBS.
|
|
|
|
During the year ended December 31, 2010, fixed maturity
securities transfers out of Level 3 of ($1,683) million
resulted primarily from increased transparency of both new
issuances that subsequent to issuance and establishment of
trading activity, became priced by independent pricing services
and existing issuances that, over time, the Company was able to
corroborate pricing received from independent pricing services
with observable inputs, or there were increases in market
activity and upgraded credit ratings primarily for certain
U.S. and foreign corporate securities, RMBS and ABS.
|
131
See Summary of Critical Accounting
Estimates Estimated Fair Value of Investments
for further information on the estimates and assumptions that
affect the amounts reported above.
See Fair Value Assets and
Liabilities Measured at Fair Value Recurring Fair
Value Measurements Valuation Techniques and Inputs
by Level Within the Three-Level Fair Value Hierarchy
by Major Classes of Assets and Liabilities in Note 5
for further information about the valuation techniques and
inputs by level by major classes of invested assets that affect
the amounts reported above.
Fixed Maturity Securities Credit Quality
Ratings. The Securities Valuation Office of the
National Association of Insurance Commissioners
(NAIC) evaluates the fixed maturity security
investments of insurers for regulatory reporting and capital
assessment purposes and assigns securities to one of six credit
quality categories called NAIC designations. If no
rating is available from the NAIC, then as permitted by the
NAIC, an internally developed rating is used. The NAIC ratings
are generally similar to the credit quality designations of the
Nationally Recognized Statistical Ratings Organizations
(NRSROs) for marketable fixed maturity securities,
called rating agency designations, except for
certain structured securities as described below. NAIC ratings 1
and 2 include fixed maturity securities generally considered
investment grade (i.e., rated Baa3 or better by
Moodys Investors Service (Moodys) or
rated BBB or better by S&P and Fitch Ratings
(Fitch)) by such rating organizations. NAIC ratings
3 through 6 include fixed maturity securities generally
considered below investment grade (i.e., rated Ba1
or lower by Moodys or rated BB+ or lower by
S&P and Fitch) by such rating organizations.
The NAIC adopted revised rating methodologies for non-agency
RMBS, including RMBS backed by
sub-prime
mortgage loans reported within ABS, that became effective
December 31, 2009 and for CMBS and all other ABS that
became effective December 31, 2010. The NAICs
objective with the revised rating methodologies for these
structured securities was to increase the accuracy in assessing
expected losses, and to use the improved assessment to determine
a more appropriate capital requirement for such structured
securities. The revised methodologies reduce regulatory reliance
on rating agencies and allow for greater regulatory input into
the assumptions used to estimate expected losses from such
structured securities.
The three tables below present fixed maturity securities based
on rating agency designations and equivalent designations of the
NAIC, with the exception of certain structured securities held
by the Companys insurance subsidiaries that file NAIC
statutory financial statements. Non-agency RMBS, including RMBS
backed by
sub-prime
mortgage loans reported within ABS, CMBS and all other ABS held
by the Companys insurance subsidiaries that file NAIC
statutory financial statements are presented based on final
ratings from the revised NAIC rating methodologies described
above (which may not correspond to rating agency designations).
All NAIC designation (e.g., NAIC 1) amounts and percentages
presented herein are based on the revised NAIC methodologies
described above. All rating agency designation (e.g., Aaa/AAA)
amounts and percentages presented herein are based on rating
agency designations without adjustment for the revised NAIC
methodologies described above.
The following three tables present information about the
Companys fixed maturity securities holdings by NAIC credit
quality ratings. Comparisons between NAIC ratings and rating
agency designations are published by the NAIC. Rating agency
designations are based on availability of applicable ratings
from rating agencies on the NAIC acceptable rating organizations
list, including Moodys, S&P, Fitch and Realpoint,
LLC. If no rating is available from a rating agency, then an
internally developed rating is used.
132
The following table presents the Companys total fixed
maturity securities by NRSRO designation and the equivalent
designations of the NAIC, except for certain structured
securities, which are presented using final ratings from the
revised NAIC rating methodologies as described above, as well as
the percentage, based on estimated fair value, that each
designation is comprised of at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
|
|
|
Estimated
|
|
|
|
|
NAIC
|
|
|
|
Amortized
|
|
|
Fair
|
|
|
% of
|
|
|
Amortized
|
|
|
Fair
|
|
|
% of
|
|
Rating
|
|
Rating Agency Designation:
|
|
Cost
|
|
|
Value
|
|
|
Total
|
|
|
Cost
|
|
|
Value
|
|
|
Total
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
Aaa/Aa/A
|
|
$
|
228,875
|
|
|
$
|
233,540
|
|
|
|
71.4
|
%
|
|
$
|
151,391
|
|
|
$
|
151,136
|
|
|
|
66.4
|
%
|
2
|
|
Baa
|
|
|
65,550
|
|
|
|
68,858
|
|
|
|
21.0
|
|
|
|
55,508
|
|
|
|
56,305
|
|
|
|
24.7
|
|
3
|
|
Ba
|
|
|
15,335
|
|
|
|
15,294
|
|
|
|
4.7
|
|
|
|
13,184
|
|
|
|
12,003
|
|
|
|
5.3
|
|
4
|
|
B
|
|
|
8,752
|
|
|
|
8,316
|
|
|
|
2.5
|
|
|
|
7,474
|
|
|
|
6,461
|
|
|
|
2.9
|
|
5
|
|
Caa and lower
|
|
|
1,343
|
|
|
|
1,146
|
|
|
|
0.4
|
|
|
|
1,809
|
|
|
|
1,425
|
|
|
|
0.6
|
|
6
|
|
In or near default
|
|
|
153
|
|
|
|
130
|
|
|
|
|
|
|
|
343
|
|
|
|
312
|
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
320,008
|
|
|
$
|
327,284
|
|
|
|
100.0
|
%
|
|
$
|
229,709
|
|
|
$
|
227,642
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following tables present the Companys total fixed
maturity securities, based on estimated fair value, by sector
classification and by NRSRO designation and the equivalent
designations of the NAIC, except for certain structured
securities, which are presented as described above, that each
designation is comprised of at December 31, 2010 and 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Maturity Securities by Sector & Credit
Quality Rating at December 31, 2010
|
|
NAIC Rating
|
|
1
|
|
|
2
|
|
|
3
|
|
|
4
|
|
|
5
|
|
|
6
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Caa and
|
|
|
In or Near
|
|
|
Estimated
|
|
Rating Agency Designation:
|
|
Aaa/Aa/A
|
|
|
Baa
|
|
|
Ba
|
|
|
B
|
|
|
Lower
|
|
|
Default
|
|
|
Fair Value
|
|
|
|
(In millions)
|
|
|
U.S. corporate securities
|
|
$
|
46,754
|
|
|
$
|
34,326
|
|
|
$
|
7,635
|
|
|
$
|
3,460
|
|
|
$
|
353
|
|
|
$
|
40
|
|
|
$
|
92,568
|
|
Foreign corporate securities
|
|
|
39,652
|
|
|
|
24,414
|
|
|
|
2,476
|
|
|
|
1,454
|
|
|
|
173
|
|
|
|
9
|
|
|
|
68,178
|
|
RMBS (1)
|
|
|
38,984
|
|
|
|
1,109
|
|
|
|
2,271
|
|
|
|
1,993
|
|
|
|
331
|
|
|
|
45
|
|
|
|
44,733
|
|
Foreign government securities
|
|
|
32,957
|
|
|
|
7,184
|
|
|
|
2,179
|
|
|
|
1,080
|
|
|
|
|
|
|
|
|
|
|
|
43,400
|
|
U.S. Treasury, agency and government guaranteed securities
|
|
|
33,304
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,304
|
|
CMBS (1)
|
|
|
19,385
|
|
|
|
665
|
|
|
|
363
|
|
|
|
205
|
|
|
|
56
|
|
|
|
1
|
|
|
|
20,675
|
|
ABS (1)
|
|
|
13,136
|
|
|
|
435
|
|
|
|
338
|
|
|
|
120
|
|
|
|
226
|
|
|
|
35
|
|
|
|
14,290
|
|
State and political subdivision securities
|
|
|
9,368
|
|
|
|
722
|
|
|
|
32
|
|
|
|
|
|
|
|
7
|
|
|
|
|
|
|
|
10,129
|
|
Other fixed maturity securities
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
233,540
|
|
|
$
|
68,858
|
|
|
$
|
15,294
|
|
|
$
|
8,316
|
|
|
$
|
1,146
|
|
|
$
|
130
|
|
|
$
|
327,284
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of total
|
|
|
71.4
|
%
|
|
|
21.0
|
%
|
|
|
4.7
|
%
|
|
|
2.5
|
%
|
|
|
0.4
|
%
|
|
|
|
%
|
|
|
100.0
|
%
|
133
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Maturity Securities by Sector & Credit
Quality Rating at December 31, 2009
|
|
NAIC Rating
|
|
1
|
|
|
2
|
|
|
3
|
|
|
4
|
|
|
5
|
|
|
6
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Caa and
|
|
|
In or Near
|
|
|
Estimated
|
|
Rating Agency Designation:
|
|
Aaa/Aa/A
|
|
|
Baa
|
|
|
Ba
|
|
|
B
|
|
|
Lower
|
|
|
Default
|
|
|
Fair Value
|
|
|
|
(In millions)
|
|
|
U.S. corporate securities
|
|
$
|
31,848
|
|
|
$
|
30,266
|
|
|
$
|
6,319
|
|
|
$
|
2,965
|
|
|
$
|
616
|
|
|
$
|
173
|
|
|
$
|
72,187
|
|
Foreign corporate securities
|
|
|
16,678
|
|
|
|
17,393
|
|
|
|
2,067
|
|
|
|
1,530
|
|
|
|
281
|
|
|
|
81
|
|
|
|
38,030
|
|
RMBS (1)
|
|
|
38,464
|
|
|
|
1,563
|
|
|
|
2,260
|
|
|
|
1,391
|
|
|
|
339
|
|
|
|
3
|
|
|
|
44,020
|
|
Foreign government securities
|
|
|
5,786
|
|
|
|
4,841
|
|
|
|
890
|
|
|
|
415
|
|
|
|
|
|
|
|
15
|
|
|
|
11,947
|
|
U.S. Treasury, agency and government guaranteed securities
|
|
|
25,447
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,447
|
|
CMBS
|
|
|
15,000
|
|
|
|
434
|
|
|
|
152
|
|
|
|
22
|
|
|
|
14
|
|
|
|
|
|
|
|
15,622
|
|
ABS
|
|
|
11,573
|
|
|
|
1,033
|
|
|
|
275
|
|
|
|
124
|
|
|
|
117
|
|
|
|
40
|
|
|
|
13,162
|
|
State and political subdivision securities
|
|
|
6,337
|
|
|
|
765
|
|
|
|
40
|
|
|
|
8
|
|
|
|
58
|
|
|
|
|
|
|
|
7,208
|
|
Other fixed maturity securities
|
|
|
3
|
|
|
|
10
|
|
|
|
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
151,136
|
|
|
$
|
56,305
|
|
|
$
|
12,003
|
|
|
$
|
6,461
|
|
|
$
|
1,425
|
|
|
$
|
312
|
|
|
$
|
227,642
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of total
|
|
|
66.4
|
%
|
|
|
24.7
|
%
|
|
|
5.3
|
%
|
|
|
2.9
|
%
|
|
|
0.6
|
%
|
|
|
0.1
|
%
|
|
|
100.0
|
%
|
|
|
|
(1) |
|
Presented using the final rating from revised NAIC rating
methodologies. |
Fixed Maturity and Equity Securities
Available-for-Sale. See
Investments Fixed Maturity and Equity
Securities
Available-for-Sale
in Note 3 of the Notes to the Consolidated Financial
Statements for tables summarizing the cost or amortized cost,
gross unrealized gains and losses, including noncredit loss
component of OTTI loss, and estimated fair value of fixed
maturity and equity securities on a sector basis, and selected
information about certain fixed maturity securities held by the
Company that were below investment grade or non-rated,
non-income producing, credit enhanced by financial guarantor
insurers by sector, and the ratings of the financial
guarantor insurers providing the credit enhancement at
December 31, 2010 and 2009.
Concentrations of Credit Risk (Equity
Securities). The Company was not exposed to any
significant concentrations of credit risk in its equity
securities portfolio of any single issuer greater than 10% of
the Companys equity, or 1% of total investments, at
December 31, 2010 and 2009.
Concentrations of Credit Risk (Fixed Maturity
Securities) Summary. See
Investments Fixed Maturity Securities
Available-for-Sale
Concentrations in Note 3 of the Notes to the
Consolidated Financial Statements for a summary of the
concentrations of credit risk related to fixed maturity
securities holdings.
Corporate Fixed Maturity Securities. The
Company maintains a diversified portfolio of corporate fixed
maturity securities across industries and issuers. This
portfolio does not have exposure to any single issuer in excess
of 1% of the total investments. See
Investments Fixed Maturity and Equity
Securities
Available-for-Sale
Concentrations of Credit Risk (Fixed Maturity
Securities) U.S. and Foreign Corporate
Securities in Note 3 of the Notes to the
Consolidated Financial Statements for the tables that present
the major industry types that comprise the corporate fixed
maturity securities holdings, the largest exposure to a single
issuer and the combined holdings in the ten issuers to which it
had the largest exposure at December 31, 2010 and 2009.
134
Structured Securities. The following table
presents the types of structured securities and portion rated
Aaa/AAA and portion rated NAIC 1 at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
|
Fair
|
|
|
% of
|
|
|
Fair
|
|
|
% of
|
|
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
RMBS
|
|
$
|
44,733
|
|
|
|
56.1
|
%
|
|
$
|
44,020
|
|
|
|
60.5
|
%
|
CMBS
|
|
|
20,675
|
|
|
|
26.0
|
|
|
|
15,622
|
|
|
|
21.4
|
|
ABS
|
|
|
14,290
|
|
|
|
17.9
|
|
|
|
13,162
|
|
|
|
18.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total structured securities
|
|
$
|
79,698
|
|
|
|
100.0
|
%
|
|
$
|
72,804
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ratings profile:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RMBS rated Aaa/AAA
|
|
$
|
36,085
|
|
|
|
80.7
|
%
|
|
$
|
35,626
|
|
|
|
80.9
|
%
|
RMBS rated NAIC 1
|
|
$
|
38,984
|
|
|
|
87.1
|
%
|
|
$
|
38,464
|
|
|
|
87.4
|
%
|
CMBS rated Aaa/AAA
|
|
$
|
16,901
|
|
|
|
81.7
|
%
|
|
$
|
13,355
|
|
|
|
85.5
|
%
|
CMBS rated NAIC 1
|
|
$
|
19,385
|
|
|
|
93.7
|
%
|
|
$
|
15,000
|
|
|
|
96.0
|
%
|
ABS rated Aaa/AAA
|
|
$
|
10,411
|
|
|
|
72.9
|
%
|
|
$
|
9,354
|
|
|
|
71.1
|
%
|
ABS rated NAIC 1
|
|
$
|
13,136
|
|
|
|
91.9
|
%
|
|
$
|
11,573
|
|
|
|
87.9
|
%
|
RMBS. See Investments Fixed
Maturity and Equity Securities
Available-for-Sale
Concentrations of Credit Risk (Fixed Maturity
Securities) RMBS in Note 3 of the Notes
to the Consolidated Financial Statements for the tables that
present the Companys RMBS holdings by security type and
risk profile at December 31, 2010 and 2009.
The majority of RMBS held by the Company was rated Aaa/AAA by
Moodys, S&P or Fitch; and the majority was rated NAIC
1 by the NAIC at December 31, 2010 and 2009, as presented
above. The majority of the agency RMBS held by the Company was
guaranteed or otherwise supported by FNMA, FHLMC or GNMA.
Non-agency RMBS includes prime and alternative residential
mortgage loans (Alt-A) RMBS. Prime residential
mortgage lending includes the origination of residential
mortgage loans to the most creditworthy borrowers with high
quality credit profiles. Alt-A is a classification of mortgage
loans where the risk profile of the borrower falls between prime
and
sub-prime.
Sub-prime
mortgage lending is the origination of residential mortgage
loans to borrowers with weak credit profiles. Included within
Alt-A RMBS are resecuritization of real estate mortgage
investment conduit (Re-REMIC) securities. Re-REMIC
Alt-A RMBS involve the pooling of previous issues of Alt-A RMBS
and restructuring the combined pools to create new senior and
subordinated securities. The credit enhancement on the senior
tranches is improved through the resecuritization. The
Companys holdings are in senior tranches with significant
credit enhancement.
The Companys Alt-A securities portfolio has superior
structure to the overall Alt-A market. At December 31, 2010
and 2009, the Companys Alt-A securities portfolio has no
exposure to option adjustable rate mortgages (ARMs)
and a minimal exposure to hybrid ARMs. The Companys Alt-A
securities portfolio is comprised primarily of fixed rate
mortgages which have performed better than both option ARMs and
hybrid ARMs in the overall Alt-A market. Additionally, 85% and
90% at December 31, 2010 and 2009, respectively, of the
Companys Alt-A securities portfolio has super senior
credit enhancement, which typically provides double the credit
enhancement of a standard Aaa/AAA rated fixed maturity security.
See Investments Fixed Maturity and Equity
Securities
Available-for-Sale
Concentrations of Credit Risk (Fixed Maturity
Securities) RMBS in Note 3 of the Notes
to Consolidated Financial Statements for a table that presents
the estimated fair value of Alt-A securities held by the Company
by vintage year, net unrealized loss, portion of holdings rated
Aa/AA or better by Moodys, S&P or Fitch, portion
rated NAIC 1 by the NAIC, and portion of holdings that are
backed by fixed rate collateral or hybrid ARM collateral at
December 31, 2010 and 2009. The Companys holdings of
Re-REMIC Alt-A RMBS reported within Alt-A RMBS were all rated
NAIC 1 and were $703 million and $782 million at
estimated fair value at December 31, 2010 and 2009,
respectively.
135
RMBS in which the present value of projected future cash flows
expected to be collected is less than amortized cost are
reviewed for impairment in accordance with our impairment
policy. Based upon the analysis of the Companys exposure
to RMBS, including Alt-A RMBS, the Company expects to receive
payments in accordance with the contractual terms of the
securities that are considered temporarily impaired.
CMBS. There have been disruptions in the CMBS
market due to market perceptions that default rates will
increase in part as a result of weakness in commercial real
estate market fundamentals and in part to relaxed underwriting
standards by some originators of commercial mortgage loans
within the more recent vintage years (i.e., 2006 and later).
These factors caused a pull-back in market liquidity, increased
credit spreads and repricing of risk, which has led to higher
levels of unrealized losses as compared to historical levels
through the first quarter of 2010. However, in the second
quarter of 2010, market conditions continued to improve and
interest rates continue to decrease, causing our portfolio to be
in a net unrealized gain position of 2% of amortized cost at
December 31, 2010.
CMBS in which the present value of projected future cash flows
expected to be collected is less than amortized cost are
reviewed for impairment in accordance with our impairment
policy. Based upon the analysis of the Companys exposure
to CMBS, the Company expects to receive payments in accordance
with the contractual terms of the securities that are considered
temporarily impaired.
The Companys holdings in CMBS were $20.7 billion and
$15.6 billion, at estimated fair value at December 31,
2010 and 2009, respectively. See Investments
Fixed Maturity and Equity Securities
Available-for-Sale
Concentrations of Credit Risk (Fixed Maturity
Securities) CMBS in Note 3 of the Notes
to the Consolidated Financial Statements for tables that present
the amortized cost and estimated fair value, rating agency
designation by Moodys, S&P, Fitch or Realpoint, LLC
and holdings by vintage year of such securities held by the
Company at December 31, 2010 and 2009. The Company had no
exposure to CMBS index securities at December 31, 2010 or
2009. The Companys holdings of commercial real estate
collateralized debt obligations securities were
$138 million and $111 million at estimated fair value
at December 31, 2010 and 2009, respectively. The weighted
average credit enhancement of the Companys CMBS holdings
was 26% and 28% at December 31, 2010 and 2009,
respectively. This credit enhancement percentage represents the
current weighted average estimated percentage of outstanding
capital structure subordinated to the Companys investment
holding that is available to absorb losses before the security
incurs the first dollar of loss of principal. The credit
protection does not include any equity interest or property
value in excess of outstanding debt.
ABS. The Companys ABS are diversified
both by collateral type and by issuer. See
Investments Fixed Maturity and Equity
Securities
Available-for-Sale
Concentrations of Credit Risk (Fixed Maturity
Securities) ABS in Note 3 of the Notes to
the Consolidated Financial Statements for a table that presents
the Companys ABS by collateral type, portion rated
Aaa/AAA, portion rated NAIC 1, and portion credit enhanced held
by the Company at December 31, 2010 and 2009.
The slowing U.S. housing market, greater use of affordable
mortgage products and relaxed underwriting standards for some
originators of
sub-prime
mortgage loans have recently led to higher delinquency and loss
rates, especially within the 2006 and 2007 vintage years. These
factors have caused a pull-back in market liquidity and
repricing of risk, which has led to higher levels of unrealized
losses on securities backed by
sub-prime
mortgage loans as compared to historical levels. However, in
2010, market conditions improved, credit spreads narrowed on
mortgage-backed and asset-backed securities and net unrealized
losses on ABS backed by
sub-prime
mortgage loans decreased from 36% to 22% of amortized cost from
December 31, 2009 to December 31, 2010.
ABS in which the present value of projected future cash flows
expected to be collected is less than amortized cost are
reviewed for impairment in accordance with our impairment
policy. Based upon the analysis of the Companys ABS,
including
sub-prime
mortgage loans through its exposure to ABS, the Company expects
to receive payments in accordance with the contractual terms of
the securities that are considered temporarily impaired.
See Investments Fixed Maturity and Equity
Securities
Available-for-Sale
Concentrations of Credit Risk (Fixed Maturity
Securities) ABS in Note 3 of the Notes to
the Consolidated Financial Statements for tables that present
the Companys holdings of ABS supported by
sub-prime
mortgage loans by rating agency designation and by vintage year
and by NAIC rating at December 31, 2010 and 2009.
136
The Company had ABS supported by
sub-prime
mortgage loans with estimated fair values of $1,119 million
and $1,044 million and unrealized losses of
$317 million and $593 million at December 31,
2010 and 2009, respectively. Approximately 54% of this portfolio
was rated Aa or better, of which 88% was in vintage year 2005
and prior at December 31, 2010. Approximately 61% of this
portfolio was rated Aa or better, of which 91% was in vintage
year 2005 and prior at December 31, 2009. These older
vintages from 2005 and prior benefit from better underwriting,
improved enhancement levels and higher residential property
price appreciation. All of the $1,119 million and
$1,044 million of ABS supported by
sub-prime
mortgage loans were classified as Level 3 fixed maturity
securities in the fair value hierarchy at December 31, 2010
and 2009, respectively.
ABS also include collateralized debt obligations backed by
sub-prime
mortgage loans at an aggregate cost of $18 million with an
estimated fair value of $17 million at December 31,
2010 and an aggregate cost of $22 million with an estimated
fair value of $8 million at December 31, 2009.
Evaluating
Available-for-Sale
Securities for
Other-Than-Temporary
Impairment
See Investments Evaluating
Available-for-Sale
Securities for
Other-Than-Temporary
Impairment in Note 3 of the Notes to the Consolidated
Financial Statements for a discussion of the regular evaluation
of
available-for-sale
securities holdings in accordance with our impairment policy,
whereby we evaluate whether such investments are
other-than-temporarily
impaired, new OTTI guidance adopted in 2009 and factors
considered by security classification in the regular OTTI
evaluation.
See Summary of Critical Accounting
Estimates.
Net
Unrealized Investment Gains (Losses)
See Investments Net Unrealized Investment
Gains (Losses) in Note 3 of the Notes to the
Consolidated Financial Statements for the components of net
unrealized investment gains (losses), included in accumulated
other comprehensive income (loss) and the changes in net
unrealized investment gains (losses) at December 31, 2010
and 2009 and for the years ended December 31, 2010, 2009
and 2008, respectively.
Fixed maturity securities with noncredit OTTI losses in
accumulated other comprehensive income (loss) of
($601) million at December 31, 2010, includes
($859) million recognized prior to January 1, 2010,
($212) million (($202) million, net of DAC) of
noncredit OTTI losses recognized in the year ended
December 31, 2010, $16 million transferred to retained
earnings in connection with the adoption of guidance related to
the consolidation of VIEs (see Note 1 of the Notes to the
Consolidated Financial Statements) for the year ended
December 31, 2010, $137 million related to securities
sold for the year ended December 31, 2010, for which a
noncredit OTTI loss was previously recognized in accumulated
other comprehensive income (loss) and $317 million of
subsequent increases in estimated fair value during the year
ended December 31, 2010, on such securities for which a
noncredit OTTI loss was previously recognized in accumulated
other comprehensive income (loss).
Fixed maturity securities with noncredit OTTI losses in
accumulated other comprehensive income (loss) of
($859) million at December 31, 2009, includes
($126) million related to the transition adjustment
recorded in 2009 upon the adoption of guidance on the
recognition and presentation of OTTI, ($939) million
(($857) million, net of DAC) of noncredit OTTI losses
recognized in the year ended December 31, 2009 (as more
fully described in Note 1 of the Notes to the Consolidated
Financial Statements), $20 million related to securities
sold during the year ended December 31, 2009 for which a
noncredit loss was previously recognized in accumulated other
comprehensive income (loss) and $186 million of subsequent
increases in estimated fair value during the year ended
December 31, 2009 on such securities for which a noncredit
OTTI loss was previously recognized in accumulated other
comprehensive income (loss).
Aging
of Gross Unrealized Loss and OTTI Loss for Fixed Maturity and
Equity Securities
Available-for-Sale
See Investments Aging of Gross Unrealized Loss
and OTTI Loss for Fixed Maturity and Equity Securities
Available-for-Sale
in Note 3 of the Notes to the Consolidated Financial
Statements for the tables that present the
137
cost or amortized cost, gross unrealized loss, including the
portion of OTTI loss on fixed maturity securities recognized in
accumulated other comprehensive income (loss) at
December 31, 2010, gross unrealized loss as a percentage of
cost or amortized cost and number of securities for fixed
maturity and equity securities where the estimated fair value
had declined and remained below cost or amortized cost by less
than 20%, or 20% or more at December 31, 2010 and 2009.
Concentration
of Gross Unrealized Loss and OTTI Loss for Fixed Maturity and
Equity Securities
Available-for-Sale
See Investments Concentration of Gross
Unrealized Loss and OTTI Loss for Fixed Maturity and Equity
Securities
Available-for-Sale
in Note 3 of the Notes to the Consolidated Financial
Statements for the tables that present the concentration by
sector and industry of the Companys gross unrealized
losses related to its fixed maturity and equity securities,
including the portion of OTTI loss on fixed maturity securities
recognized in accumulated other comprehensive loss of
$6.9 billion and $10.8 billion at December 31,
2010 and 2009, respectively.
Evaluating
Temporarily Impaired
Available-for-Sale
Securities
See Investments Fixed Maturity and Equity
Securities
Available-for-Sale
Evaluating Temporarily Impaired
Available-for-Sale
Securities in Note 3 of the Notes to the Consolidated
Financial Statements for a table that presents the
Companys fixed maturity and equity securities each with a
gross unrealized loss of greater than $10 million, the
number of securities, total gross unrealized loss and percentage
of total gross unrealized loss at December 31, 2010 and
2009.
Fixed maturity and equity securities, each with a gross
unrealized loss greater than $10 million, decreased
$2.5 billion during the year ended December 31, 2010.
The cause of the decline in, or improvement in, gross unrealized
losses for the year ended December 31, 2010 was primarily
attributable to a decrease in interest rates and narrowing of
credit spreads. These securities were included in the
Companys OTTI review process. Based upon the
Companys current evaluation of these securities in
accordance with its impairment policy and the Companys
current intentions and assessments (as applicable to the type of
security) about holding, selling, and any requirements to sell
these securities, the Company has concluded that these
securities are not
other-than-temporarily
impaired.
In the Companys impairment review process, the duration
and severity of an unrealized loss position for equity
securities is given greater weight and consideration than for
fixed maturity securities. An extended and severe unrealized
loss position on a fixed maturity security may not have any
impact on the ability of the issuer to service all scheduled
interest and principal payments and the Companys
evaluation of recoverability of all contractual cash flows or
the ability to recover an amount at least equal to its amortized
cost based on the present value of the expected future cash
flows to be collected. In contrast, for an equity security,
greater weight and consideration is given by the Company to a
decline in market value and the likelihood such market value
decline will recover.
See Investments Fixed Maturity and Equity
Securities
Available-for-Sale
Evaluating Temporarily Impaired
Available-for-Sale
Securities in Note 3 of the Notes to the Consolidated
Financial Statements for a table that presents certain
information about the Companys equity securities
available-for-sale
with a gross unrealized loss of 20% or more at December 31,
2010.
In connection with the equity securities impairment review
process at December 31, 2010, the Company evaluated its
holdings in non-redeemable preferred stock, particularly those
of financial services companies. The Company considered several
factors including whether there has been any deterioration in
credit of the issuer and the likelihood of recovery in value of
non-redeemable preferred stock with a severe or an extended
unrealized loss. The Company also considered whether any
non-redeemable preferred stock with an unrealized loss held by
the Company, regardless of credit rating, have deferred any
dividend payments. No such dividend payments had been deferred.
138
With respect to common stock holdings, the Company considered
the duration and severity of the unrealized losses for
securities in an unrealized loss position of 20% or more and the
duration of unrealized losses for securities in an unrealized
loss position of less than 20% in an extended unrealized loss
position (i.e., for 12 months or greater).
Future OTTI will depend primarily on economic fundamentals,
issuer performance (including changes in the present value of
future cash flows expected to be collected), changes in credit
rating, changes in collateral valuation, changes in interest
rates and changes in credit spreads. If economic fundamentals
and any of the above factors deteriorate, additional OTTI may be
incurred in upcoming quarters.
Net
Investment Gains (Losses) Including OTTI Losses Recognized in
Earnings
Effective April 1, 2009, the Company adopted guidance on
the recognition and presentation of OTTI that amends the
methodology to determine for fixed maturity securities whether
an OTTI exists, and for certain fixed maturity securities,
changes how OTTI losses that are charged to earnings are
measured. There was no change in the methodology for
identification and measurement of OTTI losses charged to
earnings for impaired equity securities.
See Investments Fixed Maturity and Equity
Securities
Available-for-Sale
Net Investment Gains (Losses) in Note 3 of the Notes
to the Consolidated Financial Statements for a table that
presents proceeds from sales or disposals of fixed maturity and
equity securities and the components of fixed maturity and
equity securities net investment gains (losses) for the years
ended December 31, 2010, 2009 and 2008, respectively.
Overview of Fixed Maturity and Equity Security OTTI Losses
Recognized in Earnings. Impairments of fixed
maturity and equity securities were $484 million,
$1.9 billion and $1.7 billion for the years ended
December 31, 2010, 2009 and 2008, respectively. Impairments
of fixed maturity securities were $470 million,
$1.5 billion and $1.3 billion for the years ended
December 31, 2010, 2009 and 2008, respectively. Impairments
of equity securities were $14 million, $400 million
and $430 million for the years ended December 31,
2010, 2009 and 2008, respectively.
The Companys credit-related impairments of fixed maturity
securities were $423 million, $1.1 billion and
$1.1 billion for the years ended December 31, 2010,
2009 and 2008, respectively.
The Companys three largest impairments totaled
$105 million, $508 million and $528 million for
the years ended December 31, 2010, 2009 and 2008,
respectively.
The Company records OTTI losses charged to earnings within net
investment gains (losses) and adjusts the cost basis of the
fixed maturity and equity securities accordingly. The Company
does not change the revised cost basis for subsequent recoveries
in value.
The Company sold or disposed of fixed maturity and equity
securities at a loss that had an estimated fair value of
$18.2 billion, $10.2 billion and $29.9 billion
for the years ended December 31, 2010, 2009 and 2008,
respectively. Gross losses excluding impairments for fixed
maturity and equity securities were $628 million,
$1.2 billion and $1.8 billion for the years ended
December 31, 2010, 2009 and 2008, respectively.
Explanations of changes in fixed maturity and equity securities
impairments are as follows:
|
|
|
|
|
Year Ended December 31, 2010 compared to the Year Ended
December 31, 2009 Overall OTTI losses
recognized in earnings on fixed maturity and equity securities
were $484 million for the current year as compared to
$1.9 billion in the prior year. Improving or stabilizing
market conditions across all sectors and industries,
particularly the financial services industry, as compared to the
prior year when there was significant stress in the global
financial markets, resulted in a higher level of impairments in
fixed maturity and equity securities in the prior year. The most
significant decrease in the current year, as compared to the
prior year, was in the Companys financial services
industry holdings which comprised $799 million in fixed
maturity and equity security impairments in the prior year, as
compared to $129 million in impairments in the current
year. Of the $799 million in financial services industry
impairments in the year, $340 million were in equity
securities, of which $310 million were in financial
services industry perpetual hybrid securities which were
impaired as a result of deterioration in the credit rating of
the issuer to below investment grade and due to a severe and
extended unrealized loss position on these securities.
Impairments
|
139
|
|
|
|
|
in the current year were concentrated in the RMBS, ABS and CMBS
sectors reflecting current economic conditions including higher
unemployment levels and continued weakness within the real
estate markets. Of the fixed maturity and equity securities
impairments of $484 million and $1,900 million in the
years ended December 31, 2010 and 2009, respectively,
$287 million and $449 million, or 59% and 24%
respectively, were in the Companys RMBS, ABS and CMBS
holdings.
|
|
|
|
|
|
Year Ended December 31, 2009 compared to the Year Ended
December 31, 2008 Overall OTTI losses
recognized in earnings on fixed maturity and equity securities
were $1.9 billion for the year ended December 31, 2009
as compared to $1.7 billion in the prior year. The stress
in the global financial markets that caused a significant
increase in impairments in 2008 as compared to 2007, continued
into 2009. Significant impairments were incurred in several
industry sectors in 2009, including the financial services
industry, but to a lesser degree in the financial services
industry sector than in 2008. In 2008 certain financial
institutions entered bankruptcy, entered FDIC receivership or
received significant government capital infusions causing 2008
financial services industry impairments to be higher than in
2009. Of the fixed maturity and equity securities impairments of
$1,900 million in 2009, $799 million were concentrated
in the Companys financial services industry holdings and
were comprised of $459 million in impairments on fixed
maturity securities and $340 million in impairments on
equity securities, and the $799 million included
$623 million of perpetual hybrid securities, which were
comprised of $313 million on securities classified as fixed
maturity securities and $310 million on securities
classified as non-redeemable preferred stock. Overall
impairments in 2009 were higher due to increased fixed maturity
security impairments across several industry sectors, which more
than offset a reduction in impairments in the financial services
industry sector. Impairments across these several industry
sectors increased in 2009 due to increased financial
restructurings, bankruptcy filings, ratings downgrades,
collateral deterioration or difficult operating environments of
the issuers as a result of the challenging economic environment.
Impairments on perpetual hybrid securities in 2009 were a result
of deterioration in the credit rating of the issuer to below
investment grade and due to a severe and extended unrealized
loss position.
|
See Investments Fixed Maturity and Equity
Securities
Available-for-Sale
Net Investment Gains (Losses) in Note 3 of the Notes
to the Consolidated Financial Statements for tables that present
fixed maturity security OTTI losses recognized in earnings by
sector and by industry within the U.S. and foreign
corporate securities sector for the years ended
December 31, 2010, 2009 and 2008, respectively; and equity
security OTTI losses recognized in earnings by sector and
industry for the years ended December 31, 2010, 2009 and
2008, respectively.
Future Impairments. Future OTTI will depend
primarily on economic fundamentals, issuer performance, changes
in credit ratings, changes in collateral valuation, changes in
interest rates and changes in credit spreads. If economic
fundamentals and other of the above factors deteriorate,
additional OTTI may be incurred in upcoming periods. See also
Investments Fixed Maturity and
Equity Securities
Available-for-Sale
Net Unrealized Investment Gains (Losses).
Credit
Loss Rollforward Rollforward of the Cumulative
Credit Loss Component of OTTI Loss Recognized in Earnings on
Fixed Maturity Securities Still Held for Which a Portion of the
OTTI Loss was Recognized in Other Comprehensive Income
(Loss)
See Investments Credit Loss
Rollforward Rollforward of the Cumulative Credit
Loss Component of OTTI Loss Recognized in Earnings on Fixed
Maturity Securities Still Held for Which a Portion of the OTTI
Loss was Recognized in Other Comprehensive Income (Loss)
in Note 3 of the Notes to the Consolidated Financial
Statements for the table that presents a rollforward of the
cumulative credit loss component of OTTI loss recognized in
earnings on fixed maturity securities still held by the Company
at December 31, 2010 and 2009 for which a portion of the
OTTI loss was recognized in other comprehensive income (loss)
for the years ended December 31, 2010 and 2009.
140
Securities
Lending
The Company participates in securities lending programs whereby
blocks of securities, which are included in fixed maturity
securities and short-term investments, are loaned to third
parties, primarily brokerage firms and commercial banks. The
Company generally obtains collateral, generally cash, in an
amount equal to 102% of the estimated fair value of the loaned
securities, which is obtained at the inception of a loan and
maintained at a level greater than or equal to 100% for the
duration of the loan. Securities loaned under such transactions
may be sold or repledged by the transferee. The Company is
liable to return to its counterparties the cash collateral under
its control. These transactions are treated as financing
arrangements and the associated liability recorded at the amount
of the cash received.
See Investments Securities Lending in
Note 3 of the Notes to the Consolidated Financial
Statements for information regarding the Companys
securities lending program.
The estimated fair value of the securities on loan related to
the cash collateral on open at December 31, 2010 was
$2,699 million, of which $2,317 million were
U.S. Treasury, agency and government guaranteed securities
which, if put to the Company, can be immediately sold to satisfy
the cash requirements. The remainder of the securities on loan
were primarily U.S. Treasury, agency and government
guaranteed securities, and very liquid RMBS. The
U.S. Treasury securities on loan are primarily holdings of
on-the-run
U.S. Treasury securities, the most liquid
U.S. Treasury securities available. If these high quality
securities that are on loan are put back to the Company, the
proceeds from immediately selling these securities can be used
to satisfy the related cash requirements. The reinvestment
portfolio acquired with the cash collateral consisted
principally of fixed maturity securities (including RMBS,
U.S. corporate, U.S. Treasury, agency and government
guaranteed, and ABS). If the on loan securities or the
reinvestment portfolio become less liquid, the Company has the
liquidity resources of most of its general account available to
meet any potential cash demands when securities are put back to
the Company.
Security collateral on deposit from counterparties in connection
with the securities lending transactions may not be sold or
repledged, unless the counterparty is in default, and is not
reflected in the consolidated financial statements. Separately,
the Company had $49 million and $46 million, at
estimated fair value, of cash and security collateral on deposit
from a counterparty to secure its interest in a pooled
investment that is held by a third-party trustee, as custodian,
at December 31, 2010 and 2009, respectively. This pooled
investment is included within fixed maturity securities and had
an estimated fair value of $49 million and $51 million
at December 31, 2010 and 2009, respectively.
Invested
Assets on Deposit, Held in Trust and Pledged as
Collateral
See Investments Invested Assets on Deposit,
Held in Trust and Pledged as Collateral in Note 3 of
the Notes to the Consolidated Financial Statements for a table
of the invested assets on deposit, invested assets held in trust
and invested assets pledged as collateral at December 31,
2010 and 2009.
See also Investments Securities
Lending for the amount of the Companys cash and
invested assets received from and due back to counterparties
pursuant to its securities lending program.
Trading
and Other Securities
The Company has a trading securities portfolio, principally
invested in fixed maturity securities, to support investment
strategies that involve the active and frequent purchase and
sale of securities (Actively Traded Securities) and
the execution of short sale agreements. Trading and other
securities also include securities for which the FVO has been
elected (FVO Securities). FVO Securities include
certain fixed maturity and equity securities held for investment
by the general account to support asset and liability matching
strategies for certain insurance products. FVO Securities also
include contractholder-directed investments supporting
unit-linked variable annuity type liabilities which do not
qualify for presentation as separate account summary total
assets and liabilities. These investments are primarily mutual
funds, and to a lesser extent, fixed maturity and equity
securities, short-term investments and cash and cash
equivalents. The investment returns on these investments inure
to contractholders and are offset by a corresponding change in
PABs through interest credited to PABs. Changes in
141
estimated fair value of such trading and other securities
subsequent to purchase are included in net investment income.
FVO Securities also include securities held by CSEs (former
qualifying special purpose entities) with changes in estimated
fair value subsequent to consolidation included in net
investment gains (losses). Trading and other securities were
$18.6 billion and $2.4 billion, or 3.9% and 0.7% of
total cash and invested assets at estimated fair value, at
December 31, 2010 and 2009, respectively. The significant
increase in trading and other securities in 2010 was driven
primarily by inclusion of ALICOs contractholder-directed
unit-linked investments, and to a lesser extent, growth in this
book of business that occurred during the ten month period ended
October 31, 2010 prior to the Acquisition. See
Investments Trading and Other Securities
in Note 3 of the Notes to the Consolidated Financial
Statements for tables which present information about the
Actively Traded Securities and FVO Securities, related short
sale agreement liabilities, investments pledged to secure short
sale agreement liabilities, net investment income, changes in
estimated fair value included in net investment income for
trading and other securities and changes in estimated fair value
included in net investment gains (losses) for FVO Securities
held by CSEs at December 31, 2010 and 2009 and for the
years ended December 31, 2010, 2009 and 2008.
Trading and other securities and trading (short sale agreement)
liabilities, measured at estimated fair value on a recurring
basis and their corresponding fair value hierarchy, are
presented as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
Trading and Other Securities
|
|
|
Trading Liabilities
|
|
|
|
(In millions)
|
|
|
Quoted prices in active markets for identical assets and
liabilities (Level 1)
|
|
$
|
6,270
|
|
|
|
33.7
|
%
|
|
$
|
46
|
|
|
|
100.0
|
%
|
Significant other observable inputs (Level 2) (1)
|
|
|
11,497
|
|
|
|
61.9
|
|
|
|
|
|
|
|
|
|
Significant unobservable inputs (Level 3)
|
|
|
822
|
|
|
|
4.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total estimated fair value
|
|
$
|
18,589
|
|
|
|
100.0
|
%
|
|
$
|
46
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
All FVO Securities held by CSEs are classified as Level 2. |
A rollforward of the fair value measurements for trading and
other securities measured at estimated fair value on a recurring
basis using significant unobservable (Level 3) inputs
for the year ended December 31, 2010, is as follows:
|
|
|
|
|
|
|
Year Ended December 31, 2010
|
|
|
|
(In millions)
|
|
|
Balance, at January 1,
|
|
$
|
83
|
|
Total realized/unrealized gains (losses) included in:
|
|
|
|
|
Earnings
|
|
|
(7
|
)
|
Purchases, sales, issuances and settlements (1)
|
|
|
727
|
|
Transfer in and/or out of Level 3
|
|
|
19
|
|
|
|
|
|
|
Balance, at December 31,
|
|
$
|
822
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes securities acquired from ALICO of $582 million. |
See Summary of Critical Accounting
Estimates for further information on the estimates and
assumptions that affect the amounts reported above.
Mortgage
Loans
The Companys mortgage loans are principally collateralized
by commercial real estate, agricultural real estate and
residential properties. The carrying value of mortgage loans was
$62.4 billion and $50.9 billion, or 13.1% and 15.1% of
total cash and invested assets at December 31, 2010 and
2009, respectively. See Investments Mortgage
Loans in Note 3 of the Notes to the Consolidated
Financial Statements for a table that presents the
Companys mortgage loans
held-for-investment
of $59.1 billion and $48.2 billion by portfolio
segment at December 31, 2010 and 2009, respectively, as
well as the components of the mortgage loans
held-for-sale
of $3.3 billion and $2.7 billion at December 31,
2010 and 2009, respectively. The information presented on
Mortgage
142
Loans herein excludes the effects of consolidating under GAAP
certain VIEs that are treated as CSEs. Such amounts are
presented in the aforementioned table. See
Investments Mortgage Loans in
Note 3 of the Notes to the Consolidated Financial
Statements.
Commercial Mortgage Loans by Geographic Region and Property
Type. Commercial mortgage loans are the most
significant component of the mortgage loan invested asset class
as it represents 72% of total mortgage loans
held-for-investment
(excluding the effects of consolidating under GAAP certain VIEs
that are treated as CSEs) at both December 31, 2010 and
2009. The Company diversifies its commercial mortgage loan
portfolio by both geographic region and property type to reduce
the risk of concentration. Additionally, the Company manages
risk, when originating commercial and agricultural mortgage
loans, by generally lending only up to 75% of the estimated fair
value of the underlying real estate. The tables below present
the diversification across geographic regions and property types
for commercial mortgage loans at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
% of
|
|
|
|
Amount
|
|
|
Total
|
|
|
Amount
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Region:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pacific
|
|
$
|
8,974
|
|
|
|
23.7
|
%
|
|
$
|
8,822
|
|
|
|
25.1
|
%
|
South Atlantic
|
|
|
8,016
|
|
|
|
21.2
|
|
|
|
7,460
|
|
|
|
21.2
|
|
Middle Atlantic
|
|
|
6,484
|
|
|
|
17.1
|
|
|
|
6,042
|
|
|
|
17.2
|
|
International
|
|
|
4,216
|
|
|
|
11.2
|
|
|
|
3,620
|
|
|
|
10.3
|
|
West South Central
|
|
|
3,266
|
|
|
|
8.6
|
|
|
|
2,916
|
|
|
|
8.3
|
|
East North Central
|
|
|
3,066
|
|
|
|
8.1
|
|
|
|
2,531
|
|
|
|
7.2
|
|
New England
|
|
|
1,531
|
|
|
|
4.1
|
|
|
|
1,448
|
|
|
|
4.1
|
|
Mountain
|
|
|
884
|
|
|
|
2.3
|
|
|
|
959
|
|
|
|
2.7
|
|
West North Central
|
|
|
666
|
|
|
|
1.8
|
|
|
|
675
|
|
|
|
1.9
|
|
East South Central
|
|
|
461
|
|
|
|
1.2
|
|
|
|
449
|
|
|
|
1.3
|
|
Other
|
|
|
256
|
|
|
|
0.7
|
|
|
|
254
|
|
|
|
0.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total recorded investment
|
|
|
37,820
|
|
|
|
100.0
|
%
|
|
|
35,176
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less valuation allowances
|
|
|
562
|
|
|
|
|
|
|
|
589
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying value, net of valuation allowances
|
|
$
|
37,258
|
|
|
|
|
|
|
$
|
34,587
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property Type:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Office
|
|
$
|
16,857
|
|
|
|
44.6
|
%
|
|
$
|
15,205
|
|
|
|
43.2
|
%
|
Retail
|
|
|
9,215
|
|
|
|
24.3
|
|
|
|
7,964
|
|
|
|
22.6
|
|
Apartments
|
|
|
3,630
|
|
|
|
9.6
|
|
|
|
3,731
|
|
|
|
10.6
|
|
Hotel
|
|
|
3,089
|
|
|
|
8.2
|
|
|
|
3,117
|
|
|
|
8.9
|
|
Industrial
|
|
|
2,910
|
|
|
|
7.7
|
|
|
|
2,797
|
|
|
|
8.0
|
|
Other
|
|
|
2,119
|
|
|
|
5.6
|
|
|
|
2,362
|
|
|
|
6.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total recorded investment
|
|
|
37,820
|
|
|
|
100.0
|
%
|
|
|
35,176
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less valuation allowances
|
|
|
562
|
|
|
|
|
|
|
|
589
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying value, net of valuation allowances
|
|
$
|
37,258
|
|
|
|
|
|
|
$
|
34,587
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage Loan Credit Quality Restructured,
Potentially Delinquent, Delinquent or Under
Foreclosure. The Company monitors its mortgage
loan investments on an ongoing basis, including reviewing loans
that are restructured, potentially delinquent, and delinquent or
under foreclosure. These loan classifications are consistent
with those used in industry practice.
143
The Company defines restructured mortgage loans as loans in
which the Company, for economic or legal reasons related to the
debtors financial difficulties, grants a concession to the
debtor that it would not otherwise consider. The Company defines
potentially delinquent loans as loans that, in managements
opinion, have a high probability of becoming delinquent in the
near term. The Company defines delinquent mortgage loans
consistent with industry practice, when interest and principal
payments are past due as follows: commercial mortgage
loans 60 days past due; agricultural mortgage
loans 90 days past due; and residential
mortgage loans 60 days past due. The Company
defines mortgage loans under foreclosure as loans in which
foreclosure proceedings have formally commenced.
The following table presents the recorded investment and
valuation allowance for all mortgage loans
held-for-investment
distributed by the above stated loan classifications at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
Recorded
|
|
|
% of
|
|
|
Valuation
|
|
|
Recorded
|
|
|
Recorded
|
|
|
% of
|
|
|
Valuation
|
|
|
Recorded
|
|
|
|
Investment
|
|
|
Total
|
|
|
Allowance
|
|
|
Investment
|
|
|
Investment
|
|
|
Total
|
|
|
Allowance
|
|
|
Investment
|
|
|
|
(In millions)
|
|
|
Commercial:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performing
|
|
$
|
37,489
|
|
|
|
99.1
|
%
|
|
$
|
528
|
|
|
|
1.4
|
%
|
|
|
$
|
35,066
|
|
|
|
99.7
|
%
|
|
$
|
548
|
|
|
|
1.6
|
%
|
|
Restructured
|
|
|
93
|
|
|
|
0.2
|
|
|
|
6
|
|
|
|
6.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%
|
|
Potentially delinquent
|
|
|
180
|
|
|
|
0.5
|
|
|
|
28
|
|
|
|
15.6
|
%
|
|
|
|
102
|
|
|
|
0.3
|
|
|
|
41
|
|
|
|
40.2
|
%
|
|
Delinquent or under foreclosure
|
|
|
58
|
|
|
|
0.2
|
|
|
|
|
|
|
|
|
%
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
37,820
|
|
|
|
100.0
|
%
|
|
$
|
562
|
|
|
|
1.5
|
%
|
|
|
$
|
35,176
|
|
|
|
100.0
|
%
|
|
$
|
589
|
|
|
|
1.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agricultural (1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performing
|
|
$
|
12,486
|
|
|
|
97.9
|
%
|
|
$
|
35
|
|
|
|
0.3
|
%
|
|
|
$
|
11,950
|
|
|
|
97.5
|
%
|
|
$
|
33
|
|
|
|
0.3
|
%
|
|
Restructured
|
|
|
33
|
|
|
|
0.3
|
|
|
|
8
|
|
|
|
24.2
|
%
|
|
|
|
36
|
|
|
|
0.3
|
|
|
|
10
|
|
|
|
27.8
|
%
|
|
Potentially delinquent
|
|
|
62
|
|
|
|
0.5
|
|
|
|
11
|
|
|
|
17.7
|
%
|
|
|
|
128
|
|
|
|
1.0
|
|
|
|
34
|
|
|
|
26.6
|
%
|
|
Delinquent or under foreclosure
|
|
|
170
|
|
|
|
1.3
|
|
|
|
34
|
|
|
|
20.0
|
%
|
|
|
|
141
|
|
|
|
1.2
|
|
|
|
38
|
|
|
|
27.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
12,751
|
|
|
|
100.0
|
%
|
|
$
|
88
|
|
|
|
0.7
|
%
|
|
|
$
|
12,255
|
|
|
|
100.0
|
%
|
|
$
|
115
|
|
|
|
0.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential (2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performing
|
|
$
|
2,221
|
|
|
|
96.2
|
%
|
|
$
|
12
|
|
|
|
0.5
|
%
|
|
|
$
|
1,389
|
|
|
|
94.4
|
%
|
|
$
|
16
|
|
|
|
1.2
|
%
|
|
Restructured
|
|
|
4
|
|
|
|
0.2
|
|
|
|
|
|
|
|
|
%
|
|
|
|
1
|
|
|
|
0.1
|
|
|
|
|
|
|
|
|
%
|
|
Potentially delinquent
|
|
|
4
|
|
|
|
0.2
|
|
|
|
|
|
|
|
|
%
|
|
|
|
10
|
|
|
|
0.7
|
|
|
|
|
|
|
|
|
%
|
|
Delinquent or under foreclosure
|
|
|
79
|
|
|
|
3.4
|
|
|
|
2
|
|
|
|
2.5
|
%
|
|
|
|
71
|
|
|
|
4.8
|
|
|
|
1
|
|
|
|
1.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
2,308
|
|
|
|
100.0
|
%
|
|
$
|
14
|
|
|
|
0.6
|
%
|
|
|
$
|
1,471
|
|
|
|
100.0
|
%
|
|
$
|
17
|
|
|
|
1.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Of the $12.8 billion of agricultural mortgage loans
outstanding at December 31, 2010, 53% were subject to rate
resets prior to maturity. A substantial portion of these
mortgage loans have been successfully renegotiated and remain
outstanding to maturity. |
|
(2) |
|
Residential mortgage loans
held-for-investment
consist primarily of first lien residential mortgage loans, and
to a much lesser extent, second lien residential mortgage loans
and home equity lines of credit. |
See Investments Mortgage Loans in
Note 3 of the Notes to the Consolidated Financial
Statements for tables that present, by portfolio segment,
mortgage loans by credit quality indicator and impaired loans,
as well as information on past due and nonaccrual mortgage loans
for the year ended December 31, 2010.
Mortgage Loan Credit Quality Monitoring
Process Commercial and Agricultural Mortgage
Loans. The Company reviews all commercial
mortgage loans on an ongoing basis. These reviews may include an
analysis of the property financial statements and rent roll,
lease rollover analysis, property inspections, market analysis,
estimated valuations of the underlying collateral,
loan-to-value
ratios, debt service coverage ratios, and tenant
144
creditworthiness. The monitoring process focuses on higher risk
loans, which include those that are classified as restructured,
potentially delinquent, delinquent or in foreclosure, as well as
loans with higher
loan-to-value
ratios and lower debt service coverage ratios. The monitoring
process for agricultural mortgage loans is generally similar,
with a focus on higher risk loans, such as loans with higher
loan-to-value
ratios, including reviews on a geographic and property type
basis.
Loan-to-value
ratios and debt service coverage ratios are common measures in
the assessment of the quality of commercial mortgage loans.
Loan-to-value
ratios are a common measure in the assessment of the quality of
agricultural mortgage loans.
Loan-to-value
ratios compare the amount of the loan to the estimated fair
value of the underlying collateral. A
loan-to-value
ratio greater than 100% indicates that the loan amount is
greater than the collateral value. A
loan-to-value
ratio of less than 100% indicates an excess of collateral value
over the loan amount. The debt service coverage ratio compares a
propertys net operating income to amounts needed to
service the principal and interest due under the loan. For
commercial mortgage loans, the average
loan-to-value
ratio was 66% and 68% at December 31, 2010 and 2009,
respectively, and the average debt service coverage ratio was
2.4x, as compared to 2.2x at December 31, 2009. For
agricultural mortgage loans, the average
loan-to-value
ratio was 49% at both December 31, 2010 and 2009,
respectively. The values utilized in calculating these ratios
are developed in connection with our review of the commercial
and agricultural mortgage loans, and are updated routinely,
including a periodic quality rating process and an evaluation of
the estimated fair value of the underlying collateral.
Mortgage Loan Credit Quality Monitoring
Process Residential Mortgage
Loans. The Company has a conservative residential
mortgage loan portfolio and does not hold any option ARMs,
sub-prime or
low teaser rate. Higher risk loans include those that are
classified as restructured, potentially delinquent, delinquent
or in foreclosure, as well as loans with higher
loan-to-value
ratios and interest-only loans. The Companys investment in
residential junior lien loans and residential mortgage loans
with a
loan-to-value
ratio of 80% or more was $95 million and $76 million
at December 31, 2010 and 2009, respectively, and the
majority of the higher
loan-to-value
residential mortgage loans have mortgage insurance coverage
which reduces the
loan-to-value
ratio to less than 80%. Additionally, the Companys
investment in traditional residential interest-only mortgage
loans was $389 million and $323 million at
December 31, 2010 and 2009, respectively.
Mortgage Loan Valuation Allowances. The
Companys valuation allowances are established both on a
loan specific basis for those loans considered impaired where a
property specific or market specific risk has been identified
that could likely result in a future loss, as well as for pools
of loans with similar risk characteristics where a property
specific or market specific risk has not been identified, but
for which the Company expects to incur a loss. Accordingly, a
valuation allowance is provided to absorb these estimated
probable credit losses. The Company records additions to and
decreases in its valuation allowances and gains and losses from
the sale of loans in net investment gains (losses).
The Company records valuation allowances for loans considered to
be impaired when it is probable that, based upon current
information and events, the Company will be unable to collect
all amounts due under the contractual terms of the loan
agreement. Based on the facts and circumstances of the
individual loans being impaired, loan specific valuation
allowances are established for the excess carrying value of the
loan over either: (i) the present value of expected future
cash flows discounted at the loans original effective
interest rate; (ii) the estimated fair value of the
loans underlying collateral if the loan is in the process
of foreclosure or otherwise collateral dependent; or
(iii) the loans observable market price.
The Company also establishes valuation allowances for loan
losses for pools of loans with similar risk characteristics,
such as property types,
loan-to-value
ratios and debt service coverage ratios when, based on past
experience, it is probable that a credit event has occurred and
the amount of loss can be reasonably estimated. These valuation
allowances are based on loan risk characteristics, historical
default rates and loss severities, real estate market
fundamentals and outlook, as well as, other relevant factors.
The determination of the amount of, and additions or decreases
to, valuation allowances is based upon the Companys
periodic evaluation and assessment of known and inherent risks
associated with its loan portfolios. Such evaluations and
assessments are based upon several factors, including the
Companys experience for loan losses, defaults and loss
severity, and loss expectations for loans with similar risk
characteristics. These evaluations and assessments are revised
as conditions change and new information becomes available. We
update our evaluations
145
regularly, which can cause the valuation allowances to increase
or decrease over time as such evaluations are revised. Negative
credit migration including an actual or expected increase in the
level of problem loans will result in an increase in the
valuation allowance. Positive credit migration including an
actual or expected decrease in the level of problem loans will
result in a decrease in the valuation allowance. Such changes in
the valuation allowance are recorded in net investment gains
(losses).
See Investments Mortgage Loans in
Note 3 of the Notes to the Consolidated Financial
Statements for a table that presents the activity in the
Companys valuation allowances, by portfolio segment, for
the years ended December 31, 2010, 2009 and 2008,
respectively; and for tables that present the Companys
valuation allowances, by type of credit loss, by portfolio
segment, at December 31, 2010 and 2009, respectively.
The Company held $197 million and $210 million in
mortgage loans which are carried at estimated fair value based
on the value of the underlying collateral or independent broker
quotations, if lower, of which $164 million and
$202 million relate to impaired mortgage loans
held-for-investment
and $33 million and $8 million to certain mortgage
loans
held-for-sale,
at December 31, 2010 and 2009, respectively. These impaired
mortgage loans were recorded at estimated fair value and
represent a nonrecurring fair value measurement. The estimated
fair value is categorized as Level 3. Included within net
investment gains (losses) for such impaired mortgage loans were
net impairments of $17 million and $93 million for the
years ended December 31, 2010 and 2009, respectively.
Subsequent improvements in estimated fair value on previously
impaired loans recorded through a reduction in the previously
established provision to the valuation allowance are reported as
a (release) above.
Real
Estate and Real Estate Joint Ventures
The Company diversifies its real estate investments by both
geographic region and property type to reduce risk of
concentration. Of the Companys real estate investments,
88% are located in the U.S. with the remaining 12% located
outside the U.S., at December 31, 2010. The carrying value
of the Companys real estate investments was
$8.0 billion, or 1.7%, and $6.9 billion, or 2.0%, of
total cash and invested assets at December 31, 2010 and
2009, respectively. See Investments Real
Estate in Note 3 of the Notes to the Consolidated
Financial Statements for tables that present the Companys
real estate investments by investment strategy and by property
type at December 31, 2010 and 2009.
Properties acquired through foreclosure were $165 million,
$127 million and less than $1 million for the years
ended December 31, 2010, 2009 and 2008, respectively, and
includes commercial, agricultural and residential properties.
After the Company acquires properties through foreclosure, it
evaluates whether the property is appropriate for retention in
its traditional real estate portfolio. Foreclosed real estate
held at December 31, 2010 and 2009 includes those
properties the Company has not selected for retention in its
traditional real estate portfolio and which do not meet the
criteria to be classified as
held-for-sale.
Impairments recognized on real estate
held-for-investment
were $48 million, $160 million and $20 million
for the years ended December 31, 2010, 2009 and 2008,
respectively. Impairments recognized on real estate
held-for-sale
were $1 million for the year ended December 31, 2010.
There were no impairments recognized on real estate
held-for-sale
for each of the years ended December 31, 2009 and 2008. The
Companys carrying value of real estate
held-for-sale
has been reduced by impairments recorded prior to 2009 of
$1 million at both December 31, 2010 and 2009. The
carrying value of non-income producing real estate was
$137 million, $76 million and $28 million at
December 31, 2010, 2009 and 2008, respectively.
The impaired cost method basis real estate joint ventures were
recorded at estimated fair value and represent a non-recurring
fair value measurement. The estimated fair value was categorized
as Level 3. Impairments to estimated fair value for such
cost method basis real estate joint ventures of
$25 million, $82 million, and $0 for the years ended
December 31, 2010, 2009 and 2008, respectively, were
recognized within net investment gains (losses) and are included
in the $48 million, $160 million and $20 million
of impairments on real estate investments
held-for-investment
for the years ended December 31, 2010, 2009 and 2008,
respectively. The estimated fair value of the impaired cost
method real estate joint ventures after these impairments was
$8 million and $93 million at December 31, 2010
and 2009, respectively.
146
Other
Limited Partnership Interests
The carrying value of other limited partnership interests (which
primarily represent ownership interests in pooled investment
funds that principally make private equity investments in
companies in the U.S. and overseas) was $6.4 billion
and $5.5 billion, or 1.3% and 1.6% of total cash and
invested assets at December 31, 2010 and 2009,
respectively. Included within other limited partnership
interests were $1.0 billion, at both December 31, 2010
and 2009, of investments in hedge funds.
Impairments on cost basis limited partnership interests are
recognized at estimated fair value determined from information
provided in the financial statements of the underlying other
limited partnership interests in the period in which the
impairment is recognized. Consistent with equity securities,
greater weight and consideration is given in the other limited
partnership interests impairment review process to the severity
and duration of unrealized losses on such other limited
partnership interests holdings. Impairments to estimated fair
value for such other limited partnership interests of
$12 million, $354 million and $105 million for
the years ended December 31, 2010, 2009 and 2008,
respectively, were recognized within net investment gains
(losses). The estimated fair value of the impaired other limited
partnership interests after these impairments was
$23 million, $561 million and $137 million at
December 31, 2010, 2009 and 2008, respectively. These
impairments to estimated fair value represent non-recurring fair
value measurements that have been classified as Level 3 due
to the limited activity and price transparency inherent in the
market for such investments.
Other
Invested Assets
See Investments Other Invested Assets in
Note 3 of the Notes to the Consolidated Financial
Statements for a table that presents the Companys other
invested assets by type at December 31, 2010 and 2009 and
related information.
Short-term
Investments
The carrying value of short-term investments, which include
investments with remaining maturities of one year or less, but
greater than three months, at the time of purchase was
$9.4 billion and $8.4 billion, or 2.0% and 2.5% of
total cash and invested assets at December 31, 2010 and
2009, respectively. The Company is exposed to concentrations of
credit risk related to securities of the U.S. government
and certain U.S. government agencies included within
short-term investments, which were $4.0 billion and
$7.5 billion at December 31, 2010 and 2009,
respectively.
Cash
Equivalents
The carrying value of cash equivalents, which includes
investments with an original or remaining maturity of three
months or less, at the time of purchase was $9.6 billion
and $8.4 billion at December 31, 2010 and 2009,
respectively. The Company is exposed to concentrations of credit
risk related to securities of the U.S. government and
certain U.S. government agencies included within cash
equivalents, which were $5.8 billion and $6.0 billion
at December 31, 2010 and 2009, respectively.
Derivative
Financial Instruments
Derivatives. The Company is exposed to various
risks relating to its ongoing business operations, including
interest rate risk, foreign currency risk, credit risk, and
equity market risk. The Company uses a variety of strategies to
manage these risks, including the use of derivative instruments.
See Note 4 of the Notes to Consolidated Financial
Statements for:
|
|
|
|
|
A comprehensive description of the nature of the Companys
derivative instruments, including the strategies for which
derivatives are used in managing various risks.
|
|
|
|
Information about the notional amount, estimated fair value, and
primary underlying risk exposure of the Companys
derivative financial instruments, excluding embedded derivatives
held at December 31, 2010 and 2009.
|
147
Hedging. See Note 4 of the Notes to
Consolidated Financial Statements for information about:
|
|
|
|
|
The notional amount and estimated fair value of derivatives and
non-derivative instruments designated as hedging instruments by
type of hedge designation at December 31, 2010 and 2009.
|
|
|
|
The notional amount and estimated fair value of derivatives that
are not designated or do not qualify as hedging instruments by
derivative type at December 31, 2010 and 2009.
|
|
|
|
The statement of operations effects of derivatives in cash flow,
fair value, or non-qualifying hedge relationships for the years
ended December 31, 2010, 2009, and 2008.
|
See Quantitative and Qualitative Disclosures About Market
Risk Management of Market Risk Exposures
Hedging Activities for more information about the
Companys use of derivatives by major hedge program.
Fair Value Hierarchy. Derivatives measured at
estimated fair value on a recurring basis and their
corresponding fair value hierarchy, are presented as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
Derivative
|
|
|
Derivative
|
|
|
|
Assets
|
|
|
Liabilities
|
|
|
|
(In millions)
|
|
|
Quoted prices in active markets for identical assets and
liabilities (Level 1)
|
|
$
|
156
|
|
|
|
2
|
%
|
|
$
|
45
|
|
|
|
1
|
%
|
Significant other observable inputs (Level 2)
|
|
|
7,176
|
|
|
|
92
|
|
|
|
4,245
|
|
|
|
93
|
|
Significant unobservable inputs (Level 3)
|
|
|
445
|
|
|
|
6
|
|
|
|
272
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total estimated fair value
|
|
$
|
7,777
|
|
|
|
100
|
%
|
|
$
|
4,562
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The valuation of Level 3 derivatives involves the use of
significant unobservable inputs and generally requires a higher
degree of management judgment or estimation than the valuations
of Level 1 and Level 2 derivatives. Although
Level 3 inputs are based on assumptions deemed appropriate
given the circumstances and are assumed to be consistent with
what other market participants would use when pricing such
instruments, the use of different inputs or methodologies could
have a material effect on the estimated fair value of
Level 3 derivatives and could materially affect net income.
Derivatives categorized as Level 3 at December 31,
2010 include: interest rate forwards with maturities which
extend beyond the observable portion of the yield curve;
interest rate lock commitments with certain unobservable inputs,
including pull-through rates; equity variance swaps with
unobservable volatility inputs or that are priced via
independent broker quotations; foreign currency swaps which are
cancelable and priced through independent broker quotations;
interest rate swaps with maturities which extend beyond the
observable portion of the yield curve; credit default swaps
based upon baskets of credits having unobservable credit
correlations, as well as credit default swaps with maturities
which extend beyond the observable portion of the credit curves
and credit default swaps priced through independent broker
quotes; foreign currency forwards priced via independent broker
quotations or with liquidity adjustments; implied volatility
swaps with unobservable volatility inputs or that are priced via
independent broker quotations; equity options with unobservable
volatility inputs or that are priced via independent broker
quotations; currency options based upon baskets of currencies
having unobservable currency correlations; and credit forwards
having unobservable repurchase rates.
At December 31, 2010 and 2009, 2.0% and 5.5%, respectively,
of the net derivative estimated fair value was priced via
independent broker quotations.
148
A rollforward of the fair value measurements for derivatives
measured at estimated fair value on a recurring basis using
significant unobservable (Level 3) inputs for the year
ended December 31, 2010 is as follows:
|
|
|
|
|
|
|
Year Ended December 31, 2010
|
|
|
|
(In millions)
|
|
|
Balance, at January 1,
|
|
$
|
356
|
|
Total realized/unrealized gains (losses) included in:
|
|
|
|
|
Earnings
|
|
|
(5
|
)
|
Other comprehensive income (loss)
|
|
|
(81
|
)
|
Purchases, sales, issuances and settlements
|
|
|
(75
|
)
|
Transfer in and/or out of Level 3
|
|
|
(22
|
)
|
|
|
|
|
|
Balance, at December 31,
|
|
$
|
173
|
|
|
|
|
|
|
See Summary of Critical Accounting
Estimates Derivative Financial Instruments for
further information on the estimates and assumptions that affect
the amounts reported above.
Credit Risk. See Note 4 of the Notes to Consolidated
Financial Statements for information about how the Company
manages credit risk related to its freestanding derivatives,
including the use of master netting agreements and collateral
arrangements.
Credit Derivatives. See Note 4 of the Notes to
Consolidated Financial Statements for information about the
estimated fair value and maximum amount at risk related to the
Companys written credit default swaps.
Embedded Derivatives. The embedded derivatives
measured at estimated fair value on a recurring basis and their
corresponding fair value hierarchy, are presented as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
Net Embedded Derivatives Within
|
|
|
|
Asset Host Contracts
|
|
|
Liability Host Contracts
|
|
|
|
(In millions)
|
|
|
Quoted prices in active markets for identical assets and
liabilities (Level 1)
|
|
$
|
|
|
|
|
|
%
|
|
$
|
|
|
|
|
|
%
|
Significant other observable inputs (Level 2)
|
|
|
|
|
|
|
|
|
|
|
11
|
|
|
|
|
|
Significant unobservable inputs (Level 3)
|
|
|
185
|
|
|
|
100
|
|
|
|
2,623
|
|
|
|
100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total estimated fair value
|
|
$
|
185
|
|
|
|
100
|
%
|
|
$
|
2,634
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A rollforward of the fair value measurements for net embedded
derivatives measured at estimated fair value on a recurring
basis using significant unobservable (Level 3) inputs
is as follows:
|
|
|
|
|
|
|
Year Ended December 31, 2010
|
|
|
|
(In millions)
|
|
|
Balance, at January 1,
|
|
$
|
(1,455
|
)
|
Total realized/unrealized gains (losses) included in:
|
|
|
|
|
Earnings
|
|
|
(335
|
)
|
Other comprehensive income (loss)
|
|
|
(226
|
)
|
Purchases, sales, issuances and settlements
|
|
|
(422
|
)
|
Transfer in and/or out of Level 3
|
|
|
|
|
|
|
|
|
|
Balance, at December 31,
|
|
$
|
(2,438
|
)
|
|
|
|
|
|
The valuation of guaranteed minimum benefits includes an
adjustment for nonperformance risk. Included in net derivative
gains (losses) for the years ended December 31, 2010 and
2009 were gains (losses) of ($96) million and
($1,932) million, respectively, in connection with this
adjustment. These amounts are net of a loss of $955 million
relating to a refinement for estimating nonperformance risk in
fair value measurements implemented at June 30, 2010. See
Summary of Critical Accounting
Estimates.
149
See Summary of Critical Accounting
Estimates Embedded Derivatives for further
information on the estimates and assumptions that affect the
amounts reported above.
Off-Balance
Sheet Arrangements
Commitments
to Fund Partnership Investments
The Company makes commitments to fund partnership investments in
the normal course of business for the purpose of enhancing the
Companys total return on its investment portfolio. The
amounts of these unfunded commitments were $3.8 billion and
$4.1 billion at December 31, 2010 and 2009,
respectively. The Company anticipates that these amounts will be
invested in partnerships over the next five years.
Mortgage
Loan Commitments
The Company has issued interest rate lock commitments on certain
residential mortgage loan applications totaling
$2.5 billion and $2.7 billion at December 31,
2010 and 2009, respectively. The Company intends to sell the
majority of these originated residential mortgage loans.
Interest rate lock commitments to fund mortgage loans that will
be
held-for-sale
are considered derivatives pursuant to the guidance on
derivatives and hedging, and their estimated fair value and
notional amounts are included within interest rate forwards.
The Company also commits to lend funds under certain other
mortgage loan commitments that will be
held-for-investment
in the normal course of business for the purpose of enhancing
the Companys total return on its investment portfolio. The
amounts of these mortgage loan commitments were
$3.8 billion and $2.2 billion at December 31,
2010 and 2009, respectively.
Commitments
to Fund Bank Credit Facilities, Bridge Loans and Private
Corporate Bond Investments
The Company commits to lend funds under bank credit facilities,
bridge loans and private corporate bond investments in the
normal course of business for the purpose of enhancing the
Companys total return on its investment portfolio. The
amounts of these unfunded commitments were $2.4 billion and
$1.3 billion at December 31, 2010 and 2009,
respectively.
There are no other material obligations or liabilities arising
from the commitments to fund partnership investments, mortgage
loans, bank credit facilities, and bridge loans and private
corporate bond investment arrangements.
Lease
Commitments
The Company, as lessee, has entered into various lease and
sublease agreements for office space, information technology and
other equipment. The Companys commitments under such lease
agreements are included within the contractual obligations
table. See Liquidity and Capital
Resources The Company Liquidity and
Capital Uses Contractual Obligations.
Credit
Facilities, Committed Facilities and Letters of
Credit
The Company maintains committed and unsecured credit facilities
and letters of credit with various financial institutions. See
Liquidity and Capital Resources The
Company Liquidity and Capital Sources
Credit and Committed Facilities, for further descriptions
of such arrangements.
Guarantees
See Guarantees in Note 16 of the Notes to the
Consolidated Financial Statements.
Collateral
for Securities Lending
The Company has no non-cash collateral for securities lending on
deposit from customers, which cannot be sold or repledged, and
which has not been recorded on its consolidated balance sheets.
150
Insolvency
Assessments
See Note 16 of the Notes to the Consolidated Financial
Statements.
Policyholder
Liabilities
The Company establishes, and carries as liabilities, actuarially
determined amounts that are calculated to meet policy
obligations when a policy matures or is surrendered, an insured
dies or becomes disabled or upon the occurrence of other covered
events, or to provide for future annuity payments. Amounts for
actuarial liabilities are computed and reported in the
consolidated financial statements in conformity with GAAP. For
more details on Policyholder Liabilities, see
Summary of Critical Accounting Estimates. Also see
Notes 1 and 8 of the Notes to the Consolidated Financial
Statements for an analysis of certain policyholder liabilities
at December 31, 2010 and 2009.
Due to the nature of the underlying risks and the high degree of
uncertainty associated with the determination of actuarial
liabilities, the Company cannot precisely determine the amounts
that will ultimately be paid with respect to these actuarial
liabilities, and the ultimate amounts may vary from the
estimated amounts, particularly when payments may not occur
until well into the future.
However, we believe our actuarial liabilities for future
benefits are adequate to cover the ultimate benefits required to
be paid to policyholders. We periodically review our estimates
of actuarial liabilities for future benefits and compare them
with our actual experience. We revise estimates, to the extent
permitted or required under GAAP, if we determine that future
expected experience differs from assumptions used in the
development of actuarial liabilities.
The Company has experienced, and will likely in the future
experience, catastrophe losses and possibly acts of terrorism,
and turbulent financial markets that may have an adverse impact
on our business, results of operations, and financial condition.
Catastrophes can be caused by various events, including
pandemics, hurricanes, windstorms, earthquakes, hail, tornadoes,
explosions, severe winter weather (including snow, freezing
water, ice storms and blizzards), fires and man-made events such
as terrorist attacks. Due to their nature, we cannot predict the
incidence, timing, severity or amount of losses from
catastrophes and acts of terrorism, but we make broad use of
catastrophic and non-catastrophic reinsurance to manage risk
from these perils.
Future
Policy Benefits
The Company establishes liabilities for amounts payable under
insurance policies. Generally, amounts are payable over an
extended period of time and related liabilities are calculated
as the present value of expected future benefits to be paid,
reduced by the present value of expected future net premiums.
Such liabilities are established based on methods and underlying
assumptions in accordance with GAAP and applicable actuarial
standards. Principal assumptions used in the establishment of
liabilities for future policy benefits include mortality,
morbidity, policy lapse, renewal, retirement, investment
returns, inflation, expenses and other contingent events as
appropriate to the respective product type. These assumptions
are established at the time the policy is issued and are
intended to estimate the experience for the period the policy
benefits are payable. Utilizing these assumptions, liabilities
are established on a block of business basis. If experience is
less favorable than assumed and future losses are projected
under loss recognition testing, then additional liabilities may
be required, resulting in a charge to policyholder benefits and
claims.
Insurance Products. Future policy benefits are
comprised mainly of liabilities for disabled lives under
disability waiver of premium policy provisions, liabilities for
survivor income benefit insurance, long-term care
(LTC) policies, active life policies and premium
stabilization and other contingency liabilities held under
participating life insurance contracts. In order to manage risk,
the Company has often reinsured a portion of the mortality risk
on new individual life insurance policies. The reinsurance
programs are routinely evaluated and this may result in
increases or decreases to existing coverage. The Company entered
into various derivative positions, primarily interest rate swaps
and swaptions, to mitigate the risk that investment of premiums
received and reinvestment of maturing assets over the life of
the policy will be at rates below those assumed in the original
pricing of these contracts.
151
Retirement Products. Future policy benefits
are comprised mainly of liabilities for life-contingent income
annuities, supplemental contracts with and without life
contingencies, liabilities for Guaranteed Minimum Death Benefits
(GMDBs) included in certain annuity contracts, and a
certain portion of guaranteed living benefits. See
Variable Annuity Guarantees.
Corporate Benefit Funding. Liabilities are
primarily related to structured settlement annuities. There is
no interest rate crediting flexibility on these liabilities. A
sustained low interest rate environment could negatively impact
earnings as a result. The Company has various derivative
positions, primarily interest rate floors and interest rate
swaps, to mitigate the risks associated with such a scenario.
Auto & Home. Future policy benefits
include liabilities for unpaid claims and claim expenses for
property and casualty insurance and represent the amount
estimated for claims that have been reported but not settled and
claims incurred but not reported. Liabilities for unpaid claims
are estimated based upon assumptions such as rates of claim
frequencies, levels of severities, inflation, judicial trends,
legislative changes or regulatory decisions. Assumptions are
based upon the Companys historical experience and analyses
of historical development patterns of the relationship of loss
adjustment expenses to losses for each line of business, and
consider the effects of current developments, anticipated trends
and risk management programs, reduced for anticipated salvage
and subrogation.
International. Future policy benefits are held
primarily for traditional life and accident and health contracts
in Japan, Asia Pacific and immediate annuities in Latin America.
They are also held for total return pass-thru provisions
included in certain universal life and savings products mainly
in Japan and Latin America, and traditional life, endowment and
annuity contracts sold in various countries in Asia Pacific.
They also include certain liabilities for variable annuity
guarantees of minimum death benefits, and longevity guarantees
sold in Japan and Asia Pacific. Finally, in Europe and the
Middle East, they also include unearned premium liabilities
established for credit insurance contracts covering death,
disability and involuntary loss of employment, as well as
traditional life, accident and health and endowment contracts.
Factors impacting these liabilities include sustained periods of
lower yields than rates established at issue, lower than
expected asset reinvestment rates, higher than expected lapse
rates, asset default and more rapid improvement of mortality
levels than anticipated for life contingent immediate annuities.
The Company mitigates its risks by implementing an
asset/liability matching policy and through the development of
periodic experience studies. See Variable Annuity
Guarantees.
Estimates for the liabilities for unpaid claims and claim
expenses are reset as actuarial indications change and these
changes in the liability are reflected in the current results of
operation as either favorable or unfavorable development of
prior year losses.
Banking, Corporate & Other. Future
policy benefits primarily include liabilities for quota-share
reinsurance agreements for certain LTC and workers
compensation business written by MetLife Insurance Company of
Connecticut (MICC), prior to its acquisition by
MetLife, Inc. These are run-off businesses that have been
included within Banking, Corporate & Other since the
acquisition of MICC.
Policyholder
Account Balances
Policyholder account balances are generally equal to the account
value, which includes accrued interest credited, but exclude the
impact of any applicable surrender charge that may be incurred
upon surrender.
Insurance Products. Policyholder account
balances are held for death benefit disbursement retained asset
accounts, universal life policies, the fixed account of variable
life insurance policies, specialized life insurance products for
benefit programs and general account universal life policies.
Policyholder account balances are credited interest at a rate
set by the Company, which are influenced by current market
rates. The majority of the policyholder account balances have a
guaranteed minimum credited rate between 0.5% and 6.0%. A
sustained low interest rate environment could negatively impact
earnings as a result of the minimum credited rate guarantees.
The Company has various derivative positions, primarily interest
rate floors, to partially mitigate the risks associated with
such a scenario.
Retirement Products. Policyholder account
balances are held for fixed deferred annuities and the fixed
account portion of variable annuities, for certain income
annuities, and for certain portions of guaranteed benefits.
152
Policyholder account balances are credited interest at a rate
set by the Company. Credited rates for deferred annuities are
influenced by current market rates, and most of these contracts
have a minimum guaranteed rate between 1.0% and 4.0%. See
Variable Annuity Guarantees.
Corporate Benefit Funding. Policyholder
account balances are comprised of funding agreements. Interest
crediting rates vary by type of contract, and can be fixed or
variable. Variable interest crediting rates are generally tied
to an external index, most commonly
1-month or
3-month
LIBOR. MetLife is exposed to interest rate risks, and foreign
exchange risk when guaranteeing payment of interest and return
of principal at the contractual maturity date. The Company may
invest in floating rate assets, or enter into floating rate
swaps, also tied to external indices, as well as caps to
mitigate the impact of changes in market interest rates. The
Company also mitigates its risks by implementing an
asset/liability matching policy and seeks to hedge all foreign
currency risk through the use of foreign currency hedges,
including cross currency swaps.
International. Policyholder account balances
are held largely for fixed income retirement and savings plans
in Japan and Latin America and to a lesser degree, amounts for
unit-linked-type funds in certain countries across all regions
that do not meet the GAAP definition of separate accounts. Also
included are certain liabilities for retirement and savings
products sold in certain countries in Japan and Asia Pacific
that generally are sold with minimum credited rate guarantees.
Liabilities for guarantees on certain variable annuities in
Japan and Asia Pacific are established in accordance with
derivatives and hedging guidance and are also included within
policyholder account balances. These liabilities are generally
impacted by sustained periods of low interest rates, where there
are interest rate guarantees. The Company mitigates its risks by
implementing an asset/liability matching policy and by hedging
its variable annuity guarantees. Liabilities for
unit-linked-type funds are impacted by changes in the fair value
of the associated underlying investments, as the return on
assets is generally passed directly to the policyholder. See
Variable Annuity Guarantees.
Variable
Annuity Guarantees
The Company issues certain variable annuity products with
guaranteed minimum benefits that provide the policyholder a
minimum return based on their initial deposit (i.e., the benefit
base) less withdrawals. In some cases the benefit base may be
increased by additional deposits, bonus amounts, accruals or
market value resets. These guarantees are accounted for as
insurance liabilities or as embedded derivatives depending on
how and when the benefit is paid. Specifically, a guarantee is
accounted for as an embedded derivative if a guarantee is paid
without requiring (i) the occurrence of specific insurable
event, or (ii) the policyholder to annuitize.
Alternatively, a guarantee is accounted for as an insurance
liability if the guarantee is paid only upon either (i) the
occurrence of a specific insurable event, or (ii) upon
annuitization. In certain cases, a guarantee may have elements
of both an insurance liability and an embedded derivative and in
such cases the guarantee is accounted for under a split of the
two models.
The net amount at risk (NAR) for guarantees can
change significantly during periods of sizable and sustained
shifts in equity market performance, increased equity
volatility, or changes in interest rates. The NAR disclosed in
Note 8 of the Notes to the Consolidated Financial
Statements represents managements estimate of the current
value of the benefits under these guarantees if they were all
exercised simultaneously at December 31, 2010 and 2009,
respectively. However, there are features, such as deferral
periods and benefits requiring annuitization or death, that
limit the amount of benefits that will be payable in the near
future.
Guarantees, including portions thereof, accounted for as
embedded derivatives, are recorded at estimated fair value and
included in policyholder account balances. Guarantees accounted
for as embedded derivatives include GMAB, the non
life-contingent portion of GMWB and the portion of certain GMIB
that do not require annuitization. For more detail on the
determination of estimated fair value, see Note 5 of the
Notes to the Consolidated Financial Statements.
153
The table below contains the carrying value for guarantees
included in policyholder account balances at:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
U.S. Business:
|
|
|
|
|
|
|
|
|
Guaranteed minimum accumulation benefit
|
|
$
|
44
|
|
|
$
|
60
|
|
Guaranteed minimum withdrawal benefit
|
|
|
173
|
|
|
|
154
|
|
Guaranteed minimum income benefit
|
|
|
(51
|
)
|
|
|
66
|
|
International:
|
|
|
|
|
|
|
|
|
Guaranteed minimum accumulation benefit
|
|
|
454
|
|
|
|
195
|
|
Guaranteed minimum withdrawal benefit
|
|
|
1,936
|
|
|
|
1,025
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
2,556
|
|
|
$
|
1,500
|
|
|
|
|
|
|
|
|
|
|
Included in net derivative gains (losses) for the years ended
December 31, 2010 and 2009 were gains (losses) of
($269) million and $1,806 million, respectively, in
embedded derivatives related to the change in estimated fair
value of the guarantees. The carrying amount of guarantees
accounted for at estimated fair value includes an adjustment for
nonperformance risk. In connection with this adjustment, gains
(losses) of ($96) million and ($1,932) million are
included in the gains (losses) of ($269) million and
$1,806 million in net derivative gains (losses) for the
year ended December 31, 2010 and 2009, respectively.
The estimated fair value of guarantees accounted for as embedded
derivatives can change significantly during periods of sizable
and sustained shifts in equity market performance, equity
volatility, interest rates or foreign exchange rates.
Additionally, because the estimated fair value for guarantees
accounted for at estimated fair value includes an adjustment for
nonperformance risk, a decrease in the Companys credit
spreads could cause the value of these liabilities to increase.
Conversely, a widening of the Companys credit spreads
could cause the value of these liabilities to decrease. The
Company uses derivative instruments and reinsurance to mitigate
the liability exposure, risk of loss and the volatility of net
income associated with these liabilities. The derivative
instruments used are primarily equity and treasury futures,
equity options and variance swaps, and interest rate swaps. The
change in valuation arising from the nonperformance risk is not
hedged.
The table below presents the estimated fair value of the
derivatives hedging guarantees accounted for as embedded
derivatives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
Primary Underlying
|
|
|
|
|
Notional
|
|
|
Estimated Fair Value
|
|
|
Notional
|
|
|
Estimated Fair Value
|
|
Risk Exposure
|
|
Derivative Type
|
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
|
|
|
|
(In millions)
|
|
|
Interest rate
|
|
|
Interest rate swaps
|
|
|
$
|
13,762
|
|
|
$
|
401
|
|
|
$
|
193
|
|
|
$
|
8,847
|
|
|
$
|
194
|
|
|
$
|
275
|
|
|
|
|
Interest rate futures
|
|
|
|
5,822
|
|
|
|
32
|
|
|
|
10
|
|
|
|
4,997
|
|
|
|
5
|
|
|
|
4
|
|
|
|
|
Interest rate options
|
|
|
|
614
|
|
|
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency
|
|
|
Foreign currency forwards
|
|
|
|
2,320
|
|
|
|
46
|
|
|
|
1
|
|
|
|
2,016
|
|
|
|
4
|
|
|
|
30
|
|
|
|
|
Currency options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
327
|
|
|
|
14
|
|
|
|
|
|
Equity market
|
|
|
Equity futures
|
|
|
|
6,959
|
|
|
|
17
|
|
|
|
9
|
|
|
|
6,033
|
|
|
|
31
|
|
|
|
20
|
|
|
|
|
Equity options
|
|
|
|
32,942
|
|
|
|
1,720
|
|
|
|
1,196
|
|
|
|
26,661
|
|
|
|
1,596
|
|
|
|
1,018
|
|
|
|
|
Variance swaps
|
|
|
|
17,635
|
|
|
|
190
|
|
|
|
118
|
|
|
|
13,267
|
|
|
|
174
|
|
|
|
58
|
|
|
|
|
Total rate of return swaps
|
|
|
|
1,547
|
|
|
|
|
|
|
|
|
|
|
|
126
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
$
|
81,601
|
|
|
$
|
2,421
|
|
|
$
|
1527
|
|
|
$
|
62,274
|
|
|
$
|
2,018
|
|
|
$
|
1,405
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Included in net derivative gains (losses) for the years ended
December 31, 2010 and 2009 were gains (losses) of
$113 million and ($3,654) million related to the
change in estimated fair value of the above derivatives.
154
Additionally, included in net derivative gains (losses) for the
years ended December 31, 2010 and 2009 were gains (losses)
of ($35) million and $0, respectively, related to ceded
reinsurance.
Guarantees, including portions thereof, have liabilities
established that are included in future policy benefits.
Guarantees accounted for in this manner include GMDBs, the
life-contingent portion of certain GMWB, and the portion of GMIB
that require annuitization. These liabilities are accrued over
the life of the contract in proportion to actual and future
expected policy assessments based on the level of guaranteed
minimum benefits generated using multiple scenarios of separate
account returns. The scenarios use best estimate assumptions
consistent with those used to amortize deferred acquisition
costs. When current estimates of future benefits exceed those
previously projected or when current estimates of future
assessments are lower than those previously projected,
liabilities will increase, resulting in a current period charge
to net income. The opposite result occurs when the current
estimates of future benefits are lower than that previously
projected or when current estimates of future assessments exceed
those previously projected. At each reporting period, the
Company updates the actual amount of business remaining
in-force, which impacts expected future assessments and the
projection of estimated future benefits resulting in a current
period charge or increase to earnings.
The table below contains the carrying value for guarantees
included in future policy benefits at:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
U.S. Business:
|
|
|
|
|
|
|
|
|
Guaranteed minimum death benefit
|
|
$
|
167
|
|
|
$
|
137
|
|
Guaranteed minimum income benefit
|
|
|
507
|
|
|
|
394
|
|
International:
|
|
|
|
|
|
|
|
|
Guaranteed minimum death benefit
|
|
|
66
|
|
|
|
23
|
|
Guaranteed minimum income benefit
|
|
|
116
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
856
|
|
|
$
|
554
|
|
|
|
|
|
|
|
|
|
|
Included in policyholder benefits and claims for the year ended
December 31, 2010 is a charge of $302 million and for
the year ended December 31, 2009 is a credit of
$92 million, related to the respective change in
liabilities for the above guarantees.
The carrying amount of guarantees accounted for as insurance
liabilities can change significantly during periods of sizable
and sustained shifts in equity market performance, increased
equity volatility, or changes in interest rates. The Company
uses reinsurance in combination with derivative instruments to
mitigate the liability exposure, risk of loss and the volatility
of net income associated with these liabilities. Derivative
instruments used are primarily equity futures, treasury futures
and interest rate swaps.
Included in policyholder benefits and claims associated with the
hedging of the guarantees in future policy benefits for the year
ended December 31, 2010 and 2009 were gains (losses) of
$8 million and ($114) million, respectively, related
to reinsurance treaties containing embedded derivatives carried
at estimated fair value and gains (losses) of
($275) million and ($376) million, respectively,
related to freestanding derivatives.
While the Company believes that the hedging strategies employed
for guarantees included in both policyholder account balances
and in future policy benefits, as well as other management
actions, have mitigated the risks related to these benefits, the
Company remains liable for the guaranteed benefits in the event
that reinsurers or derivative counterparties are unable or
unwilling to pay. Certain of the Companys reinsurance
agreements and most derivative positions are collateralized and
derivatives positions are subject to master netting agreements,
both of which, significantly reduces the exposure to
counterparty risk. In addition, the Company is subject to the
risk that hedging and other management procedures prove
ineffective or that unanticipated policyholder behavior or
mortality, combined with adverse market events, produces
economic losses beyond the scope of the risk management
techniques employed. Lastly, because the valuation of the
guarantees accounted for as embedded derivatives includes an
adjustment for nonperformance risk that is not hedged, changes
in the nonperformance risk may result in significant volatility
in net income.
155
Other
Policy-related Balances
Other policy-related balances include policy and contract
claims, unearned revenue liabilities, premiums received in
advance, policyholder dividends due and unpaid, and policyholder
dividends left on deposit.
The liability for policy and contract claims generally relates
to incurred but not reported death, disability, LTC and dental
claims, as well as claims that have been reported but not yet
settled. The liability for these claims is based on the
Companys estimated ultimate cost of settling all claims.
The Company derives estimates for the development of incurred
but not reported claims principally from actuarial analyses of
historical patterns of claims and claims development for each
line of business. The methods used to determine these estimates
are continually reviewed. Adjustments resulting from this
continuous review process and differences between estimates and
payments for claims are recognized in policyholder benefits and
claims expense in the period in which the estimates are changed
or payments are made.
The unearned revenue liability relates to universal life-type
and investment-type products and represents policy charges for
services to be provided in future periods. The charges are
deferred as unearned revenue and amortized using the
products estimated gross profits and margins, similar to
deferred acquisition costs. Such amortization is recorded in
universal life and investment-type product policy fees.
Also included in other policy-related balances are policyholder
dividends due and unpaid on participating policies and
policyholder dividends left on deposit. Such liabilities are
presented at amounts contractually due to policyholders.
Policyholder
Dividends Payable
Policyholder dividends payable consists of liabilities related
to dividends payable in the following calendar year on
participating policies.
Liquidity
and Capital Resources
Overview
Our business and results of operations are materially affected
by conditions in the global capital markets and the economy,
generally, both in the U.S. and elsewhere around the world.
The global economy and markets are now recovering from a period
of significant stress that began in the second half of 2007 and
substantially increased through the first quarter of 2009. This
disruption adversely affected the financial services industry,
in particular. Consequently, financial institutions paid higher
spreads over benchmark U.S. Treasury securities than before
the market disruption began. The U.S. economy entered a
recession in late 2007. This recession ended in mid-2009, but
the recovery from the recession has been below historic averages
and the unemployment rate is expected to remain high for some
time. Although conditions in the financial markets continued to
materially improve in 2010, there is still some uncertainty as
to whether the stressed conditions that prevailed during the
market disruption could recur, which could affect the
Companys ability to meet liquidity needs and obtain
capital.
Liquidity
Management
Based upon the strength of its franchise, diversification of its
businesses and strong financial fundamentals, we continue to
believe the Company has ample liquidity to meet business
requirements under current market conditions and unlikely but
reasonably possible stress scenarios. The Companys
short-term liquidity position (cash and cash equivalents,
short-term investments, excluding cash collateral received under
the Companys securities lending program that has been
reinvested in cash, cash equivalents, short-term investments and
publicly-traded securities, and cash collateral received from
counterparties in connection with derivative instruments) was
$17.6 billion and $11.7 billion at December 31,
2010 and 2009, respectively. We continuously monitor and adjust
our liquidity and capital plans for the Holding Company and its
subsidiaries in light of changing needs and opportunities.
156
The
Company
Liquidity
Liquidity refers to a companys ability to generate
adequate amounts of cash to meet its needs. Liquidity needs are
determined from a rolling
6-month
forecast by portfolio of investment assets and are monitored
daily. Asset mix and maturities are adjusted based on the
forecast. Cash flow testing and stress testing provide
additional perspectives on liquidity, which include various
scenarios of the potential risk of early contractholder and
policyholder withdrawal. The Company includes provisions
limiting withdrawal rights on many of its products, including
general account institutional pension products (generally group
annuities, including funding agreements, and certain deposit
fund liabilities) sold to employee benefit plan sponsors.
Certain of these provisions prevent the customer from making
withdrawals prior to the maturity date of the product.
In the event of significant cash requirements beyond anticipated
liquidity needs, the Company has various alternatives available
depending on market conditions and the amount and timing of the
liquidity need. These options include cash flows from
operations, the sale of liquid assets, global funding sources
and various credit facilities.
Under certain stressful market and economic conditions, the
Companys access to, or cost of, liquidity may deteriorate.
If the Company requires significant amounts of cash on short
notice in excess of anticipated cash requirements, the Company
may have difficulty selling investment assets in a timely
manner, be forced to sell them for less than the Company
otherwise would have been able to realize, or both. In addition,
in the event of such forced sale, accounting rules require the
recognition of a loss for certain securities in an unrealized
loss position and may require the impairment of other securities
based upon the Companys ability to hold such securities,
which may negatively impact the Companys financial
condition.
In extreme circumstances, all general account assets
other than those which may have been pledged to a specific
purpose within a statutory legal entity are
available to fund obligations of the general account within that
legal entity.
Capital
The Companys capital position is managed to maintain its
financial strength and credit ratings and is supported by its
ability to generate strong cash flows at the operating
companies, borrow funds at competitive rates and raise
additional capital to meet its operating and growth needs.
The Company raised new capital from its debt issuances during
the difficult market conditions prevailing since the second half
of 2008, as well as during the rebound and recovery periods
beginning in the second quarter of 2009 (see The
Company Liquidity and Capital Sources
Debt Issuances and Other Borrowings). The increase in
credit spreads experienced since then has resulted in an
increase in the cost of such new capital, as well as increases
in facility fees. Conversely, as a result of reductions in
interest rates, the Companys interest expense and
dividends on floating rate securities have been lower.
Despite the still unsettled financial markets, the Company also
raised new capital from a successful offering of the Holding
Companys common stock in August 2010, which provided
financing for the Acquisition. See The
Company Liquidity and Capital Sources
Common Stock.
Rating Agencies. Rating agencies assign
insurer financial strength ratings to the Holding Companys
domestic life insurance subsidiaries and credit ratings to the
Holding Company and certain of its subsidiaries. The level and
composition of regulatory capital at the subsidiary level and
equity capital of the Company are among the many factors
considered in determining the Companys insurer financial
strength and credit ratings. Each agency has its own capital
adequacy evaluation methodology, and assessments are generally
based on a combination of factors. In addition to heightening
the level of scrutiny that they apply to insurance companies,
rating agencies have increased and may continue to increase the
frequency and scope of their credit reviews, may request
additional information from the companies that they rate and may
adjust upward the capital and other requirements employed in the
rating agency models for maintenance of certain ratings levels.
157
A downgrade in the credit or insurer financial strength ratings
of the Holding Company or its subsidiaries would likely impact
the cost and availability of financing for the Company and its
subsidiaries and result in additional collateral requirements or
other required payments under certain agreements, which are
eligible to be satisfied in cash or by posting securities held
by the subsidiaries subject to the agreements.
Statutory Capital and Dividends. Our insurance
subsidiaries have statutory surplus well above levels to meet
current regulatory requirements.
Except for American Life, RBC requirements are used as minimum
capital requirements by the NAIC and the state insurance
departments to identify companies that merit regulatory action.
RBC is based on a formula calculated by applying factors to
various asset, premium and statutory reserve items. The formula
takes into account the risk characteristics of the insurer,
including asset risk, insurance risk, interest rate risk and
business risk and is calculated on an annual basis. The formula
is used as an early warning regulatory tool to identify possible
inadequately capitalized insurers for purposes of initiating
regulatory action, and not as a means to rank insurers
generally. These rules apply to each of the Holding
Companys domestic insurance subsidiaries. State insurance
laws provide insurance regulators the authority to require
various actions by, or take various actions against, insurers
whose total adjusted capital does not meet or exceed certain RBC
levels. At the date of the most recent annual statutory
financial statements filed with insurance regulators, the total
adjusted capital of each of these subsidiaries was in excess of
each of those RBC levels.
American Life does not write business in Delaware or any other
domestic state and, as such, is exempt from RBC by Delaware law.
In addition to Delaware, American Life operations are regulated
by applicable authorities of the countries in which the company
operates and are subject to capital and solvency requirements in
those countries.
The amount of dividends that our insurance subsidiaries can pay
to the Holding Company or other parent entities is constrained
by the amount of surplus we hold to maintain our ratings and
provides an additional margin for risk protection and investment
in our businesses. We proactively take actions to maintain
capital consistent with these ratings objectives, which may
include adjusting dividend amounts and deploying financial
resources from internal or external sources of capital. Certain
of these activities may require regulatory approval.
Furthermore, the payment of dividends and other distributions to
the Company by its insurance subsidiaries is regulated by
insurance laws and regulations. See Business
U.S. Regulation Insurance Regulation,
The Holding Company Liquidity and
Capital Sources Dividends from Subsidiaries
and Note 18 of the Notes to the Consolidated Financial
Statements.
158
Summary of Primary Sources and Uses of Liquidity and
Capital. The Companys primary sources and
uses of liquidity and capital are described below, and
summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Sources:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
$
|
7,996
|
|
|
$
|
3,803
|
|
|
$
|
10,702
|
|
Net cash provided by changes in policyholder account balances
|
|
|
4,557
|
|
|
|
|
|
|
|
13,645
|
|
Net cash provided by changes in payables for collateral under
securities loaned and other transactions
|
|
|
3,076
|
|
|
|
|
|
|
|
|
|
Net cash provided by changes in bank deposits
|
|
|
|
|
|
|
3,164
|
|
|
|
2,185
|
|
Net cash provided by short-term debt issuances
|
|
|
|
|
|
|
|
|
|
|
1,992
|
|
Long-term debt issued, net of issuance costs
|
|
|
5,076
|
|
|
|
2,931
|
|
|
|
305
|
|
Collateral financing arrangements issued
|
|
|
|
|
|
|
105
|
|
|
|
310
|
|
Net cash received in connection with collateral financing
arrangements
|
|
|
|
|
|
|
375
|
|
|
|
|
|
Junior subordinated debt securities issued
|
|
|
|
|
|
|
500
|
|
|
|
750
|
|
Common stock issued, net of issuance costs
|
|
|
3,576
|
|
|
|
|
|
|
|
290
|
|
Common stock issued to settle stock forward contracts
|
|
|
|
|
|
|
1,035
|
|
|
|
|
|
Treasury stock issued in connection with common stock issuance,
net of issuance costs
|
|
|
|
|
|
|
|
|
|
|
1,936
|
|
Treasury stock issued to settle stock forward contracts
|
|
|
|
|
|
|
|
|
|
|
1,035
|
|
Cash provided by other, net
|
|
|
|
|
|
|
|
|
|
|
7
|
|
Cash provided by the effect of change in foreign currency
exchange rates
|
|
|
|
|
|
|
108
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total sources
|
|
|
24,281
|
|
|
|
12,021
|
|
|
|
33,157
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Uses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
18,314
|
|
|
|
13,935
|
|
|
|
2,671
|
|
Net cash used for changes in policyholder account balances
|
|
|
|
|
|
|
2,282
|
|
|
|
|
|
Net cash used for changes in payables for collateral under
securities loaned and other transactions
|
|
|
|
|
|
|
6,863
|
|
|
|
13,077
|
|
Net cash used for changes in bank deposits
|
|
|
32
|
|
|
|
|
|
|
|
|
|
Net cash used for short-term debt repayments
|
|
|
606
|
|
|
|
1,747
|
|
|
|
|
|
Long-term debt repaid
|
|
|
1,061
|
|
|
|
555
|
|
|
|
422
|
|
Net cash paid in connection with collateral financing
arrangements
|
|
|
|
|
|
|
|
|
|
|
800
|
|
Treasury stock acquired in connection with share repurchase
agreements
|
|
|
|
|
|
|
|
|
|
|
1,250
|
|
Dividends on preferred stock
|
|
|
122
|
|
|
|
122
|
|
|
|
125
|
|
Dividends on common stock
|
|
|
784
|
|
|
|
610
|
|
|
|
592
|
|
Cash used in other, net
|
|
|
299
|
|
|
|
34
|
|
|
|
|
|
Cash used in the effect of change in foreign currency exchange
rates
|
|
|
129
|
|
|
|
|
|
|
|
349
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total uses
|
|
|
21,347
|
|
|
|
26,148
|
|
|
|
19,286
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
$
|
2,934
|
|
|
$
|
(14,127
|
)
|
|
$
|
13,871
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liquidity
and Capital Sources
Cash Flows from Operations. The Companys
principal cash inflows from its insurance activities come from
insurance premiums, annuity considerations and deposit funds. A
primary liquidity concern with respect to these
159
cash inflows is the risk of early contractholder and
policyholder withdrawal. See The
Company Liquidity and Capital Uses
Contractual Obligations.
Cash Flows from Investments. The
Companys principal cash inflows from its investment
activities come from repayments of principal, proceeds from
maturities, sales of invested assets and net investment income.
The primary liquidity concerns with respect to these cash
inflows are the risk of default by debtors and market
volatility. The Company closely monitors and manages these risks
through its credit risk management process.
Liquid Assets. An integral part of the
Companys liquidity management is the amount of liquid
assets it holds. Liquid assets include cash, cash equivalents,
short-term investments and publicly-traded securities,
excluding: (i) cash collateral received under the
Companys securities lending program that has been
reinvested in cash, cash equivalents, short-term investments and
publicly-traded securities; (ii) cash collateral received
from counterparties in connection with derivative instruments;
(iii) cash, cash equivalents, short-term investments and
securities on deposit with regulatory agencies; and
(iv) securities held in trust in support of collateral
financing arrangements and pledged in support of debt and
funding agreements. At December 31, 2010 and 2009, the
Company had $245.7 billion and $158.4 billion in
liquid assets, respectively. For further discussion of invested
assets on deposit with regulatory agencies, held in trust in
support of collateral financing arrangements and pledged in
support of debt and funding agreements, see
Investments Invested Assets on Deposit, Held in
Trust and Pledged as Collateral.
Global Funding Sources. Liquidity is provided
by a variety of short-term instruments, including funding
agreements, credit facilities and commercial paper. Capital is
provided by a variety of instruments, including short-term and
long-term debt, preferred securities, junior subordinated debt
securities and equity and equity-linked securities. The
diversity of the Companys funding sources enhances funding
flexibility, limits dependence on any one market or source of
funds and generally lowers the cost of funds. The Companys
global funding sources include:
|
|
|
|
|
The Holding Company and MetLife Funding, Inc. (MetLife
Funding) each have commercial paper programs supported by
$4.0 billion in general corporate credit facilities (see
The Company Liquidity and Capital
Sources Credit and Committed Facilities).
MetLife Funding, a subsidiary of MLIC, serves as a centralized
finance unit for the Company. MetLife Funding raises cash from
its commercial paper program and uses the proceeds to extend
loans, through MetLife Credit Corp., another subsidiary of MLIC,
to the Holding Company, MLIC and other affiliates in order to
enhance the financial flexibility and liquidity of these
companies. Outstanding balances for the commercial paper program
fluctuate in line with changes to affiliates financing
arrangements. Pursuant to a support agreement, MLIC has agreed
to cause MetLife Funding to have a tangible net worth of at
least one dollar. At both December 31, 2010 and 2009,
MetLife Funding had a tangible net worth of $12 million. At
December 31, 2010 and 2009, MetLife Funding had total
outstanding liabilities for its commercial paper program,
including accrued interest payable, of $102 million and
$319 million, respectively.
|
|
|
|
MetLife Bank is a depository institution that is approved to use
the Federal Reserve Bank of New York Discount Window borrowing
privileges. To utilize these privileges, MetLife Bank has
pledged qualifying loans and investment securities to the
Federal Reserve Bank of New York as collateral. At both
December 31, 2010 and 2009, MetLife Bank had no liability
for advances from the Federal Reserve Bank of New York under
this facility.
|
|
|
|
MetLife Bank has a cash need to fund residential mortgage loans
that it originates and generally holds for a relatively short
period before selling them to one of the government-sponsored
enterprises such as FNMA or FHLMC. The outstanding volume of
residential mortgage originations varies from month to month and
is cyclical within a month. To meet the variable funding
requirements from this mortgage activity, as well as to increase
overall liquidity from time to time, MetLife Bank takes
advantage of short-term collateralized borrowing opportunities
with the Federal Home Loan Bank of New York (FHLB of
NY). MetLife Bank has entered into advances agreements
with the FHLB of NY whereby MetLife Bank has received cash
advances and under which the FHLB of NY has been granted a
blanket lien on certain of MetLife Banks residential
mortgages, mortgage loans
held-for-sale,
commercial mortgages and mortgage-backed securities to
collateralize MetLife Banks repayment obligations. Upon
any event of default by MetLife Bank, the
|
160
|
|
|
|
|
FHLB of NYs recovery is limited to the amount of MetLife
Banks liability under the advances agreement. MetLife Bank
has received advances from the FHLB of NY on both short- and
long-term bases, with a total liability of $3.8 billion and
$2.4 billion at December 31, 2010 and 2009,
respectively.
|
|
|
|
|
|
The Company also had obligations under funding agreements with
the FHLB of NY of $12.6 billion and $13.7 billion at
December 31, 2010 and 2009, respectively, for MLIC, and
with the Federal Home Loan Bank of Boston (FHLB of
Boston) of $100 million and $326 million at
December 31, 2010 and 2009, respectively, for MICC. See
Note 8 of the Notes to the Consolidated Financial
Statements. In September 2010, MetLife Investors Insurance
Company and General American Life Insurance Company,
subsidiaries of MetLife, Inc., each became a member of the
Federal Home Loan Bank of Des Moines (FHLB of Des
Moines), and each purchased $10 million of FHLB of
Des Moines common stock. Membership in the FHLB of Des Moines
provides an additional source of contingent liquidity for the
Company. There were no funding agreements with the FHLB of Des
Moines at December 31, 2010.
|
|
|
|
The Company issues fixed and floating rate funding agreements,
which are denominated in either U.S. dollars or foreign
currencies, to certain special purpose entities
(SPEs) that have issued either debt securities or
commercial paper for which payment of interest and principal is
secured by such funding agreements. During the years ended
December 31, 2010, 2009 and 2008, the Company issued
$34.1 billion, $28.6 billion and $20.9 billion,
respectively, and repaid $30.9 billion, $32.0 billion
and $19.8 billion, respectively, of such funding
agreements. At December 31, 2010 and 2009, funding
agreements outstanding, which are included in policyholder
account balances, were $27.2 billion and
$23.3 billion, respectively.
|
|
|
|
MLIC and MICC have each issued funding agreements to certain
SPEs that have issued debt securities for which payment of
interest and principal is secured by such funding agreements,
and such debt securities are also guaranteed as to payment of
interest and principal by the Federal Agricultural Mortgage
Corporation, a federally chartered instrumentality of the U.S.
The obligations under these funding agreements are secured by a
pledge of certain eligible agricultural real estate mortgage
loans and may, under certain circumstances, be secured by other
qualified collateral. The amount of the Companys liability
for funding agreements issued to such SPEs was $2.8 billion
and $2.5 billion at December 31, 2010 and 2009,
respectively, which is included in policyholder account
balances. The obligations under these funding agreements are
collateralized by designated agricultural real estate mortgage
loans with estimated fair values of $3.2 billion and
$2.9 billion at December 31, 2010 and 2009,
respectively.
|
Outstanding Debt. The following table
summarizes the outstanding debt of the Company at:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
2010
|
|
2009
|
|
|
(In millions)
|
|
Short-term debt
|
|
$
|
306
|
|
|
$
|
912
|
|
Long-term debt (1)
|
|
$
|
20,766
|
|
|
$
|
13,156
|
|
Collateral financing arrangements
|
|
$
|
5,297
|
|
|
$
|
5,297
|
|
Junior subordinated debt securities
|
|
$
|
3,191
|
|
|
$
|
3,191
|
|
|
|
|
(1) |
|
Excludes $6,820 million at December 31, 2010 of
long-term debt relating to CSEs. |
Debt Issuances and Other Borrowings. In
connection with the financing of the Acquisition (see
Note 2 of the Notes to the Consolidated Financial
Statements), in November 2010, MetLife, Inc. issued to ALICO
Holdings $3,000 million in three series of debt securities
(the Series C Debt Securities, the
Series D Debt Securities and the
Series E Debt Securities, and, together, the
Debt Securities), which constitute a part of the
MetLife, Inc. common equity units (the Equity Units)
more fully described in Note 14 of the Notes to the
Consolidated Financial Statements. The Debt Securities are
subject to remarketing, initially bear interest at 1.56%, 1.92%
and 2.46%, respectively (an average rate of 1.98%), and carry
initial maturity dates of June 15, 2023, June 15, 2024
and June 15, 2045, respectively. The interest rates will be
reset in connection with the successful remarketings of the Debt
Securities. Prior to the first scheduled attempted remarketing
of the Series C Debt Securities, such Debt Securities will
be divided into two tranches equal in principal amount with
maturity dates of June 15, 2018 and June 15, 2023.
Prior to the first scheduled attempted remarketing of the
Series E Debt Securities, such Debt
161
Securities will be divided into two tranches equal in principal
amount with maturity dates of June 15, 2018 and
June 15, 2045.
In August 2010, in anticipation of the Acquisition, the Holding
Company issued senior notes as follows:
|
|
|
|
|
$1,000 million senior notes due February 6, 2014,
which bear interest at a fixed rate of 2.375%, payable
semi-annually;
|
|
|
|
$1,000 million senior notes due February 8, 2021,
which bear interest at a fixed rate of 4.75%, payable
semi-annually;
|
|
|
|
$750 million senior notes due February 6, 2041, which
bear interest at a fixed rate of 5.875%, payable
semi-annually; and
|
|
|
|
$250 million floating rate senior notes due August 6,
2013, which bear interest at a rate equal to three-month LIBOR,
reset quarterly, plus 1.25%, payable quarterly.
|
In connection with these offerings, the Holding Company incurred
$15 million of issuance costs which have been capitalized
and included in other assets. These costs are being amortized
over the terms of the senior notes.
In July 2009, the Holding Company issued $500 million of
junior subordinated debt securities with a final maturity of
August 2069. Interest is payable semi-annually at a fixed rate
of 10.75% up to, but not including, August 1, 2039, the
scheduled redemption date. In the event the debt securities are
not redeemed on or before the scheduled redemption date,
interest will accrue at an annual rate of
3-month
LIBOR plus a margin equal to 7.548%, payable quarterly in
arrears. In connection with the offering, the Holding Company
incurred $5 million of issuance costs which have been
capitalized and included in other assets. These costs are being
amortized over the term of the securities. See Note 13 of
the Notes to the Consolidated Financial Statements for a
description of the terms of the junior subordinated debt
securities.
In May 2009, the Holding Company issued $1.3 billion of
senior notes due June 1, 2016. The notes bear interest at a
fixed rate of 6.75%, payable semi-annually. In connection with
the offering, the Holding Company incurred $6 million of
issuance costs which have been capitalized and included in other
assets. These costs are being amortized over the term of the
notes.
In March 2009, the Holding Company issued $397 million of
floating rate senior notes due June 2012 under the FDICs
Temporary Liquidity Guarantee Program. The notes bear interest
at a rate equal to three-month LIBOR, reset quarterly, plus
0.32%. The notes are not redeemable prior to their maturity. In
connection with the offering, the Holding Company incurred
$15 million of issuance costs which have been capitalized
and included in other assets. These costs are being amortized
over the term of the notes.
In February 2009, the Holding Company remarketed its existing
$1.0 billion 4.91% Series B junior subordinated debt
securities as 7.717% senior debt securities, Series B,
due 2019. In August 2008, the Holding Company remarketed its
existing $1.0 billion 4.82% Series A junior
subordinated debt securities as 6.817% senior debt
securities, Series A, due 2018. Interest on both series of
debt securities is payable semi-annually. The Series A and
Series B junior subordinated debt securities were
originally issued in 2005 in connection with the common equity
units. See The Company Liquidity and
Capital Sources Remarketing of Junior Subordinated
Debt Securities and Settlement of Stock Purchase Contracts.
In April 2008, MetLife Capital Trust X, a VIE consolidated
by the Company, issued exchangeable surplus trust securities
(the 2008 Trust Securities) with a face amount
of $750 million. Interest on the 2008 Trust Securities
or debt securities is payable semi-annually at a fixed rate of
9.25% up to, but not including, April 8, 2038, the
scheduled redemption date. In the event the 2008
Trust Securities or debt securities are not redeemed on or
before the scheduled redemption date, interest will accrue at an
annual rate of
3-month
LIBOR plus a margin equal to 5.540%, payable quarterly in
arrears. See Note 13 of the Notes to the Consolidated
Financial Statements for a description of the terms of these
debt securities.
162
Collateral Financing Arrangements. As
described more fully in Note 12 of the Notes to the
Consolidated Financial Statements:
|
|
|
|
|
In December 2007, the Holding Company, in connection with the
collateral financing arrangement associated with MetLife
Reinsurance Company of Charlestons (MRC)
reinsurance of the closed block liabilities, entered into an
agreement with the unaffiliated financial institution that
referenced the $2.5 billion aggregate principal amount of
35-year
surplus notes issued by MRC. Under the agreement, the Holding
Company is entitled to the interest paid by MRC on the surplus
notes of
3-month
LIBOR plus 0.55% in exchange for the payment of
3-month
LIBOR plus 1.12%, payable quarterly on such amount as adjusted,
as described below.
|
Under this agreement, the Holding Company may also be required
to pledge collateral or make payments to the unaffiliated
financial institution related to any decline in the estimated
fair value of the surplus notes. Any such payments would be
accounted for as a receivable and included in other assets on
the Companys consolidated balance sheets and would not
reduce the principal amount outstanding of the surplus notes.
Such payments would, however, reduce the amount of interest
payments due from the Holding Company under the agreement. Any
payment received from the unaffiliated financial institution
would reduce the receivable by an amount equal to such payment
and would also increase the amount of interest payments due from
the Holding Company under the agreement. In addition, the
unaffiliated financial institution may be required to pledge
collateral to the Holding Company related to any increase in the
estimated fair value of the surplus notes. During 2008, the
Holding Company paid an aggregate of $800 million to the
unaffiliated financial institution relating to declines in the
estimated fair value of the surplus notes. The Holding Company
did not receive any payments from the unaffiliated financial
institution during 2008. During 2009, on a net basis, the
Holding Company received $375 million from the unaffiliated
financial institution related to changes in the estimated fair
value of the surplus notes. No payments were made or received by
the Holding Company during 2010. Since the closing of the
collateral financing arrangement in December 2007, on a net
basis, the Holding Company has paid $425 million to the
unaffiliated financial institution related to changes in the
estimated fair value of the surplus notes. In addition, at
December 31, 2010, the Holding Company had pledged
collateral with an estimated fair value of $49 million to
the unaffiliated financial institution. At December 31,
2009, the Holding Company had no collateral pledged to the
unaffiliated financial institution in connection with this
agreement. The Holding Company may also be required to make a
payment to the unaffiliated financial institution in connection
with any early termination of this agreement.
|
|
|
|
|
In May 2007, the Holding Company, in connection with the
collateral financing arrangement associated with MetLife
Reinsurance Company of South Carolinas (MRSC)
reinsurance of universal life secondary guarantees, entered into
an agreement with an unaffiliated financial institution under
which the Holding Company is entitled to the return on the
investment portfolio held by trusts established in connection
with this collateral financing arrangement in exchange for the
payment of a stated rate of return to the unaffiliated financial
institution of
3-month
LIBOR plus 0.70%, payable quarterly. The collateral financing
agreement may be extended by agreement of the Holding Company
and the unaffiliated financial institution on each anniversary
of the closing. The Holding Company may also be required to make
payments to the unaffiliated financial institution, for deposit
into the trusts, related to any decline in the estimated fair
value of the assets held by the trusts, as well as amounts
outstanding upon maturity or early termination of the collateral
financing arrangement. During 2010, no payments were made or
received by the Holding Company. During 2009 and 2008, the
Holding Company contributed $360 million and
$320 million, respectively, as a result of declines in the
estimated fair value of the assets in the trusts. Cumulatively,
since May 2007, the Holding Company has contributed a total of
$680 million as a result of declines in the estimated fair
value of the assets in the trusts, all of which was deposited
into the trusts.
|
In addition, the Holding Company may be required to pledge
collateral to the unaffiliated financial institution under this
agreement. At December 31, 2010 and 2009, the Holding
Company had pledged $63 million and $80 million under
the agreement, respectively.
163
Remarketing of Junior Subordinated Debt Securities and
Settlement of Stock Purchase Contracts. In
February 2009, the Holding Company closed the successful
remarketing of the Series B portion of the junior
subordinated debt securities underlying the common equity units.
The Series B junior subordinated debt securities were
modified as permitted by their terms to be 7.717% senior
debt securities, Series B, due February 15, 2019. The
Holding Company did not receive any proceeds from the
remarketing. Most common equity unit holders chose to have their
junior subordinated debt securities remarketed and used the
remarketing proceeds to settle their payment obligations under
the applicable stock purchase contract. For those common equity
unit holders that elected not to participate in the remarketing
and elected to use their own cash to satisfy the payment
obligations under the stock purchase contract, the terms of the
debt are the same as the remarketed debt. The subsequent
settlement of the stock purchase contracts occurred on
February 17, 2009, providing proceeds to the Holding
Company of $1,035 million in exchange for shares of the
Holding Companys common stock. The Holding Company
delivered 24,343,154 shares of its newly issued common
stock to settle the stock purchase contracts.
In August 2008, the Holding Company closed the successful
remarketing of the Series A portion of the junior
subordinated debt securities underlying the common equity units.
The Series A junior subordinated debt securities were
modified as permitted by their terms to be 6.817% senior
debt securities, Series A, due August 15, 2018. The
Holding Company did not receive any proceeds from the
remarketing. Most common equity unit holders chose to have their
junior subordinated debt securities remarketed and used the
remarketing proceeds to settle their payment obligations under
the applicable stock purchase contract. For those common equity
unit holders that elected not to participate in the remarketing
and elected to use their own cash to satisfy the payment
obligations under the stock purchase contract, the terms of the
debt are the same as the remarketed debt. The initial settlement
of the stock purchase contracts occurred on August 15,
2008, providing proceeds to the Holding Company of
$1,035 million in exchange for shares of the Holding
Companys common stock. The Holding Company delivered
20,244,549 shares of its common stock held in treasury at a
value of $1,064 million to settle the stock purchase
contracts.
Other. In March 2009, the Company sold Cova
Corporation, the parent company of Texas Life Insurance Company,
for $130 million in cash consideration, excluding
$1 million of transaction costs. The proceeds of the
transaction were paid to the Holding Company.
Credit and Committed Facilities. The Company
maintains unsecured credit facilities and committed facilities,
which aggregated $4.0 billion and $12.4 billion,
respectively, at December 31, 2010. When drawn upon, these
facilities bear interest at varying rates in accordance with the
respective agreements.
The unsecured credit facilities are used for general corporate
purposes, to support the borrowers commercial paper
programs and for the issuance of letters of credit. At
December 31, 2010, the Company had outstanding
$1.5 billion in letters of credit and no drawdowns against
these facilities. Remaining unused commitments were
$2.5 billion at December 31, 2010.
The committed facilities are used for collateral for certain of
the Companys affiliated reinsurance liabilities. At
December 31, 2010, the Company had outstanding
$5.4 billion in letters of credit and $2.8 billion in
aggregate drawdowns against these facilities. Remaining unused
commitments were $4.2 billion at December 31, 2010.
See Note 11 of the Notes to the Consolidated Financial
Statements for further discussion of these facilities.
We have no reason to believe that our lending counterparties
will be unable to fulfill their respective contractual
obligations under these facilities. As commitments associated
with letters of credit and financing arrangements may expire
unused, these amounts do not necessarily reflect the
Companys actual future cash funding requirements.
As a result of the successful offerings of certain senior notes
and common stock in August 2010, the commitment letter for a
$5.0 billion senior credit facility, which the Holding
Company signed to partially finance the Acquisition, was
terminated. During March 2010, the Holding Company paid
$28 million in fees related to this senior credit facility,
all of which were expensed during the year ended
December 31, 2010.
Covenants. Certain of the Companys debt
instruments, credit facilities and committed facilities contain
various administrative, reporting, legal and financial
covenants. The Company believes it was in compliance with all
covenants at December 31, 2010 and 2009.
164
Preferred Stock. During the year ended
December 31, 2010, the Holding Company did not issue any
non-convertible preferred stock. In December 2008, the Holding
Company entered into a replacement capital covenant (the
Replacement Capital Covenant) whereby the Company
agreed for the benefit of holders of one or more series of the
Companys unsecured long-term indebtedness designated from
time to time by the Company in accordance with the terms of the
Replacement Capital Covenant (Covered Debt), that
the Company will not repay, redeem or purchase and will cause
its subsidiaries not to repay, redeem or purchase, on or before
the termination of the Replacement Capital Covenant on
December 31, 2018 (or earlier termination by agreement of
the holders of Covered Debt or when there is no longer any
outstanding series of unsecured long-term indebtedness which
qualifies for designation as Covered Debt), the
Floating Rate Non-Cumulative Preferred Stock, Series A, of
the Holding Company or the 6.500% Non-Cumulative Preferred
Stock, Series B, of the Holding Company, unless such
repayment, redemption or purchase is made from the proceeds of
the issuance of certain replacement capital securities and
pursuant to the other terms and conditions set forth in the
Replacement Capital Covenant.
Convertible Preferred Stock. In November 2010,
the Holding Company issued to ALICO Holdings in connection with
the financing of the Acquisition 6,857,000 shares of
Series B contingent convertible junior participating
non-cumulative perpetual preferred stock (the Convertible
Preferred Stock) convertible into approximately
68,570,000 shares (valued at $40.90 per share at the time
of the Acquisition) of the Holding Companys common stock
(subject to anti-dilution adjustments) upon a favorable vote of
the Holding Companys common stockholders. If a favorable
vote of its common stockholders is not obtained by the first
anniversary of the Acquisition Date, then the Holding Company
must pay ALICO Holdings $300 million and use reasonable
efforts to list the preferred stock on NYSE. Management
considers the likelihood that the Holding Company will fail to
obtain a vote of its common stockholders to be remote.
Common Stock. In November 2010, the Holding
Company issued to ALICO Holdings in connection with the
financing of the Acquisition 78,239,712 new shares of its common
stock at $40.90 per share. The aggregate amount of MetLife,
Inc.s common stock to be issued to ALICO Holdings in
connection with the transaction is expected to be
214.6 million to 231.5 million shares, consisting of
the 78.2 million shares issued at closing,
68.6 million shares to be issued upon conversion of the
Convertible Preferred Stock (with the stockholder vote on such
conversion to be held within one year after the closing)
(together with $3.0 billion aggregate stated amount of
Equity Units of MetLife, Inc., the Securities) and
between 67.8 million and 84.7 million shares of common
stock, in total, issuable upon settlement of the purchase
contracts forming part of the Equity Units (in three tranches
approximately two, three and four years after the closing). The
ownership of the Securities is subject to an investor rights
agreement, which grants to ALICO Holdings certain rights and
sets forth certain agreements with respect to ALICO
Holdings ownership, voting and transfer of the Securities,
including minimum holding periods, restrictions on the number of
shares ALICO Holdings can sell at one time, its agreement to
vote the common stock in the same proportion as the common stock
voted by all other stockholders, and its agreement not to seek
control or influence the Companys management or Board of
Directors. ALICO Holdings has indicated that it intends to
monetize the Securities over time, subject to market conditions,
following the lapse of
agreed-upon
minimum holding periods. See The
Company Liquidity and Capital Sources
Equity Units.
In August 2010, the Holding Company issued 86,250,000 new shares
of its common stock at a price of $42.00 per share for gross
proceeds of $3,623 million. In connection with the offering
of common stock, the Holding Company incurred $94 million
of issuance costs which have been recorded as a reduction of
additional
paid-in-capital.
In connection with the remarketing of the junior subordinated
debt securities, in February 2009, the Holding Company delivered
24,343,154 shares of its newly issued common stock, and in
August 2008, the Holding Company delivered
20,244,549 shares of its common stock from treasury stock,
to settle the stock purchase contracts. See The
Company Liquidity and Capital Sources
Remarketing of Junior Subordinated Debt Securities and
Settlement of Stock Purchase Contracts.
In October 2008, the Holding Company issued
86,250,000 shares of its common stock at a price of $26.50
per share for gross proceeds of $2.3 billion. Of these
shares issued, 75,000,000 shares were issued from treasury
stock, and 11,250,000 were newly issued shares.
165
During the years ended December 31, 2010, 2009 and 2008,
332,121 shares, 861,586 shares and
2,271,188 shares of common stock were issued from treasury
stock for $18 million, $46 million and
$118 million, respectively, to satisfy various stock option
exercises. During the year ended December 31, 2010,
2,182,174 new shares of common stock were issued for
$74 million to satisfy various stock option exercises.
During both the years ended December 31, 2009 and 2008, no
new shares of common stock were issued to satisfy stock option
exercises.
Equity Units. In November 2010, the Holding
Company issued to ALICO Holdings in connection with the
financing of the Acquisition $3.0 billion aggregate stated
amount of Equity Units. The Equity Units, which are mandatorily
convertible securities, will initially consist of
(i) purchase contracts obligating the holder to purchase a
variable number of shares of MetLife, Inc.s common stock
on each of three specified future settlement dates (expected to
be approximately two, three and four years after closing of the
Acquisition), for a fixed amount per purchase contract, (an
aggregate of $1.0 billion on each settlement date) and
(ii) an interest in each of three series of Debt Securities
of MetLife, Inc. The value of the purchase contracts at issuance
of $247 million was calculated as the present value of the
future contract payments and was recorded in other liabilities.
At future dates, the Series C, D and E Debt Securities will
be subject to remarketing and sold to investors. Holders of the
Equity Units who elect to include their Debt Securities in a
remarketing can use the proceeds thereof to meet their
obligations under the purchase contracts.
See Note 14 of the Notes to the Consolidated Financial
Statements for further discussion of the Equity Units.
Liquidity
and Capital Uses
Acquisitions. The computation of the purchase
price of the Acquisition is presented below:
|
|
|
|
|
|
|
November 1, 2010
|
|
|
|
(In millions)
|
|
|
Cash (includes $396 million of contractual purchase price
adjustments)
|
|
$
|
7,196
|
|
MetLife, Inc.s common stock (78,239,712 shares at
$40.90 per share)
|
|
|
3,200
|
|
MetLife, Inc.s Convertible Preferred Stock
|
|
|
2,805
|
|
MetLife, Inc.s Equity Units ($3.0 billion aggregate
stated amount)
|
|
|
3,189
|
|
|
|
|
|
|
Total purchase price
|
|
$
|
16,390
|
|
|
|
|
|
|
Debt Repayments. During the years ended
December 31, 2010, 2009 and 2008, MetLife Bank made
repayments of $349 million, $497 million and
$371 million, respectively, to the FHLB of NY related to
long-term borrowings. During the years ended December 31,
2010, 2009 and 2008, MetLife Bank made repayments to the FHLB of
NY related to short-term borrowings of $12.9 billion,
$26.4 billion and $4.6 billion, respectively. During
the years ended December 31, 2009 and 2008, MetLife Bank
made repayments related to short-term borrowings to the Federal
Reserve Bank of New York of $21.2 billion and
650 million, respectively. No repayments were made to the
Federal Reserve Bank of New York during the year ended
December 31, 2010. During the year ended December 31,
2009, MICC made repayments of $300 million to the FHLB of
Boston related to short-term borrowings. No repayments were made
to the FHLB of Boston during the years ended December 31,
2010 and 2008.
Debt Repurchases. We may from time to time
seek to retire or purchase our outstanding debt through cash
purchases
and/or
exchanges for other securities, in open market purchases,
privately negotiated transactions or otherwise. Any such
repurchases or exchanges will be dependent upon several factors,
including our liquidity requirements, contractual restrictions,
general market conditions, and applicable regulatory, legal and
accounting factors. Whether or not to repurchase any debt and
the size and timing of any such repurchases will be determined
in the Companys discretion.
Insurance Liabilities. The Companys
principal cash outflows primarily relate to the liabilities
associated with its various life insurance, property and
casualty, annuity and group pension products, operating expenses
and income tax, as well as principal and interest on its
outstanding debt obligations. Liabilities arising from its
insurance activities primarily relate to benefit payments under
the aforementioned products, as well as payments for policy
166
surrenders, withdrawals and loans. For annuity or deposit type
products, surrender or lapse product behavior differs somewhat
by segment. In the Retirement Products segment, which includes
individual annuities, lapses and surrenders tend to occur in the
normal course of business. During the years ended
December 31, 2010 and 2009, general account surrenders and
withdrawals from annuity products were $3.8 billion and
$4.3 billion, respectively. In the Corporate Benefit
Funding segment, which includes pension closeouts, bank owned
life insurance and other fixed annuity contracts, as well as
funding agreements (including funding agreements with the FHLB
of NY and the FHLB of Boston) and other capital market products,
most of the products offered have fixed maturities or fairly
predictable surrenders or withdrawals. With regard to Corporate
Benefit Funding liabilities that provide customers with limited
liquidity rights, at December 31, 2010 there were
$1,615 million of funding agreements and other capital
market products that could be put back to the Company after a
period of notice. Of these liabilities, $1,565 million were
subject to notice periods between 15 and 90 days. The
remainder of the balance was subject to a notice period of
9 months or greater. An additional $375 million of
Corporate Benefit Funding liabilities were subject to credit
ratings downgrade triggers that permit early termination subject
to a notice period of 90 days. See The
Company Liquidity and Capital Uses
Contractual Obligations.
Dividends. The table below presents
declaration, record and payment dates, as well as per share and
aggregate dividend amounts, for the common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend
|
Declaration Date
|
|
Record Date
|
|
Payment Date
|
|
Per Share
|
|
Aggregate
|
|
|
|
|
|
|
(In millions, except per share data)
|
|
October 26, 2010
|
|
|
November 9, 2010
|
|
|
|
December 14, 2010
|
|
|
$
|
0.74
|
|
|
$
|
784
|
(1)
|
October 29, 2009
|
|
|
November 9, 2009
|
|
|
|
December 14, 2009
|
|
|
$
|
0.74
|
|
|
$
|
610
|
|
October 28, 2008
|
|
|
November 10, 2008
|
|
|
|
December 15, 2008
|
|
|
$
|
0.74
|
|
|
$
|
592
|
|
|
|
|
(1) |
|
Includes dividends on Convertible Preferred Stock issued in
November 2010. See The Company
Liquidity and Capital Sources Convertible Preferred
Stock. |
Future common stock dividend decisions will be determined by the
Holding Companys Board of Directors after taking into
consideration factors such as the Companys current
earnings, expected medium- and long-term earnings, financial
condition, regulatory capital position, and applicable
governmental regulations and policies. Furthermore, the payment
of dividends and other distributions to the Holding Company by
its insurance subsidiaries is regulated by insurance laws and
regulations.
167
Information on the declaration, record and payment dates, as
well as per share and aggregate dividend amounts, for the
Holding Companys Floating Rate Non-Cumulative Preferred
Stock, Series A and 6.500%
Non-Cumulative
Preferred Stock, Series B is as follows for the years ended
December 31, 2010, 2009 and 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend
|
|
|
|
|
|
|
|
Series A
|
|
|
Series A
|
|
|
Series B
|
|
|
Series B
|
|
Declaration Date
|
|
Record Date
|
|
Payment Date
|
|
Per Share
|
|
|
Aggregate
|
|
|
per Share
|
|
|
Aggregate
|
|
|
|
|
|
|
|
(In millions, except per share data)
|
|
|
November 15, 2010
|
|
November 30, 2010
|
|
December 15, 2010
|
|
$
|
0.2527777
|
|
|
$
|
7
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
August 16, 2010
|
|
August 31, 2010
|
|
September 15, 2010
|
|
$
|
0.2555555
|
|
|
|
6
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
May 17, 2010
|
|
May 31, 2010
|
|
June 15, 2010
|
|
$
|
0.2555555
|
|
|
|
7
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
March 5, 2010
|
|
February 28, 2010
|
|
March 15, 2010
|
|
$
|
0.2500000
|
|
|
|
6
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
26
|
|
|
|
|
|
|
$
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 16, 2009
|
|
November 30, 2009
|
|
December 15, 2009
|
|
$
|
0.2527777
|
|
|
$
|
7
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
August 17, 2009
|
|
August 31, 2009
|
|
September 15, 2009
|
|
$
|
0.2555555
|
|
|
|
6
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
May 15, 2009
|
|
May 31, 2009
|
|
June 15, 2009
|
|
$
|
0.2555555
|
|
|
|
7
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
March 5, 2009
|
|
February 28, 2009
|
|
March 16, 2009
|
|
$
|
0.2500000
|
|
|
|
6
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
26
|
|
|
|
|
|
|
$
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 17, 2008
|
|
November 30, 2008
|
|
December 15, 2008
|
|
$
|
0.2527777
|
|
|
$
|
7
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
August 15, 2008
|
|
August 31, 2008
|
|
September 15, 2008
|
|
$
|
0.2555555
|
|
|
|
6
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
May 15, 2008
|
|
May 31, 2008
|
|
June 16, 2008
|
|
$
|
0.2555555
|
|
|
|
7
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
March 5, 2008
|
|
February 29, 2008
|
|
March 17, 2008
|
|
$
|
0.3785745
|
|
|
|
9
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
29
|
|
|
|
|
|
|
$
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share Repurchases. At January 1, 2008,
the Company had $511 million remaining under its common
stock repurchase program authorizations. In both January and
April 2008, the Companys Board of Directors authorized
$1.0 billion common stock repurchase programs. During the
year ended December 31, 2008, the Company repurchased
19,716,418 shares for $1.2 billion under accelerated
share repurchases and 1,550,000 shares for $88 million
in open market repurchases. At December 31, 2008, the
Company had $1.3 billion remaining under its common stock
repurchase program authorizations. During the years ended
December 31, 2010 and 2009, the Company did not repurchase
any shares.
Under these common stock repurchase program authorizations, the
Holding Company may purchase its common stock from the MetLife
Policyholder Trust, in the open market (including pursuant to
the terms of a pre-set trading plan meeting the requirements of
Rule 10b5-1
under the Exchange Act) and in privately negotiated
transactions. Any future common stock repurchases will be
dependent upon several factors, including the Companys
capital position, its liquidity, its financial strength and
credit ratings, general market conditions and the price of
MetLife, Inc.s common stock compared to managements
assessment of the stocks underlying value and applicable
regulatory, legal and accounting factors. Whether or not to
purchase any common stock and the size and timing of any such
purchases will be determined in the Companys complete
discretion.
Residential Mortgage Loans
Held-for-Sale. At
December 31, 2010, the Company held $3,321 million in
residential mortgage loans
held-for-sale,
compared with $2,728 million at December 31, 2009, an
increase of $593 million. From time to time, MetLife Bank
has an increased cash need to fund mortgage loans that it
generally holds for a relatively short period before selling
them to one of the government-sponsored enterprises such as FNMA
or FHLMC. To meet these increased funding requirements, as well
as to increase overall liquidity, MetLife Bank takes advantage
of collateralized borrowing opportunities with the Federal
Reserve Bank of New York and the FHLB of NY. For further detail
on MetLife Banks use of these funding sources, see
The Company Liquidity and Capital
Sources Global Funding Sources.
Investment and Other. Additional cash outflows
include those related to obligations of securities lending
activities, investments in real estate, limited partnerships and
joint ventures, as well as litigation-related liabilities. Also,
the Company pledges collateral to, and has collateral pledged to
it by, counterparties under the Companys current
derivative transactions. With respect to derivative transactions
with credit ratings downgrade triggers, a two-
168
notch downgrade would have increased the Companys
derivative collateral requirements by $159 million at
December 31, 2010. In addition, the Company has pledged
collateral and has had collateral pledged to it, and may be
required from time to time to pledge additional collateral or be
entitled to have additional collateral pledged to it, in
connection with collateral financing arrangements related to the
reinsurance of closed block liabilities and universal life
secondary guarantee liabilities. See The
Company Liquidity and Capital Sources
Collateral Financing Arrangements.
Securities Lending. The Company participates
in a securities lending program whereby blocks of securities,
which are included in fixed maturity securities and short-term
investments, are loaned to third parties, primarily brokerage
firms and commercial banks, and the Company receives cash
collateral from the borrower, which must be returned to the
borrower when the loaned securities are returned to the Company.
Under the Companys securities lending program, the Company
was liable for cash collateral under its control of
$24.6 billion and $21.5 billion at December 31,
2010 and 2009, respectively. Of these amounts, $2.8 billion
and $3.3 billion at December 31, 2010 and 2009,
respectively, were on open terms, meaning that the related
loaned security could be returned to the Company on the next
business day upon return of cash collateral. Of the
$2.7 billion of estimated fair value of the securities
related to the cash collateral on open terms at
December 31, 2010, $2.3 billion were
U.S. Treasury, agency and government guaranteed securities
which, if put to the Company, can be immediately sold to satisfy
the cash requirements. See Investments
Securities Lending for further information.
Other. In September 2008, in connection with
the split-off of Reinsurance Group of America (RGA)
as described in Note 2 of the Notes to the Consolidated
Financial Statements, the Company received from MetLife
stockholders 23,093,689 shares of MetLife, Inc.s
common stock with a market value of $1.3 billion and, in
exchange, delivered 29,243,539 shares of RGA Class B
common stock with a net book value of $1.7 billion
resulting in a loss on disposition, including transaction costs,
of $458 million.
Contractual Obligations. The following table
summarizes the Companys major contractual obligations at
December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
More Than
|
|
|
More Than
|
|
|
|
|
|
|
|
|
|
One Year
|
|
|
One Year to
|
|
|
Three Years
|
|
|
More Than
|
|
Contractual Obligations
|
|
Total
|
|
|
or Less
|
|
|
Three Years
|
|
|
to Five Years
|
|
|
Five Years
|
|
|
|
(In millions)
|
|
|
Future policy benefits
|
|
$
|
319,565
|
|
|
$
|
6,271
|
|
|
$
|
10,295
|
|
|
$
|
12,205
|
|
|
$
|
290,794
|
|
Policyholder account balances
|
|
|
289,823
|
|
|
|
35,981
|
|
|
|
46,274
|
|
|
|
35,280
|
|
|
|
172,288
|
|
Other policyholder liabilities
|
|
|
9,983
|
|
|
|
7,995
|
|
|
|
485
|
|
|
|
124
|
|
|
|
1,379
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
27,272
|
|
|
|
27,272
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bank deposits
|
|
|
10,406
|
|
|
|
8,879
|
|
|
|
1,499
|
|
|
|
28
|
|
|
|
|
|
Short-term debt
|
|
|
306
|
|
|
|
306
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
31,184
|
|
|
|
2,340
|
|
|
|
4,773
|
|
|
|
5,932
|
|
|
|
18,139
|
|
Collateral financing arrangements
|
|
|
6,696
|
|
|
|
64
|
|
|
|
127
|
|
|
|
127
|
|
|
|
6,378
|
|
Junior subordinated debt securities
|
|
|
10,191
|
|
|
|
258
|
|
|
|
517
|
|
|
|
516
|
|
|
|
8,900
|
|
Commitments to lend funds
|
|
|
12,537
|
|
|
|
11,215
|
|
|
|
710
|
|
|
|
55
|
|
|
|
557
|
|
Operating leases
|
|
|
2,151
|
|
|
|
366
|
|
|
|
517
|
|
|
|
303
|
|
|
|
965
|
|
Other
|
|
|
15,356
|
|
|
|
14,873
|
|
|
|
52
|
|
|
|
3
|
|
|
|
428
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
735,470
|
|
|
$
|
115,820
|
|
|
$
|
65,249
|
|
|
$
|
54,573
|
|
|
$
|
499,828
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future policy benefits Future policy benefits
include liabilities related to traditional whole life policies,
term life policies, pension closeout and other group annuity
contracts, structured settlements, master terminal funding
agreements, single premium immediate annuities, long-term
disability policies, individual disability income policies, LTC
policies and property and casualty contracts. Included within
future policy benefits are contracts where the Company is
currently making payments and will continue to do so until the
occurrence of a specific event such as death, as well as those
where the timing of a portion of the payments has been
determined |
169
|
|
|
|
|
by the contract. Also included are contracts where the Company
is not currently making payments and will not make payments
until the occurrence of an insurable event, such as death or
illness, or where the occurrence of the payment triggering
event, such as a surrender of a policy or contract, is outside
the control of the Company. The Company has estimated the timing
of the cash flows related to these contracts based on historical
experience, as well as its expectation of future payment
patterns. |
|
|
|
Liabilities related to accounting conventions, or which are not
contractually due, such as shadow liabilities, excess interest
reserves and property and casualty loss adjustment expenses, of
$1.4 billion have been excluded from amounts presented in
the table above. |
|
|
|
Amounts presented in the table above, excluding those related to
property and casualty contracts, represent the estimated cash
payments for benefits under such contracts including assumptions
related to the receipt of future premiums and assumptions
related to mortality, morbidity, policy lapse, renewal,
retirement, inflation, disability incidence, disability
terminations, policy loans and other contingent events as
appropriate to the respective product type. Payments for case
reserve liabilities and incurred but not reported liabilities
associated with property and casualty contracts of
$1.5 billion have been included using an estimate of the
ultimate amount to be settled under the policies based upon
historical payment patterns. The ultimate amount to be paid
under property and casualty contracts is not determined until
the Company reaches a settlement with the claimant, which may
vary significantly from the liability or contractual obligation
presented above especially as it relates to incurred but not
reported liabilities. All estimated cash payments presented in
the table above are undiscounted as to interest, net of
estimated future premiums on policies currently in-force and
gross of any reinsurance recoverable. The more than five years
category includes estimated payments due for periods extending
for more than 100 years from the present date. |
|
|
|
The sum of the estimated cash flows shown for all years in the
table of $319.6 billion exceeds the liability amount of
$173.4 billion included on the consolidated balance sheet
principally due to the time value of money, which accounts for
at least 80% of the difference, as well as differences in
assumptions, most significantly mortality, between the date the
liabilities were initially established and the current date. |
|
|
|
For the majority of the Companys insurance operations,
estimated contractual obligations for future policy benefits and
policyholder account balance liabilities as presented in the
table above are derived from the annual asset adequacy analysis
used to develop actuarial opinions of statutory reserve adequacy
for state regulatory purposes. These cash flows are materially
representative of the cash flows under GAAP. (See
Policyholder account balances below.) |
|
|
|
Actual cash payments to policyholders may differ significantly
from the liabilities as presented in the consolidated balance
sheet and the estimated cash payments as presented in the table
above due to differences between actual experience and the
assumptions used in the establishment of these liabilities and
the estimation of these cash payments. |
|
|
|
Policyholder account balances Policyholder
account balances include liabilities related to conventional
guaranteed interest contracts, guaranteed interest contracts
associated with formal offering programs, funding agreements,
individual and group annuities, total control accounts,
individual and group universal life, variable universal life and
company-owned life insurance. |
|
|
|
Included within policyholder account balances are contracts
where the amount and timing of the payment is essentially fixed
and determinable. These amounts relate to policies where the
Company is currently making payments and will continue to do so,
as well as those where the timing of the payments has been
determined by the contract. Other contracts involve payment
obligations where the timing of future payments is uncertain and
where the Company is not currently making payments and will not
make payments until the occurrence of an insurable event, such
as death, or where the occurrence of the payment triggering
event, such as a surrender of or partial withdrawal on a policy
or deposit contract, is outside the control of the Company. The
Company has estimated the timing of the cash flows related to
these contracts based on historical experience, as well as its
expectation of future payment patterns. |
|
|
|
Excess interest reserves representing purchase accounting
adjustments of $539 million, as well as $2.4 billion
relating to embedded derivatives, have been excluded from
amounts presented in the table above as they represent
accounting conventions and not contractual obligations. |
170
|
|
|
|
|
Amounts presented in the table above represent the estimated
cash payments to be made to policyholders undiscounted as to
interest and including assumptions related to the receipt of
future premiums and deposits; withdrawals, including unscheduled
or partial withdrawals; policy lapses; surrender charges;
annuitization; mortality; future interest credited; policy loans
and other contingent events as appropriate to the respective
product type. Such estimated cash payments are also presented
net of estimated future premiums on policies currently in-force
and gross of any reinsurance recoverable. For obligations
denominated in foreign currencies, cash payments have been
estimated using current spot rates. |
|
|
|
The sum of the estimated cash flows shown for all years in the
table of $289.8 billion exceeds the liability amount of
$211.0 billion included on the consolidated balance sheet
principally due to the time value of money, which accounts for
at least 80% of the difference, as well as differences in
assumptions between the date the liabilities were initially
established and the current date. See the comments under
Future policy benefits above regarding
the source and uncertainties associated with the estimation of
the contractual obligations related to future policyholder
benefits and policyholder account balances. |
|
|
|
Other policyholder liabilities Other
policyholder liabilities are comprised of other policy-related
balances, policyholder dividends payable and the policyholder
dividend obligation. Amounts included in the table above related
to these balances are as follows: |
|
|
|
a. Other policy-related balances includes liabilities for
incurred but not reported claims and claims payable on group
term life, long-term disability, long-term care and dental;
policyholder dividends left on deposit and policyholder
dividends due and unpaid related primarily to traditional life
and group life and health; and premiums received in advance.
Liabilities related to unearned revenue and negative VOBA of
$2.2 billion and $4.3 billion, respectively, have been
excluded from the cash payments presented in the table above
because they reflect accounting conventions and not contractual
obligations. With the exception of policyholder dividends left
on deposit, and those items excluded as noted in the preceding
sentence, the contractual obligation presented in the table
above related to other policy-related balances is equal to the
liability reflected in the consolidated balance sheet. Such
amounts are reported in the one year or less category due to the
short-term nature of the liabilities. Contractual obligations on
policyholder dividends left on deposit are projected based on
assumptions of policyholder withdrawal activity.
|
|
|
|
b. Policyholder dividends payable consists of liabilities
related to dividends payable in the following calendar year on
participating policies. As such, the contractual obligation
related to policyholder dividends payable is presented in the
table above in the one year or less category at the amount of
the liability presented in the consolidated balance sheet.
|
|
|
|
c. The nature of the policyholder dividend obligation is
described in Note 18 of the Notes to the Consolidated
Financial Statements. Because the exact timing and amount of the
ultimate policyholder dividend obligation is subject to
significant uncertainty and the amount of the policyholder
dividend obligation is based upon a long-term projection of the
performance of the closed block, we have reflected the
obligation at the amount of the liability, if any, presented in
the consolidated balance sheet in the more than five years
category. This was presented to reflect the long-duration of the
liability and the uncertainty of the ultimate cash payment.
|
|
|
|
Payables for collateral under securities loaned and other
transactions The Company has accepted cash
collateral in connection with securities lending and derivative
transactions. As the securities lending transactions expire
within the next year or the timing of the return of the
collateral is uncertain, the return of the collateral has been
included in the one year or less category in the table above.
The Company also holds non-cash collateral, which is not
reflected as a liability in the consolidated balance sheet, of
$984 million at December 31, 2010. |
|
|
|
Bank deposits Bank deposits of
$10.4 billion exceed the amount on the balance sheet of
$10.3 billion due to the inclusion of estimated interest
payments. Liquid deposits, including demand deposit accounts,
money market accounts and savings accounts, are assumed to
mature at carrying value within one year. Certificates of
deposit are assumed to pay all interest and principal at
maturity. |
|
|
|
Short-term debt, long-term debt, collateral financing
arrangements and junior subordinated debt
securities Amounts presented in the table above
for short-term debt, long-term debt, collateral financing
arrangements and junior subordinated debt securities differ from
the balances presented on the consolidated balance sheet as the
amounts presented in the table above do not include premiums or
discounts upon issuance or purchase |
171
|
|
|
|
|
accounting fair value adjustments. The amounts presented above
also include interest on such obligations as described below. |
|
|
|
Short-term debt consists of borrowings with original maturities
of one year or less carrying fixed interest rates. The
contractual obligation for short-term debt presented in the
table above represents the principal amounts due upon maturity
plus the related interest for the period from January 1,
2011 through maturity. |
|
|
|
Long-term debt bears interest at fixed and variable interest
rates through their respective maturity dates. Interest on fixed
rate debt was computed using the stated rate on the obligations
for the period from January 1, 2011 through maturity.
Interest on variable rate debt was computed using prevailing
rates at December 31, 2010 and, as such, does not consider
the impact of future rate movements. Long-term debt also
includes payments under capital lease obligations of
$3 million, $2 million, $0 and $27 million, in
the one year or less, more than one year to three years, more
than three years to five years and more than five years
categories, respectively. Long-term debt presented in the table
above excludes $6,820 million at December 31, 2010 of
long-term debt relating to CSEs. |
|
|
|
Collateral financing arrangements bear interest at fixed and
variable interest rates through their respective maturity dates.
Interest on fixed rate debt was computed using the stated rate
on the obligations for the period from January 1, 2011
through maturity. Interest on variable rate debt was computed
using prevailing rates at December 31, 2010 and, as such,
does not consider the impact of future rate movements. Pursuant
to these collateral financing arrangements, the Holding Company
may be required to deliver cash or pledge collateral to the
respective unaffiliated financial institutions. See
The Company Liquidity and Capital
Sources Collateral Financing Arrangements. |
|
|
|
Junior subordinated debt securities bear interest at fixed
interest rates through their respective redemption dates.
Interest was computed using the stated rates on the obligations
for the period from January 1, 2011 through the scheduled
redemption dates as it is the Companys expectation that
the debt will be redeemed at that time. Inclusion of interest
payments on junior subordinated debt through the final maturity
dates would increase the contractual obligation by
$7.7 billion. |
|
|
|
Commitments to lend funds The Company commits
to lend funds under mortgage loans, partnerships, bank credit
facilities, bridge loans and private corporate bond investments.
In the table above, the timing of the funding of mortgage loans
and private corporate bond investments is based on the
expiration date of the commitment. As it relates to commitments
to lend funds to partnerships and under bank credit facilities,
the Company anticipates that these amounts could be invested any
time over the next five years; however, as the timing of the
fulfillment of the obligation cannot be predicted, such
obligations are presented in the one year or less category in
the table above. Commitments to fund bridge loans are short-term
obligations and, as a result, are presented in the one year or
less category in the table above. See
Off-Balance Sheet Arrangements. |
|
|
|
Operating leases As a lessee, the Company has
various operating leases, primarily for office space.
Contractual provisions exist that could increase or accelerate
those lease obligations presented, including various leases with
early buyouts
and/or
escalation clauses. However, the impact of any such transactions
would not be material to the Companys financial position
or results of operations. See Off-Balance
Sheet Arrangements. |
|
|
|
Other Includes other miscellaneous
contractual obligations of $32 million not included
elsewhere in the table above. Other liabilities presented in the
table above are principally comprised of amounts due under
reinsurance arrangements, payables related to securities
purchased but not yet settled, securities sold short, accrued
interest on debt obligations, estimated fair value of derivative
obligations, deferred compensation arrangements, guaranty
liabilities, the estimated fair value of forward stock purchase
contracts, as well as general accruals and accounts payable due
under contractual obligations. If the timing of any of the other
liabilities is sufficiently uncertain, the amounts are included
within the one year or less category. |
|
|
|
The other liabilities presented in the table above differ from
the amount presented in the consolidated balance sheet by
$5.0 billion due primarily to the exclusion of items such
as legal liabilities, pension and postretirement benefit
obligations, taxes due other than income tax, unrecognized tax
benefits and related accrued interest, accrued severance and
employee incentive compensation and other liabilities such as
deferred gains and losses. Such items have been excluded from
the table above as they represent accounting conventions or are
not liabilities due under contractual obligations. |
172
|
|
|
|
|
The net funded status of the Companys pension and other
postretirement liabilities included within other liabilities has
been excluded from the amounts presented in the table above.
Rather, the amounts presented represent the discretionary
contributions of $175 million to be made by the Company to
our pension plan in 2011 and the discretionary contributions of
$120 million, based on the current years expected
gross benefit payments to participants, to be made by the
Company to the postretirement benefit plans during 2011.
Virtually all contributions to the pension and postretirement
benefit plans are made by the insurance subsidiaries of the
Holding Company with little impact on the Holding Companys
cash flows. |
|
|
|
Excluded from the table above are unrecognized tax benefits and
related accrued interest of $810 million and
$221 million, respectively, for which the Company cannot
reliably determine the timing of payment. Current income tax
payable is also excluded from the table. |
|
|
|
See also Off-Balance Sheet Arrangements. |
Separate account liabilities are excluded from the table above.
Generally, the separate account owner, rather than the Company,
bears the investment risk of these funds. The separate account
assets are legally segregated and are not subject to the claims
that arise out of any other business of the Company. Net
deposits, net investment income and realized and unrealized
capital gains and losses on the separate accounts are fully
offset by corresponding amounts credited to contractholders
whose liability is reflected with the separate account
liabilities. Separate account liabilities are fully funded by
cash flows from the separate account assets and are set equal to
the estimated fair value of separate account assets.
The Company also enters into agreements to purchase goods and
services in the normal course of business; however, these
purchase obligations were not material to its consolidated
results of operations or financial position at December 31,
2010.
Additionally, the Company has agreements in place for services
it conducts, generally at cost, between subsidiaries relating to
insurance, reinsurance, loans and capitalization. Intercompany
transactions have appropriately been eliminated in
consolidation. Intercompany transactions among insurance
subsidiaries and affiliates have been approved by the
appropriate departments of insurance as required.
Support Agreements. The Holding Company and
several of its subsidiaries (each, an Obligor) are
parties to various capital support commitments, guarantees and
contingent reinsurance agreements with certain subsidiaries of
the Holding Company and a corporation in which the Holding
Company owns 50% of the equity. Under these arrangements, each
Obligor, with respect to the applicable entity, has agreed to
cause such entity to meet specified capital and surplus levels,
has guaranteed certain contractual obligations or has agreed to
provide, upon the occurrence of certain contingencies,
reinsurance for such entitys insurance liabilities. We
anticipate that in the event that these arrangements place
demands upon the Company, there will be sufficient liquidity and
capital to enable the Company to meet anticipated demands. See
The Holding Company Liquidity and
Capital Uses Support Agreements.
Litigation. Putative or certified class action
litigation and other litigation, and claims and assessments
against the Company, in addition to those discussed elsewhere
herein and those otherwise provided for in the Companys
consolidated financial statements, have arisen in the course of
the Companys business, including, but not limited to, in
connection with its activities as an insurer, mortgage lending
bank, employer, investor, investment advisor and taxpayer.
Further, state insurance regulatory authorities and other
federal and state authorities regularly make inquiries and
conduct investigations concerning the Companys compliance
with applicable insurance and other laws and regulations.
It is not possible to predict or determine the ultimate outcome
of all pending investigations and legal proceedings. In some of
the matters referred to herein, very large
and/or
indeterminate amounts, including punitive and treble damages,
are sought. Although in light of these considerations, it is
possible that an adverse outcome in certain cases could have a
material adverse effect upon the Companys financial
position, based on information currently known by the
Companys management, in its opinion, the outcome of such
pending investigations and legal proceedings are not likely to
have such an effect. However, given the large
and/or
indeterminate amounts sought in certain of these matters and the
inherent unpredictability of litigation, it is possible that an
adverse
173
outcome in certain matters could, from time to time, have a
material adverse effect on the Companys consolidated net
income or cash flows in particular quarterly or annual periods.
The
Holding Company
Capital
Restrictions and Limitations on Bank Holding Companies and
Financial Holding Companies. The Holding Company
and its insured depository institution subsidiary, MetLife Bank,
are subject to risk-based and leverage capital guidelines issued
by the federal banking regulatory agencies for banks and bank
and financial holding companies. The federal banking regulatory
agencies are required by law to take specific prompt corrective
actions with respect to institutions that do not meet minimum
capital standards. As of their most recently filed reports with
the federal banking regulatory agencies, the Holding Company and
MetLife Bank met the minimum capital standards as per federal
banking regulatory agencies with all of MetLife Banks
risk-based and leverage capital ratios meeting the federal
banking regulatory agencies well capitalized
standards and all of the Holding Companys risk-based and
leverage capital ratios meeting the adequately
capitalized standards. In addition to requirements which
may be imposed in connection with the implementation of
Dodd-Frank, if endorsed and adopted in the U.S., Basel III
will also lead to increased capital and liquidity requirements
for bank holding companies, such as MetLife, Inc. See
Industry Trends Financial and
Economic Environment Regulatory Changes.
The following table contains the RBC ratios and the regulatory
requirements for MetLife, Inc., as a bank holding company, and
MetLife Bank:
MetLife,
Inc.
RBC Ratios Bank Holding Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Regulatory
|
|
Regulatory
|
|
|
December 31,
|
|
Requirements
|
|
Requirements
|
|
|
2010
|
|
2009
|
|
Minimum
|
|
Well Capitalized
|
|
Total RBC Ratio
|
|
|
8.52
|
%
|
|
|
9.88
|
%
|
|
|
8.00
|
%
|
|
|
10.00
|
%
|
Tier 1 RBC Ratio
|
|
|
8.21
|
%
|
|
|
9.44
|
%
|
|
|
4.00
|
%
|
|
|
6.00
|
%
|
Tier 1 Leverage Ratio
|
|
|
5.11
|
%
|
|
|
5.71
|
%
|
|
|
4.00
|
%
|
|
|
n/a
|
|
MetLife
Bank
RBC Ratios Bank
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Regulatory
|
|
Regulatory
|
|
|
December 31,
|
|
Requirements
|
|
Requirements
|
|
|
2010
|
|
2009
|
|
Minimum
|
|
Well Capitalized
|
|
Total RBC Ratio
|
|
|
15.00
|
%
|
|
|
13.41
|
%
|
|
|
8.00
|
%
|
|
|
10.00
|
%
|
Tier 1 RBC Ratio
|
|
|
14.16
|
%
|
|
|
12.16
|
%
|
|
|
4.00
|
%
|
|
|
6.00
|
%
|
Tier 1 Leverage Ratio
|
|
|
7.14
|
%
|
|
|
6.64
|
%
|
|
|
4.00
|
%
|
|
|
5.00
|
%
|
Summary of Primary Sources and Uses of Liquidity and
Capital. For information regarding the primary
sources and uses of Holding Company liquidity and capital, see
The Company Capital
Summary of Primary Sources and Uses of Liquidity and
Capital.
Liquidity
and Capital
Liquidity and capital are managed to preserve stable, reliable
and cost-effective sources of cash to meet all current and
future financial obligations and are provided by a variety of
sources, including a portfolio of liquid assets, a diversified
mix of short- and long-term funding sources from the wholesale
financial markets and the ability to borrow through credit and
committed credit facilities. The Holding Company is an active
participant in the global financial markets through which it
obtains a significant amount of funding. These markets, which
serve as cost-effective sources of funds, are critical
components of the Holding Companys liquidity and capital
management. Decisions to access these markets are based upon
relative costs, prospective views of balance
174
sheet growth and a targeted liquidity profile and capital
structure. A disruption in the financial markets could limit the
Holding Companys access to liquidity.
The Holding Companys ability to maintain regular access to
competitively priced wholesale funds is fostered by its current
credit ratings from the major credit rating agencies. We view
our capital ratios, credit quality, stable and diverse earnings
streams, diversity of liquidity sources and our liquidity
monitoring procedures as critical to retaining such credit
ratings. See The Company
Capital Rating Agencies.
Liquidity is monitored through the use of internal liquidity
risk metrics, including the composition and level of the liquid
asset portfolio, timing differences in short-term cash flow
obligations, access to the financial markets for capital and
debt transactions and exposure to contingent draws on the
Holding Companys liquidity.
Liquidity
and Capital Sources
Dividends from Subsidiaries. The Holding
Company relies in part on dividends from its subsidiaries to
meet its cash requirements. The Holding Companys insurance
subsidiaries are subject to regulatory restrictions on the
payment of dividends imposed by the regulators of their
respective domiciles. The dividend limitation for
U.S. insurance subsidiaries is generally based on the
surplus to policyholders at the end of the immediately preceding
calendar year and statutory net gain from operations for the
immediately preceding calendar year. Statutory accounting
practices, as prescribed by insurance regulators of various
states in which the Company conducts business, differ in certain
respects from accounting principles used in financial statements
prepared in conformity with GAAP. The significant differences
relate to the treatment of DAC, certain deferred income tax,
required investment liabilities, statutory reserve calculation
assumptions, goodwill and surplus notes.
The table below sets forth the dividends permitted to be paid by
the respective insurance subsidiary without insurance regulatory
approval and the respective dividends paid:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2011
|
|
2010
|
|
2009
|
|
2008
|
|
|
Permitted
|
|
|
|
Permitted
|
|
|
|
Permitted
|
|
|
|
Permitted
|
|
|
w/o
|
|
|
|
w/o
|
|
|
|
w/o
|
|
|
|
w/o
|
Company
|
|
Approval (1)
|
|
Paid (2)
|
|
Approval (3)
|
|
Paid (2)
|
|
Approval (3)
|
|
Paid (2)
|
|
Approval (3)
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
Metropolitan Life Insurance Company
|
|
$
|
1,321
|
|
|
$
|
631
|
(4)
|
|
$
|
1,262
|
|
|
$
|
|
|
|
$
|
552
|
|
|
$
|
1,318
|
(5)
|
|
$
|
1,299
|
|
American Life Insurance Company (6)
|
|
$
|
661
|
|
|
$
|
|
|
|
$
|
511
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
MetLife Insurance Company of Connecticut
|
|
$
|
517
|
|
|
$
|
330
|
|
|
$
|
659
|
|
|
$
|
|
|
|
$
|
714
|
|
|
$
|
500
|
|
|
$
|
1,026
|
|
Metropolitan Property and Casualty Insurance Company
|
|
$
|
|
|
|
$
|
260
|
|
|
$
|
|
|
|
$
|
300
|
|
|
$
|
9
|
|
|
$
|
300
|
|
|
$
|
|
|
Metropolitan Tower Life Insurance Company
|
|
$
|
80
|
|
|
$
|
569
|
(7)
|
|
$
|
93
|
|
|
$
|
|
|
|
$
|
88
|
|
|
$
|
277
|
(8)
|
|
$
|
113
|
|
|
|
|
(1) |
|
Reflects dividend amounts that may be paid during 2011 without
prior regulatory approval. However, because dividend tests may
be based on dividends previously paid over rolling
12-month
periods, if paid before a specified date during 2011, some or
all of such dividends may require regulatory approval. |
|
(2) |
|
All amounts paid, including those requiring regulatory approval. |
|
(3) |
|
Reflects dividend amounts that could have been paid during the
relevant year without prior regulatory approval. |
|
(4) |
|
Includes securities transferred to the Holding Company of
$399 million. |
|
(5) |
|
Consists of shares of RGA stock distributed by MLIC to the
Holding Company as an in-kind dividend of $1,318 million. |
|
(6) |
|
Reflects dividends permitted to be paid and the respective
dividends paid since the Acquisition Date. See Note 2 to
the Notes to the Consolidated Financial Statements. |
|
(7) |
|
Includes shares of an affiliate distributed to the Holding
Company as an in-kind dividend of $475 million. |
175
|
|
|
(8) |
|
Includes shares of an affiliate distributed to the Holding
Company as an in-kind dividend of $164 million. |
In addition to the amounts presented in the table above, for the
years ended December 31, 2010, 2009 and 2008, cash
dividends in the aggregate amount of $0, $215 million and
$235 million, respectively, were paid to the Holding
Company.
The dividend capacity of
non-U.S. operations
is subject to similar restrictions established by the local
regulators. The
non-U.S. regulatory
regimes also commonly limit the dividend payments to the parent
to a portion of the prior years statutory income, as
determined by the local accounting principles. The regulators of
the
non-U.S. operations,
including the Japan branch of American Life, may also limit or
not permit profit repatriations or other transfers of funds to
the U.S. if such transfers would be detrimental to the solvency
or financial strength of the operations of the
non-U.S. operations,
or for other reasons. Most of the
non-U.S. subsidiaries
are second tier subsidiaries and are not directly owned by the
Holding Company. The capital and rating considerations
applicable to the first tier subsidiaries may also impact the
dividend flow into the Holding Company.
The Companys management actively manages its target and
excess capital levels and dividend flows on a pro-active basis
and forecasts local capital positions as part of the financial
planning cycle. The dividend capacity of certain U.S. and
non-U.S. subsidiaries
is also subject to business targets in excess of the minimum
capital necessary to maintain the desired rating or level of
financial strength in the relevant market. Management of the
Holding Company cannot provide assurances that the Holding
Companys subsidiaries will have statutory earnings to
support payment of dividends to the Holding Company in an amount
sufficient to fund its cash requirements and pay cash dividends
and that the applicable regulators will not disapprove any
dividends that such subsidiaries must submit for approval. See
Note 18 of the Notes to the Consolidated Financial
Statements.
Liquid Assets. An integral part of the Holding
Companys liquidity management is the amount of liquid
assets it holds. Liquid assets include cash, cash equivalents,
short-term investments and publicly-traded securities,
excluding: (i) cash collateral received under the
Companys securities lending program that has been
reinvested in cash, cash equivalents, short-term investments and
publicly-traded securities; and (ii) cash collateral
received from counterparties in connection with derivative
instruments. At December 31, 2010 and 2009, the Holding
Company had $2.8 billion and $3.8 billion,
respectively, in liquid assets. In addition, the Holding Company
has pledged collateral and has had collateral pledged to it, and
may be required from time to time to pledge additional
collateral or be entitled to have additional collateral pledged
to it. At December 31, 2010 and 2009, the Holding Company
had pledged $362 million and $289 million,
respectively, of liquid assets under collateral support
agreements.
Shelf Registration. In November 2010, the
Holding Company filed a shelf registration statement (the
2010 Shelf Registration Statement) with the
U.S. Securities and Exchange Commission (SEC),
which was automatically effective upon filing, in accordance
with SEC rules. SEC rules also allow for pay-as-you-go fees and
the ability to add securities by filing automatically effective
amendments for companies, such as the Holding Company, which
qualify as Well-Known Seasoned Issuers. The 2010
Shelf Registration Statement registered an unlimited amount of
debt and equity securities and replaces the shelf registration
statement that the Holding Company filed in November 2007, which
expired in the fourth quarter of 2010. The terms of any offering
will be established at the time of the offering.
Global Funding Sources. Liquidity is also
provided by a variety of short-term instruments, including
commercial paper. Capital is provided by a variety of
instruments, including medium- and long-term debt, junior
subordinated debt securities, collateral financing arrangements,
capital securities and stockholders equity. The diversity
of the Holding Companys funding sources enhances funding
flexibility, limits dependence on any one source of funds and
generally lowers the cost of funds. Other sources of the Holding
Companys liquidity include programs for short-and
long-term borrowing, as needed.
We continuously monitor and adjust our liquidity and capital
plans for the Holding Company and its subsidiaries in light of
changing requirements and market conditions.
176
Long-term Debt. The following table summarizes
the outstanding long-term debt of the Holding Company at:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Long-term debt unaffiliated
|
|
$
|
16,258
|
|
|
$
|
10,458
|
|
Long-term debt affiliated
|
|
$
|
665
|
(1)
|
|
$
|
500
|
|
Collateral financing arrangements
|
|
$
|
2,797
|
|
|
$
|
2,797
|
|
Junior subordinated debt securities
|
|
$
|
1,748
|
|
|
$
|
1,748
|
|
|
|
|
(1) |
|
Includes $165 million of affiliated senior notes associated
with bonds held by ALICO. |
Short-term Debt. MetLife, Inc. maintains a
commercial paper program, proceeds of which can be used to
finance the general liquidity needs of MetLife, Inc. and its
subsidiaries. The Holding Company had no short-term debt
outstanding at both December 31, 2010 and 2009. There was
no short-term debt activity in 2010. During the years ended
December 31, 2009 and 2008, the weighted average interest
rate on short-term debt, comprised only of commercial paper, was
1.25% and 2.5%, respectively. During the year ended
December 31, 2009, the average daily balance on short-term
debt was $5 million, and the average days outstanding was
6 days.
Debt Issuances and Other Borrowings. For
information on debt issuances and other borrowings entered into
by the Holding Company, see The
Company Liquidity and Capital Sources
Debt Issuances and Other Borrowings.
Senior Notes. The following table summarizes
the Holding Companys outstanding senior notes series by
maturity date, excluding any premium or discount, at
December 31, 2010:
|
|
|
|
|
|
|
Maturity Date
|
|
Principal
|
|
Interest Rate
|
|
|
(In millions)
|
|
|
|
2011
|
|
$
|
750
|
|
|
6.13%
|
2012
|
|
$
|
400
|
|
|
5.38%
|
2012
|
|
$
|
397
|
|
|
3-month LIBOR + .032%
|
2013
|
|
$
|
500
|
|
|
5.00%
|
2013
|
|
$
|
250
|
|
|
3-month LIBOR + 1.25%
|
2014
|
|
$
|
350
|
|
|
5.50%
|
2014
|
|
$
|
1,000
|
|
|
2.38%
|
2015
|
|
$
|
1,000
|
|
|
5.00%
|
2016
|
|
$
|
1,250
|
|
|
6.75%
|
2018
|
|
$
|
1,035
|
|
|
6.82%
|
2018 (1)
|
|
$
|
500
|
|
|
1.56%
|
2018 (2)
|
|
$
|
500
|
|
|
2.46%
|
2019
|
|
$
|
1,035
|
|
|
7.72%
|
2020
|
|
$
|
729
|
|
|
5.25%
|
2021
|
|
$
|
1,000
|
|
|
4.75%
|
2023 (1)
|
|
$
|
500
|
|
|
1.56%
|
2024
|
|
$
|
1,000
|
|
|
1.92%
|
2024
|
|
$
|
673
|
|
|
5.38%
|
2032
|
|
$
|
600
|
|
|
6.50%
|
2033
|
|
$
|
200
|
|
|
5.88%
|
2034
|
|
$
|
750
|
|
|
6.38%
|
2035
|
|
$
|
1,000
|
|
|
5.70%
|
2041
|
|
$
|
750
|
|
|
5.88%
|
2045 (2)
|
|
$
|
500
|
|
|
2.46%
|
|
|
|
(1) |
|
Represents one of two tranches comprising the Series C Debt
Securities. |
|
(2) |
|
Represents one of two tranches comprising the Series E Debt
Securities. |
177
Collateral Financing Arrangements. For
information on collateral financing arrangements entered into by
the Holding Company, see The
Company Liquidity and Capital Sources
Collateral Financing Arrangements.
Credit and Committed Facilities. At
December 31, 2010, the Holding Company, along with MetLife
Funding, maintained $4.0 billion in unsecured credit
facilities, the proceeds of which are available to be used for
general corporate purposes, to support the borrowers
commercial paper programs and for the issuance of letters of
credit. At December 31, 2010, the Holding Company had
outstanding $1.5 billion in letters of credit and no
drawdowns against this facility. Remaining unused commitments
were $2.5 billion at December 31, 2010.
The Holding Company maintains committed facilities with a
capacity of $300 million. At December 31, 2010, the
Holding Company had outstanding $300 million in letters of
credit and no drawdowns against these facilities. There were no
remaining unused commitments at December 31, 2010. In
addition, the Holding Company is a party to committed facilities
of certain of its subsidiaries, which aggregated
$12.1 billion at December 31, 2010. The committed
facilities are used as collateral for certain of the
Companys affiliated reinsurance liabilities.
See Note 11 of the Notes to the Consolidated Financial
Statements for further detail on these facilities.
Covenants. Certain of the Holding
Companys debt instruments, credit facilities and committed
facilities contain various administrative, reporting, legal and
financial covenants. The Holding Company believes it was in
compliance with all covenants at December 31, 2010 and 2009.
Preferred Stock, Convertible Preferred Stock, Common Stock
and Equity Units. For information on preferred
stock, convertible preferred stock, common stock and common
equity units issued by the Holding Company, see
The Company Liquidity and Capital
Sources Preferred Stock,
Convertible Preferred Stock,
Common Stock, and
Equity Units, respectively.
Liquidity
and Capital Uses
The primary uses of liquidity of the Holding Company include
debt service, cash dividends on preferred, convertible preferred
and common stock, capital contributions to subsidiaries, payment
of general operating expenses and acquisitions. Based on our
analysis and comparison of our current and future cash inflows
from the dividends we receive from subsidiaries that are
permitted to be paid without prior insurance regulatory
approval, our asset portfolio and other cash flows and
anticipated access to the capital markets, we believe there will
be sufficient liquidity and capital to enable the Holding
Company to make payments on debt, make cash dividend payments on
its preferred, convertible preferred and common stock,
contribute capital to its subsidiaries, pay all general
operating expenses and meet its cash needs.
Acquisitions. For information regarding the
purchase price of the Acquisition, see The
Company Liquidity and Capital Uses
Acquisitions.
Affiliated Capital Transactions. During the
years ended December 31, 2010, 2009 and 2008, the Holding
Company invested an aggregate of $699 million (excludes the
Acquisition), $986 million and $2.6 billion,
respectively, in various subsidiaries.
The Holding Company lends funds, as necessary, to its
subsidiaries, some of which are regulated, to meet their capital
requirements. Such loans are included in loans to subsidiaries
and consisted of the following at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
Subsidiaries
|
|
Interest Rate
|
|
Maturity Date
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Metropolitan Life Insurance Company
|
|
6-month LIBOR + 1.80%
|
|
December 31, 2011
|
|
$
|
775
|
|
|
$
|
775
|
|
Metropolitan Life Insurance Company
|
|
6-month LIBOR + 1.80%
|
|
December 31, 2011
|
|
|
|
|
|
|
300
|
|
Metropolitan Life Insurance Company
|
|
7.13%
|
|
December 15, 2032
|
|
|
400
|
|
|
|
400
|
|
Metropolitan Life Insurance Company
|
|
7.13%
|
|
January 15, 2033
|
|
|
100
|
|
|
|
100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
$
|
1,275
|
|
|
$
|
1,575
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
178
Debt Repayments. The Holding Company intends
to either repay all or refinance in whole or in part the debt
that is due in December 2011. See The Holding
Company Liquidity and Capital Sources
Senior Notes.
Support Agreements. The Holding Company is
party to various capital support commitments and guarantees with
certain of its subsidiaries and a corporation in which it owns
50% of the equity. Under these arrangements, the Holding Company
has agreed to cause each such entity to meet specified capital
and surplus levels or has guaranteed certain contractual
obligations.
In November 2010, the Holding Company guaranteed the obligations
of Exeter Reassurance Company, Ltd. (Exeter) in an
aggregate amount up to $1.0 billion, under a reinsurance
agreement with MetLife Europe Limited (MEL), under
which Exeter reinsures the guaranteed living benefits and
guaranteed death benefits associated with certain unit-linked
annuity contracts issued by MEL.
In January 2010, the Holding Company guaranteed the obligations
of its subsidiary, Missouri Reinsurance (Barbados) Inc.
(MoRe), under a retrocession agreement with RGA
Reinsurance (Barbados) Inc., pursuant to which MoRe retrocedes
certain group term life insurance issued by MLIC.
In December 2009, the Holding Company, in connection with
MetLife Reinsurance Company of Vermont (MRV)s
reinsurance of certain universal life and term life insurance
risks, committed to the Vermont Department of Banking,
Insurance, Securities and Health Care Administration to take
necessary action to cause the third protected cell of MRV to
maintain total adjusted capital equal to or greater than 200% of
such protected cells authorized control level RBC, as
defined in state insurance statutes. See The
Company Liquidity and Capital Sources
Credit and Committed Facilities and Note 11 of the
Notes to the Consolidated Financial Statements.
The Holding Company, in connection with MRVs reinsurance
of certain universal life and term life insurance risks,
committed to the Vermont Department of Banking, Insurance,
Securities and Health Care Administration to take necessary
action to cause each of the two initial protected cells of MRV
to maintain total adjusted capital equal to or greater than 200%
of such protected cells authorized control level RBC,
as defined in state insurance statutes. See
The Company Liquidity and Capital
Sources Credit and Committed Facilities and
Note 11 of the Notes to the Consolidated Financial
Statements.
The Holding Company, in connection with the collateral financing
arrangement associated with MRCs reinsurance of a portion
of the liabilities associated with the closed block, committed
to the South Carolina Department of Insurance to make capital
contributions, if necessary, to MRC so that MRC may at all times
maintain its total adjusted capital at a level of not less than
200% of the company action level RBC, as defined in state
insurance statutes as in effect on the date of determination or
December 31, 2007, whichever calculation produces the
greater capital requirement, or as otherwise required by the
South Carolina Department of Insurance. See
The Company Liquidity and Capital
Sources Debt Issuances and Other Borrowings
and Note 12 of the Notes to the Consolidated Financial
Statements.
The Holding Company, in connection with the collateral financing
arrangement associated with MRSCs reinsurance of universal
life secondary guarantees, committed to the South Carolina
Department of Insurance to take necessary action to cause MRSC
to maintain total adjusted capital equal to the greater of
$250,000 or 100% of MRSCs authorized control
level RBC, as defined in state insurance statutes. See
The Company Liquidity and Capital
Sources Debt Issuances and Other Borrowings
and Note 12 of the Notes to the Consolidated Financial
Statements.
The Holding Company has net worth maintenance agreements with
two of its insurance subsidiaries, MetLife Investors Insurance
Company and First MetLife Investors Insurance Company. Under
these agreements, as subsequently amended, the Holding Company
agreed, without limitation as to the amount, to cause each of
these subsidiaries to have a minimum capital and surplus of
$10 million, total adjusted capital at a level not less
than 150% of the company action level RBC, as defined by
state insurance statutes, and liquidity necessary to enable it
to meet its current obligations on a timely basis.
The Holding Company entered into a net worth maintenance
agreement with Mitsui Sumitomo MetLife Insurance Company Limited
(MSI MetLife), an investment in Japan of which the
Holding Company owns 50% of the equity. Under the agreement, the
Holding Company agreed, without limitation as to amount, to
cause MSI
179
MetLife to have the amount of capital and surplus necessary for
MSI MetLife to maintain a solvency ratio of at least 400%, as
calculated in accordance with the Insurance Business Law of
Japan, and to make such loans to MSI MetLife as may be necessary
to ensure that MSI MetLife has sufficient cash or other liquid
assets to meet its payment obligations as they fall due. As
described in Note 2 of the Notes to the Consolidated
Financial Statements, the Holding Company reached an agreement
to sell its 50% interest in MSI MetLife to a third-party. Upon
the close of such sale, the Holding Companys obligations
under the net worth maintenance agreement will terminate.
The Holding Company has guaranteed the obligations of its
subsidiary, Exeter, under a reinsurance agreement with MSI
MetLife, under which Exeter reinsures variable annuity business
written by MSI MetLife. This guarantee will remain in place
until such time as the reinsurance agreement between Exeter and
MSI MetLife is terminated, notwithstanding any prior disposition
of the Holding Companys interest in MSI MetLife as
described in Note 2 of the Notes to the Consolidated
Financial Statements.
The Holding Company also guarantees the obligations of a number
of its subsidiaries under credit facilities with third-party
banks. See Note 11 of the Notes to the Consolidated
Financial Statements.
Adoption
of New Accounting Pronouncements
See Adoption of New Accounting Pronouncements in
Note 1 of the Notes to the Consolidated Financial
Statements.
Future
Adoption of New Accounting Pronouncements
See Future Adoption of New Accounting Pronouncements
in Note 1 of the Notes to the Consolidated Financial
Statements.
Subsequent
Events
Dividends
On February 18, 2011, the Holding Company announced
dividends of $0.2500000 per share, for a total of
$6 million, on its Series A preferred shares, and
$0.4062500 per share, for a total of $24 million, on its
Series B preferred shares, subject to the final
confirmation that it has met the financial tests specified in
the Series A and Series B preferred shares, which the
Company anticipates will be made on or about March 7, 2011. Both
dividends will be payable March 15, 2011 to shareholders of
record as of February 28, 2011.
Credit
Facility
On February 1, 2011, the Holding Company entered into a
committed facility with a third-party bank to provide letters of
credit for the benefit of MoRe, a captive reinsurance
subsidiary, to address its short-term solvency needs based on
guidance from the regulator. This one-year facility provides for
the issuance of letters of credit in amounts up to
$350 million. Under the facility, a letter of credit for
$250 million was issued on February 2, 2011 and
increased to $295 million on February 23, 2011, which
management believes satisfies MoRes solvency requirements.
|
|
Item 7A.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
Risk
Management
The Company must effectively manage, measure and monitor the
market risk associated with its assets and liabilities. It has
developed an integrated process for managing risk, which it
conducts through its Enterprise Risk Management Department,
Asset/Liability Management Unit, Treasury Department and
Investment Department along with the management of the business
segments. The Company has established and implemented
comprehensive policies and procedures at both the corporate and
business segment level to minimize the effects of potential
market volatility.
The Company regularly analyzes its exposure to interest rate,
equity market price and foreign currency exchange rate risks. As
a result of that analysis, the Company has determined that the
estimated fair values of certain
180
assets and liabilities are materially exposed to changes in
interest rates, foreign currency exchange rates and changes in
the equity markets.
Enterprise Risk Management. MetLife has
established several financial and non-financial senior
management committees as part of its risk management process.
These committees manage capital and risk positions, approve ALM
strategies and establish appropriate corporate business
standards. Further enhancing its committee structure, during the
second quarter of 2010, MetLife created an Enterprise Risk
Committee made up of the following voting members: the Chief
Financial Officer, the Chief Investment Officer, the President
of U.S. Business, the President of International and the
Chief Risk Officer. This committee is responsible for reviewing
all material risks to the enterprise and deciding on actions if
necessary, in the event risks exceed desirable targets, taking
into consideration best practices to resolve or mitigate those
risks.
MetLife also has a separate Enterprise Risk Management
Department, which is responsible for risk management throughout
MetLife and reports to MetLifes Chief Risk Officer. The
Enterprise Risk Management Departments primary
responsibilities consist of:
|
|
|
|
|
implementing a corporate risk framework, which outlines the
Companys approach for managing risk on an enterprise-wide
basis;
|
|
|
|
developing policies and procedures for managing, measuring,
monitoring and controlling those risks identified in the
corporate risk framework;
|
|
|
|
establishing appropriate corporate risk tolerance levels;
|
|
|
|
deploying capital on an economic capital basis; and
|
|
|
|
reporting on a periodic basis to the Finance and Risk Committee
of the Companys Board of Directors; with respect to credit
risk, to the Investment Committee of the Companys Board of
Directors; and, reporting on various aspects of risk, to
financial and non-financial senior management committees.
|
Asset/Liability Management. The Company
actively manages its assets using an approach that balances
quality, diversification, asset/liability matching, liquidity,
concentration and investment return. The goals of the investment
process are to optimize, net of income tax, risk-adjusted
investment income and risk-adjusted total return while ensuring
that the assets and liabilities are reasonably managed on a cash
flow and duration basis. The ALM process is the shared
responsibility of the Financial Risk Management and
Asset/Liability Management Unit, Enterprise Risk Management, the
Portfolio Management Unit, and the senior members of the
business segments and is governed by the ALM Committees. The ALM
Committees duties include reviewing and approving target
portfolios, establishing investment guidelines and limits and
providing oversight of the ALM process on a periodic basis. The
directives of the ALM Committees are carried out and monitored
through ALM Working Groups which are set up to manage by product
type. In addition, an ALM Steering Committee oversees the
activities of the underlying ALM Committees.
MetLife establishes target asset portfolios for each major
insurance product, which represent the investment strategies
used to profitably fund its liabilities within acceptable levels
of risk. These strategies are monitored through regular review
of portfolio metrics, such as effective duration, yield curve
sensitivity, convexity, liquidity, asset sector concentration
and credit quality by the ALM Working Groups.
Market
Risk Exposures
The Company has exposure to market risk through its insurance
operations and investment activities. For purposes of this
disclosure, market risk is defined as the risk of
loss resulting from changes in interest rates, foreign currency
exchange rates and equity market.
Interest Rates. The Companys exposure to
interest rate changes results most significantly from its
holdings of fixed maturity securities, as well as its interest
rate sensitive liabilities. The fixed maturity securities
include U.S. and foreign government bonds, securities
issued by government agencies, corporate bonds and
mortgage-backed securities, all of which are mainly exposed to
changes in medium- and long-term interest rates. The interest
rate sensitive liabilities for purposes of this disclosure
include debt, policyholder account balances related to certain
investment type contracts, and net embedded derivatives on
variable annuities with guaranteed minimum benefits
181
which have the same type of interest rate exposure (medium- and
long-term interest rates) as fixed maturity securities. The
Company employs product design, pricing and ALM strategies to
reduce the adverse effects of interest rate movements. Product
design and pricing strategies include the use of surrender
charges or restrictions on withdrawals in some products and the
ability to reset credited rates for certain products. ALM
strategies include the use of derivatives and duration mismatch
limits. See Risk Factors Changes in Market
Interest Rates May Significantly Affect Our Profitability.
Foreign Currency Exchange Rates. The
Companys exposure to fluctuations in foreign currency
exchange rates against the U.S. dollar results from its
holdings in
non-U.S. dollar
denominated fixed maturity and equity securities, mortgage
loans, and certain liabilities, as well as through its
investments in foreign subsidiaries. The principal currencies
that create foreign currency exchange rate risk in the
Companys investment portfolios are the Euro, the Japanese
yen and the Canadian dollar. The principal currencies that
create foreign currency risk in the Companys liabilities
are the British pound, the Euro and the Swiss franc.
Selectively, the Company uses U.S. dollar assets to support
certain long duration foreign currency liabilities. Through its
investments in foreign subsidiaries and joint ventures, the
Company is primarily exposed to the Mexican peso, the Japanese
yen, the South Korean won, the Canadian dollar, the British
pound, the Chilean peso, the Australian dollar, the Argentine
peso, the Polish zloty, the Euro and the Hong Kong dollar. In
addition to hedging with foreign currency swaps, forwards and
options, local surplus in some countries is held entirely or in
part in U.S. dollar assets which further minimizes exposure
to foreign currency exchange rate fluctuation risk. The Company
has matched much of its foreign currency liabilities in its
foreign subsidiaries with their respective foreign currency
assets, thereby reducing its risk to foreign currency exchange
rate fluctuation. See Risk Factors
Fluctuations in Foreign Currency Exchange Rates Could Negatively
Affect Our Profitability.
Equity Market. The Company has exposure to
equity market risk through certain liabilities that involve
long-term guarantees on equity performance such as net embedded
derivatives on variable annuities with guaranteed minimum
benefits, certain policyholder account balances along with
investments in equity securities. We manage this risk on an
integrated basis with other risks through our ALM strategies
including the dynamic hedging of certain variable annuity
guarantee benefits. The Company also manages equity market risk
exposure in its investment portfolio through the use of
derivatives. Equity exposures associated with other limited
partnership interests are excluded from this section as they are
not considered financial instruments under GAAP.
Management
of Market Risk Exposures
The Company uses a variety of strategies to manage interest
rate, foreign currency exchange rate and equity market risk,
including the use of derivative instruments.
Interest Rate Risk Management. To manage
interest rate risk, the Company analyzes interest rate risk
using various models, including multi-scenario cash flow
projection models that forecast cash flows of the liabilities
and their supporting investments, including derivative
instruments. These projections involve evaluating the potential
gain or loss on most of the Companys in-force business
under various increasing and decreasing interest rate
environments. The New York State Insurance Department
regulations require that MetLife perform some of these analyses
annually as part of MetLifes review of the sufficiency of
its regulatory reserves. For several of its legal entities, the
Company maintains segmented operating and surplus asset
portfolios for the purpose of ALM and the allocation of
investment income to product lines. For each segment, invested
assets greater than or equal to the GAAP liabilities less the
DAC asset and any non-invested assets allocated to the segment
are maintained, with any excess swept to the surplus segment.
The business segments may reflect differences in legal entity,
statutory line of business and any product market characteristic
which may drive a distinct investment strategy with respect to
duration, liquidity or credit quality of the invested assets.
Certain smaller entities make use of unsegmented general
accounts for which the investment strategy reflects the
aggregate characteristics of liabilities in those entities. The
Company measures relative sensitivities of the value of its
assets and liabilities to changes in key assumptions utilizing
Company models. These models reflect specific product
characteristics and include assumptions based on current and
anticipated experience regarding lapse, mortality and interest
crediting rates. In addition, these models include asset cash
flow projections reflecting interest payments, sinking fund
payments, principal payments, bond calls, mortgage prepayments
and defaults.
182
Common industry metrics, such as duration and convexity, are
also used to measure the relative sensitivity of assets and
liability values to changes in interest rates. In computing the
duration of liabilities, consideration is given to all
policyholder guarantees and to how the Company intends to set
indeterminate policy elements such as interest credits or
dividends. Each asset portfolio has a duration target based on
the liability duration and the investment objectives of that
portfolio. Where a liability cash flow may exceed the maturity
of available assets, as is the case with certain retirement and
non-medical health products, the Company may support such
liabilities with equity investments, derivatives or curve
mismatch strategies.
Foreign Currency Exchange Rate Risk
Management. Foreign currency exchange rate risk
is assumed primarily in three ways: investments in foreign
subsidiaries, purchases of foreign currency denominated
investments in the investment portfolio and the sale of certain
insurance products.
|
|
|
|
|
The Companys Treasury Department is responsible for
managing the exposure to investments in foreign subsidiaries.
Limits to exposures are established and monitored by the
Treasury Department and managed by the Investment Department.
|
|
|
|
The Investment Department is responsible for managing the
exposure to foreign currency investments. Exposure limits to
unhedged foreign currency investments are incorporated into the
standing authorizations granted to management by the Board of
Directors and are reported to the Board of Directors on a
periodic basis.
|
|
|
|
The lines of business are responsible for establishing limits
and managing any foreign exchange rate exposure caused by the
sale or issuance of insurance products.
|
MetLife uses foreign currency swaps and forwards to hedge its
foreign currency denominated fixed income investments, its
equity exposure in subsidiaries and its foreign currency
exposures caused by the sale of insurance products.
Equity Market Risk Management. Equity market
risk exposure through the issuance of variable annuities is
managed by the Companys Asset/Liability Management Unit in
partnership with the Investment Department. Equity market risk
is realized through its investment in equity securities and is
managed by its Investment Department. MetLife uses derivatives
to hedge its equity exposure both in certain liability
guarantees such as variable annuities with guaranteed minimum
benefit and equity securities. These derivatives include
exchange-traded equity futures, equity index options contracts
and equity variance swaps. The Company also employs reinsurance
to manage these exposures.
Hedging Activities. MetLife uses derivative
contracts primarily to hedge a wide range of risks including
interest rate risk, foreign currency risk, and equity risk.
Derivative hedges are designed to reduce risk on an economic
basis while considering their impact on accounting results and
GAAP and Statutory capital. The construction of the
Companys derivative hedge programs vary depending on the
type of risk being hedged. Some hedge programs are asset or
liability specific while others are portfolio hedges that reduce
risk related to a group of liabilities or assets. The
Companys use of derivatives by major hedge programs is as
follows:
|
|
|
|
|
Risks Related to Living Guarantee Benefits The
Company uses a wide range of derivative contracts to hedge the
risk associated with variable annuity living guarantee benefits.
These hedges include equity and interest rate futures, interest
rate swaps, currency futures/forwards, equity indexed options
and interest rate option contracts and equity variance swaps.
|
|
|
|
Minimum Interest Rate Guarantees For certain Company
liability contracts, the Company provides the contractholder a
guaranteed minimum interest rate. These contracts include
certain fixed annuities and other insurance liabilities. The
Company purchases interest rate floors to reduce risk associated
with these liability guarantees.
|
|
|
|
Reinvestment Risk in Long Duration Liability
Contracts Derivatives are used to hedge interest
rate risk related to certain long duration liability contracts,
such as deferred annuities. Hedges include zero coupon interest
rate swaps and swaptions.
|
183
|
|
|
|
|
Foreign Currency Risk The Company uses currency
swaps and forwards to hedge foreign currency risk. These hedges
primarily swap foreign currency denominated bonds, investments
in foreign subsidiaries or equity exposures to U.S. dollars.
|
|
|
|
General ALM Hedging Strategies In the ordinary
course of managing the Companys asset/liability risks, the
Company uses interest rate futures, interest rate swaps,
interest rate caps, interest rate floors and inflation swaps.
These hedges are designed to reduce interest rate risk or
inflation risk related to the existing assets or liabilities or
related to expected future cash flows.
|
Risk
Measurement: Sensitivity Analysis
The Company measures market risk related to its market sensitive
assets and liabilities based on changes in interest rates,
equity prices and foreign currency exchange rates utilizing a
sensitivity analysis. This analysis estimates the potential
changes in estimated fair value based on a hypothetical 10%
change (increase or decrease) in interest rates, equity market
prices and foreign currency exchange rates. The Company believes
that a 10% change (increase or decrease) in these market rates
and prices is reasonably possible in the near-term. In
performing the analysis summarized below, the Company used
market rates at December 31, 2010. The sensitivity analysis
separately calculates each of the Companys market risk
exposures (interest rate, equity market and foreign currency
exchange rate) relating to its trading and non-trading assets
and liabilities. The Company modeled the impact of changes in
market rates and prices on the estimated fair values of its
market sensitive assets and liabilities as follows:
|
|
|
|
|
the net present values of its interest rate sensitive exposures
resulting from a 10% change (increase or decrease) in interest
rates;
|
|
|
|
the U.S. dollar equivalent estimated fair values of the
Companys foreign currency exposures due to a 10% change
(increase or decrease) in foreign currency exchange
rates; and
|
|
|
|
the estimated fair value of its equity positions due to a 10%
change (increase or decrease) in equity market prices.
|
The sensitivity analysis is an estimate and should not be viewed
as predictive of the Companys future financial
performance. The Company cannot ensure that its actual losses in
any particular period will not exceed the amounts indicated in
the table below. Limitations related to this sensitivity
analysis include:
|
|
|
|
|
the market risk information is limited by the assumptions and
parameters established in creating the related sensitivity
analysis, including the impact of prepayment rates on mortgages;
|
|
|
|
for the derivatives that qualify as hedges, the impact on
reported earnings may be materially different from the change in
market values;
|
|
|
|
the analysis excludes other significant real estate holdings and
liabilities pursuant to insurance contracts; and
|
|
|
|
the model assumes that the composition of assets and liabilities
remains unchanged throughout the period.
|
Accordingly, the Company uses such models as tools and not as
substitutes for the experience and judgment of its management.
Based on its analysis of the impact of a 10% change (increase or
decrease) in market rates and prices, MetLife has determined
that such a change could have a material adverse effect on the
estimated fair value of certain assets and liabilities from
interest rate, foreign currency exchange rate and equity
exposures.
The table below illustrates the potential loss in estimated fair
value for each market risk exposure of the Companys market
sensitive assets and liabilities at December 31, 2010:
|
|
|
|
|
|
|
December 31, 2010
|
|
|
(In millions)
|
|
Non-trading:
|
|
|
|
|
Interest rate risk
|
|
$
|
5,358
|
|
Foreign currency exchange rate risk
|
|
$
|
3,669
|
|
Equity market risk
|
|
$
|
14
|
|
Trading:
|
|
|
|
|
Interest rate risk
|
|
$
|
24
|
|
Foreign currency exchange rate risk
|
|
$
|
346
|
|
184
Sensitivity Analysis: Interest Rates. The table below
provides additional detail regarding the potential loss in fair
value of the Companys trading and non-trading interest
sensitive financial instruments at December 31, 2010 by
type of asset or liability:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
|
|
|
|
|
|
Assuming a
|
|
|
|
|
|
|
Estimated
|
|
|
10% Increase
|
|
|
|
Notional
|
|
|
Fair
|
|
|
in the Yield
|
|
|
|
Amount
|
|
|
Value (3)
|
|
|
Curve
|
|
|
|
(In millions)
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
|
|
|
$
|
327,284
|
|
|
$
|
(5,961
|
)
|
Equity securities
|
|
|
|
|
|
|
3,606
|
|
|
|
|
|
Trading and other securities
|
|
|
|
|
|
|
18,589
|
|
|
|
(25
|
)
|
Mortgage loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-for-investment
|
|
|
|
|
|
|
60,846
|
|
|
|
(355
|
)
|
Held-for-sale
|
|
|
|
|
|
|
3,321
|
|
|
|
(24
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans, net
|
|
|
|
|
|
|
64,167
|
|
|
|
(379
|
)
|
Policy loans
|
|
|
|
|
|
|
13,406
|
|
|
|
(179
|
)
|
Real estate joint ventures (1)
|
|
|
|
|
|
|
482
|
|
|
|
|
|
Other limited partnership interests (1)
|
|
|
|
|
|
|
1,619
|
|
|
|
|
|
Short-term investments
|
|
|
|
|
|
|
9,387
|
|
|
|
(2
|
)
|
Other invested assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage servicing rights
|
|
|
|
|
|
|
950
|
|
|
|
70
|
|
Other
|
|
|
|
|
|
|
1,490
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
|
|
|
|
13,046
|
|
|
|
(2
|
)
|
Accrued investment income
|
|
|
|
|
|
|
4,381
|
|
|
|
|
|
Premiums, reinsurance and other receivables
|
|
|
|
|
|
|
4,048
|
|
|
|
(331
|
)
|
Other assets
|
|
|
|
|
|
|
453
|
|
|
|
(9
|
)
|
Net embedded derivatives within asset host contracts (2)
|
|
|
|
|
|
|
185
|
|
|
|
(17
|
)
|
Mortgage loan commitments
|
|
$
|
3,754
|
|
|
|
(17
|
)
|
|
|
(13
|
)
|
Commitments to fund bank credit facilities, bridge loans and
private corporate bond investments
|
|
$
|
2,437
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Assets
|
|
|
|
|
|
|
|
|
|
$
|
(6,848
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances
|
|
|
|
|
|
$
|
152,850
|
|
|
$
|
849
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
|
|
|
|
27,272
|
|
|
|
|
|
Bank deposits
|
|
|
|
|
|
|
10,371
|
|
|
|
5
|
|
Short-term debt
|
|
|
|
|
|
|
306
|
|
|
|
|
|
Long-term debt
|
|
|
|
|
|
|
21,892
|
|
|
|
361
|
|
Collateral financing arrangements
|
|
|
|
|
|
|
4,757
|
|
|
|
(9
|
)
|
Junior subordinated debt securities
|
|
|
|
|
|
|
3,461
|
|
|
|
160
|
|
Other liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading liabilities
|
|
|
|
|
|
|
46
|
|
|
|
1
|
|
Other
|
|
|
|
|
|
|
2,777
|
|
|
|
|
|
Net embedded derivatives within liability host contracts (2)
|
|
|
|
|
|
|
2,634
|
|
|
|
1,515
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Liabilities
|
|
|
|
|
|
|
|
|
|
$
|
2,882
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps
|
|
$
|
54,803
|
|
|
$
|
1,138
|
|
|
$
|
(1,254
|
)
|
Interest rate floors
|
|
$
|
23,866
|
|
|
|
564
|
|
|
|
(67
|
)
|
Interest rate caps
|
|
$
|
35,412
|
|
|
|
175
|
|
|
|
57
|
|
Interest rate futures
|
|
$
|
9,385
|
|
|
|
26
|
|
|
|
20
|
|
Interest rate options
|
|
$
|
8,761
|
|
|
|
121
|
|
|
|
(8
|
)
|
Interest rate forwards
|
|
$
|
10,374
|
|
|
|
(29
|
)
|
|
|
(32
|
)
|
Synthetic GICs
|
|
$
|
4,397
|
|
|
|
|
|
|
|
|
|
Foreign currency swaps
|
|
$
|
17,626
|
|
|
|
334
|
|
|
|
(12
|
)
|
Foreign currency forwards
|
|
$
|
10,443
|
|
|
|
28
|
|
|
|
1
|
|
Currency futures
|
|
$
|
493
|
|
|
|
2
|
|
|
|
|
|
Currency options
|
|
$
|
5,426
|
|
|
|
50
|
|
|
|
|
|
Non-derivative hedging instruments
|
|
$
|
169
|
|
|
|
(185
|
)
|
|
|
|
|
Credit default swaps
|
|
$
|
10,957
|
|
|
|
69
|
|
|
|
|
|
Credit forwards
|
|
$
|
90
|
|
|
|
(1
|
)
|
|
|
|
|
Equity futures
|
|
$
|
8,794
|
|
|
|
12
|
|
|
|
|
|
Equity options
|
|
$
|
33,688
|
|
|
|
646
|
|
|
|
(96
|
)
|
Variance swaps
|
|
$
|
18,022
|
|
|
|
80
|
|
|
|
(9
|
)
|
Total rate of return swaps
|
|
$
|
1,547
|
|
|
|
|
|
|
|
(16
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivative Instruments
|
|
|
|
|
|
|
|
|
|
$
|
(1,416
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change
|
|
|
|
|
|
|
|
|
|
$
|
(5,382
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
185
|
|
|
(1) |
|
Represents only those investments accounted for using the cost
method. |
|
(2) |
|
Embedded derivatives are recognized in the consolidated balance
sheet in the same caption as the host contract. |
|
(3) |
|
Separate account assets and liabilities which are interest rate
sensitive are not included herein as any interest rate risk is
borne by the holder of the separate account. |
This quantitative measure of risk has increased by
$1,325 million, or 33%, to $5,382 million at
December 31, 2010 from $4,057 million at
December 31, 2009. Excluding the Acquisition which
increased risk by $647 million, the quantitative measure of
risk increased by $678 million or 17% at December 31,
2010 from December 31, 2009. The increase in risk is due to
a change in the net assets and liabilities bases of
$641 million. In addition, an increase of $954 million
was due to the use of derivatives employed by the Company
($445 million), an increase in the duration of the
investment portfolio ($389 million), and an increase in
premiums, reinsurance and other receivables ($120 million).
This increase in risk was partially offset by a decrease in
interest rates across the long end of the Swaps and
U.S. Treasury curves resulting in a decrease of
$424 million. Additionally, net embedded derivatives within
liability host contracts increased by $520 million,
partially due to a change made in the second quarter of 2010
related to how the Company estimates the spread over the swap
curve for purposes of determining the discount rate used to
value those derivatives, which caused a corresponding decrease
in risk. The remainder of the fluctuation is attributable to
numerous immaterial items.
186
Sensitivity Analysis: Foreign Currency Exchange Rates.
The table below provides additional detail regarding the
potential loss in estimated fair value of the Companys
portfolio due to a 10% change in foreign currency exchange rates
at December 31, 2010 by type of asset or liability:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
|
|
|
|
|
|
Assuming a
|
|
|
|
|
|
|
Estimated
|
|
|
10% Increase
|
|
|
|
Notional
|
|
|
Fair
|
|
|
in the Foreign
|
|
|
|
Amount
|
|
|
Value (1)
|
|
|
Exchange Rate
|
|
|
|
(In millions)
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
|
|
|
$
|
327,284
|
|
|
$
|
(6,516
|
)
|
Equity securities
|
|
|
|
|
|
|
3,606
|
|
|
|
(74
|
)
|
Trading and other securities
|
|
|
|
|
|
|
18,589
|
|
|
|
(346
|
)
|
Mortgage loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-for-investment
|
|
|
|
|
|
|
60,846
|
|
|
|
(414
|
)
|
Held-for-sale
|
|
|
|
|
|
|
3,321
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans, net
|
|
|
|
|
|
|
64,167
|
|
|
|
(414
|
)
|
Policy loans
|
|
|
|
|
|
|
13,406
|
|
|
|
(199
|
)
|
Short-term investments
|
|
|
|
|
|
|
9,387
|
|
|
|
(200
|
)
|
Other invested assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage servicing rights
|
|
|
|
|
|
|
950
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
1,490
|
|
|
|
(143
|
)
|
Cash and cash equivalents
|
|
|
|
|
|
|
13,046
|
|
|
|
(139
|
)
|
Accrued investment income
|
|
|
|
|
|
|
4,381
|
|
|
|
(11
|
)
|
Premiums, reinsurance and other receivables
|
|
|
|
|
|
|
4,048
|
|
|
|
(16
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Assets
|
|
|
|
|
|
|
|
|
|
$
|
(8,058
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances
|
|
|
|
|
|
$
|
152,850
|
|
|
$
|
3,255
|
|
Bank deposits
|
|
|
|
|
|
|
10,371
|
|
|
|
|
|
Long-term debt
|
|
|
|
|
|
|
21,892
|
|
|
|
37
|
|
Other liabilities
|
|
|
|
|
|
|
2,777
|
|
|
|
9
|
|
Net embedded derivatives within liability host contracts (2)
|
|
|
|
|
|
|
2,634
|
|
|
|
437
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Liabilities
|
|
|
|
|
|
|
|
|
|
$
|
3,738
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps
|
|
$
|
54,083
|
|
|
$
|
1,138
|
|
|
$
|
(17
|
)
|
Interest rate floors
|
|
$
|
23,866
|
|
|
|
564
|
|
|
|
|
|
Interest rate caps
|
|
$
|
35,412
|
|
|
|
175
|
|
|
|
|
|
Interest rate futures
|
|
$
|
9,385
|
|
|
|
26
|
|
|
|
(2
|
)
|
Interest rate options
|
|
$
|
8,761
|
|
|
|
121
|
|
|
|
(2
|
)
|
Interest rate forwards
|
|
$
|
10,374
|
|
|
|
(29
|
)
|
|
|
|
|
Synthetic GICs
|
|
$
|
4,397
|
|
|
|
|
|
|
|
|
|
Foreign currency swaps
|
|
$
|
17,626
|
|
|
|
334
|
|
|
|
271
|
|
Foreign currency forwards
|
|
$
|
10,443
|
|
|
|
28
|
|
|
|
73
|
|
Currency futures
|
|
$
|
493
|
|
|
|
2
|
|
|
|
(49
|
)
|
Currency options
|
|
$
|
5,426
|
|
|
|
50
|
|
|
|
107
|
|
Non-derivative hedging instruments
|
|
$
|
169
|
|
|
|
(185
|
)
|
|
|
|
|
Credit default swaps
|
|
$
|
10,957
|
|
|
|
69
|
|
|
|
|
|
Credit forwards
|
|
$
|
90
|
|
|
|
(1
|
)
|
|
|
|
|
Equity futures
|
|
$
|
8,794
|
|
|
|
12
|
|
|
|
2
|
|
Equity options
|
|
$
|
33,688
|
|
|
|
646
|
|
|
|
(77
|
)
|
Variance swaps
|
|
$
|
18,022
|
|
|
|
80
|
|
|
|
(1
|
)
|
Total rate of return swaps
|
|
$
|
1,547
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivative Instruments
|
|
|
|
|
|
|
|
|
|
$
|
305
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change
|
|
|
|
|
|
|
|
|
|
$
|
(4,015
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
187
|
|
|
(1) |
|
Estimated fair value presented in the table above represents the
estimated fair value of all financial instruments within this
financial statement caption not necessarily those solely subject
to foreign exchange risk. |
|
(2) |
|
Embedded derivatives are recognized in the consolidated balance
sheet in the same caption as the host contract. |
Foreign currency exchange rate risk increased by
$3,124 million, to $4,015 million at December 31,
2010 from $891 million at December 31, 2009. Excluding
the Acquisition which increased risk by $2,646 million, the
foreign currency exchange risk has increased by
$478 million or 54% at December 31, 2010 from
December 31, 2009. This change was due to an increase in
exchange rate risk relating to fixed maturity securities of
$722 million due to higher exposures primarily within the
British pound and the Euro and to the sale of the pension
closeout business in the U.K. Additionally, a decrease in the
foreign exposure related to long-term debt and PABs contributed
$66 million and $41 million, respectively, to the
increase. This was partially offset by an increase in the
foreign exposure related to net embedded derivatives within
liability host contracts and the use of derivatives employed by
the Company of $315 million and $101 million,
respectively. The remainder of the fluctuation is attributable
to numerous immaterial items.
188
Sensitivity Analysis: Equity Market
Prices. The table below provides additional
detail regarding the potential loss in estimated fair value of
the Companys portfolio due to a 10% change in equity at
December 31, 2010 by type of asset or liability:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
|
|
|
|
|
|
Assuming a
|
|
|
|
|
|
|
Estimated
|
|
|
10% Decrease
|
|
|
|
Notional
|
|
|
Fair
|
|
|
in Equity
|
|
|
|
Amount
|
|
|
Value (1)
|
|
|
Prices
|
|
|
|
(In millions)
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities
|
|
|
|
|
|
$
|
3,606
|
|
|
$
|
(355
|
)
|
Other invested assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives within asset host contracts (2)
|
|
|
|
|
|
|
185
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Assets
|
|
|
|
|
|
|
|
|
|
$
|
(344
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances
|
|
|
|
|
|
$
|
152,850
|
|
|
$
|
|
|
Bank deposits
|
|
|
|
|
|
|
10,371
|
|
|
|
|
|
Other liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives within liability host contracts (2)
|
|
|
|
|
|
|
2,634
|
|
|
|
(456
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Liabilities
|
|
|
|
|
|
|
|
|
|
$
|
(456
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps
|
|
$
|
54,803
|
|
|
$
|
1,138
|
|
|
$
|
|
|
Interest rate floors
|
|
$
|
23,866
|
|
|
|
564
|
|
|
|
|
|
Interest rate caps
|
|
$
|
35,412
|
|
|
|
175
|
|
|
|
|
|
Interest rate futures
|
|
$
|
9,385
|
|
|
|
26
|
|
|
|
|
|
Interest rate options
|
|
$
|
8,761
|
|
|
|
121
|
|
|
|
|
|
Interest rate forwards
|
|
$
|
10,374
|
|
|
|
(29
|
)
|
|
|
|
|
Synthetic GICs
|
|
$
|
4,397
|
|
|
|
|
|
|
|
|
|
Foreign currency swaps
|
|
$
|
17,626
|
|
|
|
334
|
|
|
|
|
|
Foreign currency forwards
|
|
$
|
10,443
|
|
|
|
28
|
|
|
|
|
|
Currency futures
|
|
$
|
493
|
|
|
|
2
|
|
|
|
|
|
Currency options
|
|
$
|
5,426
|
|
|
|
50
|
|
|
|
|
|
Non-derivative hedging instruments
|
|
$
|
169
|
|
|
|
(185
|
)
|
|
|
|
|
Credit default swaps
|
|
$
|
10,957
|
|
|
|
69
|
|
|
|
|
|
Credit forwards
|
|
$
|
90
|
|
|
|
(1
|
)
|
|
|
|
|
Equity futures
|
|
$
|
8,794
|
|
|
|
12
|
|
|
|
3
|
|
Equity options
|
|
$
|
33,688
|
|
|
|
646
|
|
|
|
628
|
|
Variance swaps
|
|
$
|
18,022
|
|
|
|
80
|
|
|
|
|
|
Total rate of return swaps
|
|
$
|
1,547
|
|
|
|
|
|
|
|
155
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivative Instruments
|
|
|
|
|
|
|
|
|
|
$
|
786
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change
|
|
|
|
|
|
|
|
|
|
$
|
(14
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Estimated fair value presented in the table above represents the
estimated fair value of all financial instruments within this
financial statement caption not necessarily those solely subject
to equity market risk. |
|
(2) |
|
Embedded derivatives are recognized in the consolidated balance
sheet in the same caption as the host contract. |
189
|
|
|
(3) |
|
During the fourth quarter of 2010, the analysis of the impact of
a 10% change (increase or decrease) in equity market rates
determined that due to the inclusion of ALICO, a decrease of 10%
had the most adverse effect on our equity risk while the prior
year ends analysis of equity market rates shows an
increase of 10% had the most adverse effect. |
Equity price risk decreased by $204 million to
$14 million at December 31, 2010 from
$218 million at December 31, 2009. Excluding the
Acquisition which shifted the impact of a 10% change to a
decrease in the equity market rates, the equity price risk has
decreased by $191 million at December 31, 2010 from
December 31, 2009. This decrease is primarily due to a
change of $210 million attributed to the use of derivatives
employed by the Company to hedge its equity exposures.
Additionally, an increase in the net exposures related to net
embedded derivatives within liability host contracts of
$42 million contributed to the decrease. This was partially
offset by a decrease of $60 million in equity securities.
The remainder of the fluctuation is attributable to numerous
insignificant items.
190
|
|
Item 8.
|
Financial
Statements and Supplementary Data
|
Index to
Consolidated Financial Statements and Schedules
|
|
|
|
|
|
|
Page
|
|
|
|
|
F-1
|
|
Financial Statements at December 31, 2010 and 2009 and for
the Years Ended December 31, 2010, 2009, and 2008:
|
|
|
|
|
|
|
|
F-2
|
|
|
|
|
F-3
|
|
|
|
|
F-4
|
|
|
|
|
F-7
|
|
|
|
|
F-9
|
|
Financial Statement Schedules at December 31, 2010 and 2009
and for the Years Ended December 31, 2010, 2009, and 2008:
|
|
|
|
|
|
|
|
F-212
|
|
|
|
|
F-213
|
|
|
|
|
F-221
|
|
|
|
|
F-223
|
|
191
Report of
Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders of
MetLife, Inc.:
We have audited the accompanying consolidated balance sheets of
MetLife, Inc. and subsidiaries (the Company) as of
December 31, 2010 and 2009, and the related consolidated
statements of operations, equity, and cash flows for each of the
three years in the period ended December 31, 2010. Our
audits also included the financial statement schedules listed in
the Index to Consolidated Financial Statements and Schedules.
These consolidated financial statements and financial statement
schedules are the responsibility of the Companys
management. Our responsibility is to express an opinion on the
consolidated financial statements and financial statement
schedules based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial
statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and
disclosures in the consolidated financial statements. An audit
also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating
the overall financial statement presentation. We believe that
our audits provide a reasonable basis for our opinion.
In our opinion, such consolidated financial statements present
fairly, in all material respects, the financial position of
MetLife, Inc. and subsidiaries as of December 31, 2010 and
2009, and the results of their operations and their cash flows
for each of the three years in the period ended
December 31, 2010, in conformity with accounting principles
generally accepted in the United States of America. Also, in our
opinion, such financial statement schedules, when considered in
relation to the basic consolidated financial statements taken as
a whole, present fairly, in all material respects, the
information set forth therein.
As discussed in Note 1, the Company changed its method of
accounting for the recognition and presentation of
other-than-temporary
impairment losses for certain investments as required by
accounting guidance adopted on April 1, 2009, and changed
its method of accounting for certain assets and liabilities to a
fair value measurement approach as required by accounting
guidance adopted on January 1, 2008.
We have also audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
Companys internal control over financial reporting as of
December 31, 2010, based on the criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission, and our report, dated February 24, 2011, expressed
an unqualified opinion on the Companys internal control
over financial reporting.
/s/ DELOITTE &
TOUCHE LLP
DELOITTE &
TOUCHE LLP
New York, New York
February 24, 2011
F-1
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Assets
|
|
|
|
|
|
|
|
|
Investments:
|
|
|
|
|
|
|
|
|
Fixed maturity securities
available-for-sale,
at estimated fair value (amortized cost: $320,008 and $229,709,
respectively; includes $3,330 and $3,171, respectively, relating
to variable interest entities)
|
|
$
|
327,284
|
|
|
$
|
227,642
|
|
Equity securities
available-for-sale,
at estimated fair value (cost: $3,625 and $3,187, respectively)
|
|
|
3,606
|
|
|
|
3,084
|
|
Trading and other securities, at estimated fair value (includes
$463 and $420 of actively traded securities, respectively; and
$387 and $0, respectively, relating to variable interest
entities)
|
|
|
18,589
|
|
|
|
2,384
|
|
Mortgage loans:
|
|
|
|
|
|
|
|
|
Held-for-investment,
principally at amortized cost (net of valuation allowances of
$664 and $721, respectively; includes $6,840 and $0,
respectively, at estimated fair value, relating to variable
interest entities)
|
|
|
59,055
|
|
|
|
48,181
|
|
Held-for-sale,
principally at estimated fair value
|
|
|
3,321
|
|
|
|
2,728
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans, net
|
|
|
62,376
|
|
|
|
50,909
|
|
Policy loans
|
|
|
11,914
|
|
|
|
10,061
|
|
Real estate and real estate joint ventures (includes $10 and
$18, respectively, relating to variable interest entities)
|
|
|
8,030
|
|
|
|
6,896
|
|
Other limited partnership interests (includes $298 and $236,
respectively, relating to variable interest entities)
|
|
|
6,416
|
|
|
|
5,508
|
|
Short-term investments, principally at estimated fair value
|
|
|
9,387
|
|
|
|
8,374
|
|
Other invested assets, principally at estimated fair value
(includes $104 and $137, respectively, relating to variable
interest entities)
|
|
|
15,430
|
|
|
|
12,709
|
|
|
|
|
|
|
|
|
|
|
Total investments
|
|
|
463,032
|
|
|
|
327,567
|
|
Cash and cash equivalents, principally at estimated fair value
(includes $69 and $68, respectively, relating to variable
interest entities)
|
|
|
13,046
|
|
|
|
10,112
|
|
Accrued investment income (includes $34 and $0, respectively,
relating to variable interest entities)
|
|
|
4,381
|
|
|
|
3,173
|
|
Premiums, reinsurance and other receivables (includes $2 and $0,
respectively, relating to variable interest entities)
|
|
|
19,830
|
|
|
|
16,752
|
|
Deferred policy acquisition costs and value of business acquired
|
|
|
27,307
|
|
|
|
19,256
|
|
Current income tax recoverable
|
|
|
|
|
|
|
316
|
|
Deferred income tax assets
|
|
|
|
|
|
|
1,228
|
|
Goodwill
|
|
|
11,781
|
|
|
|
5,047
|
|
Other assets (includes $6 and $16, respectively, relating to
variable interest entities)
|
|
|
8,192
|
|
|
|
6,822
|
|
Separate account assets
|
|
|
183,337
|
|
|
|
149,041
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
730,906
|
|
|
$
|
539,314
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Equity
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
Future policy benefits
|
|
$
|
173,373
|
|
|
$
|
135,879
|
|
Policyholder account balances
|
|
|
211,020
|
|
|
|
138,673
|
|
Other policy-related balances
|
|
|
15,806
|
|
|
|
8,446
|
|
Policyholder dividends payable
|
|
|
830
|
|
|
|
761
|
|
Policyholder dividend obligation
|
|
|
876
|
|
|
|
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
27,272
|
|
|
|
24,196
|
|
Bank deposits
|
|
|
10,316
|
|
|
|
10,211
|
|
Short-term debt
|
|
|
306
|
|
|
|
912
|
|
Long-term debt (includes $6,902 and $64, respectively, at
estimated fair value, relating to variable interest entities)
|
|
|
27,586
|
|
|
|
13,220
|
|
Collateral financing arrangements
|
|
|
5,297
|
|
|
|
5,297
|
|
Junior subordinated debt securities
|
|
|
3,191
|
|
|
|
3,191
|
|
Current income tax payable
|
|
|
316
|
|
|
|
|
|
Deferred income tax liability
|
|
|
1,881
|
|
|
|
|
|
Other liabilities (includes $93 and $26, respectively, relating
to variable interest entities)
|
|
|
20,386
|
|
|
|
15,989
|
|
Separate account liabilities
|
|
|
183,337
|
|
|
|
149,041
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
681,793
|
|
|
|
505,816
|
|
|
|
|
|
|
|
|
|
|
Contingencies, Commitments and Guarantees (Note 16)
|
|
|
|
|
|
|
|
|
Redeemable noncontrolling interests in partially owned
consolidated subsidiaries
|
|
|
117
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
MetLife, Inc.s stockholders equity:
|
|
|
|
|
|
|
|
|
Preferred stock, par value $0.01 per share;
200,000,000 shares authorized:
|
|
|
|
|
|
|
|
|
Preferred stock, 84,000,000 shares issued and outstanding;
$2,100 aggregate liquidation preference
|
|
|
1
|
|
|
|
1
|
|
Convertible preferred stock, 6,857,000 shares issued and
outstanding at December 31, 2010
|
|
|
|
|
|
|
|
|
Common stock, par value $0.01 per share;
3,000,000,000 shares authorized; 989,031,704 and
822,359,818 shares issued at December 31, 2010 and
2009, respectively; 985,837,817 and 818,833,810 shares
outstanding at December 31, 2010 and 2009, respectively
|
|
|
10
|
|
|
|
8
|
|
Additional paid-in capital
|
|
|
26,423
|
|
|
|
16,859
|
|
Retained earnings
|
|
|
21,363
|
|
|
|
19,501
|
|
Treasury stock, at cost; 3,193,887 and 3,526,008 shares at
December 31, 2010 and 2009, respectively
|
|
|
(172
|
)
|
|
|
(190
|
)
|
Accumulated other comprehensive income (loss)
|
|
|
1,000
|
|
|
|
(3,058
|
)
|
|
|
|
|
|
|
|
|
|
Total MetLife, Inc.s stockholders equity
|
|
|
48,625
|
|
|
|
33,121
|
|
Noncontrolling interests
|
|
|
371
|
|
|
|
377
|
|
|
|
|
|
|
|
|
|
|
Total equity
|
|
|
48,996
|
|
|
|
33,498
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and equity
|
|
$
|
730,906
|
|
|
$
|
539,314
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the consolidated financial
statements.
F-2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
27,394
|
|
|
$
|
26,460
|
|
|
$
|
25,914
|
|
Universal life and investment-type product policy fees
|
|
|
6,037
|
|
|
|
5,203
|
|
|
|
5,381
|
|
Net investment income
|
|
|
17,615
|
|
|
|
14,837
|
|
|
|
16,289
|
|
Other revenues
|
|
|
2,328
|
|
|
|
2,329
|
|
|
|
1,586
|
|
Net investment gains (losses):
|
|
|
|
|
|
|
|
|
|
|
|
|
Other-than-temporary
impairments on fixed maturity securities
|
|
|
(682
|
)
|
|
|
(2,439
|
)
|
|
|
(1,296
|
)
|
Other-than-temporary
impairments on fixed maturity securities transferred to other
comprehensive income (loss)
|
|
|
212
|
|
|
|
939
|
|
|
|
|
|
Other net investment gains (losses)
|
|
|
78
|
|
|
|
(1,406
|
)
|
|
|
(802
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net investment gains (losses)
|
|
|
(392
|
)
|
|
|
(2,906
|
)
|
|
|
(2,098
|
)
|
Net derivative gains (losses)
|
|
|
(265
|
)
|
|
|
(4,866
|
)
|
|
|
3,910
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
52,717
|
|
|
|
41,057
|
|
|
|
50,982
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
29,545
|
|
|
|
28,336
|
|
|
|
27,437
|
|
Interest credited to policyholder account balances
|
|
|
4,925
|
|
|
|
4,849
|
|
|
|
4,788
|
|
Policyholder dividends
|
|
|
1,486
|
|
|
|
1,650
|
|
|
|
1,751
|
|
Other expenses
|
|
|
12,803
|
|
|
|
10,556
|
|
|
|
11,947
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
48,759
|
|
|
|
45,391
|
|
|
|
45,923
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before provision for
income tax
|
|
|
3,958
|
|
|
|
(4,334
|
)
|
|
|
5,059
|
|
Provision for income tax expense (benefit)
|
|
|
1,181
|
|
|
|
(2,015
|
)
|
|
|
1,580
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income tax
|
|
|
2,777
|
|
|
|
(2,319
|
)
|
|
|
3,479
|
|
Income (loss) from discontinued operations, net of income tax
|
|
|
9
|
|
|
|
41
|
|
|
|
(201
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
2,786
|
|
|
|
(2,278
|
)
|
|
|
3,278
|
|
Less: Net income (loss) attributable to noncontrolling interests
|
|
|
(4
|
)
|
|
|
(32
|
)
|
|
|
69
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to MetLife, Inc.
|
|
|
2,790
|
|
|
|
(2,246
|
)
|
|
|
3,209
|
|
Less: Preferred stock dividends
|
|
|
122
|
|
|
|
122
|
|
|
|
125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.s common
shareholders
|
|
$
|
2,668
|
|
|
$
|
(2,368
|
)
|
|
$
|
3,084
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income tax,
available to MetLife, Inc.s common shareholders per common
share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
3.01
|
|
|
$
|
(2.94
|
)
|
|
$
|
4.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
2.99
|
|
|
$
|
(2.94
|
)
|
|
$
|
4.54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.s common
shareholders per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
3.02
|
|
|
$
|
(2.89
|
)
|
|
$
|
4.19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
3.00
|
|
|
$
|
(2.89
|
)
|
|
$
|
4.14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends per common share
|
|
$
|
0.74
|
|
|
$
|
0.74
|
|
|
$
|
0.74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the consolidated financial
statements.
F-3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
|
|
|
|
Foreign
|
|
|
Defined
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible
|
|
|
|
|
|
Additional
|
|
|
|
|
|
Treasury
|
|
|
Unrealized
|
|
|
Other-Than-
|
|
|
Currency
|
|
|
Benefit
|
|
|
MetLife, Inc.s
|
|
|
|
|
|
|
|
|
|
Preferred
|
|
|
Preferred
|
|
|
Common
|
|
|
Paid-in
|
|
|
Retained
|
|
|
Stock
|
|
|
Investment
|
|
|
Temporary
|
|
|
Translation
|
|
|
Plans
|
|
|
Stockholders
|
|
|
Noncontrolling
|
|
|
Total
|
|
|
|
Stock
|
|
|
Stock
|
|
|
Stock
|
|
|
Capital
|
|
|
Earnings
|
|
|
at Cost
|
|
|
Gains (Losses)
|
|
|
Impairments
|
|
|
Adjustments
|
|
|
Adjustment
|
|
|
Equity
|
|
|
Interests (1)
|
|
|
Equity
|
|
|
Balance at December 31, 2009
|
|
$
|
1
|
|
|
$
|
|
|
|
$
|
8
|
|
|
$
|
16,859
|
|
|
$
|
19,501
|
|
|
$
|
(190
|
)
|
|
$
|
(817
|
)
|
|
$
|
(513
|
)
|
|
$
|
(183
|
)
|
|
$
|
(1,545
|
)
|
|
$
|
33,121
|
|
|
$
|
377
|
|
|
$
|
33,498
|
|
Cumulative effect of change in accounting principle, net of
income tax (Note 1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(12
|
)
|
|
|
|
|
|
|
31
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
30
|
|
|
|
|
|
|
|
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1, 2010
|
|
|
1
|
|
|
|
|
|
|
|
8
|
|
|
|
16,859
|
|
|
|
19,489
|
|
|
|
(190
|
)
|
|
|
(786
|
)
|
|
|
(502
|
)
|
|
|
(183
|
)
|
|
|
(1,545
|
)
|
|
|
33,151
|
|
|
|
377
|
|
|
|
33,528
|
|
Cumulative effect of change in accounting principle, net of
income tax (Note 1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10
|
)
|
|
|
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible preferred stock issuance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,805
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,805
|
|
|
|
|
|
|
|
2,805
|
|
Common stock issuance newly issued shares related to
business acquisition
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
6,727
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,729
|
|
|
|
|
|
|
|
6,729
|
|
Issuance of stock purchase contracts related to common equity
units
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(69
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(69
|
)
|
|
|
|
|
|
|
(69
|
)
|
Stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101
|
|
|
|
|
|
|
|
18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
119
|
|
|
|
|
|
|
|
119
|
|
Dividends on preferred stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(122
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(122
|
)
|
|
|
|
|
|
|
(122
|
)
|
Dividends on common stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(784
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(784
|
)
|
|
|
|
|
|
|
(784
|
)
|
Change in equity of noncontrolling interests
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(9
|
)
|
|
|
(9
|
)
|
Comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,790
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,790
|
|
|
|
(2
|
)
|
|
|
2,788
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gains (losses) on derivative instruments, net of
income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11
|
|
|
|
|
|
|
|
11
|
|
Unrealized investment gains (losses), net of related offsets and
income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,121
|
|
|
|
136
|
|
|
|
|
|
|
|
|
|
|
|
4,257
|
|
|
|
(3
|
)
|
|
|
4,254
|
|
Foreign currency translation adjustments, net of income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(358
|
)
|
|
|
|
|
|
|
(358
|
)
|
|
|
8
|
|
|
|
(350
|
)
|
Defined benefit plans adjustment, net of income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96
|
|
|
|
96
|
|
|
|
|
|
|
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,006
|
|
|
|
5
|
|
|
|
4,011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,796
|
|
|
|
3
|
|
|
|
6,799
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2010
|
|
$
|
1
|
|
|
$
|
|
|
|
$
|
10
|
|
|
$
|
26,423
|
|
|
$
|
21,363
|
|
|
$
|
(172
|
)
|
|
$
|
3,356
|
|
|
$
|
(366
|
)
|
|
$
|
(541
|
)
|
|
$
|
(1,449
|
)
|
|
$
|
48,625
|
|
|
$
|
371
|
|
|
$
|
48,996
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Net income (loss) attributable to noncontrolling interests
excludes gains (losses) of redeemable noncontrolling interests
in partially owned consolidated subsidiaries of
($2) million. |
See accompanying notes to the consolidated financial
statements.
F-4
MetLife,
Inc.
Consolidated Statements of Equity
(Continued)
For the Year Ended December 31, 2009
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
|
|
|
|
Foreign
|
|
|
Defined
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
Treasury
|
|
|
Unrealized
|
|
|
Other-Than-
|
|
|
Currency
|
|
|
Benefit
|
|
|
MetLife, Inc.s
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred
|
|
|
Common
|
|
|
Paid-in
|
|
|
Retained
|
|
|
Stock
|
|
|
Investment
|
|
|
Temporary
|
|
|
Translation
|
|
|
Plans
|
|
|
Stockholders
|
|
|
Noncontrolling
|
|
|
Total
|
|
|
|
|
|
|
Stock
|
|
|
Stock
|
|
|
Capital
|
|
|
Earnings
|
|
|
at Cost
|
|
|
Gains (Losses)
|
|
|
Impairments
|
|
|
Adjustments
|
|
|
Adjustment
|
|
|
Equity
|
|
|
Interests
|
|
|
Equity
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
1
|
|
|
$
|
8
|
|
|
$
|
15,811
|
|
|
$
|
22,403
|
|
|
$
|
(236
|
)
|
|
$
|
(12,564
|
)
|
|
$
|
|
|
|
$
|
(246
|
)
|
|
$
|
(1,443
|
)
|
|
$
|
23,734
|
|
|
$
|
251
|
|
|
$
|
23,985
|
|
|
|
|
|
Cumulative effect of change in accounting principle, net of
income tax (Note 1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
76
|
|
|
|
|
|
|
|
|
|
|
|
(76
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issuance newly issued shares
|
|
|
|
|
|
|
|
|
|
|
1,035
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,035
|
|
|
|
|
|
|
|
1,035
|
|
|
|
|
|
Treasury stock transactions, net
|
|
|
|
|
|
|
|
|
|
|
(7
|
)
|
|
|
|
|
|
|
14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
|
|
|
|
7
|
|
|
|
|
|
Stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
20
|
|
|
|
|
|
|
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52
|
|
|
|
|
|
|
|
52
|
|
|
|
|
|
Dividends on preferred stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(122
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(122
|
)
|
|
|
|
|
|
|
(122
|
)
|
|
|
|
|
Dividends on common stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(610
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(610
|
)
|
|
|
|
|
|
|
(610
|
)
|
|
|
|
|
Change in equity of noncontrolling interests
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
169
|
|
|
|
169
|
|
|
|
|
|
Comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,246
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,246
|
)
|
|
|
(32
|
)
|
|
|
(2,278
|
)
|
|
|
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gains (losses) on derivative instruments, net of
income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(116
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(116
|
)
|
|
|
|
|
|
|
(116
|
)
|
|
|
|
|
Unrealized investment gains (losses), net of related offsets and
income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,863
|
|
|
|
(437
|
)
|
|
|
|
|
|
|
|
|
|
|
11,426
|
|
|
|
(11
|
)
|
|
|
11,415
|
|
|
|
|
|
Foreign currency translation adjustments, net of income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
63
|
|
|
|
|
|
|
|
63
|
|
|
|
|
|
|
|
63
|
|
|
|
|
|
Defined benefit plans adjustment, net of income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(102
|
)
|
|
|
(102
|
)
|
|
|
|
|
|
|
(102
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,271
|
|
|
|
(11
|
)
|
|
|
11,260
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,025
|
|
|
|
(43
|
)
|
|
|
8,982
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2009
|
|
$
|
1
|
|
|
$
|
8
|
|
|
$
|
16,859
|
|
|
$
|
19,501
|
|
|
$
|
(190
|
)
|
|
$
|
(817
|
)
|
|
$
|
(513
|
)
|
|
$
|
(183
|
)
|
|
$
|
(1,545
|
)
|
|
$
|
33,121
|
|
|
$
|
377
|
|
|
$
|
33,498
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the consolidated financial
statements.
F-5
MetLife,
Inc.
Consolidated Statements of Equity (Continued)
For the Year Ended December 31, 2008
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive Income (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
|
Foreign
|
|
|
Defined
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
Treasury
|
|
|
Unrealized
|
|
|
Currency
|
|
|
Benefit
|
|
|
MetLife, Inc.s
|
|
|
Noncontrolling Interests
|
|
|
|
|
|
|
|
|
|
Preferred
|
|
|
Common
|
|
|
Paid-in
|
|
|
Retained
|
|
|
Stock
|
|
|
Investment
|
|
|
Translation
|
|
|
Plans
|
|
|
Stockholders
|
|
|
Discontinued
|
|
|
Continuing
|
|
|
Total
|
|
|
|
|
|
|
Stock
|
|
|
Stock
|
|
|
Capital
|
|
|
Earnings
|
|
|
at Cost
|
|
|
Gains (Losses)
|
|
|
Adjustments
|
|
|
Adjustment
|
|
|
Equity
|
|
|
Operations
|
|
|
Operations
|
|
|
Equity
|
|
|
|
|
|
Balance at December 31, 2007
|
|
$
|
1
|
|
|
$
|
8
|
|
|
$
|
17,098
|
|
|
$
|
19,884
|
|
|
$
|
(2,890
|
)
|
|
$
|
971
|
|
|
$
|
347
|
|
|
$
|
(240
|
)
|
|
$
|
35,179
|
|
|
$
|
1,534
|
|
|
$
|
272
|
|
|
$
|
36,985
|
|
|
|
|
|
Cumulative effect of changes in accounting principles, net of
income tax (Note 1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27
|
|
|
|
|
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
17
|
|
|
|
|
|
|
|
|
|
|
|
17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1, 2008
|
|
|
1
|
|
|
|
8
|
|
|
|
17,098
|
|
|
|
19,911
|
|
|
|
(2,890
|
)
|
|
|
961
|
|
|
|
347
|
|
|
|
(240
|
)
|
|
|
35,196
|
|
|
|
1,534
|
|
|
|
272
|
|
|
|
37,002
|
|
|
|
|
|
Common stock issuance newly issued shares
|
|
|
|
|
|
|
|
|
|
|
290
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
290
|
|
|
|
|
|
|
|
|
|
|
|
290
|
|
|
|
|
|
Treasury stock transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquired in connection with share repurchase agreements
|
|
|
|
|
|
|
|
|
|
|
450
|
|
|
|
|
|
|
|
(1,250
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(800
|
)
|
|
|
|
|
|
|
|
|
|
|
(800
|
)
|
|
|
|
|
Issued in connection with common stock issuance
|
|
|
|
|
|
|
|
|
|
|
(2,104
|
)
|
|
|
|
|
|
|
4,040
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,936
|
|
|
|
|
|
|
|
|
|
|
|
1,936
|
|
|
|
|
|
Issued to settle stock forward contracts
|
|
|
|
|
|
|
|
|
|
|
(29
|
)
|
|
|
|
|
|
|
1,064
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,035
|
|
|
|
|
|
|
|
|
|
|
|
1,035
|
|
|
|
|
|
Acquired in connection with split-off of subsidiary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,318
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,318
|
)
|
|
|
|
|
|
|
|
|
|
|
(1,318
|
)
|
|
|
|
|
Other, net
|
|
|
|
|
|
|
|
|
|
|
(35
|
)
|
|
|
|
|
|
|
118
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
83
|
|
|
|
|
|
|
|
|
|
|
|
83
|
|
|
|
|
|
Deferral of stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
141
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
141
|
|
|
|
|
|
|
|
|
|
|
|
141
|
|
|
|
|
|
Dividends on preferred stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(125
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(125
|
)
|
|
|
|
|
|
|
|
|
|
|
(125
|
)
|
|
|
|
|
Dividends on common stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(592
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(592
|
)
|
|
|
|
|
|
|
|
|
|
|
(592
|
)
|
|
|
|
|
Dividends on subsidiary common stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34
|
|
|
|
|
|
|
|
34
|
|
|
|
|
|
Change in equity of noncontrolling interests
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,409
|
)
|
|
|
(6
|
)
|
|
|
(1,415
|
)
|
|
|
|
|
Comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,209
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,209
|
|
|
|
94
|
|
|
|
(25
|
)
|
|
|
3,278
|
|
|
|
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gains (losses) on derivative instruments, net of
income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
241
|
|
|
|
|
|
|
|
|
|
|
|
241
|
|
|
|
|
|
|
|
|
|
|
|
241
|
|
|
|
|
|
Unrealized investment gains (losses), net of related offsets and
income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(13,766
|
)
|
|
|
|
|
|
|
|
|
|
|
(13,766
|
)
|
|
|
(150
|
)
|
|
|
10
|
|
|
|
(13,906
|
)
|
|
|
|
|
Foreign currency translation adjustments, net of income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(593
|
)
|
|
|
|
|
|
|
(593
|
)
|
|
|
(107
|
)
|
|
|
|
|
|
|
(700
|
)
|
|
|
|
|
Defined benefit plans adjustment, net of income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,203
|
)
|
|
|
(1,203
|
)
|
|
|
4
|
|
|
|
|
|
|
|
(1,199
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15,321
|
)
|
|
|
(253
|
)
|
|
|
10
|
|
|
|
(15,564
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(12,112
|
)
|
|
|
(159
|
)
|
|
|
(15
|
)
|
|
|
(12,286
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
1
|
|
|
$
|
8
|
|
|
$
|
15,811
|
|
|
$
|
22,403
|
|
|
$
|
(236
|
)
|
|
$
|
(12,564
|
)
|
|
$
|
(246
|
)
|
|
$
|
(1,443
|
)
|
|
$
|
23,734
|
|
|
$
|
|
|
|
$
|
251
|
|
|
$
|
23,985
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the consolidated financial
statements.
F-6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
2,786
|
|
|
$
|
(2,278
|
)
|
|
$
|
3,278
|
|
Adjustments to reconcile net income (loss) to net cash provided
by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization expenses
|
|
|
585
|
|
|
|
520
|
|
|
|
375
|
|
Amortization of premiums and accretion of discounts associated
with investments, net
|
|
|
(1,078
|
)
|
|
|
(967
|
)
|
|
|
(939
|
)
|
(Gains) losses on investments and derivatives and from sales of
businesses, net
|
|
|
854
|
|
|
|
7,715
|
|
|
|
(1,127
|
)
|
Undistributed equity earnings of real estate joint ventures and
other limited partnership interests
|
|
|
(430
|
)
|
|
|
1,118
|
|
|
|
679
|
|
Interest credited to policyholder account balances
|
|
|
4,925
|
|
|
|
4,852
|
|
|
|
4,911
|
|
Interest credited to bank deposits
|
|
|
137
|
|
|
|
163
|
|
|
|
166
|
|
Universal life and investment-type product policy fees
|
|
|
(6,037
|
)
|
|
|
(5,218
|
)
|
|
|
(5,462
|
)
|
Change in trading and other securities
|
|
|
(1,369
|
)
|
|
|
(1,152
|
)
|
|
|
(418
|
)
|
Change in residential mortgage loans
held-for-sale,
net
|
|
|
(487
|
)
|
|
|
(800
|
)
|
|
|
(1,946
|
)
|
Change in mortgage servicing rights
|
|
|
(165
|
)
|
|
|
(687
|
)
|
|
|
(185
|
)
|
Change in accrued investment income
|
|
|
(206
|
)
|
|
|
(110
|
)
|
|
|
428
|
|
Change in premiums, reinsurance and other receivables
|
|
|
(1,023
|
)
|
|
|
(1,653
|
)
|
|
|
(1,929
|
)
|
Change in deferred policy acquisition costs, net
|
|
|
(541
|
)
|
|
|
(1,837
|
)
|
|
|
545
|
|
Change in income tax recoverable (payable)
|
|
|
1,292
|
|
|
|
(2,614
|
)
|
|
|
920
|
|
Change in other assets
|
|
|
1,948
|
|
|
|
(660
|
)
|
|
|
5,737
|
|
Change in insurance-related liabilities and policy-related
balances
|
|
|
6,489
|
|
|
|
6,401
|
|
|
|
5,307
|
|
Change in other liabilities
|
|
|
(315
|
)
|
|
|
865
|
|
|
|
163
|
|
Other, net
|
|
|
631
|
|
|
|
145
|
|
|
|
199
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
7,996
|
|
|
|
3,803
|
|
|
|
10,702
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales, maturities and repayments of:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
86,529
|
|
|
|
64,428
|
|
|
|
102,250
|
|
Equity securities
|
|
|
1,371
|
|
|
|
2,545
|
|
|
|
2,707
|
|
Mortgage loans
|
|
|
6,361
|
|
|
|
5,769
|
|
|
|
6,077
|
|
Real estate and real estate joint ventures
|
|
|
322
|
|
|
|
43
|
|
|
|
140
|
|
Other limited partnership interests
|
|
|
522
|
|
|
|
947
|
|
|
|
593
|
|
Purchases of:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
(100,713
|
)
|
|
|
(83,940
|
)
|
|
|
(86,874
|
)
|
Equity securities
|
|
|
(949
|
)
|
|
|
(1,986
|
)
|
|
|
(1,494
|
)
|
Mortgage loans
|
|
|
(8,967
|
)
|
|
|
(4,692
|
)
|
|
|
(10,096
|
)
|
Real estate and real estate joint ventures
|
|
|
(786
|
)
|
|
|
(579
|
)
|
|
|
(1,170
|
)
|
Other limited partnership interests
|
|
|
(1,008
|
)
|
|
|
(803
|
)
|
|
|
(1,643
|
)
|
Cash received in connection with freestanding derivatives
|
|
|
1,814
|
|
|
|
3,292
|
|
|
|
8,168
|
|
Cash paid in connection with freestanding derivatives
|
|
|
(2,548
|
)
|
|
|
(5,393
|
)
|
|
|
(6,454
|
)
|
Sales of businesses, net of cash and cash equivalents disposed
of $0, $180 and $0, respectively
|
|
|
|
|
|
|
(50
|
)
|
|
|
(4
|
)
|
Disposal of subsidiary
|
|
|
|
|
|
|
(19
|
)
|
|
|
(313
|
)
|
Purchases of businesses, net of cash and cash equivalents
acquired of $4,175, $0 and $314, respectively
|
|
|
(3,021
|
)
|
|
|
|
|
|
|
(469
|
)
|
Net change in policy loans
|
|
|
(225
|
)
|
|
|
(259
|
)
|
|
|
(467
|
)
|
Net change in short-term investments
|
|
|
3,033
|
|
|
|
5,534
|
|
|
|
(11,269
|
)
|
Net change in other invested assets
|
|
|
137
|
|
|
|
1,388
|
|
|
|
(2,206
|
)
|
Other, net
|
|
|
(186
|
)
|
|
|
(160
|
)
|
|
|
(147
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
$
|
(18,314
|
)
|
|
$
|
(13,935
|
)
|
|
$
|
(2,671
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the consolidated financial
statements.
F-7
MetLife,
Inc.
Consolidated Statements of Cash
Flows (Continued)
For the Years Ended December 31, 2010,
2009 and 2008
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances:
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits
|
|
$
|
74,296
|
|
|
$
|
77,517
|
|
|
$
|
70,051
|
|
Withdrawals
|
|
|
(69,739
|
)
|
|
|
(79,799
|
)
|
|
|
(56,406
|
)
|
Net change in payables for collateral under securities loaned
and other transactions
|
|
|
3,076
|
|
|
|
(6,863
|
)
|
|
|
(13,077
|
)
|
Net change in bank deposits
|
|
|
(32
|
)
|
|
|
3,164
|
|
|
|
2,185
|
|
Net change in short-term debt
|
|
|
(606
|
)
|
|
|
(1,747
|
)
|
|
|
1,992
|
|
Long-term debt issued
|
|
|
5,090
|
|
|
|
2,961
|
|
|
|
339
|
|
Long-term debt repaid
|
|
|
(1,061
|
)
|
|
|
(555
|
)
|
|
|
(422
|
)
|
Collateral financing arrangements issued
|
|
|
|
|
|
|
105
|
|
|
|
310
|
|
Cash received in connection with collateral financing
arrangements
|
|
|
|
|
|
|
775
|
|
|
|
|
|
Cash paid in connection with collateral financing arrangements
|
|
|
|
|
|
|
(400
|
)
|
|
|
(800
|
)
|
Junior subordinated debt securities issued
|
|
|
|
|
|
|
500
|
|
|
|
750
|
|
Debt issuance costs
|
|
|
(14
|
)
|
|
|
(30
|
)
|
|
|
(34
|
)
|
Common stock issued, net of issuance costs
|
|
|
3,576
|
|
|
|
|
|
|
|
290
|
|
Common stock issued to settle stock forward contracts
|
|
|
|
|
|
|
1,035
|
|
|
|
|
|
Treasury stock acquired in connection with share repurchase
agreements
|
|
|
|
|
|
|
|
|
|
|
(1,250
|
)
|
Treasury stock issued in connection with common stock issuance,
net of issuance costs
|
|
|
|
|
|
|
|
|
|
|
1,936
|
|
Treasury stock issued to settle stock forward contracts
|
|
|
|
|
|
|
|
|
|
|
1,035
|
|
Dividends on preferred stock
|
|
|
(122
|
)
|
|
|
(122
|
)
|
|
|
(125
|
)
|
Dividends on common stock
|
|
|
(784
|
)
|
|
|
(610
|
)
|
|
|
(592
|
)
|
Other, net
|
|
|
(299
|
)
|
|
|
(34
|
)
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
13,381
|
|
|
|
(4,103
|
)
|
|
|
6,189
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of change in foreign currency exchange rates on cash and
cash equivalents balances
|
|
|
(129
|
)
|
|
|
108
|
|
|
|
(349
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents
|
|
|
2,934
|
|
|
|
(14,127
|
)
|
|
|
13,871
|
|
Cash and cash equivalents, beginning of year
|
|
|
10,112
|
|
|
|
24,239
|
|
|
|
10,368
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of year
|
|
$
|
13,046
|
|
|
$
|
10,112
|
|
|
$
|
24,239
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, subsidiaries
held-for-sale,
beginning of year
|
|
$
|
|
|
|
$
|
32
|
|
|
$
|
407
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, subsidiaries
held-for-sale,
end of year
|
|
$
|
|
|
|
$
|
|
|
|
$
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, from continuing operations, beginning
of year
|
|
$
|
10,112
|
|
|
$
|
24,207
|
|
|
$
|
9,961
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, from continuing operations, end of
year
|
|
$
|
13,046
|
|
|
$
|
10,112
|
|
|
$
|
24,207
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash paid (received) during the year for:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
$
|
1,489
|
|
|
$
|
989
|
|
|
$
|
1,107
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax
|
|
$
|
(23
|
)
|
|
$
|
397
|
|
|
$
|
27
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash transactions during the year:
|
|
|
|
|
|
|
|
|
|
|
|
|
Business acquisitions:
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets acquired
|
|
$
|
125,689
|
|
|
$
|
|
|
|
$
|
2,083
|
|
Liabilities assumed
|
|
|
(109,267
|
)
|
|
|
|
|
|
|
(1,300
|
)
|
Redeemable and non-redeemable noncontrolling interests assumed
|
|
|
(130
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net assets acquired
|
|
|
16,292
|
|
|
|
|
|
|
|
783
|
|
Cash paid, excluding transaction costs of $88, $0 and $0,
respectively
|
|
|
(7,196
|
)
|
|
|
|
|
|
|
(783
|
)
|
Other purchase price adjustments
|
|
|
98
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities issued
|
|
$
|
9,194
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disposal of subsidiary:
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets disposed
|
|
$
|
|
|
|
$
|
|
|
|
$
|
22,135
|
|
Liabilities disposed
|
|
|
|
|
|
|
|
|
|
|
(20,689
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net assets disposed
|
|
|
|
|
|
|
|
|
|
|
1,446
|
|
Cash disposed
|
|
|
|
|
|
|
|
|
|
|
270
|
|
Transaction costs, including cash paid of $0, $19 and $43,
respectively
|
|
|
|
|
|
|
2
|
|
|
|
60
|
|
Treasury stock received in common stock exchange
|
|
|
|
|
|
|
|
|
|
|
(1,318
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on disposal of subsidiary
|
|
$
|
|
|
|
$
|
2
|
|
|
$
|
458
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remarketing of debt securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities redeemed
|
|
$
|
|
|
|
$
|
32
|
|
|
$
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt issued
|
|
$
|
|
|
|
$
|
1,035
|
|
|
$
|
1,035
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Junior subordinated debt securities redeemed
|
|
$
|
|
|
|
$
|
1,067
|
|
|
$
|
1,067
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase money mortgage loans on sales of real estate joint
ventures
|
|
$
|
2
|
|
|
$
|
93
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities received in connection with insurance
contract commutation
|
|
$
|
|
|
|
$
|
|
|
|
$
|
115
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real estate and real estate joint ventures acquired in
satisfaction of debt
|
|
$
|
93
|
|
|
$
|
211
|
|
|
$
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the consolidated financial
statements.
F-8
MetLife,
Inc.
|
|
1.
|
Business,
Basis of Presentation and Summary of Significant Accounting
Policies
|
Business
MetLife or the Company refers to
MetLife, Inc., a Delaware corporation incorporated in 1999 (the
Holding Company), its subsidiaries and affiliates.
MetLife is a leading global provider of insurance, annuities and
employee benefit programs throughout the United States, Japan,
Latin America, Asia Pacific and Europe and the Middle East.
Through its subsidiaries and affiliates, MetLife offers life
insurance, annuities, auto and homeowners insurance, mortgage
and deposit products and other financial services to
individuals, as well as group insurance and
retirement & savings products and services to
corporations and other institutions.
Basis
of Presentation
The accompanying consolidated financial statements include the
accounts of the Holding Company and its subsidiaries, as well as
partnerships and joint ventures in which the Company has
control, and variable interest entities (VIEs) for
which the Company is the primary beneficiary. See
Adoption of New Accounting
Pronouncements. Closed block assets, liabilities, revenues
and expenses are combined on a
line-by-line
basis with the assets, liabilities, revenues and expenses
outside the closed block based on the nature of the particular
item. See Note 10. Intercompany accounts and transactions
have been eliminated.
On November 1, 2010 (the Acquisition Date),
MetLife, Inc. completed the acquisition of American Life
Insurance Company (American Life) from ALICO
Holdings LLC (ALICO Holdings), a subsidiary of
American International Group, Inc. (AIG), and
Delaware American Life Insurance Company (DelAm)
from AIG, (American Life, together with DelAm, collectively,
ALICO) (the Acquisition) for a total
purchase price of $16.4 billion. The Acquisition has been
accounted for using the acquisition method of accounting, which
requires, among other things, that the consideration transferred
be measured at fair value at the Acquisition Date and that most
assets acquired and liabilities assumed be recognized at their
estimated fair values as of the Acquisition Date. In addition,
acquisition-related transaction costs are expensed as incurred.
Any excess of the purchase price consideration over the assigned
values of the net assets acquired is recorded as goodwill.
ALICOs fiscal year-end is November 30. Accordingly,
the Companys consolidated financial statements reflect the
assets and liabilities of ALICO as of November 30, 2010 and
the operating results of ALICO from the Acquisition Date through
November 30, 2010. See Note 2.
Certain amounts in the prior years consolidated financial
statements have been reclassified to conform with the 2010
presentation. Such reclassifications include:
|
|
|
|
|
Reclassification from other net investment gains (losses) of
($4,866) million and $3,910 million to net derivative
gains (losses) in the consolidated statements of operations for
the years ended December 31, 2009 and 2008, respectively;
|
|
|
|
Reclassification from net change in other invested assets of
$3,292 million and $8,168 million to cash received in
connection with freestanding derivatives and
($5,393) million and ($6,454) million to cash paid in
connection with freestanding derivatives, all within cash flows
from investing activities, in the consolidated statements of
cash flows for the years ended December 31, 2009 and 2008,
respectively; and
|
|
|
|
Realignment that affected assets, liabilities and results of
operations on a segment basis with no impact to the consolidated
results. See Note 22.
|
See Note 23 for reclassifications related to discontinued
operations.
F-9
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Summary
of Significant Accounting Policies and Critical Accounting
Estimates
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States of
America (GAAP) requires management to adopt
accounting policies and make estimates and assumptions that
affect amounts reported in the consolidated financial statements.
A description of critical estimates is incorporated within the
discussion of the related accounting policies which follows. In
applying these policies, management makes subjective and complex
judgments that frequently require estimates about matters that
are inherently uncertain. Many of these policies, estimates and
related judgments are common in the insurance and financial
services industries; others are specific to the Companys
businesses and operations. Actual results could differ from
these estimates.
Fair
Value
As described below, certain assets and liabilities are measured
at estimated fair value on the Companys consolidated
balance sheets. In addition, the notes to these consolidated
financial statements include further disclosures of estimated
fair values. The Company defines fair value as the price that
would be received to sell an asset or paid to transfer a
liability (an exit price) in the principal or most advantageous
market for the asset or liability in an orderly transaction
between market participants on the measurement date. In many
cases, the exit price and the transaction (or entry) price will
be the same at initial recognition. However, in certain cases,
the transaction price may not represent fair value. The fair
value of a liability is based on the amount that would be paid
to transfer a liability to a third party with the same credit
standing. It requires that fair value be a market-based
measurement in which the fair value is determined based on a
hypothetical transaction at the measurement date, considered
from the perspective of a market participant. When quoted prices
are not used to determine fair value of an asset, the Company
considers three broad valuation techniques: (i) the market
approach, (ii) the income approach, and (iii) the cost
approach. The Company determines the most appropriate valuation
technique to use, given what is being measured and the
availability of sufficient inputs. The Company prioritizes the
inputs to fair valuation techniques and allows for the use of
unobservable inputs to the extent that observable inputs are not
available. The Company categorizes its assets and liabilities
measured at estimated fair value into a three-level hierarchy,
based on the priority of the inputs to the respective valuation
technique. The fair value hierarchy gives the highest priority
to quoted prices in active markets for identical assets or
liabilities (Level 1) and the lowest priority to
unobservable inputs (Level 3). An asset or liabilitys
classification within the fair value hierarchy is based on the
lowest level of input to its valuation. The input levels are as
follows:
|
|
|
|
Level 1
|
Unadjusted quoted prices in active markets for identical assets
or liabilities. The Company defines active markets based on
average trading volume for equity securities. The size of the
bid/ask spread is used as an indicator of market activity for
fixed maturity securities.
|
|
|
Level 2
|
Quoted prices in markets that are not active or inputs that are
observable either directly or indirectly. Level 2 inputs
include quoted prices for similar assets or liabilities other
than quoted prices in Level 1; quoted prices in markets
that are not active; or other significant inputs that are
observable or can be derived principally from or corroborated by
observable market data for substantially the full term of the
assets or liabilities.
|
|
|
Level 3
|
Unobservable inputs that are supported by little or no market
activity and are significant to the estimated fair value of the
assets or liabilities. Unobservable inputs reflect the reporting
entitys own assumptions about the assumptions that market
participants would use in pricing the asset or liability.
Level 3 assets and liabilities include financial
instruments whose values are determined using pricing models,
discounted cash flow methodologies, or similar techniques, as
well as instruments for which the determination of estimated
fair value requires significant management judgment or
estimation.
|
Prior to January 1, 2009, the measurement and disclosures
of fair value based on exit price excluded certain items such as
nonfinancial assets and nonfinancial liabilities initially
measured at estimated fair value in a business
F-10
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
combination, reporting units measured at estimated fair value in
the first step of a goodwill impairment test and
indefinite-lived intangible assets measured at estimated fair
value for impairment assessment.
In addition, the Company elected the fair value option
(FVO) for certain of its financial instruments to
better match measurement of assets and liabilities in the
consolidated statements of operations.
Investments
The accounting policies for the Companys principal
investments are as follows:
Fixed Maturity and Equity Securities. The
Companys fixed maturity and equity securities are
classified as
available-for-sale
and are reported at their estimated fair value.
Unrealized investment gains and losses on these securities are
recorded as a separate component of other comprehensive income
(loss), net of policyholder-related amounts and deferred income
taxes. All security transactions are recorded on a trade date
basis. Investment gains and losses on sales of securities are
determined on a specific identification basis.
Interest income on fixed maturity securities is recorded when
earned using an effective yield method giving effect to
amortization of premiums and accretion of discounts. Dividends
on equity securities are recorded when declared. These dividends
and interest income are recorded in net investment income.
Included within fixed maturity securities are loan-backed
securities including mortgage-backed and asset-backed securities
(ABS). Amortization of the premium or discount from
the purchase of these securities considers the estimated timing
and amount of prepayments of the underlying loans. Actual
prepayment experience is periodically reviewed and effective
yields are recalculated when differences arise between the
prepayments originally anticipated and the actual prepayments
received and currently anticipated. Prepayment assumptions for
single class and multi-class mortgage-backed and ABS are
estimated by management using inputs obtained from third-party
specialists, including broker-dealers, and based on
managements knowledge of the current market. For
credit-sensitive mortgage-backed and ABS and certain
prepayment-sensitive securities, the effective yield is
recalculated on a prospective basis. For all other
mortgage-backed and ABS, the effective yield is recalculated on
a retrospective basis.
The Company periodically evaluates fixed maturity and equity
securities for impairment. The assessment of whether impairments
have occurred is based on managements
case-by-case
evaluation of the underlying reasons for the decline in
estimated fair value. The Companys review of its fixed
maturity and equity securities for impairments includes an
analysis of the total gross unrealized losses by three
categories of severity
and/or age
of the gross unrealized loss, as summarized in Note 3
Aging of Gross Unrealized Loss and OTTI Loss
for Fixed Maturity and Equity Securities
Available-for-Sale.
An extended and severe unrealized loss position on a fixed
maturity security may not have any impact on the ability of the
issuer to service all scheduled interest and principal payments
and the Companys evaluation of recoverability of all
contractual cash flows or the ability to recover an amount at
least equal to its amortized cost based on the present value of
the expected future cash flows to be collected. In contrast, for
certain equity securities, greater weight and consideration are
given by the Company to a decline in market value and the
likelihood such market value decline will recover.
Additionally, management considers a wide range of factors about
the security issuer and uses its best judgment in evaluating the
cause of the decline in the estimated fair value of the security
and in assessing the prospects for near-term recovery. Inherent
in managements evaluation of the security are assumptions
and estimates about the operations of the issuer and its future
earnings potential. Considerations used by the Company in the
impairment evaluation process include, but are not limited to:
(i) the length of time and the extent to which the
estimated fair value has been below cost or amortized cost;
(ii) the potential for impairments of securities when the
issuer is experiencing significant financial difficulties;
(iii) the
F-11
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
potential for impairments in an entire industry sector or
sub-sector;
(iv) the potential for impairments in certain economically
depressed geographic locations; (v) the potential for
impairments of securities where the issuer, series of issuers or
industry has suffered a catastrophic type of loss or has
exhausted natural resources; (vi) with respect to fixed
maturity securities, whether the Company has the intent to sell
or will more likely than not be required to sell a particular
security before the decline in estimated fair value below cost
or amortized cost recovers; (vii) with respect to equity
securities, whether the Companys ability and intent to
hold the security for a period of time sufficient to allow for
the recovery of its estimated fair value to an amount equal to
or greater than cost; (viii) unfavorable changes in
forecasted cash flows on mortgage-backed and ABS; and
(ix) other subjective factors, including concentrations and
information obtained from regulators and rating agencies.
Effective April 1, 2009, the Company prospectively adopted
guidance on the recognition and presentation of
other-than-temporary
impairment (OTTI) losses as described in
Adoption of New Accounting
Pronouncements Financial Instruments. The
guidance requires that an OTTI be recognized in earnings for a
fixed maturity security in an unrealized loss position when it
is anticipated that the amortized cost will not be recovered. In
such situations, the OTTI recognized in earnings is the entire
difference between the fixed maturity securitys amortized
cost and its estimated fair value only when either: (i) the
Company has the intent to sell the fixed maturity security; or
(ii) it is more likely than not that the Company will be
required to sell the fixed maturity security before recovery of
the decline in estimated fair value below amortized cost. If
neither of these two conditions exist, the difference between
the amortized cost of the fixed maturity security and the
present value of projected future cash flows expected to be
collected is recognized as an OTTI in earnings (credit
loss). If the estimated fair value is less than the
present value of projected future cash flows expected to be
collected, this portion of OTTI related to other-than credit
factors (noncredit loss) is recorded in other
comprehensive income (loss). There was no change for equity
securities which, when an OTTI has occurred, continue to be
impaired for the entire difference between the equity
securitys cost and its estimated fair value with a
corresponding charge to earnings. The Company does not make any
adjustments for subsequent recoveries in value.
Prior to the adoption of the OTTI guidance, the Company
recognized in earnings an OTTI for a fixed maturity security in
an unrealized loss position unless it could assert that it had
both the intent and ability to hold the fixed maturity security
for a period of time sufficient to allow for a recovery of
estimated fair value to the securitys amortized cost.
Also, prior to the adoption of this guidance, the entire
difference between the fixed maturity securitys amortized
cost basis and its estimated fair value was recognized in
earnings if it was determined to have an OTTI.
With respect to equity securities, the Company considers in its
OTTI analysis its intent and ability to hold a particular equity
security for a period of time sufficient to allow for the
recovery of its estimated fair value to an amount equal to or
greater than cost. If a sale decision is made for an equity
security and it is not expected to recover to an amount at least
equal to cost prior to the expected time of the sale, the
security will be deemed
other-than-temporarily
impaired in the period that the sale decision was made and an
OTTI loss will be recorded in earnings. When an OTTI loss has
occurred, the OTTI loss is the entire difference between the
equity securitys cost and its estimated fair value with a
corresponding charge to earnings.
With respect to perpetual hybrid securities that have attributes
of both debt and equity, some of which are classified as fixed
maturity securities and some of which are classified as
non-redeemable preferred stock within equity securities, the
Company considers in its OTTI analysis whether there has been
any deterioration in credit of the issuer and the likelihood of
recovery in value of the securities that are in a severe and
extended unrealized loss position. The Company also considers
whether any perpetual hybrid securities, with an unrealized
loss, regardless of credit rating, have deferred any dividend
payments. When an OTTI loss has occurred, the OTTI loss is the
entire difference between the perpetual hybrid securitys
cost and its estimated fair value with a corresponding charge to
earnings.
F-12
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The Companys methodology and significant inputs used to
determine the amount of the credit loss on fixed maturity
securities under the OTTI guidance are as follows:
|
|
|
|
(i)
|
The Company calculates the recovery value by performing a
discounted cash flow analysis based on the present value of
future cash flows expected to be received. The discount rate is
generally the effective interest rate of the fixed maturity
security prior to impairment.
|
|
|
(ii)
|
When determining the collectability and the period over which
value is expected to recover, the Company applies the same
considerations utilized in its overall impairment evaluation
process which incorporates information regarding the specific
security, fundamentals of the industry and geographic area in
which the security issuer operates, and overall macroeconomic
conditions. Projected future cash flows are estimated using
assumptions derived from managements best estimates of
likely scenario-based outcomes after giving consideration to a
variety of variables that include, but are not limited to:
general payment terms of the security; the likelihood that the
issuer can service the scheduled interest and principal
payments; the quality and amount of any credit enhancements; the
securitys position within the capital structure of the
issuer; possible corporate restructurings or asset sales by the
issuer; and changes to the rating of the security or the issuer
by rating agencies.
|
|
|
(iii)
|
Additional considerations are made when assessing the unique
features that apply to certain structured securities such as
residential mortgage-backed securities (RMBS),
commercial mortgage-backed securities (CMBS) and
ABS. These additional factors for structured securities include,
but are not limited to: the quality of underlying collateral;
expected prepayment speeds; current and forecasted loss
severity; consideration of the payment terms of the underlying
assets backing a particular security; and the payment priority
within the tranche structure of the security.
|
|
|
(iv)
|
When determining the amount of the credit loss for U.S. and
foreign corporate securities, foreign government securities and
state and political subdivision securities, management considers
the estimated fair value as the recovery value when available
information does not indicate that another value is more
appropriate. When information is identified that indicates a
recovery value other than estimated fair value, management
considers in the determination of recovery value the same
considerations utilized in its overall impairment evaluation
process which incorporates available information and
managements best estimate of scenarios-based outcomes
regarding the specific security and issuer; possible corporate
restructurings or asset sales by the issuer; the quality and
amount of any credit enhancements; the securitys position
within the capital structure of the issuer; fundamentals of the
industry and geographic area in which the security issuer
operates, and the overall macroeconomic conditions.
|
The cost or amortized cost of fixed maturity and equity
securities is adjusted for OTTI in the period in which the
determination is made. These impairments are included within net
investment gains (losses). The Company does not change the
revised cost basis for subsequent recoveries in value.
In periods subsequent to the recognition of OTTI on a fixed
maturity security, the Company accounts for the impaired
security as if it had been purchased on the measurement date of
the impairment. Accordingly, the discount (or reduced premium)
based on the new cost basis is accreted into net investment
income over the remaining term of the fixed maturity security in
a prospective manner based on the amount and timing of estimated
future cash flows.
The Company purchases and receives beneficial interests in
special purpose entities (SPEs), which enhance the
Companys total return on its investment portfolio
principally by providing equity-based returns on fixed maturity
securities. These investments are generally made through
structured notes and similar instruments (collectively,
Structured Investment Transactions). The Company has
not guaranteed the performance, liquidity or obligations of the
SPEs and its exposure to loss is limited to its carrying value
of the beneficial interests in the SPEs. The Company does not
consolidate such SPEs as it has determined it is not the primary
beneficiary. These Structured Investment Transactions are
included in fixed maturity
F-13
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
securities and their investment income is generally recognized
using the retrospective interest method. Impairments of these
investments are included in net investment gains (losses). In
addition, the Company has invested in certain structured
transactions that are VIEs. These structured transactions
include reinsurance trusts, asset-backed securitizations, hybrid
securities, real estate joint ventures, other limited
partnership interests, and limited liability companies. The
Company consolidates those VIEs for which it is deemed to be the
primary beneficiary. The Company reconsiders whether it is the
primary beneficiary for investments designated as VIEs on a
quarterly basis.
Trading and Other Securities. Trading and
other securities are stated at estimated fair value. Trading and
other securities include investments that are actively purchased
and sold (Actively Traded Securities). These
Actively Traded Securities are principally fixed maturity
securities. Short sale agreement liabilities related to Actively
Traded Securities, included in other liabilities, are also
stated at estimated fair value. Trading and other securities
also includes securities for which the FVO has been elected
(FVO Securities). FVO Securities include certain
fixed maturity and equity securities
held-for-investment
by the general account to support asset and liability matching
strategies for certain insurance products. FVO Securities also
include contractholder-directed investments supporting
unit-linked variable annuity type liabilities which do not
qualify for presentation and reporting as separate account
summary total assets and liabilities. These investments are
primarily mutual funds and, to a lesser extent, fixed maturity
and equity securities, short-term investments and cash and cash
equivalents. The investment returns on these investments inure
to contractholders and are offset by a corresponding change in
policyholder account balances through interest credited to
policyholder account balances. Changes in estimated fair value
of such trading and other securities subsequent to purchase are
included in net investment income. FVO Securities also include
securities held by consolidated securitization entities
(CSEs) (former qualifying special purpose entities
(QSPEs)) with changes in estimated fair value
subsequent to consolidation included in net investment gains
(losses). Interest and dividends related to all trading and
other securities are included in net investment income.
Securities Lending. Securities loaned
transactions, whereby blocks of securities, which are included
in fixed maturity securities and short-term investments, are
loaned to third parties, are treated as financing arrangements
and the associated liability is recorded at the amount of cash
received. At the inception of a loan, the Company obtains
collateral, generally cash, in an amount at least equal to 102%
of the estimated fair value of the securities loaned and
maintains it at a level greater than or equal to 100% for the
duration of the loan. The Company monitors the estimated fair
value of the securities loaned on a daily basis with additional
collateral obtained as necessary. Substantially all of the
Companys securities loaned transactions are with brokerage
firms and commercial banks. Income and expenses associated with
securities loaned transactions are reported as investment income
and investment expense, respectively, within net investment
income.
Mortgage Loans Mortgage Loans
Held-For-Investment. For
the purposes of determining valuation allowances the Company
disaggregates its mortgage loan investments into three portfolio
segments: (1) commercial, (2) agricultural, and
(3) residential. The accounting and valuation allowance
policies that are applicable to all portfolio segments are
presented below, followed by the policies applicable to both
commercial and agricultural loans, which are very similar, as
well as policies applicable to residential loans.
Commercial, Agricultural and Residential Mortgage
Loans Mortgage loans
held-for-investment
are stated at unpaid principal balance, adjusted for any
unamortized premium or discount, deferred fees or expenses, and
net of valuation allowances. Interest income is accrued on the
principal amount of the loan based on the loans
contractual interest rate. Amortization of premiums and
discounts is recorded using the effective yield method. Interest
income, amortization of premiums and discounts and prepayment
fees are reported in net investment income. Interest ceases to
accrue when collection of interest is not considered probable
and/or when
interest or principal payments are past due as follows:
commercial 60 days; and agricultural and
residential 90 days, unless, in the case of a
residential loan, it is both well-secured and in the process of
collection. When a loan is placed on non-accrual status,
uncollected
F-14
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
past due interest is charged-off against net investment income.
Generally, the accrual of interest income resumes after all
delinquent amounts are paid and management believes all future
principal and interest payments will be collected. Cash receipts
on non-accruing loans are recorded in accordance with the loan
agreement as a reduction of principal
and/or
interest income. Charge-offs occur upon the realization of a
credit loss, typically through foreclosure or after a decision
is made to sell a loan, or for residential loans when, after
considering the individual consumers financial status,
management believes that uncollectability is
other-than-temporary.
Gain or loss upon charge-off is recorded, net of previously
established valuation allowances, in net investment gains
(losses). Cash recoveries on principal amounts previously
charged-off are generally recorded as an increase to the
valuation allowance, unless the valuation allowance adequately
provides for expected credit losses; then the recovery is
recorded in net investment gains (losses). Gains and losses from
sales of loans and increases or decreases to valuation
allowances are recorded in net investment gains (losses).
Mortgage loans are considered to be impaired when it is probable
that, based upon current information and events, the Company
will be unable to collect all amounts due under the contractual
terms of the loan agreement. Specific valuation allowances are
established using the same methodology for all three portfolio
segments as the excess carrying value of a loan over either
(i) the present value of expected future cash flows
discounted at the loans original effective interest rate,
(ii) the estimated fair value of the loans underlying
collateral if the loan is in the process of foreclosure or
otherwise collateral dependent, or (iii) the loans
observable market price. A common evaluation framework is used
for establishing non-specific valuation allowances for all loan
portfolio segments; however, a separate non-specific valuation
allowance is calculated and maintained for each loan portfolio
segment that is based on inputs unique to each loan portfolio
segment. Non-specific valuation allowances are established for
pools of loans with similar risk characteristics where a
property-specific or market-specific risk has not been
identified, but for which the Company expects to incur a credit
loss. These evaluations are based upon several loan portfolio
segment-specific factors, including the Companys
experience for loan losses, defaults and loss severity, and loss
expectations for loans with similar risk characteristics. The
Company typically uses ten years, or more, of historical
experience, in these evaluations. These evaluations are revised
as conditions change and new information becomes available.
Commercial and Agricultural Mortgage Loans
All commercial and agricultural loans are monitored on an
ongoing basis for potential credit losses. For commercial loans,
these ongoing reviews may include an analysis of the property
financial statements and rent roll, lease rollover analysis,
property inspections, market analysis, estimated valuations of
the underlying collateral,
loan-to-value
ratios, debt service coverage ratios, and tenant
creditworthiness. The monitoring process focuses on higher risk
loans, which include those that are classified as restructured,
potentially delinquent, delinquent or in foreclosure, as well as
loans with higher
loan-to-value
ratios and lower debt service coverage ratios. The monitoring
process for agricultural loans is generally similar, with a
focus on higher risk loans, including reviews on a geographic
and property-type basis. Higher risk commercial and agricultural
loans are reviewed individually on an ongoing basis for
potential credit loss and specific valuation allowances are
established using the methodology described above for all loan
portfolio segments. Quarterly, the remaining loans are reviewed
on a pool basis by aggregating groups of loans that have similar
risk characteristics for potential credit loss, and non-specific
valuation allowances are established as described above using
inputs that are unique to each segment of the loan portfolio.
For commercial loans, the Companys primary credit quality
indicator is the debt service coverage ratio, which compares a
propertys net operating income to amounts needed to
service the principal and interest due under the loan.
Generally, the lower the debt service coverage ratio, the higher
the risk of experiencing a credit loss. The values utilized in
calculating these ratios are developed in connection with the
ongoing review of the commercial loan portfolio and are
routinely updated.
F-15
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
For agricultural loans, the Companys primary credit
qualify indicator is the
loan-to-value
ratio.
Loan-to-value
ratios compare the amount of the loan to the estimated fair
value of the underlying collateral. A
loan-to-value
ratio greater than 100% indicates that the loan amount is
greater than the collateral value. A
loan-to-value
ratio of less than 100% indicates an excess of collateral value
over the loan amount. Generally, the higher the
loan-to-value
ratio, the higher the risk of experiencing a credit loss. The
values utilized in calculating these ratios are developed in
connection with the ongoing review of the agricultural loan
portfolio and are routinely updated.
Residential Mortgage Loans The Companys
residential loan portfolio is comprised primarily of closed end,
amortizing residential loans and home equity lines of credit and
it does not hold any optional adjustable rate mortgages,
sub-prime,
or low teaser rate loans.
In contrast to the commercial and agricultural loan portfolios,
residential loans are smaller-balance homogeneous loans that are
collectively evaluated for impairment. Non-specific valuation
allowances are established using the evaluation framework
described above for pools of loans with similar risk
characteristics from inputs that are unique to the residential
segment of the loan portfolio. Loan specific valuation
allowances are only established on residential loans when they
have been restructured and are established using the methodology
described above for all loan portfolio segments.
For residential loans, the Companys primary credit quality
indicator is whether the loan is performing or non-performing.
The Company generally defines non-performing residential loans
as those that are 90 or more days past due
and/or in
non-accrual status. The determination of performing or
non-performing status is assessed monthly. Generally,
non-performing residential loans have a higher risk of
experiencing a credit loss.
Also included in mortgage loans
held-for-investment
are commercial mortgage loans held by CSEs that were
consolidated by the Company on January 1, 2010 upon the
adoption of new guidance. The Company elected FVO for these
commercial mortgage loans, and thus they are stated at estimated
fair value with changes in estimated fair value subsequent to
consolidation recognized in net investment gains (losses).
Mortgage Loans Mortgage Loans
Held-For-Sale. Mortgage
loans
held-for-sale
primarily include residential mortgage loans which are
originated with the intent to sell and for which FVO was
elected. These residential mortgage loans are stated at
estimated fair value with subsequent changes in estimated fair
value recognized in other revenue. This caption also includes
mortgage loans previously designated as
held-for-investment
about which the Company has subsequently changed its intention.
At the time of transfer to
held-for-sale
status, such mortgage loans are recorded at the lower of
amortized cost or estimated fair value less expected disposition
costs determined on an individual loan basis. Amortized cost is
determined in the same manner as for mortgage loans
held-for-investment
as described above. The amount by which amortized cost exceeds
estimated fair value, less expected disposition costs, is
recognized in net investment gains (losses).
Policy Loans. Policy loans are stated at
unpaid principal balances. Interest income on such loans is
recorded as earned in net investment income using the
contractually agreed upon interest rate. Generally, interest is
capitalized on the policys anniversary date. Valuation
allowances are not established for policy loans, as these loans
are fully collateralized by the cash surrender value of the
underlying insurance policies. Any unpaid principal or interest
on the loan is deducted from the cash surrender value or the
death benefit prior to settlement of the policy.
Real Estate. Real estate
held-for-investment,
including related improvements, is stated at cost less
accumulated depreciation. Depreciation is provided on a
straight-line basis over the estimated useful life of the asset
(typically 20 to 55 years). Rental income is recognized on
a straight-line basis over the term of the respective leases.
The Company classifies a property as
held-for-sale
if it commits to a plan to sell a property within one year and
actively markets the property in its current condition for a
price that is reasonable in
F-16
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
comparison to its estimated fair value. The Company classifies
the results of operations and the gain or loss on sale of a
property that either has been disposed of or classified as
held-for-sale
as discontinued operations, if the ongoing operations of the
property will be eliminated from the ongoing operations of the
Company and if the Company will not have any significant
continuing involvement in the operations of the property after
the sale. Real estate
held-for-sale
is stated at the lower of depreciated cost or estimated fair
value less expected disposition costs. Real estate is not
depreciated while it is classified as
held-for-sale.
The Company periodically reviews its properties
held-for-investment
for impairment and tests properties for recoverability whenever
events or changes in circumstances indicate the carrying amount
of the asset may not be recoverable and the carrying value of
the property exceeds its estimated fair value. Properties whose
carrying values are greater than their undiscounted cash flows
are written down to their estimated fair value, with the
impairment loss included in net investment gains (losses).
Impairment losses are based upon the estimated fair value of
real estate, which is generally computed using the present value
of expected future cash flows from the real estate discounted at
a rate commensurate with the underlying risks. Real estate
acquired upon foreclosure is recorded at the lower of estimated
fair value or the carrying value of the mortgage loan at the
date of foreclosure.
Real Estate Joint Ventures and Other Limited Partnership
Interests. The Company uses the equity method of
accounting for investments in real estate joint ventures and
other limited partnership interests consisting of leveraged
buy-out funds, hedge funds and other private equity funds in
which it has more than a minor equity interest or more than a
minor influence over the joint ventures or partnerships
operations, but does not have a controlling interest and is not
the primary beneficiary. The equity method is also used for such
investments in which the Company has more than a minor influence
or more than a 20% interest. Generally, the Company records its
share of earnings using a three-month lag methodology for
instances where the timely financial information is available
and the contractual right exists to receive such financial
information on a timely basis. The Company uses the cost method
of accounting for investments in real estate joint ventures and
other limited partnership interests in which it has a minor
equity investment and virtually no influence over the joint
ventures or the partnerships operations. The Company
reports the distributions from real estate joint ventures and
other limited partnership interests accounted for under the cost
method and equity in earnings from real estate joint ventures
and other limited partnership interests accounted for under the
equity method in net investment income. In addition to the
investees performing regular evaluations for the impairment of
underlying investments, the Company routinely evaluates its
investments in real estate joint ventures and other limited
partnerships for impairments. The Company considers its cost
method investments for OTTI when the carrying value of real
estate joint ventures and other limited partnership interests
exceeds the net asset value (NAV). The Company takes
into consideration the severity and duration of this excess when
deciding if the cost method investment is
other-than-temporarily
impaired. For equity method investees, the Company considers
financial and other information provided by the investee, other
known information and inherent risks in the underlying
investments, as well as future capital commitments, in
determining whether an impairment has occurred. When an OTTI is
deemed to have occurred, the Company records a realized capital
loss within net investment gains (losses) to record the
investment at its estimated fair value.
Short-term Investments. Short-term investments
include investments with remaining maturities of one year or
less, but greater than three months, at the time of purchase and
are stated at amortized cost, which approximates estimated fair
value, or stated at estimated fair value, if available.
Other Invested Assets. Other invested assets
consist principally of freestanding derivatives with positive
estimated fair values, leveraged leases, investments in
insurance enterprise joint ventures, tax credit partnerships,
funding agreements, mortgage servicing rights (MSRs)
and funds withheld.
Freestanding derivatives with positive estimated fair values are
described in the derivatives accounting policy which follows.
F-17
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Leveraged leases are recorded net of non-recourse debt. The
Company participates in lease transactions which are diversified
by industry, asset type and geographic area. The Company
recognizes income on the leveraged leases by applying the
leveraged leases estimated rate of return to the net
investment in the lease. The Company regularly reviews residual
values and impairs them to expected values.
Joint venture investments represent the Companys
investments in entities that engage in insurance underwriting
activities and are accounted for under the equity method.
Tax credit partnerships are established for the purpose of
investing in low-income housing and other social causes, where
the primary return on investment is in the form of tax credits
and are also accounted for under the equity method or under the
effective yield method. The Company reports the equity in
earnings of joint venture investments and tax credit
partnerships in net investment income.
Funding agreements represent arrangements where the Company has
long-term interest bearing amounts on deposit with third parties
and are generally stated at amortized cost.
MSRs are measured at estimated fair value and are either
acquired or are generated from the sale of originated
residential mortgage loans where the servicing rights are
retained by the Company. Changes in estimated fair value of MSRs
are reported in other revenues in the period in which the change
occurs.
Funds withheld represent amounts contractually withheld by
ceding companies in accordance with reinsurance agreements. The
Company records a funds withheld receivable rather than the
underlying investments. The Company recognizes interest on funds
withheld at rates defined by the terms of the agreement which
may be contractually specified or directly related to the
underlying investments and records it in net investment income.
Investments Risks and Uncertainties. The
Companys investments are exposed to four primary sources
of risk: credit, interest rate, liquidity risk, and market
valuation. The financial statement risks, stemming from such
investment risks, are those associated with the determination of
estimated fair values, the diminished ability to sell certain
investments in times of strained market conditions, the
recognition of impairments, the recognition of income on certain
investments and the potential consolidation of VIEs. The use of
different methodologies, assumptions and inputs relating to
these financial statement risks may have a material effect on
the amounts presented within the consolidated financial
statements.
When available, the estimated fair value of the Companys
fixed maturity and equity securities are based on quoted prices
in active markets that are readily and regularly obtainable.
Generally, these are the most liquid of the Companys
securities holdings and valuation of these securities does not
involve management judgment.
When quoted prices in active markets are not available, the
determination of estimated fair value is based on market
standard valuation methodologies. The market standard valuation
methodologies utilized include: discounted cash flow
methodologies, matrix pricing or other similar techniques. The
inputs to these market standard valuation methodologies include,
but are not limited to: interest rates, credit standing of the
issuer or counterparty, industry sector of the issuer, coupon
rate, call provisions, sinking fund requirements, maturity,
estimated duration and managements assumptions regarding
liquidity and estimated future cash flows. Accordingly, the
estimated fair values are based on available market information
and managements judgments about financial instruments.
The significant inputs to the market standard valuation
methodologies for certain types of securities with reasonable
levels of price transparency are inputs that are observable in
the market or can be derived principally from or corroborated by
observable market data. Such observable inputs include
benchmarking prices for similar assets in active, liquid
markets, quoted prices in markets that are not active and
observable yields and spreads in the market.
F-18
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
When observable inputs are not available, the market standard
valuation methodologies for determining the estimated fair value
of certain types of securities that trade infrequently, and
therefore have little or no price transparency, rely on inputs
that are significant to the estimated fair value that are not
observable in the market or cannot be derived principally from
or corroborated by observable market data. These unobservable
inputs can be based in large part on management judgment or
estimation, and cannot be supported by reference to market
activity. Even though unobservable, these inputs are based on
assumptions deemed appropriate given the circumstances and
consistent with what other market participants would use when
pricing such securities.
The estimated fair value of residential mortgage loans
held-for-sale
is determined based on observable pricing of residential
mortgage loans
held-for-sale
with similar characteristics, or observable pricing for
securities backed by similar types of loans, adjusted to convert
the securities prices to loan prices. Generally, quoted market
prices are not available. When observable pricing for similar
loans, or securities that are backed by similar loans, are not
available, the estimated fair values of residential mortgage
loans
held-for-sale
are determined using independent broker quotations, which is
intended to approximate the amounts that would be received from
third parties. Certain other mortgage loans have also been
designated as
held-for-sale
which are recorded at the lower of amortized cost or estimated
fair value less expected disposition costs determined on an
individual loan basis. For these loans, estimated fair value is
determined using independent broker quotations or, when the loan
is in foreclosure or otherwise determined to be collateral
dependent, the estimated fair value of the underlying collateral
estimated using internal models.
The estimated fair value of MSRs is principally determined
through the use of internal discounted cash flow models which
utilize various assumptions. Valuation inputs and assumptions
include generally observable items such as type and age of loan,
loan interest rates, current market interest rates, and certain
unobservable inputs, including assumptions regarding estimates
of discount rates, loan prepayments and servicing costs, all of
which are sensitive to changing market conditions. The use of
different valuation assumptions and inputs, as well as
assumptions relating to the collection of expected cash flows,
may have a material effect on the estimated fair values of MSRs.
Financial markets are susceptible to severe events evidenced by
rapid depreciation in asset values accompanied by a reduction in
asset liquidity. The Companys ability to sell securities,
or the price ultimately realized for these securities, depends
upon the demand and liquidity in the market and increases the
use of judgment in determining the estimated fair value of
certain securities.
The determination of the amount of allowances and impairments,
as applicable, is described previously by investment type. The
determination of such allowances and impairments is highly
subjective and is based upon the Companys periodic
evaluation and assessment of known and inherent risks associated
with the respective asset class. Such evaluations and
assessments are revised as conditions change and new information
becomes available.
The recognition of income on certain investments (e.g.
loan-backed securities, including mortgage-backed and ABS,
certain structured investment transactions, trading and other
securities) is dependent upon market conditions, which could
result in prepayments and changes in amounts to be earned.
The accounting guidance for the determination of when an entity
is a VIE and when to consolidate a VIE is complex and requires
significant management judgment. The determination of the
VIEs primary beneficiary requires an evaluation of the
contractual and implied rights and obligations associated with
each partys relationship with or involvement in the
entity, an estimate of the entitys expected losses and
expected residual returns and the allocation of such estimates
to each party involved in the entity. The Company generally uses
a qualitative approach to determine whether it is the primary
beneficiary.
For most VIEs, the entity that has both the ability to direct
the most significant activities of the VIE and the obligation to
absorb losses or receive benefits that could be significant to
the VIE is considered the primary beneficiary. However, for VIEs
that are investment companies or apply measurement principles
consistent
F-19
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
with those utilized by investment companies, the primary
beneficiary is based on a risks and rewards model and is defined
as the entity that will absorb a majority of a VIEs
expected losses, receive a majority of a VIEs expected
residual returns if no single entity absorbs a majority of
expected losses, or both. The Company reassesses its involvement
with VIEs on a quarterly basis. The use of different
methodologies, assumptions and inputs in the determination of
the primary beneficiary could have a material effect on the
amounts presented within the consolidated financial statements.
Derivative
Financial Instruments
Derivatives are financial instruments whose values are derived
from interest rates, foreign currency exchange rates, credit
spreads,
and/or other
financial indices. Derivatives may be exchange-traded or
contracted in the
over-the-counter
market. The Company uses a variety of derivatives, including
swaps, forwards, futures and option contracts, to manage various
risks relating to its ongoing business. To a lesser extent, the
Company uses credit derivatives, such as credit default swaps,
to synthetically replicate investment risks and returns which
are not readily available in the cash market. The Company also
purchases certain securities, issues certain insurance policies
and investment contracts and engages in certain reinsurance
contracts that have embedded derivatives.
Freestanding derivatives are carried on the Companys
consolidated balance sheets either as assets within other
invested assets or as liabilities within other liabilities at
estimated fair value as determined through the use of quoted
market prices for exchange-traded derivatives and interest rate
forwards to sell certain to-be-announced securities or through
the use of pricing models for
over-the-counter
derivatives. The determination of estimated fair value, when
quoted market values are not available, is based on market
standard valuation methodologies and inputs that are assumed to
be consistent with what other market participants would use when
pricing the instruments. Derivative valuations can be affected
by changes in interest rates, foreign currency exchange rates,
financial indices, credit spreads, default risk (including the
counterparties to the contract), volatility, liquidity and
changes in estimates and assumptions used in the pricing models.
The Company does not offset the fair value amounts recognized
for derivatives executed with the same counterparty under the
same master netting agreement.
If a derivative is not designated as an accounting hedge or its
use in managing risk does not qualify for hedge accounting,
changes in the estimated fair value of the derivative are
generally reported in net derivative gains (losses) except for
those (i) in policyholder benefits and claims for economic
hedges of variable annuity guarantees included in future policy
benefits; (ii) in net investment income for economic hedges
of equity method investments in joint ventures, or for all
derivatives held in relation to the trading portfolios;
(iii) in other revenues for derivatives held in connection
with the Companys mortgage banking activities; and
(iv) in other expenses for economic hedges of foreign
currency exposure related to the Companys international
subsidiaries. The fluctuations in estimated fair value of
derivatives which have not been designated for hedge accounting
can result in significant volatility in net income.
To qualify for hedge accounting, at the inception of the hedging
relationship, the Company formally documents its risk management
objective and strategy for undertaking the hedging transaction,
as well as its designation of the hedge as either (i) a
hedge of the estimated fair value of a recognized asset or
liability (fair value hedge); (ii) a hedge of a
forecasted transaction or of the variability of cash flows to be
received or paid related to a recognized asset or liability
(cash flow hedge); or (iii) a hedge of a net
investment in a foreign operation. In this documentation, the
Company sets forth how the hedging instrument is expected to
hedge the designated risks related to the hedged item and sets
forth the method that will be used to retrospectively and
prospectively assess the hedging instruments effectiveness
and the method which will be used to measure ineffectiveness. A
derivative designated as a hedging instrument must be assessed
as being highly effective in offsetting the designated risk of
the hedged item. Hedge effectiveness is formally assessed at
inception and periodically throughout the life of the designated
hedging relationship. Assessments of hedge effectiveness and
measurements of ineffectiveness are also subject to
interpretation and estimation and different interpretations or
estimates may have a material effect on the amount reported in
net income.
F-20
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The accounting for derivatives is complex and interpretations of
the primary accounting guidance continue to evolve in practice.
Judgment is applied in determining the availability and
application of hedge accounting designations and the appropriate
accounting treatment under such accounting guidance. If it was
determined that hedge accounting designations were not
appropriately applied, reported net income could be materially
affected.
Under a fair value hedge, changes in the estimated fair value of
the hedging derivative, including amounts measured as
ineffectiveness, and changes in the estimated fair value of the
hedged item related to the designated risk being hedged, are
reported within net derivative gains (losses). The estimated
fair values of the hedging derivatives are exclusive of any
accruals that are separately reported in the consolidated
statement of operations within interest income or interest
expense to match the location of the hedged item. However,
accruals that are not scheduled to settle until maturity are
included in the estimated fair value of derivatives in the
consolidated balance sheets.
Under a cash flow hedge, changes in the estimated fair value of
the hedging derivative measured as effective are reported within
other comprehensive income (loss), a separate component of
stockholders equity, and the deferred gains or losses on
the derivative are reclassified into the consolidated statement
of operations when the Companys earnings are affected by
the variability in cash flows of the hedged item. Changes in the
estimated fair value of the hedging instrument measured as
ineffectiveness are reported within net derivative gains
(losses). The estimated fair values of the hedging derivatives
are exclusive of any accruals that are separately reported in
the consolidated statement of operations within interest income
or interest expense to match the location of the hedged item.
However, accruals that are not scheduled to settle until
maturity are included in the estimated fair value of derivatives
in the consolidated balance sheets.
In a hedge of a net investment in a foreign operation, changes
in the estimated fair value of the hedging derivative that are
measured as effective are reported within other comprehensive
income (loss) consistent with the translation adjustment for the
hedged net investment in the foreign operation. Changes in the
estimated fair value of the hedging instrument measured as
ineffectiveness are reported within net derivative gains
(losses).
The Company discontinues hedge accounting prospectively when:
(i) it is determined that the derivative is no longer
highly effective in offsetting changes in the estimated fair
value or cash flows of a hedged item; (ii) the derivative
expires, is sold, terminated, or exercised; (iii) it is no
longer probable that the hedged forecasted transaction will
occur; or (iv) the derivative is de-designated as a hedging
instrument.
When hedge accounting is discontinued because it is determined
that the derivative is not highly effective in offsetting
changes in the estimated fair value or cash flows of a hedged
item, the derivative continues to be carried in the consolidated
balance sheets at its estimated fair value, with changes in
estimated fair value recognized currently in net derivative
gains (losses). The carrying value of the hedged recognized
asset or liability under a fair value hedge is no longer
adjusted for changes in its estimated fair value due to the
hedged risk, and the cumulative adjustment to its carrying value
is amortized into income over the remaining life of the hedged
item. Provided the hedged forecasted transaction is still
probable of occurrence, the changes in estimated fair value of
derivatives recorded in other comprehensive income (loss)
related to discontinued cash flow hedges are released into the
consolidated statement of operations when the Companys
earnings are affected by the variability in cash flows of the
hedged item.
When hedge accounting is discontinued because it is no longer
probable that the forecasted transactions will occur on the
anticipated date or within two months of that date, the
derivative continues to be carried in the consolidated balance
sheets at its estimated fair value, with changes in estimated
fair value recognized currently in net derivative gains
(losses). Deferred gains and losses of a derivative recorded in
other comprehensive income (loss) pursuant to the discontinued
cash flow hedge of a forecasted transaction that is no longer
probable are recognized immediately in net derivative gains
(losses).
In all other situations in which hedge accounting is
discontinued, the derivative is carried at its estimated fair
value in the consolidated balance sheets, with changes in its
estimated fair value recognized in the current period as net
derivative gains (losses).
F-21
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The Company is also a party to financial instruments that
contain terms which are deemed to be embedded derivatives. The
Company assesses each identified embedded derivative to
determine whether it is required to be bifurcated. If the
instrument would not be accounted for in its entirety at
estimated fair value and it is determined that the terms of the
embedded derivative are not clearly and closely related to the
economic characteristics of the host contract, and that a
separate instrument with the same terms would qualify as a
derivative instrument, the embedded derivative is bifurcated
from the host contract and accounted for as a freestanding
derivative. Such embedded derivatives are carried in the
consolidated balance sheets at estimated fair value with the
host contract and changes in their estimated fair value are
generally reported in net derivative gains (losses) except for
those in policyholder benefits and claims related to ceded
reinsurance of guaranteed minimum income benefits
(GMIBs). If the Company is unable to properly
identify and measure an embedded derivative for separation from
its host contract, the entire contract is carried on the balance
sheet at estimated fair value, with changes in estimated fair
value recognized in the current period in net investment gains
(losses) or net investment income. Additionally, the Company may
elect to carry an entire contract on the balance sheet at
estimated fair value, with changes in estimated fair value
recognized in the current period in net investment gains
(losses) or net investment income if that contract contains an
embedded derivative that requires bifurcation.
Cash and
Cash Equivalents
The Company considers all highly liquid investments purchased
with an original or remaining maturity of three months or less
at the date of purchase to be cash equivalents. Cash equivalents
are stated at amortized cost, which approximates estimated fair
value.
Property,
Equipment, Leasehold Improvements and Computer
Software
Property, equipment and leasehold improvements, which are
included in other assets, are stated at cost, less accumulated
depreciation and amortization. Depreciation is determined using
the straight-line method over the estimated useful lives of the
assets, as appropriate. The estimated life for company occupied
real estate property is generally 40 years. Estimated lives
generally range from five to ten years for leasehold
improvements and three to seven years for all other property and
equipment. The cost basis of the property, equipment and
leasehold improvements was $2.4 billion and
$1.9 billion at December 31, 2010 and 2009,
respectively. Accumulated depreciation and amortization of
property, equipment and leasehold improvements was
$1.2 billion and $1.0 billion at December 31,
2010 and 2009, respectively. Related depreciation and
amortization expense was $152 million, $152 million
and $150 million for the years ended December 31,
2010, 2009 and 2008, respectively.
Computer software, which is included in other assets, is stated
at cost, less accumulated amortization. Purchased software
costs, as well as certain internal and external costs incurred
to develop internal-use computer software during the application
development stage, are capitalized. Such costs are amortized
generally over a four-year period using the straight-line
method. The cost basis of computer software was
$2.0 billion and $1.7 billion at December 31,
2010 and 2009, respectively. Accumulated amortization of
capitalized software was $1.4 billion and $1.2 billion
at December 31, 2010 and 2009, respectively. Related
amortization expense was $189 million, $171 million
and $153 million for the years ended December 31,
2010, 2009 and 2008, respectively.
Deferred
Policy Acquisition Costs (DAC) and Value of Business
Acquired (VOBA)
The Company incurs significant costs in connection with
acquiring new and renewal insurance business. Costs that vary
with and relate to the production of new business are deferred
as DAC. Such costs consist principally of commissions and agency
and policy issuance expenses. VOBA is an intangible asset that
represents the excess of book value over the estimated fair
value of acquired insurance, annuity, and investment-type
contracts in-force at the acquisition date. The estimated fair
value of the acquired liabilities is based on actuarially
determined projections, by each block of business, of future
policy and contract charges, premiums, mortality and morbidity,
separate account performance, surrenders, operating expenses,
investment returns, nonperformance risk adjustment
F-22
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
and other factors. Actual experience on the purchased business
may vary from these projections. The recovery of DAC and VOBA is
dependent upon the future profitability of the related business.
DAC and VOBA are aggregated in the consolidated financial
statements for reporting purposes.
DAC for credit, property and casualty insurance contracts, which
is primarily composed of commissions and certain underwriting
expenses, is amortized on a pro rata basis over the applicable
contract term or reinsurance treaty.
DAC and VOBA on life insurance, accident and health or
investment-type contracts are amortized in proportion to gross
premiums, gross margins or gross profits, depending on the type
of contract as described below.
The Company amortizes DAC and VOBA related to non-participating
and non-dividend-paying traditional contracts (term insurance,
non-participating whole life insurance, traditional group life
insurance, credit insurance, non-medical health insurance, and
accident and health insurance) over the entire premium paying
period in proportion to the present value of actual historic and
expected future gross premiums. The present value of expected
premiums is based upon the premium requirement of each policy
and assumptions for mortality, morbidity, persistency and
investment returns at policy issuance, or policy acquisition (as
it relates to VOBA), that include provisions for adverse
deviation and are consistent with the assumptions used to
calculate future policyholder benefit liabilities. These
assumptions are not revised after policy issuance or acquisition
unless the DAC or VOBA balance is deemed to be unrecoverable
from future expected profits. Absent a premium deficiency,
variability in amortization after policy issuance or acquisition
is caused only by variability in premium volumes.
The Company amortizes DAC and VOBA related to participating,
dividend-paying traditional contracts over the estimated lives
of the contracts in proportion to actual and expected future
gross margins. The amortization includes interest based on rates
in effect at inception or acquisition of the contracts. The
future gross margins are dependent principally on investment
returns, policyholder dividend scales, mortality, persistency,
expenses to administer the business, creditworthiness of
reinsurance counterparties and certain economic variables, such
as inflation. For participating contracts within the closed
block (dividend paying traditional contracts) future gross
margins are also dependent upon changes in the policyholder
dividend obligation. Of these factors, the Company anticipates
that investment returns, expenses, persistency and other factor
changes as well as policyholder dividend scales are reasonably
likely to impact significantly the rate of DAC and VOBA
amortization. Each reporting period, the Company updates the
estimated gross margins with the actual gross margins for that
period. When the actual gross margins change from previously
estimated gross margins, the cumulative DAC and VOBA
amortization is re-estimated and adjusted by a cumulative charge
or credit to current operations. When actual gross margins
exceed those previously estimated, the DAC and VOBA amortization
will increase, resulting in a current period charge to earnings.
The opposite result occurs when the actual gross margins are
below the previously estimated gross margins. Each reporting
period, the Company also updates the actual amount of business
in-force, which impacts expected future gross margins. When
expected future gross margins are below those previously
estimated, the DAC and VOBA amortization will increase,
resulting in a current period charge to earnings. The opposite
result occurs when the expected future gross margins are above
the previously estimated expected future gross margins. Each
period, the Company also reviews the estimated gross margins for
each block of business to determine the recoverability of DAC
and VOBA balances.
The Company amortizes DAC and VOBA related to fixed and variable
universal life contracts and fixed and variable deferred annuity
contracts over the estimated lives of the contracts in
proportion to actual and expected future gross profits. The
amortization includes interest based on rates in effect at
inception or acquisition of the contracts. The amount of future
gross profits is dependent principally upon returns in excess of
the amounts credited to policyholders, mortality, persistency,
interest crediting rates, expenses to administer the business,
creditworthiness of reinsurance counterparties, the effect of
any hedges used and certain economic variables, such as
inflation. Of these factors, the Company anticipates that
investment returns, expenses and persistency are reasonably
likely to impact significantly the rate of DAC and VOBA
amortization. Each reporting period, the Company updates the
estimated gross profits with the actual gross profits for that
period. When the actual gross
F-23
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
profits change from previously estimated gross profits, the
cumulative DAC and VOBA amortization is re-estimated and
adjusted by a cumulative charge or credit to current operations.
When actual gross profits exceed those previously estimated, the
DAC and VOBA amortization will increase, resulting in a current
period charge to earnings. The opposite result occurs when the
actual gross profits are below the previously estimated gross
profits. Each reporting period, the Company also updates the
actual amount of business remaining in-force, which impacts
expected future gross profits. When expected future gross
profits are below those previously estimated, the DAC and VOBA
amortization will increase, resulting in a current period charge
to earnings. The opposite result occurs when the expected future
gross profits are above the previously estimated expected future
gross profits. Each period, the Company also reviews the
estimated gross profits for each block of business to determine
the recoverability of DAC and VOBA balances.
Separate account rates of return on variable universal life
contracts and variable deferred annuity contracts affect
in-force account balances on such contracts each reporting
period which can result in significant fluctuations in
amortization of DAC and VOBA. Returns that are higher than the
Companys long-term expectation produce higher account
balances, which increases the Companys future fee
expectations and decreases future benefit payment expectations
on minimum death and living benefit guarantees, resulting in
higher expected future gross profits. The opposite result occurs
when returns are lower than the Companys long-term
expectation. The Companys practice to determine the impact
of gross profits resulting from returns on separate accounts
assumes that long-term appreciation in equity markets is not
changed by short-term market fluctuations, but is only changed
when sustained interim deviations are expected. The Company
monitors these events and only changes the assumption when its
long-term expectation changes.
The Company also periodically reviews other long-term
assumptions underlying the projections of estimated gross
margins and profits. These include investment returns,
policyholder dividend scales, interest crediting rates,
mortality, persistency and expenses to administer business.
Management annually updates assumptions used in the calculation
of estimated gross margins and profits which may have
significantly changed. If the update of assumptions causes
expected future gross margins and profits to increase, DAC and
VOBA amortization will decrease, resulting in a current period
increase to earnings. The opposite result occurs when the
assumption update causes expected future gross margins and
profits to decrease.
Periodically, the Company modifies product benefits, features,
rights or coverages that occur by the exchange of a contract for
a new contract, or by amendment, endorsement, or rider to a
contract, or by election or coverage within a contract. If such
modification, referred to as an internal replacement,
substantially changes the contract, the associated DAC or VOBA
is written off immediately through income and any new deferrable
costs associated with the replacement contract are deferred. If
the modification does not substantially change the contract, the
DAC or VOBA amortization on the original contract will continue
and any acquisition costs associated with the related
modification are expensed.
Sales
Inducements
The Company generally has two different types of sales
inducements which are included in other assets: (i) the
policyholder receives a bonus whereby the policyholders
initial account balance is increased by an amount equal to a
specified percentage of the customers deposit; and
(ii) the policyholder receives a higher interest rate using
a dollar cost averaging method than would have been received
based on the normal general account interest rate credited. The
Company defers sales inducements and amortizes them over the
life of the policy using the same methodology and assumptions
used to amortize DAC. The amortization of sales inducements is
included in policyholder benefits and claims. Each year, or more
frequently if circumstances indicate a potentially significant
recoverability issue exists, the Company reviews the deferred
sales inducements to determine the recoverability of these
balances.
F-24
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Value of
Distribution Agreements and Customer Relationships
Acquired
Value of distribution agreements (VODA) is reported
in other assets and represents the present value of expected
future profits associated with the expected future business
derived from the distribution agreements. Value of customer
relationships acquired (VOCRA) is also reported in
other assets and represents the present value of the expected
future profits associated with the expected future business
acquired through existing customers of the acquired company or
business. The VODA and VOCRA associated with past acquisitions
are amortized over useful lives ranging from 10 to 40 years
and such amortization is included in other expenses. Each year,
or more frequently if circumstances indicate a potentially
significant recoverability issue exists, the Company reviews
VODA and VOCRA to determine the recoverability of these balances.
Goodwill
Goodwill is the excess of cost over the estimated fair value of
net assets acquired which represents the future economic
benefits arising from such net assets acquired that could not be
individually identified. Goodwill is not amortized but is tested
for impairment at least annually or more frequently if events or
circumstances, such as adverse changes in the business climate,
indicate that there may be justification for conducting an
interim test. The Company performs its annual goodwill
impairment testing during the third quarter of each year based
upon data as of the close of the second quarter. Goodwill
associated with a business acquisition is not tested for
impairment during the year the business is acquired unless there
is a significant identified impairment event.
Impairment testing is performed using the fair value approach,
which requires the use of estimates and judgment, at the
reporting unit level. A reporting unit is the
operating segment or a business one level below the operating
segment, if discrete financial information is prepared and
regularly reviewed by management at that level. For purposes of
goodwill impairment testing, a significant portion of goodwill
within Banking, Corporate & Other is allocated to
reporting units within the Companys segments.
For purposes of goodwill impairment testing, if the carrying
value of a reporting unit exceeds its estimated fair value,
there might be an indication of impairment. In such instances,
the implied fair value of the goodwill is determined in the same
manner as the amount of goodwill that would be determined in a
business acquisition. The excess of the carrying value of
goodwill over the implied fair value of goodwill would be
recognized as an impairment and recorded as a charge against net
income.
In performing the Companys goodwill impairment tests, the
estimated fair values of the reporting units are first
determined using a market multiple approach. When further
corroboration is required, the Company uses a discounted cash
flow approach. For reporting units which are particularly
sensitive to market assumptions, such as the retirement products
and individual life reporting units, the Company may use
additional valuation methodologies to estimate the reporting
units fair values.
The key inputs, judgments and assumptions necessary in
determining estimated fair value of the reporting units include
projected earnings, current book value (with and without
accumulated other comprehensive income), the level of economic
capital required to support the mix of business, long-term
growth rates, comparative market multiples, the account value of
in-force business, projections of new and renewal business, as
well as margins on such business, the level of interest rates,
credit spreads, equity market levels and the discount rate that
the Company believes is appropriate for the respective reporting
unit. The estimated fair values of the retirement products and
individual life reporting units are particularly sensitive to
the equity market levels.
When testing goodwill for impairment, the Company also considers
its market capitalization in relation to the aggregate estimated
fair value of its reporting units.
The Company applies significant judgment when determining the
estimated fair value of the Companys reporting units and
when assessing the relationship of market capitalization to the
aggregate estimated fair value of its reporting units. The
valuation methodologies utilized are subject to key judgments
and assumptions that are
F-25
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
sensitive to change. Estimates of fair value are inherently
uncertain and represent only managements reasonable
expectation regarding future developments. These estimates and
the judgments and assumptions upon which the estimates are based
will, in all likelihood, differ in some respects from actual
future results. Declines in the estimated fair value of the
Companys reporting units could result in goodwill
impairments in future periods which could materially adversely
affect the Companys results of operations or financial
position.
During the 2010 impairment tests of goodwill, the Company
concluded that the fair values of all reporting units were in
excess of their carrying values and, therefore, goodwill was not
impaired. On an ongoing basis, the Company evaluates potential
triggering events that may affect the estimated fair value of
the Companys reporting units to assess whether any
goodwill impairment exists. Deteriorating or adverse market
conditions for certain reporting units may have a significant
impact on the estimated fair value of these reporting units and
could result in future impairments of goodwill.
See Note 7 for further consideration of goodwill impairment
testing during 2010.
Liability
for Future Policy Benefits and Policyholder Account
Balances
The Company establishes liabilities for amounts payable under
insurance policies, including traditional life insurance,
traditional annuities, certain accident and health, and
non-medical health insurance. Generally, amounts are payable
over an extended period of time and related liabilities are
calculated as the present value of future expected benefits to
be paid reduced by the present value of future expected
premiums. Such liabilities are established based on methods and
underlying assumptions in accordance with GAAP and applicable
actuarial standards. Principal assumptions used in the
establishment of liabilities for future policy benefits are
mortality, morbidity, policy lapse, renewal, retirement,
disability incidence, disability terminations, investment
returns, inflation, expenses and other contingent events as
appropriate to the respective product type and geographical
area. These assumptions are established at the time the policy
is issued and are intended to estimate the experience for the
period the policy benefits are payable. Utilizing these
assumptions, liabilities are established on a block of business
basis.
Future policy benefit liabilities for participating traditional
life insurance policies are equal to the aggregate of
(i) net level premium reserves for death and endowment
policy benefits (calculated based upon the non-forfeiture
interest rate, ranging from 3% to 7% for domestic business and
1% to 12% for international business, and mortality rates
guaranteed in calculating the cash surrender values described in
such contracts); and (ii) the liability for terminal
dividends for domestic business.
Participating business represented approximately 6% of the
Companys life insurance in-force at both December 31,
2010 and 2009. Participating policies represented approximately
26%, 28% and 27% of gross life insurance premiums for the years
ended December 31, 2010, 2009 and 2008, respectively.
Future policy benefit liabilities for non-participating
traditional life insurance policies are equal to the aggregate
of the present value of expected future benefit payments and
related expenses less the present value of expected future net
premiums. Assumptions as to mortality and persistency are based
upon the Companys experience when the basis of the
liability is established. Interest rate assumptions for the
aggregate future policy benefit liabilities range from 3% to 8%
for domestic business and 1% to 12% for international business.
Future policy benefit liabilities for individual and group
traditional fixed annuities after annuitization are equal to the
present value of expected future payments. Interest rate
assumptions used in establishing such liabilities range from 2%
to 11% for domestic business and 3% to 12% for international
business.
Future policy benefit liabilities for non-medical health
insurance, primarily related to domestic business, are
calculated using the net level premium method and assumptions as
to future morbidity, withdrawals and interest, which provide a
margin for adverse deviation. Interest rate assumptions used in
establishing such liabilities range from 4% to 7%.
F-26
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Future policy benefit liabilities for disabled lives are
estimated using the present value of benefits method and
experience assumptions as to claim terminations, expenses and
interest. Interest rate assumptions used in establishing such
liabilities range from 3% to 8% for domestic business and 2% to
9% for international business.
Liabilities for unpaid claims and claim expenses for property
and casualty insurance are included in future policyholder
benefits and represent the amount estimated for claims that have
been reported but not settled and claims incurred but not
reported. Liabilities for unpaid claims are estimated based upon
the Companys historical experience and other actuarial
assumptions that consider the effects of current developments,
anticipated trends and risk management programs, reduced for
anticipated salvage and subrogation. The effects of changes in
such estimated liabilities are included in the results of
operations in the period in which the changes occur.
The Company establishes future policy benefit liabilities for
minimum death and income benefit guarantees relating to certain
annuity contracts and secondary and
paid-up
guarantees relating to certain life policies as follows:
|
|
|
|
|
Guaranteed minimum death benefit (GMDB) liabilities
are determined by estimating the expected value of death
benefits in excess of the projected account balance and
recognizing the excess ratably over the accumulation period
based on total expected assessments. The Company regularly
evaluates estimates used and adjusts the additional liability
balance, with a related charge or credit to benefit expense, if
actual experience or other evidence suggests that earlier
assumptions should be revised. The assumptions used in
estimating the GMDB liabilities are consistent with those used
for amortizing DAC, and are thus subject to the same variability
and risk. The assumptions of investment performance and
volatility are consistent with the historical experience of the
appropriate underlying equity index, such as the
Standard & Poors (S&P) 500
Index. The benefit assumptions used in calculating the
liabilities are based on the average benefits payable over a
range of scenarios.
|
|
|
|
Guaranteed minimum income benefit (GMIB) liabilities
are determined by estimating the expected value of the income
benefits in excess of the projected account balance at any
future date of annuitization and recognizing the excess ratably
over the accumulation period based on total expected
assessments. The Company regularly evaluates estimates used and
adjusts the additional liability balance, with a related charge
or credit to benefit expense, if actual experience or other
evidence suggests that earlier assumptions should be revised.
The assumptions used for estimating the GMIB liabilities are
consistent with those used for estimating the GMDB liabilities.
In addition, the calculation of guaranteed annuitization benefit
liabilities incorporates an assumption for the percentage of the
potential annuitizations that may be elected by the
contractholder. Certain GMIBs have settlement features that
result in a portion of that guarantee being accounted for as an
embedded derivative and are recorded in policyholder account
balances as described below.
|
Liabilities for universal and variable life secondary guarantees
and paid-up
guarantees are determined by estimating the expected value of
death benefits payable when the account balance is projected to
be zero and recognizing those benefits ratably over the
accumulation period based on total expected assessments. The
Company regularly evaluates estimates used and adjusts the
additional liability balances, with a related charge or credit
to benefit expense, if actual experience or other evidence
suggests that earlier assumptions should be revised. The
assumptions used in estimating the secondary and
paid-up
guarantee liabilities are consistent with those used for
amortizing DAC, and are thus subject to the same variability and
risk. The assumptions of investment performance and volatility
for variable products are consistent with historical S&P
experience. The benefits used in calculating the liabilities are
based on the average benefits payable over a range of scenarios.
The Company establishes policyholder account balances for
guaranteed minimum benefits relating to certain variable annuity
products as follows:
|
|
|
|
|
Guaranteed minimum withdrawal benefits (GMWB)
guarantee the contractholder a return of their purchase payment
via partial withdrawals, even if the account value is reduced to
zero, provided that
|
F-27
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
the contractholders cumulative withdrawals in a contract
year do not exceed a certain limit. The initial guaranteed
withdrawal amount is equal to the initial benefit base as
defined in the contract (typically, the initial purchase
payments plus applicable bonus amounts). The GMWB is an embedded
derivative, which is measured at estimated fair value separately
from the host variable annuity product.
|
|
|
|
|
|
Guaranteed minimum accumulation benefits (GMAB) and
settlement features in certain GMIB described above provide the
contractholder, after a specified period of time determined at
the time of issuance of the variable annuity contract, with a
minimum accumulation of their purchase payments even if the
account value is reduced to zero. The initial guaranteed
accumulation amount is equal to the initial benefit base as
defined in the contract (typically, the initial purchase
payments plus applicable bonus amounts). The GMAB is an embedded
derivative, which is measured at estimated fair value separately
from the host variable annuity product.
|
For GMWB, GMAB and certain GMIB, the initial benefit base is
increased by additional purchase payments made within a certain
time period and decreases by benefits paid
and/or
withdrawal amounts. After a specified period of time, the
benefit base may also increase as a result of an optional reset
as defined in the contract.
GMWB, GMAB and certain GMIB are accounted for as embedded
derivatives with changes in estimated fair value reported in net
derivative gains (losses).
At inception of the GMWB, GMAB and certain GMIB contracts, the
Company attributes to the embedded derivative a portion of the
projected future guarantee fees to be collected from the
policyholder equal to the present value of projected future
guaranteed benefits. Any additional fees represent
excess fees and are reported in universal life and
investment-type product policy fees.
The estimated fair values of these embedded derivatives are then
determined based on the present value of projected future
benefits minus the present value of projected future fees. The
projections of future benefits and future fees require capital
market and actuarial assumptions including expectations
concerning policyholder behavior. A risk neutral valuation
methodology is used under which the cash flows from the
guarantees are projected under multiple capital market scenarios
using observable risk free rates. The valuation of these
embedded derivatives also includes an adjustment for the
Companys nonperformance risk and risk margins for
non-capital market inputs. The nonperformance adjustment is
determined by taking into consideration publicly available
information relating to spreads in the secondary market for the
Holding Companys debt, including related credit default
swaps. These observable spreads are then adjusted, as necessary,
to reflect the priority of these liabilities and the claims
paying ability of the issuing insurance subsidiaries compared to
the Holding Company. Risk margins are established to capture the
non-capital market risks of the instrument which represent the
additional compensation a market participant would require to
assume the risks related to the uncertainties of such actuarial
assumptions as annuitization, premium persistency, partial
withdrawal and surrenders. The establishment of risk margins
requires the use of significant management judgment.
These guaranteed minimum benefits may be more costly than
expected in volatile or declining equity markets. Market
conditions including, but not limited to, changes in interest
rates, equity indices, market volatility and foreign currency
exchange rates, changes in nonperformance risk, variations in
actuarial assumptions regarding policyholder behavior, mortality
and risk margins related to non-capital market inputs may result
in significant fluctuations in the estimated fair value of the
guarantees that could materially affect net income.
The Company periodically reviews its estimates of actuarial
liabilities for future policy benefits and compares them with
its actual experience. Differences between actual experience and
the assumptions used in pricing these policies and guarantees,
and in the establishment of the related liabilities result in
variances in profit and could result in losses. The effects of
changes in such estimated liabilities are included in the
results of operations in the period in which the changes occur.
F-28
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Policyholder account balances relate to investment-type
contracts, universal life-type policies and certain guaranteed
minimum benefits. Investment-type contracts principally include
traditional individual fixed annuities in the accumulation phase
and non-variable group annuity contracts. Policyholder account
balances for these contracts are equal to (i) policy
account values, which consist of an accumulation of gross
premium payments and investment performance; (ii) credited
interest, ranging from 1% to 17% for domestic business and 1% to
38% for international business, less expenses, mortality charges
and withdrawals; and (iii) fair value adjustments relating
to business combinations.
Other
Policy-Related Balances
Other policy-related balances include policy and contract
claims, unearned revenue liabilities, premiums received in
advance, negative VOBA, policyholder dividends due and unpaid
and policyholder dividends left on deposit.
The liability for policy and contract claims generally relates
to incurred but not reported death, disability, long-term care
and dental claims, as well as claims which have been reported
but not yet settled. The liability for these claims is based on
the Companys estimated ultimate cost of settling all
claims. The Company derives estimates for the development of
incurred but not reported claims principally from actuarial
analyses of historical patterns of claims and claims development
for each line of business. The methods used to determine these
estimates are continually reviewed. Adjustments resulting from
this continuous review process and differences between estimates
and payments for claims are recognized in policyholder benefits
and claims expense in the period in which the estimates are
changed or payments are made.
The unearned revenue liability relates to universal life-type
and investment-type products and represents policy charges for
services to be provided in future periods. The charges are
deferred as unearned revenue and amortized using the
products estimated gross profits and margins, similar to
DAC. Such amortization is recorded in universal life and
investment-type product policy fees.
The Company accounts for the prepayment of premiums on its
individual life, group life and health contracts as premium
received in advance and applies the cash received to premiums
when due.
For certain acquired blocks of business, the estimated fair
value of the in-force contract obligations exceeded the book
value of assumed in-force insurance policy liabilities,
resulting in negative VOBA, which is presented separately from
VOBA as an additional insurance liability. The fair value of the
in-force contract obligations is based on actuarial determined
projections by each block of business. Negative VOBA is
amortized over the policy period in proportion to the
approximate consumption of losses included in the liability
usually expressed in terms of insurance in-force or account
value. Such amortization is recorded as a contra-expense in
other expenses in the consolidated statements of operations.
Also included in other policy-related balances are policyholder
dividends due and unpaid on participating policies and
policyholder dividends left on deposit. Such liabilities are
presented at amounts contractually due to policyholders.
Recognition
of Insurance Revenue and Related Benefits
Premiums related to traditional life and annuity policies with
life contingencies and long-duration accident and health and
credit insurance policies are recognized as revenues when due
from policyholders. Policyholder benefits and expenses are
provided against such revenues to recognize profits over the
estimated lives of the policies. When premiums are due over a
significantly shorter period than the period over which benefits
are provided, any excess profit is deferred and recognized into
operations in a constant relationship to insurance in-force or,
for annuities, the amount of expected future policy benefit
payments.
F-29
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Premiums related to short-duration non-medical health and
disability contracts are recognized on a pro rata basis over the
applicable contract term.
Deposits related to universal life-type and investment-type
products are credited to policyholder account balances. Revenues
from such contracts consist of amounts assessed against
policyholder account balances for mortality, policy
administration and surrender charges and are recorded in
universal life and investment-type product policy fees in the
period in which services are provided. Amounts that are charged
to operations include interest credited and benefit claims
incurred in excess of related policyholder account balances.
Premiums related to property and casualty contracts are
recognized as revenue on a pro rata basis over the applicable
contract term. Unearned premiums, representing the portion of
premium written relating to the unexpired coverage, are included
in future policy benefits.
Premiums, policy fees, policyholder benefits and expenses are
presented net of reinsurance.
The portion of fees allocated to embedded derivatives described
previously is recognized within net derivative gains (losses) as
part of the estimated fair value of embedded derivatives.
Other
Revenues
Other revenues include, in addition to items described elsewhere
herein, advisory fees, broker-dealer commissions and fees and
administrative service fees. Such fees and commissions are
recognized in the period in which services are performed. Other
revenues also include changes in account value relating to
corporate-owned life insurance (COLI). Under certain
COLI contracts, if the Company reports certain unlikely adverse
results in its consolidated financial statements, withdrawals
would not be immediately available and would be subject to
market value adjustment, which could result in a reduction of
the account value.
Policyholder
Dividends
Policyholder dividends are approved annually by the insurance
subsidiaries boards of directors. The aggregate amount of
policyholder dividends is related to actual interest, mortality,
morbidity and expense experience for the year, as well as
managements judgment as to the appropriate level of
statutory surplus to be retained by the insurance subsidiaries.
Income
Taxes
The Holding Company and its includable life insurance and
non-life insurance subsidiaries file a consolidated
U.S. federal income tax return in accordance with the
provisions of the Internal Revenue Code of 1986, as amended (the
Code). Non-includable subsidiaries file either
separate individual corporate tax returns or separate
consolidated tax returns.
The Companys accounting for income taxes represents
managements best estimate of various events and
transactions.
Deferred tax assets and liabilities resulting from temporary
differences between the financial reporting and tax bases of
assets and liabilities are measured at the balance sheet date
using enacted tax rates expected to apply to taxable income in
the years the temporary differences are expected to reverse.
For U.S. federal income tax purposes, the Company
anticipates making an election under the Code Section 338
as it relates to the Acquisition. As such, the tax basis in the
acquired assets and liabilities is adjusted as of the
Acquisition Date resulting in a change to the related deferred
income taxes.
The realization of deferred tax assets depends upon the
existence of sufficient taxable income within the carryback or
carryforward periods under the tax law in the applicable tax
jurisdiction. Valuation allowances are established when
management determines, based on available information, that it
is more likely than not that
F-30
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
deferred income tax assets will not be realized. Significant
judgment is required in determining whether valuation allowances
should be established, as well as the amount of such allowances.
When making such determination, consideration is given to, among
other things, the following:
|
|
|
|
(i)
|
future taxable income exclusive of reversing temporary
differences and carryforwards;
|
|
|
(ii)
|
future reversals of existing taxable temporary differences;
|
|
|
(iii)
|
taxable income in prior carryback years; and
|
|
|
(iv)
|
tax planning strategies.
|
The Company may be required to change its provision for income
taxes in certain circumstances. Examples of such circumstances
include when the ultimate deductibility of certain items is
challenged by taxing authorities (see Note 15) or when
estimates used in determining valuation allowances on deferred
tax assets significantly change or when receipt of new
information indicates the need for adjustment in valuation
allowances. Additionally, future events, such as changes in tax
laws, tax regulations, or interpretations of such laws or
regulations, could have an impact on the provision for income
tax and the effective tax rate. Any such changes could
significantly affect the amounts reported in the consolidated
financial statements in the year these changes occur.
The Company determines whether it is more likely than not that a
tax position will be sustained upon examination by the
appropriate taxing authorities before any part of the benefit
can be recorded in the financial statements. A tax position is
measured at the largest amount of benefit that is greater than
50 percent likely of being realized upon settlement.
Unrecognized tax benefits due to tax uncertainties that do not
meet the threshold are included within other liabilities and are
charged to earnings in the period that such determination is
made.
The Company classifies interest recognized as interest expense
and penalties recognized as a component of income tax.
Reinsurance
The Company enters into reinsurance agreements primarily as a
purchaser of reinsurance for its various insurance products and
also as a provider of reinsurance for some insurance products
issued by third parties.
For each of its reinsurance agreements, the Company determines
whether the agreement provides indemnification against loss or
liability relating to insurance risk in accordance with
applicable accounting standards. The Company reviews all
contractual features, particularly those that may limit the
amount of insurance risk to which the reinsurer is subject or
features that delay the timely reimbursement of claims.
For reinsurance of existing in-force blocks of long-duration
contracts that transfer significant insurance risk, the
difference, if any, between the amounts paid (received), and the
liabilities ceded (assumed) related to the underlying contracts
is considered the net cost of reinsurance at the inception of
the reinsurance agreement. The net cost of reinsurance is
recorded as an adjustment to DAC and recognized as a component
of other expenses on a basis consistent with the way the
acquisition costs on the underlying reinsured contracts would be
recognized. Subsequent amounts paid (received) on the
reinsurance of in-force blocks, as well as amounts paid
(received) related to new business, are recorded as ceded
(assumed) premiums and ceded (assumed) future policy benefit
liabilities are established.
For prospective reinsurance of short-duration contracts that
meet the criteria for reinsurance accounting, amounts paid
(received) are recorded as ceded (assumed) premiums and ceded
(assumed) unearned premiums and are reflected as a component of
premiums and other receivables (future policy benefits). Such
amounts are amortized through earned premiums over the remaining
contract period in proportion to the amount of protection
provided. For retroactive reinsurance of short-duration
contracts that meet the criteria of reinsurance accounting,
amounts paid (received) in excess of (which do not exceed) the
related insurance liabilities ceded (assumed) are
F-31
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
recognized immediately as a loss. Any gains on such retroactive
agreements are deferred and recorded in other liabilities. The
gains are amortized primarily using the recovery method.
The assumptions used to account for both long and short-duration
reinsurance agreements are consistent with those used for the
underlying contracts. Ceded policyholder and contract related
liabilities, other than those currently due, are reported gross
on the balance sheet.
Amounts currently recoverable under reinsurance agreements are
included in premiums, reinsurance and other receivables and
amounts currently payable are included in other liabilities.
Such assets and liabilities relating to reinsurance agreements
with the same reinsurer may be recorded net on the balance
sheet, if a right of offset exists within the reinsurance
agreement. In the event that reinsurers do not meet their
obligations to the Company under the terms of the reinsurance
agreements, reinsurance balances recoverable could become
uncollectible. In such instances, reinsurance recoverable
balances are stated net of allowances for uncollectible
reinsurance.
Premiums, fees and policyholder benefits and claims include
amounts assumed under reinsurance agreements and are net of
reinsurance ceded. Amounts received from reinsurers for policy
administration are reported in other revenues.
If the Company determines that a reinsurance agreement does not
expose the reinsurer to a reasonable possibility of a
significant loss from insurance risk, the Company records the
agreement using the deposit method of accounting. Deposits
received are included in other liabilities and deposits made are
included within premiums, reinsurance and other receivables. As
amounts are paid or received, consistent with the underlying
contracts, the deposit assets or liabilities are adjusted.
Interest on such deposits is recorded as other revenues or other
expenses, as appropriate. Periodically, the Company evaluates
the adequacy of the expected payments or recoveries and adjusts
the deposit asset or liability through other revenues or other
expenses, as appropriate.
Accounting for reinsurance requires extensive use of assumptions
and estimates, particularly related to the future performance of
the underlying business and the potential impact of counterparty
credit risks. The Company periodically reviews actual and
anticipated experience compared to the aforementioned
assumptions used to establish assets and liabilities relating to
ceded and assumed reinsurance and evaluates the financial
strength of counterparties to its reinsurance agreements using
criteria similar to that evaluated in the security impairment
process discussed previously.
Cessions under reinsurance arrangements do not discharge the
Companys obligations as the primary insurer.
Employee
Benefit Plans
Certain subsidiaries of the Holding Company (the
Subsidiaries) sponsor
and/or
administer various plans that provide defined benefit pension
and other postretirement benefits covering eligible employees
and sales representatives. Measurement dates used for all of the
Subsidiaries defined benefit pension and other
postretirement benefit plans correspond with the fiscal year
ends of sponsoring Subsidiaries, which are December 31 for
U.S. Subsidiaries and November 30 for most foreign
Subsidiaries.
Pension benefits are provided utilizing either a traditional
formula or cash balance formula. The traditional formula
provides benefits based upon years of credited service and
either final average or career average earnings. The cash
balance formula utilizes hypothetical or notional accounts which
credit participants with benefits equal to a percentage of
eligible pay, as well as earnings credits, determined annually
based upon the average annual rate of interest on
30-year
Treasury securities, for each account balance.
The Subsidiaries also provide certain postemployment benefits
and certain postretirement medical and life insurance benefits
for retired employees. Employees of the Subsidiaries who were
hired prior to 2003 (or, in certain cases, rehired during or
after 2003) and meet age and service criteria while working
for one of the Subsidiaries, may become eligible for these other
postretirement benefits, at various levels, in accordance with
the applicable plans.
F-32
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Virtually all retirees, or their beneficiaries, contribute a
portion of the total cost of postretirement medical benefits.
Employees hired after 2003 are not eligible for any employer
subsidy for postretirement medical benefits.
The projected pension benefit obligation (PBO) is
defined as the actuarially calculated present value of vested
and non-vested pension benefits accrued based on future salary
levels. The accumulated pension benefit obligation
(ABO) is the actuarial present value of vested and
non-vested pension benefits accrued based on current salary
levels. Obligations, both PBO and ABO, of the defined benefit
pension plans are determined using a variety of actuarial
assumptions, from which actual results may vary, as described
below.
The expected postretirement plan benefit obligations
(EPBO) represents the actuarial present value of all
other postretirement benefits expected to be paid after
retirement to employees and their dependents and is used in
measuring the periodic postretirement benefit expense. The
accumulated postretirement plan benefit obligations
(APBO) represents the actuarial present value of
future other postretirement benefits attributed to employee
services rendered through a particular date and is the valuation
basis upon which liabilities are established. The APBO is
determined using a variety of actuarial assumptions, from which
actual results may vary, as described below.
The Company recognizes the funded status of the PBO for pension
plans and the APBO for other postretirement plans for each of
its plans in the consolidated balance sheets. The actuarial
gains or losses, prior service costs and credits and the
remaining net transition asset or obligation that had not yet
been included in net periodic benefit costs are charged, net of
income tax, to accumulated other comprehensive income (loss).
Net periodic benefit cost is determined using management
estimates and actuarial assumptions to derive service cost,
interest cost, and expected return on plan assets for a
particular year. Net periodic benefit cost also includes the
applicable amortization of any prior service cost (credit)
arising from the increase (decrease) in prior years
benefit costs due to plan amendments or initiation of new plans.
These costs are amortized into net periodic benefit cost over
the expected service years of employees whose benefits are
affected by such plan amendments. Actual experience related to
plan assets
and/or the
benefit obligations may differ from that originally assumed when
determining net periodic benefit cost for a particular period,
resulting in gains or losses. To the extent such aggregate gains
or losses exceed 10 percent of the greater of the benefit
obligations or the market-related asset value of the plans, they
are amortized into net periodic benefit cost over the expected
service years of employees expected to receive benefits under
the plans.
The obligations and expenses associated with these plans require
an extensive use of assumptions such as the discount rate,
expected rate of return on plan assets, rate of future
compensation increases, healthcare cost trend rates, as well as
assumptions regarding participant demographics such as rate and
age of retirements, withdrawal rates and mortality. Management,
in consultation with its external consulting actuarial firms,
determines these assumptions based upon a variety of factors
such as historical performance of the plan and its assets,
currently available market and industry data and expected
benefit payout streams. The assumptions used may differ
materially from actual results due to, among other factors,
changing market and economic conditions and changes in
participant demographics. These differences may have a
significant effect on the Companys consolidated financial
statements and liquidity.
The Subsidiaries also sponsor defined contribution savings and
investment plans (SIP) for substantially all
employees under which a portion of employee contributions is
matched. Applicable matching contributions are made each payroll
period. Accordingly, the Company recognizes compensation cost
for current matching contributions. As all contributions are
transferred currently as earned to the SIP trust, no liability
for matching contributions is recognized in the consolidated
balance sheets.
Stock-Based
Compensation
As more fully described in Note 18, the Company grants
certain employees and directors stock-based compensation awards
under various plans that are subject to specific vesting
conditions. The cost of all stock-based
F-33
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
transactions is measured at fair value at grant date and
recognized over the period during which a grantee is required to
provide goods or services in exchange for the award. Although
the terms of the Companys stock-based plans do not
accelerate vesting upon retirement, or the attainment of
retirement eligibility, the requisite service period subsequent
to attaining such eligibility is considered nonsubstantive.
Accordingly, the Company recognizes compensation expense related
to stock-based awards over the shorter of the requisite service
period or the period to attainment of retirement eligibility. An
estimation of future forfeitures of stock-based awards is
incorporated into the determination of compensation expense when
recognizing expense over the requisite service period.
Foreign
Currency
Assets, liabilities and operations of foreign affiliates and
subsidiaries are recorded based on the functional currency of
each entity. The determination of the functional currency is
made based on the appropriate economic and management
indicators. With the exception of certain foreign operations,
primarily Japan, where multiple functional currencies exist, the
local currencies of foreign operations are the functional
currencies. Assets and liabilities of foreign affiliates and
subsidiaries are translated from the functional currency to
U.S. dollars at the exchange rates in effect at each
year-end and income and expense accounts are translated at the
average rates of exchange prevailing during the year. The
resulting translation adjustments are charged or credited
directly to other comprehensive income or loss, net of
applicable taxes. Gains and losses from foreign currency
transactions, including the effect of re-measurement of monetary
assets and liabilities to the appropriate functional currency,
are reported as part of net investment gains (losses) in the
period in which they occur.
Discontinued
Operations
The results of operations of a component of the Company that
either has been disposed of or is classified as
held-for-sale
are reported in discontinued operations if the operations and
cash flows of the component have been or will be eliminated from
the ongoing operations of the Company as a result of the
disposal transaction and the Company will not have any
significant continuing involvement in the operations of the
component after the disposal transaction.
Earnings
Per Common Share
Basic earnings per common share are computed based on the
weighted average number of common shares, or their equivalent,
outstanding during the period. The difference between the number
of shares assumed issued and number of shares assumed purchased
represents the dilutive shares. Diluted earnings per common
share include the dilutive effect of the assumed:
(i) exercise or issuance of stock-based awards using the
treasury stock method; (ii) settlement of stock purchase
contracts underlying common equity units using the treasury
stock method; and (iii) settlement of accelerated common
stock repurchase contracts. Under the treasury stock method,
exercise or issuance of stock-based awards and settlement of the
stock purchase contracts underlying common equity units is
assumed to occur with the proceeds used to purchase common stock
at the average market price for the period. See Notes 14,
18 and 20.
Litigation
Contingencies
The Company is a party to a number of legal actions and is
involved in a number of regulatory investigations. Given the
inherent unpredictability of these matters, it is difficult to
estimate the impact on the Companys financial position.
Liabilities are established when it is probable that a loss has
been incurred and the amount of the loss can be reasonably
estimated. On a quarterly and annual basis, the Company reviews
relevant information with respect to liabilities for litigation,
regulatory investigations and litigation-related contingencies
to be reflected in the Companys consolidated financial
statements. It is possible that an adverse outcome in certain of
the Companys litigation and regulatory investigations, or
the use of different assumptions in the determination of
F-34
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
amounts recorded, could have a material effect upon the
Companys consolidated net income or cash flows in
particular quarterly or annual periods.
Separate
Accounts
Separate accounts are established in conformity with insurance
laws and are generally not chargeable with liabilities that
arise from any other business of the Company. Separate account
assets are subject to general account claims only to the extent
the value of such assets exceeds the separate account
liabilities. Assets within the Companys separate accounts
primarily include: mutual funds, fixed maturity and equity
securities, mortgage loans, derivatives, hedge funds, other
limited partnership interests, short-term investments and cash
and cash equivalents. The Company reports separately, as assets
and liabilities, investments held in separate accounts and
liabilities of the separate accounts if (i) such separate
accounts are legally recognized; (ii) assets supporting the
contract liabilities are legally insulated from the
Companys general account liabilities;
(iii) investments are directed by the contractholder; and
(iv) all investment performance, net of contract fees and
assessments, is passed through to the contractholder. The
Company reports separate account assets meeting such criteria at
their fair value which is based on the estimated fair values of
the underlying assets comprising the portfolios of an individual
separate account. Investment performance (including investment
income, net investment gains (losses) and changes in unrealized
gains (losses)) and the corresponding amounts credited to
contractholders of such separate accounts are offset within the
same line in the consolidated statements of operations. Separate
accounts credited with a contractual investment return are
combined on a
line-by-line
basis with the Companys general account assets,
liabilities, revenues and expenses and the accounting for these
investments is consistent with the methodologies described
herein for similar financial instruments held within the general
account. Unit-linked separate account investments which are
directed by contractholders but do not meet one or more of the
other above criteria are included in trading and other
securities.
The Companys revenues reflect fees charged to the separate
accounts, including mortality charges, risk charges, policy
administration fees, investment management fees and surrender
charges.
Adoption
of New Accounting Pronouncements
Financial
Instruments
Effective December 31, 2010, the Company adopted new
guidance regarding disclosures about the credit quality of
financing receivables and valuation allowances for credit
losses, including credit quality indicators. Such disclosures
must be disaggregated by portfolio segment or class based on how
a company develops its valuation allowances for credit losses
and how it manages its credit exposure. The Company has provided
all material required disclosures in its consolidated financial
statements. Certain additional disclosures will be required for
reporting periods beginning March 31, 2011 and certain
disclosures relating to troubled debt restructurings have been
deferred indefinitely.
Effective July 1, 2010, the Company adopted new guidance
regarding accounting for embedded credit derivatives within
structured securities. This guidance clarifies the type of
embedded credit derivative that is exempt from embedded
derivative bifurcation requirements. Specifically, embedded
credit derivatives resulting only from subordination of one
financial instrument to another continue to qualify for the
scope exception. Embedded credit derivative features other than
subordination must be analyzed to determine whether they require
bifurcation and separate accounting.
As a result of the adoption of this guidance, the Company
elected FVO for certain structured securities that were
previously accounted for as fixed maturity securities. Upon
adoption, the Company reclassified $50 million of
securities from fixed maturity securities to trading and other
securities. These securities had cumulative unrealized losses of
$10 million, net of income tax, which was recognized as a
cumulative effect adjustment to decrease
F-35
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
retained earnings with a corresponding increase to accumulated
other comprehensive income (loss) as of July 1, 2010.
Effective January 1, 2010, the Company adopted new guidance
related to financial instrument transfers and consolidation of
VIEs. The financial instrument transfer guidance eliminates the
concept of a QSPE, eliminates the guaranteed mortgage
securitization exception, changes the criteria for achieving
sale accounting when transferring a financial asset and changes
the initial recognition of retained beneficial interests. The
new consolidation guidance changes the definition of the primary
beneficiary, as well as the method of determining whether an
entity is a primary beneficiary of a VIE from a quantitative
model to a qualitative model. Under the new qualitative model,
the entity that has both the ability to direct the most
significant activities of the VIE and the obligation to absorb
losses or receive benefits that could be significant to the VIE
is considered to be the primary beneficiary of the VIE. The
guidance requires a quarterly reassessment, as well as enhanced
disclosures, including the effects of a companys
involvement with VIEs on its financial statements.
As a result of the adoption of this guidance, the Company
consolidated certain former QSPEs that were previously accounted
for as fixed maturity CMBS and equity security collateralized
debt obligations. The Company also elected FVO for all of the
consolidated assets and liabilities of these entities. Upon
consolidation, the Company recorded $278 million of
securities classified as trading and other securities,
$6,769 million of commercial mortgage loans and
$6,822 million of long-term debt based on estimated fair
values at January 1, 2010 and de-recognized
$179 million in fixed maturity securities and less than
$1 million in equity securities. The consolidation also
resulted in a decrease in retained earnings of $12 million,
net of income tax, and an increase in accumulated other
comprehensive income (loss) of $42 million, net of income
tax, at January 1, 2010. For the year ended
December 31, 2010, the Company recorded $426 million
of net investment income on the consolidated assets,
$411 million of interest expense in other expenses on the
related long-term debt, and $6 million in net investment
gains (losses) to remeasure the assets and liabilities at their
estimated fair values.
In addition, the Company also deconsolidated certain
partnerships for which the Company does not have the power to
direct activities and for which the Company has concluded it is
no longer the primary beneficiary. These deconsolidations did
not result in a cumulative effect adjustment to retained
earnings and did not have a material impact on the
Companys consolidated financial statements.
Also effective January 1, 2010, the Company adopted new
guidance that indefinitely defers the above changes relating to
the Companys interests in entities that have all the
attributes of an investment company or for which it is industry
practice to apply measurement principles for financial reporting
that are consistent with those applied by an investment company.
As a result of the deferral, the above guidance did not apply to
certain real estate joint ventures and other limited partnership
interests held by the Company.
As more fully described in Summary of Significant
Accounting Policies and Critical Accounting Estimates,
effective April 1, 2009, the Company adopted OTTI guidance.
This guidance amends the previously used methodology for
determining whether an OTTI exists for fixed maturity
securities, changes the presentation of OTTI for fixed maturity
securities and requires additional disclosures for OTTI on fixed
maturity and equity securities in interim and annual financial
statements.
The Companys net cumulative effect adjustment of adopting
the OTTI guidance was an increase of $76 million to
retained earnings with a corresponding increase to accumulated
other comprehensive loss to reclassify the noncredit loss
portion of previously recognized OTTI losses on fixed maturity
securities held at April 1, 2009. This cumulative effect
adjustment was comprised of an increase in the amortized cost
basis of fixed maturity securities of $126 million, net of
policyholder related amounts of $10 million and net of
deferred income taxes of $40 million, resulting in the net
cumulative effect adjustment of $76 million. The increase
in the amortized cost basis of fixed maturity securities of
$126 million by sector was as follows:
$53 million ABS, $43 million
RMBS, $17 million U.S. corporate
securities and $13 million CMBS.
F-36
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
As a result of the adoption of the OTTI guidance, the
Companys pre-tax earnings for the year ended
December 31, 2009 increased by $857 million, offset by
an increase in other comprehensive loss representing OTTI
relating to noncredit losses recognized during the year ended
December 31, 2009.
Effective January 1, 2009, the Company adopted guidance on
disclosures about derivative instruments and hedging. This
guidance requires enhanced qualitative disclosures about
objectives and strategies for using derivatives, quantitative
disclosures about fair value amounts of and gains and losses on
derivative instruments and disclosures about credit risk-related
contingent features in derivative agreements. The Company has
provided all of the material disclosures in its consolidated
financial statements.
The following pronouncements relating to financial instruments
had no material impact on the Companys consolidated
financial statements:
.
|
|
|
|
|
Effective January 1, 2009, the Company adopted
prospectively an update on accounting for transfers of financial
assets and repurchase financing transactions. This update
provides guidance for evaluating whether to account for a
transfer of a financial asset and repurchase financing as a
single transaction or as two separate transactions.
|
.
|
|
|
|
|
Effective December 31, 2008, the Company adopted guidance
on the recognition of interest income and impairment on
purchased beneficial interests and beneficial interests that
continue to be held by a transferor in securitized financial
assets. This new guidance more closely aligns the determination
of whether an OTTI has occurred for a beneficial interest in a
securitized financial asset with the original guidance for fixed
maturity securities classified as
available-for-sale
or
held-to-maturity.
|
.
|
|
|
|
|
Effective January 1, 2008, the Company adopted guidance
relating to application of the shortcut method of accounting for
derivative instruments and hedging activities. This guidance
permits interest rate swaps to have a non-zero fair value at
inception when applying the shortcut method of assessing hedge
effectiveness as long as the difference between the transaction
price (zero) and the fair value (exit price), as defined by
current accounting guidance on fair value measurements, is
solely attributable to a bid-ask spread. In addition, entities
are not precluded from applying the shortcut method of assessing
hedge effectiveness in a hedging relationship of interest rate
risk involving an interest bearing asset or liability in
situations where the hedged item is not recognized for
accounting purposes until settlement date as long as the period
between trade date and settlement date of the hedged item is
consistent with generally established conventions in the
marketplace.
|
.
|
|
|
|
|
Effective January 1, 2008, the Company adopted guidance
that permits a reporting entity to offset fair value amounts
recognized for the right to reclaim cash collateral (a
receivable) or the obligation to return cash collateral (a
payable) against fair value amounts recognized for derivative
instruments executed with the same counterparty under the same
master netting arrangement that have been offset. This guidance
also includes certain terminology modifications. Upon adoption
of this guidance, the Company did not change its accounting
policy of not offsetting fair value amounts recognized for
derivative instruments under master netting arrangements.
|
.
Business
Combinations and Noncontrolling Interests
Effective January 1, 2009, the Company adopted revised
guidance on business combinations and accounting for
noncontrolling interests in the consolidated financial
statements. Under this guidance:
|
|
|
|
|
All business combinations (whether full, partial or
step acquisitions) result in all assets and
liabilities of an acquired business being recorded at fair
value, with limited exceptions.
|
|
|
|
Acquisition costs are generally expensed as incurred;
restructuring costs associated with a business combination are
generally expensed as incurred subsequent to the acquisition
date.
|
F-37
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
The fair value of the purchase price, including the issuance of
equity securities, is determined on the acquisition date.
|
|
|
|
Assets acquired and liabilities assumed in a business
combination that arise from contingencies are recognized at fair
value if the acquisition-date fair value can be reasonably
determined. If the fair value is not estimable, an asset or
liability is recorded if existence or incurrence at the
acquisition date is probable and its amount is reasonably
estimable.
|
|
|
|
Changes in deferred income tax asset valuation allowances and
income tax uncertainties after the acquisition date generally
affect income tax expense.
|
|
|
|
Noncontrolling interests (formerly known as minority
interests) are valued at fair value at the acquisition
date and are presented as equity rather than liabilities.
|
|
|
|
Net income (loss) includes amounts attributable to
noncontrolling interests.
|
|
|
|
When control is attained on previously noncontrolling interests,
the previously held equity interests are remeasured at fair
value and a gain or loss is recognized.
|
|
|
|
Purchases or sales of equity interests that do not result in a
change in control are accounted for as equity transactions.
|
|
|
|
When control is lost in a partial disposition, realized gains or
losses are recorded on equity ownership sold and the remaining
ownership interest is remeasured and holding gains or losses are
recognized.
|
The adoption of this guidance on a prospective basis did not
have an impact on the Companys consolidated financial
statements. Financial statements and disclosures for periods
prior to 2009 reflect the retrospective application of the
accounting for noncontrolling interests as required under this
guidance.
.
Effective January 1, 2009, the Company adopted
prospectively guidance on determination of the useful life of
intangible assets. This guidance amends the factors that should
be considered in developing renewal or extension assumptions
used to determine the useful life of a recognized intangible
asset. This change is intended to improve the consistency
between the useful life of a recognized intangible asset and the
period of expected future cash flows used to measure the fair
value of the asset. The Company determines useful lives and
provides all of the material disclosures prospectively on
intangible assets acquired on or after January 1, 2009 in
accordance with this guidance.
Fair
Value
Effective January 1, 2010, the Company adopted new guidance
that requires new disclosures about significant transfers into
and/or out
of Levels 1 and 2 of the fair value hierarchy and activity
in Level 3. In addition, this guidance provides
clarification of existing disclosure requirements about level of
disaggregation and inputs and valuation techniques. The adoption
of this guidance did not have an impact on the Companys
consolidated financial statements.
Effective January 1, 2008, the Company adopted fair value
measurements guidance which defines fair value, establishes a
consistent framework for measuring fair value, establishes a
fair value hierarchy based on the observability of inputs used
to measure fair value, and requires enhanced disclosures about
fair value measurements and applied this guidance prospectively
to assets and liabilities measured at fair value. The adoption
of this guidance changed the valuation of certain freestanding
derivatives by moving from a mid to bid pricing convention as it
relates to certain volatility inputs, as well as the addition of
liquidity adjustments and adjustments for risks inherent in a
particular input or valuation technique. The adoption of this
guidance also changed the valuation of the Companys
embedded derivatives, most significantly the valuation of
embedded derivatives associated with certain guarantees on
variable annuity contracts. The change in valuation of embedded
derivatives associated with guarantees on annuity contracts
resulted from the incorporation of risk margins associated with
non-capital market inputs and the inclusion of the
Companys nonperformance risk in their valuation. At
January 1, 2008, the impact of
F-38
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
adopting the guidance on assets and liabilities measured at
estimated fair value was $30 million ($19 million, net
of income tax) and was recognized as a change in estimate in the
accompanying consolidated statement of operations where it was
presented in the respective statement of operations caption to
which the item measured at estimated fair value is presented.
There were no significant changes in estimated fair value of
items measured at fair value and reflected in accumulated other
comprehensive income (loss). The addition of risk margins and
the Companys nonperformance risk adjustment in the
valuation of embedded derivatives associated with annuity
contracts may result in significant volatility in the
Companys consolidated net income in future periods. The
Company provided all of the material disclosures in Note 5.
In February 2007, the Financial Accounting Standards Board
(FASB) issued guidance related to the FVO for
financial assets and financial liabilities. This guidance
permits entities the option to measure most financial
instruments and certain other items at fair value at specified
election dates and to recognize related unrealized gains and
losses in earnings. The FVO is applied on an
instrument-by-instrument
basis upon adoption of the standard, upon the acquisition of an
eligible financial asset, financial liability or firm commitment
or when certain specified reconsideration events occur. The fair
value election is an irrevocable election. Effective
January 1, 2008, the Company elected FVO on fixed maturity
and equity securities backing certain pension products sold in
Brazil. Such securities are presented as trading and other
securities in the consolidated balance sheets with subsequent
changes in estimated fair value recognized in net investment
income. Previously, these securities were accounted for as
available-for-sale
securities and unrealized gains and losses on these securities
were recorded as a separate component of accumulated other
comprehensive income (loss). The Companys insurance joint
venture in Japan also elected FVO for certain of its existing
single premium deferred annuities and the assets supporting such
liabilities. FVO was elected to achieve improved reporting of
the asset/liability matching associated with these products.
Adoption of this guidance by the Company and its Japanese joint
venture resulted in an increase in retained earnings of
$27 million, net of income tax, at January 1, 2008.
The election of FVO resulted in the reclassification of
$10 million, net of income tax, of net unrealized gains
from accumulated other comprehensive income (loss) to retained
earnings on January 1, 2008.
The following pronouncements relating to fair value had no
material impact on the Companys consolidated financial
statements:
|
|
|
|
|
Effective September 30, 2008, the Company adopted guidance
relating to the fair value measurements of financial assets when
the market for those assets is not active. It provides guidance
on how a companys internal cash flow and discount rate
assumptions should be considered in the measurement of fair
value when relevant market data does not exist, how observable
market information in an inactive market affects fair value
measurement and how the use of market quotes should be
considered when assessing the relevance of observable and
unobservable data available to measure fair value.
|
.
|
|
|
|
|
Effective January 1, 2009, the Company implemented fair
value measurements guidance for certain nonfinancial assets and
liabilities that are recorded at fair value on a non-recurring
basis. This guidance applies to such items as:
(i) nonfinancial assets and nonfinancial liabilities
initially measured at estimated fair value in a business
combination; (ii) reporting units measured at estimated
fair value in the first step of a goodwill impairment test; and
(iii) indefinite-lived intangible assets measured at
estimated fair value for impairment assessment.
|
.
|
|
|
|
|
Effective January 1, 2009, the Company adopted
prospectively guidance on issuers accounting for
liabilities measured at fair value with a third-party credit
enhancement. This guidance states that an issuer of a liability
with a third-party credit enhancement should not include the
effect of the credit enhancement in the fair value measurement
of the liability. In addition, it requires disclosures about the
existence of any third-party credit enhancement related to
liabilities that are measured at fair value.
|
.
|
|
|
|
|
Effective April 1, 2009, the Company adopted guidance on:
(i) estimating the fair value of an asset or liability if
there was a significant decrease in the volume and level of
trading activity for these assets or
|
F-39
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
liabilities; and (ii) identifying transactions that are not
orderly. The Company has provided all of the material
disclosures in its consolidated financial statements.
|
.
|
|
|
|
|
Effective December 31, 2009, the Company adopted guidance
on: (i) measuring the fair value of investments in certain
entities that calculate NAV per share; (ii) how investments
within its scope would be classified in the fair value
hierarchy; and (iii) enhanced disclosure requirements, for
both interim and annual periods, about the nature and risks of
investments measured at fair value on a recurring or
non-recurring basis.
|
.
|
|
|
|
|
Effective December 31, 2009, the Company adopted guidance
on measuring liabilities at fair value. This guidance provides
clarification for measuring fair value in circumstances in which
a quoted price in an active market for the identical liability
is not available. In such circumstances a company is required to
measure fair value using either a valuation technique that uses:
(i) the quoted price of the identical liability when traded
as an asset; or (ii) quoted prices for similar liabilities
or similar liabilities when traded as assets; or
(iii) another valuation technique that is consistent with
the principles of fair value measurement such as an income
approach (e.g., present value technique) or a market approach
(e.g., entry value technique).
|
.
Defined
Benefit and Other Postretirement Plans
Effective December 31, 2009, the Company adopted guidance
to enhance the transparency surrounding the types of assets and
associated risks in an employers defined benefit pension
or other postretirement benefit plans. This guidance requires an
employer to disclose information about the valuation of plan
assets similar to that required under other fair value
disclosure guidance. The Company provided all of the material
disclosures in its consolidated financial statements.
.
Other
Pronouncements
Effective April 1, 2009, the Company adopted prospectively
guidance which establishes general standards for accounting and
disclosures of events that occur subsequent to the balance sheet
date but before financial statements are issued or available to
be issued. The Company has provided all of the material
disclosures in its consolidated financial statements.
The following pronouncements had no material impact on the
Companys consolidated financial statements:
.
|
|
|
|
|
Effective January 1, 2009, the Company adopted guidance on
determining whether an instrument (or embedded feature) is
indexed to an entitys own stock. This guidance provides a
framework for evaluating the terms of a particular instrument
and whether such terms qualify the instrument as being indexed
to an entitys own stock.
|
.
|
|
|
|
|
Effective January 1, 2008, the Company adopted guidance on
written loan commitments recorded at fair value through
earnings. It provides guidance on (i) incorporating
expected net future cash flows when related to the associated
servicing of a loan when measuring fair value; and
(ii) broadening the U.S. Securities and Exchange
Commission (SEC) staffs view that
internally-developed intangible assets should not be recorded as
part of the fair value of a derivative loan commitment or to
written loan commitments that are accounted for at fair value
through earnings. Internally-developed intangible assets are not
considered a component of the related instruments.
|
.
|
|
|
|
|
Effective January 1, 2008, the Company prospectively
adopted guidance on the sale of real estate when the agreement
includes a buy-sell clause. This guidance addresses whether the
existence of a buy-sell arrangement would preclude partial sales
treatment when real estate is sold to a jointly owned entity and
concludes that the existence of a buy-sell clause does not
necessarily preclude partial sale treatment under current
guidance.
|
F-40
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Future
Adoption of New Accounting Pronouncements
In December 2010, the FASB issued new guidance addressing when a
business combination should be assumed to have occurred for the
purpose of providing pro forma disclosure (Accounting Standards
Update (ASU)
2010-29,
Business Combinations (Topic 805): Disclosure of
Supplementary Pro Forma Information for Business
Combinations). Under the new guidance, if an entity presents
comparative financial statements, the entity should disclose
revenue and earnings of the combined entity as though the
business combination that occurred during the current year had
occurred as of the beginning of the comparable prior annual
reporting period. The guidance also expands the supplemental pro
forma disclosures to include additional narratives. The guidance
is effective for fiscal years beginning on or after
December 15, 2010. The Company will apply the guidance
prospectively on its accounting for future acquisitions and does
not expect the adoption of this guidance to have a material
impact on the Companys consolidated financial statements.
In December 2010, the FASB issued new guidance regarding
goodwill impairment testing (ASU
2010-28,
Intangibles Goodwill and Other (Topic 350): When
to Perform Step 2 of the Goodwill Impairment Test for Reporting
Units with Zero or Negative Carrying Amounts). This guidance
modifies Step 1 of the goodwill impairment test for reporting
units with zero or negative carrying amounts. For those
reporting units, an entity would be required to perform Step 2
of the test if qualitative factors indicate that it is more
likely than not that goodwill impairment exists. The guidance is
effective for the first quarter of 2011. The Company does not
expect the adoption of this new guidance to have a material
impact on its consolidated financial statements.
In October 2010, the FASB issued new guidance regarding
accounting for deferred acquisition costs
(ASU 2010-26,
Accounting for Costs Associated with Acquiring or Renewing
Insurance Contracts) effective for the first quarter of
2012. This guidance clarifies the costs that should be deferred
by insurance entities when issuing and renewing insurance
contracts. The guidance also specifies that only costs related
directly to successful acquisition of new or renewal contracts
can be capitalized. All other acquisition-related costs should
be expensed as incurred. The Company is currently evaluating the
impact of this guidance on its consolidated financial statements.
In April 2010, the FASB issued new guidance regarding accounting
for investment funds determined to be VIEs (ASU
2010-15,
How Investments Held through Separate Accounts Affect an
Insurers Consolidation Analysis of Those Investments).
Under this guidance, an insurance entity would not be required
to consolidate a voting-interest investment fund when it holds
the majority of the voting interests of the fund through its
separate accounts. In addition, an insurance entity would not
consider the interests held through separate accounts for the
benefit of policyholders in the insurers evaluation of its
economics in a VIE, unless the separate account contractholder
is a related party. The guidance is effective for the first
quarter of 2011. The Company does not expect the adoption of
this new guidance to have a material impact on its consolidated
financial statements.
|
|
2.
|
Acquisitions
and Dispositions
|
2010
Acquisition of ALICO
Description
of Transaction
On the Acquisition Date, MetLife, Inc. acquired all of the
issued and outstanding capital stock of American Life from ALICO
Holdings, a subsidiary of AIG, and DelAm from AIG for a total
purchase price of $16.4 billion, which consisted of
(i) cash of $7.2 billion (includes settlement of
intercompany balances and certain other adjustments), and
(ii) securities of MetLife, Inc. valued at
$9.2 billion.
The $7.2 billion cash portion of the purchase price was
funded through the issuance of common stock as described in
Note 18, fixed and floating rate senior debt as described
in Note 11 as well as cash on hand. The securities issued
to ALICO Holdings included (a) 78,239,712 shares of
MetLife, Inc.s common stock;
(b) 6,857,000 shares of Series B Contingent
Convertible Junior Participating Non-Cumulative Perpetual
Preferred Stock (the Convertible Preferred Stock) of
MetLife, Inc.; and (c) 40 million common equity units
F-41
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
of MetLife, Inc. (the Equity Units) with an
aggregate stated amount at issuance of $3.0 billion,
initially consisting of (i) three purchase contracts (the
Series C Purchase Contracts, the
Series D Purchase Contracts and the
Series E Purchase Contracts and, together, the
Purchase Contracts), obligating the holder to
purchase, on specified future settlement dates, a variable
number of shares of MetLife, Inc.s common stock for a
fixed price; and (ii) an interest in each of three series
of debt securities (the Series C Debt
Securities, the Series D Debt Securities
and the Series E Debt Securities, and,
together, the Debt Securities) issued by MetLife,
Inc. Distributions on the Equity Units will be made quarterly,
through contract payments on the Purchase Contracts and interest
payments on the Debt Securities, initially at an aggregate
annual rate of 5.00% (an average annual rate of 3.02% on the
Purchase Contracts and an average annual rate of 1.98% on the
Debt Securities) as described in Note 14.
ALICO is an international life insurance company, providing
consumers and businesses with products and services for life
insurance, accident and health insurance, retirement and wealth
management solutions in 54 countries. The Acquisition will
significantly broaden the Companys diversification by
product, distribution and geography, meaningfully accelerate
MetLifes global growth strategy, and create the
opportunity to build an international franchise leveraging the
key strengths of ALICO. ALICOs largest international
market is Japan. As of December 31, 2010, the Japan
operations total assets represented approximately 12% of
the Companys total assets.
Fair
Value and Allocation of Purchase Price
The computation of total purchase consideration and the amounts
recognized for each major class of assets acquired and
liabilities assumed, based upon their respective fair values at
the Acquisition Date, and the resulting goodwill, are presented
below:
|
|
|
|
|
|
|
November 1, 2010
|
|
|
|
(In millions)
|
|
|
Cash
|
|
$
|
6,800
|
|
MetLife, Inc.s common stock (78,239,712 shares) (1)
|
|
|
3,200
|
|
MetLife, Inc.s Convertible Preferred Stock (1),(2)
|
|
|
2,805
|
|
MetLife, Inc.s Equity Units ($3.0 billion aggregate
stated amount) (3)
|
|
|
3,189
|
|
|
|
|
|
|
Total cash paid and securities issued to ALICO Holdings
|
|
$
|
15,994
|
|
Contractual purchase price adjustments (4)
|
|
|
396
|
|
|
|
|
|
|
Total purchase price
|
|
$
|
16,390
|
|
Effective settlement of pre-existing relationships (5)
|
|
|
(186
|
)
|
Contingent consideration (6)
|
|
|
88
|
|
|
|
|
|
|
Total purchase consideration for ALICO
|
|
$
|
16,292
|
|
|
|
|
|
|
|
|
|
(1) |
|
Fair value is based on the opening price of MetLife, Inc.s
common stock of $40.90 on the New York Stock Exchange
(NYSE) on November 1, 2010. |
|
(2) |
|
Convertible into 68,570,000 shares of MetLife, Inc.s
common stock upon a favorable vote of MetLife, Inc.s
common stockholders before the first anniversary of the
Acquisition Date. See Note 18. |
|
(3) |
|
The Equity Units include the Debt Securities and the Purchase
Contracts that will settle in MetLife, Inc.s common stock
on specified future dates. See Note 14. |
|
(4) |
|
Relates to the cash settlement of intercompany balances prior to
the Acquisition for amounts in excess of certain
agreed-upon
thresholds and certain other adjustments. |
F-42
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
(5) |
|
Effective settlement of debt securities issued by MetLife, Inc.
that are owned by ALICO and reduces the total purchase
consideration. |
|
(6) |
|
Estimated fair value of potential payments related to the
adequacy of reserves for guarantees on the fair value of a fund
of assets backing certain United Kingdom (U.K.)
unit-linked contracts. |
The aggregate amount of MetLife, Inc.s common stock to be
issued to ALICO Holdings in connection with the transaction is
expected to be between 214.6 million to 231.5 million
shares, consisting of 78.2 million shares issued at
closing, 68.6 million shares to be issued upon conversion
of the Convertible Preferred Stock and between 67.8 million
and 84.7 million shares of common stock, in total, issuable
upon settlement of the Purchase Contracts forming part of the
Equity Units. See Note 14. The ownership of the shares
issued to ALICO Holdings is subject to an investor rights
agreement, which grants to ALICO Holdings certain rights and
sets forth certain agreements with respect to ALICO
Holdings ownership of, voting on and transfer of the
shares, including minimum holding periods and restrictions on
the number of shares ALICO Holdings can sell at one time.
Recording
of Assets Acquired and Liabilities Assumed
The following table summarizes the amounts recognized at fair
value for each major class of assets acquired and liabilities
assumed and the resulting goodwill as of the Acquisition Date.
|
|
|
|
|
|
|
November 1, 2010
|
|
|
|
(In millions)
|
|
|
Assets acquired:
|
|
|
|
|
Total investments
|
|
$
|
101,036
|
|
Cash and cash equivalents
|
|
|
4,175
|
|
Accrued investment income
|
|
|
948
|
|
Premiums, reinsurance and other receivables
|
|
|
1,971
|
|
VOBA
|
|
|
9,210
|
|
Other assets
|
|
|
1,146
|
|
Separate account assets
|
|
|
244
|
|
|
|
|
|
|
Total assets
|
|
$
|
118,730
|
|
|
|
|
|
|
Liabilities assumed:
|
|
|
|
|
Future policy benefits
|
|
$
|
31,811
|
|
Policyholder account balances
|
|
|
66,652
|
|
Other policy-related balances
|
|
|
7,306
|
|
Current and deferred income tax liability
|
|
|
336
|
|
Other liabilities
|
|
|
2,918
|
|
Separate account liabilities
|
|
|
244
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
109,267
|
|
|
|
|
|
|
Redeemable noncontrolling interests in partially owned
consolidated subsidiaries assumed
|
|
$
|
109
|
|
|
|
|
|
|
Noncontrolling interests
|
|
|
(21
|
)
|
Goodwill
|
|
|
6,959
|
|
|
|
|
|
|
Net assets acquired
|
|
$
|
16,292
|
|
|
|
|
|
|
F-43
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Goodwill
Goodwill is calculated as the excess of the consideration
transferred over the net assets recognized and represents the
future economic benefits arising from other assets acquired and
liabilities assumed that could not be individually identified.
The goodwill recorded as part of the Acquisition includes the
expected synergies and other benefits that management believes
will result from combining the operations of ALICO with the
operations of MetLife, including further diversification in
geographic mix and product offerings and an increase in
distribution strength.
Of the $7.0 billion of goodwill, approximately
$4.0 billion is estimated to be deductible for tax
purposes. Of the $4.0 billion, approximately
$573 million is estimated to be deductible for
U.S. tax purposes prior to the completion of the
anticipated restructuring of American Lifes foreign
branches. See Branch Restructuring. The
goodwill resulting from the Acquisition was presented within the
Companys International segment.
Identified
Intangibles
VOBA reflects the estimated fair value of in-force contracts
acquired and represents the portion of the purchase price that
is allocated to the value of future profits embedded in acquired
insurance annuity and investment-type contracts in-force at the
Acquisition Date.
The value of VODA and VOCRA, included in other assets, reflects
the estimated fair value of ALICOs distribution agreements
and customer relationships acquired at November 1, 2010 and
will be amortized over the useful lives. Each year the Company
will review VODA and VOCRA to determine the recoverability of
these balances.
The use of discount rates was necessary to establish the fair
value of VOBA and the identifiable intangibles. In selecting the
appropriate discount rates, management considered its weighted
average cost of capital, as well as the weighted average cost of
capital required by market participants. The fair value of
acquired liabilities was determined using risk free rates
adjusted for a nonperformance risk premium. The nonperformance
adjustment was determined by taking into consideration publicly
available information relating to spreads in the secondary
market for the Holding Companys debt, including related
credit default swaps. These observable spreads were then
adjusted to reflect the priority of these liabilities, the
claims paying ability of the insurance subsidiaries compared to
the Holding Company and, as necessary, the relative credit
spreads of the liabilities currencies of denomination as
compared to USD spreads.
The fair values of business acquired, distribution agreements
and customer relationships and the weighted average amortization
periods are as follows as of November 1, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
November 1, 2010
|
|
|
Amortization Period
|
|
|
|
(In millions)
|
|
|
(In years)
|
|
|
VOBA
|
|
$
|
9,210
|
|
|
|
8.2
|
|
VODA and VOCRA
|
|
|
341
|
|
|
|
10.3
|
|
|
|
|
|
|
|
|
|
|
Total value of amortizable intangible assets acquired
|
|
$
|
9,551
|
|
|
|
8.6
|
|
|
|
|
|
|
|
|
|
|
The estimated future amortization expense allocated to other
expenses for the next five years for VOBA, VODA and VOCRA is
$1,312 million in 2011, $1,076 million in 2012,
$884 million in 2013, $759 million in 2014 and
$653 million in 2015.
For certain acquired blocks of business, the estimated fair
value of acquired liabilities exceeded the initial policy
reserves assumed at November 1, 2010, resulting in a
negative VOBA of $4.4 billion recorded at the Acquisition
Date. Negative VOBA is recorded in other policy-related
balances. The fair value of the in-force contract obligations
was based on actuarially determined projections for each block
of business. Negative VOBA is amortized over the policy period
in proportion to premiums or the approximate consumption of
losses included in the liability usually expressed in terms of
insurance in-force or account value. Such amortization is
recorded as a contra-expense in other expenses.
F-44
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Trademark
Assets
In connection with the Acquisition, the Company recognized
$47 million in trademark assets recorded in other assets.
The fair value of the trademark assets will be recognized
ratably over their expected useful lives which is generally
between five to ten years.
Indemnification
Assets and Contingent Consideration
The stock purchase agreement dated as of March 7, 2010, as
amended by and among MetLife, Inc., AIG and ALICO Holdings (the
Stock Purchase Agreement) and related agreements
include indemnification provisions that allocate the risk of
losses arising out of contingencies or other uncertainties that
existed as of the Acquisition Date in accordance with the terms,
and subject to the limitations and procedures, provided by such
provisions. As applicable, the Company recognizes an
indemnification asset at the same time that it recognizes the
indemnified item, measured on the same basis as the indemnified
item. The Company recognized the following indemnification
assets and contingencies as of the Acquisition Date in
accordance with the indemnification provisions of the Stock
Purchase Agreement and related agreements:
Investments The Company established
indemnification assets for the fair value of amounts expected to
be recovered from defaults of certain fixed maturity securities,
CMBS and mortgage loans. These indemnification assets are
included in other invested assets at December 31, 2010.
Litigation The Company established
indemnification assets associated with certain settlements
expected to be made in connection with the suspension of
withdrawals from certain unit-linked funds offered to certain
policyholders. These indemnification assets are included in
other assets at December 31, 2010.
Section 338 Elections MetLife, Inc. and
American Life will be fully indemnified by ALICO Holdings for
all taxes and any interest and penalties resulting from
anticipated elections to be made with respect to American Life
and its subsidiaries under Section 338(h)(10) and
Section 338(g) of the Code. This indemnification asset is
included in premiums, reinsurance and other receivables at
December 31, 2010.
The Company recognized an aggregate amount of $574 million
for indemnification assets as of the Acquisition Date in
accordance with the indemnification provisions of the Stock
Purchase Agreement and related agreements.
Contingent Consideration American Life has
guaranteed that the fair value of a fund of assets backing
certain U.K. unit-linked contracts will have a value of at least
£1 per unit on July 1, 2012. In accordance with the
provisions of the Stock Purchase Agreement if the shortfall
between the aggregate guaranteed amount and the fair value of
the fund exceeds £106 million AIG will pay the
difference to American Life and conversely, if the shortfall at
July 1, 2012 is less than £106 million ALICO will
pay the difference to AIG. The Company believes that the fair
value of the fund will equal or exceed the guaranteed amount by
July 1, 2012. Therefore, the Company recognized a
contingent consideration liability in the amount of
$88 million as of the Acquisition Date which was included
as additional purchase consideration in determining the amount
paid for ALICO.
Indemnification
Collateral
ALICO Holdings may satisfy certain of its indemnification and
other payment obligations by delivering cash, shares of stock or
Equity Units issued by MetLife, Inc. in connection with the
Acquisition. The Equity Units were deposited into an
indemnification collateral account on the Acquisition Date as
security for these obligations. This collateral will be released
periodically over a
30-month
period on each of the
12-month,
24-month and
30-month
anniversaries of the Acquisition Date as follows: Equity Units
with an aggregate stated amount of $1.0 billion (or such
amount of net cash proceeds from the sale of Equity Units or
other eligible collateral equal to such stated amount), less, on
each such release date, specified reserve amounts, including,
but not limited to, amounts
F-45
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
necessary to satisfy then outstanding indemnification claims
made by MetLife, Inc. However, if an AIG bankruptcy event
occurs, any then remaining indemnification collateral will
remain in the indemnification collateral account and will be
released in part on each of the
30-month,
36-month and
48-month
anniversaries of the Acquisition Date, less, on each such
release date, any such specified reserved amounts.
Branch
Restructuring
On March 4, 2010, American Life entered into a closing
agreement (the Closing Agreement) with the
Commissioner of the IRS with respect to a U.S. withholding
tax issue arising as a result of payments made by its foreign
branches. The Closing Agreement provides that American
Lifes foreign branches will not be required to withhold
U.S. income tax on the income portion of payments made
pursuant to American Lifes life insurance and annuity
contracts (Covered Payments) for any tax periods
beginning on January 1, 2005 and ending on
December 31, 2013 (the Deferral Period). The
Closing Agreement requires that American Life submit a plan to
the IRS within 90 days after the close of the Acquisition,
indicating the steps American Life will take (on a country by
country basis) to ensure that no substantial amount of
U.S. withholding tax will arise from Covered Payments made
by American Lifes foreign branches to foreign customers
after the Deferral Period. Such plan, which was submitted to the
Internal Revenue Service (IRS) on January 29,
2011, involves the transfer of businesses from certain of the
foreign branches of American Life to one or more existing or
newly-formed subsidiaries of MetLife, Inc. or American Life.
A liability of $277 million was recognized in purchase
accounting as of November 1, 2010, for the anticipated and
estimated costs associated with restructuring American
Lifes foreign branches into subsidiaries in connection
with the Closing Agreement.
Current
and Deferred Income Tax
The future tax effects of temporary differences between
financial reporting and tax bases of assets and liabilities are
measured at the balance sheet dates and are recorded as deferred
income tax assets and liabilities, with certain exceptions such
as certain temporary differences relating to goodwill under
purchase accounting.
For federal income tax purposes, MetLife, Inc. and ALICO
Holdings are expected to make Section 338 elections with
respect to American Life and certain of its subsidiaries. In
addition, MetLife, Inc. and AIG are expected to make a
Section 338 election with respect to DelAm. Under such
elections, the U.S. tax basis of the assets deemed acquired
and liabilities assumed of ALICO were adjusted as of the
Acquisition Date to reflect the consequences of the
Section 338 elections.
The reversal of temporary differences (between financial
reporting and U.S. tax bases of assets and liabilities) of
American Lifes foreign branches, post-branch
restructuring, in connection with the Closing Agreement (i.e.,
generally, after the end of the Deferral Period) is not expected
to result in any direct U.S. tax effect. Thus, as of
November 1, 2010, American Life reduced its net deferred
tax asset of $425 million by $671 million that
reflects the amount of U.S. deferred tax asset that is expected
to reverse post-branch restructuring. Therefore, American Life
recognized a U.S. net deferred tax liability of
approximately $246 million in purchase accounting.
As of the Acquisition Date, ALICOs current and deferred
income tax liabilities are provisional and not yet finalized.
Current income taxes may be adjusted pending the resolution of
the tax value of MetLife, Inc. securities delivered to ALICO
Holdings as part of the purchase consideration on the
Acquisition Date, the amount of taxes resulting from the
Section 338 elections and the filing of income tax returns.
Deferred income taxes may be adjusted as a result of changes in
estimates and assumptions relating to the reversal of
U.S. temporary differences prior to the completion of the
anticipated restructuring of American Lifes foreign
branches, the filing of income tax returns and as additional
information becomes available during the measurement period. We
expect to finalize these amounts as soon as possible but no
later than one year from the Acquisition Date.
F-46
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Revenues
and Earnings of ALICO
The following table presents information for ALICO that is
included in the Companys consolidated statement of
operations from the Acquisition Date through November 30,
2010:
|
|
|
|
|
|
|
ALICOs Operations
|
|
|
Included in MetLifes
|
|
|
Results for the
|
|
|
Year Ended December 31, 2010
|
|
|
(In millions)
|
|
Total revenues
|
|
$
|
950
|
|
Income (loss) from continuing operations, net of income tax
|
|
$
|
(2
|
)
|
Supplemental
Pro Forma Information (unaudited)
The following table presents unaudited supplemental pro forma
information as if the Acquisition had occurred on
January 1, 2010 for the year ended December 31, 2010
and on January 1, 2009 for the year ended December 31,
2009.
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions, except
|
|
|
|
per share data)
|
|
|
Total revenues
|
|
$
|
64,680
|
|
|
$
|
54,282
|
|
Income (loss) from continuing operations, net of income tax,
attributable to common shareholders
|
|
$
|
3,888
|
|
|
$
|
(1,353
|
)
|
Income (loss) from continuing operations, net of income tax,
attributable to common shareholders per common share:
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
3.60
|
|
|
$
|
(1.29
|
)
|
Diluted
|
|
$
|
3.57
|
|
|
$
|
(1.29
|
)
|
The pro forma information was derived from the historical
financial information of MetLife and ALICO, reflecting the
results of operations of MetLife and ALICO for 2010 and 2009.
The historical financial information has been adjusted to give
effect to the pro forma events that are directly attributable to
the Acquisition and factually supportable and expected to have a
continuing impact on the combined results. Discontinued
operations and the related earnings per share have been excluded
from the presentation as they are non-recurring in nature. The
pro forma information is not intended to reflect the results of
operations of the combined company that would have resulted had
the Acquisition been effective during the periods presented or
the results that may be obtained by the combined company in the
future. The pro forma information does not reflect future events
that may occur after the Acquisition, including, but not limited
to, expense efficiencies or revenue enhancements arising from
the Acquisition and also does not give effect to certain
one-time charges that MetLife expects to incur such as
restructuring and integration costs.
The pro forma information primarily reflects the following pro
forma adjustments:
|
|
|
|
|
reduction in net investment income to reflect the amortization
or accretion associated with the new cost basis of the acquired
fixed maturities
available-for-sale
portfolio;
|
|
|
|
elimination of amortization associated with the elimination of
ALICOs historical DAC;
|
|
|
|
amortization of VOBA, VODA and VOCRA associated with the
establishment of VOBA, VODA and VOCRA arising from the
Acquisition;
|
|
|
|
reduction in other expenses associated with the amortization of
negative VOBA;
|
|
|
|
reduction in revenues associated with the elimination of
ALICOs historical unearned revenue liability;
|
F-47
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
interest expense associated with the issuance of the Debt
Securities to ALICO Holdings and the public issuance of senior
notes in connection with the financing of the Acquisition;
|
|
|
|
certain adjustments to conform to MetLifes accounting
policies; and
|
|
|
|
reversal of investment and derivative gains (losses) associated
with certain transactions that were completed prior to the
Acquisition Date (conditions of closing).
|
Costs
Related to Acquisition
Transaction and Integration-Related
Expenses. The Company incurred $100 million
of transaction costs for the year ended December 31, 2010.
Transaction costs represent costs directly related to effecting
the Acquisition and primarily include banking and legal
expenses. Such costs have been expensed as incurred and are
included in other expenses. These expenses have been reported
within Banking, Corporate & Other.
Integration-related expenses incurred for the year ended
December 31, 2010 and included in other expenses were
$176 million. Integration costs represent incremental costs
directly related to integrating ALICO, including expenses for
consulting, rebranding and the integration of information
systems. As the integration of ALICO is an enterprise-wide
initiative, these expenses have been reported within Banking,
Corporate & Other.
Restructuring Costs and Other Charges. As part
of the integration of ALICOs operations, management has
initiated restructuring plans focused on increasing productivity
and improving the efficiency of the Companys operations.
For the year ended December 31, 2010, the Company
recognized a severance-related restructuring charge of
$4 million associated with the termination of certain
employees in connection with this initiative which were
reflected within other expenses. The Company did not make any
cash payments related to these severance costs as of
December 31, 2010.
Estimated restructuring costs may change as management continues
to execute its restructuring plans. Management anticipates
further restructuring charges including severance, contract
termination costs and other associated costs through the year
ended December 31, 2011. However, such restructuring plans
are not sufficiently developed to enable the Company to make an
estimate of such restructuring charges at December 31, 2010.
2010
Pending Disposition
In October 2010, the Company and its joint venture partner,
MS&AD Insurance Group Holdings, Inc.
(MS&AD), reached an agreement under which the
Company intends to sell its 50% interest in Mitsui Sumitomo
MetLife Insurance Co., Ltd. (MSI MetLife), a Japan
domiciled life insurance company, to MS&AD for
approximately $275 million
(¥22.5 billion). During the year ended
December 31, 2010, the Company recorded an investment loss
of $136 million, net of income tax, to record its
investment in MSI MetLife at its estimated recoverable amount.
It is anticipated that the sale will close on or about
April 1, 2011, subject to customary closing conditions,
including obtaining required regulatory approvals.
2009
Disposition
In March 2009, the Company sold Cova Corporation
(Cova), the parent company of Texas Life Insurance
Company (Texas Life) to a third-party for
$130 million in cash consideration, excluding
$1 million of transaction costs. The net assets sold were
$101 million, resulting in a gain on disposal of
$28 million, net of income tax. The Company also
reclassified $4 million, net of income tax, of the 2009
operations of Texas Life into discontinued operations in the
consolidated financial statements. As a result, the Company
recognized income from discontinued operations of
$32 million, net of income tax, during the year ended
December 31, 2009. See Note 23.
F-48
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
2009
Disposition through Assumption Reinsurance
On October 30, 2009, the Company completed the disposal,
through assumption reinsurance, of substantially all of the
insurance business of MetLife Canada, a wholly-owned indirect
subsidiary, to a third-party. Pursuant to the assumption
reinsurance agreement, the consideration paid by the Company was
$259 million, comprised of cash of $14 million and
fixed maturity securities, mortgage loans and other assets
totaling $245 million. At the date of the assumption
reinsurance agreement, the carrying value of insurance
liabilities transferred was $267 million, resulting in a
gain of $5 million, net of income tax. The gain was
recognized in net investment gains (losses).
2008
Acquisitions and Disposition
During 2008, the Company made five acquisitions for
$783 million. As a result of these acquisitions,
MetLifes Insurance Products segment increased its product
offering of dental and vision benefit plans, MetLife Bank,
National Association (MetLife Bank) within Banking,
Corporate & Other entered the mortgage origination and
servicing business and the International segment increased its
presence in Mexico and Brazil. The acquisitions were each
accounted for using the purchase method of accounting and,
accordingly, commenced being included in the operating results
of the Company upon their respective closing dates. Total
consideration paid by the Company for these acquisitions
consisted of $763 million in cash and $20 million in
transaction costs. The net fair value of assets acquired and
liabilities assumed totaled $527 million, resulting in
goodwill of $256 million. Goodwill increased by
$122 million, $73 million and $61 million in the
International segment, Insurance Products segment and Banking,
Corporate & Other, respectively. The goodwill is
deductible for tax purposes. VOCRA, VOBA and other intangibles
increased by $137 million, $7 million and
$6 million, respectively, as a result of these
acquisitions. Further information on VOBA, goodwill and VOCRA is
provided in Notes 6, 7 and 8, respectively.
In September 2008, the Company completed a tax-free split-off of
its majority-owned subsidiary, Reinsurance Group of America,
Incorporated (RGA). The Company and RGA entered into
a recapitalization and distribution agreement, pursuant to which
the Company agreed to divest substantially all of its 52%
interest in RGA to the Companys stockholders. The
split-off was effected through the following:
|
|
|
|
|
A recapitalization of RGA common stock into two classes of
common stock RGA Class A common stock and RGA
Class B common stock. Pursuant to the terms of the
recapitalization, each outstanding share of RGA common stock,
including the 32,243,539 shares of RGA common stock
beneficially owned by the Company and its subsidiaries, was
reclassified as one share of RGA Class A common stock.
Immediately thereafter, the Company and its subsidiaries
exchanged 29,243,539 shares of its RGA Class A common
stock which represented all of the RGA Class A
common stock beneficially owned by the Company and its
subsidiaries other than 3,000,000 shares of RGA
Class A common stock with RGA for
29,243,539 shares of RGA Class B common stock.
|
|
|
|
An exchange offer, pursuant to which the Company offered to
acquire MetLife common stock from its stockholders in exchange
for all of its 29,243,539 shares of RGA Class B common
stock. The exchange ratio was determined based upon a ratio of
the value of the MetLife and RGA shares during the
three-day
period prior to the closing of the exchange offer. The
3,000,000 shares of the RGA Class A common stock were
not subject to the tax-free exchange.
|
As a result of completion of the recapitalization and exchange
offer, the Company received from MetLife stockholders
23,093,689 shares of the Holding Companys common
stock with a market value of $1,318 million and, in
exchange, delivered 29,243,539 shares of RGAs
Class B common stock with a net book value of
$1,716 million. The resulting loss on disposition,
inclusive of transaction costs of $60 million, was
$458 million. During the third quarter of 2009, the Company
incurred $2 million, net of income tax, of additional costs
related to this split-off. The 3,000,000 shares of RGA
Class A common stock retained by the Company are marketable
equity securities which do not constitute significant continuing
involvement in the operations of RGA; accordingly, they were
classified within equity securities in the consolidated
financial statements of the Company at a cost basis of
F-49
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
$157 million which is equivalent to the net book value of
the shares. The equity securities have been recorded at fair
value at each subsequent reporting date. The Company agreed to
dispose of the remaining shares of RGA within the next five
years. In connection with the Companys agreement to
dispose of the remaining shares, the Company also recognized, in
its provision for income tax on continuing operations, a
deferred tax liability of $16 million which represents the
difference between the book and taxable basis of the remaining
investment in RGA. On February 15, 2011, the Company sold to RGA
such remaining shares. The impact of the disposition of the
Companys investment in RGA was reflected in the
Companys consolidated financial statements as discontinued
operations. See Note 23.
Fixed
Maturity and Equity Securities
Available-for-Sale
The following tables present the cost or amortized cost, gross
unrealized gain and loss, estimated fair value of the
Companys fixed maturity and equity securities and the
percentage that each sector represents by the respective total
holdings for the periods shown. The unrealized loss amounts
presented below include the noncredit loss component of OTTI
loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
Cost or
|
|
|
Gross Unrealized
|
|
|
Estimated
|
|
|
|
|
|
|
Amortized
|
|
|
|
|
|
Temporary
|
|
|
OTTI
|
|
|
Fair
|
|
|
% of
|
|
|
|
Cost
|
|
|
Gain
|
|
|
Loss
|
|
|
Loss
|
|
|
Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Fixed Maturity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
89,713
|
|
|
$
|
4,486
|
|
|
$
|
1,631
|
|
|
$
|
|
|
|
$
|
92,568
|
|
|
|
28.3
|
%
|
Foreign corporate securities
|
|
|
65,784
|
|
|
|
3,333
|
|
|
|
939
|
|
|
|
|
|
|
|
68,178
|
|
|
|
20.8
|
|
RMBS
|
|
|
44,468
|
|
|
|
1,652
|
|
|
|
917
|
|
|
|
470
|
|
|
|
44,733
|
|
|
|
13.7
|
|
Foreign government securities
|
|
|
42,154
|
|
|
|
1,856
|
|
|
|
610
|
|
|
|
|
|
|
|
43,400
|
|
|
|
13.2
|
|
U.S. Treasury, agency and government guaranteed securities (1)
|
|
|
32,469
|
|
|
|
1,394
|
|
|
|
559
|
|
|
|
|
|
|
|
33,304
|
|
|
|
10.2
|
|
CMBS
|
|
|
20,213
|
|
|
|
740
|
|
|
|
266
|
|
|
|
12
|
|
|
|
20,675
|
|
|
|
6.3
|
|
ABS
|
|
|
14,725
|
|
|
|
274
|
|
|
|
590
|
|
|
|
119
|
|
|
|
14,290
|
|
|
|
4.4
|
|
State and political subdivision securities
|
|
|
10,476
|
|
|
|
171
|
|
|
|
518
|
|
|
|
|
|
|
|
10,129
|
|
|
|
3.1
|
|
Other fixed maturity securities
|
|
|
6
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities (2), (3)
|
|
$
|
320,008
|
|
|
$
|
13,907
|
|
|
$
|
6,030
|
|
|
$
|
601
|
|
|
$
|
327,284
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
2,060
|
|
|
$
|
146
|
|
|
$
|
12
|
|
|
$
|
|
|
|
$
|
2,194
|
|
|
|
60.8
|
%
|
Non-redeemable preferred stock (2)
|
|
|
1,565
|
|
|
|
76
|
|
|
|
229
|
|
|
|
|
|
|
|
1,412
|
|
|
|
39.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities (4)
|
|
$
|
3,625
|
|
|
$
|
222
|
|
|
$
|
241
|
|
|
$
|
|
|
|
$
|
3,606
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-50
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
|
Cost or
|
|
|
Gross Unrealized
|
|
|
Estimated
|
|
|
|
|
|
|
Amortized
|
|
|
|
|
|
Temporary
|
|
|
OTTI
|
|
|
Fair
|
|
|
% of
|
|
|
|
Cost
|
|
|
Gain
|
|
|
Loss
|
|
|
Loss
|
|
|
Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Fixed Maturity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
72,075
|
|
|
$
|
2,821
|
|
|
$
|
2,699
|
|
|
$
|
10
|
|
|
$
|
72,187
|
|
|
|
31.7
|
%
|
Foreign corporate securities
|
|
|
37,254
|
|
|
|
2,011
|
|
|
|
1,226
|
|
|
|
9
|
|
|
|
38,030
|
|
|
|
16.7
|
|
RMBS
|
|
|
45,343
|
|
|
|
1,234
|
|
|
|
1,957
|
|
|
|
600
|
|
|
|
44,020
|
|
|
|
19.3
|
|
Foreign government securities
|
|
|
11,010
|
|
|
|
1,076
|
|
|
|
139
|
|
|
|
|
|
|
|
11,947
|
|
|
|
5.2
|
|
U.S. Treasury, agency and government guaranteed securities (1)
|
|
|
25,712
|
|
|
|
745
|
|
|
|
1,010
|
|
|
|
|
|
|
|
25,447
|
|
|
|
11.2
|
|
CMBS
|
|
|
16,555
|
|
|
|
191
|
|
|
|
1,106
|
|
|
|
18
|
|
|
|
15,622
|
|
|
|
6.9
|
|
ABS
|
|
|
14,272
|
|
|
|
189
|
|
|
|
1,077
|
|
|
|
222
|
|
|
|
13,162
|
|
|
|
5.8
|
|
State and political subdivision securities
|
|
|
7,468
|
|
|
|
151
|
|
|
|
411
|
|
|
|
|
|
|
|
7,208
|
|
|
|
3.2
|
|
Other fixed maturity securities
|
|
|
20
|
|
|
|
1
|
|
|
|
2
|
|
|
|
|
|
|
|
19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities (2), (3)
|
|
$
|
229,709
|
|
|
$
|
8,419
|
|
|
$
|
9,627
|
|
|
$
|
859
|
|
|
$
|
227,642
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
1,537
|
|
|
$
|
92
|
|
|
$
|
8
|
|
|
$
|
|
|
|
$
|
1,621
|
|
|
|
52.6
|
%
|
Non-redeemable preferred stock (2)
|
|
|
1,650
|
|
|
|
80
|
|
|
|
267
|
|
|
|
|
|
|
|
1,463
|
|
|
|
47.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities (4)
|
|
$
|
3,187
|
|
|
$
|
172
|
|
|
$
|
275
|
|
|
$
|
|
|
|
$
|
3,084
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Company has classified within the U.S. Treasury, agency and
government guaranteed securities caption certain corporate fixed
maturity securities issued by U.S. financial institutions that
were guaranteed by the Federal Deposit Insurance Corporation
(FDIC) pursuant to the FDICs Temporary
Liquidity Guarantee Program (FDIC Program) of
$223 million and $407 million at estimated fair value
with unrealized gains of $4 million and $2 million at
December 31, 2010 and 2009, respectively. |
|
(2) |
|
Upon acquisition, the Company classifies perpetual securities
that have attributes of both debt and equity as fixed maturity
securities if the security has an interest rate
step-up
feature which, when combined with other qualitative factors,
indicates that the security has more debt-like characteristics.
The Company classifies perpetual securities with an interest
rate step-up
feature which, when combined with other qualitative factors,
indicates that the security has more equity-like
characteristics, as equity securities within non-redeemable
preferred stock. Many of such securities have been issued by
non-U.S.
financial institutions that are accorded Tier 1 and Upper
Tier 2 capital treatment by their respective regulatory
bodies and are commonly referred to as perpetual hybrid
securities. The following table presents the perpetual
hybrid securities held by the Company at: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
2010
|
|
2009
|
|
|
|
|
|
|
Estimated
|
|
Estimated
|
Classification
|
|
Fair
|
|
Fair
|
Consolidated Balance Sheets
|
|
Sector Table
|
|
Primary Issuers
|
|
Value
|
|
Value
|
|
|
|
|
|
|
(In millions)
|
|
Equity securities
|
|
Non-redeemable preferred stock
|
|
Non-U.S. financial institutions
|
|
$
|
1,046
|
|
|
$
|
988
|
|
Equity securities
|
|
Non-redeemable preferred stock
|
|
U.S. financial institutions
|
|
$
|
236
|
|
|
$
|
349
|
|
Fixed maturity securities
|
|
Foreign corporate securities
|
|
Non-U.S. financial institutions
|
|
$
|
2,038
|
|
|
$
|
2,626
|
|
Fixed maturity securities
|
|
U.S. corporate securities
|
|
U.S. financial institutions
|
|
$
|
83
|
|
|
$
|
91
|
|
F-51
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
(3) |
|
The Companys holdings in redeemable preferred stock with
stated maturity dates, commonly referred to as capital
securities, were primarily issued by U.S. financial
institutions and have cumulative interest deferral features. The
Company held $2.7 billion and $2.5 billion at
estimated fair value of such securities at December 31,
2010 and 2009, respectively, which are included in the U.S. and
foreign corporate securities sectors within fixed maturity
securities. |
|
(4) |
|
Equity securities primarily consist of investments in common and
preferred stocks, including certain perpetual hybrid securities
and mutual fund interests. Privately-held equity securities were
$1.3 billion and $1.0 billion at estimated fair value
at December 31, 2010 and 2009, respectively. |
The Company held foreign currency derivatives with notional
amounts of $12.2 billion and $9.1 billion to hedge the
exchange rate risk associated with foreign denominated fixed
maturity securities at December 31, 2010 and 2009,
respectively.
The below investment grade and non-income producing amounts
presented below are based on rating agency designations and
equivalent designations of the National Association of Insurance
Commissioners (NAIC), with the exception of certain
structured securities described below held by the Companys
insurance subsidiaries that file NAIC statutory financial
statements. Non-agency RMBS, including RMBS backed by
sub-prime
mortgage loans reported within ABS, CMBS and all other ABS held
by the Companys insurance subsidiaries that file NAIC
statutory financial statements are presented based on final
ratings from the revised NAIC rating methodologies which became
effective December 31, 2009 for non-agency RMBS, including
RMBS backed by
sub-prime
mortgage loans reported within ABS, and December 31, 2010
for CMBS and the remaining ABS (which may not correspond to
rating agency designations). All NAIC designation (e.g., NAIC
1 6) amounts and percentages presented herein
are based on the revised NAIC methodologies. All rating agency
designation (e.g., Aaa/AAA) amounts and percentages presented
herein are based on rating agency designations without
adjustment for the revised NAIC methodologies described above.
Rating agency designations are based on availability of
applicable ratings from rating agencies on the NAIC acceptable
rating organization list, including Moodys Investors
Service (Moodys), S&P and Fitch Ratings
(Fitch).
The following table presents selected information about certain
fixed maturity securities held by the Company at:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Below investment grade or non-rated fixed maturity securities:
|
|
|
|
|
|
|
|
|
Estimated fair value
|
|
$
|
24,886
|
|
|
$
|
20,201
|
|
Net unrealized gain (loss)
|
|
$
|
(696
|
)
|
|
$
|
(2,609
|
)
|
Non-income producing fixed maturity securities:
|
|
|
|
|
|
|
|
|
Estimated fair value
|
|
$
|
130
|
|
|
$
|
312
|
|
Net unrealized gain (loss)
|
|
$
|
(23
|
)
|
|
$
|
(31
|
)
|
Concentrations of Credit Risk (Fixed Maturity
Securities) Summary. The following
section contains a summary of the concentrations of credit risk
related to fixed maturity securities holdings.
The Company was not exposed to any concentrations of credit risk
of any single issuer greater than 10% of the Companys
equity, other than the government securities summarized in the
table below. The estimated fair value of the Companys
holdings in sovereign fixed maturity securities of Portugal,
Ireland, Italy, Greece and Spain, commonly referred to as
Europes perimeter region, was
$1,562 million and $6 million prior to, and was
$1,392 million and $6 million, after considering net
purchased credit default swap protection at December 31,
2010 and 2009, respectively. Collectively, the net exposure in
these Europe perimeter region sovereign fixed maturity
securities was 2.8% of the Companys equity and 0.3% of
total cash and invested assets at December 31, 2010.
F-52
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
Estimated Fair Value
|
|
|
|
(In millions)
|
|
|
Government and agency fixed maturity securities:
|
|
|
|
|
|
|
|
|
United States (1)
|
|
$
|
33,304
|
|
|
$
|
25,447
|
|
Japan
|
|
$
|
15,591
|
|
|
$
|
|
|
Mexico
|
|
$
|
5,050
|
|
|
$
|
4,813
|
|
|
|
|
(1) |
|
Includes certain corporate fixed maturity securities guaranteed
by the FDIC Program, as described above. |
Concentrations of Credit Risk (Fixed Maturity
Securities) U.S. and Foreign Corporate
Securities. The Company maintains a diversified
portfolio of corporate fixed maturity securities across
industries and issuers. This portfolio does not have an exposure
to any single issuer in excess of 1% of total investments. The
tables below present for all corporate fixed maturity securities
holdings, corporate securities by sector, U.S. corporate
securities by major industry types, the largest exposure to a
single issuer and the combined holdings in the ten issuers to
which it had the largest exposure at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
|
Fair
|
|
|
% of
|
|
|
Fair
|
|
|
% of
|
|
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Corporate fixed maturity securities by sector:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign corporate fixed maturity securities (1)
|
|
$
|
68,178
|
|
|
|
42.4
|
%
|
|
$
|
38,030
|
|
|
|
34.5
|
%
|
U.S. corporate fixed maturity securities by industry:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial
|
|
|
22,314
|
|
|
|
13.9
|
|
|
|
17,246
|
|
|
|
15.6
|
|
Consumer
|
|
|
21,737
|
|
|
|
13.5
|
|
|
|
16,924
|
|
|
|
15.4
|
|
Finance
|
|
|
20,917
|
|
|
|
13.0
|
|
|
|
13,756
|
|
|
|
12.5
|
|
Utility
|
|
|
17,027
|
|
|
|
10.6
|
|
|
|
14,785
|
|
|
|
13.4
|
|
Communications
|
|
|
7,375
|
|
|
|
4.6
|
|
|
|
6,580
|
|
|
|
6.0
|
|
Other
|
|
|
3,198
|
|
|
|
2.0
|
|
|
|
2,896
|
|
|
|
2.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
160,746
|
|
|
|
100.0
|
%
|
|
$
|
110,217
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes U.S. dollar-denominated debt obligations of foreign
obligors and other foreign fixed maturity securities. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
2010
|
|
2009
|
|
|
Estimated
|
|
|
|
Estimated
|
|
|
|
|
Fair
|
|
% of Total
|
|
Fair
|
|
% of Total
|
|
|
Value
|
|
Investments
|
|
Value
|
|
Investments
|
|
|
(In millions)
|
|
Concentrations within corporate fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Largest exposure to a single issuer
|
|
$
|
2,291
|
|
|
|
0.5
|
%
|
|
$
|
1,038
|
|
|
|
0.3
|
%
|
Holdings in ten issuers with the largest exposures
|
|
$
|
14,247
|
|
|
|
3.1
|
%
|
|
$
|
7,506
|
|
|
|
2.3
|
%
|
F-53
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Concentrations of Credit Risk (Fixed Maturity
Securities) RMBS. The table below
presents the Companys RMBS holdings and portion rated
Aaa/AAA and portion rated NAIC 1 at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
|
Fair
|
|
|
% of
|
|
|
Fair
|
|
|
% of
|
|
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
By security type:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pass-through securities
|
|
$
|
22,430
|
|
|
|
50.1
|
%
|
|
$
|
19,540
|
|
|
|
44.4
|
%
|
Collateralized mortgage obligations
|
|
|
22,303
|
|
|
|
49.9
|
|
|
|
24,480
|
|
|
|
55.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total RMBS
|
|
$
|
44,733
|
|
|
|
100.0
|
%
|
|
$
|
44,020
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By risk profile:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agency
|
|
$
|
34,254
|
|
|
|
76.6
|
%
|
|
$
|
33,334
|
|
|
|
75.7
|
%
|
Prime
|
|
|
6,258
|
|
|
|
14.0
|
|
|
|
6,775
|
|
|
|
15.4
|
|
Alternative residential mortgage loans
|
|
|
4,221
|
|
|
|
9.4
|
|
|
|
3,911
|
|
|
|
8.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total RMBS
|
|
$
|
44,733
|
|
|
|
100.0
|
%
|
|
$
|
44,020
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Portion rated Aaa/AAA
|
|
$
|
36,085
|
|
|
|
80.7
|
%
|
|
$
|
35,626
|
|
|
|
80.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Portion rated NAIC 1
|
|
$
|
38,984
|
|
|
|
87.1
|
%
|
|
$
|
38,464
|
|
|
|
87.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pass-through mortgage-backed securities are a type of
asset-backed security that is secured by a mortgage or
collection of mortgages. The monthly mortgage payments from
homeowners pass from the originating bank through an
intermediary, such as a government agency or investment bank,
which collects the payments, and for a fee, remits or passes
these payments through to the holders of the pass-through
securities. Collateralized mortgage obligations are a type of
mortgage-backed security structured by dividing the cash flows
of mortgages into separate pools or tranches of risk that create
multiple classes of bonds with varying maturities and priority
of payments.
Prime residential mortgage lending includes the origination of
residential mortgage loans to the most creditworthy borrowers
with high quality credit profiles. Alternative residential
mortgage loans (Alt-A) are a classification of
mortgage loans where the risk profile of the borrower falls
between prime and
sub-prime.
Sub-prime
mortgage lending is the origination of residential mortgage
loans to borrowers with weak credit profiles. Included within
Alt-A RMBS are resecuritization of real estate mortgage
investment conduit (Re-REMIC) securities. Re-REMIC
Alt-A RMBS involve the pooling of previous issues of Alt-A RMBS
and restructuring the combined pools to create new senior and
subordinated securities. The credit enhancement on the senior
tranches is improved through the resecuritization. The
Companys holdings are in senior tranches with significant
credit enhancement.
F-54
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following tables present the Companys investment in
Alt-A RMBS by vintage year (vintage year refers to the year of
origination and not to the year of purchase) and certain other
selected data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
|
Fair
|
|
|
% of
|
|
|
Fair
|
|
|
% of
|
|
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Vintage Year:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2004 & Prior
|
|
$
|
93
|
|
|
|
2.2
|
%
|
|
$
|
109
|
|
|
|
2.8
|
%
|
2005
|
|
|
1,483
|
|
|
|
35.1
|
|
|
|
1,395
|
|
|
|
35.7
|
|
2006
|
|
|
1,013
|
|
|
|
24.0
|
|
|
|
811
|
|
|
|
20.7
|
|
2007
|
|
|
922
|
|
|
|
21.8
|
|
|
|
814
|
|
|
|
20.8
|
|
2008
|
|
|
7
|
|
|
|
0.2
|
|
|
|
|
|
|
|
|
|
2009 (1)
|
|
|
671
|
|
|
|
15.9
|
|
|
|
782
|
|
|
|
20.0
|
|
2010 (1)
|
|
|
32
|
|
|
|
0.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
4,221
|
|
|
|
100.0
|
%
|
|
$
|
3,911
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
All of the Companys Alt-A RMBS holdings in the 2009 and
2010 vintage years are Re-REMIC Alt-A RMBS that were purchased
in 2009 and 2010 and are comprised of original issue vintage
year 2005 through 2007 Alt-A RMBS. All of the Companys
Re-REMIC Alt-A RMBS holdings are NAIC 1 rated. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
% of
|
|
|
|
Amount
|
|
|
Total
|
|
|
Amount
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Net unrealized gain (loss)
|
|
$
|
(670
|
)
|
|
|
|
|
|
$
|
(1,248
|
)
|
|
|
|
|
Rated Aa/AA or better
|
|
|
|
|
|
|
15.9
|
%
|
|
|
|
|
|
|
26.3
|
%
|
Rated NAIC 1
|
|
|
|
|
|
|
39.5
|
%
|
|
|
|
|
|
|
31.3
|
%
|
Distribution of holdings at estimated fair
value by collateral type:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed rate mortgage loans collateral
|
|
|
|
|
|
|
90.7
|
%
|
|
|
|
|
|
|
89.3
|
%
|
Hybrid adjustable rate mortgage loans collateral
|
|
|
|
|
|
|
9.3
|
|
|
|
|
|
|
|
10.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Alt-A RMBS
|
|
|
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Concentrations of Credit Risk (Fixed Maturity
Securities) CMBS. The Companys
holdings in CMBS were $20.7 billion and $15.6 billion
at estimated fair value at December 31, 2010 and 2009,
respectively. The Company had no exposure to CMBS index
securities at December 31, 2010 or 2009. The Company held
commercial real estate collateralized debt obligations
securities of $138 million and $111 million at
estimated fair value at December 31, 2010 and 2009,
respectively.
F-55
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following tables present the Companys holdings of CMBS
by rating agency designation and by vintage year at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Below
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment
|
|
|
|
|
|
|
Aaa
|
|
|
Aa
|
|
|
A
|
|
|
Baa
|
|
|
Grade
|
|
|
Total
|
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
2003 & Prior
|
|
$
|
7,411
|
|
|
$
|
7,640
|
|
|
$
|
282
|
|
|
$
|
282
|
|
|
$
|
228
|
|
|
$
|
227
|
|
|
$
|
74
|
|
|
$
|
71
|
|
|
$
|
28
|
|
|
$
|
24
|
|
|
$
|
8,023
|
|
|
$
|
8,244
|
|
2004
|
|
|
3,489
|
|
|
|
3,620
|
|
|
|
277
|
|
|
|
273
|
|
|
|
216
|
|
|
|
209
|
|
|
|
181
|
|
|
|
175
|
|
|
|
91
|
|
|
|
68
|
|
|
|
4,254
|
|
|
|
4,345
|
|
2005
|
|
|
3,113
|
|
|
|
3,292
|
|
|
|
322
|
|
|
|
324
|
|
|
|
286
|
|
|
|
280
|
|
|
|
263
|
|
|
|
255
|
|
|
|
73
|
|
|
|
66
|
|
|
|
4,057
|
|
|
|
4,217
|
|
2006
|
|
|
1,463
|
|
|
|
1,545
|
|
|
|
159
|
|
|
|
160
|
|
|
|
168
|
|
|
|
168
|
|
|
|
385
|
|
|
|
398
|
|
|
|
166
|
|
|
|
156
|
|
|
|
2,341
|
|
|
|
2,427
|
|
2007
|
|
|
840
|
|
|
|
791
|
|
|
|
344
|
|
|
|
298
|
|
|
|
96
|
|
|
|
95
|
|
|
|
119
|
|
|
|
108
|
|
|
|
122
|
|
|
|
133
|
|
|
|
1,521
|
|
|
|
1,425
|
|
2008
|
|
|
2
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
2
|
|
2009
|
|
|
3
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3
|
|
|
|
3
|
|
2010
|
|
|
8
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
16,329
|
|
|
$
|
16,901
|
|
|
$
|
1,384
|
|
|
$
|
1,337
|
|
|
$
|
998
|
|
|
$
|
983
|
|
|
$
|
1,022
|
|
|
$
|
1,007
|
|
|
$
|
480
|
|
|
$
|
447
|
|
|
$
|
20,213
|
|
|
$
|
20,675
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ratings Distribution
|
|
|
|
|
|
|
81.7
|
%
|
|
|
|
|
|
|
6.4
|
%
|
|
|
|
|
|
|
4.8
|
%
|
|
|
|
|
|
|
4.9
|
%
|
|
|
|
|
|
|
2.2
|
%
|
|
|
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The December 31, 2010 table reflects rating agency
designations assigned by nationally recognized rating agencies
including Moodys, S&P, Fitch and Realpoint, LLC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Below
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment
|
|
|
|
|
|
|
Aaa
|
|
|
Aa
|
|
|
A
|
|
|
Baa
|
|
|
Grade
|
|
|
Total
|
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
2003 & Prior
|
|
$
|
6,836
|
|
|
$
|
6,918
|
|
|
$
|
394
|
|
|
$
|
365
|
|
|
$
|
162
|
|
|
$
|
140
|
|
|
$
|
52
|
|
|
$
|
41
|
|
|
$
|
36
|
|
|
$
|
18
|
|
|
$
|
7,480
|
|
|
$
|
7,482
|
|
2004
|
|
|
2,240
|
|
|
|
2,255
|
|
|
|
200
|
|
|
|
166
|
|
|
|
114
|
|
|
|
71
|
|
|
|
133
|
|
|
|
87
|
|
|
|
88
|
|
|
|
58
|
|
|
|
2,775
|
|
|
|
2,637
|
|
2005
|
|
|
2,956
|
|
|
|
2,853
|
|
|
|
144
|
|
|
|
108
|
|
|
|
85
|
|
|
|
65
|
|
|
|
39
|
|
|
|
24
|
|
|
|
57
|
|
|
|
51
|
|
|
|
3,281
|
|
|
|
3,101
|
|
2006
|
|
|
1,087
|
|
|
|
1,009
|
|
|
|
162
|
|
|
|
139
|
|
|
|
380
|
|
|
|
323
|
|
|
|
187
|
|
|
|
129
|
|
|
|
123
|
|
|
|
48
|
|
|
|
1,939
|
|
|
|
1,648
|
|
2007
|
|
|
432
|
|
|
|
314
|
|
|
|
13
|
|
|
|
12
|
|
|
|
361
|
|
|
|
257
|
|
|
|
234
|
|
|
|
153
|
|
|
|
35
|
|
|
|
13
|
|
|
|
1,075
|
|
|
|
749
|
|
2008
|
|
|
5
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5
|
|
|
|
5
|
|
2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
13,556
|
|
|
$
|
13,354
|
|
|
$
|
913
|
|
|
$
|
790
|
|
|
$
|
1,102
|
|
|
$
|
856
|
|
|
$
|
645
|
|
|
$
|
434
|
|
|
$
|
339
|
|
|
$
|
188
|
|
|
$
|
16,555
|
|
|
$
|
15,622
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ratings Distribution
|
|
|
|
|
|
|
85.4
|
%
|
|
|
|
|
|
|
5.1
|
%
|
|
|
|
|
|
|
5.5
|
%
|
|
|
|
|
|
|
2.8
|
%
|
|
|
|
|
|
|
1.2
|
%
|
|
|
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The December 31, 2009 table reflects rating agency
designations assigned by nationally recognized rating agencies
including Moodys, S&P and Fitch.
F-56
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The NAIC rating distribution of the Companys holdings of
CMBS was as follows at:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
NAIC 1
|
|
|
93.7
|
%
|
|
|
96.0
|
%
|
NAIC 2
|
|
|
3.2
|
%
|
|
|
2.8
|
%
|
NAIC 3
|
|
|
1.8
|
%
|
|
|
1.0
|
%
|
NAIC 4
|
|
|
1.0
|
%
|
|
|
0.1
|
%
|
NAIC 5
|
|
|
0.3
|
%
|
|
|
0.1
|
%
|
NAIC 6
|
|
|
|
%
|
|
|
|
%
|
Concentrations of Credit Risk (Fixed Maturity
Securities) ABS. The Companys
holdings in ABS were $14.3 billion and $13.2 billion
at estimated fair value at December 31, 2010 and 2009,
respectively. The Companys ABS are diversified both by
collateral type and by issuer.
The following table presents the collateral type and certain
other information about ABS held by the Company at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
|
Fair
|
|
|
% of
|
|
|
Fair
|
|
|
% of
|
|
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
By collateral type:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit card loans
|
|
$
|
6,027
|
|
|
|
42.2
|
%
|
|
$
|
7,057
|
|
|
|
53.6
|
%
|
Student loans
|
|
|
2,416
|
|
|
|
16.9
|
|
|
|
1,855
|
|
|
|
14.1
|
|
RMBS backed by
sub-prime
mortgage loans
|
|
|
1,119
|
|
|
|
7.8
|
|
|
|
1,044
|
|
|
|
7.9
|
|
Automobile loans
|
|
|
605
|
|
|
|
4.2
|
|
|
|
963
|
|
|
|
7.3
|
|
Other loans
|
|
|
4,123
|
|
|
|
28.9
|
|
|
|
2,243
|
|
|
|
17.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
14,290
|
|
|
|
100.0
|
%
|
|
$
|
13,162
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Portion rated Aaa/AAA
|
|
$
|
10,411
|
|
|
|
72.9
|
%
|
|
$
|
9,354
|
|
|
|
71.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Portion rated NAIC 1
|
|
$
|
13,136
|
|
|
|
91.9
|
%
|
|
$
|
11,573
|
|
|
|
87.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company had ABS supported by
sub-prime
mortgage loans with estimated fair values of $1,119 million
and $1,044 million and unrealized losses of
$317 million and $593 million at December 31,
2010 and 2009, respectively. Approximately 54% of this portfolio
was rated Aa or better, of which 88% was in vintage year 2005
and prior at December 31, 2010. Approximately 61% of this
portfolio was rated Aa or better, of which 91% was in vintage
year 2005 and prior at December 31, 2009. These older
vintages from 2005 and prior benefit from better underwriting,
improved enhancement levels and higher residential property
price appreciation. Approximately 66% and 73% of this portfolio
was rated NAIC 2 or better at December 31, 2010 and 2009,
respectively.
Concentrations of Credit Risk (Equity
Securities). The Company was not exposed to any
concentrations of credit risk in its equity securities holdings
of any single issuer greater than 10% of the Companys
equity or 1% of total investments at December 31, 2010 and
2009.
F-57
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Maturities of Fixed Maturity Securities. The
amortized cost and estimated fair value of fixed maturity
securities, by contractual maturity date (excluding scheduled
sinking funds), were as follows at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
Due in one year or less
|
|
$
|
8,593
|
|
|
$
|
8,715
|
|
|
$
|
6,845
|
|
|
$
|
6,924
|
|
Due after one year through five years
|
|
|
65,378
|
|
|
|
67,040
|
|
|
|
38,408
|
|
|
|
39,399
|
|
Due after five years through ten years
|
|
|
77,054
|
|
|
|
80,163
|
|
|
|
40,448
|
|
|
|
41,568
|
|
Due after ten years
|
|
|
89,577
|
|
|
|
91,668
|
|
|
|
67,838
|
|
|
|
66,947
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
240,602
|
|
|
|
247,586
|
|
|
|
153,539
|
|
|
|
154,838
|
|
RMBS, CMBS and ABS
|
|
|
79,406
|
|
|
|
79,698
|
|
|
|
76,170
|
|
|
|
72,804
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
320,008
|
|
|
$
|
327,284
|
|
|
$
|
229,709
|
|
|
$
|
227,642
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actual maturities may differ from contractual maturities due to
the exercise of call or prepayment options. Fixed maturity
securities not due at a single maturity date have been included
in the above table in the year of final contractual maturity.
RMBS, CMBS and ABS are shown separately in the table, as they
are not due at a single maturity.
As discussed further in Note 2, an indemnification asset
has been established in connection with certain investments
acquired from American Life.
Evaluating
Available-for-Sale
Securities for
Other-Than-Temporary
Impairment
As described more fully in Note 1, the Company performs a
regular evaluation, on a
security-by-security
basis, of its
available-for-sale
securities holdings, including fixed maturity securities, equity
securities and perpetual hybrid securities, in accordance with
its impairment policy in order to evaluate whether such
investments are
other-than-temporarily
impaired. As described more fully in Note 1, effective
April 1, 2009, the Company adopted OTTI guidance that
amends the methodology for determining for fixed maturity
securities whether an OTTI exists, and for certain fixed
maturity securities, changes how the amount of the OTTI loss
that is charged to earnings is determined. There was no change
in the OTTI methodology for equity securities.
F-58
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Net
Unrealized Investment Gains (Losses)
The components of net unrealized investment gains (losses),
included in accumulated other comprehensive income (loss), were
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities
|
|
$
|
7,817
|
|
|
$
|
(1,208
|
)
|
|
$
|
(21,246
|
)
|
Fixed maturity securities with noncredit OTTI losses in
accumulated other comprehensive income (loss)
|
|
|
(601
|
)
|
|
|
(859
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
|
7,216
|
|
|
|
(2,067
|
)
|
|
|
(21,246
|
)
|
Equity securities
|
|
|
(3
|
)
|
|
|
(103
|
)
|
|
|
(934
|
)
|
Derivatives
|
|
|
(59
|
)
|
|
|
(144
|
)
|
|
|
(2
|
)
|
Other
|
|
|
42
|
|
|
|
71
|
|
|
|
53
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
7,196
|
|
|
|
(2,243
|
)
|
|
|
(22,129
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts allocated from:
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance liability loss recognition
|
|
|
(672
|
)
|
|
|
(118
|
)
|
|
|
42
|
|
DAC and VOBA related to noncredit OTTI losses recognized in
accumulated other comprehensive income (loss)
|
|
|
38
|
|
|
|
71
|
|
|
|
|
|
DAC and VOBA
|
|
|
(1,205
|
)
|
|
|
145
|
|
|
|
3,025
|
|
Policyholder dividend obligation
|
|
|
(876
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
(2,715
|
)
|
|
|
98
|
|
|
|
3,067
|
|
Deferred income tax benefit (expense) related to noncredit OTTI
losses recognized in accumulated other comprehensive income
(loss)
|
|
|
197
|
|
|
|
275
|
|
|
|
|
|
Deferred income tax benefit (expense)
|
|
|
(1,692
|
)
|
|
|
539
|
|
|
|
6,508
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized investment gains (losses)
|
|
|
2,986
|
|
|
|
(1,331
|
)
|
|
|
(12,554
|
)
|
Net unrealized investment gains (losses) attributable to
noncontrolling interests
|
|
|
4
|
|
|
|
1
|
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized investment gains (losses) attributable to
MetLife, Inc.
|
|
$
|
2,990
|
|
|
$
|
(1,330
|
)
|
|
$
|
(12,564
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities with noncredit OTTI losses in
accumulated other comprehensive income (loss), as presented
above of ($601) million at December 31, 2010, includes
($859) million recognized prior to January 1, 2010,
($212) million (($202) million, net of DAC) of
noncredit OTTI losses recognized in the year ended
December 31, 2010, $16 million transferred to retained
earnings in connection with the adoption of guidance related to
the consolidation of VIEs (see Note 1) for the year
ended December 31, 2010, $137 million related to
securities sold during the year ended December 31, 2010 for
which a noncredit OTTI loss was previously recognized in
accumulated other comprehensive income (loss) and
$317 million of subsequent increases in estimated fair
value during the year ended December 31, 2010 on such
securities for which a noncredit OTTI loss was previously
recognized in accumulated other comprehensive income (loss).
Fixed maturity securities with noncredit OTTI losses in
accumulated other comprehensive income (loss), as presented
above of ($859) million at December 31, 2009, includes
($126) million related to the transition adjustment
recorded in 2009 upon the adoption of guidance on the
recognition and presentation of OTTI, ($939) million
(($857) million, net of DAC) of noncredit OTTI losses
recognized in the year ended December 31, 2009 (as more
fully described in Note 1), $20 million related to
securities sold during the year ended December 31, 2009 for
which a noncredit OTTI loss was previously recognized in
accumulated comprehensive income (loss) and $186 million of
subsequent increases in estimated fair value during the year
F-59
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
ended December 31, 2009 on such securities for which a
noncredit OTTI loss was previously recognized in accumulated
other comprehensive income (loss).
The changes in net unrealized investment gains (losses) were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Balance, beginning of period
|
|
$
|
(1,330
|
)
|
|
$
|
(12,564
|
)
|
|
$
|
971
|
|
Cumulative effect of change in accounting principles, net of
income tax
|
|
|
52
|
|
|
|
(76
|
)
|
|
|
(10
|
)
|
Fixed maturity securities on which noncredit OTTI losses have
been recognized
|
|
|
242
|
|
|
|
(733
|
)
|
|
|
|
|
Unrealized investment gains (losses) during the year
|
|
|
9,117
|
|
|
|
20,745
|
|
|
|
(25,536
|
)
|
Unrealized investment losses of subsidiaries at the date of
disposal
|
|
|
|
|
|
|
|
|
|
|
149
|
|
Unrealized investment gains (losses) relating to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance liability gain (loss) recognition
|
|
|
(554
|
)
|
|
|
(160
|
)
|
|
|
650
|
|
DAC and VOBA related to noncredit OTTI losses recognized in
accumulated other comprehensive income (loss)
|
|
|
(33
|
)
|
|
|
61
|
|
|
|
|
|
DAC and VOBA
|
|
|
(1,350
|
)
|
|
|
(2,880
|
)
|
|
|
3,370
|
|
DAC and VOBA of subsidiary at date of disposal
|
|
|
|
|
|
|
|
|
|
|
(18
|
)
|
Policyholder dividend obligation
|
|
|
(876
|
)
|
|
|
|
|
|
|
789
|
|
Deferred income tax benefit (expense) related to noncredit OTTI
losses recognized in accumulated other comprehensive income
(loss)
|
|
|
(73
|
)
|
|
|
235
|
|
|
|
|
|
Deferred income tax benefit (expense)
|
|
|
(2,208
|
)
|
|
|
(5,969
|
)
|
|
|
6,991
|
|
Deferred income tax benefit (expense) of subsidiaries at date of
disposal
|
|
|
|
|
|
|
|
|
|
|
(60
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized investment gains (losses)
|
|
|
2,987
|
|
|
|
(1,341
|
)
|
|
|
(12,704
|
)
|
Net unrealized investment gains (losses) attributable to
noncontrolling interests
|
|
|
3
|
|
|
|
11
|
|
|
|
(10
|
)
|
Net unrealized investment gains (losses) attributable to
noncontrolling interests of subsidiary at date of disposal
|
|
|
|
|
|
|
|
|
|
|
150
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
$
|
2,990
|
|
|
$
|
(1,330
|
)
|
|
$
|
(12,564
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in net unrealized investment gains (losses)
|
|
$
|
4,317
|
|
|
$
|
11,223
|
|
|
$
|
(13,665
|
)
|
Change in net unrealized investment gains (losses) attributable
to noncontrolling interests
|
|
|
3
|
|
|
|
11
|
|
|
|
(10
|
)
|
Change in net unrealized investment gains (losses) attributable
to noncontrolling interests of subsidiary at date of disposal
|
|
|
|
|
|
|
|
|
|
|
150
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in net unrealized investment gains (losses) attributable
to MetLife, Inc.
|
|
$
|
4,320
|
|
|
$
|
11,234
|
|
|
$
|
(13,525
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuous
Gross Unrealized Loss and OTTI Loss for Fixed Maturity and
Equity Securities
Available-for-Sale
by Sector
The following tables present the estimated fair value and gross
unrealized loss of the Companys fixed maturity and equity
securities in an unrealized loss position, aggregated by sector
and by length of time that the securities have been in a
continuous unrealized loss position. The unrealized loss amounts
presented below include the noncredit component of OTTI loss.
Fixed maturity securities on which a noncredit OTTI loss has
been
F-60
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
recognized in accumulated other comprehensive income (loss) are
categorized by length of time as being less than
12 months or equal to or greater than
12 months in a continuous unrealized loss position
based on the point in time that the estimated fair value
initially declined to below the amortized cost basis and not the
period of time since the unrealized loss was deemed a noncredit
OTTI loss.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
|
|
|
Equal to or Greater
|
|
|
|
|
|
|
Less than 12 Months
|
|
|
than 12 Months
|
|
|
Total
|
|
|
|
Estimated
|
|
|
Gross
|
|
|
Estimated
|
|
|
Gross
|
|
|
Estimated
|
|
|
Gross
|
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
|
Value
|
|
|
Loss
|
|
|
Value
|
|
|
Loss
|
|
|
Value
|
|
|
Loss
|
|
|
|
(In millions, except number of securities)
|
|
|
Fixed Maturity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
23,309
|
|
|
$
|
464
|
|
|
$
|
8,386
|
|
|
$
|
1,167
|
|
|
$
|
31,695
|
|
|
$
|
1,631
|
|
Foreign corporate securities
|
|
|
22,530
|
|
|
|
417
|
|
|
|
4,007
|
|
|
|
522
|
|
|
|
26,537
|
|
|
|
939
|
|
RMBS
|
|
|
7,588
|
|
|
|
212
|
|
|
|
6,700
|
|
|
|
1,175
|
|
|
|
14,288
|
|
|
|
1,387
|
|
Foreign government securities
|
|
|
26,828
|
|
|
|
593
|
|
|
|
189
|
|
|
|
17
|
|
|
|
27,017
|
|
|
|
610
|
|
U.S. Treasury, agency and government guaranteed securities
|
|
|
13,401
|
|
|
|
530
|
|
|
|
118
|
|
|
|
29
|
|
|
|
13,519
|
|
|
|
559
|
|
CMBS
|
|
|
3,787
|
|
|
|
29
|
|
|
|
1,363
|
|
|
|
249
|
|
|
|
5,150
|
|
|
|
278
|
|
ABS
|
|
|
2,713
|
|
|
|
42
|
|
|
|
3,029
|
|
|
|
667
|
|
|
|
5,742
|
|
|
|
709
|
|
State and political subdivision securities
|
|
|
5,061
|
|
|
|
246
|
|
|
|
988
|
|
|
|
272
|
|
|
|
6,049
|
|
|
|
518
|
|
Other fixed maturity securities
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
105,218
|
|
|
$
|
2,533
|
|
|
$
|
24,780
|
|
|
$
|
4,098
|
|
|
$
|
129,998
|
|
|
$
|
6,631
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
89
|
|
|
$
|
12
|
|
|
$
|
1
|
|
|
$
|
|
|
|
$
|
90
|
|
|
$
|
12
|
|
Non-redeemable preferred stock
|
|
|
191
|
|
|
|
9
|
|
|
|
824
|
|
|
|
220
|
|
|
|
1,015
|
|
|
|
229
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
280
|
|
|
$
|
21
|
|
|
$
|
825
|
|
|
$
|
220
|
|
|
$
|
1,105
|
|
|
$
|
241
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total number of securities in an unrealized loss position
|
|
|
5,793
|
|
|
|
|
|
|
|
1,738
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-61
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
|
|
|
|
Equal to or Greater
|
|
|
|
|
|
|
Less than 12 Months
|
|
|
than 12 Months
|
|
|
Total
|
|
|
|
Estimated
|
|
|
Gross
|
|
|
Estimated
|
|
|
Gross
|
|
|
Estimated
|
|
|
Gross
|
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
|
Value
|
|
|
Loss
|
|
|
Value
|
|
|
Loss
|
|
|
Value
|
|
|
Loss
|
|
|
|
(In millions, except number of securities)
|
|
|
Fixed Maturity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
8,641
|
|
|
$
|
395
|
|
|
$
|
18,004
|
|
|
$
|
2,314
|
|
|
$
|
26,645
|
|
|
$
|
2,709
|
|
Foreign corporate securities
|
|
|
3,786
|
|
|
|
139
|
|
|
|
7,282
|
|
|
|
1,096
|
|
|
|
11,068
|
|
|
|
1,235
|
|
RMBS
|
|
|
5,623
|
|
|
|
119
|
|
|
|
10,268
|
|
|
|
2,438
|
|
|
|
15,891
|
|
|
|
2,557
|
|
Foreign government securities
|
|
|
2,318
|
|
|
|
55
|
|
|
|
507
|
|
|
|
84
|
|
|
|
2,825
|
|
|
|
139
|
|
U.S. Treasury, agency and government guaranteed securities
|
|
|
15,051
|
|
|
|
990
|
|
|
|
51
|
|
|
|
20
|
|
|
|
15,102
|
|
|
|
1,010
|
|
CMBS
|
|
|
2,052
|
|
|
|
29
|
|
|
|
5,435
|
|
|
|
1,095
|
|
|
|
7,487
|
|
|
|
1,124
|
|
ABS
|
|
|
1,259
|
|
|
|
143
|
|
|
|
5,875
|
|
|
|
1,156
|
|
|
|
7,134
|
|
|
|
1,299
|
|
State and political subdivision securities
|
|
|
2,086
|
|
|
|
94
|
|
|
|
1,843
|
|
|
|
317
|
|
|
|
3,929
|
|
|
|
411
|
|
Other fixed maturity securities
|
|
|
6
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
6
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
40,822
|
|
|
$
|
1,966
|
|
|
$
|
49,265
|
|
|
$
|
8,520
|
|
|
$
|
90,087
|
|
|
$
|
10,486
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
56
|
|
|
$
|
7
|
|
|
$
|
14
|
|
|
$
|
1
|
|
|
$
|
70
|
|
|
$
|
8
|
|
Non-redeemable preferred stock
|
|
|
66
|
|
|
|
41
|
|
|
|
930
|
|
|
|
226
|
|
|
|
996
|
|
|
|
267
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
122
|
|
|
$
|
48
|
|
|
$
|
944
|
|
|
$
|
227
|
|
|
$
|
1,066
|
|
|
$
|
275
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total number of securities in an unrealized loss position
|
|
|
2,210
|
|
|
|
|
|
|
|
3,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-62
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Aging
of Gross Unrealized Loss and OTTI Loss for Fixed Maturity and
Equity Securities
Available-for-Sale
The following tables present the cost or amortized cost, gross
unrealized loss, including the portion of OTTI loss on fixed
maturity securities recognized in accumulated other
comprehensive income (loss), gross unrealized loss as a
percentage of cost or amortized cost and number of securities
for fixed maturity and equity securities where the estimated
fair value had declined and remained below cost or amortized
cost by less than 20%, or 20% or more at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
Cost or Amortized Cost
|
|
|
Gross Unrealized Loss
|
|
|
Number of Securities
|
|
|
|
Less than
|
|
|
20% or
|
|
|
Less than
|
|
|
20% or
|
|
|
Less than
|
|
|
20% or
|
|
|
|
20%
|
|
|
more
|
|
|
20%
|
|
|
more
|
|
|
20%
|
|
|
more
|
|
|
|
(In millions, except number of securities)
|
|
|
Fixed Maturity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than six months
|
|
$
|
105,968
|
|
|
$
|
1,408
|
|
|
$
|
2,379
|
|
|
$
|
369
|
|
|
|
5,472
|
|
|
|
125
|
|
Six months or greater but less than nine months
|
|
|
1,125
|
|
|
|
376
|
|
|
|
29
|
|
|
|
102
|
|
|
|
104
|
|
|
|
29
|
|
Nine months or greater but less than twelve months
|
|
|
375
|
|
|
|
89
|
|
|
|
28
|
|
|
|
27
|
|
|
|
51
|
|
|
|
9
|
|
Twelve months or greater
|
|
|
21,721
|
|
|
|
5,567
|
|
|
|
1,876
|
|
|
|
1,821
|
|
|
|
1,267
|
|
|
|
316
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
129,189
|
|
|
$
|
7,440
|
|
|
$
|
4,312
|
|
|
$
|
2,319
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of amortized cost
|
|
|
|
|
|
|
|
|
|
|
3
|
%
|
|
|
31
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than six months
|
|
$
|
247
|
|
|
$
|
94
|
|
|
$
|
10
|
|
|
$
|
22
|
|
|
|
131
|
|
|
|
33
|
|
Six months or greater but less than nine months
|
|
|
29
|
|
|
|
65
|
|
|
|
5
|
|
|
|
16
|
|
|
|
7
|
|
|
|
2
|
|
Nine months or greater but less than twelve months
|
|
|
6
|
|
|
|
47
|
|
|
|
|
|
|
|
16
|
|
|
|
4
|
|
|
|
2
|
|
Twelve months or greater
|
|
|
518
|
|
|
|
340
|
|
|
|
56
|
|
|
|
116
|
|
|
|
40
|
|
|
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
800
|
|
|
$
|
546
|
|
|
$
|
71
|
|
|
$
|
170
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of cost
|
|
|
|
|
|
|
|
|
|
|
9
|
%
|
|
|
31
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-63
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
|
Cost or Amortized Cost
|
|
|
Gross Unrealized Loss
|
|
|
Number of Securities
|
|
|
|
Less than
|
|
|
20% or
|
|
|
Less than
|
|
|
20% or
|
|
|
Less than
|
|
|
20% or
|
|
|
|
20%
|
|
|
more
|
|
|
20%
|
|
|
more
|
|
|
20%
|
|
|
more
|
|
|
|
(In millions, except number of securities)
|
|
|
Fixed Maturity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than six months
|
|
$
|
35,163
|
|
|
$
|
2,658
|
|
|
$
|
933
|
|
|
$
|
713
|
|
|
|
1,725
|
|
|
|
186
|
|
Six months or greater but less than nine months
|
|
|
4,908
|
|
|
|
674
|
|
|
|
508
|
|
|
|
194
|
|
|
|
124
|
|
|
|
49
|
|
Nine months or greater but less than twelve months
|
|
|
1,723
|
|
|
|
1,659
|
|
|
|
167
|
|
|
|
517
|
|
|
|
106
|
|
|
|
79
|
|
Twelve months or greater
|
|
|
41,721
|
|
|
|
12,067
|
|
|
|
3,207
|
|
|
|
4,247
|
|
|
|
2,369
|
|
|
|
724
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
83,515
|
|
|
$
|
17,058
|
|
|
$
|
4,815
|
|
|
$
|
5,671
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of amortized cost
|
|
|
|
|
|
|
|
|
|
|
6
|
%
|
|
|
33
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than six months
|
|
$
|
66
|
|
|
$
|
63
|
|
|
$
|
7
|
|
|
$
|
14
|
|
|
|
199
|
|
|
|
8
|
|
Six months or greater but less than nine months
|
|
|
6
|
|
|
|
1
|
|
|
|
1
|
|
|
|
1
|
|
|
|
15
|
|
|
|
2
|
|
Nine months or greater but less than twelve months
|
|
|
13
|
|
|
|
94
|
|
|
|
2
|
|
|
|
39
|
|
|
|
8
|
|
|
|
6
|
|
Twelve months or greater
|
|
|
610
|
|
|
|
488
|
|
|
|
73
|
|
|
|
138
|
|
|
|
50
|
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
695
|
|
|
$
|
646
|
|
|
$
|
83
|
|
|
$
|
192
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of cost
|
|
|
|
|
|
|
|
|
|
|
12
|
%
|
|
|
30
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities with a gross unrealized loss of 20% or more
for twelve months or greater decreased from $138 million at
December 31, 2009 to $116 million at December 31,
2010. As shown in the section Evaluating
Temporarily Impaired
Available-for-Sale
Securities below, the $116 million of equity
securities with a gross unrealized loss of 20% or more for
twelve months or greater at December 31, 2010 were
non-redeemable preferred stock, of which $115 million, or
99%, were financial services industry investment grade
non-redeemable preferred stock, of which 77% were rated A or
better.
F-64
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Concentration
of Gross Unrealized Loss and OTTI Loss for Fixed Maturity and
Equity Securities
Available-for-Sale
The Companys gross unrealized losses related to its fixed
maturity and equity securities, including the portion of OTTI
loss on fixed maturity securities recognized in accumulated
other comprehensive income (loss) of $6.9 billion and
$10.8 billion at December 31, 2010 and 2009,
respectively, were concentrated, calculated as a percentage of
gross unrealized loss and OTTI loss, by sector and industry as
follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
Sector:
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
|
24
|
%
|
|
|
25
|
%
|
RMBS
|
|
|
20
|
|
|
|
24
|
|
Foreign corporate securities
|
|
|
14
|
|
|
|
11
|
|
ABS
|
|
|
10
|
|
|
|
12
|
|
Foreign government securities
|
|
|
9
|
|
|
|
1
|
|
U.S. Treasury, agency and government guaranteed securities
|
|
|
8
|
|
|
|
9
|
|
State and political subdivision securities
|
|
|
8
|
|
|
|
4
|
|
CMBS
|
|
|
4
|
|
|
|
10
|
|
Other
|
|
|
3
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
Industry:
|
|
|
|
|
|
|
|
|
Mortgage-backed
|
|
|
24
|
%
|
|
|
34
|
%
|
Finance
|
|
|
21
|
|
|
|
22
|
|
Asset-backed
|
|
|
10
|
|
|
|
12
|
|
Foreign government securities
|
|
|
9
|
|
|
|
1
|
|
U.S. Treasury, agency and government guaranteed securities
|
|
|
8
|
|
|
|
9
|
|
State and political subdivision securities
|
|
|
8
|
|
|
|
4
|
|
Utility
|
|
|
5
|
|
|
|
4
|
|
Consumer
|
|
|
4
|
|
|
|
4
|
|
Communications
|
|
|
2
|
|
|
|
2
|
|
Industrial
|
|
|
2
|
|
|
|
1
|
|
Other
|
|
|
7
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
F-65
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Evaluating
Temporarily Impaired
Available-for-Sale
Securities
The following table presents the Companys fixed maturity
and equity securities, each with a gross unrealized loss of
greater than $10 million, the number of securities, total
gross unrealized loss and percentage of total gross unrealized
loss at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
2010
|
|
2009
|
|
|
Fixed Maturity
|
|
Equity
|
|
Fixed Maturity
|
|
Equity
|
|
|
Securities
|
|
Securities
|
|
Securities
|
|
Securities
|
|
|
(In millions, except number of securities)
|
|
Number of securities
|
|
|
107
|
|
|
|
6
|
|
|
|
223
|
|
|
|
9
|
|
Total gross unrealized loss
|
|
$
|
2,014
|
|
|
$
|
103
|
|
|
$
|
4,465
|
|
|
$
|
132
|
|
Percentage of total gross unrealized loss
|
|
|
30
|
%
|
|
|
43
|
%
|
|
|
43
|
%
|
|
|
48
|
%
|
Fixed maturity and equity securities, each with a gross
unrealized loss greater than $10 million, decreased
$2.5 billion during the year ended December 31, 2010.
The cause of the decline in, or improvement in, gross unrealized
losses for the year ended December 31, 2010, was primarily
attributable to a decrease in interest rates and narrowing of
credit spreads. These securities were included in the
Companys OTTI review process. Based upon the
Companys current evaluation of these securities and other
available-for-sale
securities in an unrealized loss position in accordance with its
impairment policy, and the Companys current intentions and
assessments (as applicable to the type of security) about
holding, selling and any requirements to sell these securities,
the Company has concluded that these securities are not
other-than-temporarily
impaired.
In the Companys impairment review process, the duration
and severity of an unrealized loss position for equity
securities is given greater weight and consideration than for
fixed maturity securities. An extended and severe unrealized
loss position on a fixed maturity security may not have any
impact on the ability of the issuer to service all scheduled
interest and principal payments and the Companys
evaluation of recoverability of all contractual cash flows or
the ability to recover an amount at least equal to its amortized
cost based on the present value of the expected future cash
flows to be collected. In contrast, for an equity security,
greater weight and consideration is given by the Company to a
decline in market value and the likelihood such market value
decline will recover.
The following table presents certain information about the
Companys equity securities
available-for-sale
with a gross unrealized loss of 20% or more at December 31,
2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Redeemable Preferred Stock
|
|
|
|
|
|
|
All Types of
|
|
|
|
|
|
|
|
|
|
All Equity
|
|
|
Non-Redeemable
|
|
|
Investment Grade
|
|
|
|
Securities
|
|
|
Preferred Stock
|
|
|
All Industries
|
|
|
Financial Services Industry
|
|
|
|
Gross
|
|
|
Gross
|
|
|
% of All
|
|
|
Gross
|
|
|
% of All
|
|
|
Gross
|
|
|
|
|
|
% A
|
|
|
|
Unrealized
|
|
|
Unrealized
|
|
|
Equity
|
|
|
Unrealized
|
|
|
Non-Redeemable
|
|
|
Unrealized
|
|
|
% of All
|
|
|
Rated or
|
|
|
|
Loss
|
|
|
Loss
|
|
|
Securities
|
|
|
Loss
|
|
|
Preferred Stock
|
|
|
Loss
|
|
|
Industries
|
|
|
Better
|
|
|
|
(In millions)
|
|
|
Less than six months
|
|
$
|
22
|
|
|
$
|
18
|
|
|
|
82
|
%
|
|
$
|
9
|
|
|
|
50
|
%
|
|
$
|
9
|
|
|
|
100
|
%
|
|
|
100
|
%
|
Six months or greater but less than twelve months
|
|
|
32
|
|
|
|
32
|
|
|
|
100
|
%
|
|
|
32
|
|
|
|
100
|
%
|
|
|
32
|
|
|
|
100
|
%
|
|
|
50
|
%
|
Twelve months or greater
|
|
|
116
|
|
|
|
116
|
|
|
|
100
|
%
|
|
|
115
|
|
|
|
99
|
%
|
|
|
115
|
|
|
|
100
|
%
|
|
|
77
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All equity securities with a gross unrealized loss of 20% or more
|
|
$
|
170
|
|
|
$
|
166
|
|
|
|
98
|
%
|
|
$
|
156
|
|
|
|
94
|
%
|
|
$
|
156
|
|
|
|
100
|
%
|
|
|
73
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In connection with the equity securities impairment review
process, the Company evaluated its holdings in non-redeemable
preferred stock, particularly those companies in the financial
services industry. The Company considered several factors
including whether there has been any deterioration in credit of
the issuer and the likelihood of recovery in value of
non-redeemable preferred stock with a severe or an extended
unrealized loss. The
F-66
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Company also considered whether any issuers of non-redeemable
preferred stock with an unrealized loss held by the Company,
regardless of credit rating, have deferred any dividend
payments. No such dividend payments had been deferred.
With respect to common stock holdings, the Company considered
the duration and severity of the unrealized losses for
securities in an unrealized loss position of 20% or more; and
the duration of unrealized losses for securities in an
unrealized loss position of less than 20% in an extended
unrealized loss position (i.e., 12 months or greater).
Future OTTIs will depend primarily on economic fundamentals,
issuer performance (including changes in the present value of
future cash flows expected to be collected), changes in credit
rating, changes in collateral valuation, changes in interest
rates and changes in credit spreads. If economic fundamentals
and any of the above factors deteriorate, additional OTTIs may
be incurred in upcoming quarters.
Net
Investment Gains (Losses)
See Evaluating
Available-for-Sale
Securities for
Other-Than-Temporary
Impairment for a discussion of changes in guidance adopted
April 1, 2009 that impacted how fixed maturity security
OTTI losses that are charged to earnings are measured.
The components of net investment gains (losses) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Total gains (losses) on fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Total OTTI losses recognized
|
|
$
|
(682
|
)
|
|
$
|
(2,439
|
)
|
|
$
|
(1,296
|
)
|
Less: Noncredit portion of OTTI losses transferred to and
recognized in other comprehensive income (loss)
|
|
|
212
|
|
|
|
939
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net OTTI losses on fixed maturity securities recognized in
earnings
|
|
|
(470
|
)
|
|
|
(1,500
|
)
|
|
|
(1,296
|
)
|
Fixed maturity securities net gains (losses) on
sales and disposals
|
|
|
215
|
|
|
|
(163
|
)
|
|
|
(657
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total gains (losses) on fixed maturity securities
|
|
|
(255
|
)
|
|
|
(1,663
|
)
|
|
|
(1,953
|
)
|
Other net investment gains (losses):
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities
|
|
|
104
|
|
|
|
(399
|
)
|
|
|
(253
|
)
|
Mortgage loans
|
|
|
22
|
|
|
|
(442
|
)
|
|
|
(136
|
)
|
Real estate and real estate joint ventures
|
|
|
(54
|
)
|
|
|
(164
|
)
|
|
|
(18
|
)
|
Other limited partnership interests
|
|
|
(18
|
)
|
|
|
(356
|
)
|
|
|
(140
|
)
|
Other investment portfolio gains (losses)
|
|
|
(6
|
)
|
|
|
(26
|
)
|
|
|
134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal investment portfolio gains (losses)
|
|
|
(207
|
)
|
|
|
(3,050
|
)
|
|
|
(2,366
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FVO consolidated securitization entities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial mortgage loans
|
|
|
758
|
|
|
|
|
|
|
|
|
|
Securities
|
|
|
(78
|
)
|
|
|
|
|
|
|
|
|
Long-term debt related to commercial mortgage loans
|
|
|
(722
|
)
|
|
|
|
|
|
|
|
|
Long-term debt related to securities
|
|
|
48
|
|
|
|
|
|
|
|
|
|
Other gains (losses) (1)
|
|
|
(191
|
)
|
|
|
144
|
|
|
|
268
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal FVO consolidated securitization entities and other
gains (losses)
|
|
|
(185
|
)
|
|
|
144
|
|
|
|
268
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net investment gains (losses)
|
|
$
|
(392
|
)
|
|
$
|
(2,906
|
)
|
|
$
|
(2,098
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Other gains (losses) for the year ended December 31, 2010
includes a loss of $209 million related to recording the
Companys investment in MSI MetLife at its estimated
recoverable amount. See Note 2. |
F-67
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
See Variable Interest Entities for
discussion of CSEs included in the table above.
Gains (losses) from foreign currency transactions included
within net investment gains (losses) were $246 million,
$226 million and $363 million for the years ended
December 31, 2010, 2009 and 2008, respectively.
Proceeds from sales or disposals of fixed maturity and equity
securities and the components of fixed maturity and equity
securities net investment gains (losses) were as shown below.
Investment gains and losses on sales of securities are
determined on a specific identification basis.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
Years Ended December 31,
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
Fixed Maturity Securities
|
|
|
Equity Securities
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Proceeds
|
|
$
|
54,559
|
|
|
$
|
38,972
|
|
|
$
|
62,495
|
|
|
$
|
623
|
|
|
$
|
950
|
|
|
$
|
2,107
|
|
|
$
|
55,182
|
|
|
$
|
39,922
|
|
|
$
|
64,602
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross investment gains
|
|
|
832
|
|
|
|
947
|
|
|
|
858
|
|
|
|
129
|
|
|
|
134
|
|
|
|
440
|
|
|
|
961
|
|
|
|
1,081
|
|
|
|
1,298
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross investment losses
|
|
|
(617
|
)
|
|
|
(1,110
|
)
|
|
|
(1,515
|
)
|
|
|
(11
|
)
|
|
|
(133
|
)
|
|
|
(263
|
)
|
|
|
(628
|
)
|
|
|
(1,243
|
)
|
|
|
(1,778
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total OTTI losses recognized in earnings:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit-related
|
|
|
(423
|
)
|
|
|
(1,137
|
)
|
|
|
(1,138
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(423
|
)
|
|
|
(1,137
|
)
|
|
|
(1,138
|
)
|
Other (1)
|
|
|
(47
|
)
|
|
|
(363
|
)
|
|
|
(158
|
)
|
|
|
(14
|
)
|
|
|
(400
|
)
|
|
|
(430
|
)
|
|
|
(61
|
)
|
|
|
(763
|
)
|
|
|
(588
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total OTTI losses recognized in earnings
|
|
|
(470
|
)
|
|
|
(1,500
|
)
|
|
|
(1,296
|
)
|
|
|
(14
|
)
|
|
|
(400
|
)
|
|
|
(430
|
)
|
|
|
(484
|
)
|
|
|
(1,900
|
)
|
|
|
(1,726
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment gains (losses)
|
|
$
|
(255
|
)
|
|
$
|
(1,663
|
)
|
|
$
|
(1,953
|
)
|
|
$
|
104
|
|
|
$
|
(399
|
)
|
|
$
|
(253
|
)
|
|
$
|
(151
|
)
|
|
$
|
(2,062
|
)
|
|
$
|
(2,206
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Other OTTI losses recognized in earnings include impairments on
equity securities, impairments on perpetual hybrid securities
classified within fixed maturity securities where the primary
reason for the impairment was the severity and/or the duration
of an unrealized loss position and fixed maturity securities
where there is an intent to sell or it is more likely than not
that the Company will be required to sell the security before
recovery of the decline in estimated fair value. |
F-68
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Fixed maturity security OTTI losses recognized in earnings
related to the following sectors and industries within the
U.S. and foreign corporate securities sector:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Sector:
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. and foreign corporate securities by industry:
|
|
|
|
|
|
|
|
|
|
|
|
|
Finance
|
|
$
|
126
|
|
|
$
|
459
|
|
|
$
|
673
|
|
Consumer
|
|
|
36
|
|
|
|
211
|
|
|
|
107
|
|
Communications
|
|
|
16
|
|
|
|
235
|
|
|
|
134
|
|
Utility
|
|
|
3
|
|
|
|
89
|
|
|
|
5
|
|
Industrial
|
|
|
2
|
|
|
|
30
|
|
|
|
26
|
|
Other industries
|
|
|
|
|
|
|
26
|
|
|
|
185
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. and foreign corporate securities
|
|
|
183
|
|
|
|
1,050
|
|
|
|
1,130
|
|
ABS
|
|
|
103
|
|
|
|
168
|
|
|
|
99
|
|
RMBS
|
|
|
98
|
|
|
|
193
|
|
|
|
|
|
CMBS
|
|
|
86
|
|
|
|
88
|
|
|
|
65
|
|
Foreign government securities
|
|
|
|
|
|
|
1
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
470
|
|
|
$
|
1,500
|
|
|
$
|
1,296
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity security OTTI losses recognized in earnings related to
the following sectors and industries:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Sector:
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-redeemable preferred stock
|
|
$
|
7
|
|
|
$
|
333
|
|
|
$
|
319
|
|
Common stock
|
|
|
7
|
|
|
|
67
|
|
|
|
111
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
14
|
|
|
$
|
400
|
|
|
$
|
430
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry:
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial services industry:
|
|
|
|
|
|
|
|
|
|
|
|
|
Perpetual hybrid securities
|
|
$
|
3
|
|
|
$
|
310
|
|
|
$
|
90
|
|
Common and remaining non-redeemable preferred stock
|
|
|
|
|
|
|
30
|
|
|
|
251
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total financial services industry
|
|
|
3
|
|
|
|
340
|
|
|
|
341
|
|
Other industries
|
|
|
11
|
|
|
|
60
|
|
|
|
89
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
14
|
|
|
$
|
400
|
|
|
$
|
430
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-69
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Credit
Loss Rollforward Rollforward of the Cumulative
Credit Loss Component of OTTI Loss Recognized in Earnings on
Fixed Maturity Securities Still Held for Which a Portion of the
OTTI Loss Was Recognized in Other Comprehensive Income
(Loss)
The table below presents a rollforward of the cumulative credit
loss component of OTTI loss recognized in earnings on fixed
maturity securities still held by the Company at
December 31, 2010 and 2009, respectively, for which a
portion of the OTTI loss was recognized in other comprehensive
income (loss):
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Balance, at January 1,
|
|
$
|
581
|
|
|
$
|
|
|
Credit loss component of OTTI loss not reclassified to other
comprehensive income (loss) in the cumulative effect transition
adjustment
|
|
|
|
|
|
|
230
|
|
Additions:
|
|
|
|
|
|
|
|
|
Initial impairments credit loss OTTI recognized on
securities not previously impaired
|
|
|
109
|
|
|
|
311
|
|
Additional impairments credit loss OTTI recognized
on securities previously impaired
|
|
|
125
|
|
|
|
91
|
|
Reductions:
|
|
|
|
|
|
|
|
|
Due to sales (maturities, pay downs or prepayments) during the
period of securities previously credit loss OTTI impaired
|
|
|
(260
|
)
|
|
|
(49
|
)
|
Due to securities de-recognized in connection with the adoption
of new guidance related to the consolidation of VIEs
|
|
|
(100
|
)
|
|
|
|
|
Due to securities impaired to net present value of expected
future cash flows
|
|
|
(2
|
)
|
|
|
|
|
Due to increases in cash flows accretion of previous
credit loss OTTI
|
|
|
(10
|
)
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
Balance, at December 31,
|
|
$
|
443
|
|
|
$
|
581
|
|
|
|
|
|
|
|
|
|
|
F-70
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Net
Investment Income
The components of net investment income were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Investment income:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
$
|
12,489
|
|
|
$
|
11,617
|
|
|
$
|
13,577
|
|
Equity securities
|
|
|
128
|
|
|
|
178
|
|
|
|
258
|
|
Trading and other securities Actively Traded
Securities and FVO general account securities
|
|
|
73
|
|
|
|
116
|
|
|
|
(27
|
)
|
Mortgage loans
|
|
|
2,826
|
|
|
|
2,743
|
|
|
|
2,855
|
|
Policy loans
|
|
|
657
|
|
|
|
648
|
|
|
|
601
|
|
Real estate and real estate joint ventures
|
|
|
439
|
|
|
|
(197
|
)
|
|
|
572
|
|
Other limited partnership interests
|
|
|
879
|
|
|
|
174
|
|
|
|
(170
|
)
|
Cash, cash equivalents and short-term investments
|
|
|
102
|
|
|
|
129
|
|
|
|
353
|
|
International joint ventures (1)
|
|
|
(81
|
)
|
|
|
(115
|
)
|
|
|
43
|
|
Other
|
|
|
235
|
|
|
|
205
|
|
|
|
350
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
17,747
|
|
|
|
15,498
|
|
|
|
18,412
|
|
Less: Investment expenses
|
|
|
930
|
|
|
|
945
|
|
|
|
1,957
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal, net
|
|
|
16,817
|
|
|
|
14,553
|
|
|
|
16,455
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading and other securities FVO
contractholder-directed unit-linked investments
|
|
|
372
|
|
|
|
284
|
|
|
|
(166
|
)
|
FVO consolidated securitization entities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial mortgage loans
|
|
|
411
|
|
|
|
|
|
|
|
|
|
Securities
|
|
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
798
|
|
|
|
284
|
|
|
|
(166
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income
|
|
$
|
17,615
|
|
|
$
|
14,837
|
|
|
$
|
16,289
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Amounts are presented net of changes in estimated fair value of
derivatives related to economic hedges of the Companys
investment in these equity method international joint venture
investments that do not qualify for hedge accounting of
$36 million, ($143) million and $178 million for
the years ended December 31, 2010, 2009 and 2008,
respectively. |
See Variable Interest Entities for
discussion of CSEs included in the table above.
Securities
Lending
The Company participates in securities lending programs whereby
blocks of securities, which are included in fixed maturity
securities and short-term investments, are loaned to third
parties, primarily brokerage firms and commercial banks. The
Company generally obtains collateral, generally cash, in an
amount equal to 102% of the estimated fair value of the
securities loaned, which is obtained at the inception of a loan
and maintained at a level greater than or equal to 100% for the
duration of the loan. Securities loaned under such transactions
may be sold or repledged by the transferee. The Company is
liable to return to its counterparties the cash collateral under
its control. These transactions are treated as financing
arrangements and the associated liability is recorded at the
amount of the cash received.
F-71
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Elements of the securities lending programs are presented below
at:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Securities on loan:
|
|
|
|
|
|
|
|
|
Amortized cost
|
|
$
|
23,715
|
|
|
$
|
21,012
|
|
Estimated fair value
|
|
$
|
24,230
|
|
|
$
|
20,949
|
|
Aging of cash collateral liability:
|
|
|
|
|
|
|
|
|
Open (1)
|
|
$
|
2,752
|
|
|
$
|
3,290
|
|
Less than thirty days
|
|
|
12,301
|
|
|
|
13,605
|
|
Thirty days or greater but less than sixty days
|
|
|
4,399
|
|
|
|
3,534
|
|
Sixty days or greater but less than ninety days
|
|
|
2,291
|
|
|
|
92
|
|
Ninety days or greater
|
|
|
2,904
|
|
|
|
995
|
|
|
|
|
|
|
|
|
|
|
Total cash collateral liability
|
|
$
|
24,647
|
|
|
$
|
21,516
|
|
|
|
|
|
|
|
|
|
|
Security collateral on deposit from counterparties
|
|
$
|
|
|
|
$
|
6
|
|
|
|
|
|
|
|
|
|
|
Reinvestment portfolio estimated fair value
|
|
$
|
24,177
|
|
|
$
|
20,339
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Open meaning that the related loaned security could
be returned to the Company on the next business day requiring
the Company to immediately return the cash collateral. |
The estimated fair value of the securities on loan related to
the cash collateral on open at December 31, 2010 was $2.7
billion, of which $2.3 billion were U.S. Treasury, agency
and government guaranteed securities which, if put to the
Company, can be immediately sold to satisfy the cash
requirements. The remainder of the securities on loan were
primarily U.S. Treasury, agency and government guaranteed
securities, and very liquid RMBS. The reinvestment portfolio
acquired with the cash collateral consisted principally of fixed
maturity securities (including RMBS, U.S. corporate,
U.S. Treasury, agency and government guaranteed and ABS).
Security collateral on deposit from counterparties in connection
with the securities lending transactions may not be sold or
repledged, unless the counterparty is in default, and is not
reflected in the consolidated financial statements. Separately,
the Company had $49 million and $46 million, at
estimated fair value, of cash and security collateral on deposit
from a counterparty to secure its interest in a pooled
investment that is held by a third-party trustee, as custodian,
at December 31, 2010 and 2009, respectively. This pooled
investment is included within fixed maturity securities and had
an estimated fair value of $49 million and $51 million
at December 31, 2010 and 2009, respectively.
F-72
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Invested
Assets on Deposit, Held in Trust and Pledged as
Collateral
The invested assets on deposit, invested assets held in trust
and invested assets pledged as collateral are presented in the
table below. The amounts presented in the table below are at
estimated fair value for cash and cash equivalents, short-term
investments, fixed maturity, equity, trading and other
securities and at carrying value for mortgage loans.
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Invested assets on deposit:
|
|
|
|
|
|
|
|
|
Regulatory agencies (1)
|
|
$
|
2,110
|
|
|
$
|
1,383
|
|
Invested assets held in trust:
|
|
|
|
|
|
|
|
|
Collateral financing arrangements (2)
|
|
|
5,340
|
|
|
|
5,653
|
|
Reinsurance arrangements (3)
|
|
|
3,090
|
|
|
|
2,719
|
|
Invested assets pledged as collateral:
|
|
|
|
|
|
|
|
|
Funding agreements and advances FHLB of NY (4)
|
|
|
21,975
|
|
|
|
20,612
|
|
Funding agreements FHLB of Boston (4)
|
|
|
211
|
|
|
|
419
|
|
Funding agreements Farmer Mac (5)
|
|
|
3,159
|
|
|
|
2,871
|
|
Federal Reserve Bank of New York (6)
|
|
|
1,822
|
|
|
|
1,537
|
|
Collateral financing arrangements (7)
|
|
|
112
|
|
|
|
80
|
|
Derivative transactions (8)
|
|
|
1,726
|
|
|
|
1,671
|
|
Short sale agreements (9)
|
|
|
465
|
|
|
|
496
|
|
|
|
|
|
|
|
|
|
|
Total invested assets on deposit, held in trust and pledged as
collateral
|
|
$
|
40,010
|
|
|
$
|
37,441
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Company has investment assets on deposit with regulatory
agencies consisting primarily of cash and cash equivalents,
short-term investments, fixed maturity securities and equity
securities. |
|
(2) |
|
The Company held in trust cash and securities, primarily fixed
maturity and equity securities, to satisfy collateral
requirements. |
|
(3) |
|
The Company held in trust certain investments, primarily fixed
maturity securities, in connection with certain reinsurance
transactions. |
|
(4) |
|
The Company has pledged fixed maturity securities and mortgage
loans in support of its funding agreements with, and advances
from, the Federal Home Loan Bank of New York (FHLB of
NY) and has pledged fixed maturity securities in support
of its funding agreements with the Federal Home Loan Bank of
Boston (FHLB of Boston). The nature of these Federal
Home Loan Bank arrangements is described in Notes 8 and 11. |
|
(5) |
|
The Company has pledged certain agricultural mortgage loans in
connection with funding agreements issued to certain SPEs that
have issued securities guaranteed by the Federal Agricultural
Mortgage Corporation (Farmer Mac). The nature of
these Farmer Mac arrangements is described in Note 8. |
|
(6) |
|
The Company has pledged qualifying mortgage loans and fixed
maturity securities in connection with collateralized borrowings
from the Federal Reserve Bank of New Yorks Term Auction
Facility. The nature of the Federal Reserve Bank of New York
arrangements is described in Note 11. |
|
(7) |
|
The Holding Company has pledged certain collateral in support of
the collateral financing arrangements described in Note 12. |
|
(8) |
|
Certain of the Companys invested assets are pledged as
collateral for various derivative transactions as described in
Note 4. |
F-73
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
(9) |
|
Certain of the Companys Actively Traded Securities and
cash and cash equivalents are pledged to secure liabilities
associated with short sale agreements in the Actively Traded
Securities portfolio. |
See also Securities Lending for the
amount of the Companys cash received from and due back to
counterparties pursuant to the Companys securities lending
program. See Variable Interest Entities
for assets of certain CSEs that can only be used to settle
liabilities of such entities.
Trading
and Other Securities
The tables below present certain information about the
Companys trading securities and other securities for which
the FVO has been elected:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Actively Traded Securities
|
|
$
|
463
|
|
|
$
|
420
|
|
FVO general account securities
|
|
|
131
|
|
|
|
78
|
|
FVO contractholder-directed unit-linked investments
|
|
|
17,794
|
|
|
|
1,886
|
|
FVO securities held by consolidated securitization entities
|
|
|
201
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading and other securities at estimated fair
value
|
|
$
|
18,589
|
|
|
$
|
2,384
|
|
|
|
|
|
|
|
|
|
|
Actively Traded Securities at estimated fair value
|
|
$
|
463
|
|
|
$
|
420
|
|
Short sale agreement liabilities at estimated fair
value
|
|
|
(46
|
)
|
|
|
(106
|
)
|
|
|
|
|
|
|
|
|
|
Net long/short position at estimated fair value
|
|
$
|
417
|
|
|
$
|
314
|
|
|
|
|
|
|
|
|
|
|
Investments pledged to secure short sale agreement liabilities
|
|
$
|
465
|
|
|
$
|
496
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Actively Traded Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income
|
|
$
|
54
|
|
|
$
|
98
|
|
|
$
|
(13
|
)
|
Changes in estimated fair value included in net investment income
|
|
$
|
12
|
|
|
$
|
18
|
|
|
$
|
(2
|
)
|
FVO general account securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income
|
|
$
|
19
|
|
|
$
|
18
|
|
|
$
|
(14
|
)
|
Changes in estimated fair value included in net investment income
|
|
$
|
18
|
|
|
$
|
16
|
|
|
$
|
(17
|
)
|
FVO contractholder-directed unit-linked investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income
|
|
$
|
372
|
|
|
$
|
284
|
|
|
$
|
(166
|
)
|
Changes in estimated fair value included in net investment income
|
|
$
|
322
|
|
|
$
|
275
|
|
|
$
|
(155
|
)
|
FVO securities held by consolidated securitization entities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income
|
|
$
|
15
|
|
|
$
|
|
|
|
$
|
|
|
Changes in estimated fair value included in net investment gains
(losses)
|
|
$
|
(78
|
)
|
|
$
|
|
|
|
$
|
|
|
See Note 1 for discussion of FVO contractholder-directed
unit-linked investments and Variable Interest
Entities for discussion of CSEs included in the tables
above. The FVO contractholder-directed unit-linked investments
held as of December 31, 2010 were primarily due to the
Acquisition (see Note 2).
F-74
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Mortgage
Loans
Mortgage loans are summarized as follows at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
Carrying
|
|
|
% of
|
|
|
Carrying
|
|
|
% of
|
|
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Mortgage loans
held-for-investment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial mortgage loans
|
|
$
|
37,820
|
|
|
|
60.7
|
%
|
|
$
|
35,176
|
|
|
|
69.0
|
%
|
Agricultural mortgage loans
|
|
|
12,751
|
|
|
|
20.4
|
|
|
|
12,255
|
|
|
|
24.1
|
|
Residential mortgage loans
|
|
|
2,308
|
|
|
|
3.7
|
|
|
|
1,471
|
|
|
|
2.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
52,879
|
|
|
|
84.8
|
|
|
|
48,902
|
|
|
|
96.0
|
|
Valuation allowances
|
|
|
(664
|
)
|
|
|
(1.1
|
)
|
|
|
(721
|
)
|
|
|
(1.4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal mortgage loans
held-for-investment,
net
|
|
|
52,215
|
|
|
|
83.7
|
|
|
|
48,181
|
|
|
|
94.6
|
|
Commercial mortgage loans held by consolidated securitization
entities FVO
|
|
|
6,840
|
|
|
|
11.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total mortgage loans
held-for-investment,
net
|
|
|
59,055
|
|
|
|
94.7
|
|
|
|
48,181
|
|
|
|
94.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans
held-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential mortgage loans FVO
|
|
|
2,510
|
|
|
|
4.0
|
|
|
|
2,470
|
|
|
|
4.9
|
|
Mortgage loans lower of amortized cost or estimated
fair value (1)
|
|
|
811
|
|
|
|
1.3
|
|
|
|
258
|
|
|
|
0.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total mortgage loans
held-for-sale
|
|
|
3,321
|
|
|
|
5.3
|
|
|
|
2,728
|
|
|
|
5.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total mortgage loans, net
|
|
$
|
62,376
|
|
|
|
100.0
|
%
|
|
$
|
50,909
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes agricultural and residential mortgage loans. |
See Variable Interest Entities for
discussion of CSEs included in the table above.
Concentration of Credit Risk The Company
diversifies its mortgage loan portfolio by both geographic
region and property type to reduce the risk of concentration.
The Companys commercial and agricultural mortgage loans
are collateralized by properties primarily located in the United
States, at 91%, with the remaining 9% collateralized by
properties located outside the United States, calculated as a
percent of total mortgage loans
held-for-investment
(excluding commercial mortgage loans held by CSEs) at
December 31, 2010. The carrying value of the Companys
commercial and agricultural mortgage loans located in
California, New York and Texas were 21%, 8% and 7%,
respectively, of total mortgage loans
held-for-investment
(excluding commercial mortgage loans held by CSEs) at
December 31, 2010. Additionally, the Company manages risk
when originating commercial and agricultural mortgage loans by
generally lending only up to 75% of the estimated fair value of
the underlying real estate.
Certain of the Companys real estate joint ventures have
mortgage loans with the Company. The carrying values of such
mortgage loans were $283 million and $368 million at
December 31, 2010 and 2009, respectively.
F-75
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following tables present the recorded investment in mortgage
loans
held-for-investment,
by portfolio segment, by method of evaluation of credit loss,
and the related valuation allowances, by type of credit loss, at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2010
|
|
|
2009
|
|
|
2010
|
|
|
2009
|
|
|
2010
|
|
|
2009
|
|
|
|
Commercial
|
|
|
Agricultural
|
|
|
Residential
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Mortgage loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Evaluated individually for credit losses
|
|
$
|
120
|
|
|
$
|
102
|
|
|
$
|
146
|
|
|
$
|
211
|
|
|
$
|
15
|
|
|
$
|
3
|
|
|
$
|
281
|
|
|
$
|
316
|
|
Evaluated collectively for credit losses
|
|
|
37,700
|
|
|
|
35,074
|
|
|
|
12,605
|
|
|
|
12,044
|
|
|
|
2,293
|
|
|
|
1,468
|
|
|
|
52,598
|
|
|
|
48,586
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total mortgage loans
|
|
|
37,820
|
|
|
|
35,176
|
|
|
|
12,751
|
|
|
|
12,255
|
|
|
|
2,308
|
|
|
|
1,471
|
|
|
|
52,879
|
|
|
|
48,902
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation allowances:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Specific credit losses
|
|
|
36
|
|
|
|
41
|
|
|
|
52
|
|
|
|
82
|
|
|
|
|
|
|
|
|
|
|
|
88
|
|
|
|
123
|
|
Non-specifically identified credit losses
|
|
|
526
|
|
|
|
548
|
|
|
|
36
|
|
|
|
33
|
|
|
|
14
|
|
|
|
17
|
|
|
|
576
|
|
|
|
598
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total valuation allowances
|
|
|
562
|
|
|
|
589
|
|
|
|
88
|
|
|
|
115
|
|
|
|
14
|
|
|
|
17
|
|
|
|
664
|
|
|
|
721
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans, net of valuation allowance
|
|
$
|
37,258
|
|
|
$
|
34,587
|
|
|
$
|
12,663
|
|
|
$
|
12,140
|
|
|
$
|
2,294
|
|
|
$
|
1,454
|
|
|
$
|
52,215
|
|
|
$
|
48,181
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following tables present the changes in the valuation
allowance, by portfolio segment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage Loan Valuation Allowances
|
|
|
|
Commercial
|
|
|
Agricultural
|
|
|
Residential
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Balance at January 1, 2008
|
|
$
|
167
|
|
|
$
|
24
|
|
|
$
|
6
|
|
|
$
|
197
|
|
Provision (release)
|
|
|
145
|
|
|
|
49
|
|
|
|
6
|
|
|
|
200
|
|
Charge-offs, net of recoveries
|
|
|
(80
|
)
|
|
|
(12
|
)
|
|
|
(1
|
)
|
|
|
(93
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
|
232
|
|
|
|
61
|
|
|
|
11
|
|
|
|
304
|
|
Provision (release)
|
|
|
384
|
|
|
|
79
|
|
|
|
12
|
|
|
|
475
|
|
Charge-offs, net of recoveries
|
|
|
(27
|
)
|
|
|
(25
|
)
|
|
|
(6
|
)
|
|
|
(58
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2009
|
|
|
589
|
|
|
|
115
|
|
|
|
17
|
|
|
|
721
|
|
Provision (release)
|
|
|
(5
|
)
|
|
|
12
|
|
|
|
2
|
|
|
|
9
|
|
Charge-offs, net of recoveries
|
|
|
(22
|
)
|
|
|
(39
|
)
|
|
|
(5
|
)
|
|
|
(66
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2010
|
|
$
|
562
|
|
|
$
|
88
|
|
|
$
|
14
|
|
|
$
|
664
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-76
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Commercial Mortgage Loans by Credit Quality
Indicators with Estimated Fair Value: Presented
below for the commercial mortgage loans
held-for-investment
is the recorded investment, prior to valuation allowances, by
the indicated
loan-to-value
ratio categories and debt service coverage ratio categories and
estimated fair value of such mortgage loans by the indicated
loan-to-value
ratio categories at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
Recorded Investment
|
|
|
|
|
|
|
|
|
|
Debt Service Coverage Ratios
|
|
|
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
|
> 1.20x
|
|
|
1.00x - 1.20x
|
|
|
< 1.00x
|
|
|
Total
|
|
|
% of Total
|
|
|
Fair Value
|
|
|
% of Total
|
|
|
|
(In millions)
|
|
|
(In millions)
|
|
|
Loan-to-value
ratios:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than 65%
|
|
$
|
16,664
|
|
|
$
|
125
|
|
|
$
|
483
|
|
|
$
|
17,272
|
|
|
|
45.7
|
%
|
|
$
|
18,183
|
|
|
|
46.9
|
%
|
65% to 75%
|
|
|
9,023
|
|
|
|
765
|
|
|
|
513
|
|
|
|
10,301
|
|
|
|
27.2
|
|
|
|
10,686
|
|
|
|
27.6
|
|
76% to 80%
|
|
|
3,033
|
|
|
|
304
|
|
|
|
135
|
|
|
|
3,472
|
|
|
|
9.2
|
|
|
|
3,536
|
|
|
|
9.1
|
|
Greater than 80%
|
|
|
4,155
|
|
|
|
1,813
|
|
|
|
807
|
|
|
|
6,775
|
|
|
|
17.9
|
|
|
|
6,374
|
|
|
|
16.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
32,875
|
|
|
$
|
3,007
|
|
|
$
|
1,938
|
|
|
$
|
37,820
|
|
|
|
100.0
|
%
|
|
$
|
38,779
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agricultural and Residential Mortgage Loans by
Credit Quality Indicator: The recorded investment
in agricultural and residential mortgage loans
held-for-investment,
prior to valuation allowances, by credit quality indicator, was
at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
Agricultural Mortgage Loans
|
|
|
|
|
Residential Mortgage Loans
|
|
|
|
Recorded Investment
|
|
|
% of Total
|
|
|
|
|
Recorded Investment
|
|
|
% of Total
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Loan-to-value
ratios:
|
|
|
|
|
|
|
|
|
|
Performance indicators:
|
|
|
|
|
|
|
|
|
Less than 65%
|
|
$
|
11,483
|
|
|
|
90.1
|
%
|
|
Performing
|
|
$
|
2,225
|
|
|
|
96.4
|
%
|
65% to 75%
|
|
|
885
|
|
|
|
6.9
|
|
|
Nonperforming
|
|
|
83
|
|
|
|
3.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
76% to 80%
|
|
|
48
|
|
|
|
0.4
|
|
|
Total
|
|
$
|
2,308
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Greater than 80%
|
|
|
335
|
|
|
|
2.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
12,751
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Past Due and Interest Accrual Status of Mortgage
Loans. The Company has a high quality, well
performing, mortgage loan portfolio with approximately 99% of
all mortgage loans classified as performing.
Past Due. The Company defines delinquent
mortgage loans consistent with industry practice, when interest
and principal payments are past due as follows: commercial
mortgage loans 60 days past due; agricultural
mortgage loans 90 days past due; and
residential mortgage loans 60 days past due.
The recorded investment in mortgage loans
held-for-investment,
prior to valuation allowances, past due according to these aging
categories was $58 million, $159 million and
$79 million for commercial, agricultural and residential
mortgage loans, respectively, at December 31, 2010; and for
all mortgage loans was $296 million and $220 million
at December 31, 2010 and 2009, respectively.
Accrual Status. Past Due 90 Days or More and Still Accruing
Interest. The recorded investment in mortgage
loans
held-for-investment,
prior to valuation allowances, that were past due 90 days
or more and still accruing interest was $1 million,
$13 million and $11 million for commercial,
agricultural and residential mortgage loans, respectively, at
December 31, 2010; and for all mortgage loans, was
$25 million and $14 million at December 31, 2010
and 2009, respectively.
Accrual Status. Mortgage Loans in Nonaccrual
Status. The recorded investment in mortgage loans
held-for-investment,
prior to valuation allowances, that were in nonaccrual status
was $7 million, $177 million
F-77
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
and $25 million for commercial, agricultural and
residential mortgage loans, respectively, at December 31,
2010; and for all mortgage loans, was $209 million and
$263 million at December 31, 2010 and 2009,
respectively.
Impaired Mortgage Loans. The unpaid principal
balance, recorded investment, valuation allowances and carrying
value, net of valuation allowances, for impaired mortgage loans
held-for-investment,
by portfolio segment, at December 31, 2010 and for all
impaired mortgage loans
held-for-investment
at December 31, 2009, were as follows at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impaired Mortgage Loans
|
|
|
|
|
|
|
Loans without
|
|
|
|
|
|
|
Loans with a Valuation Allowance
|
|
|
a Valuation Allowance
|
|
|
All Impaired Loans
|
|
|
|
Unpaid
|
|
|
|
|
|
|
|
|
|
|
|
Unpaid
|
|
|
|
|
|
Unpaid
|
|
|
|
|
|
|
Principal
|
|
|
Recorded
|
|
|
Valuation
|
|
|
Carrying
|
|
|
Principal
|
|
|
Recorded
|
|
|
Principal
|
|
|
Carrying
|
|
|
|
Balance
|
|
|
Investment
|
|
|
Allowances
|
|
|
Value
|
|
|
Balance
|
|
|
Investment
|
|
|
Balance
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
At December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial mortgage loans
|
|
$
|
120
|
|
|
$
|
120
|
|
|
$
|
36
|
|
|
$
|
84
|
|
|
$
|
99
|
|
|
$
|
87
|
|
|
$
|
219
|
|
|
$
|
171
|
|
Agricultural mortgage loans
|
|
|
146
|
|
|
|
146
|
|
|
|
52
|
|
|
|
94
|
|
|
|
123
|
|
|
|
119
|
|
|
|
269
|
|
|
|
213
|
|
Residential mortgage loans
|
|
|
3
|
|
|
|
3
|
|
|
|
|
|
|
|
3
|
|
|
|
16
|
|
|
|
16
|
|
|
|
19
|
|
|
|
19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
269
|
|
|
$
|
269
|
|
|
$
|
88
|
|
|
$
|
181
|
|
|
$
|
238
|
|
|
$
|
222
|
|
|
$
|
507
|
|
|
$
|
403
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total mortgage loans at December 31, 2009
|
|
$
|
316
|
|
|
$
|
316
|
|
|
$
|
123
|
|
|
$
|
193
|
|
|
$
|
106
|
|
|
$
|
106
|
|
|
$
|
422
|
|
|
$
|
299
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unpaid principal balance is generally prior to any charge-off.
The average investment in impaired mortgage loans
held-for-investment,
and the related interest income, by portfolio segment, for the
year ended December 31, 2010 and for all mortgage loans for
the years ended December 31, 2009 and 2008, respectively,
was:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Investment
|
|
|
|
|
|
|
|
|
|
Impaired Mortgage Loans
|
|
|
|
|
|
|
Interest Income Recognized
|
|
|
|
|
|
|
Cash Basis
|
|
|
Accrual Basis
|
|
|
|
(In millions)
|
|
|
For the Year Ended December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial mortgage loans
|
|
$
|
192
|
|
|
$
|
5
|
|
|
$
|
1
|
|
Agricultural mortgage loans
|
|
|
284
|
|
|
|
6
|
|
|
|
2
|
|
Residential mortgage loans
|
|
|
16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
492
|
|
|
$
|
11
|
|
|
$
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2009
|
|
$
|
338
|
|
|
$
|
8
|
|
|
$
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2008
|
|
$
|
389
|
|
|
$
|
12
|
|
|
$
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-78
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Real
Estate and Real Estate Joint Ventures
Real estate investments by type consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
Carrying
|
|
|
% of
|
|
|
Carrying
|
|
|
% of
|
|
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Traditional
|
|
$
|
5,163
|
|
|
|
64.3
|
%
|
|
$
|
4,135
|
|
|
|
60.0
|
%
|
Real estate joint ventures and funds
|
|
|
2,707
|
|
|
|
33.7
|
|
|
|
2,579
|
|
|
|
37.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real estate and real estate joint ventures
|
|
|
7,870
|
|
|
|
98.0
|
|
|
|
6,714
|
|
|
|
97.4
|
|
Foreclosed
|
|
|
152
|
|
|
|
1.9
|
|
|
|
127
|
|
|
|
1.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real estate
held-for-investment
|
|
|
8,022
|
|
|
|
99.9
|
|
|
|
6,841
|
|
|
|
99.2
|
|
Real estate
held-for-sale
|
|
|
8
|
|
|
|
0.1
|
|
|
|
55
|
|
|
|
0.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total real estate and real estate joint ventures
|
|
$
|
8,030
|
|
|
|
100.0
|
%
|
|
$
|
6,896
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company classifies within traditional real estate its
investment in income-producing real estate, which is comprised
primarily of wholly-owned real estate and, to a much lesser
extent joint ventures with interests in single property
income-producing real estate. The Company classifies within real
estate joint ventures and funds, its investments in joint
ventures with interests in multi-property projects with varying
strategies ranging from the development of properties to the
operation of income-producing properties as well as its
investments in real estate private equity funds. From time to
time, the Company transfers investments from these joint
ventures to traditional real estate, if the Company retains an
interest in the joint venture after a completed property
commences operations and the Company intends to retain an
interest in the property.
Properties acquired through foreclosure were $165 million,
$127 million and less than $1 million for the years
ended December 31, 2010, 2009 and 2008, respectively, and
includes commercial, agricultural and residential properties.
After the Company acquires properties through foreclosure, it
evaluates whether the property is appropriate for retention in
its traditional real estate portfolio. Foreclosed real estate
held at December 31, 2010 and 2009 includes those
properties the Company has not selected for retention in its
traditional real estate portfolio and which do not meet the
criteria to be classified as
held-for-sale.
The wholly-owned real estate within traditional real estate is
net of accumulated depreciation of $1.7 billion and $1.4 billion
at December 31, 2010 and 2009, respectively. Related
depreciation expense on traditional wholly-owned real estate was
$151 million, $135 million and $136 million for
the years ended December 31, 2010, 2009 and 2008,
respectively. These amounts include depreciation expense related
to discontinued operations of less than $1 million for the
year ended December 31, 2010, and $1 million for both
the years ended December 31, 2009 and 2008. The estimated
fair value of the traditional real estate investment portfolio
was $6.6 billion and $5.4 billion at December 31, 2010, and
2009, respectively.
Impairments recognized on real estate
held-for-investment
were $48 million, $160 million and $20 million
for the years ended December 31, 2010, 2009 and 2008,
respectively. Impairments recognized on real estate
held-for-sale
were $1 million for the year ended December 31, 2010.
There were no impairments recognized on real estate
held-for-sale
for each of the years ended December 31, 2009 and 2008. The
Companys carrying value of real estate
held-for-sale
has been reduced by impairments recorded prior to 2009 of
$1 million at both December 31, 2010 and 2009. The
carrying value of non-income producing real estate was
$137 million, $76 million and $28 million at
December 31, 2010, 2009 and 2008, respectively.
The Company diversifies its real estate investments by both
geographic region and property type to reduce risk of
concentration. The Companys real estate investments are
primarily located in the United States, at 88%, with the
F-79
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
remaining 12% located outside the United States , at
December 31, 2010. The three locations with the largest
real estate investments were California, Florida and Japan at
21%, 12% and 10%, respectively, at December 31, 2010.
The Companys real estate investments by property type are
categorized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
Carrying
|
|
|
% of
|
|
|
Carrying
|
|
|
% of
|
|
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Office
|
|
$
|
4,369
|
|
|
|
54.4
|
%
|
|
$
|
3,557
|
|
|
|
51.6
|
%
|
Apartments
|
|
|
1,774
|
|
|
|
22.1
|
|
|
|
1,438
|
|
|
|
20.9
|
|
Real estate private equity funds
|
|
|
552
|
|
|
|
6.9
|
|
|
|
504
|
|
|
|
7.3
|
|
Industrial
|
|
|
433
|
|
|
|
5.4
|
|
|
|
436
|
|
|
|
6.3
|
|
Retail
|
|
|
389
|
|
|
|
4.8
|
|
|
|
467
|
|
|
|
6.8
|
|
Hotel
|
|
|
233
|
|
|
|
2.9
|
|
|
|
203
|
|
|
|
2.9
|
|
Land
|
|
|
133
|
|
|
|
1.7
|
|
|
|
110
|
|
|
|
1.6
|
|
Agriculture
|
|
|
17
|
|
|
|
0.2
|
|
|
|
57
|
|
|
|
0.8
|
|
Other
|
|
|
130
|
|
|
|
1.6
|
|
|
|
124
|
|
|
|
1.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total real estate and real estate joint ventures
|
|
$
|
8,030
|
|
|
|
100.0
|
%
|
|
$
|
6,896
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
Limited Partnership Interests
The carrying value of other limited partnership interests (which
primarily represent ownership interests in pooled investment
funds that principally make private equity investments in
companies in the United States and overseas) was
$6.4 billion and $5.5 billion at December 31,
2010 and 2009, respectively. Included within other limited
partnership interests were $1.0 billion, at both
December 31, 2010 and 2009, of investments in hedge funds.
Impairments of other limited partnership interests, principally
cost method other limited partnership interests, were
$12 million, $354 million and $105 million for
the years ended December 31, 2010, 2009 and 2008,
respectively.
Collectively
Significant Equity Method Investments
The Company holds investments in real estate joint ventures,
real estate funds and other limited partnership interests
consisting of leveraged buy-out funds, hedge funds, private
equity funds, joint ventures and other funds. The portion of
these investments accounted for under the equity method had a
carrying value of $8.7 billion as of December 31,
2010. The Companys maximum exposure to loss related to
these equity method investments is limited to the carrying value
of these investments plus unfunded commitments of
$2.9 billion as of December 31, 2010. Except for
certain real estate joint ventures, the Companys
investments in real estate funds and other limited partnership
interests are generally of a passive nature in that the Company
does not participate in the management of the entities.
As further described in Note 1, the Company generally
records its share of earnings in its equity method investments
using a three-month lag methodology and within net investment
income. As of December 31, 2010, aggregate net investment
income from these equity method real estate joint ventures, real
estate funds and other limited partnership interests exceeded
10% of the Companys consolidated pre-tax income (loss)
from continuing operations. Accordingly, the Company is
providing the following aggregated summarized financial data for
such equity method investments. This aggregated summarized
financial data does not represent the Companys
proportionate share of the assets, liabilities, or earnings of
such entities.
As of, and for the year ended December 31, 2010, the
aggregated summarized financial data presented below reflects
the latest available financial information. Aggregate total
assets of these entities totaled $262.9 billion and
F-80
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
$209.9 billion as of December 31, 2010 and 2009,
respectively. Aggregate total liabilities of these entities
totaled $77.6 billion and $64.5 billion as of
December 31, 2010 and 2009, respectively. Aggregate net
income (loss) of these entities totaled $18.7 billion,
$22.8 billion and ($23.3) billion for the years ended
December 31, 2010, 2009 and 2008, respectively. Aggregate
net income (loss) from real estate joint ventures, real estate
funds and other limited partnership interests is primarily
comprised of investment income, including recurring investment
income and realized and unrealized investment gains (losses).
Other
Invested Assets
The following table presents the carrying value of the
Companys other invested assets by type at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
Carrying
|
|
|
% of
|
|
|
Carrying
|
|
|
% of
|
|
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Freestanding derivatives with positive fair values
|
|
$
|
7,777
|
|
|
|
50.4
|
%
|
|
$
|
6,133
|
|
|
|
48.2
|
%
|
Leveraged leases, net of non-recourse debt
|
|
|
2,191
|
|
|
|
14.2
|
|
|
|
2,227
|
|
|
|
17.5
|
|
Tax credit partnerships
|
|
|
976
|
|
|
|
6.3
|
|
|
|
719
|
|
|
|
5.7
|
|
MSRs
|
|
|
950
|
|
|
|
6.2
|
|
|
|
878
|
|
|
|
6.9
|
|
Joint venture investments
|
|
|
694
|
|
|
|
4.5
|
|
|
|
977
|
|
|
|
7.7
|
|
Funds withheld
|
|
|
551
|
|
|
|
3.6
|
|
|
|
505
|
|
|
|
4.0
|
|
Funding agreements
|
|
|
|
|
|
|
|
|
|
|
409
|
|
|
|
3.2
|
|
Other
|
|
|
2,291
|
|
|
|
14.8
|
|
|
|
861
|
|
|
|
6.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
15,430
|
|
|
|
100.0
|
%
|
|
$
|
12,709
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Note 4 for information regarding the freestanding
derivatives with positive estimated fair values. See the
following sections, Leveraged Leases and
Mortgage Servicing Rights, for the composition of
leveraged leases and for information on MSRs. Tax credit
partnerships are established for the purpose of investing in
low-income housing and other social causes, where the primary
return on investment is in the form of income tax credits, and
are accounted for under the equity method or under the effective
yield method. Joint venture investments are accounted for under
the equity method and represent the Companys investment in
insurance underwriting joint ventures in China, Japan (see
Note 2) and Chile. Funds withheld represent amounts
contractually withheld by ceding companies in accordance with
reinsurance agreements. Funding agreements represent
arrangements where the Company has long-term interest bearing
amounts on deposit with third parties and are generally stated
at amortized cost.
Leveraged
Leases
Investment in leveraged leases, included in other invested
assets, consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Rental receivables, net
|
|
$
|
1,882
|
|
|
$
|
1,698
|
|
Estimated residual values
|
|
|
1,682
|
|
|
|
1,921
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
3,564
|
|
|
|
3,619
|
|
Unearned income
|
|
|
(1,373
|
)
|
|
|
(1,392
|
)
|
|
|
|
|
|
|
|
|
|
Investment in leveraged leases
|
|
$
|
2,191
|
|
|
$
|
2,227
|
|
|
|
|
|
|
|
|
|
|
F-81
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The rental receivables set forth above are generally due in
periodic installments. The payment periods range from one to
15 years, but in certain circumstances are as long as
30 years. For rental receivables, the Companys
primary credit quality indicator is whether the rental
receivable is performing or non-performing. The Company
generally defines non-performing rental receivables as those
that are 90 days or more past due. The determination of
performing or non-performing status is assessed monthly. As of
December 31, 2010, all of the rental receivables were
performing.
The Companys deferred income tax liability related to
leveraged leases was $1.4 billion and $1.3 billion at
December 31, 2010 and 2009, respectively.
The components of net income from investment in leveraged leases
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Net income from investment in leveraged leases
|
|
$
|
123
|
|
|
$
|
114
|
|
|
$
|
116
|
|
Less: Income tax expense on leveraged leases net investment
income
|
|
|
(43
|
)
|
|
|
(40
|
)
|
|
|
(40
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income after income tax from investment in
leveraged leases
|
|
$
|
80
|
|
|
$
|
74
|
|
|
$
|
76
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage
Servicing Rights
The following table presents the carrying value and changes in
capitalized MSRs, which are included in other invested assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Estimated fair value at January 1,
|
|
$
|
878
|
|
|
$
|
191
|
|
|
$
|
|
|
Acquisition of MSRs
|
|
|
110
|
|
|
|
117
|
|
|
|
350
|
|
Origination of MSRs
|
|
|
220
|
|
|
|
511
|
|
|
|
|
|
Reductions due to loan payments
|
|
|
(136
|
)
|
|
|
(113
|
)
|
|
|
(10
|
)
|
Reductions due to loan sales
|
|
|
(43
|
)
|
|
|
|
|
|
|
|
|
Changes in estimated fair value due to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in valuation model inputs or assumptions
|
|
|
(79
|
)
|
|
|
172
|
|
|
|
(149
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated fair value at December 31,
|
|
$
|
950
|
|
|
$
|
878
|
|
|
$
|
191
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company recognizes the rights to service residential
mortgage loans as MSRs. MSRs are either acquired or are
generated from the sale of originated residential mortgage loans
where the servicing rights are retained by the Company. MSRs are
carried at estimated fair value and changes in estimated fair
value, primarily due to changes in valuation inputs and
assumptions and to the collection of expected cash flows, are
reported in other revenues in the period in which the change
occurs. Valuation inputs and assumptions include generally
observable inputs such as type and age of loan, loan interest
rates, current market interest rates and certain unobservable
inputs, including assumptions regarding estimates of discount
rates, loan prepayments and servicing costs, all of which are
sensitive to changing market conditions. See Note 5 for
further information about how the estimated fair value of MSRs
is determined and other related information.
Short-term
Investments
The carrying value of short-term investments, which includes
investments with remaining maturities of one year or less, but
greater than three months, at the time of purchase was
$9.4 billion and $8.4 billion at December 31,
2010 and 2009, respectively. The Company is exposed to
concentrations of credit risk related to securities of the
F-82
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
U.S. government and certain U.S. government agencies
included within short-term investments, which were
$4.0 billion and $7.5 billion at December 31,
2010 and 2009, respectively.
Cash
Equivalents
The carrying value of cash equivalents, which includes
investments with an original or remaining maturity of three
months or less, at the time of purchase was $9.6 billion
and $8.4 billion at December 31, 2010 and 2009,
respectively. The Company is exposed to concentrations of credit
risk related to securities of the U.S. government and
certain U.S. government agencies included within cash
equivalents, which were $5.8 billion and $6.0 billion
at December 31, 2010 and 2009, respectively.
Purchased
Credit Impaired Investments
Investments acquired with evidence of credit quality
deterioration since origination and for which it is probable at
the acquisition date that the Company will be unable to collect
all contractually required payments are classified as purchased
credit impaired investments. For each investment, the excess of
the cash flows expected to be collected as of the acquisition
date over its acquisition date fair value is referred to as the
accretable yield and is recognized as net investment income on
an effective yield basis. If subsequently, based on current
information and events, it is probable that there is a
significant increase in cash flows previously expected to be
collected or if actual cash flows are significantly greater than
cash flows previously expected to be collected, the accretable
yield is adjusted prospectively. The excess of the contractually
required payments (including interest) as of the acquisition
date over the cash flows expected to be collected as of the
acquisition date is referred to as the nonaccretable difference,
and this amount is not expected to be realized as net investment
income. Decreases in cash flows expected to be collected can
result in OTTI or the recognition of mortgage loan valuation
allowances (see Note 1).
The table below presents the purchased credit impaired
investments, by invested asset class, held at:
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
Fixed Maturity Securities
|
|
Mortgage Loans
|
|
|
(In millions)
|
|
Outstanding principal and interest balance (1)
|
|
$
|
1,548
|
|
|
$
|
504
|
|
Carrying value (2)
|
|
$
|
1,050
|
|
|
$
|
195
|
|
|
|
|
(1) |
|
Represents the contractually required payments which is the sum
of contractual principal, whether or not currently due, and
accrued interest. |
|
(2) |
|
Estimated fair value plus accrued interest for fixed maturity
securities and amortized cost, plus accrued interest, less any
valuation allowances for mortgage loans. |
The following table presents information about purchased credit
impaired investments, as of their respective acquisition dates,
for:
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2010
|
|
|
Fixed Maturity Securities
|
|
Mortgage Loans
|
|
|
(In millions)
|
|
Contractually required payments (including interest)
|
|
$
|
2,126
|
|
|
$
|
553
|
|
Cash flows expected to be collected (1) (2)
|
|
$
|
1,782
|
|
|
$
|
374
|
|
Fair value of investments acquired
|
|
$
|
1,076
|
|
|
$
|
201
|
|
|
|
|
(1) |
|
Represents undiscounted principal and interest cash flow
expectations, at the date of acquisition. |
|
(2) |
|
A portion of the difference between the contractually required
payments (including interest) and the cash flows expected to be
collected on certain of the investments acquired from American
Life has been established as an indemnification asset as
discussed further in Note 2. |
F-83
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following table presents activity for the accretable yield
on purchased credit impaired investments for:
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
Fixed Maturity Securities
|
|
|
Mortgage Loans
|
|
|
|
(In millions)
|
|
|
Accretable yield, January 1,
|
|
$
|
|
|
|
$
|
|
|
Investments purchased
|
|
|
606
|
|
|
|
|
|
Acquisition (1)
|
|
|
100
|
|
|
|
173
|
|
Accretion recognized in net investment income
|
|
|
(62
|
)
|
|
|
(3
|
)
|
Reclassification (to) from nonaccretable difference
|
|
|
(103
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accretable yield, December 31,
|
|
$
|
541
|
|
|
$
|
170
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
As described further in Note 2, all investments acquired
with American Life were recorded at estimated fair value as of
the Acquisition Date. This activity relates to acquired fixed
maturity securities and mortgage loans with a credit impairment
inherent in the estimated fair value. |
Variable
Interest Entities
The Company holds investments in certain entities that are VIEs.
In certain instances, the Company holds both the power to direct
the most significant activities of the entity, as well as an
economic interest in the entity and, as such, consistent with
the new guidance described in Note 1, is deemed to be the
primary beneficiary or consolidator of the entity. The following
table presents the total assets and total liabilities relating
to VIEs for which the Company has concluded that it is the
primary beneficiary and which are consolidated in the
Companys financial statements at December 31, 2010
and 2009. Creditors or beneficial interest holders of VIEs where
the Company is the primary beneficiary have no recourse to the
general credit of the Company, as the Companys obligation
to the VIEs is limited to the amount of its committed investment.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
Total
|
|
|
Total
|
|
|
Total
|
|
|
Total
|
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Assets
|
|
|
Liabilities
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Consolidated securitization entities (1)
|
|
$
|
7,114
|
|
|
$
|
6,892
|
|
|
$
|
|
|
|
$
|
|
|
MRSC collateral financing arrangement (2)
|
|
|
3,333
|
|
|
|
|
|
|
|
3,230
|
|
|
|
|
|
Other limited partnership interests
|
|
|
319
|
|
|
|
85
|
|
|
|
367
|
|
|
|
72
|
|
Trading securities
|
|
|
186
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other invested assets
|
|
|
108
|
|
|
|
1
|
|
|
|
27
|
|
|
|
1
|
|
Real estate joint ventures
|
|
|
20
|
|
|
|
17
|
|
|
|
22
|
|
|
|
17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
11,080
|
|
|
$
|
6,995
|
|
|
$
|
3,646
|
|
|
$
|
90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
As discussed in Note 1, upon the adoption of new guidance
effective January 1, 2010, the Company consolidated former
QSPEs that are structured as CMBS and former QSPEs that are
structured as collateralized debt obligations. At
December 31, 2010, these entities held total assets of
$7,114 million, consisting of $201 million of FVO
securities held by CSEs classified within trading and other
securities, $6,840 million of commercial mortgage loans,
$34 million of accrued investment income and
$39 million of cash. These entities had total liabilities
of $6,892 million, consisting of $6,820 million of
long-term debt and $72 million of other liabilities. The
assets of these entities can only be used to settle their
respective liabilities, and under no circumstances is the
Company or any of its subsidiaries or affiliates liable for any
principal or interest shortfalls should any arise. The
Companys exposure is limited to that of its remaining
investment in the |
F-84
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
former QSPEs of $201 million at estimated fair value at
December 31, 2010. The long-term debt referred to above
bears interest at primarily fixed rates ranging from 2.25% to
5.57%, payable primarily on a monthly basis and is expected to
be repaid over the next 7 years. Interest expense related
to these obligations, included in other expenses, was
$411 million for the year ended December 31, 2010. |
|
(2) |
|
See Note 12 for a description of the MetLife Reinsurance
Company of South Carolina (MRSC) collateral
financing arrangement. These assets consist of the following, at
estimated fair value at: |
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities
available-for-sale:
|
|
|
|
|
|
|
|
|
ABS
|
|
$
|
1,333
|
|
|
$
|
963
|
|
U.S. corporate securities
|
|
|
893
|
|
|
|
1,049
|
|
RMBS
|
|
|
547
|
|
|
|
672
|
|
CMBS
|
|
|
383
|
|
|
|
348
|
|
Foreign corporate securities
|
|
|
139
|
|
|
|
80
|
|
U.S. Treasury, agency and government guaranteed securities
|
|
|
|
|
|
|
33
|
|
State and political subdivision securities
|
|
|
30
|
|
|
|
21
|
|
Foreign government securities
|
|
|
5
|
|
|
|
5
|
|
Cash and cash equivalents (including cash held in trust of less
than $1 million for both years)
|
|
|
3
|
|
|
|
59
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
3,333
|
|
|
$
|
3,230
|
|
|
|
|
|
|
|
|
|
|
The following table presents the carrying amount and maximum
exposure to loss relating to VIEs for which the Company holds
significant variable interests but is not the primary
beneficiary and which have not been consolidated at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
Maximum
|
|
|
|
|
|
Maximum
|
|
|
|
Carrying
|
|
|
Exposure
|
|
|
Carrying
|
|
|
Exposure
|
|
|
|
Amount
|
|
|
to Loss (1)
|
|
|
Amount
|
|
|
to Loss (1)
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Fixed maturity securities
available-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RMBS (2)
|
|
$
|
44,733
|
|
|
$
|
44,733
|
|
|
$
|
|
|
|
$
|
|
|
CMBS (2)
|
|
|
20,675
|
|
|
|
20,675
|
|
|
|
|
|
|
|
|
|
ABS (2)
|
|
|
14,290
|
|
|
|
14,290
|
|
|
|
|
|
|
|
|
|
Foreign corporate securities
|
|
|
2,968
|
|
|
|
2,968
|
|
|
|
1,254
|
|
|
|
1,254
|
|
U.S. corporate securities
|
|
|
2,447
|
|
|
|
2,447
|
|
|
|
1,216
|
|
|
|
1,216
|
|
Other limited partnership interests
|
|
|
4,383
|
|
|
|
6,479
|
|
|
|
2,543
|
|
|
|
2,887
|
|
Trading securities
|
|
|
789
|
|
|
|
789
|
|
|
|
|
|
|
|
|
|
Other invested assets
|
|
|
576
|
|
|
|
773
|
|
|
|
416
|
|
|
|
409
|
|
Mortgage loans
|
|
|
350
|
|
|
|
350
|
|
|
|
|
|
|
|
|
|
Real estate joint ventures
|
|
|
40
|
|
|
|
108
|
|
|
|
30
|
|
|
|
30
|
|
Equity securities
available-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-redeemable preferred stock
|
|
|
|
|
|
|
|
|
|
|
31
|
|
|
|
31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
91,251
|
|
|
$
|
93,612
|
|
|
$
|
5,490
|
|
|
$
|
5,827
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-85
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
(1) |
|
The maximum exposure to loss relating to the fixed maturity,
equity and trading securities is equal to the carrying amounts
or carrying amounts of retained interests. The maximum exposure
to loss relating to the other limited partnership interests and
real estate joint ventures is equal to the carrying amounts plus
any unfunded commitments of the Company. Such a maximum loss
would be expected to occur only upon bankruptcy of the issuer or
investee. The maximum exposure to loss relating to the mortgage
loans is equal to the carrying amounts plus any unfunded
commitments of the Company. For certain of its investments in
other invested assets, the Companys return is in the form
of income tax credits which are guaranteed by a creditworthy
third-party. For such investments, the maximum exposure to loss
is equal to the carrying amounts plus any unfunded commitments,
reduced by amounts guaranteed by third parties of
$231 million and $232 million at December 31,
2010 and 2009, respectively. |
|
(2) |
|
As discussed in Note 1, the Company adopted new guidance
effective January 1, 2010 which eliminated the concept of a
QSPE. As a result, the Company concluded it held variable
interests in RMBS, CMBS and ABS. For these interests, the
Companys involvement is limited to that of a passive
investor. |
As described in Note 16, the Company makes commitments to
fund partnership investments in the normal course of business.
Excluding these commitments, the Company did not provide
financial or other support to investees designated as VIEs
during the years ended December 31, 2010, 2009 and 2008.
|
|
4.
|
Derivative
Financial Instruments
|
Accounting
for Derivative Financial Instruments
See Note 1 for a description of the Companys
accounting policies for derivative financial instruments.
See Note 5 for information about the fair value hierarchy
for derivatives.
Primary
Risks Managed by Derivative Financial Instruments and
Non-Derivative Financial Instruments
The Company is exposed to various risks relating to its ongoing
business operations, including interest rate risk, foreign
currency risk, credit risk and equity market risk. The Company
uses a variety of strategies to manage these risks, including
the use of derivative instruments. The following table presents
the gross notional amount,
F-86
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
estimated fair value and primary underlying risk exposure of the
Companys derivative financial instruments, excluding
embedded derivatives, held at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
|
|
Estimated Fair
|
|
|
|
|
|
Estimated Fair
|
|
Primary Underlying
|
|
|
|
Notional
|
|
|
Value (1)
|
|
|
Notional
|
|
|
Value (1)
|
|
Risk Exposure
|
|
Instrument Type
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
|
|
|
(In millions)
|
|
|
Interest rate
|
|
Interest rate swaps
|
|
$
|
54,803
|
|
|
$
|
2,654
|
|
|
$
|
1,516
|
|
|
$
|
38,152
|
|
|
$
|
1,570
|
|
|
$
|
1,255
|
|
|
|
Interest rate floors
|
|
|
23,866
|
|
|
|
630
|
|
|
|
66
|
|
|
|
23,691
|
|
|
|
461
|
|
|
|
37
|
|
|
|
Interest rate caps
|
|
|
35,412
|
|
|
|
176
|
|
|
|
1
|
|
|
|
28,409
|
|
|
|
283
|
|
|
|
|
|
|
|
Interest rate futures
|
|
|
9,385
|
|
|
|
43
|
|
|
|
17
|
|
|
|
7,563
|
|
|
|
8
|
|
|
|
10
|
|
|
|
Interest rate options
|
|
|
8,761
|
|
|
|
144
|
|
|
|
23
|
|
|
|
4,050
|
|
|
|
117
|
|
|
|
57
|
|
|
|
Interest rate forwards
|
|
|
10,374
|
|
|
|
106
|
|
|
|
135
|
|
|
|
9,921
|
|
|
|
66
|
|
|
|
27
|
|
|
|
Synthetic GICs
|
|
|
4,397
|
|
|
|
|
|
|
|
|
|
|
|
4,352
|
|
|
|
|
|
|
|
|
|
Foreign currency
|
|
Foreign currency swaps
|
|
|
17,626
|
|
|
|
1,616
|
|
|
|
1,282
|
|
|
|
16,879
|
|
|
|
1,514
|
|
|
|
1,392
|
|
|
|
Foreign currency forwards
|
|
|
10,443
|
|
|
|
119
|
|
|
|
91
|
|
|
|
6,485
|
|
|
|
83
|
|
|
|
57
|
|
|
|
Currency futures
|
|
|
493
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency options
|
|
|
5,426
|
|
|
|
50
|
|
|
|
|
|
|
|
822
|
|
|
|
18
|
|
|
|
|
|
|
|
Non-derivative hedging instruments (2)
|
|
|
169
|
|
|
|
|
|
|
|
185
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit
|
|
Credit default swaps
|
|
|
10,957
|
|
|
|
173
|
|
|
|
104
|
|
|
|
6,723
|
|
|
|
74
|
|
|
|
130
|
|
|
|
Credit forwards
|
|
|
90
|
|
|
|
2
|
|
|
|
3
|
|
|
|
220
|
|
|
|
2
|
|
|
|
6
|
|
Equity market
|
|
Equity futures
|
|
|
8,794
|
|
|
|
21
|
|
|
|
9
|
|
|
|
7,405
|
|
|
|
44
|
|
|
|
21
|
|
|
|
Equity options
|
|
|
33,688
|
|
|
|
1,843
|
|
|
|
1,197
|
|
|
|
27,175
|
|
|
|
1,712
|
|
|
|
1,018
|
|
|
|
Variance swaps
|
|
|
18,022
|
|
|
|
198
|
|
|
|
118
|
|
|
|
13,654
|
|
|
|
181
|
|
|
|
58
|
|
|
|
Total rate of return swaps
|
|
|
1,547
|
|
|
|
|
|
|
|
|
|
|
|
376
|
|
|
|
|
|
|
|
47
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
254,253
|
|
|
$
|
7,777
|
|
|
$
|
4,747
|
|
|
$
|
195,877
|
|
|
$
|
6,133
|
|
|
$
|
4,115
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The estimated fair value of all derivatives in an asset position
is reported within other invested assets in the consolidated
balance sheets and the estimated fair value of all derivatives
in a liability position is reported within other liabilities in
the consolidated balance sheets. |
|
(2) |
|
The estimated fair value of non-derivative hedging instruments
represents the amortized cost of the instruments, as adjusted
for foreign currency transaction gains or losses. Non-derivative
hedging instruments are reported within policyholder account
balances in the consolidated balance sheets. |
F-87
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following table presents the gross notional amount of
derivative financial instruments by maturity at
December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining Life
|
|
|
|
|
|
|
After One Year
|
|
|
After Five Years
|
|
|
|
|
|
|
|
|
|
One Year or
|
|
|
Through Five
|
|
|
Through Ten
|
|
|
After Ten
|
|
|
|
|
|
|
Less
|
|
|
Years
|
|
|
Years
|
|
|
Years
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Interest rate swaps
|
|
$
|
4,970
|
|
|
$
|
14,491
|
|
|
$
|
16,403
|
|
|
$
|
18,939
|
|
|
$
|
54,803
|
|
Interest rate floors
|
|
|
|
|
|
|
13,048
|
|
|
|
7,318
|
|
|
|
3,500
|
|
|
|
23,866
|
|
Interest rate caps
|
|
|
5,000
|
|
|
|
28,436
|
|
|
|
1,976
|
|
|
|
|
|
|
|
35,412
|
|
Interest rate futures
|
|
|
9,385
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,385
|
|
Interest rate options
|
|
|
1,853
|
|
|
|
5,206
|
|
|
|
1,702
|
|
|
|
|
|
|
|
8,761
|
|
Interest rate forwards
|
|
|
9,409
|
|
|
|
860
|
|
|
|
105
|
|
|
|
|
|
|
|
10,374
|
|
Synthetic GICs
|
|
|
4,397
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,397
|
|
Foreign currency swaps
|
|
|
3,262
|
|
|
|
5,857
|
|
|
|
5,999
|
|
|
|
2,508
|
|
|
|
17,626
|
|
Foreign currency forwards
|
|
|
10,337
|
|
|
|
24
|
|
|
|
20
|
|
|
|
62
|
|
|
|
10,443
|
|
Currency futures
|
|
|
493
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
493
|
|
Currency options
|
|
|
5,426
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,426
|
|
Non-derivative hedging instruments
|
|
|
169
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
169
|
|
Credit default swaps
|
|
|
111
|
|
|
|
10,197
|
|
|
|
649
|
|
|
|
|
|
|
|
10,957
|
|
Credit forwards
|
|
|
90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
90
|
|
Equity futures
|
|
|
8,794
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,794
|
|
Equity options
|
|
|
20,856
|
|
|
|
3,346
|
|
|
|
9,486
|
|
|
|
|
|
|
|
33,688
|
|
Variance swaps
|
|
|
1,411
|
|
|
|
1,795
|
|
|
|
14,493
|
|
|
|
323
|
|
|
|
18,022
|
|
Total rate of return swaps
|
|
|
1,492
|
|
|
|
55
|
|
|
|
|
|
|
|
|
|
|
|
1,547
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
87,455
|
|
|
$
|
83,315
|
|
|
$
|
58,151
|
|
|
$
|
25,332
|
|
|
$
|
254,253
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps are used by the Company primarily to reduce
market risks from changes in interest rates and to alter
interest rate exposure arising from mismatches between assets
and liabilities (duration mismatches). In an interest rate swap,
the Company agrees with another party to exchange, at specified
intervals, the difference between fixed rate and floating rate
interest amounts as calculated by reference to an agreed
notional principal amount. These transactions are entered into
pursuant to master agreements that provide for a single net
payment to be made by the counterparty at each due date. The
Company utilizes interest rate swaps in fair value, cash flow
and non-qualifying hedging relationships.
The Company also enters into basis swaps to better match the
cash flows from assets and related liabilities. In a basis swap,
both legs of the swap are floating with each based on a
different index. Generally, no cash is exchanged at the outset
of the contract and no principal payments are made by either
party. A single net payment is usually made by one counterparty
at each due date. Basis swaps are included in interest rate
swaps in the preceding table. The Company utilizes basis swaps
in non-qualifying hedging relationships.
Inflation swaps are used as an economic hedge to reduce
inflation risk generated from inflation-indexed liabilities.
Inflation swaps are included in interest rate swaps in the
preceding table. The Company utilizes inflation swaps in
non-qualifying hedging relationships.
Implied volatility swaps are used by the Company primarily as
economic hedges of interest rate risk associated with the
Companys investments in mortgage-backed securities. In an
implied volatility swap, the Company exchanges fixed payments
for floating payments that are linked to certain market
volatility measures. If implied volatility rises, the floating
payments that the Company receives will increase, and if implied
volatility falls, the floating payments that the Company
receives will decrease. Implied volatility swaps are included in
interest rate
F-88
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
swaps in the preceding table. The Company utilizes implied
volatility swaps in non-qualifying hedging relationships.
The Company purchases interest rate caps and floors primarily to
protect its floating rate liabilities against rises in interest
rates above a specified level, and against interest rate
exposure arising from mismatches between assets and liabilities
(duration mismatches), as well as to protect its minimum rate
guarantee liabilities against declines in interest rates below a
specified level, respectively. In certain instances, the Company
locks in the economic impact of existing purchased caps and
floors by entering into offsetting written caps and floors. The
Company utilizes interest rate caps and floors in non-qualifying
hedging relationships.
In exchange-traded interest rate (Treasury and swap) futures
transactions, the Company agrees to purchase or sell a specified
number of contracts, the value of which is determined by the
different classes of interest rate securities, and to post
variation margin on a daily basis in an amount equal to the
difference in the daily market values of those contracts. The
Company enters into exchange- traded futures with regulated
futures commission merchants that are members of the exchange.
Exchange-traded interest rate (Treasury and swap) futures are
used primarily to hedge mismatches between the duration of
assets in a portfolio and the duration of liabilities supported
by those assets, to hedge against changes in value of securities
the Company owns or anticipates acquiring and to hedge against
changes in interest rates on anticipated liability issuances by
replicating Treasury or swap curve performance. The Company
utilizes exchange-traded interest rate futures in non-qualifying
hedging relationships.
Swaptions are used by the Company to hedge interest rate risk
associated with the Companys long-term liabilities and
invested assets. A swaption is an option to enter into a swap
with a forward starting effective date. In certain instances,
the Company locks in the economic impact of existing purchased
swaptions by entering into offsetting written swaptions. The
Company pays a premium for purchased swaptions and receives a
premium for written swaptions. Swaptions are included in
interest rate options in the preceding table. The Company
utilizes swaptions in non-qualifying hedging relationships.
The Company writes covered call options on its portfolio of
U.S. Treasuries as an income generation strategy. In a
covered call transaction, the Company receives a premium at the
inception of the contract in exchange for giving the derivative
counterparty the right to purchase the referenced security from
the Company at a predetermined price. The call option is
covered because the Company owns the referenced
security over the term of the option. Covered call options are
included in interest rate options in the preceding table. The
Company utilizes covered call options in non-qualifying hedging
relationships.
The Company enters into interest rate forwards to buy and sell
securities. The price is agreed upon at the time of the contract
and payment for such a contract is made at a specified future
date. The Company also uses interest rate forwards to sell to be
announced securities as economic hedges against the risk of
changes in the fair value of mortgage loans
held-for-sale
and interest rate lock commitments. The Company utilizes
interest rate forwards in cash flow and non-qualifying hedging
relationships.
Interest rate lock commitments are short-term commitments to
fund mortgage loan applications in process (the pipeline) for a
fixed term for a fixed rate or spread. During the term of an
interest rate lock commitment, the Company is exposed to the
risk that interest rates will change from the rate quoted to the
potential borrower. Interest rate lock commitments to fund
mortgage loans that will be
held-for-sale
are considered derivative instruments. Interest rate lock
commitments are included in interest rate forwards in the
preceding table. Interest rate lock commitments are not
designated as hedging instruments.
A synthetic GIC is a contract that simulates the performance of
a traditional guaranteed interest contract through the use of
financial instruments. Under a synthetic GIC, the policyholder
owns the underlying assets. The Company guarantees a rate return
on those assets for a premium. Synthetic GICs are not designated
as hedging instruments.
F-89
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Foreign currency derivatives, including foreign currency swaps,
foreign currency forwards and currency option contracts, are
used by the Company to reduce the risk from fluctuations in
foreign currency exchange rates associated with its assets and
liabilities denominated in foreign currencies. The Company also
uses foreign currency forwards and swaps to hedge the foreign
currency risk associated with certain of its net investments in
foreign operations.
In a foreign currency swap transaction, the Company agrees with
another party to exchange, at specified intervals, the
difference between one currency and another at a fixed exchange
rate, generally set at inception, calculated by reference to an
agreed upon principal amount. The principal amount of each
currency is exchanged at the inception and termination of the
currency swap by each party. The Company utilizes foreign
currency swaps in fair value, cash flow, net investment in
foreign operations and non-qualifying hedging relationships.
In a foreign currency forward transaction, the Company agrees
with another party to deliver a specified amount of an
identified currency at a specified future date. The price is
agreed upon at the time of the contract and payment for such a
contract is made in a different currency at the specified future
date. The Company utilizes foreign currency forwards in net
investment in foreign operations and non-qualifying hedging
relationships.
In exchange-traded currency futures transactions, the Company
agrees to purchase or sell a specified number of contracts, the
value of which is determined by referenced currencies, and to
post variation margin on a daily basis in an amount equal to the
difference in the daily market values of those contracts. The
Company enters into exchange-traded futures with regulated
futures commission merchants that are members of the exchange.
Exchange-traded currency futures are used primarily to hedge
currency mismatches between assets and liabilities. The Company
utilizes exchange-traded currency futures in non-qualifying
hedging relationships.
The Company enters into currency option contracts that give it
the right, but not the obligation, to sell the foreign currency
amount in exchange for a functional currency amount within a
limited time at a contracted price. The contracts may also be
net settled in cash, based on differentials in the foreign
exchange rate and the strike price. The Company uses currency
options to hedge against the foreign currency exposure inherent
in certain of its variable annuity products. The Company also
uses currency options as an economic hedge of foreign currency
exposure related to the Companys international
subsidiaries. The Company utilizes currency options in
non-qualifying hedging relationships.
The Company uses certain of its foreign currency denominated
funding agreements to hedge portions of its net investments in
foreign operations against adverse movements in exchange rates.
Such contracts are included in non-derivative hedging
instruments in the preceding table.
Swap spreadlocks are used by the Company to hedge invested
assets on an economic basis against the risk of changes in
credit spreads. Swap spreadlocks are forward transactions
between two parties whose underlying reference index is a
forward starting interest rate swap where the Company agrees to
pay a coupon based on a predetermined reference swap spread in
exchange for receiving a coupon based on a floating rate. The
Company has the option to cash settle with the counterparty in
lieu of maintaining the swap after the effective date. The
Company utilizes swap spreadlocks in non-qualifying hedging
relationships.
Certain credit default swaps are used by the Company to hedge
against credit-related changes in the value of its investments
and to diversify its credit risk exposure in certain portfolios.
In a credit default swap transaction, the Company agrees with
another party, at specified intervals, to pay a premium to hedge
credit risk. If a credit event, as defined by the contract,
occurs, generally the contract will require the swap to be
settled gross by the delivery of par quantities of the
referenced investment equal to the specified swap notional in
exchange for the payment of cash amounts by the counterparty
equal to the par value of the investment surrendered. The
Company utilizes credit default swaps in non-qualifying hedging
relationships.
Credit default swaps are also used to synthetically create
investments that are either more expensive to acquire or
otherwise unavailable in the cash markets. These transactions
are a combination of a derivative and a cash
F-90
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
instrument such as a U.S. Treasury or Agency security. The
Company also enters into certain credit default swaps held in
relation to trading portfolios for the purpose of generating
profits on short-term differences in price. These credit default
swaps are not designated as hedging instruments.
The Company enters into forwards to lock in the price to be paid
for forward purchases of certain securities. The price is agreed
upon at the time of the contract and payment for the contract is
made at a specified future date. When the primary purpose of
entering into these transactions is to hedge against the risk of
changes in purchase price due to changes in credit spreads, the
Company designates these as credit forwards. The Company
utilizes credit forwards in cash flow hedging relationships.
In exchange-traded equity futures transactions, the Company
agrees to purchase or sell a specified number of contracts, the
value of which is determined by the different classes of equity
securities, and to post variation margin on a daily basis in an
amount equal to the difference in the daily market values of
those contracts. The Company enters into exchange-traded futures
with regulated futures commission merchants that are members of
the exchange. Exchange-traded equity futures are used primarily
to hedge liabilities embedded in certain variable annuity
products offered by the Company. The Company utilizes
exchange-traded equity futures in non-qualifying hedging
relationships.
Equity index options are used by the Company primarily to hedge
minimum guarantees embedded in certain variable annuity products
offered by the Company. To hedge against adverse changes in
equity indices, the Company enters into contracts to sell the
equity index within a limited time at a contracted price. The
contracts will be net settled in cash based on differentials in
the indices at the time of exercise and the strike price.
Certain of these contracts may also contain settlement
provisions linked to interest rates. In certain instances, the
Company may enter into a combination of transactions to hedge
adverse changes in equity indices within a pre-determined range
through the purchase and sale of options. Equity index options
are included in equity options in the preceding table. The
Company utilizes equity index options in non-qualifying hedging
relationships.
Equity variance swaps are used by the Company primarily to hedge
minimum guarantees embedded in certain variable annuity products
offered by the Company. In an equity variance swap, the Company
agrees with another party to exchange amounts in the future,
based on changes in equity volatility over a defined period.
Equity variance swaps are included in variance swaps in the
preceding table. The Company utilizes equity variance swaps in
non-qualifying hedging relationships.
Total rate of return swaps (TRRs) are swaps whereby
the Company agrees with another party to exchange, at specified
intervals, the difference between the economic risk and reward
of an asset or a market index and the London Inter-Bank Offer
Rate (LIBOR), calculated by reference to an agreed
notional principal amount. No cash is exchanged at the outset of
the contract. Cash is paid and received over the life of the
contract based on the terms of the swap. These transactions are
entered into pursuant to master agreements that provide for a
single net payment to be made by the counterparty at each due
date. The Company uses TRRs to hedge its equity market
guarantees in certain of its insurance products. TRRs can be
used as hedges or to synthetically create investments. The
Company utilizes TRRs in non-qualifying hedging relationships.
F-91
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Hedging
The following table presents the gross notional amount and
estimated fair value of derivatives designated as hedging
instruments by type of hedge designation at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
Notional
|
|
|
Fair Value
|
|
|
Notional
|
|
|
Fair Value
|
|
Derivatives Designated as Hedging Instruments
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
|
(In millions)
|
|
|
Fair Value Hedges:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency swaps
|
|
$
|
4,524
|
|
|
$
|
907
|
|
|
$
|
145
|
|
|
$
|
4,807
|
|
|
$
|
854
|
|
|
$
|
132
|
|
Interest rate swaps
|
|
|
5,108
|
|
|
|
823
|
|
|
|
169
|
|
|
|
4,824
|
|
|
|
500
|
|
|
|
75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
9,632
|
|
|
|
1,730
|
|
|
|
314
|
|
|
|
9,631
|
|
|
|
1,354
|
|
|
|
207
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flow Hedges:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency swaps
|
|
|
5,556
|
|
|
|
213
|
|
|
|
347
|
|
|
|
4,108
|
|
|
|
127
|
|
|
|
347
|
|
Interest rate swaps
|
|
|
3,562
|
|
|
|
102
|
|
|
|
116
|
|
|
|
1,740
|
|
|
|
|
|
|
|
48
|
|
Interest rate forwards
|
|
|
1,140
|
|
|
|
|
|
|
|
107
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit forwards
|
|
|
90
|
|
|
|
2
|
|
|
|
3
|
|
|
|
220
|
|
|
|
2
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
10,348
|
|
|
|
317
|
|
|
|
573
|
|
|
|
6,068
|
|
|
|
129
|
|
|
|
401
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Operations Hedges:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forwards
|
|
|
1,935
|
|
|
|
9
|
|
|
|
26
|
|
|
|
1,880
|
|
|
|
27
|
|
|
|
13
|
|
Non-derivative hedging instruments
|
|
|
169
|
|
|
|
|
|
|
|
185
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
2,104
|
|
|
|
9
|
|
|
|
211
|
|
|
|
1,880
|
|
|
|
27
|
|
|
|
13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Qualifying Hedges
|
|
$
|
22,084
|
|
|
$
|
2,056
|
|
|
$
|
1,098
|
|
|
$
|
17,579
|
|
|
$
|
1,510
|
|
|
$
|
621
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-92
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following table presents the gross notional amount and
estimated fair value of derivatives that were not designated or
do not qualify as hedging instruments by derivative type at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
Derivatives Not Designated or Not
|
|
Notional
|
|
|
Fair Value
|
|
|
Notional
|
|
|
Fair Value
|
|
Qualifying as Hedging Instruments
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
|
(In millions)
|
|
|
Interest rate swaps
|
|
$
|
46,133
|
|
|
$
|
1,729
|
|
|
$
|
1,231
|
|
|
$
|
31,588
|
|
|
$
|
1,070
|
|
|
$
|
1,132
|
|
Interest rate floors
|
|
|
23,866
|
|
|
|
630
|
|
|
|
66
|
|
|
|
23,691
|
|
|
|
461
|
|
|
|
37
|
|
Interest rate caps
|
|
|
35,412
|
|
|
|
176
|
|
|
|
1
|
|
|
|
28,409
|
|
|
|
283
|
|
|
|
|
|
Interest rate futures
|
|
|
9,385
|
|
|
|
43
|
|
|
|
17
|
|
|
|
7,563
|
|
|
|
8
|
|
|
|
10
|
|
Interest rate options
|
|
|
8,761
|
|
|
|
144
|
|
|
|
23
|
|
|
|
4,050
|
|
|
|
117
|
|
|
|
57
|
|
Interest rate forwards
|
|
|
9,234
|
|
|
|
106
|
|
|
|
28
|
|
|
|
9,921
|
|
|
|
66
|
|
|
|
27
|
|
Synthetic GICs
|
|
|
4,397
|
|
|
|
|
|
|
|
|
|
|
|
4,352
|
|
|
|
|
|
|
|
|
|
Foreign currency swaps
|
|
|
7,546
|
|
|
|
496
|
|
|
|
790
|
|
|
|
7,964
|
|
|
|
533
|
|
|
|
913
|
|
Foreign currency forwards
|
|
|
8,508
|
|
|
|
110
|
|
|
|
65
|
|
|
|
4,605
|
|
|
|
56
|
|
|
|
44
|
|
Currency futures
|
|
|
493
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency options
|
|
|
5,426
|
|
|
|
50
|
|
|
|
|
|
|
|
822
|
|
|
|
18
|
|
|
|
|
|
Credit default swaps
|
|
|
10,957
|
|
|
|
173
|
|
|
|
104
|
|
|
|
6,723
|
|
|
|
74
|
|
|
|
130
|
|
Equity futures
|
|
|
8,794
|
|
|
|
21
|
|
|
|
9
|
|
|
|
7,405
|
|
|
|
44
|
|
|
|
21
|
|
Equity options
|
|
|
33,688
|
|
|
|
1,843
|
|
|
|
1,197
|
|
|
|
27,175
|
|
|
|
1,712
|
|
|
|
1,018
|
|
Variance swaps
|
|
|
18,022
|
|
|
|
198
|
|
|
|
118
|
|
|
|
13,654
|
|
|
|
181
|
|
|
|
58
|
|
Total rate of return swaps
|
|
|
1,547
|
|
|
|
|
|
|
|
|
|
|
|
376
|
|
|
|
|
|
|
|
47
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total non-designated or non-qualifying derivatives
|
|
$
|
232,169
|
|
|
$
|
5,721
|
|
|
$
|
3,649
|
|
|
$
|
178,298
|
|
|
$
|
4,623
|
|
|
$
|
3,494
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Derivative Gains (Losses)
The components of net derivative gains (losses) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Derivatives and hedging gains (losses) (1)
|
|
$
|
122
|
|
|
$
|
(6,624
|
)
|
|
$
|
6,560
|
|
Embedded derivatives
|
|
|
(387
|
)
|
|
|
1,758
|
|
|
|
(2,650
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net derivative gains (losses)
|
|
$
|
(265
|
)
|
|
$
|
(4,866
|
)
|
|
$
|
3,910
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes foreign currency transaction gains (losses) on hedged
items in cash flow and non-qualifying hedge relationships, which
are not presented elsewhere in this note. |
F-93
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following table presents the settlement payments recorded in
income for the:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Qualifying hedges:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income
|
|
$
|
83
|
|
|
$
|
49
|
|
|
$
|
19
|
|
Interest credited to policyholder account balances
|
|
|
233
|
|
|
|
220
|
|
|
|
105
|
|
Other expenses
|
|
|
(6
|
)
|
|
|
(3
|
)
|
|
|
(9
|
)
|
Non-qualifying hedges:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income
|
|
|
(3
|
)
|
|
|
(2
|
)
|
|
|
1
|
|
Net derivative gains (losses)
|
|
|
65
|
|
|
|
91
|
|
|
|
49
|
|
Other revenues
|
|
|
108
|
|
|
|
77
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
480
|
|
|
$
|
432
|
|
|
$
|
168
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair
Value Hedges
The Company designates and accounts for the following as fair
value hedges when they have met the requirements of fair value
hedging: (i) interest rate swaps to convert fixed rate
investments to floating rate investments; (ii) interest
rate swaps to convert fixed rate liabilities to floating rate
liabilities; and (iii) foreign currency swaps to hedge the
foreign currency fair value exposure of foreign currency
denominated investments and liabilities.
The Company recognizes gains and losses on derivatives and the
related hedged items in fair value hedges within net derivative
gains (losses). The following table represents the amount of
such net derivative gains (losses) recognized for the years
ended December 31, 2010, 2009 and 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Derivative
|
|
|
|
|
|
Ineffectiveness
|
|
|
|
|
|
Gains (Losses)
|
|
|
Net Derivative Gains
|
|
|
Recognized in
|
|
Derivatives in Fair Value
|
|
Hedged Items in Fair Value
|
|
Recognized
|
|
|
(Losses) Recognized
|
|
|
Net Derivative
|
|
Hedging Relationships
|
|
Hedging Relationships
|
|
for Derivatives
|
|
|
for Hedged Items
|
|
|
Gains (Losses)
|
|
|
|
|
|
(In millions)
|
|
|
For the Year Ended December 31, 2010:
|
Interest rate swaps:
|
|
Fixed maturity securities
|
|
$
|
(14
|
)
|
|
$
|
16
|
|
|
$
|
2
|
|
|
|
Policyholder account balances (1)
|
|
|
140
|
|
|
|
(142
|
)
|
|
|
(2
|
)
|
Foreign currency swaps:
|
|
Foreign-denominated fixed maturity securities
|
|
|
14
|
|
|
|
(14
|
)
|
|
|
|
|
|
|
Foreign-denominated policyholder account balances (2)
|
|
|
9
|
|
|
|
(20
|
)
|
|
|
(11
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
149
|
|
|
$
|
(160
|
)
|
|
$
|
(11
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2009:
|
Interest rate swaps:
|
|
Fixed maturity securities
|
|
$
|
49
|
|
|
$
|
(42
|
)
|
|
$
|
7
|
|
|
|
Policyholder account balances (1)
|
|
|
(963
|
)
|
|
|
951
|
|
|
|
(12
|
)
|
Foreign currency swaps:
|
|
Foreign-denominated fixed maturity securities
|
|
|
(13
|
)
|
|
|
10
|
|
|
|
(3
|
)
|
|
|
Foreign-denominated policyholder account balances (2)
|
|
|
462
|
|
|
|
(449
|
)
|
|
|
13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
(465
|
)
|
|
$
|
470
|
|
|
$
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2008
|
|
$
|
245
|
|
|
$
|
(248
|
)
|
|
$
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Fixed rate liabilities |
|
(2) |
|
Fixed rate or floating rate liabilities |
F-94
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
All components of each derivatives gain or loss were
included in the assessment of hedge effectiveness.
Cash
Flow Hedges
The Company designates and accounts for the following as cash
flow hedges when they have met the requirements of cash flow
hedging: (i) interest rate swaps to convert floating rate
investments to fixed rate investments; (ii) interest rate
swaps to convert floating rate liabilities to fixed rate
liabilities; (iii) foreign currency swaps to hedge the
foreign currency cash flow exposure of foreign currency
denominated investments and liabilities; (iv) interest rate
forwards and credit forwards to lock in the price to be paid for
forward purchases of investments; (v) interest rate swaps
and interest rate forwards to hedge the forecasted purchases of
fixed-rate investments; and (vi) interest rate swaps and
interest rate forwards to hedge forecasted fixed-rate borrowings.
For the years ended December 31, 2010 and 2009, the Company
recognized $1 million and ($3) million, respectively,
of net derivative gains (losses) which represented the
ineffective portion of all cash flow hedges. For the year ended
December 31, 2008, the Company did not recognize any net
derivative gains (losses) which represented the ineffective
portion of all cash flow hedges. All components of each
derivatives gain or loss were included in the assessment
of hedge effectiveness. In certain instances, the Company
discontinued cash flow hedge accounting because the forecasted
transactions did not occur on the anticipated date or within two
months of that date. The net amounts reclassified into net
derivative gains (losses) for the years ended December 31,
2010, 2009 and 2008 related to such discontinued cash flow
hedges were gains (losses) of $9 million, ($7) million
and ($12) million, respectively. At December 31, 2010
and 2009, the maximum length of time over which the Company was
hedging its exposure to variability in future cash flows for
forecasted transactions did not exceed seven years and five
years, respectively. There were no hedged forecasted
transactions, other than the receipt or payment of variable
interest payments, for the year ended December 31, 2008.
The following table presents the components of accumulated other
comprehensive income (loss), before income tax, related to cash
flow hedges:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Accumulated other comprehensive income (loss), balance at
January 1,
|
|
$
|
(76
|
)
|
|
$
|
82
|
|
|
$
|
(270
|
)
|
Gains (losses) deferred in other comprehensive income (loss) on
the effective portion of cash flow hedges
|
|
|
(51
|
)
|
|
|
(221
|
)
|
|
|
203
|
|
Amounts reclassified to net derivative gains (losses)
|
|
|
65
|
|
|
|
54
|
|
|
|
140
|
|
Amounts reclassified to net investment income
|
|
|
4
|
|
|
|
8
|
|
|
|
9
|
|
Amounts reclassified to other expenses
|
|
|
(1
|
)
|
|
|
3
|
|
|
|
(1
|
)
|
Amortization of transition adjustment
|
|
|
|
|
|
|
(2
|
)
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive income (loss), balance at
December 31,
|
|
$
|
(59
|
)
|
|
$
|
(76
|
)
|
|
$
|
82
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2010, $3 million of deferred net
losses on derivatives in accumulated other comprehensive income
(loss) was expected to be reclassified to earnings within the
next 12 months.
F-95
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following table presents the effects of derivatives in cash
flow hedging relationships on the consolidated statements of
operations and the consolidated statements of equity for the
years ended December 31, 2010, 2009 and 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of Gains
|
|
|
Amount and Location
|
|
|
|
|
|
|
(Losses) Deferred
|
|
|
of Gains (Losses)
|
|
|
Amount and Location
|
|
|
|
in Accumulated Other
|
|
|
Reclassified from
|
|
|
of Gains (Losses)
|
|
Derivatives in Cash Flow
|
|
Comprehensive Income
|
|
|
Accumulated Other Comprehensive
|
|
|
Recognized in Income (Loss)
|
|
Hedging Relationships
|
|
(Loss) on Derivatives
|
|
|
Income (Loss) into Income (Loss)
|
|
|
on Derivatives
|
|
|
|
|
|
|
|
|
|
(Ineffective Portion and
|
|
|
|
|
|
|
|
|
|
Amount Excluded from
|
|
|
|
(Effective Portion)
|
|
|
(Effective Portion)
|
|
|
Effectiveness Testing)
|
|
|
|
|
|
|
Net Derivative
|
|
|
Net Investment
|
|
|
Other
|
|
|
Net Derivative
|
|
|
Net Investment
|
|
|
|
|
|
|
Gains (Losses)
|
|
|
Income
|
|
|
Expenses
|
|
|
Gains (Losses)
|
|
|
Income
|
|
|
|
(In millions)
|
|
|
For the Year Ended December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps
|
|
$
|
13
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(1
|
)
|
|
$
|
3
|
|
|
$
|
|
|
Foreign currency swaps
|
|
|
34
|
|
|
|
(79
|
)
|
|
|
(6
|
)
|
|
|
2
|
|
|
|
|
|
|
|
|
|
Interest rate forwards
|
|
|
(117
|
)
|
|
|
14
|
|
|
|
2
|
|
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
Credit forwards
|
|
|
19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
(51
|
)
|
|
$
|
(65
|
)
|
|
$
|
(4
|
)
|
|
$
|
1
|
|
|
$
|
1
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps
|
|
$
|
(45
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(4
|
)
|
|
$
|
(2
|
)
|
|
$
|
|
|
Foreign currency swaps
|
|
|
(319
|
)
|
|
|
(133
|
)
|
|
|
(6
|
)
|
|
|
1
|
|
|
|
(1
|
)
|
|
|
|
|
Interest rate forwards
|
|
|
147
|
|
|
|
79
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit forwards
|
|
|
(4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
(221
|
)
|
|
$
|
(54
|
)
|
|
$
|
(6
|
)
|
|
$
|
(3
|
)
|
|
$
|
(3
|
)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency swaps
|
|
$
|
203
|
|
|
$
|
(140
|
)
|
|
$
|
(10
|
)
|
|
$
|
1
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hedges
of Net Investments in Foreign Operations
The Company uses foreign exchange contracts, which may include
foreign currency swaps, forwards and options, to hedge portions
of its net investments in foreign operations against adverse
movements in exchange rates. The Company measures
ineffectiveness on these contracts based upon the change in
forward rates. In addition, the Company may also use
non-derivative financial instruments to hedge portions of its
net investments in foreign operations against adverse movements
in exchange rates. The Company measures ineffectiveness on
non-derivative financial instruments based upon the change in
spot rates.
When net investments in foreign operations are sold or
substantially liquidated, the amounts in accumulated other
comprehensive income (loss) are reclassified to the consolidated
statements of operations, while a pro rata portion will be
reclassified upon partial sale of the net investments in foreign
operations.
F-96
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following table presents the effects of derivatives and
non-derivative financial instruments in net investment hedging
relationships in the consolidated statements of operations and
the consolidated statements of equity for the years ended
December 31, 2010, 2009 and 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount and Location
|
|
|
|
|
|
|
|
|
|
|
|
|
of Gains (Losses)
|
|
|
|
|
|
|
|
|
|
|
|
|
Reclassified From Accumulated Other
|
|
|
|
Amount of Gains (Losses)
|
|
|
Comprehensive Income
|
|
|
|
Deferred in Accumulated
|
|
|
(Loss) into Income (Loss)
|
|
|
|
Other Comprehensive Income (Loss)
|
|
|
(Effective Portion)
|
|
|
|
(Effective Portion)
|
|
|
Net Investment Gains (Losses)
|
|
Derivatives and Non-Derivative Hedging Instruments in Net
|
|
Years Ended December 31,
|
|
|
Years Ended December 31,
|
|
Investment Hedging Relationships (1), (2)
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Foreign currency forwards
|
|
$
|
(167
|
)
|
|
$
|
(244
|
)
|
|
$
|
338
|
|
|
$
|
|
|
|
$
|
(59
|
)
|
|
$
|
|
|
Foreign currency swaps
|
|
|
|
|
|
|
(18
|
)
|
|
|
76
|
|
|
|
|
|
|
|
(63
|
)
|
|
|
|
|
Non-derivative hedging instruments
|
|
|
(16
|
)
|
|
|
(37
|
)
|
|
|
81
|
|
|
|
|
|
|
|
(11
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
(183
|
)
|
|
$
|
(299
|
)
|
|
$
|
495
|
|
|
$
|
|
|
|
$
|
(133
|
)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
During the years ended December 31, 2010 and 2008, there
were no sales or substantial liquidations of net investments in
foreign operations that would have required the reclassification
of gains or losses from accumulated other comprehensive income
(loss) into earnings. During the year ended December 31,
2009, the Company substantially liquidated, through assumption
reinsurance (see Note 2), the portion of its Canadian
operations that was being hedged in a net investment hedging
relationship. As a result, the Company reclassified losses of
$133 million from accumulated other comprehensive income
(loss) into earnings. |
|
(2) |
|
There was no ineffectiveness recognized for the Companys
hedges of net investments in foreign operations. |
At December 31, 2010 and 2009, the cumulative foreign
currency translation gain (loss) recorded in accumulated other
comprehensive income (loss) related to hedges of net investments
in foreign operations was ($223) million and
($40) million, respectively.
Non-Qualifying
Derivatives and Derivatives for Purposes Other Than
Hedging
The Company enters into the following derivatives that do not
qualify for hedge accounting or for purposes other than hedging:
(i) interest rate swaps, implied volatility swaps, caps and
floors and interest rate futures to economically hedge its
exposure to interest rates; (ii) foreign currency forwards,
swaps, option contracts, and future contracts to economically
hedge its exposure to adverse movements in exchange rates;
(iii) credit default swaps to economically hedge exposure
to adverse movements in credit; (iv) equity futures, equity
index options, interest rate futures, TRRs and equity variance
swaps to economically hedge liabilities embedded in certain
variable annuity products; (v) swap spreadlocks to
economically hedge invested assets against the risk of changes
in credit spreads; (vi) interest rate forwards to buy and
sell securities to economically hedge its exposure to interest
rates; (vii) credit default swaps and TRRs to synthetically
create investments; (viii) basis swaps to better match the
cash flows of assets and related liabilities; (ix) credit
default swaps held in relation to trading portfolios;
(x) swaptions to hedge interest rate risk;
(xi) inflation swaps to reduce risk generated from
inflation-indexed liabilities; (xii) covered call options
for income generation; (xiii) interest rate lock
commitments; (xiv) synthetic GICs; and (xv) equity
options to economically hedge certain invested assets against
adverse changes in equity indices.
F-97
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following tables present the amount and location of gains
(losses) recognized in income for derivatives that were not
designated or qualifying as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
|
Net
|
|
|
Policyholder
|
|
|
|
|
|
|
|
|
|
Derivative
|
|
|
Investment
|
|
|
Benefits
|
|
|
Other
|
|
|
Other
|
|
|
|
Gains (Losses)
|
|
|
Income (1)
|
|
|
and Claims (2)
|
|
|
Revenues (3)
|
|
|
Expenses (4)
|
|
|
|
(In millions)
|
|
|
For the Year Ended December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps
|
|
$
|
622
|
|
|
$
|
4
|
|
|
$
|
39
|
|
|
$
|
172
|
|
|
$
|
|
|
Interest rate floors
|
|
|
144
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate caps
|
|
|
(185
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate futures
|
|
|
77
|
|
|
|
(4
|
)
|
|
|
|
|
|
|
(3
|
)
|
|
|
|
|
Equity futures
|
|
|
(58
|
)
|
|
|
(25
|
)
|
|
|
(314
|
)
|
|
|
|
|
|
|
|
|
Foreign currency swaps
|
|
|
52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forwards
|
|
|
250
|
|
|
|
55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency futures
|
|
|
(23
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency options
|
|
|
(83
|
)
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
(4
|
)
|
Equity options
|
|
|
(683
|
)
|
|
|
(16
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate options
|
|
|
25
|
|
|
|
|
|
|
|
|
|
|
|
(6
|
)
|
|
|
|
|
Interest rate forwards
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
(74
|
)
|
|
|
|
|
Variance swaps
|
|
|
(55
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit default swaps
|
|
|
34
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Total rate of return swaps
|
|
|
14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
139
|
|
|
$
|
11
|
|
|
$
|
(275
|
)
|
|
$
|
89
|
|
|
$
|
(4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps
|
|
$
|
(1,700
|
)
|
|
$
|
(5
|
)
|
|
$
|
(13
|
)
|
|
$
|
(161
|
)
|
|
$
|
|
|
Interest rate floors
|
|
|
(907
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate caps
|
|
|
33
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate futures
|
|
|
(366
|
)
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity futures
|
|
|
(681
|
)
|
|
|
(38
|
)
|
|
|
(363
|
)
|
|
|
|
|
|
|
|
|
Foreign currency swaps
|
|
|
(405
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forwards
|
|
|
(102
|
)
|
|
|
(24
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency options
|
|
|
(36
|
)
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
(3
|
)
|
Equity options
|
|
|
(1,713
|
)
|
|
|
(68
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate options
|
|
|
(379
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate forwards
|
|
|
(7
|
)
|
|
|
|
|
|
|
|
|
|
|
(4
|
)
|
|
|
|
|
Variance swaps
|
|
|
(276
|
)
|
|
|
(13
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap spreadlocks
|
|
|
(38
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit default swaps
|
|
|
(243
|
)
|
|
|
(11
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Total rate of return swaps
|
|
|
63
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
(6,757
|
)
|
|
$
|
(158
|
)
|
|
$
|
(376
|
)
|
|
$
|
(165
|
)
|
|
$
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2008
|
|
$
|
6,688
|
|
|
$
|
240
|
|
|
$
|
331
|
|
|
$
|
146
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Changes in estimated fair value related to economic hedges of
equity method investments in joint ventures, and changes in
estimated fair value related to derivatives held in relation to
trading portfolios. |
F-98
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
(2) |
|
Changes in estimated fair value related to economic hedges of
variable annuity guarantees included in future policy benefits. |
|
(3) |
|
Changes in estimated fair value related to derivatives held in
connection with the Companys mortgage banking activities. |
|
(4) |
|
Changes in estimated fair value related to economic hedges of
foreign currency exposure associated with the Companys
international subsidiaries. |
Credit
Derivatives
In connection with synthetically created investment transactions
and credit default swaps held in relation to the trading
portfolio, the Company writes credit default swaps for which it
receives a premium to insure credit risk. Such credit
derivatives are included within the non-qualifying derivatives
and derivatives for purposes other than hedging table. If a
credit event occurs, as defined by the contract, generally the
contract will require the Company to pay the counterparty the
specified swap notional amount in exchange for the delivery of
par quantities of the referenced credit obligation. The
Companys maximum amount at risk, assuming the value of all
referenced credit obligations is zero, was $5,089 million
and $3,101 million at December 31, 2010 and 2009,
respectively. The Company can terminate these contracts at any
time through cash settlement with the counterparty at an amount
equal to the then current fair value of the credit default
swaps. At December 31, 2010 and 2009, the Company would
have received $62 million and $53 million,
respectively, to terminate all of these contracts.
The following table presents the estimated fair value, maximum
amount of future payments and weighted average years to maturity
of written credit default swaps at December 31, 2010 and
2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
Maximum
|
|
|
|
|
|
|
|
|
Maximum
|
|
|
|
|
|
|
Estimated
|
|
|
Amount
|
|
|
|
|
|
Estimated
|
|
|
Amount of
|
|
|
|
|
|
|
Fair Value
|
|
|
of Future
|
|
|
Weighted
|
|
|
Fair Value
|
|
|
Future
|
|
|
Weighted
|
|
|
|
of Credit
|
|
|
Payments under
|
|
|
Average
|
|
|
of Credit
|
|
|
Payments under
|
|
|
Average
|
|
Rating Agency Designation of Referenced
|
|
Default
|
|
|
Credit Default
|
|
|
Years to
|
|
|
Default
|
|
|
Credit Default
|
|
|
Years to
|
|
Credit Obligations (1)
|
|
Swaps
|
|
|
Swaps (2)
|
|
|
Maturity (3)
|
|
|
Swaps
|
|
|
Swaps (2)
|
|
|
Maturity (3)
|
|
|
|
(In millions)
|
|
|
Aaa/Aa/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Single name credit default swaps (corporate)
|
|
$
|
5
|
|
|
$
|
470
|
|
|
|
3.8
|
|
|
$
|
5
|
|
|
$
|
175
|
|
|
|
4.3
|
|
Credit default swaps referencing indices
|
|
|
45
|
|
|
|
2,928
|
|
|
|
3.7
|
|
|
|
46
|
|
|
|
2,676
|
|
|
|
3.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
50
|
|
|
|
3,398
|
|
|
|
3.7
|
|
|
|
51
|
|
|
|
2,851
|
|
|
|
3.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Baa
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Single name credit default swaps (corporate)
|
|
|
5
|
|
|
|
735
|
|
|
|
4.3
|
|
|
|
2
|
|
|
|
195
|
|
|
|
4.8
|
|
Credit default swaps referencing indices
|
|
|
7
|
|
|
|
931
|
|
|
|
5.0
|
|
|
|
|
|
|
|
10
|
|
|
|
5.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
12
|
|
|
|
1,666
|
|
|
|
4.7
|
|
|
|
2
|
|
|
|
205
|
|
|
|
4.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ba
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Single name credit default swaps (corporate)
|
|
|
|
|
|
|
25
|
|
|
|
4.4
|
|
|
|
|
|
|
|
25
|
|
|
|
5.0
|
|
Credit default swaps referencing indices
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
|
|
|
|
25
|
|
|
|
4.4
|
|
|
|
|
|
|
|
25
|
|
|
|
5.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
B
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Single name credit default swaps (corporate)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit default swaps referencing indices
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20
|
|
|
|
5.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20
|
|
|
|
5.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
62
|
|
|
$
|
5,089
|
|
|
|
4.1
|
|
|
$
|
53
|
|
|
$
|
3,101
|
|
|
|
3.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-99
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
(1) |
|
The rating agency designations are based on availability and the
midpoint of the applicable ratings among Moodys, S&P
and Fitch. If no rating is available from a rating agency, then
an internally developed rating is used. |
|
(2) |
|
Assumes the value of the referenced credit obligations is zero. |
|
(3) |
|
The weighted average years to maturity of the credit default
swaps is calculated based on weighted average notional amounts. |
The Company has also entered into credit default swaps to
purchase credit protection on certain of the referenced credit
obligations in the table above. As a result, the maximum amounts
of potential future recoveries available to offset the
$5,089 million and $3,101 million from the table above
were $120 million and $31 million at December 31,
2010 and 2009, respectively.
Credit
Risk on Freestanding Derivatives
The Company may be exposed to credit-related losses in the event
of nonperformance by counterparties to derivative financial
instruments. Generally, the current credit exposure of the
Companys derivative contracts is limited to the net
positive estimated fair value of derivative contracts at the
reporting date after taking into consideration the existence of
netting agreements and any collateral received pursuant to
credit support annexes.
The Company manages its credit risk related to
over-the-counter
derivatives by entering into transactions with creditworthy
counterparties, maintaining collateral arrangements and through
the use of master agreements that provide for a single net
payment to be made by one counterparty to another at each due
date and upon termination. Because exchange-traded futures are
effected through regulated exchanges, and positions are marked
to market on a daily basis, the Company has minimal exposure to
credit-related losses in the event of nonperformance by
counterparties to such derivative instruments. See Note 5
for a description of the impact of credit risk on the valuation
of derivative instruments.
The Company enters into various collateral arrangements, which
require both the pledging and accepting of collateral in
connection with its derivative instruments. At December 31,
2010 and 2009, the Company was obligated to return cash
collateral under its control of $2,625 million and
$2,680 million, respectively. This unrestricted cash
collateral is included in cash and cash equivalents or in
short-term investments and the obligation to return it is
included in payables for collateral under securities loaned and
other transactions in the consolidated balance sheets. At
December 31, 2010 and 2009, the Company had also accepted
collateral consisting of various securities with a fair market
value of $984 million and $221 million, respectively,
which were held in separate custodial accounts. The Company is
permitted by contract to sell or repledge this collateral, but
at December 31, 2010, none of the collateral had been sold
or repledged.
The Companys collateral arrangements for its
over-the-counter
derivatives generally require the counterparty in a net
liability position, after considering the effect of netting
agreements, to pledge collateral when the fair value of that
counterpartys derivatives reaches a pre-determined
threshold. Certain of these arrangements also include
credit-contingent provisions that provide for a reduction of
these thresholds (on a sliding scale that converges toward zero)
in the event of downgrades in the credit ratings of the Company
and/or the
counterparty. In addition, certain of the Companys netting
agreements for derivative instruments contain provisions that
require the Company to maintain a specific investment grade
credit rating from at least one of the major credit rating
agencies. If the Companys credit ratings were to fall
below that specific investment grade credit rating, it would be
in violation of these provisions, and the counterparties to the
derivative instruments could request immediate payment or demand
immediate and ongoing full overnight collateralization on
derivative instruments that are in a net liability position
after considering the effect of netting agreements.
The following table presents the estimated fair value of the
Companys
over-the-counter
derivatives that are in a net liability position after
considering the effect of netting agreements, together with the
estimated fair value and
F-100
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
balance sheet location of the collateral pledged. The table also
presents the incremental collateral that the Company would be
required to provide if there was a one notch downgrade in the
Companys credit rating at the reporting date or if the
Companys credit rating sustained a downgrade to a level
that triggered full overnight collateralization or termination
of the derivative position at the reporting date. Derivatives
that are not subject to collateral agreements are not included
in the scope of this table.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated Fair Value of
|
|
|
Fair Value of Incremental Collateral
|
|
|
|
|
|
|
Collateral Provided:
|
|
|
Provided Upon:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Downgrade in the
|
|
|
|
|
|
|
|
|
|
|
|
|
One Notch
|
|
|
Companys Credit Rating
|
|
|
|
|
|
|
|
|
|
|
|
|
Downgrade
|
|
|
to a Level that Triggers
|
|
|
|
Estimated
|
|
|
|
|
|
|
|
|
in the
|
|
|
Full Overnight
|
|
|
|
Fair Value (1) of
|
|
|
|
|
|
|
|
|
Companys
|
|
|
Collateralization or
|
|
|
|
Derivatives in Net
|
|
|
Fixed Maturity
|
|
|
|
|
|
Credit
|
|
|
Termination
|
|
|
|
Liability Position
|
|
|
Securities (2)
|
|
|
Cash (3)
|
|
|
Rating
|
|
|
of the Derivative Position
|
|
|
|
(In millions)
|
|
|
December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives subject to credit-contingent provisions
|
|
$
|
1,167
|
|
|
$
|
1,024
|
|
|
$
|
|
|
|
$
|
99
|
|
|
$
|
231
|
|
Derivatives not subject to credit-contingent provisions
|
|
|
22
|
|
|
|
|
|
|
|
43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,189
|
|
|
$
|
1,024
|
|
|
$
|
43
|
|
|
$
|
99
|
|
|
$
|
231
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives subject to credit-contingent provisions
|
|
$
|
1,163
|
|
|
$
|
1,017
|
|
|
$
|
|
|
|
$
|
90
|
|
|
$
|
218
|
|
Derivatives not subject to credit-contingent provisions
|
|
|
48
|
|
|
|
42
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,211
|
|
|
$
|
1,059
|
|
|
$
|
|
|
|
$
|
90
|
|
|
$
|
218
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
After taking into consideration the existence of netting
agreements. |
|
(2) |
|
Included in fixed maturity securities in the consolidated
balance sheets. The counterparties are permitted by contract to
sell or repledge this collateral. |
|
(3) |
|
Included in premiums, reinsurance and other receivables in the
consolidated balance sheets. |
Without considering the effect of netting agreements, the
estimated fair value of the Companys
over-the-counter
derivatives with credit-contingent provisions that were in a
gross liability position at December 31, 2010 was
$1,742 million. At December 31, 2010, the Company
provided securities collateral of $1,024 million in
connection with these derivatives. In the unlikely event that
both: (i) the Companys credit rating was downgraded
to a level that triggers full overnight collateralization or
termination of all derivative positions; and (ii) the
Companys netting agreements were deemed to be legally
unenforceable, then the additional collateral that the Company
would be required to provide to its counterparties in connection
with its derivatives in a gross liability position at
December 31, 2010 would be $718 million. This amount
does not consider gross derivative assets of $575 million
for which the Company has the contractual right of offset.
The Company also has exchange-traded futures and options, which
require the pledging of collateral. At December 31, 2010
and 2009, the Company pledged securities collateral for
exchange-traded futures and options of $40 million and
$50 million, respectively, which is included in fixed
maturity securities. The counterparties are permitted by
contract to sell or repledge this collateral. At
December 31, 2010 and 2009, the Company provided cash
collateral for exchange-traded futures and options of
$662 million and $562 million, respectively, which is
included in premiums, reinsurance and other receivables.
F-101
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Embedded
Derivatives
The Company has certain embedded derivatives that are required
to be separated from their host contracts and accounted for as
derivatives. These host contracts principally include: variable
annuities with guaranteed minimum benefits, including GMWBs,
GMABs and certain GMIBs; ceded reinsurance contracts of
guaranteed minimum benefits related to GMABs and certain GMIBs;
and funding agreements with equity or bond indexed crediting
rates.
The following table presents the estimated fair value of the
Companys embedded derivatives at:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Net embedded derivatives within asset host contracts:
|
|
|
|
|
|
|
|
|
Ceded guaranteed minimum benefits
|
|
$
|
185
|
|
|
$
|
76
|
|
Options embedded in debt or equity securities
|
|
|
(57
|
)
|
|
|
(37
|
)
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives within asset host contracts
|
|
$
|
128
|
|
|
$
|
39
|
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives within liability host contracts:
|
|
|
|
|
|
|
|
|
Direct guaranteed minimum benefits
|
|
$
|
2,556
|
|
|
$
|
1,500
|
|
Other
|
|
|
78
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives within liability host contracts
|
|
$
|
2,634
|
|
|
$
|
1,505
|
|
|
|
|
|
|
|
|
|
|
The following table presents changes in estimated fair value
related to embedded derivatives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2010
|
|
2009
|
|
2008
|
|
|
(In millions)
|
|
Net derivative gains (losses) (1)
|
|
$
|
(387
|
)
|
|
$
|
1,758
|
|
|
$
|
(2,650
|
)
|
Policyholder benefits and claims
|
|
$
|
8
|
|
|
$
|
(114
|
)
|
|
$
|
182
|
|
|
|
|
(1) |
|
The valuation of guaranteed minimum benefits includes an
adjustment for nonperformance risk. Included in net derivative
gains (losses), in connection with this adjustment, were gains
(losses) of ($96) million, ($1,932) million and
$2,994 million for the years ended December 31, 2010,
2009 and 2008, respectively. Net derivative gains (losses) for
the year ended December 31, 2010 included a loss of
$955 million relating to a refinement for estimating
nonperformance risk in fair value measurements implemented at
June 30, 2010. See Note 5. |
Considerable judgment is often required in interpreting market
data to develop estimates of fair value and the use of different
assumptions or valuation methodologies may have a material
effect on the estimated fair value amounts.
F-102
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Assets
and Liabilities Measured at Fair Value
Recurring
Fair Value Measurements
The assets and liabilities measured at estimated fair value on a
recurring basis, including those items for which the Company has
elected the FVO, were determined as described below. These
estimated fair values and their corresponding placement in the
fair value hierarchy are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
Fair Value Measurements at Reporting Date Using
|
|
|
|
|
|
|
Quoted Prices in
|
|
|
|
|
|
|
|
|
|
|
|
|
Active Markets for
|
|
|
|
|
|
Significant
|
|
|
Total
|
|
|
|
Identical Assets
|
|
|
Significant Other
|
|
|
Unobservable
|
|
|
Estimated
|
|
|
|
and Liabilities
|
|
|
Observable Inputs
|
|
|
Inputs
|
|
|
Fair
|
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
|
|
|
$
|
85,419
|
|
|
$
|
7,149
|
|
|
$
|
92,568
|
|
Foreign corporate securities
|
|
|
|
|
|
|
62,401
|
|
|
|
5,777
|
|
|
|
68,178
|
|
RMBS
|
|
|
274
|
|
|
|
43,037
|
|
|
|
1,422
|
|
|
|
44,733
|
|
Foreign government securities
|
|
|
149
|
|
|
|
40,092
|
|
|
|
3,159
|
|
|
|
43,400
|
|
U.S. Treasury, agency and government guaranteed securities
|
|
|
14,602
|
|
|
|
18,623
|
|
|
|
79
|
|
|
|
33,304
|
|
CMBS
|
|
|
|
|
|
|
19,664
|
|
|
|
1,011
|
|
|
|
20,675
|
|
ABS
|
|
|
|
|
|
|
10,142
|
|
|
|
4,148
|
|
|
|
14,290
|
|
State and political subdivision securities
|
|
|
|
|
|
|
10,083
|
|
|
|
46
|
|
|
|
10,129
|
|
Other fixed maturity securities
|
|
|
|
|
|
|
3
|
|
|
|
4
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
|
15,025
|
|
|
|
289,464
|
|
|
|
22,795
|
|
|
|
327,284
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
832
|
|
|
|
1,094
|
|
|
|
268
|
|
|
|
2,194
|
|
Non-redeemable preferred stock
|
|
|
|
|
|
|
507
|
|
|
|
905
|
|
|
|
1,412
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
|
832
|
|
|
|
1,601
|
|
|
|
1,173
|
|
|
|
3,606
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading and other securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actively Traded Securities
|
|
|
|
|
|
|
453
|
|
|
|
10
|
|
|
|
463
|
|
FVO general account securities
|
|
|
|
|
|
|
54
|
|
|
|
77
|
|
|
|
131
|
|
FVO contractholder-directed unit-linked investments
|
|
|
6,270
|
|
|
|
10,789
|
|
|
|
735
|
|
|
|
17,794
|
|
FVO securities held by consolidated securitization entities
|
|
|
|
|
|
|
201
|
|
|
|
|
|
|
|
201
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading and other securities
|
|
|
6,270
|
|
|
|
11,497
|
|
|
|
822
|
|
|
|
18,589
|
|
Short-term investments (1)
|
|
|
3,026
|
|
|
|
4,681
|
|
|
|
858
|
|
|
|
8,565
|
|
Mortgage loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans held by consolidated securitization entities
|
|
|
|
|
|
|
6,840
|
|
|
|
|
|
|
|
6,840
|
|
Mortgage loans
held-for-sale
(2)
|
|
|
|
|
|
|
2,486
|
|
|
|
24
|
|
|
|
2,510
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total mortgage loans
|
|
|
|
|
|
|
9,326
|
|
|
|
24
|
|
|
|
9,350
|
|
MSRs (3)
|
|
|
|
|
|
|
|
|
|
|
950
|
|
|
|
950
|
|
Other invested assets investment funds
|
|
|
373
|
|
|
|
121
|
|
|
|
|
|
|
|
494
|
|
Derivative assets: (4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts
|
|
|
131
|
|
|
|
3,583
|
|
|
|
39
|
|
|
|
3,753
|
|
Foreign currency contracts
|
|
|
2
|
|
|
|
1,711
|
|
|
|
74
|
|
|
|
1,787
|
|
Credit contracts
|
|
|
|
|
|
|
125
|
|
|
|
50
|
|
|
|
175
|
|
Equity market contracts
|
|
|
23
|
|
|
|
1,757
|
|
|
|
282
|
|
|
|
2,062
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total derivative assets
|
|
|
156
|
|
|
|
7,176
|
|
|
|
445
|
|
|
|
7,777
|
|
Net embedded derivatives within asset host contracts (5)
|
|
|
|
|
|
|
|
|
|
|
185
|
|
|
|
185
|
|
Separate account assets (6)
|
|
|
25,660
|
|
|
|
155,589
|
|
|
|
2,088
|
|
|
|
183,337
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
51,342
|
|
|
$
|
479,455
|
|
|
$
|
29,340
|
|
|
$
|
560,137
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-103
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
Fair Value Measurements at Reporting Date Using
|
|
|
|
|
|
|
Quoted Prices in
|
|
|
|
|
|
|
|
|
|
|
|
|
Active Markets for
|
|
|
|
|
|
Significant
|
|
|
Total
|
|
|
|
Identical Assets
|
|
|
Significant Other
|
|
|
Unobservable
|
|
|
Estimated
|
|
|
|
and Liabilities
|
|
|
Observable Inputs
|
|
|
Inputs
|
|
|
Fair
|
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities: (4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts
|
|
$
|
35
|
|
|
$
|
1,598
|
|
|
$
|
125
|
|
|
$
|
1,758
|
|
Foreign currency contracts
|
|
|
|
|
|
|
1,372
|
|
|
|
1
|
|
|
|
1,373
|
|
Credit contracts
|
|
|
|
|
|
|
101
|
|
|
|
6
|
|
|
|
107
|
|
Equity market contracts
|
|
|
10
|
|
|
|
1,174
|
|
|
|
140
|
|
|
|
1,324
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total derivative liabilities
|
|
|
45
|
|
|
|
4,245
|
|
|
|
272
|
|
|
|
4,562
|
|
Net embedded derivatives within liability host contracts (5)
|
|
|
|
|
|
|
11
|
|
|
|
2,623
|
|
|
|
2,634
|
|
Long-term debt of consolidated securitization entities
|
|
|
|
|
|
|
6,636
|
|
|
|
184
|
|
|
|
6,820
|
|
Trading liabilities (7)
|
|
|
46
|
|
|
|
|
|
|
|
|
|
|
|
46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
91
|
|
|
$
|
10,892
|
|
|
$
|
3,079
|
|
|
$
|
14,062
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Variable Interest Entities in
Note 3 for discussion of CSEs included in the table above.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
|
Fair Value Measurements at Reporting Date Using
|
|
|
|
|
|
|
Quoted Prices in
|
|
|
|
|
|
|
|
|
|
|
|
|
Active Markets for
|
|
|
|
|
|
Significant
|
|
|
Total
|
|
|
|
Identical Assets
|
|
|
Significant Other
|
|
|
Unobservable
|
|
|
Estimated
|
|
|
|
and Liabilities
|
|
|
Observable Inputs
|
|
|
Inputs
|
|
|
Fair
|
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
|
|
|
$
|
65,493
|
|
|
$
|
6,694
|
|
|
$
|
72,187
|
|
Foreign corporate securities
|
|
|
|
|
|
|
32,738
|
|
|
|
5,292
|
|
|
|
38,030
|
|
RMBS
|
|
|
|
|
|
|
42,180
|
|
|
|
1,840
|
|
|
|
44,020
|
|
Foreign government securities
|
|
|
306
|
|
|
|
11,240
|
|
|
|
401
|
|
|
|
11,947
|
|
U.S. Treasury, agency and government guaranteed securities
|
|
|
10,951
|
|
|
|
14,459
|
|
|
|
37
|
|
|
|
25,447
|
|
CMBS
|
|
|
|
|
|
|
15,483
|
|
|
|
139
|
|
|
|
15,622
|
|
ABS
|
|
|
|
|
|
|
10,450
|
|
|
|
2,712
|
|
|
|
13,162
|
|
State and political subdivision securities
|
|
|
|
|
|
|
7,139
|
|
|
|
69
|
|
|
|
7,208
|
|
Other fixed maturity securities
|
|
|
|
|
|
|
13
|
|
|
|
6
|
|
|
|
19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
|
11,257
|
|
|
|
199,195
|
|
|
|
17,190
|
|
|
|
227,642
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
490
|
|
|
|
995
|
|
|
|
136
|
|
|
|
1,621
|
|
Non-redeemable preferred stock
|
|
|
|
|
|
|
359
|
|
|
|
1,104
|
|
|
|
1,463
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
|
490
|
|
|
|
1,354
|
|
|
|
1,240
|
|
|
|
3,084
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading and other securities
|
|
|
1,886
|
|
|
|
415
|
|
|
|
83
|
|
|
|
2,384
|
|
Short-term investments (1)
|
|
|
5,650
|
|
|
|
2,500
|
|
|
|
23
|
|
|
|
8,173
|
|
Mortgage loans
held-for-sale
(2)
|
|
|
|
|
|
|
2,445
|
|
|
|
25
|
|
|
|
2,470
|
|
MSRs (3)
|
|
|
|
|
|
|
|
|
|
|
878
|
|
|
|
878
|
|
Derivative assets (4)
|
|
|
103
|
|
|
|
5,600
|
|
|
|
430
|
|
|
|
6,133
|
|
Net embedded derivatives within asset host contracts (5)
|
|
|
|
|
|
|
|
|
|
|
76
|
|
|
|
76
|
|
Separate account assets (6)
|
|
|
17,601
|
|
|
|
129,545
|
|
|
|
1,895
|
|
|
|
149,041
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
36,987
|
|
|
$
|
341,054
|
|
|
$
|
21,840
|
|
|
$
|
399,881
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities (4)
|
|
$
|
51
|
|
|
$
|
3,990
|
|
|
$
|
74
|
|
|
$
|
4,115
|
|
Net embedded derivatives within liability host contracts (5)
|
|
|
|
|
|
|
(26
|
)
|
|
|
1,531
|
|
|
|
1,505
|
|
Trading liabilities (7)
|
|
|
106
|
|
|
|
|
|
|
|
|
|
|
|
106
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
157
|
|
|
$
|
3,964
|
|
|
$
|
1,605
|
|
|
$
|
5,726
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-104
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
(1) |
|
Short-term investments as presented in the tables above differ
from the amounts presented in the consolidated balance sheets
because certain short-term investments are not measured at
estimated fair value (e.g., time deposits, etc.), and therefore
are excluded from the tables presented above. |
|
(2) |
|
Mortgage loans
held-for-sale
as presented in the tables above differ from the amount
presented in the consolidated balance sheets as these tables
only include residential mortgage loans
held-for-sale
measured at estimated fair value on a recurring basis. |
|
(3) |
|
MSRs are presented within other invested assets in the
consolidated balance sheets. |
|
(4) |
|
Derivative assets are presented within other invested assets in
the consolidated balance sheets and derivative liabilities are
presented within other liabilities in the consolidated balance
sheets. The amounts are presented gross in the tables above to
reflect the presentation in the consolidated balance sheets, but
are presented net for purposes of the rollforward in the Fair
Value Measurements Using Significant Unobservable Inputs
(Level 3) tables which follow. At December 31,
2010 and 2009, certain non-derivative hedging instruments of
$185 million and $0, respectively, which are carried at
amortized cost, are included with the liabilities total in
Note 4 but excluded from derivative liabilities in the
tables above as they are not derivative instruments. |
|
(5) |
|
Net embedded derivatives within asset host contracts are
presented within premiums, reinsurance and other receivables in
the consolidated balance sheets. Net embedded derivatives within
liability host contracts are presented primarily within
policyholder account balances in the consolidated balance
sheets. At December 31, 2010, fixed maturity securities and
equity securities also included embedded derivatives of
$5 million and ($62) million, respectively. At
December 31, 2009, fixed maturity securities and equity
securities included embedded derivatives of $0 and
($37) million, respectively. |
|
(6) |
|
Separate account assets are measured at estimated fair value.
Investment performance related to separate account assets is
fully offset by corresponding amounts credited to
contractholders whose liability is reflected within separate
account liabilities. Separate account liabilities are set equal
to the estimated fair value of separate account assets. |
|
(7) |
|
Trading liabilities are presented within other liabilities in
the consolidated balance sheets. |
The methods and assumptions used to estimate the fair value of
financial instruments are summarized as follows:
Fixed
Maturity Securities, Equity Securities, Trading and Other
Securities and Short-term Investments
When available, the estimated fair value of the Companys
fixed maturity, equity and trading and other securities are
based on quoted prices in active markets that are readily and
regularly obtainable. Generally, these are the most liquid of
the Companys securities holdings and valuation of these
securities does not involve management judgment.
When quoted prices in active markets are not available, the
determination of estimated fair value is based on market
standard valuation methodologies. The market standard valuation
methodologies utilized include: discounted cash flow
methodologies, matrix pricing or other similar techniques. The
inputs in applying these market standard valuation methodologies
include, but are not limited to: interest rates, credit standing
of the issuer or counterparty, industry sector of the issuer,
coupon rate, call provisions, sinking fund requirements,
maturity and managements assumptions regarding estimated
duration, liquidity and estimated future cash flows.
Accordingly, the estimated fair values are based on available
market information and managements judgments about
financial instruments.
The significant inputs to the market standard valuation
methodologies for certain types of securities with reasonable
levels of price transparency are inputs that are observable in
the market or can be derived principally
F-105
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
from or corroborated by observable market data. Such observable
inputs include benchmarking prices for similar assets in active
markets, quoted prices in markets that are not active and
observable yields and spreads in the market.
When observable inputs are not available, the market standard
valuation methodologies for determining the estimated fair value
of certain types of securities that trade infrequently, and
therefore have little or no price transparency, rely on inputs
that are significant to the estimated fair value that are not
observable in the market or cannot be derived principally from
or corroborated by observable market data. These unobservable
inputs can be based in large part on management judgment or
estimation and cannot be supported by reference to market
activity. Even though unobservable, these inputs are assumed to
be consistent with what other market participants would use when
pricing such securities and are considered appropriate given the
circumstances.
The estimated fair value of FVO securities held by CSEs is
determined on a basis consistent with the methodologies
described herein for fixed maturity securities and equity
securities. As discussed in Note 1, the Company adopted new
guidance effective January 1, 2010 and consolidated certain
securitization entities that hold securities that have been
accounted for under the FVO and classified within trading and
other securities.
The use of different methodologies, assumptions and inputs may
have a material effect on the estimated fair values of the
Companys securities holdings.
Mortgage
Loans
Mortgage loans presented in the tables above consist of
commercial mortgage loans held by CSEs and residential mortgage
loans
held-for-sale
for which the Company has elected the FVO and which are carried
at estimated fair value. As discussed in Note 1, the
Company adopted new guidance effective January 1, 2010 and
consolidated certain securitization entities that hold
commercial mortgage loans. See Valuation
Techniques and Inputs by Level Within the
Three-Level Fair Value Hierarchy by Major Classes of Assets
and Liabilities below for a discussion of the methods and
assumptions used to estimate the fair value of these financial
instruments.
MSRs
Although MSRs are not financial instruments, the Company has
included them in the preceding table as a result of its election
to carry MSRs at estimated fair value. See
Valuation Techniques and Inputs by
Level Within the Three-Level Fair Value Hierarchy by
Major Classes of Assets and Liabilities below for a
discussion of the methods and assumptions used to estimate the
fair value of these financial instruments.
Other
Invested Assets Investment Funds
The estimated fair value of these investment funds is determined
on a basis consistent with the methodologies described herein
for trading and other securities.
Derivatives
The estimated fair value of derivatives is determined through
the use of quoted market prices for exchange-traded derivatives
and interest rate forwards to sell certain to be announced
securities, or through the use of pricing models for
over-the-counter
derivatives. The determination of estimated fair value, when
quoted market values are not available, is based on market
standard valuation methodologies and inputs that are assumed to
be consistent with what other market participants would use when
pricing the instruments. Derivative valuations can be affected
by changes in interest rates, foreign currency exchange rates,
financial indices, credit spreads, default risk (including the
counterparties to the contract), volatility, liquidity and
changes in estimates and assumptions used in the pricing models.
The significant inputs to the pricing models for most
over-the-counter
derivatives are inputs that are observable in the market or can
be derived principally from or corroborated by observable market
data.
F-106
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Significant inputs that are observable generally include:
interest rates, foreign currency exchange rates, interest rate
curves, credit curves and volatility. However, certain
over-the-counter
derivatives may rely on inputs that are significant to the
estimated fair value that are not observable in the market or
cannot be derived principally from or corroborated by observable
market data. Significant inputs that are unobservable generally
include: independent broker quotes, credit correlation
assumptions, references to emerging market currencies and inputs
that are outside the observable portion of the interest rate
curve, credit curve, volatility or other relevant market
measure. These unobservable inputs may involve significant
management judgment or estimation. Even though unobservable,
these inputs are based on assumptions deemed appropriate given
the circumstances and are assumed to be consistent with what
other market participants would use when pricing such
instruments.
The credit risk of both the counterparty and the Company are
considered in determining the estimated fair value for all
over-the-counter
derivatives, and any potential credit adjustment is based on the
net exposure by counterparty after taking into account the
effects of netting agreements and collateral arrangements. The
Company values its derivative positions using the standard swap
curve which includes a spread to the risk free rate. This credit
spread is appropriate for those parties that execute trades at
pricing levels consistent with the standard swap curve. As the
Company and its significant derivative counterparties
consistently execute trades at such pricing levels, additional
credit risk adjustments are not currently required in the
valuation process. The Companys ability to consistently
execute at such pricing levels is in part due to the netting
agreements and collateral arrangements that are in place with
all of its significant derivative counterparties. The evaluation
of the requirement to make additional credit risk adjustments is
performed by the Company each reporting period.
Most inputs for
over-the-counter
derivatives are mid market inputs but, in certain cases, bid
level inputs are used when they are deemed more representative
of exit value. Market liquidity, as well as the use of different
methodologies, assumptions and inputs, may have a material
effect on the estimated fair values of the Companys
derivatives and could materially affect net income.
Embedded
Derivatives Within Asset and Liability Host Contracts
Embedded derivatives principally include certain direct, assumed
and ceded variable annuity guarantees and equity or bond indexed
crediting rates within certain funding agreements. Embedded
derivatives are recorded in the consolidated financial
statements at estimated fair value with changes in estimated
fair value reported in net income.
The Company issues certain variable annuity products with
guaranteed minimum benefit guarantees. GMWBs, GMABs and certain
GMIBs are embedded derivatives, which are measured at estimated
fair value separately from the host variable annuity contract,
with changes in estimated fair value reported in net derivative
gains (losses). These embedded derivatives are classified within
policyholder account balances in the consolidated balance sheets.
The fair value of these guarantees is estimated using the
present value of future benefits minus the present value of
future fees using actuarial and capital market assumptions
related to the projected cash flows over the expected lives of
the contracts. A risk neutral valuation methodology is used
under which the cash flows from the guarantees are projected
under multiple capital market scenarios using observable risk
free rates, currency exchange rates and observable and estimated
implied volatilities.
The valuation of these guarantee liabilities includes
adjustments for nonperformance risk and for a risk margin
related to non-capital market inputs. Both of these adjustments
are captured as components of the spread which, when combined
with the risk free rate, is used to discount the cash flows of
the liability for purposes of determining its fair value.
The nonperformance adjustment is determined by taking into
consideration publicly available information relating to spreads
in the secondary market for the Holding Companys debt,
including related credit default swaps.
F-107
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
These observable spreads are then adjusted, as necessary, to
reflect the priority of these liabilities and the claims paying
ability of the issuing insurance subsidiaries compared to the
Holding Company.
Risk margins are established to capture the non-capital market
risks of the instrument which represent the additional
compensation a market participant would require to assume the
risks related to the uncertainties of such actuarial assumptions
as annuitization, premium persistency, partial withdrawal and
surrenders. The establishment of risk margins requires the use
of significant management judgment, including assumptions of the
amount and cost of capital needed to cover the guarantees. These
guarantees may be more costly than expected in volatile or
declining equity markets. Market conditions including, but not
limited to, changes in interest rates, equity indices, market
volatility and foreign currency exchange rates; changes in
nonperformance risk; and variations in actuarial assumptions
regarding policyholder behavior, mortality and risk margins
related to non-capital market inputs may result in significant
fluctuations in the estimated fair value of the guarantees that
could materially affect net income.
The Company ceded the risk associated with certain of the GMIB
and GMAB described above. These reinsurance contracts contain
embedded derivatives which are included in premiums, reinsurance
and other receivables in the consolidated balance sheets with
changes in estimated fair value reported in net derivative gains
(losses) or policyholder benefits and claims depending on the
statement of operations classification of the direct risk. The
value of the embedded derivatives on the ceded risk is
determined using a methodology consistent with that described
previously for the guarantees directly written by the Company.
As part of its regular review of critical accounting estimates,
the Company periodically assesses inputs for estimating
nonperformance risk (commonly referred to as own
credit) in fair value measurements. During the second
quarter of 2010, the Company completed a study that aggregated
and evaluated data, including historical recovery rates of
insurance companies, as well as policyholder behavior observed
over the past two years as the recent financial crisis evolved.
As a result, at the end of the second quarter of 2010, the
Company refined the way in which its insurance subsidiaries
incorporate expected recovery rates into the nonperformance risk
adjustment for purposes of estimating the fair value of
investment-type contracts and embedded derivatives within
insurance contracts. The Company recognized a loss of
$577 million, net of DAC and income tax, relating to
implementing the refinement at June 30, 2010. The
refinement reduced both basic and diluted net income available
to MetLife, Inc.s common shareholders per common share by
$0.65 for the year ended December 31, 2010.
The estimated fair value of the embedded derivatives within
funds withheld related to certain ceded reinsurance is
determined based on the change in estimated fair value of the
underlying assets held by the Company in a reference portfolio
backing the funds withheld liability. The estimated fair value
of the underlying assets is determined as described above in
Fixed Maturity Securities, Equity Securities,
Trading and Other Securities and Short-term Investments.
The estimated fair value of these embedded derivatives is
included, along with their funds withheld hosts, in other
liabilities in the consolidated balance sheets with changes in
estimated fair value recorded in net derivative gains (losses).
Changes in the credit spreads on the underlying assets, interest
rates and market volatility may result in significant
fluctuations in the estimated fair value of these embedded
derivatives that could materially affect net income.
The estimated fair value of the embedded equity and bond indexed
derivatives contained in certain funding agreements is
determined using market standard swap valuation models and
observable market inputs, including an adjustment for
nonperformance risk. The estimated fair value of these embedded
derivatives are included, along with their funding agreements
host, within policyholder account balances with changes in
estimated fair value recorded in net derivative gains (losses).
Changes in equity and bond indices, interest rates and the
Companys credit standing may result in significant
fluctuations in the estimated fair value of these embedded
derivatives that could materially affect net income.
F-108
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Separate
Account Assets
Separate account assets are carried at estimated fair value and
reported as a summarized total on the consolidated balance
sheets. The estimated fair value of separate account assets is
based on the estimated fair value of the underlying assets owned
by the separate account. Assets within the Companys
separate accounts include: mutual funds, fixed maturity
securities, equity securities, mortgage loans, derivatives,
hedge funds, other limited partnership interests, short-term
investments and cash and cash equivalents. See
Valuation Techniques and Inputs by
Level Within the Three-Level Fair Value Hierarchy by
Major Classes of Assets and Liabilities below for a
discussion of the methods and assumptions used to estimate the
fair value of these financial instruments.
Long-term
Debt of CSEs
The Company has elected the FVO for the long-term debt of CSEs,
which are carried at estimated fair value. See
Valuation Techniques and Inputs by
Level Within the Three-Level Fair Value Hierarchy by
Major Classes of Assets and Liabilities below for a
discussion of the methods and assumptions used to estimate the
fair value of these financial instruments.
Trading
Liabilities
Trading liabilities are recorded at estimated fair value with
subsequent changes in estimated fair value recognized in net
investment income. The estimated fair value of trading
liabilities is determined on a basis consistent with the
methodologies described in Fixed Maturity
Securities, Equity Securities and Trading and Other
Securities.
Valuation
Techniques and Inputs by Level Within the
Three-Level Fair Value Hierarchy by Major Classes of Assets
and Liabilities
A description of the significant valuation techniques and inputs
to the determination of estimated fair value for the more
significant asset and liability classes measured at fair value
on a recurring basis is as follows:
The Company determines the estimated fair value of its
investments using primarily the market approach and the income
approach. The use of quoted prices for identical assets and
matrix pricing or other similar techniques are examples of
market approaches, while the use of discounted cash flow
methodologies is an example of the income approach. The Company
attempts to maximize the use of observable inputs and minimize
the use of unobservable inputs in selecting whether the market
or income approach is used.
While certain investments have been classified as Level 1
from the use of unadjusted quoted prices for identical
investments supported by high volumes of trading activity and
narrow bid/ask spreads, most investments have been classified as
Level 2 because the significant inputs used to measure the
fair value on a recurring basis of the same or similar
investment are market observable or can be corroborated using
market observable information for the full term of the
investment. Level 3 investments include those where
estimated fair values are based on significant unobservable
inputs that are supported by little or no market activity and
may reflect our own assumptions about what factors market
participants would use in pricing these investments.
Level 1
Measurements:
Fixed
Maturity Securities, Equity Securities, Trading and Other
Securities and Short-term Investments
These securities are comprised of U.S. Treasury, agency and
government guaranteed fixed maturity securities, foreign
government securities, RMBS principally
to-be-announced securities, exchange traded common stock,
exchange traded mutual fund interests included in equity
securities, exchange traded registered mutual fund interests
included in trading and other securities and short-term money
market securities, including U.S. Treasury bills. Valuation
of these securities is based on unadjusted quoted prices in
active markets that are readily and
F-109
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
regularly available. Contractholder-directed unit-linked
investments reported within trading and other securities include
certain registered mutual fund interests priced using daily NAV
provided by the fund managers.
Derivative
Assets and Derivative Liabilities
These assets and liabilities are comprised of exchange-traded
derivatives, as well as interest rate forwards to sell certain
to be announced securities. Valuation of these assets and
liabilities is based on unadjusted quoted prices in active
markets that are readily and regularly available.
Separate
Account Assets
These assets are comprised of securities that are similar in
nature to the fixed maturity securities, equity securities and
short-term investments referred to above; and certain
exchange-traded derivatives, including financial futures and
owned options. Valuation is based on unadjusted quoted prices in
active markets that are readily and regularly available.
Level 2
Measurements:
Fixed
Maturity Securities, Equity Securities, Trading and Other
Securities and Short-term Investments
This level includes fixed maturity securities and equity
securities priced principally by independent pricing services
using observable inputs. Trading and other securities and
short-term investments within this level are of a similar nature
and class to the Level 2 securities described below;
accordingly, the valuation techniques and significant market
standard observable inputs used in their valuation are also
similar to those described below. Contractholder-directed
unit-linked investments reported within trading and other
securities include certain mutual fund interests without readily
determinable fair values given prices are not published
publicly. Valuation of these mutual funds is based upon quoted
prices or reported NAV provided by the fund managers, which were
based on observable inputs.
U.S. corporate and foreign corporate
securities. These securities are principally
valued using the market and income approaches. Valuation is
based primarily on quoted prices in markets that are not active,
or using matrix pricing or other similar techniques that use
standard market observable inputs such as a benchmark yields,
spreads off benchmark yields, new issuances, issuer rating,
duration, and trades of identical or comparable securities.
Investment grade privately placed securities are valued using a
discounted cash flow methodologies using standard market
observable inputs, and inputs derived from, or corroborated by,
market observable data including market yield curve, duration,
call provisions, observable prices and spreads for similar
publicly traded or privately traded issues that incorporate the
credit quality and industry sector of the issuer. This level
also includes certain below investment grade privately placed
fixed maturity securities priced by independent pricing services
that use observable inputs.
Structured securities comprised of RMBS, CMBS and
ABS. These securities are principally valued
using the market approach. Valuation is based primarily on
matrix pricing or other similar techniques using standard market
inputs including spreads for actively traded securities, spreads
off benchmark yields, expected prepayment speeds and volumes,
current and forecasted loss severity, rating, weighted average
coupon, weighted average maturity, average delinquency rates,
geographic region, debt-service coverage ratios and
issuance-specific information including, but not limited to:
collateral type, payment terms of the underlying assets, payment
priority within the tranche, structure of the security, deal
performance and vintage of loans.
U.S. Treasury, agency and government guaranteed
securities. These securities are principally
valued using the market approach. Valuation is based primarily
on quoted prices in markets that are not active, or using matrix
pricing or other similar techniques using standard market
observable inputs such as benchmark U.S. Treasury yield
curve, the spread off the U.S. Treasury curve for the
identical security and comparable securities that are actively
traded.
F-110
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Foreign government and state and political subdivision
securities. These securities are principally
valued using the market approach. Valuation is based primarily
on matrix pricing or other similar techniques using standard
market observable inputs including benchmark U.S. Treasury
or other yields, issuer ratings, broker-dealer quotes, issuer
spreads and reported trades of similar securities, including
those within the same
sub-sector
or with a similar maturity or credit rating.
Common and non-redeemable preferred
stock. These securities are principally valued
using the market approach where market quotes are available but
are not considered actively traded. Valuation is based
principally on observable inputs including quoted prices in
markets that are not considered active.
Mortgage
Loans Held by CSEs
These commercial mortgage loans are principally valued using the
market approach. The principal market for these commercial loan
portfolios is the securitization market. The Company uses the
quoted securitization market price of the obligations of the
CSEs to determine the estimated fair value of these commercial
loan portfolios. These market prices are determined principally
by independent pricing services using observable inputs.
Mortgage
Loans
Held-For-Sale
Residential mortgage loans
held-for-sale
are principally valued using the market approach and valued
primarily using readily available observable pricing for similar
loans or securities backed by similar loans. The unobservable
adjustments to such prices are insignificant.
Derivative
Assets and Derivative Liabilities
This level includes all types of derivative instruments utilized
by the Company with the exception of exchange-traded derivatives
and interest rate forwards to sell certain to be announced
securities included within Level 1 and those derivative
instruments with unobservable inputs as described in
Level 3. These derivatives are principally valued using an
income approach.
Interest
rate contracts.
Non-option-based Valuations are based on present
value techniques, which utilize significant inputs that may
include the swap yield curve, LIBOR basis curves, and repurchase
rates.
Option-based Valuations are based on option pricing
models, which utilize significant inputs that may include the
swap yield curve, LIBOR basis curves, and interest rate
volatility.
Foreign
currency contracts.
Non-option-based Valuations are based on present
value techniques, which utilize significant inputs that may
include the swap yield curve, LIBOR basis curves, currency spot
rates, and cross currency basis curves.
Option-based Valuations are based on option pricing
models, which utilize significant inputs that may include the
swap yield curve, LIBOR basis curves, currency spot rates, cross
currency basis curves, and currency volatility.
Credit
contracts.
Non-option-based Valuations are based on present
value techniques, which utilize significant inputs that may
include the swap yield curve, credit curves, and recovery rates.
F-111
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Equity
market contracts.
Non-option-based Valuations are based on present
value techniques, which utilize significant inputs that may
include the swap yield curve, spot equity index levels, and
dividend yield curves.
Option-based Valuations are based on option pricing
models, which utilize significant inputs that may include the
swap yield curve, spot equity index levels, dividend yield
curves, and equity volatility.
Embedded
Derivatives Contained in Certain Funding Agreements
These derivatives are principally valued using an income
approach. Valuations are based on present value techniques,
which utilize significant inputs that may include the swap yield
curve and the spot equity and bond index level.
Separate
Account Assets
These assets are comprised of investments that are similar in
nature to the fixed maturity securities, equity securities,
short-term investments and derivatives referred to above. Also
included are certain mutual funds and hedge funds without
readily determinable fair values given prices are not published
publicly. Valuation of the mutual funds and hedge funds is based
upon quoted prices or reported NAV provided by the fund managers.
Long-term
Debt of CSEs
The estimated fair value of the long-term debt of the
Companys CSEs is based on quoted prices when traded as
assets in active markets or, if not available, based on market
standard valuation methodologies, consistent with the
Companys methods and assumptions used to estimate the fair
value of comparable fixed maturity securities.
Level 3
Measurements:
In general, investments classified within Level 3 use many
of the same valuation techniques and inputs as described above.
However, if key inputs are unobservable, or if the investments
are less liquid and there is very limited trading activity, the
investments are generally classified as Level 3. The use of
independent non-binding broker quotations to value investments
generally indicates there is a lack of liquidity or the general
lack of transparency in the process to develop the valuation
estimates generally causing these investments to be classified
in Level 3.
Fixed
Maturity Securities, Equity Securities, Trading and Other
Securities and Short-term Investments
This level includes fixed maturity securities and equity
securities priced principally by independent broker quotations
or market standard valuation methodologies using inputs that are
not market observable or cannot be derived principally from or
corroborated by observable market data. Trading and other
securities and short-term investments within this level are of a
similar nature and class to the Level 3 securities
described below; accordingly, the valuation techniques and
significant market standard observable inputs used in their
valuation are also similar to those described below.
U.S. corporate and foreign corporate
securities. These securities, including financial
services industry hybrid securities classified within fixed
maturity securities, are principally valued using the market and
income approaches. Valuations are based primarily on matrix
pricing or other similar techniques that utilize unobservable
inputs or cannot be derived principally from, or corroborated
by, observable market data, including illiquidity premiums and
spread adjustments to reflect industry trends or specific
credit-related issues. Valuations may be based on independent
non-binding broker quotations. Generally, below investment grade
privately placed or distressed securities included in this level
are valued using discounted cash flow
F-112
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
methodologies which rely upon significant, unobservable inputs
and inputs that cannot be derived principally from, or
corroborated by, observable market data.
Structured securities comprised of RMBS, CMBS and
ABS. These securities are principally valued
using the market approach. Valuation is based primarily on
matrix pricing or other similar techniques that utilize inputs
that are unobservable or cannot be derived principally from, or
corroborated by, observable market data, or are based on
independent non-binding broker quotations. Below investment
grade securities and ABS supported by
sub-prime
mortgage loans included in this level are valued based on inputs
including quoted prices for identical or similar securities that
are less liquid and based on lower levels of trading activity
than securities classified in Level 2, and certain of these
securities are valued based on independent non-binding broker
quotations.
Foreign government and state and political subdivision
securities. These securities are principally
valued using the market approach. Valuation is based primarily
on matrix pricing or other similar techniques, however these
securities are less liquid and certain of the inputs are based
on very limited trading activity.
Common and non-redeemable preferred
stock. These securities, including privately held
securities and financial services industry hybrid securities
classified within equity securities, are principally valued
using the market and income approaches. Valuations are based
primarily on matrix pricing or other similar techniques using
inputs such as comparable credit rating and issuance structure.
Equity securities valuations determined with discounted cash
flow methodologies use inputs such as earnings multiples based
on comparable public companies, and industry-specific
non-earnings based multiples. Certain of these securities are
valued based on independent non-binding broker quotations.
Mortgage
Loans
Mortgage loans include residential mortgage loans
held-for-sale
for which pricing for similar loans or securities backed by
similar loans is not observable and the estimated fair value is
determined using unobservable independent broker quotations or
valuation models.
MSRs
MSRs, which are valued using an income approach, are carried at
estimated fair value and have multiple significant unobservable
inputs including assumptions regarding estimates of discount
rates, loan prepayments and servicing costs. Sales of MSRs tend
to occur in private transactions where the precise terms and
conditions of the sales are typically not readily available and
observable market valuations are limited. As such, the Company
relies primarily on a discounted cash flow model to estimate the
fair value of the MSRs. The model requires inputs such as type
of loan (fixed vs. variable and agency vs. other), age of loan,
loan interest rates and current market interest rates that are
generally observable. The model also requires the use of
unobservable inputs including assumptions regarding estimates of
discount rates, loan prepayments and servicing costs.
Derivative
Assets and Derivative Liabilities
These derivatives are principally valued using an income
approach. Valuations of non-option-based derivatives utilize
present value techniques, whereas valuations of option-based
derivatives utilize option pricing models. These valuation
methodologies generally use the same inputs as described in the
corresponding sections above for Level 2 measurements of
derivatives. However, these derivatives result in Level 3
classification because one or more of the significant inputs are
not observable in the market or cannot be derived principally
from, or corroborated by, observable market data.
Interest
rate contracts.
Non-option-based Significant unobservable inputs may
include pull through rates on interest rate lock commitments and
the extrapolation beyond observable limits of the swap yield
curve and LIBOR basis curves.
F-113
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Option-based Significant unobservable inputs may
include the extrapolation beyond observable limits of the swap
yield curve, LIBOR basis curves, and interest rate volatility.
Foreign
currency contracts.
Non-option-based Significant unobservable inputs may
include the extrapolation beyond observable limits of the swap
yield curve, LIBOR basis curves and cross currency basis curves.
Certain of these derivatives are valued based on independent
non-binding broker quotations.
Option-based Significant unobservable inputs may
include currency correlation and the extrapolation beyond
observable limits of the swap yield curve, LIBOR basis curves,
cross currency basis curves and currency volatility.
Credit
contracts.
Non-option-based Significant unobservable inputs may
include credit correlation, repurchase rates, and the
extrapolation beyond observable limits of the swap yield curve
and credit curves. Certain of these derivatives are valued based
on independent non-binding broker quotations.
Equity
market contracts.
Non-option-based Significant unobservable inputs may
include the extrapolation beyond observable limits of dividend
yield curves.
Option-based Significant unobservable inputs may
include the extrapolation beyond observable limits of dividend
yield curves and equity volatility. Certain of these derivatives
are valued based on independent non-binding broker quotations.
Guaranteed
Minimum Benefit Guarantees
These embedded derivatives are principally valued using an
income approach. Valuations are based on option pricing
techniques, which utilize significant inputs that may include
swap yield curve, currency exchange rates and implied
volatilities. These embedded derivatives result in Level 3
classification because one or more of the significant inputs are
not observable in the market or cannot be derived principally
from, or corroborated by, observable market data. Significant
unobservable inputs generally include: the extrapolation beyond
observable limits of the swap yield curve and implied
volatilities, actuarial assumptions for policyholder behavior
and mortality and the potential variability in policyholder
behavior and mortality, nonperformance risk and cost of capital
for purposes of calculating the risk margin.
Reinsurance
Ceded on Certain Guaranteed Minimum Benefit Guarantees
These embedded derivatives are principally valued using an
income approach. Valuations are based on option pricing
techniques, which utilize significant inputs that may include
swap yield curve, currency exchange rates and implied
volatilities. These embedded derivatives result in Level 3
classification because one or more of the significant inputs are
not observable in the market or cannot be derived principally
from, or corroborated by, observable market data. Significant
unobservable inputs generally include: the extrapolation beyond
observable limits of the swap yield curve and implied
volatilities, actuarial assumptions for policyholder behavior
and mortality and the potential variability in policyholder
behavior and mortality, counterparty credit spreads and cost of
capital for purposes of calculating the risk margin.
Embedded
Derivatives Within Funds Withheld Related to Certain Ceded
Reinsurance
These derivatives are principally valued using an income
approach. Valuations are based on present value techniques,
which utilize significant inputs that may include the swap yield
curve and the fair value of assets within the
F-114
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
reference portfolio. These embedded derivatives result in
Level 3 classification because one or more of the
significant inputs are not observable in the market or cannot be
derived principally from, or corroborated by, observable market
data. Significant unobservable inputs generally include: the
fair value of certain assets within the reference portfolio
which are not observable in the market and cannot be derived
principally from, or corroborated by, observable market data.
Separate
Account Assets
These assets are comprised of investments that are similar in
nature to the fixed maturity securities, equity securities and
derivatives referred to above. Separate account assets within
this level also include mortgage loans and other limited
partnership interests. The estimated fair value of mortgage
loans is determined by discounting expected future cash flows,
using current interest rates for similar loans with similar
credit risk. Other limited partnership interests are valued
giving consideration to the value of the underlying holdings of
the partnerships and by applying a premium or discount, if
appropriate, for factors such as liquidity, bid/ask spreads, the
performance record of the fund manager or other relevant
variables which may impact the exit value of the particular
partnership interest.
Long-term
Debt of CSEs
The estimated fair value of the long-term debt of the
Companys CSEs are priced principally through independent
broker quotations or market standard valuation methodologies
using inputs that are not market observable or cannot be derived
from or corroborated by observable market data.
Transfers
between Levels 1 and 2:
During the year ended December 31, 2010, transfers between
Levels 1 and 2 were not significant.
Transfers
into or out of Level 3:
Overall, transfers into
and/or out
of Level 3 are attributable to a change in the
observability of inputs. Assets and liabilities are transferred
into Level 3 when a significant input cannot be
corroborated with market observable data. This occurs when
market activity decreases significantly and underlying inputs
cannot be observed, current prices are not available,
and/or when
there are significant variances in quoted prices, thereby
affecting transparency. Assets and liabilities are transferred
out of Level 3 when circumstances change such that a
significant input can be corroborated with market observable
data. This may be due to a significant increase in market
activity, a specific event, or one or more significant input(s)
becoming observable. Transfers into
and/or out
of any level are assumed to occur at the beginning of the
period. Significant transfers into
and/or out
of Level 3 assets and liabilities for the year ended
December 31, 2010 are summarized below.
During the year ended December 31, 2010, fixed maturity
securities transfers into Level 3 of $1,736 million
and separate account assets transfers into Level 3 of
$46 million, resulted primarily from current market
conditions characterized by a lack of trading activity,
decreased liquidity and credit ratings downgrades (e.g., from
investment grade to below investment grade). These current
market conditions have resulted in decreased transparency of
valuations and an increased use of broker quotations and
unobservable inputs to determine estimated fair value
principally for certain private placements included in
U.S. and foreign corporate securities and certain CMBS.
During the year ended December 31, 2010, fixed maturity
securities transfers out of Level 3 of $1,683 million
and separate account assets transfers out of Level 3 of
$234 million, resulted primarily from increased
transparency of both new issuances that subsequent to issuance
and establishment of trading activity, became priced by
independent pricing services and existing issuances that, over
time, the Company was able to corroborate pricing received from
independent pricing services with observable inputs or increases
in market activity and upgraded credit ratings primarily for
certain U.S. and foreign corporate securities, RMBS and ABS.
F-115
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
A rollforward of all assets and liabilities measured at
estimated fair value on a recurring basis using significant
unobservable (Level 3) inputs is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements Using Significant Unobservable Inputs
(Level 3)
|
|
|
|
|
|
|
Total Realized/Unrealized
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gains (Losses) included in:
|
|
|
Purchases,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
Sales,
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance,
|
|
|
|
|
|
Comprehensive
|
|
|
Issuances and
|
|
|
Transfer Into
|
|
|
Transfer Out
|
|
|
Balance,
|
|
|
|
January 1,
|
|
|
Earnings (1), (2)
|
|
|
Income (Loss)
|
|
|
Settlements (3)
|
|
|
Level 3 (4)
|
|
|
of Level 3 (4)
|
|
|
December 31,
|
|
|
|
(In millions)
|
|
|
Year Ended December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
6,694
|
|
|
$
|
9
|
|
|
$
|
277
|
|
|
$
|
(415
|
)
|
|
$
|
898
|
|
|
$
|
(314
|
)
|
|
$
|
7,149
|
|
Foreign corporate securities
|
|
|
5,292
|
|
|
|
(19
|
)
|
|
|
323
|
|
|
|
304
|
|
|
|
501
|
|
|
|
(624
|
)
|
|
|
5,777
|
|
RMBS
|
|
|
1,840
|
|
|
|
27
|
|
|
|
63
|
|
|
|
(303
|
)
|
|
|
87
|
|
|
|
(292
|
)
|
|
|
1,422
|
|
Foreign government securities
|
|
|
401
|
|
|
|
1
|
|
|
|
(93
|
)
|
|
|
2,965
|
|
|
|
40
|
|
|
|
(155
|
)
|
|
|
3,159
|
|
U.S. Treasury, agency and government guaranteed securities
|
|
|
37
|
|
|
|
|
|
|
|
2
|
|
|
|
(6
|
)
|
|
|
46
|
|
|
|
|
|
|
|
79
|
|
CMBS
|
|
|
139
|
|
|
|
(5
|
)
|
|
|
89
|
|
|
|
684
|
|
|
|
132
|
|
|
|
(28
|
)
|
|
|
1,011
|
|
ABS
|
|
|
2,712
|
|
|
|
(53
|
)
|
|
|
411
|
|
|
|
1,286
|
|
|
|
32
|
|
|
|
(240
|
)
|
|
|
4,148
|
|
State and political subdivision securities
|
|
|
69
|
|
|
|
|
|
|
|
(2
|
)
|
|
|
9
|
|
|
|
|
|
|
|
(30
|
)
|
|
|
46
|
|
Other fixed maturity securities
|
|
|
6
|
|
|
|
1
|
|
|
|
2
|
|
|
|
(5
|
)
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
17,190
|
|
|
$
|
(39
|
)
|
|
$
|
1,072
|
|
|
$
|
4,519
|
|
|
$
|
1,736
|
|
|
$
|
(1,683
|
)
|
|
$
|
22,795
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
136
|
|
|
$
|
5
|
|
|
$
|
7
|
|
|
$
|
128
|
|
|
$
|
1
|
|
|
$
|
(9
|
)
|
|
$
|
268
|
|
Non-redeemable preferred stock
|
|
|
1,104
|
|
|
|
46
|
|
|
|
12
|
|
|
|
(250
|
)
|
|
|
|
|
|
|
(7
|
)
|
|
|
905
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
1,240
|
|
|
$
|
51
|
|
|
$
|
19
|
|
|
$
|
(122
|
)
|
|
$
|
1
|
|
|
$
|
(16
|
)
|
|
$
|
1,173
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading and other securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actively Traded Securities
|
|
$
|
32
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(22
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
10
|
|
FVO general account securities
|
|
|
51
|
|
|
|
8
|
|
|
|
|
|
|
|
(1
|
)
|
|
|
37
|
|
|
|
(18
|
)
|
|
|
77
|
|
FVO contractholder-directed unit-linked investments
|
|
|
|
|
|
|
(15
|
)
|
|
|
|
|
|
|
750
|
|
|
|
|
|
|
|
|
|
|
|
735
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading and other securities
|
|
$
|
83
|
|
|
$
|
(7
|
)
|
|
$
|
|
|
|
$
|
727
|
|
|
$
|
37
|
|
|
$
|
(18
|
)
|
|
$
|
822
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term investments
|
|
$
|
23
|
|
|
$
|
2
|
|
|
$
|
(9
|
)
|
|
$
|
842
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
858
|
|
Mortgage loans
held-for-sale
|
|
$
|
25
|
|
|
$
|
(2
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
10
|
|
|
$
|
(9
|
)
|
|
$
|
24
|
|
MSRs (5), (6)
|
|
$
|
878
|
|
|
$
|
(79
|
)
|
|
$
|
|
|
|
$
|
151
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
950
|
|
Net derivatives: (7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts
|
|
$
|
7
|
|
|
$
|
37
|
|
|
$
|
(107
|
)
|
|
$
|
(23
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(86
|
)
|
Foreign currency contracts
|
|
|
108
|
|
|
|
42
|
|
|
|
2
|
|
|
|
(57
|
)
|
|
|
|
|
|
|
(22
|
)
|
|
|
73
|
|
Credit contracts
|
|
|
42
|
|
|
|
4
|
|
|
|
13
|
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
|
44
|
|
Equity market contracts
|
|
|
199
|
|
|
|
(88
|
)
|
|
|
11
|
|
|
|
20
|
|
|
|
|
|
|
|
|
|
|
|
142
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net derivatives
|
|
$
|
356
|
|
|
$
|
(5
|
)
|
|
$
|
(81
|
)
|
|
$
|
(75
|
)
|
|
$
|
|
|
|
$
|
(22
|
)
|
|
$
|
173
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separate account assets (8)
|
|
$
|
1,895
|
|
|
$
|
139
|
|
|
$
|
|
|
|
$
|
242
|
|
|
$
|
46
|
|
|
$
|
(234
|
)
|
|
$
|
2,088
|
|
F-116
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements Using Significant Unobservable Inputs
(Level 3)
|
|
|
|
|
Total Realized/Unrealized
|
|
|
|
|
|
|
|
|
|
|
|
|
(Gains) Losses included in:
|
|
Purchases,
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
Sales,
|
|
|
|
|
|
|
|
|
Balance,
|
|
|
|
Comprehensive
|
|
Issuances and
|
|
Transfer Into
|
|
Transfer Out
|
|
Balance,
|
|
|
January 1,
|
|
Earnings (1), (2)
|
|
Income (Loss)
|
|
Settlements (3)
|
|
Level 3 (4)
|
|
of Level 3 (4)
|
|
December 31,
|
|
|
(In millions)
|
|
Year Ended December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives (9)
|
|
$
|
1,455
|
|
|
$
|
335
|
|
|
$
|
226
|
|
|
$
|
422
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
2,438
|
|
Long-term debt of consolidated securitization entities (10)
|
|
$
|
|
|
|
$
|
(48
|
)
|
|
$
|
|
|
|
$
|
232
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
184
|
|
Trading liabilities
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements Using Significant Unobservable Inputs
(Level 3)
|
|
|
|
|
|
|
Total Realized/Unrealized
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gains (Losses) included in:
|
|
|
Purchases,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
Sales,
|
|
|
Transfer Into
|
|
|
|
|
|
|
Balance,
|
|
|
|
|
|
Comprehensive
|
|
|
Issuances and
|
|
|
and/or Out
|
|
|
Balance,
|
|
|
|
January 1,
|
|
|
Earnings (1), (2)
|
|
|
Income (Loss)
|
|
|
Settlements (3)
|
|
|
of Level 3 (4)
|
|
|
December 31,
|
|
|
|
(In millions)
|
|
|
Year Ended December 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
7,498
|
|
|
$
|
(429
|
)
|
|
$
|
939
|
|
|
$
|
(1,358
|
)
|
|
$
|
44
|
|
|
$
|
6,694
|
|
Foreign corporate securities
|
|
|
5,944
|
|
|
|
(330
|
)
|
|
|
1,517
|
|
|
|
(511
|
)
|
|
|
(1,328
|
)
|
|
|
5,292
|
|
RMBS
|
|
|
595
|
|
|
|
31
|
|
|
|
105
|
|
|
|
1,199
|
|
|
|
(90
|
)
|
|
|
1,840
|
|
Foreign government securities
|
|
|
408
|
|
|
|
(40
|
)
|
|
|
54
|
|
|
|
6
|
|
|
|
(27
|
)
|
|
|
401
|
|
U.S. Treasury, agency and government guaranteed securities
|
|
|
88
|
|
|
|
|
|
|
|
(1
|
)
|
|
|
(29
|
)
|
|
|
(21
|
)
|
|
|
37
|
|
CMBS
|
|
|
260
|
|
|
|
(36
|
)
|
|
|
53
|
|
|
|
(44
|
)
|
|
|
(94
|
)
|
|
|
139
|
|
ABS
|
|
|
2,452
|
|
|
|
(121
|
)
|
|
|
578
|
|
|
|
(212
|
)
|
|
|
15
|
|
|
|
2,712
|
|
State and political subdivision securities
|
|
|
123
|
|
|
|
|
|
|
|
7
|
|
|
|
(19
|
)
|
|
|
(42
|
)
|
|
|
69
|
|
Other fixed maturity securities
|
|
|
40
|
|
|
|
1
|
|
|
|
|
|
|
|
(35
|
)
|
|
|
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
17,408
|
|
|
$
|
(924
|
)
|
|
$
|
3,252
|
|
|
$
|
(1,003
|
)
|
|
$
|
(1,543
|
)
|
|
$
|
17,190
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
105
|
|
|
$
|
(2
|
)
|
|
$
|
6
|
|
|
$
|
23
|
|
|
$
|
4
|
|
|
$
|
136
|
|
Non-redeemable preferred stock
|
|
|
1,274
|
|
|
|
(357
|
)
|
|
|
486
|
|
|
|
(254
|
)
|
|
|
(45
|
)
|
|
|
1,104
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
1,379
|
|
|
$
|
(359
|
)
|
|
$
|
492
|
|
|
$
|
(231
|
)
|
|
$
|
(41
|
)
|
|
$
|
1,240
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading and other securities
|
|
$
|
175
|
|
|
$
|
16
|
|
|
$
|
|
|
|
$
|
(108
|
)
|
|
$
|
|
|
|
$
|
83
|
|
Short-term investments
|
|
$
|
100
|
|
|
$
|
(21
|
)
|
|
$
|
|
|
|
$
|
(51
|
)
|
|
$
|
(5
|
)
|
|
$
|
23
|
|
Mortgage loans
held-for-sale
|
|
$
|
177
|
|
|
$
|
(3
|
)
|
|
$
|
|
|
|
$
|
2
|
|
|
$
|
(151
|
)
|
|
$
|
25
|
|
MSRs (5), (6)
|
|
$
|
191
|
|
|
$
|
172
|
|
|
$
|
|
|
|
$
|
515
|
|
|
$
|
|
|
|
$
|
878
|
|
Net derivatives (7)
|
|
$
|
2,547
|
|
|
$
|
(273
|
)
|
|
$
|
(11
|
)
|
|
$
|
97
|
|
|
$
|
(2,004
|
)
|
|
$
|
356
|
|
Separate account assets (8)
|
|
$
|
1,758
|
|
|
$
|
(213
|
)
|
|
$
|
|
|
|
$
|
485
|
|
|
$
|
(135
|
)
|
|
$
|
1,895
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements Using Significant Unobservable Inputs
(Level 3)
|
|
|
|
|
Total Realized/Unrealized
|
|
|
|
|
|
|
|
|
|
|
(Gains) Losses included in:
|
|
Purchases,
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
Sales,
|
|
Transfer Into
|
|
|
|
|
Balance,
|
|
|
|
Comprehensive
|
|
Issuances and
|
|
and/or Out
|
|
Balance,
|
|
|
January 1,
|
|
Earnings (1), (2)
|
|
Income (Loss)
|
|
Settlements (3)
|
|
of Level 3 (4)
|
|
December 31,
|
|
|
(In millions)
|
|
Year Ended December 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives (9)
|
|
$
|
2,929
|
|
|
$
|
(1,602
|
)
|
|
$
|
(15
|
)
|
|
$
|
143
|
|
|
$
|
|
|
|
$
|
1,455
|
|
F-117
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements Using Significant Unobservable Inputs
(Level 3)
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Realized/Unrealized
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gains (Losses) included in:
|
|
|
Purchases,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
Sales,
|
|
|
Transfer Into
|
|
|
|
|
|
|
Balance,
|
|
|
Impact of
|
|
|
Balance,
|
|
|
|
|
|
Comprehensive
|
|
|
Issuances and
|
|
|
and/or Out
|
|
|
Balance,
|
|
|
|
December 31, 2007
|
|
|
Adoption (11)
|
|
|
January 1,
|
|
|
Earnings (1), (2)
|
|
|
Income (Loss)
|
|
|
Settlements (3)
|
|
|
of Level 3 (4)
|
|
|
December 31,
|
|
|
|
(In millions)
|
|
|
Year Ended December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
8,368
|
|
|
$
|
|
|
|
$
|
8,368
|
|
|
$
|
(696
|
)
|
|
$
|
(1,758
|
)
|
|
$
|
859
|
|
|
$
|
725
|
|
|
$
|
7,498
|
|
Foreign corporate securities
|
|
|
7,228
|
|
|
|
(8
|
)
|
|
|
7,220
|
|
|
|
(12
|
)
|
|
|
(2,873
|
)
|
|
|
(57
|
)
|
|
|
1,666
|
|
|
|
5,944
|
|
RMBS
|
|
|
1,423
|
|
|
|
|
|
|
|
1,423
|
|
|
|
4
|
|
|
|
(218
|
)
|
|
|
(204
|
)
|
|
|
(410
|
)
|
|
|
595
|
|
Foreign government securities
|
|
|
785
|
|
|
|
|
|
|
|
785
|
|
|
|
19
|
|
|
|
(101
|
)
|
|
|
(295
|
)
|
|
|
|
|
|
|
408
|
|
U.S. Treasury, agency and government guaranteed securities
|
|
|
80
|
|
|
|
|
|
|
|
80
|
|
|
|
|
|
|
|
(1
|
)
|
|
|
3
|
|
|
|
6
|
|
|
|
88
|
|
CMBS
|
|
|
539
|
|
|
|
|
|
|
|
539
|
|
|
|
(72
|
)
|
|
|
(136
|
)
|
|
|
2
|
|
|
|
(73
|
)
|
|
|
260
|
|
ABS
|
|
|
4,490
|
|
|
|
|
|
|
|
4,490
|
|
|
|
(125
|
)
|
|
|
(1,136
|
)
|
|
|
(740
|
)
|
|
|
(37
|
)
|
|
|
2,452
|
|
State and political subdivision securities
|
|
|
124
|
|
|
|
|
|
|
|
124
|
|
|
|
|
|
|
|
(8
|
)
|
|
|
45
|
|
|
|
(38
|
)
|
|
|
123
|
|
Other fixed maturity securities
|
|
|
289
|
|
|
|
|
|
|
|
289
|
|
|
|
1
|
|
|
|
(41
|
)
|
|
|
(209
|
)
|
|
|
|
|
|
|
40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
23,326
|
|
|
$
|
(8
|
)
|
|
$
|
23,318
|
|
|
$
|
(881
|
)
|
|
$
|
(6,272
|
)
|
|
$
|
(596
|
)
|
|
$
|
1,839
|
|
|
$
|
17,408
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
183
|
|
|
$
|
|
|
|
$
|
183
|
|
|
$
|
(2
|
)
|
|
$
|
(12
|
)
|
|
$
|
(46
|
)
|
|
$
|
(18
|
)
|
|
$
|
105
|
|
Non-redeemable preferred stock
|
|
|
2,188
|
|
|
|
|
|
|
|
2,188
|
|
|
|
(195
|
)
|
|
|
(466
|
)
|
|
|
(242
|
)
|
|
|
(11
|
)
|
|
|
1,274
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
2,371
|
|
|
$
|
|
|
|
$
|
2,371
|
|
|
$
|
(197
|
)
|
|
$
|
(478
|
)
|
|
$
|
(288
|
)
|
|
$
|
(29
|
)
|
|
$
|
1,379
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading and other securities
|
|
$
|
183
|
|
|
$
|
8
|
|
|
$
|
191
|
|
|
$
|
(26
|
)
|
|
$
|
|
|
|
$
|
18
|
|
|
$
|
(8
|
)
|
|
$
|
175
|
|
Short-term investments
|
|
$
|
179
|
|
|
$
|
|
|
|
$
|
179
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(79
|
)
|
|
$
|
|
|
|
$
|
100
|
|
Mortgage loans
held-for-sale
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
4
|
|
|
$
|
|
|
|
$
|
171
|
|
|
$
|
2
|
|
|
$
|
177
|
|
MSRs (5), (6)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(149
|
)
|
|
$
|
|
|
|
$
|
340
|
|
|
$
|
|
|
|
$
|
191
|
|
Net derivatives (7)
|
|
$
|
789
|
|
|
$
|
(1
|
)
|
|
$
|
788
|
|
|
$
|
1,729
|
|
|
$
|
|
|
|
$
|
29
|
|
|
$
|
1
|
|
|
$
|
2,547
|
|
Separate account assets (8)
|
|
$
|
1,464
|
|
|
$
|
|
|
|
$
|
1,464
|
|
|
$
|
(129
|
)
|
|
$
|
|
|
|
$
|
90
|
|
|
$
|
333
|
|
|
$
|
1,758
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements Using Significant Unobservable Inputs
(Level 3)
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Realized/Unrealized
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Gains) Losses included in:
|
|
|
Purchases,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
Sales,
|
|
|
Transfer Into
|
|
|
|
|
|
|
Balance,
|
|
|
Impact of
|
|
|
Balance,
|
|
|
|
|
|
Comprehensive
|
|
|
Issuances and
|
|
|
and/or Out
|
|
|
Balance,
|
|
|
|
December 31, 2007
|
|
|
Adoption (11)
|
|
|
January 1,
|
|
|
Earnings (1), (2)
|
|
|
Income (Loss)
|
|
|
Settlements (3)
|
|
|
of Level 3 (4)
|
|
|
December 31,
|
|
|
|
(In millions)
|
|
|
Year Ended December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives (9)
|
|
$
|
278
|
|
|
$
|
(24
|
)
|
|
$
|
254
|
|
|
$
|
2,500
|
|
|
$
|
81
|
|
|
$
|
94
|
|
|
$
|
|
|
|
$
|
2,929
|
|
|
|
|
(1) |
|
Amortization of premium/discount is included within net
investment income which is reported within the earnings caption
of total gains (losses). Impairments charged to earnings on
securities and certain mortgage loans are included within net
investment gains (losses) which are reported within the earnings
caption of total gains (losses); while changes in estimated fair
value of certain mortgage loans and MSRs are recorded in other
revenues. Lapses associated with embedded derivatives are
included with the earnings caption of total gains (losses). |
F-118
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
(2) |
|
Interest and dividend accruals, as well as cash interest coupons
and dividends received, are excluded from the rollforward. |
|
(3) |
|
The amount reported within purchases, sales, issuances and
settlements is the purchase/issuance price (for purchases and
issuances) and the sales/settlement proceeds (for sales and
settlements) based upon the actual date purchased/issued or
sold/settled. Items purchased/issued and sold/settled in the
same period are excluded from the rollforward. For embedded
derivatives, attributed fees are included within this caption
along with settlements, if any. Purchases, sales, issuances and
settlements for the year ended December 31, 2010 include
financial instruments acquired from ALICO as follows: fixed
maturity securities $5,435 million, equity securities
$68 million, trading and other securities
$582 million, short-term investments $216 million, net
derivatives ($10) million, separate account assets
$244 million and net embedded derivatives
($116) million. |
|
(4) |
|
Total gains and losses (in earnings and other comprehensive
income (loss)) are calculated assuming transfers into and/or out
of Level 3 occurred at the beginning of the period. Items
transferred into and out in the same period are excluded from
the rollforward. |
|
(5) |
|
The additions and reductions (due to loan payments and sales)
affecting MSRs were $330 million and ($179) million,
respectively, for the year ended December 31, 2010. The
additions and reductions (due to loan payments) affecting MSRs
were $628 million and ($113) million, respectively,
for the year ended December 31, 2009. The additions and
reductions (due to loan payments) affecting MSRs were
$350 million and ($10) million, respectively, for the
year ended December 31, 2008. |
|
(6) |
|
The changes in estimated fair value due to changes in valuation
model inputs or assumptions and other changes in estimated fair
value affecting MSRs were ($79) million, $172 million
and ($149) million for the years ended December 31,
2010, 2009 and 2008, respectively. |
|
(7) |
|
Freestanding derivative assets and liabilities are presented net
for purposes of the rollforward. |
|
(8) |
|
Investment performance related to separate account assets is
fully offset by corresponding amounts credited to
contractholders whose liability is reflected within separate
account liabilities. |
|
(9) |
|
Embedded derivative assets and liabilities are presented net for
purposes of the rollforward. |
|
(10) |
|
The long-term debt at January 1, 2010 of the CSEs is
reported within the purchases, sales, issuances and settlements
activity column of the rollforward. |
|
(11) |
|
The impact of adoption of fair value measurement guidance
represents the amount recognized in earnings resulting from a
change in estimate for certain Level 3 financial
instruments held at January 1, 2008. The net impact of
adoption on Level 3 assets and liabilities presented in the
table above was a $23 million increase to net assets. Such
amount was also impacted by an increase to DAC of
$17 million. The impact of this adoption on RGA
not reflected in the table above as a result of the inclusion of
RGA in discontinued operations was a net increase of
$2 million (i.e., a decrease in Level 3 net
embedded derivative liabilities of $17 million, offset by a
DAC decrease of $15 million) for a total increase of
$42 million in Level 3 net assets. This increase
of $42 million, offset by a $12 million reduction in
the estimated fair value of Level 2 freestanding
derivatives, resulted in a total net impact of adoption of
$30 million. |
F-119
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The tables below summarize both realized and unrealized gains
and losses due to changes in estimated fair value recorded in
earnings for Level 3 assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Gains and Losses
|
|
|
|
Classification of Realized/Unrealized Gains
|
|
|
|
(Losses) included in Earnings
|
|
|
|
|
|
|
Net
|
|
|
Net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
|
Investment
|
|
|
Derivative
|
|
|
|
|
|
Policyholder
|
|
|
|
|
|
|
|
|
|
Investment
|
|
|
Gains
|
|
|
Gains
|
|
|
Other
|
|
|
Benefits and
|
|
|
Other
|
|
|
|
|
|
|
Income
|
|
|
(Losses)
|
|
|
(Losses)
|
|
|
Revenues
|
|
|
Claims
|
|
|
Expenses
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Year Ended December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
22
|
|
|
$
|
(13
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
9
|
|
Foreign corporate securities
|
|
|
15
|
|
|
|
(34
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(19
|
)
|
RMBS
|
|
|
36
|
|
|
|
(9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27
|
|
Foreign government securities
|
|
|
6
|
|
|
|
(5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
CMBS
|
|
|
1
|
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5
|
)
|
ABS
|
|
|
37
|
|
|
|
(90
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(53
|
)
|
State and political subdivision securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other fixed maturity securities
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
118
|
|
|
$
|
(157
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(39
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
|
|
|
$
|
5
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
5
|
|
Non-redeemable preferred stock
|
|
|
|
|
|
|
46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
|
|
|
$
|
51
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading and other securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actively Traded Securities
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
FVO general account securities
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8
|
|
FVO contractholder-directed unit-linked investments
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading and other securities
|
|
$
|
(7
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term investments
|
|
$
|
2
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
2
|
|
Mortgage loans
held-for-sale
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(2
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(2
|
)
|
MSRs
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(79
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(79
|
)
|
Net derivatives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts
|
|
$
|
|
|
|
$
|
|
|
|
$
|
36
|
|
|
$
|
1
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
37
|
|
Foreign currency contracts
|
|
|
|
|
|
|
|
|
|
|
46
|
|
|
|
|
|
|
|
|
|
|
|
(4
|
)
|
|
|
42
|
|
Credit contracts
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
Equity market contracts
|
|
|
|
|
|
|
|
|
|
|
(88
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(88
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net derivatives
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(2
|
)
|
|
$
|
1
|
|
|
$
|
|
|
|
$
|
(4
|
)
|
|
$
|
(5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(343
|
)
|
|
$
|
|
|
|
$
|
8
|
|
|
$
|
|
|
|
$
|
(335
|
)
|
Long-term debt of consolidated securitization entities
|
|
$
|
|
|
|
$
|
48
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
48
|
|
F-120
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Gains and Losses
|
|
|
|
Classification of Realized/Unrealized Gains
|
|
|
|
(Losses) included in Earnings
|
|
|
|
|
|
|
Net
|
|
|
Net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
|
Investment
|
|
|
Derivative
|
|
|
|
|
|
Policyholder
|
|
|
|
|
|
|
|
|
|
Investment
|
|
|
Gains
|
|
|
Gains
|
|
|
Other
|
|
|
Benefits and
|
|
|
Other
|
|
|
|
|
|
|
Income
|
|
|
(Losses)
|
|
|
(Losses)
|
|
|
Revenues
|
|
|
Claims
|
|
|
Expenses
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Year Ended December 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
15
|
|
|
$
|
(444
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(429
|
)
|
Foreign corporate securities
|
|
|
(4
|
)
|
|
|
(326
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(330
|
)
|
RMBS
|
|
|
30
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31
|
|
Foreign government securities
|
|
|
12
|
|
|
|
(52
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(40
|
)
|
CMBS
|
|
|
1
|
|
|
|
(37
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(36
|
)
|
ABS
|
|
|
8
|
|
|
|
(129
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(121
|
)
|
State and political subdivision securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other fixed maturity securities
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
63
|
|
|
$
|
(987
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(924
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
|
|
|
$
|
(2
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(2
|
)
|
Non-redeemable preferred stock
|
|
|
|
|
|
|
(357
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(357
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
|
|
|
$
|
(359
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(359
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading and other securities
|
|
$
|
16
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
16
|
|
Short-term investments
|
|
$
|
|
|
|
$
|
(21
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(21
|
)
|
Mortgage loans
held-for-sale
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(3
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(3
|
)
|
MSRs
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
172
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
172
|
|
Net derivatives
|
|
$
|
(13
|
)
|
|
$
|
|
|
|
$
|
(225
|
)
|
|
$
|
(33
|
)
|
|
$
|
|
|
|
$
|
(2
|
)
|
|
$
|
(273
|
)
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives
|
|
$
|
|
|
|
$
|
|
|
|
$
|
1,716
|
|
|
$
|
|
|
|
$
|
(114
|
)
|
|
$
|
|
|
|
$
|
1,602
|
|
F-121
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Gains and Losses
|
|
|
|
Classification of Realized/Unrealized Gains
|
|
|
|
(Losses) included in Earnings
|
|
|
|
|
|
|
Net
|
|
|
Net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
|
Investment
|
|
|
Derivative
|
|
|
|
|
|
Policyholder
|
|
|
|
|
|
|
|
|
|
Investment
|
|
|
Gains
|
|
|
Gains
|
|
|
Other
|
|
|
Benefits and
|
|
|
Other
|
|
|
|
|
|
|
Income
|
|
|
(Losses)
|
|
|
(Losses)
|
|
|
Revenues
|
|
|
Claims
|
|
|
Expenses
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Year Ended December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
15
|
|
|
$
|
(711
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(696
|
)
|
Foreign corporate securities
|
|
|
123
|
|
|
|
(135
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(12
|
)
|
RMBS
|
|
|
3
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
Foreign government securities
|
|
|
27
|
|
|
|
(8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19
|
|
CMBS
|
|
|
4
|
|
|
|
(76
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(72
|
)
|
ABS
|
|
|
4
|
|
|
|
(129
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(125
|
)
|
State and political subdivision securities
|
|
|
(1
|
)
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other fixed maturity securities
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
176
|
|
|
$
|
(1,057
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(881
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
|
|
|
$
|
(2
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(2
|
)
|
Non-redeemable preferred stock
|
|
|
|
|
|
|
(195
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(195
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
|
|
|
$
|
(197
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(197
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading and other securities
|
|
$
|
(26
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(26
|
)
|
Short-term investments
|
|
$
|
1
|
|
|
$
|
(1
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Mortgage loans
held-for-sale
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
4
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
4
|
|
MSRs
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(149
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(149
|
)
|
Net derivatives
|
|
$
|
103
|
|
|
$
|
|
|
|
$
|
1,587
|
|
|
$
|
39
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
1,729
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(2,682
|
)
|
|
$
|
|
|
|
$
|
182
|
|
|
$
|
|
|
|
$
|
(2,500
|
)
|
F-122
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The tables below summarize the portion of unrealized gains and
losses, due to changes in estimated fair value, recorded in
earnings for Level 3 assets and liabilities that were still
held at the respective time periods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in Unrealized Gains (Losses)
|
|
|
|
Relating to Assets and Liabilities Held at December 31,
2010
|
|
|
|
|
|
|
Net
|
|
|
Net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
|
Investment
|
|
|
Derivative
|
|
|
|
|
|
Policyholder
|
|
|
|
|
|
|
|
|
|
Investment
|
|
|
Gains
|
|
|
Gains
|
|
|
Other
|
|
|
Benefits and
|
|
|
Other
|
|
|
|
|
|
|
Income
|
|
|
(Losses)
|
|
|
(Losses)
|
|
|
Revenues
|
|
|
Claims
|
|
|
Expenses
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Year Ended December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
13
|
|
|
$
|
(44
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(31
|
)
|
Foreign corporate securities
|
|
|
15
|
|
|
|
(43
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(28
|
)
|
RMBS
|
|
|
36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36
|
|
Foreign government securities
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10
|
|
CMBS
|
|
|
1
|
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5
|
)
|
ABS
|
|
|
36
|
|
|
|
(52
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(16
|
)
|
State and political subdivision securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other fixed maturity securities
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
112
|
|
|
$
|
(145
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(33
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
|
|
|
$
|
(2
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(2
|
)
|
Non-redeemable preferred stock
|
|
|
|
|
|
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
|
|
|
$
|
(5
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading and other securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actively Traded Securities
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
FVO general account securities
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12
|
|
FVO contractholder-directed unit-linked investments
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading and other securities
|
|
$
|
(3
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term investments
|
|
$
|
2
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
2
|
|
Mortgage loans
held-for-sale
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(2
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(2
|
)
|
MSRs
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(28
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(28
|
)
|
Net derivatives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts
|
|
$
|
|
|
|
$
|
|
|
|
$
|
36
|
|
|
$
|
5
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
41
|
|
Foreign currency contracts
|
|
|
|
|
|
|
|
|
|
|
45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45
|
|
Credit contracts
|
|
|
|
|
|
|
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6
|
|
Equity market contracts
|
|
|
|
|
|
|
|
|
|
|
(82
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(82
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net derivatives
|
|
$
|
|
|
|
$
|
|
|
|
$
|
5
|
|
|
$
|
5
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(363
|
)
|
|
$
|
|
|
|
$
|
8
|
|
|
$
|
|
|
|
$
|
(355
|
)
|
Long-term debt of consolidated securitization entities
|
|
$
|
|
|
|
$
|
48
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
48
|
|
F-123
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in Unrealized Gains (Losses)
|
|
|
|
Relating to Assets and Liabilities Held at December 31,
2009
|
|
|
|
|
|
|
Net
|
|
|
Net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
|
Investment
|
|
|
Derivative
|
|
|
|
|
|
Policyholder
|
|
|
|
|
|
|
|
|
|
Investment
|
|
|
Gains
|
|
|
Gains
|
|
|
Other
|
|
|
Benefits and
|
|
|
Other
|
|
|
|
|
|
|
Income
|
|
|
(Losses)
|
|
|
(Losses)
|
|
|
Revenues
|
|
|
Claims
|
|
|
Expenses
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Year Ended December 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
18
|
|
|
$
|
(412
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(394
|
)
|
Foreign corporate securities
|
|
|
(3
|
)
|
|
|
(176
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(179
|
)
|
RMBS
|
|
|
30
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36
|
|
Foreign government securities
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11
|
|
CMBS
|
|
|
1
|
|
|
|
(61
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(60
|
)
|
ABS
|
|
|
8
|
|
|
|
(136
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(128
|
)
|
State and political subdivision securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other fixed maturity securities
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
66
|
|
|
$
|
(779
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(713
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
|
|
|
$
|
(1
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(1
|
)
|
Non-redeemable preferred stock
|
|
|
|
|
|
|
(168
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(168
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
|
|
|
$
|
(169
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(169
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading and other securities
|
|
$
|
15
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
15
|
|
Short-term investments
|
|
$
|
|
|
|
$
|
1
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
1
|
|
Mortgage loans
held-for-sale
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(3
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(3
|
)
|
MSRs
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
147
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
147
|
|
Net derivatives
|
|
$
|
(13
|
)
|
|
$
|
|
|
|
$
|
(194
|
)
|
|
$
|
5
|
|
|
$
|
|
|
|
$
|
(2
|
)
|
|
$
|
(204
|
)
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives
|
|
$
|
|
|
|
$
|
|
|
|
$
|
1,697
|
|
|
$
|
|
|
|
$
|
(114
|
)
|
|
$
|
|
|
|
$
|
1,583
|
|
F-124
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in Unrealized Gains (Losses)
|
|
|
|
Relating to Assets and Liabilities Held at December 31,
2008
|
|
|
|
|
|
|
Net
|
|
|
Net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
|
Investment
|
|
|
Derivative
|
|
|
|
|
|
Policyholder
|
|
|
|
|
|
|
|
|
|
Investment
|
|
|
Gains
|
|
|
Gains
|
|
|
Other
|
|
|
Benefits and
|
|
|
Other
|
|
|
|
|
|
|
Income
|
|
|
(Losses)
|
|
|
(Losses)
|
|
|
Revenues
|
|
|
Claims
|
|
|
Expenses
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Year Ended December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
12
|
|
|
$
|
(497
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(485
|
)
|
Foreign corporate securities
|
|
|
117
|
|
|
|
(125
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8
|
)
|
RMBS
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
Foreign government securities
|
|
|
23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23
|
|
CMBS
|
|
|
4
|
|
|
|
(69
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(65
|
)
|
ABS
|
|
|
3
|
|
|
|
(102
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(99
|
)
|
State and political subdivision securities
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
Other fixed maturity securities
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
163
|
|
|
$
|
(793
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(630
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
|
|
|
$
|
(1
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(1
|
)
|
Non-redeemable preferred stock
|
|
|
|
|
|
|
(163
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(163
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
|
|
|
$
|
(164
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(164
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading and other securities
|
|
$
|
(17
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(17
|
)
|
Short-term investments
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Mortgage loans
held-for-sale
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
3
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
3
|
|
MSRs
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(150
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(150
|
)
|
Net derivatives
|
|
$
|
114
|
|
|
$
|
|
|
|
$
|
1,504
|
|
|
$
|
38
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
1,656
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(2,779
|
)
|
|
$
|
|
|
|
$
|
182
|
|
|
$
|
|
|
|
$
|
(2,597
|
)
|
F-125
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
FVO
Mortgage Loans
Held-For-Sale
The following table presents residential mortgage loans
held-for-sale
carried under the FVO at:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Unpaid principal balance
|
|
$
|
2,473
|
|
|
$
|
2,418
|
|
Excess of estimated fair value over unpaid principal balance
|
|
|
37
|
|
|
|
52
|
|
|
|
|
|
|
|
|
|
|
Carrying value at estimated fair value
|
|
$
|
2,510
|
|
|
$
|
2,470
|
|
|
|
|
|
|
|
|
|
|
Loans in non-accrual status
|
|
$
|
2
|
|
|
$
|
4
|
|
Loans more than 90 days past due
|
|
$
|
3
|
|
|
$
|
2
|
|
Loans in non-accrual status or more than 90 days past due,
or both difference between aggregate estimated fair
value and unpaid principal balance
|
|
$
|
(1
|
)
|
|
$
|
(2
|
)
|
Residential mortgage loans
held-for-sale
accounted for under the FVO are initially measured at estimated
fair value. Interest income on residential mortgage loans
held-for-sale
is recorded based on the stated rate of the loan and is recorded
in net investment income. Gains and losses from initial
measurement, subsequent changes in estimated fair value and
gains or losses on sales are recognized in other revenues. Such
changes in estimated fair value for these loans were due to the
following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Instrument-specific credit risk based on changes in credit
spreads for non-agency loans and adjustments in individual loan
quality
|
|
$
|
(1
|
)
|
|
$
|
(2
|
)
|
|
$
|
|
|
Other changes in estimated fair value
|
|
|
487
|
|
|
|
600
|
|
|
|
55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total gains (losses) recognized in other revenues
|
|
$
|
486
|
|
|
$
|
598
|
|
|
$
|
55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FVO
Consolidated Securitization Entities
As discussed in Note 1, upon the adoption of new guidance
effective January 1, 2010, the Company elected fair value
accounting for the following assets and liabilities held by
CSEs: commercial mortgage loans, securities and long-term debt.
Information on the estimated fair value of the securities
classified as trading and other securities is presented in
Note 3. The following table presents these commercial
mortgage loans carried under the FVO at:
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
(In millions)
|
|
|
Unpaid principal balance
|
|
$
|
6,636
|
|
Excess of estimated fair value over unpaid principal balance
|
|
|
204
|
|
|
|
|
|
|
Carrying value at estimated fair value
|
|
$
|
6,840
|
|
|
|
|
|
|
F-126
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following table presents the long-term debt carried under
the FVO related to both the commercial mortgage loans and
securities classified as trading and other securities at:
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
(In millions)
|
|
|
Contractual principal balance
|
|
$
|
6,619
|
|
Excess of estimated fair value over contractual principal balance
|
|
|
201
|
|
|
|
|
|
|
Carrying value at estimated fair value
|
|
$
|
6,820
|
|
|
|
|
|
|
Interest income on both commercial mortgage loans and securities
classified as trading and other securities held by CSEs is
recorded in net investment income. Interest expense on long-term
debt of CSEs is recorded in other expenses. Gains and losses
from initial measurement, subsequent changes in estimated fair
value and gains or losses on sales of both the commercial
mortgage loans and long-term debt are recognized in net
investment gains (losses), which is summarized in Note 3.
Non-Recurring
Fair Value Measurements
Certain assets are measured at estimated fair value on a
non-recurring basis and are not included in the tables presented
above. The amounts below relate to certain investments measured
at estimated fair value during the period and still held at the
reporting dates.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
|
|
|
Estimated
|
|
|
Net
|
|
|
|
|
|
Estimated
|
|
|
Net
|
|
|
|
|
|
Estimated
|
|
|
Net
|
|
|
|
Carrying
|
|
|
Fair
|
|
|
Investment
|
|
|
Carrying
|
|
|
Fair
|
|
|
Investment
|
|
|
Carrying
|
|
|
Fair
|
|
|
Investment
|
|
|
|
Value Prior to
|
|
|
Value After
|
|
|
Gains
|
|
|
Value Prior to
|
|
|
Value After
|
|
|
Gains
|
|
|
Value Prior to
|
|
|
Value After
|
|
|
Gains
|
|
|
|
Measurement
|
|
|
Measurement
|
|
|
(Losses)
|
|
|
Measurement
|
|
|
Measurement
|
|
|
(Losses)
|
|
|
Measurement
|
|
|
Measurement
|
|
|
(Losses)
|
|
|
|
(In millions)
|
|
|
Mortgage loans: (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-for-investment
|
|
$
|
179
|
|
|
$
|
164
|
|
|
$
|
(15
|
)
|
|
$
|
294
|
|
|
$
|
202
|
|
|
$
|
(92
|
)
|
|
$
|
257
|
|
|
$
|
188
|
|
|
$
|
(69
|
)
|
Held-for-sale
|
|
|
35
|
|
|
|
33
|
|
|
|
(2
|
)
|
|
|
9
|
|
|
|
8
|
|
|
|
(1
|
)
|
|
|
42
|
|
|
|
32
|
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans, net
|
|
$
|
214
|
|
|
$
|
197
|
|
|
$
|
(17
|
)
|
|
$
|
303
|
|
|
$
|
210
|
|
|
$
|
(93
|
)
|
|
$
|
299
|
|
|
$
|
220
|
|
|
$
|
(79
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other limited partnership interests (2)
|
|
$
|
35
|
|
|
$
|
23
|
|
|
$
|
(12
|
)
|
|
$
|
915
|
|
|
$
|
561
|
|
|
$
|
(354
|
)
|
|
$
|
242
|
|
|
$
|
137
|
|
|
$
|
(105
|
)
|
Real estate joint ventures (3)
|
|
$
|
33
|
|
|
$
|
8
|
|
|
$
|
(25
|
)
|
|
$
|
175
|
|
|
$
|
93
|
|
|
$
|
(82
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
(1) |
|
Mortgage loans The impaired mortgage loans
presented above were written down to their estimated fair values
at the date the impairments were recognized and are reported as
losses above. Subsequent improvements in estimated fair value on
previously impaired loans recorded through a reduction in the
previously established valuation allowance are reported as gains
above. Estimated fair values for impaired mortgage loans are
based on observable market prices or, if the loans are in
foreclosure or are otherwise determined to be collateral
dependent, on the estimated fair value of the underlying
collateral, or the present value of the expected future cash
flows. Impairments to estimated fair value and decreases in
previous impairments from subsequent improvements in estimated
fair value represent non-recurring fair value measurements that
have been categorized as Level 3 due to the lack of price
transparency inherent in the limited markets for such mortgage
loans. |
|
(2) |
|
Other limited partnership interests The
impaired investments presented above were accounted for using
the cost method. Impairments on these cost method investments
were recognized at estimated fair value determined from
information provided in the financial statements of the
underlying entities in the period in which the impairment was
incurred. These impairments to estimated fair value represent
non-recurring fair value measurements that have been classified
as Level 3 due to the limited activity and price
transparency |
F-127
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
inherent in the market for such investments. This category
includes several private equity and debt funds that typically
invest primarily in a diversified pool of investments across
certain investment strategies including domestic and
international leveraged buyout funds; power, energy, timber and
infrastructure development funds; venture capital funds; below
investment grade debt and mezzanine debt funds. The estimated
fair values of these investments have been determined using the
NAV of the Companys ownership interest in the
partners capital. Distributions from these investments
will be generated from investment gains, from operating income
from the underlying investments of the funds and from
liquidation of the underlying assets of the funds. It is
estimated that the underlying assets of the funds will be
liquidated over the next 2 to 10 years. Unfunded
commitments for these investments were $34 million at
December 31, 2010. |
|
(3) |
|
Real estate joint ventures The impaired
investments presented above were accounted for using the cost
method. Impairments on these cost method investments were
recognized at estimated fair value determined from information
provided in the financial statements of the underlying entities
in the period in which the impairment was incurred. These
impairments to estimated fair value represent non-recurring fair
value measurements that have been classified as Level 3 due
to the limited activity and price transparency inherent in the
market for such investments. This category includes several real
estate funds that typically invest primarily in commercial real
estate. The estimated fair values of these investments have been
determined using the NAV of the Companys ownership
interest in the partners capital. Distributions from these
investments will be generated from investment gains, from
operating income from the underlying investments of the funds
and from liquidation of the underlying assets of the funds. It
is estimated that the underlying assets of the funds will be
liquidated over the next 2 to 10 years. Unfunded
commitments for these investments were $6 million at
December 31, 2010. |
F-128
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Fair
Value of Financial Instruments
Amounts related to the Companys financial instruments that
were not measured at fair value on a recurring basis, were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated
|
|
|
|
Notional
|
|
|
Carrying
|
|
|
Fair
|
|
December 31, 2010
|
|
Amount
|
|
|
Value
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans: (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-for-investment
|
|
|
|
|
|
$
|
52,215
|
|
|
$
|
54,006
|
|
Held-for-sale
|
|
|
|
|
|
$
|
811
|
|
|
$
|
811
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans, net
|
|
|
|
|
|
$
|
53,026
|
|
|
$
|
54,817
|
|
Policy loans
|
|
|
|
|
|
$
|
11,914
|
|
|
$
|
13,406
|
|
Real estate joint ventures (2)
|
|
|
|
|
|
$
|
451
|
|
|
$
|
482
|
|
Other limited partnership interests (2)
|
|
|
|
|
|
$
|
1,539
|
|
|
$
|
1,619
|
|
Short-term investments (3)
|
|
|
|
|
|
$
|
822
|
|
|
$
|
822
|
|
Other invested assets (2)
|
|
|
|
|
|
$
|
1,490
|
|
|
$
|
1,490
|
|
Cash and cash equivalents
|
|
|
|
|
|
$
|
13,046
|
|
|
$
|
13,046
|
|
Accrued investment income
|
|
|
|
|
|
$
|
4,381
|
|
|
$
|
4,381
|
|
Premiums, reinsurance and other receivables (2)
|
|
|
|
|
|
$
|
3,752
|
|
|
$
|
4,048
|
|
Other assets (2)
|
|
|
|
|
|
$
|
466
|
|
|
$
|
453
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances (2)
|
|
|
|
|
|
$
|
146,927
|
|
|
$
|
152,850
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
|
|
|
$
|
27,272
|
|
|
$
|
27,272
|
|
Bank deposits
|
|
|
|
|
|
$
|
10,316
|
|
|
$
|
10,371
|
|
Short-term debt
|
|
|
|
|
|
$
|
306
|
|
|
$
|
306
|
|
Long-term debt (2)
|
|
|
|
|
|
$
|
20,734
|
|
|
$
|
21,892
|
|
Collateral financing arrangements
|
|
|
|
|
|
$
|
5,297
|
|
|
$
|
4,757
|
|
Junior subordinated debt securities
|
|
|
|
|
|
$
|
3,191
|
|
|
$
|
3,461
|
|
Other liabilities (2)
|
|
|
|
|
|
$
|
2,777
|
|
|
$
|
2,777
|
|
Separate account liabilities (2)
|
|
|
|
|
|
$
|
42,160
|
|
|
$
|
42,160
|
|
Commitments (4)
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loan commitments
|
|
$
|
3,754
|
|
|
$
|
|
|
|
$
|
(17
|
)
|
Commitments to fund bank credit facilities, bridge loans and
private corporate bond investments
|
|
$
|
2,437
|
|
|
$
|
|
|
|
$
|
|
|
F-129
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated
|
|
|
|
Notional
|
|
|
Carrying
|
|
|
Fair
|
|
December 31, 2009
|
|
Amount
|
|
|
Value
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans: (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-for-investment
|
|
|
|
|
|
$
|
48,181
|
|
|
$
|
46,315
|
|
Held-for-sale
|
|
|
|
|
|
|
258
|
|
|
|
258
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans, net
|
|
|
|
|
|
$
|
48,439
|
|
|
$
|
46,573
|
|
Policy loans
|
|
|
|
|
|
$
|
10,061
|
|
|
$
|
11,294
|
|
Real estate joint ventures (2)
|
|
|
|
|
|
$
|
115
|
|
|
$
|
127
|
|
Other limited partnership interests (2)
|
|
|
|
|
|
$
|
1,571
|
|
|
$
|
1,581
|
|
Short-term investments (3)
|
|
|
|
|
|
$
|
201
|
|
|
$
|
201
|
|
Other invested assets (2)
|
|
|
|
|
|
$
|
1,241
|
|
|
$
|
1,284
|
|
Cash and cash equivalents
|
|
|
|
|
|
$
|
10,112
|
|
|
$
|
10,112
|
|
Accrued investment income
|
|
|
|
|
|
$
|
3,173
|
|
|
$
|
3,173
|
|
Premiums, reinsurance and other receivables (2)
|
|
|
|
|
|
$
|
3,375
|
|
|
$
|
3,532
|
|
Other assets (2)
|
|
|
|
|
|
$
|
425
|
|
|
$
|
440
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances (2)
|
|
|
|
|
|
$
|
97,131
|
|
|
$
|
96,735
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
|
|
|
$
|
24,196
|
|
|
$
|
24,196
|
|
Bank deposits
|
|
|
|
|
|
$
|
10,211
|
|
|
$
|
10,300
|
|
Short-term debt
|
|
|
|
|
|
$
|
912
|
|
|
$
|
912
|
|
Long-term debt (2)
|
|
|
|
|
|
$
|
13,185
|
|
|
$
|
13,831
|
|
Collateral financing arrangements
|
|
|
|
|
|
$
|
5,297
|
|
|
$
|
2,877
|
|
Junior subordinated debt securities
|
|
|
|
|
|
$
|
3,191
|
|
|
$
|
3,167
|
|
Other liabilities (2)
|
|
|
|
|
|
$
|
1,788
|
|
|
$
|
1,788
|
|
Separate account liabilities (2)
|
|
|
|
|
|
$
|
32,171
|
|
|
$
|
32,171
|
|
Commitments (4)
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loan commitments
|
|
$
|
2,220
|
|
|
$
|
|
|
|
$
|
(48
|
)
|
Commitments to fund bank credit facilities, bridge loans and
private corporate bond investments
|
|
$
|
1,261
|
|
|
$
|
|
|
|
$
|
(52
|
)
|
|
|
|
(1) |
|
Mortgage loans
held-for-investment
as presented in the tables above differ from the amount
presented in the consolidated balance sheets because these
tables do not include commercial mortgage loans held by CSEs.
Mortgage loans
held-for-sale
as presented in the tables above differ from the amount
presented in the consolidated balance sheets because these
tables do not include residential mortgage loans
held-for-sale
accounted for under the FVO. |
|
(2) |
|
Carrying values presented herein differ from those presented in
the consolidated balance sheets because certain items within the
respective financial statement caption are not considered
financial instruments. Financial statement captions excluded
from the table above are not considered financial instruments. |
|
(3) |
|
Short-term investments as presented in the tables above differ
from the amounts presented in the consolidated balance sheets
because these tables do not include short-term investments that
meet the definition of a security, which are measured at
estimated fair value on a recurring basis. |
|
(4) |
|
Commitments are off-balance sheet obligations. Negative
estimated fair values represent off-balance sheet liabilities. |
F-130
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The methods and assumptions used to estimate the fair value of
financial instruments are summarized as follows:
The assets and liabilities measured at estimated fair value on a
recurring basis include: fixed maturity securities, equity
securities, trading and other securities, mortgage loans held by
CSEs, mortgage loans
held-for-sale
accounted for under the FVO, MSRs, derivative assets and
liabilities, net embedded derivatives within asset and liability
host contracts, separate account assets, long-term debt of CSEs
and trading liabilities. These assets and liabilities are
described in the section Recurring Fair Value
Measurements and, therefore, are excluded from the tables
above. The estimated fair value for these financial instruments
approximates carrying value.
Mortgage
Loans
These mortgage loans are principally comprised of commercial and
agricultural mortgage loans, which are originated for investment
purposes and are primarily carried at amortized cost.
Residential mortgage and consumer loans are generally purchased
from third parties for investment purposes and are principally
carried at amortized cost, while those originated for sale and
not carried under the FVO are carried at the lower of cost or
estimated fair value. The estimated fair values of these
mortgage loans are determined as follows:
Mortgage loans
held-for-investment.
For commercial and agricultural mortgage loans
held-for-investment
and carried at amortized cost, estimated fair value was
primarily determined by estimating expected future cash flows
and discounting them using current interest rates for similar
mortgage loans with similar credit risk. For residential
mortgage loans
held-for-investment
and carried at amortized cost, estimated fair value was
primarily determined from observable pricing for similar loans.
Mortgage loans
held-for-sale.
Certain mortgage loans previously classified as
held-for-investment
have been designated as
held-for-sale.
For these mortgage loans, estimated fair value is determined
using independent broker quotations or, when the mortgage loan
is in foreclosure or otherwise determined to be collateral
dependent, the fair value of the underlying collateral is
estimated using internal models. For residential mortgage loans
originated for sale, the estimated fair value is determined
principally from observable market pricing or from internal
models.
Policy
Loans
For policy loans with fixed interest rates, estimated fair
values are determined using a discounted cash flow model applied
to groups of similar policy loans determined by the nature of
the underlying insurance liabilities. Cash flow estimates are
developed applying a weighted-average interest rate to the
outstanding principal balance of the respective group of policy
loans and an estimated average maturity determined through
experience studies of the past performance of policyholder
repayment behavior for similar loans. These cash flows are
discounted using current risk-free interest rates with no
adjustment for borrower credit risk as these loans are fully
collateralized by the cash surrender value of the underlying
insurance policy. The estimated fair value for policy loans with
variable interest rates approximates carrying value due to the
absence of borrower credit risk and the short time period
between interest rate resets, which presents minimal risk of a
material change in estimated fair value due to changes in market
interest rates.
Real
Estate Joint Ventures and Other Limited Partnership
Interests
Real estate joint ventures and other limited partnership
interests included in the preceding tables consist of those
investments accounted for using the cost method. The remaining
carrying value recognized in the consolidated balance sheets
represents investments in real estate carried at cost less
accumulated depreciation, or real estate joint ventures and
other limited partnership interests accounted for using the
equity method, which do not meet the definition of financial
instruments for which fair value is required to be disclosed.
F-131
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The estimated fair values for other limited partnership
interests and real estate joint ventures accounted for under the
cost method are generally based on the Companys share of
the NAV as provided in the financial statements of the
investees. In certain circumstances, management may adjust the
NAV by a premium or discount when it has sufficient evidence to
support applying such adjustments.
Short-term
Investments
Certain short-term investments do not qualify as securities and
are recognized at amortized cost in the consolidated balance
sheets. For these instruments, the Company believes that there
is minimal risk of material changes in interest rates or credit
of the issuer such that estimated fair value approximates
carrying value. In light of recent market conditions, short-term
investments have been monitored to ensure there is sufficient
demand and maintenance of issuer credit quality and the Company
has determined additional adjustment is not required.
Other
Invested Assets
Other invested assets within the preceding tables are
principally comprised of an investment in a funding agreement,
funds withheld, various interest-bearing assets held in foreign
subsidiaries and certain amounts due under contractual
indemnifications.
The estimated fair value of the investment in funding agreements
is estimated by discounting the expected future cash flows using
current market rates and the credit risk of the note issuer. For
funds withheld and the various interest-bearing assets held in
foreign subsidiaries, the Company evaluates the specific facts
and circumstances of each instrument to determine the
appropriate estimated fair values. These estimated fair values
were not materially different from the recognized carrying
values.
Cash and
Cash Equivalents
Due to the short-term maturities of cash and cash equivalents,
the Company believes there is minimal risk of material changes
in interest rates or credit of the issuer such that estimated
fair value generally approximates carrying value. In light of
recent market conditions, cash and cash equivalent instruments
have been monitored to ensure there is sufficient demand and
maintenance of issuer credit quality, or sufficient solvency in
the case of depository institutions, and the Company has
determined additional adjustment is not required.
Accrued
Investment Income
Due to the short term until settlement of accrued investment
income, the Company believes there is minimal risk of material
changes in interest rates or credit of the issuer such that
estimated fair value approximates carrying value. In light of
recent market conditions, the Company has monitored the credit
quality of the issuers and has determined additional adjustment
is not required.
Premiums,
Reinsurance and Other Receivables
Premiums, reinsurance and other receivables in the preceding
tables are principally comprised of certain amounts recoverable
under reinsurance contracts, amounts on deposit with financial
institutions to facilitate daily settlements related to certain
derivative positions and amounts receivable for securities sold
but not yet settled.
Premiums receivable and those amounts recoverable under
reinsurance treaties determined to transfer sufficient risk are
not financial instruments subject to disclosure and thus have
been excluded from the amounts presented in the preceding
tables. Amounts recoverable under ceded reinsurance contracts,
which the Company has determined do not transfer sufficient risk
such that they are accounted for using the deposit method of
accounting, have been included in the preceding tables. The
estimated fair value is determined as the present value of
expected future cash flows under the related contracts, which
were discounted using an interest rate determined to reflect the
appropriate credit standing of the assuming counterparty.
F-132
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The amounts on deposit for derivative settlements essentially
represent the equivalent of demand deposit balances and amounts
due for securities sold are generally received over short
periods such that the estimated fair value approximates carrying
value. In light of recent market conditions, the Company has
monitored the solvency position of the financial institutions
and has determined additional adjustments are not required.
Other
Assets
Other assets in the preceding tables is a receivable for cash
paid to an unaffiliated financial institution under the MetLife
Reinsurance Company of Charleston (MRC) collateral
financing arrangement as described in Note 12. With the
exception of the receivable for cash paid to the unaffiliated
financial institution, other assets are not considered financial
instruments subject to disclosure. Accordingly, the amount
presented in the preceding tables represents the receivable for
the cash paid to the unaffiliated financial institution under
the MRC collateral financing arrangement for which the estimated
fair value was determined by discounting the expected future
cash flows using a discount rate that reflects the credit rating
of the unaffiliated financial institution.
Policyholder
Account Balances
Policyholder account balances in the tables above include
investment contracts. Embedded derivatives on investment
contracts and certain variable annuity guarantees accounted for
as embedded derivatives are included in this caption in the
consolidated financial statements but excluded from this caption
in the tables above as they are separately presented in
Recurring Fair Value Measurements. The
remaining difference between the amounts reflected as
policyholder account balances in the preceding table and those
recognized in the consolidated balance sheets represents those
amounts due under contracts that satisfy the definition of
insurance contracts and are not considered financial instruments.
The investment contracts primarily include certain funding
agreements, fixed deferred annuities, modified guaranteed
annuities, fixed term payout annuities and total control
accounts. The fair values for these investment contracts are
estimated by discounting best estimate future cash flows using
current market risk-free interest rates and adding a spread to
reflect the nonperformance risk in the liability.
Payables
for Collateral Under Securities Loaned and Other
Transactions
The estimated fair value for payables for collateral under
securities loaned and other transactions approximates carrying
value. The related agreements to loan securities are short-term
in nature such that the Company believes there is limited risk
of a material change in market interest rates. Additionally,
because borrowers are cross-collateralized by the borrowed
securities, the Company believes no additional consideration for
changes in nonperformance risk are necessary.
Bank
Deposits
Due to the frequency of interest rate resets on customer bank
deposits held in money market accounts, the Company believes
that there is minimal risk of a material change in interest
rates such that the estimated fair value approximates carrying
value. For time deposits, estimated fair values are estimated by
discounting the expected cash flows to maturity using a discount
rate based on an average market rate for certificates of deposit
being offered by a representative group of large financial
institutions at the date of the valuation.
Short-term
and Long-term Debt, Collateral Financing Arrangements and Junior
Subordinated Debt Securities
The estimated fair value for short-term debt approximates
carrying value due to the short-term nature of these
obligations. The estimated fair values of long-term debt,
collateral financing arrangements and junior subordinated debt
securities are generally determined by discounting expected
future cash flows using market rates currently available for
debt with similar remaining maturities and reflecting the credit
risk of the Company, including inputs
F-133
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
when available, from actively traded debt of the Company or
other companies with similar types of borrowing arrangements.
Risk-adjusted discount rates applied to the expected future cash
flows can vary significantly based upon the specific terms of
each individual arrangement, including, but not limited to:
subordinated rights; contractual interest rates in relation to
current market rates; the structuring of the arrangement; and
the nature and observability of the applicable valuation inputs.
Use of different risk-adjusted discount rates could result in
different estimated fair values.
The carrying value of long-term debt presented in the table
above differs from the amounts presented in the consolidated
balance sheets as it does not include capital leases which are
not required to be disclosed at estimated fair value.
Other
Liabilities
Other liabilities included in the tables above reflect those
other liabilities that satisfy the definition of financial
instruments subject to disclosure. These items consist primarily
of interest and dividends payable; amounts due for securities
purchased but not yet settled; and amounts payable under certain
assumed reinsurance treaties accounted for as deposit type
treaties. The Company evaluates the specific terms, facts and
circumstances of each instrument to determine the appropriate
estimated fair values, which were not materially different from
the carrying values.
Separate
Account Liabilities
Separate account liabilities included in the preceding tables
represent those balances due to policyholders under contracts
that are classified as investment contracts. The remaining
amounts presented in the consolidated balance sheets represent
those contracts classified as insurance contracts, which do not
satisfy the definition of financial instruments.
Separate account liabilities classified as investment contracts
primarily represent variable annuities with no significant
mortality risk to the Company such that the death benefit is
equal to the account balance; funding agreements related to
group life contracts; and certain contracts that provide for
benefit funding.
Separate account liabilities are recognized in the consolidated
balance sheets at an equivalent value of the related separate
account assets. Separate account assets, which equal net
deposits, net investment income and realized and unrealized
investment gains and losses, are fully offset by corresponding
amounts credited to the contractholders liability which is
reflected in separate account liabilities. Since separate
account liabilities are fully funded by cash flows from the
separate account assets which are recognized at estimated fair
value as described in the section Recurring
Fair Value Measurements, the Company believes the value of
those assets approximates the estimated fair value of the
related separate account liabilities.
Mortgage
Loan Commitments and Commitments to Fund Bank Credit
Facilities, Bridge Loans and Private Corporate Bond
Investments
The estimated fair values for mortgage loan commitments that
will be held for investment and commitments to fund bank credit
facilities, bridge loans and private corporate bonds that will
be held for investment reflected in the above tables represent
the difference between the discounted expected future cash flows
using interest rates that incorporate current credit risk for
similar instruments on the reporting date and the principal
amounts of the commitments.
F-134
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
6.
|
Deferred
Policy Acquisition Costs and Value of Business
Acquired
|
Information regarding DAC and VOBA is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DAC
|
|
|
VOBA
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Balance at January 1, 2008
|
|
$
|
14,260
|
|
|
$
|
3,550
|
|
|
$
|
17,810
|
|
Capitalizations
|
|
|
3,092
|
|
|
|
|
|
|
|
3,092
|
|
Acquisitions
|
|
|
|
|
|
|
(5
|
)
|
|
|
(5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
17,352
|
|
|
|
3,545
|
|
|
|
20,897
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization related to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment gains (losses)
|
|
|
(489
|
)
|
|
|
(32
|
)
|
|
|
(521
|
)
|
Other expenses
|
|
|
(2,460
|
)
|
|
|
(508
|
)
|
|
|
(2,968
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amortization
|
|
|
(2,949
|
)
|
|
|
(540
|
)
|
|
|
(3,489
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized investment gains (losses)
|
|
|
2,753
|
|
|
|
599
|
|
|
|
3,352
|
|
Effect of foreign currency translation and other
|
|
|
(503
|
)
|
|
|
(113
|
)
|
|
|
(616
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
|
16,653
|
|
|
|
3,491
|
|
|
|
20,144
|
|
Capitalizations
|
|
|
3,019
|
|
|
|
|
|
|
|
3,019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
19,672
|
|
|
|
3,491
|
|
|
|
23,163
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization related to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment gains (losses)
|
|
|
625
|
|
|
|
87
|
|
|
|
712
|
|
Other expenses
|
|
|
(1,754
|
)
|
|
|
(265
|
)
|
|
|
(2,019
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amortization
|
|
|
(1,129
|
)
|
|
|
(178
|
)
|
|
|
(1,307
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized investment gains (losses)
|
|
|
(2,314
|
)
|
|
|
(505
|
)
|
|
|
(2,819
|
)
|
Effect of foreign currency translation and other
|
|
|
163
|
|
|
|
56
|
|
|
|
219
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2009
|
|
|
16,392
|
|
|
|
2,864
|
|
|
|
19,256
|
|
Capitalizations
|
|
|
3,343
|
|
|
|
|
|
|
|
3,343
|
|
Acquisitions
|
|
|
|
|
|
|
9,210
|
|
|
|
9,210
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
19,735
|
|
|
|
12,074
|
|
|
|
31,809
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization related to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment gains (losses)
|
|
|
(108
|
)
|
|
|
(16
|
)
|
|
|
(124
|
)
|
Other expenses
|
|
|
(2,247
|
)
|
|
|
(494
|
)
|
|
|
(2,741
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amortization
|
|
|
(2,355
|
)
|
|
|
(510
|
)
|
|
|
(2,865
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized investment gains (losses)
|
|
|
(1,258
|
)
|
|
|
(125
|
)
|
|
|
(1,383
|
)
|
Effect of foreign currency translation and other
|
|
|
97
|
|
|
|
(351
|
)
|
|
|
(254
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2010
|
|
$
|
16,219
|
|
|
$
|
11,088
|
|
|
$
|
27,307
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Note 2 for a description of acquisitions and
dispositions.
The estimated future amortization expense allocated to other
expenses for the next five years for VOBA is $1,661 million
in 2011, $1,373 million in 2012, $1,128 million in
2013, $959 million in 2014 and $816 million in 2015.
F-135
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Amortization of DAC and VOBA is attributed to both investment
gains and losses and to other expenses for the amount of gross
margins or profits originating from transactions other than
investment gains and losses. Unrealized investment gains and
losses represent the amount of DAC and VOBA that would have been
amortized if such gains and losses had been recognized.
Information regarding DAC and VOBA by segment and reporting unit
is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DAC
|
|
|
VOBA
|
|
|
Total
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2010
|
|
|
2009
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
U.S. Business:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance Products:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Group life
|
|
$
|
25
|
|
|
$
|
27
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
25
|
|
|
$
|
27
|
|
Individual life
|
|
|
7,257
|
|
|
|
8,129
|
|
|
|
833
|
|
|
|
1,005
|
|
|
|
8,090
|
|
|
|
9,134
|
|
Non-medical health
|
|
|
965
|
|
|
|
942
|
|
|
|
|
|
|
|
|
|
|
|
965
|
|
|
|
942
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insurance Products
|
|
|
8,247
|
|
|
|
9,098
|
|
|
|
833
|
|
|
|
1,005
|
|
|
|
9,080
|
|
|
|
10,103
|
|
Retirement Products
|
|
|
4,706
|
|
|
|
4,612
|
|
|
|
1,094
|
|
|
|
1,412
|
|
|
|
5,800
|
|
|
|
6,024
|
|
Corporate Benefit Funding
|
|
|
74
|
|
|
|
72
|
|
|
|
1
|
|
|
|
2
|
|
|
|
75
|
|
|
|
74
|
|
Auto & Home
|
|
|
190
|
|
|
|
181
|
|
|
|
|
|
|
|
|
|
|
|
190
|
|
|
|
181
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Business
|
|
|
13,217
|
|
|
|
13,963
|
|
|
|
1,928
|
|
|
|
2,419
|
|
|
|
15,145
|
|
|
|
16,382
|
|
International
|
|
|
3,000
|
|
|
|
2,426
|
|
|
|
9,159
|
|
|
|
444
|
|
|
|
12,159
|
|
|
|
2,870
|
|
Banking, Corporate & Other
|
|
|
2
|
|
|
|
3
|
|
|
|
1
|
|
|
|
1
|
|
|
|
3
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
16,219
|
|
|
$
|
16,392
|
|
|
$
|
11,088
|
|
|
$
|
2,864
|
|
|
$
|
27,307
|
|
|
$
|
19,256
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill is the excess of cost over the estimated fair value of
net assets acquired. Information regarding goodwill is as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Balance at January 1,
|
|
$
|
5,047
|
|
|
$
|
5,008
|
|
|
$
|
4,814
|
|
Acquisitions
|
|
|
6,959
|
|
|
|
|
|
|
|
256
|
|
Effect of foreign currency translation and other
|
|
|
(225
|
)
|
|
|
39
|
|
|
|
(62
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
11,781
|
|
|
$
|
5,047
|
|
|
$
|
5,008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-136
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Information regarding allocated goodwill by segment and
reporting unit is as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
U.S. Business:
|
|
|
|
|
|
|
|
|
Insurance Products:
|
|
|
|
|
|
|
|
|
Group life
|
|
$
|
2
|
|
|
$
|
2
|
|
Individual life
|
|
|
1,263
|
|
|
|
1,263
|
|
Non-medical health
|
|
|
149
|
|
|
|
149
|
|
|
|
|
|
|
|
|
|
|
Total Insurance Products
|
|
|
1,414
|
|
|
|
1,414
|
|
Retirement Products
|
|
|
1,692
|
|
|
|
1,692
|
|
Corporate Benefit Funding
|
|
|
900
|
|
|
|
900
|
|
Auto & Home
|
|
|
157
|
|
|
|
157
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Business
|
|
|
4,163
|
|
|
|
4,163
|
|
|
|
|
|
|
|
|
|
|
International:
|
|
|
|
|
|
|
|
|
Latin America
|
|
|
229
|
|
|
|
214
|
|
Asia Pacific
|
|
|
72
|
|
|
|
160
|
|
Europe and the Middle East
|
|
|
38
|
|
|
|
40
|
|
|
|
|
|
|
|
|
|
|
Total International
|
|
|
339
|
|
|
|
414
|
|
|
|
|
|
|
|
|
|
|
Banking, Corporate & Other
|
|
|
470
|
|
|
|
470
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
4,972
|
|
|
$
|
5,047
|
|
|
|
|
|
|
|
|
|
|
The above table does not include goodwill of $6,809 million
at December 31, 2010, associated with ALICO which has not
yet been allocated to a reporting unit due to the timing of the
Acquisition. See Note 2 for a description of acquisitions
and dispositions.
As described in more detail in Note 1, the Company
performed its annual goodwill impairment tests during the third
quarter of 2010 based upon data at June 30, 2010. The tests
indicated that goodwill was not impaired.
Management continues to evaluate current market conditions that
may affect the estimated fair value of the Companys
reporting units to assess whether any goodwill impairment
exists. Continued deteriorating or adverse market conditions for
certain reporting units may have a significant impact on the
estimated fair value of these reporting units and could result
in future impairments of goodwill.
F-137
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Insurance
Liabilities
Insurance liabilities were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future Policy
|
|
|
Policyholder Account
|
|
|
Other Policy-Related
|
|
|
|
Benefits
|
|
|
Balances
|
|
|
Balances
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2010
|
|
|
2009
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
U.S. Business:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance Products:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Group life
|
|
$
|
2,717
|
|
|
$
|
2,981
|
|
|
$
|
9,175
|
|
|
$
|
8,985
|
|
|
$
|
2,454
|
|
|
$
|
2,411
|
|
Individual life
|
|
|
56,533
|
|
|
|
55,291
|
|
|
|
19,731
|
|
|
|
18,632
|
|
|
|
2,752
|
|
|
|
2,911
|
|
Non-medical health
|
|
|
13,686
|
|
|
|
12,738
|
|
|
|
501
|
|
|
|
501
|
|
|
|
625
|
|
|
|
616
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insurance Products
|
|
|
72,936
|
|
|
|
71,010
|
|
|
|
29,407
|
|
|
|
28,118
|
|
|
|
5,831
|
|
|
|
5,938
|
|
Retirement Products
|
|
|
8,829
|
|
|
|
8,226
|
|
|
|
46,517
|
|
|
|
46,855
|
|
|
|
146
|
|
|
|
122
|
|
Corporate Benefit Funding
|
|
|
39,187
|
|
|
|
37,377
|
|
|
|
57,773
|
|
|
|
55,522
|
|
|
|
184
|
|
|
|
197
|
|
Auto & Home
|
|
|
3,036
|
|
|
|
2,972
|
|
|
|
|
|
|
|
|
|
|
|
171
|
|
|
|
184
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Business
|
|
|
123,988
|
|
|
|
119,585
|
|
|
|
133,697
|
|
|
|
130,495
|
|
|
|
6,332
|
|
|
|
6,441
|
|
International
|
|
|
43,587
|
|
|
|
10,830
|
|
|
|
77,281
|
|
|
|
8,128
|
|
|
|
9,051
|
|
|
|
1,637
|
|
Banking, Corporate & Other
|
|
|
5,798
|
|
|
|
5,464
|
|
|
|
42
|
|
|
|
50
|
|
|
|
423
|
|
|
|
368
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
173,373
|
|
|
$
|
135,879
|
|
|
$
|
211,020
|
|
|
$
|
138,673
|
|
|
$
|
15,806
|
|
|
$
|
8,446
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value
of Distribution Agreements and Customer Relationships
Acquired
Information regarding VODA and VOCRA, which are reported in
other assets, was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Balance at January 1,
|
|
$
|
792
|
|
|
$
|
822
|
|
|
$
|
706
|
|
Acquisitions
|
|
|
356
|
|
|
|
|
|
|
|
144
|
|
Amortization
|
|
|
(42
|
)
|
|
|
(34
|
)
|
|
|
(25
|
)
|
Effect of foreign currency translation and other
|
|
|
(12
|
)
|
|
|
4
|
|
|
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
1,094
|
|
|
$
|
792
|
|
|
$
|
822
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The estimated future amortization expense allocated to other
expenses for the next five years for VODA and VOCRA is
$63 million in 2011, $74 million in 2012,
$80 million in 2013, $84 million in 2014 and
$82 million in 2015. See Note 2 for a description of
acquisitions and dispositions.
F-138
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Sales
Inducements
Information regarding deferred sales inducements, which are
reported in other assets, was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Balance at January 1,
|
|
$
|
841
|
|
|
$
|
711
|
|
|
$
|
677
|
|
Capitalization
|
|
|
157
|
|
|
|
193
|
|
|
|
176
|
|
Amortization
|
|
|
(80
|
)
|
|
|
(63
|
)
|
|
|
(142
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
918
|
|
|
$
|
841
|
|
|
$
|
711
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separate
Accounts
Separate account assets and liabilities include two categories
of account types: pass-through separate accounts totaling
$149.2 billion and $121.4 billion at December 31,
2010 and 2009, respectively, for which the policyholder assumes
all investment risk, and separate accounts for which the Company
contractually guarantees either a minimum return or account
value to the policyholder which totaled $34.1 billion and
$27.6 billion at December 31, 2010 and 2009,
respectively. The latter category consisted primarily of funding
agreements and participating close-out contracts. The average
interest rate credited on these contracts was 3.32% and 3.35% at
December 31, 2010 and 2009, respectively.
Fees charged to the separate accounts by the Company (including
mortality charges, policy administration fees and surrender
charges) are reflected in the Companys revenues as
universal life and investment-type product policy fees and
totaled $3.2 billion, $2.6 billion and
$3.2 billion for the years ended December 31, 2010,
2009 and 2008, respectively.
The Companys proportional interest in separate accounts
was included in the consolidated balance sheets as follows at:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities
|
|
$
|
257
|
|
|
$
|
11
|
|
Equity securities
|
|
$
|
33
|
|
|
$
|
57
|
|
Cash and cash equivalents
|
|
$
|
74
|
|
|
$
|
2
|
|
For the years ended December 31, 2010, 2009 and 2008, there
were no investment gains (losses) on transfers of assets from
the general account to the separate accounts.
Obligations
Under Funding Agreements
The Company issues fixed and floating rate funding agreements,
which are denominated in either U.S. dollars or foreign
currencies, to certain SPEs that have issued either debt
securities or commercial paper for which payment of interest and
principal is secured by such funding agreements. During the
years ended December 31, 2010, 2009 and 2008, the Company
issued $34.1 billion, $28.6 billion and
$20.9 billion, respectively, and repaid $30.9 billion,
$32.0 billion and $19.8 billion, respectively, of such
funding agreements. At December 31, 2010 and 2009, funding
agreements outstanding, which are included in policyholder
account balances, were $27.2 billion and
$23.3 billion, respectively. During the years ended
December 31, 2010, 2009 and 2008, interest credited on the
funding agreements, which is included in interest credited to
policyholder account balances, was $0.6 billion,
$0.7 billion and $1.1 billion, respectively.
F-139
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
MetLife Insurance Company of Connecticut (MICC) is a
member of the FHLB of Boston and held $70 million of common
stock of the FHLB of Boston at both December 31, 2010 and
2009, which is included in equity securities. MICC has also
entered into funding agreements with the FHLB of Boston in
exchange for cash and for which the FHLB of Boston has been
granted a blanket lien on certain MICC assets, including RMBS,
to collateralize MICCs obligations under the funding
agreements. MICC maintains control over these pledged assets,
and may use, commingle, encumber or dispose of any portion of
the collateral as long as there is no event of default and the
remaining qualified collateral is sufficient to satisfy the
collateral maintenance level. Upon any event of default by MICC,
the FHLB of Bostons recovery on the collateral is limited
to the amount of MICCs liability to the FHLB of Boston.
The amount of MICCs liability for funding agreements with
the FHLB of Boston was $100 million and $326 million
at December 31, 2010 and 2009, respectively, which is
included in policyholder account balances. The advances on these
funding agreements are collateralized by mortgage-backed
securities with estimated fair values of $211 million and
$419 million at December 31, 2010 and 2009,
respectively. During the years ended December 31, 2010,
2009 and 2008, interest credited on the funding agreements,
which is included in interest credited to policyholder account
balances, was $1 million, $6 million and
$15 million, respectively.
Metropolitan Life Insurance Company (MLIC) is a
member of the FHLB of NY and held $890 million and
$742 million of common stock of the FHLB of NY at
December 31, 2010 and 2009, respectively, which is included
in equity securities. MLIC has also entered into funding
agreements with the FHLB of NY in exchange for cash and for
which the FHLB of NY has been granted a lien on certain MLIC
assets, including RMBS to collateralize MLICs obligations
under the funding agreements. MLIC maintains control over these
pledged assets, and may use, commingle, encumber or dispose of
any portion of the collateral as long as there is no event of
default and the remaining qualified collateral is sufficient to
satisfy the collateral maintenance level. Upon any event of
default by MLIC, the FHLB of NYs recovery on the
collateral is limited to the amount of MLICs liability to
the FHLB of NY. The amount of the MLICs liability for
funding agreements with the FHLB of NY was $12.6 billion
and $13.7 billion at December 31, 2010 and 2009,
respectively, which is included in policyholder account
balances. The advances on these agreements were collateralized
by mortgage-backed securities with estimated fair values of
$14.2 billion and $15.1 billion at December 31,
2010 and 2009, respectively. During the years ended
December 31, 2010, 2009 and 2008, interest credited on the
funding agreements, which is included in interest credited to
policyholder account balances, was $276 million,
$333 million and $229 million, respectively.
During 2010, MetLife Investors Insurance Company
(MLIIC) and General American Life Insurance Company
(GALIC) became members of the Federal Home Loan Bank
of Des Moines (FHLB of Des Moines) and each held
$10 million of common stock of the FHLB of Des Moines at
December 31, 2010, which is included in equity securities.
MLIIC and GALIC had no funding agreements with the FHLB of Des
Moines at December 31, 2010.
MLIC and MICC have each issued funding agreements to certain
SPEs that have issued debt securities for which payment of
interest and principal is secured by such funding agreements,
and such debt securities are also guaranteed as to payment of
interest and principal by Farmer Mac, a federally chartered
instrumentality of the United States. The obligations under
these funding agreements are secured by a pledge of certain
eligible agricultural real estate mortgage loans and may, under
certain circumstances, be secured by other qualified collateral.
The amount of the Companys liability for funding
agreements issued to such SPEs was $2.8 billion and
$2.5 billion at December 31, 2010 and 2009,
respectively, which is included in policyholder account
balances. The obligations under these funding agreements are
collateralized by designated agricultural real estate mortgage
loans with estimated fair values of $3.2 billion and
$2.9 billion at December 31, 2010 and 2009,
respectively. During the years ended December 31, 2010,
2009 and 2008, interest credited on the funding agreements,
which is included in interest credited to policyholder account
balances, was $135 million, $132 million and
$132 million, respectively.
F-140
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Liabilities
for Unpaid Claims and Claim Expenses
Information regarding the liabilities for unpaid claims and
claim expenses relating to property and casualty, group accident
and non-medical health policies and contracts, which are
reported in future policy benefits and other policy-related
balances, is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Balance at January 1,
|
|
$
|
8,219
|
|
|
$
|
8,260
|
|
|
$
|
7,836
|
|
Less: Reinsurance recoverables
|
|
|
547
|
|
|
|
1,042
|
|
|
|
955
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net balance at January 1,
|
|
|
7,672
|
|
|
|
7,218
|
|
|
|
6,881
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisitions, net
|
|
|
583
|
|
|
|
|
|
|
|
|
|
Incurred related to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Current year
|
|
|
6,482
|
|
|
|
6,569
|
|
|
|
6,263
|
|
Prior years
|
|
|
(75
|
)
|
|
|
(152
|
)
|
|
|
(353
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total incurred
|
|
|
6,407
|
|
|
|
6,417
|
|
|
|
5,910
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paid related to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Current year
|
|
|
(4,050
|
)
|
|
|
(3,972
|
)
|
|
|
(3,861
|
)
|
Prior years
|
|
|
(2,102
|
)
|
|
|
(1,991
|
)
|
|
|
(1,712
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total paid
|
|
|
(6,152
|
)
|
|
|
(5,963
|
)
|
|
|
(5,573
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net balance at December 31,
|
|
|
8,510
|
|
|
|
7,672
|
|
|
|
7,218
|
|
Add: Reinsurance recoverables
|
|
|
2,198
|
|
|
|
547
|
|
|
|
1,042
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
10,708
|
|
|
$
|
8,219
|
|
|
$
|
8,260
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
During 2010, 2009 and 2008, as a result of changes in estimates
of insured events in the respective prior year, claims and claim
adjustment expenses associated with prior years decreased by
$75 million, $152 million and $353 million,
respectively, due to a reduction in prior year automobile bodily
injury and homeowners severity, reduced loss adjustment
expenses, improved loss ratio for non-medical health claim
liabilities and improved claim management.
Guarantees
The Company issues annuity contracts which may include
contractual guarantees to the contractholder for:
(i) return of no less than total deposits made to the
contract less any partial withdrawals (return of net
deposits); and (ii) the highest contract value on a
specified anniversary date minus any withdrawals following the
contract anniversary, or total deposits made to the contract
less any partial withdrawals plus a minimum return
(anniversary contract value or minimum
return). The Company also issues annuity contracts that
apply a lower rate of funds deposited if the contractholder
elects to surrender the contract for cash and a higher rate if
the contractholder elects to annuitize (two tier
annuities). These guarantees include benefits that are
payable in the event of death, maturity or at annuitization.
The Company also issues universal and variable life contracts
where the Company contractually guarantees to the contractholder
a secondary guarantee or a guaranteed
paid-up
benefit.
F-141
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Information regarding the types of guarantees relating to
annuity contracts and universal and variable life contracts is
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
In the
|
|
|
At
|
|
|
In the
|
|
|
At
|
|
|
|
Event of Death
|
|
|
Annuitization
|
|
|
Event of Death
|
|
|
Annuitization
|
|
|
|
(In millions)
|
|
|
Annuity Contracts (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return of Net Deposits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separate account value
|
|
$
|
55,753
|
|
|
$
|
390
|
|
|
$
|
41,125
|
|
|
|
N/A
|
|
Net amount at risk (2)
|
|
$
|
6,194
|
(3)
|
|
$
|
289
|
(4)
|
|
$
|
4,585
|
(3)
|
|
|
N/A
|
|
Average attained age of contractholders
|
|
|
62 years
|
|
|
|
67 years
|
|
|
|
62 years
|
|
|
|
N/A
|
|
Anniversary Contract Value or Minimum Return
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separate account value
|
|
$
|
92,041
|
|
|
$
|
55,668
|
|
|
$
|
78,808
|
|
|
$
|
40,234
|
|
Net amount at risk (2)
|
|
$
|
5,297
|
(3)
|
|
$
|
6,373
|
(4)
|
|
$
|
9,039
|
(3)
|
|
$
|
7,361
|
(4)
|
Average attained age of contractholders
|
|
|
62 years
|
|
|
|
61 years
|
|
|
|
61 years
|
|
|
|
61 years
|
|
Two Tier Annuities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General account value
|
|
|
N/A
|
|
|
$
|
280
|
|
|
|
N/A
|
|
|
$
|
282
|
|
Net amount at risk (2)
|
|
|
N/A
|
|
|
$
|
49
|
(5)
|
|
|
N/A
|
|
|
$
|
50
|
(5)
|
Average attained age of contractholders
|
|
|
N/A
|
|
|
|
62 years
|
|
|
|
N/A
|
|
|
|
61 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
Secondary
|
|
|
Paid-Up
|
|
|
Secondary
|
|
|
Paid-Up
|
|
|
|
Guarantees
|
|
|
Guarantees
|
|
|
Guarantees
|
|
|
Guarantees
|
|
|
|
(In millions)
|
|
|
Universal and Variable Life Contracts (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Account value (general and separate account)
|
|
$
|
11,015
|
|
|
$
|
4,102
|
|
|
$
|
9,483
|
|
|
$
|
4,104
|
|
Net amount at risk (2)
|
|
$
|
156,432
|
(3)
|
|
$
|
26,851
|
(3)
|
|
$
|
150,905
|
(3)
|
|
$
|
28,826
|
(3)
|
Average attained age of policyholders
|
|
|
52 years
|
|
|
|
58 years
|
|
|
|
52 years
|
|
|
|
57 years
|
|
|
|
|
(1) |
|
The Companys annuity and life contracts with guarantees
may offer more than one type of guarantee in each contract.
Therefore, the amounts listed above may not be mutually
exclusive. |
|
(2) |
|
The net amount at risk is based on the direct and assumed amount
at risk (excluding ceded reinsurance). |
|
(3) |
|
The net amount at risk for guarantees of amounts in the event of
death is defined as the current GMDB in excess of the current
account balance at the balance sheet date. |
|
(4) |
|
The net amount at risk for guarantees of amounts at
annuitization is defined as the present value of the minimum
guaranteed annuity payments available to the contractholder
determined in accordance with the terms of the contract in
excess of the current account balance. |
|
(5) |
|
The net amount at risk for two tier annuities is based on the
excess of the upper tier, adjusted for a profit margin, less the
lower tier. |
F-142
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Information regarding the liabilities for guarantees (excluding
base policy liabilities) relating to annuity and universal and
variable life contracts is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Universal and Variable
|
|
|
|
|
|
|
Annuity Contracts
|
|
|
Life Contracts
|
|
|
|
|
|
|
Guaranteed
|
|
|
Guaranteed
|
|
|
|
|
|
|
|
|
|
|
|
|
Death
|
|
|
Annuitization
|
|
|
Secondary
|
|
|
Paid-Up
|
|
|
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
Guarantees
|
|
|
Guarantees
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Direct
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1, 2008
|
|
$
|
80
|
|
|
$
|
78
|
|
|
$
|
152
|
|
|
$
|
121
|
|
|
$
|
431
|
|
Incurred guaranteed benefits
|
|
|
267
|
|
|
|
325
|
|
|
|
119
|
|
|
|
19
|
|
|
|
730
|
|
Paid guaranteed benefits
|
|
|
(96
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(96
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
|
251
|
|
|
|
403
|
|
|
|
271
|
|
|
|
140
|
|
|
|
1,065
|
|
Incurred guaranteed benefits
|
|
|
118
|
|
|
|
(1
|
)
|
|
|
233
|
|
|
|
34
|
|
|
|
384
|
|
Paid guaranteed benefits
|
|
|
(201
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(201
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2009
|
|
|
168
|
|
|
|
402
|
|
|
|
504
|
|
|
|
174
|
|
|
|
1,248
|
|
Acquisitions
|
|
|
46
|
|
|
|
110
|
|
|
|
2,952
|
|
|
|
|
|
|
|
3,108
|
|
Incurred guaranteed benefits
|
|
|
149
|
|
|
|
111
|
|
|
|
536
|
|
|
|
24
|
|
|
|
820
|
|
Paid guaranteed benefits
|
|
|
(91
|
)
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
(92
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2010
|
|
$
|
272
|
|
|
$
|
623
|
|
|
$
|
3,991
|
|
|
$
|
198
|
|
|
$
|
5,084
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ceded
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1, 2008
|
|
$
|
6
|
|
|
$
|
4
|
|
|
$
|
55
|
|
|
$
|
75
|
|
|
$
|
140
|
|
Incurred guaranteed benefits
|
|
|
18
|
|
|
|
(4
|
)
|
|
|
25
|
|
|
|
15
|
|
|
|
54
|
|
Paid guaranteed benefits
|
|
|
(16
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(16
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
|
8
|
|
|
|
|
|
|
|
80
|
|
|
|
90
|
|
|
|
178
|
|
Incurred guaranteed benefits
|
|
|
26
|
|
|
|
|
|
|
|
102
|
|
|
|
32
|
|
|
|
160
|
|
Paid guaranteed benefits
|
|
|
(28
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(28
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2009
|
|
|
6
|
|
|
|
|
|
|
|
182
|
|
|
|
122
|
|
|
|
310
|
|
Acquisitions
|
|
|
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30
|
|
Incurred guaranteed benefits
|
|
|
18
|
|
|
|
(1
|
)
|
|
|
412
|
|
|
|
17
|
|
|
|
446
|
|
Paid guaranteed benefits
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2010
|
|
$
|
39
|
|
|
$
|
(1
|
)
|
|
$
|
594
|
|
|
$
|
139
|
|
|
$
|
771
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1, 2008
|
|
$
|
74
|
|
|
$
|
74
|
|
|
$
|
97
|
|
|
$
|
46
|
|
|
$
|
291
|
|
Incurred guaranteed benefits
|
|
|
249
|
|
|
|
329
|
|
|
|
94
|
|
|
|
4
|
|
|
|
676
|
|
Paid guaranteed benefits
|
|
|
(80
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(80
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
|
243
|
|
|
|
403
|
|
|
|
191
|
|
|
|
50
|
|
|
|
887
|
|
Incurred guaranteed benefits
|
|
|
92
|
|
|
|
(1
|
)
|
|
|
131
|
|
|
|
2
|
|
|
|
224
|
|
Paid guaranteed benefits
|
|
|
(173
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(173
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2009
|
|
|
162
|
|
|
|
402
|
|
|
|
322
|
|
|
|
52
|
|
|
|
938
|
|
Acquisitions
|
|
|
16
|
|
|
|
110
|
|
|
|
2,952
|
|
|
|
|
|
|
|
3,078
|
|
Incurred guaranteed benefits
|
|
|
131
|
|
|
|
112
|
|
|
|
124
|
|
|
|
7
|
|
|
|
374
|
|
Paid guaranteed benefits
|
|
|
(76
|
)
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
(77
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2010
|
|
$
|
233
|
|
|
$
|
624
|
|
|
$
|
3,397
|
|
|
$
|
59
|
|
|
$
|
4,313
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-143
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Account balances of contracts with insurance guarantees are
invested in separate account asset classes as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Fund Groupings:
|
|
|
|
|
|
|
|
|
Equity
|
|
$
|
59,546
|
|
|
$
|
48,852
|
|
Balanced
|
|
|
40,199
|
|
|
|
31,011
|
|
Bond
|
|
|
9,539
|
|
|
|
7,166
|
|
Money Market
|
|
|
1,584
|
|
|
|
2,104
|
|
Specialty
|
|
|
2,192
|
|
|
|
1,865
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
113,060
|
|
|
$
|
90,998
|
|
|
|
|
|
|
|
|
|
|
The Company participates in reinsurance activities in order to
limit losses, minimize exposure to significant risks and provide
additional capacity for future growth.
For its individual life insurance products, the Company has
historically reinsured the mortality risk primarily on an excess
of retention basis or a quota share basis. The Company currently
reinsures 90% of the mortality risk in excess of $1 million
for most products and reinsures up to 90% of the mortality risk
for certain other products. In addition to reinsuring mortality
risk as described above, the Company reinsures other risks, as
well as specific coverages. Placement of reinsurance is done
primarily on an automatic basis and also on a facultative basis
for risks with specified characteristics. On a case by case
basis, the Company may retain up to $20 million per life
and reinsure 100% of amounts in excess of the amount the Company
retains. The Company evaluates its reinsurance programs
routinely and may increase or decrease its retention at any time.
For other policies within the Insurance Products segment, the
Company generally retains most of the risk and only cedes
particular risks on certain client arrangements.
The Companys Retirement Products segment reinsures a
portion of the living and death benefit guarantees issued in
connection with its variable annuities. Under these reinsurance
agreements, the Company pays a reinsurance premium generally
based on fees associated with the guarantees collected from
policyholders, and receives reimbursement for benefits paid or
accrued in excess of account values, subject to certain
limitations.
The Companys Corporate Benefit Funding segment
periodically engages in reinsurance activities, as considered
appropriate. The impact of these activities on the financial
results of this segment has not been significant.
The Companys Auto & Home segment purchases
reinsurance to manage its exposure to large losses (primarily
catastrophe losses) and to protect statutory surplus. The
Company cedes to reinsurers a portion of losses and premiums
based upon the exposure of the policies subject to reinsurance.
To manage exposure to large property and casualty losses, the
Company utilizes property catastrophe, casualty and property per
risk excess of loss agreements.
For its life insurance products within the International
segment, the Company reinsures, depending on the product, risks
above the corporate retention limit of up to $5 million to
external reinsurers on a yearly renewable term basis. The
Companys international businesses may also reinsure
certain risks with external reinsurers depending upon the nature
of the risk and local regulatory requirements. The
Companys International segment reinsures, for selected
large corporate customers, its group employee benefits or credit
insurance business with various client-affiliated reinsurance
companies, covering policies issued to the employees or
customers of the
F-144
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
clients. Additionally, the Company cedes and assumes risk with
other insurance companies when either company requires a
business partner with the appropriate local licensing to issue
certain types of policies in certain countries. In these cases,
the assuming company typically underwrites the risks, develops
the products and assumes most or all of the risk. The
Companys International segment also has reinsurance
agreements in force that reinsure a portion of the living and
death benefit guarantees issued in connection with its variable
annuities. Under these agreements, the Company pays reinsurance
fees associated with the guarantees collected from
policyholders, and receives reimbursement for benefits paid or
accrued in excess of account values, subject to certain
limitations.
The Company also reinsures, through 100% quota share reinsurance
agreements, certain long-term care and workers
compensation business written by MICC. These are run-off
businesses which have been included within Banking,
Corporate & Other.
The Company has exposure to catastrophes, which could contribute
to significant fluctuations in the Companys results of
operations. The Company uses excess of retention and quota share
reinsurance agreements to provide greater diversification of
risk and minimize exposure to larger risks. For its
International segment, the Company currently purchases
catastrophe coverage to insure risks within certain countries
deemed by management to be exposed to the greatest catastrophic
risks.
The Company reinsures its business through a diversified group
of well-capitalized, highly rated reinsurers. The Company
analyzes recent trends in arbitration and litigation outcomes in
disputes, if any, with its reinsurers. The Company monitors
ratings and evaluates the financial strength of its reinsurers
by analyzing their financial statements. In addition, the
reinsurance recoverable balance due from each reinsurer is
evaluated as part of the overall monitoring process.
Recoverability of reinsurance recoverable balances is evaluated
based on these analyses. The Company generally secures large
reinsurance recoverable balances with various forms of
collateral, including secured trusts, funds withheld accounts
and irrevocable letters of credit. These reinsurance recoverable
balances are stated net of allowances for uncollectible
reinsurance, which at December 31, 2010 and 2009, were
immaterial.
The Company has secured certain reinsurance recoverable balances
with various forms of collateral, including secured trusts,
funds withheld accounts and irrevocable letters of credit. The
Company had $5.5 billion and $4.4 billion of unsecured
unaffiliated reinsurance recoverable balances at
December 31, 2010 and 2009, respectively.
At December 31, 2010, the Company had $13.1 billion of
net unaffiliated ceded reinsurance recoverables. Of this total,
$10.0 billion, or 76%, were with the Companys five
largest unaffiliated ceded reinsurers, including
$3.6 billion of which were unsecured. At December 31,
2009, the Company had $11.7 billion of net unaffiliated
ceded reinsurance recoverables. Of this total,
$9.2 billion, or 79%, were with the Companys five
largest unaffiliated ceded reinsurers, including
$3.0 billion of which were unsecured.
The Company has reinsured with an unaffiliated third-party
reinsurer, 49.25% of the closed block through a modified
coinsurance agreement. The Company accounts for this agreement
under the deposit method of accounting. The Company, having the
right of offset, has offset the modified coinsurance deposit
with the deposit recoverable.
F-145
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The amounts in the consolidated statements of operations include
the impact of reinsurance. Information regarding the effect of
reinsurance is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Premiums:
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct premiums
|
|
$
|
27,923
|
|
|
$
|
27,472
|
|
|
$
|
27,058
|
|
Reinsurance assumed
|
|
|
1,377
|
|
|
|
1,313
|
|
|
|
1,466
|
|
Reinsurance ceded
|
|
|
(1,906
|
)
|
|
|
(2,325
|
)
|
|
|
(2,610
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net premiums
|
|
$
|
27,394
|
|
|
$
|
26,460
|
|
|
$
|
25,914
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Universal life and investment-type product policy fees:
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct universal life and investment-type product policy fees
|
|
$
|
6,630
|
|
|
$
|
5,790
|
|
|
$
|
5,909
|
|
Reinsurance assumed
|
|
|
138
|
|
|
|
106
|
|
|
|
79
|
|
Reinsurance ceded
|
|
|
(731
|
)
|
|
|
(693
|
)
|
|
|
(607
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net universal life and investment-type product policy fees
|
|
$
|
6,037
|
|
|
$
|
5,203
|
|
|
$
|
5,381
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct other revenues
|
|
$
|
2,256
|
|
|
$
|
2,264
|
|
|
$
|
1,481
|
|
Reinsurance assumed
|
|
|
|
|
|
|
1
|
|
|
|
|
|
Reinsurance ceded
|
|
|
72
|
|
|
|
64
|
|
|
|
105
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net other revenues
|
|
$
|
2,328
|
|
|
$
|
2,329
|
|
|
$
|
1,586
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims:
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct policyholder benefits and claims
|
|
$
|
31,762
|
|
|
$
|
30,363
|
|
|
$
|
29,772
|
|
Reinsurance assumed
|
|
|
1,275
|
|
|
|
1,024
|
|
|
|
1,235
|
|
Reinsurance ceded
|
|
|
(3,492
|
)
|
|
|
(3,051
|
)
|
|
|
(3,570
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net policyholder benefits and claims
|
|
$
|
29,545
|
|
|
$
|
28,336
|
|
|
$
|
27,437
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest credited to policyholder account balances:
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct interest credited to policyholder account balances
|
|
$
|
4,923
|
|
|
$
|
4,846
|
|
|
$
|
4,787
|
|
Reinsurance assumed
|
|
|
2
|
|
|
|
3
|
|
|
|
1
|
|
Reinsurance ceded
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net interest credited to policyholder account balances
|
|
$
|
4,925
|
|
|
$
|
4,849
|
|
|
$
|
4,788
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder dividends:
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct policyholder dividends
|
|
$
|
1,486
|
|
|
$
|
1,650
|
|
|
$
|
1,751
|
|
Reinsurance assumed
|
|
|
17
|
|
|
|
13
|
|
|
|
5
|
|
Reinsurance ceded
|
|
|
(17
|
)
|
|
|
(13
|
)
|
|
|
(5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net policyholder dividends
|
|
$
|
1,486
|
|
|
$
|
1,650
|
|
|
$
|
1,751
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct other expenses
|
|
$
|
12,911
|
|
|
$
|
10,602
|
|
|
$
|
12,107
|
|
Reinsurance assumed
|
|
|
116
|
|
|
|
100
|
|
|
|
57
|
|
Reinsurance ceded
|
|
|
(224
|
)
|
|
|
(146
|
)
|
|
|
(217
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net other expenses
|
|
$
|
12,803
|
|
|
$
|
10,556
|
|
|
$
|
11,947
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-146
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The amounts in the consolidated balance sheets include the
impact of reinsurance. Information regarding the effect of
reinsurance is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance
|
|
|
|
|
|
|
|
|
Total, Net of
|
|
|
|
Sheet
|
|
|
Assumed
|
|
|
Ceded
|
|
|
Reinsurance
|
|
|
|
(In millions)
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums, reinsurance and other receivables
|
|
$
|
19,830
|
|
|
$
|
722
|
|
|
$
|
13,561
|
|
|
$
|
5,547
|
|
Deferred policy acquisition costs and value of business acquired
|
|
|
27,307
|
|
|
|
176
|
|
|
|
(179
|
)
|
|
|
27,310
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
47,137
|
|
|
$
|
898
|
|
|
$
|
13,382
|
|
|
$
|
32,857
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future policy benefits
|
|
$
|
173,373
|
|
|
$
|
2,074
|
|
|
$
|
(65
|
)
|
|
$
|
171,364
|
|
Policyholder account balances
|
|
|
211,020
|
|
|
|
2,237
|
|
|
|
|
|
|
|
208,783
|
|
Other policy-related balances
|
|
|
15,806
|
|
|
|
265
|
|
|
|
506
|
|
|
|
15,035
|
|
Other liabilities
|
|
|
20,386
|
|
|
|
608
|
|
|
|
2,703
|
|
|
|
17,075
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
420,585
|
|
|
$
|
5,184
|
|
|
$
|
3,144
|
|
|
$
|
412,257
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance
|
|
|
|
|
|
|
|
|
Total, Net of
|
|
|
|
Sheet
|
|
|
Assumed
|
|
|
Ceded
|
|
|
Reinsurance
|
|
|
|
(In millions)
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums, reinsurance and other receivables
|
|
$
|
16,752
|
|
|
$
|
550
|
|
|
$
|
12,274
|
|
|
$
|
3,928
|
|
Deferred policy acquisition costs and value of business acquired
|
|
|
19,256
|
|
|
|
190
|
|
|
|
(206
|
)
|
|
|
19,272
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
36,008
|
|
|
$
|
740
|
|
|
$
|
12,068
|
|
|
$
|
23,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future policy benefits
|
|
$
|
135,879
|
|
|
$
|
2,000
|
|
|
$
|
(43
|
)
|
|
$
|
133,922
|
|
Policyholder account balances
|
|
|
138,673
|
|
|
|
1,321
|
|
|
|
|
|
|
|
137,352
|
|
Other policy-related balances
|
|
|
8,446
|
|
|
|
257
|
|
|
|
494
|
|
|
|
7,695
|
|
Other liabilities
|
|
|
15,989
|
|
|
|
364
|
|
|
|
2,489
|
|
|
|
13,136
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
298,987
|
|
|
$
|
3,942
|
|
|
$
|
2,940
|
|
|
$
|
292,105
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reinsurance agreements that do not expose the Company to a
reasonable possibility of a significant loss from insurance risk
are recorded using the deposit method of accounting. The deposit
assets on ceded reinsurance were $2,530 million and
$2,564 million at December 31, 2010 and 2009,
respectively. The deposit liabilities for assumed reinsurance
were $47 million and $52 million at December 31,
2010 and 2009, respectively.
On April 7, 2000 (the Demutualization Date),
MLIC converted from a mutual life insurance company to a stock
life insurance company and became a wholly-owned subsidiary of
MetLife, Inc. The conversion was pursuant to an order by the New
York Superintendent of Insurance (the
Superintendent) approving MLICs plan of
reorganization, as amended (the Plan). On the
Demutualization Date, MLIC established a closed block for the
benefit of holders of certain individual life insurance policies
of MLIC. Assets have been allocated to the closed block in an
amount that has been determined to produce cash flows which,
together with anticipated revenues from the policies included in
the closed block, are reasonably expected to be sufficient to
support obligations and
F-147
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
liabilities relating to these policies, including, but not
limited to, provisions for the payment of claims and certain
expenses and taxes, and to provide for the continuation of
policyholder dividend scales in effect for 1999, if the
experience underlying such dividend scales continues, and for
appropriate adjustments in such scales if the experience
changes. At least annually, the Company compares actual and
projected experience against the experience assumed in the
then-current dividend scales. Dividend scales are adjusted
periodically to give effect to changes in experience.
The closed block assets, the cash flows generated by the closed
block assets and the anticipated revenues from the policies in
the closed block will benefit only the holders of the policies
in the closed block. To the extent that, over time, cash flows
from the assets allocated to the closed block and claims and
other experience related to the closed block are, in the
aggregate, more or less favorable than what was assumed when the
closed block was established, total dividends paid to closed
block policyholders in the future may be greater than or less
than the total dividends that would have been paid to these
policyholders if the policyholder dividend scales in effect for
1999 had been continued. Any cash flows in excess of amounts
assumed will be available for distribution over time to closed
block policyholders and will not be available to stockholders.
If the closed block has insufficient funds to make guaranteed
policy benefit payments, such payments will be made from assets
outside of the closed block. The closed block will continue in
effect as long as any policy in the closed block remains
in-force. The expected life of the closed block is over
100 years.
The Company uses the same accounting principles to account for
the participating policies included in the closed block as it
used prior to the Demutualization Date. However, the Company
establishes a policyholder dividend obligation for earnings that
will be paid to policyholders as additional dividends as
described below. The excess of closed block liabilities over
closed block assets at the Demutualization Date (adjusted to
eliminate the impact of related amounts in accumulated other
comprehensive income) represents the estimated maximum future
earnings from the closed block expected to result from
operations attributed to the closed block after income taxes.
Earnings of the closed block are recognized in income over the
period the policies and contracts in the closed block remain
in-force. Management believes that over time the actual
cumulative earnings of the closed block will approximately equal
the expected cumulative earnings due to the effect of dividend
changes. If, over the period the closed block remains in
existence, the actual cumulative earnings of the closed block
are greater than the expected cumulative earnings of the closed
block, the Company will pay the excess of the actual cumulative
earnings of the closed block over the expected cumulative
earnings to closed block policyholders as additional
policyholder dividends unless offset by future unfavorable
experience of the closed block and, accordingly, will recognize
only the expected cumulative earnings in income with the excess
recorded as a policyholder dividend obligation. If over such
period, the actual cumulative earnings of the closed block are
less than the expected cumulative earnings of the closed block,
the Company will recognize only the actual earnings in income.
However, the Company may change policyholder dividend scales in
the future, which would be intended to increase future actual
earnings until the actual cumulative earnings equal the expected
cumulative earnings.
Experience within the closed block, in particular mortality and
investment yields, as well as realized and unrealized gains and
losses, directly impact the policyholder dividend obligation.
The policyholder dividend obligation increased to
$876 million at December 31, 2010, from zero at
December 31, 2009, as a result of recent unrealized gains
in the closed block. Amortization of the closed block DAC, which
resides outside of the closed block, is based upon cumulative
actual and expected earnings within the closed block.
Accordingly, the Companys net income continues to be
sensitive to the actual performance of the closed block.
F-148
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Information regarding the closed block liabilities and assets
designated to the closed block was as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Closed Block Liabilities
|
|
|
|
|
|
|
|
|
Future policy benefits
|
|
$
|
43,456
|
|
|
$
|
43,576
|
|
Other policy-related balances
|
|
|
316
|
|
|
|
307
|
|
Policyholder dividends payable
|
|
|
579
|
|
|
|
615
|
|
Policyholder dividend obligation
|
|
|
876
|
|
|
|
|
|
Current income tax payable
|
|
|
178
|
|
|
|
|
|
Other liabilities
|
|
|
627
|
|
|
|
576
|
|
|
|
|
|
|
|
|
|
|
Total closed block liabilities
|
|
|
46,032
|
|
|
|
45,074
|
|
|
|
|
|
|
|
|
|
|
Assets Designated to the Closed Block
|
|
|
|
|
|
|
|
|
Investments:
|
|
|
|
|
|
|
|
|
Fixed maturity securities
available-for-sale,
at estimated fair value (amortized cost: $27,067 and $27,129,
respectively)
|
|
|
28,768
|
|
|
|
27,375
|
|
Equity securities
available-for-sale,
at estimated fair value (cost: $110 and $204, respectively)
|
|
|
102
|
|
|
|
218
|
|
Mortgage loans
|
|
|
6,253
|
|
|
|
6,200
|
|
Policy loans
|
|
|
4,629
|
|
|
|
4,538
|
|
Real estate and real estate joint ventures
held-for-investment
|
|
|
328
|
|
|
|
321
|
|
Short-term investments
|
|
|
1
|
|
|
|
1
|
|
Other invested assets
|
|
|
729
|
|
|
|
463
|
|
|
|
|
|
|
|
|
|
|
Total investments
|
|
|
40,810
|
|
|
|
39,116
|
|
Cash and cash equivalents
|
|
|
236
|
|
|
|
241
|
|
Accrued investment income
|
|
|
518
|
|
|
|
489
|
|
Premiums, reinsurance and other receivables
|
|
|
95
|
|
|
|
78
|
|
Current income tax recoverable
|
|
|
|
|
|
|
112
|
|
Deferred income tax assets
|
|
|
474
|
|
|
|
612
|
|
|
|
|
|
|
|
|
|
|
Total assets designated to the closed block
|
|
|
42,133
|
|
|
|
40,648
|
|
|
|
|
|
|
|
|
|
|
Excess of closed block liabilities over assets designated to the
closed block
|
|
|
3,899
|
|
|
|
4,426
|
|
|
|
|
|
|
|
|
|
|
Amounts included in accumulated other comprehensive income
(loss):
|
|
|
|
|
|
|
|
|
Unrealized investment gains (losses), net of income tax of $594
and $89, respectively
|
|
|
1,101
|
|
|
|
166
|
|
Unrealized gains (losses) on derivative instruments, net of
income tax of $5 and ($3), respectively
|
|
|
10
|
|
|
|
(5
|
)
|
Allocated to policyholder dividend obligation, net of income tax
of ($307) and $0, respectively
|
|
|
(569
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amounts included in accumulated other comprehensive income
(loss)
|
|
|
542
|
|
|
|
161
|
|
|
|
|
|
|
|
|
|
|
Maximum future earnings to be recognized from closed block
assets and liabilities
|
|
$
|
4,441
|
|
|
$
|
4,587
|
|
|
|
|
|
|
|
|
|
|
Information regarding the closed block policyholder dividend
obligation was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Balance at January 1,
|
|
$
|
|
|
|
$
|
|
|
|
$
|
789
|
|
Change in unrealized investment and derivative gains (losses)
|
|
|
876
|
|
|
|
|
|
|
|
(789
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
876
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-149
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Information regarding the closed block revenues and expenses was
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
2,461
|
|
|
$
|
2,708
|
|
|
$
|
2,787
|
|
Net investment income
|
|
|
2,294
|
|
|
|
2,197
|
|
|
|
2,248
|
|
Net investment gains (losses):
|
|
|
|
|
|
|
|
|
|
|
|
|
Other-than-temporary
impairments on fixed maturity securities
|
|
|
(32
|
)
|
|
|
(107
|
)
|
|
|
(94
|
)
|
Other-than-temporary
impairments on fixed maturity securities transferred to other
comprehensive income (loss)
|
|
|
|
|
|
|
40
|
|
|
|
|
|
Other net investment gains (losses)
|
|
|
71
|
|
|
|
327
|
|
|
|
(19
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net investment gains (losses)
|
|
|
39
|
|
|
|
260
|
|
|
|
(113
|
)
|
Net derivative gains (losses)
|
|
|
(27
|
)
|
|
|
(128
|
)
|
|
|
29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
4,767
|
|
|
|
5,037
|
|
|
|
4,951
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
3,115
|
|
|
|
3,329
|
|
|
|
3,393
|
|
Policyholder dividends
|
|
|
1,235
|
|
|
|
1,394
|
|
|
|
1,498
|
|
Other expenses
|
|
|
199
|
|
|
|
203
|
|
|
|
217
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
4,549
|
|
|
|
4,926
|
|
|
|
5,108
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues, net of expenses before provision for income tax
expense (benefit)
|
|
|
218
|
|
|
|
111
|
|
|
|
(157
|
)
|
Provision for income tax expense (benefit)
|
|
|
72
|
|
|
|
36
|
|
|
|
(68
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues, net of expenses and provision for income tax expense
(benefit)
|
|
$
|
146
|
|
|
$
|
75
|
|
|
$
|
(89
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The change in the maximum future earnings of the closed block
was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Balance at December 31,
|
|
$
|
4,441
|
|
|
$
|
4,587
|
|
|
$
|
4,518
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
Closed block adjustment (1)
|
|
|
|
|
|
|
144
|
|
|
|
|
|
Balance at January 1,
|
|
|
4,587
|
|
|
|
4,518
|
|
|
|
4,429
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change during year
|
|
$
|
(146
|
)
|
|
$
|
(75
|
)
|
|
$
|
89
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The closed block adjustment represents an intra-company
reallocation of assets which affected the closed block. The
adjustment had no impact on the Companys consolidated
financial statements. |
MLIC charges the closed block with federal income taxes, state
and local premium taxes and other additive state or local taxes,
as well as investment management expenses relating to the closed
block as provided in the Plan. MLIC also charges the closed
block for expenses of maintaining the policies included in the
closed block.
F-150
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
11.
|
Long-term
and Short-term Debt
|
Long-term and short-term debt outstanding is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rates
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
December 31,
|
|
|
|
Range
|
|
Average
|
|
|
Maturity
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Senior notes
|
|
0.61%-7.72%
|
|
|
5.58
|
%
|
|
2011-2045
|
|
$
|
16,258
|
|
|
$
|
10,458
|
|
Advances agreements
|
|
0.23%-4.86%
|
|
|
2.41
|
%
|
|
2011-2015
|
|
|
3,600
|
|
|
|
1,846
|
|
Surplus notes
|
|
7.63%-7.88%
|
|
|
7.85
|
%
|
|
2015-2025
|
|
|
699
|
|
|
|
698
|
|
Fixed rate notes
|
|
3.76%-15.00%
|
|
|
8.67
|
%
|
|
2011-2012
|
|
|
82
|
|
|
|
63
|
|
Other notes with varying interest rates
|
|
1.98%-8.00%
|
|
|
7.20
|
%
|
|
2013-2030
|
|
|
95
|
|
|
|
120
|
|
Capital lease obligations
|
|
|
|
|
|
|
|
|
|
|
32
|
|
|
|
35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total long-term debt (1)
|
|
|
|
|
|
|
|
|
|
|
20,766
|
|
|
|
13,220
|
|
Total short-term debt
|
|
|
|
|
|
|
|
|
|
|
306
|
|
|
|
912
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
$
|
21,072
|
|
|
$
|
14,132
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Excludes $6,820 million at December 31, 2010 of
long-term debt relating to CSEs. See Note 3. |
The aggregate maturities of long-term debt at December 31,
2010 for the next five years and thereafter are
$1,405 million in 2011, $1,520 million in 2012,
$1,464 million in 2013, $1,653 million in 2014,
$2,365 million in 2015 and $12,358 million thereafter.
Advances agreements and capital lease obligations are
collateralized and rank highest in priority, followed by
unsecured senior debt which consists of senior notes, fixed rate
notes and other notes with varying interest rates, followed by
subordinated debt which consists of junior subordinated debt
securities. Payments of interest and principal on the
Companys surplus notes, which are subordinate to all other
obligations at the operating company level and senior to
obligations at the Holding Company, may be made only with the
prior approval of the insurance department of the state of
domicile. Collateral financing arrangements are supported by
either surplus notes of subsidiaries or financing arrangements
with the Holding Company and, accordingly, have priority
consistent with other such obligations.
Certain of the Companys debt instruments, credit
facilities and committed facilities contain various
administrative, reporting, legal and financial covenants. The
Company believes it was in compliance with all covenants at both
December 31, 2010 and 2009.
Senior
Notes Senior Debt Securities Underlying Equity
Units
In connection with the financing of the Acquisition (see
Note 2) in November 2010, MetLife, Inc. issued to
ALICO Holdings $3,000 million (estimated fair value of
$3,011 million) in three series of Debt Securities, which
constitute a part of the Equity Units more fully described in
Note 14. The Debt Securities (Series C, D and
E) are subject to remarketing, initially bear interest at
1.56%, 1.92% and 2.46%, respectively (an average rate of 1.98%),
and carry initial maturity dates of June 15, 2023,
June 15, 2024 and June 15, 2045, respectively. The
interest rates will be reset in connection with the successful
remarketings of the Debt Securities. Prior to the first
scheduled attempted remarketing of the Series C Debt
Securities, such Debt Securities will be divided into two
tranches equal in principal amount with maturity dates of
June 15, 2018 and June 15, 2023. Prior to the first
scheduled attempted remarketing of the Series E Debt
Securities, such Debt Securities will be divided into two
tranches equal in principal amount with maturity dates of
June 15, 2018 and June 15, 2045.
F-151
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Senior
Notes Other
In August 2010, in anticipation of the Acquisition, MetLife,
Inc. issued senior notes as follows:
|
|
|
|
|
$1,000 million senior notes due February 6, 2014,
which bear interest at a fixed rate of 2.375%, payable
semiannually;
|
|
|
|
$1,000 million senior notes due February 8, 2021,
which bear interest at a fixed rate of 4.75%, payable
semiannually;
|
|
|
|
$750 million senior notes due February 6, 2041, which
bear interest at a fixed rate of 5.875%, payable
semiannually; and
|
|
|
|
$250 million floating rate senior notes due August 6,
2013, which bear interest at a rate equal to three-month LIBOR,
reset quarterly, plus 1.25%, payable quarterly.
|
In connection with these offerings, MetLife, Inc. incurred
$15 million of issuance costs which have been capitalized
and included in other assets. These costs are being amortized
over the terms of the senior notes.
In May 2009, MetLife, Inc. issued $1,250 million of senior
notes due June 1, 2016. The notes bear interest at a fixed
rate of 6.75%, payable semiannually. In connection with the
offering, the Holding Company incurred $6 million of
issuance costs which have been capitalized and included in other
assets. These costs are being amortized over the term of the
notes.
In March 2009, MetLife, Inc. issued $397 million of
floating rate senior notes due June 29, 2012 under the FDIC
Program. The notes bear interest at a rate equal to three-month
LIBOR, reset quarterly, plus 0.32%. The notes are not redeemable
prior to their maturity. In connection with the offering, the
Holding Company incurred $15 million of issuance costs
which have been capitalized and included in other assets. These
costs are being amortized over the term of the notes.
In February 2009, MetLife, Inc. remarketed its existing
$1,035 million 4.91% Series B junior subordinated debt
securities as 7.717% senior debt securities, Series B,
due 2019. In August 2008, the Holding Company remarketed its
existing $1,035 million 4.82% Series A junior
subordinated debt securities as 6.817% senior debt
securities, Series A, due 2018. Interest on both series of
debt securities is payable semiannually. The Series A and
Series B junior subordinated debt securities were
originally issued in 2005 in connection with certain common
equity units. See Notes 13 and 14.
Advances
from the Federal Home Loan Bank of New York
MetLife Bank is a member of the FHLB of NY and held
$187 million and $124 million of common stock of the
FHLB of NY at December 31, 2010 and 2009, respectively,
which is included in equity securities. MetLife Bank has also
entered into advances agreements with the FHLB of NY whereby
MetLife Bank has received cash advances and under which the FHLB
of NY has been granted a blanket lien on certain of MetLife
Banks residential mortgage loans, mortgage loans
held-for-sale,
commercial mortgage loans and mortgage-backed securities to
collateralize MetLife Banks repayment obligations. Upon
any event of default by MetLife Bank, the FHLB of NYs
recovery is limited to the amount of MetLife Banks
liability under the advances agreements. The amount of MetLife
Banks liability for advances from the FHLB of NY was
$3.8 billion and $2.4 billion at December 31,
2010 and 2009, respectively, which is included in long-term debt
and short-term debt depending upon the original tenor of the
advance. During the years ended December 31, 2010, 2009 and
2008, MetLife Bank received advances related to long-term
borrowings totaling $2,103 million, $1,280 million and
$220 million, respectively, from the FHLB of NY. MetLife
Bank made repayments to the FHLB of NY of $349 million,
$497 million and $371 million related to long-term
borrowings for the years ended December 31, 2010, 2009 and
2008, respectively. The advances related to both long-term and
short-term debt were collateralized by residential mortgage
loans, mortgage loans
held-for-sale,
F-152
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
commercial mortgage loans and mortgage-backed securities with
estimated fair values of $7.8 billion and $5.5 billion
at December 31, 2010 and 2009, respectively.
Collateralized
Borrowing from the Federal Reserve Bank of New
York
MetLife Bank is a depository institution that is approved to use
the Federal Reserve Bank of New York Discount Window borrowing
privileges. In order to utilize these privileges, MetLife Bank
has pledged qualifying loans and investment securities to the
Federal Reserve Bank of New York as collateral. MetLife Bank had
no liability for advances from the Federal Reserve Bank of New
York at both December 31, 2010 and 2009. The estimated fair
value of loan and investment security collateral pledged by
MetLife Bank to the Federal Reserve Bank of New York at
December 31, 2010 and 2009 was $1.8 billion and
$1.5 billion, respectively. During the years ended
December 31, 2009 and 2008, the weighted average interest
rate on these advances was 0.26% and 0.79%, respectively. During
the year ended December 31, 2009, the average daily balance
of these advances was $1,513 million and these advances
were outstanding for an average of 24 days. There were no
such advances during the year ended December 31, 2010.
Short-term
Debt
Short-term debt with maturities of one year or less is as
follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Commercial paper
|
|
$
|
102
|
|
|
$
|
319
|
|
MetLife Bank, N.A. Advances agreements with the FHLB
of NY
|
|
|
190
|
|
|
|
585
|
|
Other
|
|
|
14
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
Total short-term debt
|
|
$
|
306
|
|
|
$
|
912
|
|
|
|
|
|
|
|
|
|
|
Average daily balance
|
|
$
|
687
|
|
|
$
|
2,845
|
|
Average days outstanding
|
|
|
21 days
|
|
|
|
16 days
|
|
During the years ended December 31, 2010, 2009 and 2008,
the weighted average interest rate on short-term debt was 0.35%,
0.42% and 2.40%, respectively.
Interest
Expense
Interest expense related to the Companys indebtedness
included in other expenses was $815 million,
$713 million and $554 million for the years ended
December 31, 2010, 2009 and 2008, respectively, and does
not include interest expense on collateral financing
arrangements, junior subordinated debt securities or common
equity units. See Notes 12, 13 and 14.
Credit
and Committed Facilities
The Company maintains unsecured credit facilities and committed
facilities, which aggregated $4.0 billion and
$12.4 billion, respectively, at December 31, 2010.
When drawn upon, these facilities bear interest at varying rates
in accordance with the respective agreements.
Credit Facilities. The unsecured credit
facilities are used for general corporate purposes, to support
the borrowers commercial paper programs and for the
issuance of letters of credit. Total fees expensed associated
with
F-153
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
these credit facilities were $17 million, $43 million
and $17 million for the years ended December 31, 2010,
2009 and 2008, respectively. Information on these credit
facilities at December 31, 2010 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Letter of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit
|
|
|
|
|
|
Unused
|
|
Borrower(s)
|
|
Expiration
|
|
Capacity
|
|
|
Issuances
|
|
|
Drawdowns
|
|
|
Commitments
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
MetLife, Inc. and MetLife Funding, Inc.
|
|
October 2011
|
|
$
|
1,000
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
1,000
|
|
MetLife, Inc. and MetLife Funding, Inc.
|
|
October 2013 (1)
|
|
|
3,000
|
|
|
|
1,507
|
|
|
|
|
|
|
|
1,493
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
$
|
4,000
|
|
|
$
|
1,507
|
|
|
$
|
|
|
|
$
|
2,493
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
All borrowings under the credit agreement must be repaid by
October 2013, except that letters of credit outstanding upon
termination may remain outstanding until October 2014. |
Committed Facilities. The committed facilities
are used for collateral for certain of the Companys
affiliated reinsurance liabilities. Total fees expensed
associated with these committed facilities were
$92 million, $55 million and $35 million for the
years ended December 31, 2010, 2009 and 2008, respectively.
Information on these committed facilities at December 31,
2010 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Letter of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit
|
|
|
|
|
|
Unused
|
|
|
Maturity
|
|
Account Party/Borrower(s)
|
|
Expiration
|
|
Capacity
|
|
|
Issuances
|
|
|
Drawdowns
|
|
|
Commitments
|
|
|
(Years)
|
|
|
|
(In millions)
|
|
|
MetLife, Inc.
|
|
August 2011
|
|
$
|
300
|
|
|
$
|
300
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
Exeter Reassurance Company Ltd., MetLife, Inc., & Missouri
Reinsurance (Barbados), Inc.
|
|
June 2016
|
|
|
500
|
|
|
|
490
|
|
|
|
|
|
|
|
10
|
|
|
|
5
|
|
MetLife Reinsurance Company of Vermont & MetLife,
Inc.
|
|
December 2020 (1)
|
|
|
350
|
|
|
|
350
|
|
|
|
|
|
|
|
|
|
|
|
10
|
|
Exeter Reassurance Company Ltd.
|
|
December 2027 (1)
|
|
|
650
|
|
|
|
535
|
|
|
|
|
|
|
|
115
|
|
|
|
17
|
|
MetLife Reinsurance Company of South Carolina &
MetLife, Inc.
|
|
June 2037
|
|
|
3,500
|
|
|
|
|
|
|
|
2,797
|
|
|
|
703
|
|
|
|
26
|
|
MetLife Reinsurance Company of Vermont & MetLife,
Inc.
|
|
December 2037 (1)
|
|
|
2,896
|
|
|
|
1,603
|
|
|
|
|
|
|
|
1,293
|
|
|
|
27
|
|
MetLife Reinsurance Company of Vermont & MetLife,
Inc.
|
|
September 2038 (1)
|
|
|
4,250
|
|
|
|
2,160
|
|
|
|
|
|
|
|
2,090
|
|
|
|
27
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total (2)
|
|
|
|
$
|
12,446
|
|
|
$
|
5,438
|
|
|
$
|
2,797
|
|
|
$
|
4,211
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Holding Company is a guarantor under this agreement. |
|
(2) |
|
See also Note 24. |
As a result of the offerings of certain senior notes (see
Senior Notes Other) and
common stock (see Note 18), the commitment letter for a
$5.0 billion senior credit facility, which the Holding
Company signed to partially finance the Acquisition, was
terminated. During March 2010, the Holding Company paid
$28 million in fees related to this senior credit facility,
all of which were expensed during the year ended
December 31, 2010. See Note 19.
F-154
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
12.
|
Collateral
Financing Arrangements
|
Associated
with the Closed Block
In December 2007, MLIC reinsured a portion of its closed block
liabilities to MRC, a wholly-owned subsidiary of the Company. In
connection with this transaction, MRC issued, to investors
placed by an unaffiliated financial institution,
$2.5 billion in aggregate principal amount of
35-year
surplus notes to provide statutory reserve support for the
assumed closed block liabilities. Interest on the surplus notes
accrues at an annual rate of
3-month
LIBOR plus 0.55%, payable quarterly. The ability of MRC to make
interest and principal payments on the surplus notes is
contingent upon South Carolina regulatory approval. At both
December 31, 2010 and 2009, the amount of the surplus notes
outstanding was $2.5 billion.
Simultaneous with the issuance of the surplus notes, the Holding
Company entered into an agreement with the unaffiliated
financial institution, under which the Holding Company is
entitled to the interest paid by MRC on the surplus notes of
3-month
LIBOR plus 0.55% in exchange for the payment of
3-month
LIBOR plus 1.12%, payable quarterly on such amount as adjusted,
as described below. The Holding Company may also be required to
pledge collateral or make payments to the unaffiliated financial
institution related to any decline in the estimated fair value
of the surplus notes. Any such payments would be accounted for
as a receivable and included in other assets on the
Companys consolidated balance sheets and would not reduce
the principal amount outstanding of the surplus notes. Such
payments would, however, reduce the amount of interest payments
due from the Holding Company under the agreement. Any payment
received from the unaffiliated financial institution would
reduce the receivable by an amount equal to such payment and
would also increase the amount of interest payments due from the
Holding Company under the agreement. In addition, the
unaffiliated financial institution may be required to pledge
collateral to the Holding Company related to any increase in the
estimated fair value of the surplus notes. During 2008, the
Holding Company paid an aggregate of $800 million to the
unaffiliated financial institution relating to declines in the
estimated fair value of the surplus notes. The Holding Company
did not receive any payments from the unaffiliated financial
institution during 2008. During 2009, on a net basis, the
Holding Company received $375 million from the unaffiliated
financial institution related to changes in the estimated fair
value of the surplus notes. No payments were made or received by
the Holding Company during 2010. Since the closing of the
collateral financing arrangement in December 2007, on a net
basis, the Holding Company has paid $425 million to the
unaffiliated financial institution related to changes in the
estimated fair value of the surplus notes. In addition, at
December 31, 2008, the Holding Company had pledged
collateral with an estimated fair value of $230 million to
the unaffiliated financial institution. At December 31,
2009, the Holding Company had no collateral pledged to the
unaffiliated financial institution in connection with this
agreement. At December 31, 2010, the Holding Company had
pledged collateral with an estimated fair value of
$49 million to the unaffiliated financial institution. The
Holding Company may also be required to make a payment to the
unaffiliated financial institution in connection with any early
termination of this agreement.
A majority of the proceeds from the offering of the surplus
notes was placed in a trust, which is consolidated by the
Company, to support MRCs statutory obligations associated
with the assumed closed block liabilities. During 2007, MRC
deposited $2.0 billion into the trust, from the proceeds of
the surplus notes issued in 2007. During 2008, MRC deposited an
additional $314 million into the trust. No amount was
deposited into the trust during 2009. During 2010, MRC
transferred $497 million out of the trust. At
December 31, 2010 and 2009, the estimated fair value of
assets held in trust by the Company was $2.0 billion and
$2.4 billion, respectively. The assets are principally
invested in fixed maturity securities and are presented as such
within the Companys consolidated balance sheets, with the
related income included within net investment income in the
Companys consolidated statements of operations. Interest
on the collateral financing arrangement is included as a
component of other expenses.
Total interest expense related to the collateral financing
arrangement was $36 million, $51 million and
$117 million for the years ended December 31, 2010,
2009 and 2008, respectively.
F-155
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Associated
with Secondary Guarantees
In May 2007, the Holding Company and MRSC, a wholly-owned
subsidiary of the Company, entered into a
30-year
collateral financing arrangement with an unaffiliated financial
institution that provides up to $3.5 billion of statutory
reserve support for MRSC associated with reinsurance obligations
under intercompany reinsurance agreements. Such statutory
reserves are associated with universal life secondary guarantees
and are required under U.S. Valuation of Life Policies
Model Regulation (commonly referred to as
Regulation A-XXX).
At both December 31, 2010 and 2009, $2.8 billion had
been drawn upon under the collateral financing arrangement. The
collateral financing arrangement may be extended by agreement of
the Holding Company and the unaffiliated financial institution
on each anniversary of the closing.
Proceeds from the collateral financing arrangement were placed
in trusts to support MRSCs statutory obligations
associated with the reinsurance of secondary guarantees. The
trusts are VIEs which are consolidated by the Company. The
unaffiliated financial institution is entitled to the return on
the investment portfolio held by the trusts. At
December 31, 2010 and 2009, the Company held assets in
trust with an estimated fair value of $3.3 billion and
$3.2 billion, respectively, associated with the collateral
financing arrangement. The assets are principally invested in
fixed maturity securities and are presented as such within the
Companys consolidated balance sheets, with the related
income included within net investment income in the
Companys consolidated statements of operations. Interest
on the collateral financing arrangement is included as a
component of other expenses.
In connection with the collateral financing arrangement, the
Holding Company entered into an agreement with the same
unaffiliated financial institution under which the Holding
Company is entitled to the return on the investment portfolio
held by the trusts established in connection with this
collateral financing arrangement in exchange for the payment of
a stated rate of return to the unaffiliated financial
institution of
3-month
LIBOR plus 0.70%, payable quarterly. The collateral financing
agreement may be extended by agreement of the Holding Company
and the unaffiliated financial institution on each anniversary
of the closing. The Holding Company may also be required to make
payments to the unaffiliated financial institution, for deposit
into the trusts, related to any decline in the estimated fair
value of the assets held by the trusts, as well as amounts
outstanding upon maturity or early termination of the collateral
financing arrangement. During 2010, no payments were made or
received by the Holding Company. During 2009 and 2008, the
Holding Company contributed $360 million and
$320 million, respectively, as a result of declines in the
estimated fair value of the assets in the trusts. Cumulatively,
since May 2007, the Holding Company has contributed a total of
$680 million as a result of declines in the estimated fair
value of the assets in the trusts, all of which was deposited
into the trusts.
In addition, the Holding Company may be required to pledge
collateral to the unaffiliated financial institution under this
agreement. At December 31, 2010 and 2009, the Holding
Company had pledged $63 million and $80 million,
respectively, under the agreement.
Transaction costs associated with the collateral financing
arrangement of $5 million have been capitalized, are
included in other assets, and are being amortized over the
period from May 2007, the date the Holding Company entered into
the collateral financing arrangement, to its expiration. Total
interest expense related to the collateral financing arrangement
was $30 million, $44 million and $107 million for
the years ended December 31, 2010, 2009 and 2008,
respectively.
F-156
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
13.
|
Junior
Subordinated Debt Securities
|
Outstanding
Junior Subordinated Debt Securities
Outstanding junior subordinated debt securities and trust
securities which MetLife, Inc. will exchange for junior
subordinated debt securities prior to redemption or repayment
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsequent to
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Scheduled
|
|
Scheduled
|
|
|
|
Carrying Value
|
|
|
|
|
|
Face
|
|
|
Interest
|
|
|
Redemption
|
|
Redemption
|
|
Final
|
|
at December 31,
|
|
Issuer
|
|
Issue Date
|
|
Value
|
|
|
Rate (2)
|
|
|
Date
|
|
Date (3)
|
|
Maturity
|
|
2010
|
|
|
2009
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
MetLife, Inc.
|
|
July 2009
|
|
$
|
500
|
|
|
|
10.750
|
%
|
|
August 2039
|
|
LIBOR + 7.548%
|
|
August 2069
|
|
$
|
500
|
|
|
$
|
500
|
|
MetLife Capital Trust X (1)
|
|
April 2008
|
|
$
|
750
|
|
|
|
9.250
|
%
|
|
April 2038
|
|
LIBOR + 5.540%
|
|
April 2068
|
|
|
750
|
|
|
|
750
|
|
MetLife Capital Trust IV (1)
|
|
December 2007
|
|
$
|
700
|
|
|
|
7.875
|
%
|
|
December 2037
|
|
LIBOR + 3.960%
|
|
December 2067
|
|
|
694
|
|
|
|
694
|
|
MetLife, Inc.
|
|
December 2006
|
|
$
|
1,250
|
|
|
|
6.400
|
%
|
|
December 2036
|
|
LIBOR + 2.205%
|
|
December 2066
|
|
|
1,247
|
|
|
|
1,247
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,191
|
|
|
$
|
3,191
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
MetLife Capital Trust X and MetLife Capital Trust IV
are VIEs which are consolidated in the financial statements of
the Company. The securities issued by these entities are
exchangeable surplus trust securities, which will be exchanged
for a like amount of the Holding Companys junior
subordinated debt securities on the scheduled redemption date;
mandatorily under certain circumstances, and at any time upon
the Holding Company exercising its option to redeem the
securities. The exchangeable surplus trust securities are
classified as junior subordinated debt securities for purposes
of financial statement presentation. |
|
(2) |
|
Prior to the scheduled redemption date, interest is payable
semiannually in arrears. |
|
(3) |
|
In the event the securities are not redeemed on or before the
scheduled redemption date, interest will accrue after such date
at an annual rate of
3-month
LIBOR plus a margin, payable quarterly in arrears. |
In connection with each of the securities described above, the
Holding Company may redeem or may cause the redemption of the
securities (i) in whole or in part, at any time on or after
the date five years prior to the scheduled redemption date at
their principal amount plus accrued and unpaid interest to, but
excluding, the date of redemption, or (ii) in certain
circumstances, in whole or in part, prior to the date five years
prior to the scheduled redemption date at their principal amount
plus accrued and unpaid interest to, but excluding, the date of
redemption or, if greater, a make-whole price. The Holding
Company also has the right to, and in certain circumstances the
requirement to, defer interest payments on the securities for a
period up to ten years. Interest compounds during such periods
of deferral. If interest is deferred for more than five
consecutive years, the Holding Company is required to use
proceeds from the sale of its common stock or warrants on common
stock to satisfy interest payment obligation. In connection with
each of the securities described above, the Holding Company
entered into a replacement capital covenant (RCC).
As part of the RCC, the Holding Company agreed that it will not
repay, redeem, or purchase the securities on or before a date
ten years prior to the final maturity date of each issuance,
unless, subject to certain limitations, it has received proceeds
during a specified period from the sale of specified replacement
securities. The RCC will terminate upon the occurrence of
certain events, including an acceleration of the securities due
to the occurrence of an event of default. The RCC is not
intended for the benefit of holders of the securities and may
not be enforced by them. The RCC is for the benefit of holders
of one or more other designated series of the Holding
Companys indebtedness (which will initially be its
5.70% senior notes due June 2035). The Holding Company also
entered into a replacement capital obligation which will
commence during the six month period prior to the scheduled
redemption date and under which the Holding Company must use
reasonable commercial efforts to raise replacement capital to
permit repayment of the securities through the issuance of
certain qualifying capital securities.
Issuance costs associated with the issuance of the securities of
$5 million and $8 million were incurred during the
years ended December 31, 2009 and 2008, respectively. These
issuance costs have been capitalized, are
F-157
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
included in other assets, and are amortized over the period from
the issuance date until the scheduled redemption date of the
respective issuances. Interest expense on outstanding junior
subordinated debt securities was $258 million,
$231 million and $186 million for the years ended
December 31, 2010, 2009 and 2008, respectively.
Junior
Subordinated Debt Securities Underlying Common Equity
Units
In June 2005, the Holding Company issued $1,067 million
4.82% Series A and $1,067 million 4.91% Series B
junior subordinated debt securities due no later than February
2039 and February 2040, respectively, for a total of
$2,134 million, in exchange for $64 million in trust
common securities of MetLife Capital Trust II
(Series A Trust) and MetLife Capital
Trust III (Series B Trust) and, together
with the Series A Trust, (the Capital Trusts),
both subsidiary trusts of MetLife, Inc., and $2,070 million
in aggregate cash proceeds from the sale by the subsidiary
trusts of trust preferred securities, constituting part of the
common equity units. The subsidiary trusts each issued
$1,035 million of trust preferred securities and
$32 million of trust common securities.
In August 2008, the Series A Trust was dissolved and
$32 million of the Series A junior subordinated debt
securities were returned to the Holding Company concurrently
with the cancellation of the $32 million of trust common
securities of the Series A Trust held by MetLife, Inc. Upon
dissolution of the Series A Trust, the remaining
$1,035 million of Series A junior subordinated debt
securities were distributed to the holders of the trust
preferred securities and such trust preferred securities were
cancelled. In connection with the remarketing transaction in
August 2008, the remaining $1,035 million of MetLife, Inc.
Series A junior subordinated debt securities were modified,
as permitted by their terms, to be 6.817% senior debt
securities, Series A, due August 2018. The Company did not
receive any proceeds from the remarketing. See also
Notes 11, 14 and 18.
In February 2009, the Series B Trust was dissolved and
$32 million of the Series B junior subordinated debt
securities were returned to the Holding Company concurrently
with the cancellation of the $32 million of trust common
securities of the Series B Trust held by MetLife, Inc. Upon
dissolution of the Series B Trust, the remaining
$1,035 million of Series B junior subordinated debt
securities were distributed to the holders of the trust
preferred securities and such trust preferred securities were
cancelled. In connection with the remarketing transaction in
February 2009, the remaining $1,035 million of MetLife,
Inc. Series B junior subordinated debt securities were
modified, as permitted by their terms, to be 7.717% senior
debt securities, Series B, due February 2019. The Company
did not receive any proceeds from the remarketing. See also
Notes 11, 14 and 18.
Interest expense on the junior subordinated debt securities
underlying the common equity units was $6 million and
$84 million for the years ended December 31, 2009 and
2008, respectively. There was no interest expense on the junior
subordinated debt securities underlying the common equity units
for the year ended December 31, 2010.
Acquisition
of ALICO
In connection with the financing of the Acquisition (see
Note 2) in November 2010, MetLife, Inc. issued to
ALICO Holdings 40.0 million Equity Units with an aggregate
stated amount at issuance of $3,000 million and an
estimated fair value of $3,189 million. Each Equity Unit
has an initial stated amount of $75 per unit and initially
consists of: (i) three Purchase Contracts, each of which
obligates the holder to purchase, on a subsequent settlement
date, a variable number of shares of MetLife, Inc. common stock,
par value $0.01 per share, for a purchase price of $25 ($75 in
the aggregate); and (ii) a
1/40
undivided beneficial ownership interest in each of three series
of Debt Securities issued by MetLife, Inc., each series of Debt
Securities having an aggregate principal amount of
$1,000 million. Distributions on the Equity Units will be
made quarterly, and will consist of contract payments on the
Purchase Contracts and interest payments on the Debt Securities,
at an aggregate annual rate of 5.00% of the stated amount at any
time. The excess of the estimated fair value of the Equity Units
over the estimated fair value of the Debt Securities (see
Note 11), after accounting for the present value of future
contract payments recorded in
F-158
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
other liabilities, results in a net decrease to additional
paid-in capital of $69 million, representing the fair value
of the Purchase Contracts discussed below.
The Equity Units, the Debt Securities and the common stock
issuable upon settlement of the Purchase Contracts are subject
to the terms of an investor rights agreement entered into among
MetLife, Inc., AIG and ALICO Holdings, which grants to ALICO
Holdings certain rights and sets forth certain agreements with
respect to ALICO Holdings ownership, voting and transfer
of the shares, including minimum holding periods, restrictions
on the number of shares ALICO Holdings can sell at one time, its
agreement to vote the common stock in the same proportion as the
common stock voted by all other holders and its agreement not to
seek control or influence the Companys management or Board
of Directors. The Equity Units are not listed on any exchange or
inter-dealer quotation system. The Equity Units have been
pledged to secure certain indemnification obligations of ALICO
Holdings under the Stock Purchase Agreement. See Note 2.
Purchase
Contracts
Settlement of the Purchase Contracts of each series will occur
upon the successful remarketing of the related series of Debt
Securities, or upon a final failed remarketing of the related
series, as described below under Debt
Securities. On each settlement date subsequent to a
successful remarketing, the holder will pay $25 per Equity Unit
and MetLife, Inc. will issue to such holder a variable number of
shares of its common stock in settlement of the applicable
Purchase Contract. The number of shares to be issued will depend
on the average of the daily volume-weighted average prices of
MetLife, Inc.s common stock during the 20 trading day
periods ending on, and including, the third day prior to the
initial scheduled settlement date for each series of Purchase
Contracts. The initially-scheduled settlement dates are
October 10, 2012 for the Series C Purchase Contracts,
September 11, 2013 for the Series D Purchase Contracts
and October 8, 2014 for the Series E Purchase
Contracts. If the average value of MetLife, Inc.s common
stock as calculated pursuant to the Stock Purchase Agreement
during the applicable 20 trading day period is less than or
equal to $35.42, as such amount may be adjusted (the
Reference Price), the number of shares to be issued
in settlement of the Purchase Contract will equal $25 divided by
the Reference Price, as calculated pursuant to the Stock
Purchase Agreement (the Maximum Settlement Rate). If
the market value of MetLife, Inc.s common stock is greater
than or equal to $44.275, as such amount may be adjusted (the
Threshold Appreciation Price), the number of shares
to be issued in settlement of the Purchase Contract will equal
$25 divided by the Threshold Appreciation Price, as so
calculated (the Minimum Settlement Rate). If the
market value of MetLife, Inc.s common stock is greater
than the Reference Price and less than the Threshold
Appreciation Price, the number of shares to be issued will equal
$25 divided by the applicable market value, as so calculated. In
the event of an unsuccessful remarketing of any series of Debt
Securities and the postponement of settlement to a later date,
the average market value used to calculate the settlement rate
for a particular series will not be recalculated, although
certain corporate events may require adjustments to the
settlement rate. After settlement of all the Purchase Contracts,
MetLife, Inc. will receive proceeds of $3,000 million and
issue between 67.8 million and 84.7 million shares of
its common stock, subject to certain adjustments. The holder of
an Equity Unit may, at its option, settle the related Purchase
Contracts before the applicable settlement date. However, upon
early settlement, the holder will receive the Minimum Settlement
Rate.
Distributions on the Purchase Contracts will be made quarterly
at an average annual rate of 3.02%. The value of the Purchase
Contracts at issuance of $247 million was calculated as the
present value of the future contract payments and was recorded
in other liabilities with an offsetting decrease in additional
paid-in capital. The other liabilities balance will be reduced
as contract payments are made. For the year ended
December 31, 2010, no contract payments were made.
Debt
Securities
The Debt Securities are senior, unsecured notes of MetLife, Inc.
which, in the aggregate, pay quarterly distributions at an
initial average annual rate of 1.98% and are included in
long-term debt (see Note 11 for further
F-159
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
discussion of terms). The Debt Securities will be initially
pledged as collateral to secure the obligations of each Equity
Unit holder under the related Purchase Contracts. Each series of
the Debt Securities will be subject to a remarketing and sold on
behalf of participating holders to investors. The proceeds of a
remarketing, net of any related fees, will be applied on behalf
of participating holders who so elect to settle any obligation
of the holder to pay cash under the related Purchase Contract on
the applicable settlement dates. The initially-scheduled
remarketing dates are October 10, 2012 for the
Series C Debt Securities, September 11, 2013 for the
Series D Debt Securities and October 8, 2014 for the
Series E Debt Securities, subject to delay if there are one
or more unsuccessful remarketings. If the initial attempted
remarketing of a series is unsuccessful, up to two additional
remarketing attempts will occur. At the remarketing date, the
remarketing agent may reset the interest rate on the Debt
Securities, subject to a reset cap for each of the first two
attempted remarketings of each series. If a remarketing is
successful, the reset rate will apply to all outstanding Debt
Securities of the applicable tranche of the remarketed series,
whether or not the holder participated in the remarketing and
will become effective on the settlement date of such
remarketing. If the first remarketing attempt with respect to a
series is unsuccessful, the applicable Purchase Contract
settlement date will be delayed for three calendar months, at
which time a second remarketing attempt will occur in connection
with settlement. If the second remarketing attempt is
unsuccessful, one additional delay may occur on the same basis.
If both additional remarketing attempts are unsuccessful, a
final failed remarketing will have occurred, and the
interest rate on such series of Debt Securities will not be
reset and the holder may put such series of Debt Securities to
MetLife, Inc. at a price equal to its principal amount plus
accrued and unpaid interest, if any, and apply the principal
amount against the holders obligations under the related
Purchase Contract.
Earnings
Per Common Share
The treasury stock method is used to determine the potential
dilution of the Purchase Contracts on earnings per common share.
There was no dilution associated with the Purchase Contracts for
the year ended December 31, 2010.
Acquisition
of The Travelers Insurance Company
In connection with financing the acquisition of The Travelers
Insurance Company on July 1, 2005, the Holding Company
distributed and sold 82.8 million 6.375% common equity
units for $2,070 million in proceeds in a registered public
offering on June 21, 2005. The common equity units
consisted of interests in trust preferred securities issued by
MetLife Capital Trusts II and III, and stock purchase
contracts issued by the Holding Company. The only assets of
MetLife Capital Trusts II and III were junior
subordinated debt securities issued by the Holding Company. The
common equity units ceased to exist upon the closing of the
remarketing of the underlying debt instruments and the
settlement of the stock purchase contracts in August 2008 and
February 2009. See Notes 13 and 18.
F-160
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The provision for income tax from continuing operations was as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
141
|
|
|
$
|
(231
|
)
|
|
$
|
(35
|
)
|
State and local
|
|
|
21
|
|
|
|
12
|
|
|
|
10
|
|
Foreign
|
|
|
203
|
|
|
|
236
|
|
|
|
623
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
365
|
|
|
|
17
|
|
|
|
598
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
670
|
|
|
|
(2,135
|
)
|
|
|
1,056
|
|
State and local
|
|
|
(7
|
)
|
|
|
26
|
|
|
|
(6
|
)
|
Foreign
|
|
|
153
|
|
|
|
77
|
|
|
|
(68
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
816
|
|
|
|
(2,032
|
)
|
|
|
982
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
$
|
1,181
|
|
|
$
|
(2,015
|
)
|
|
$
|
1,580
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The reconciliation of the income tax provision at the
U.S. statutory rate to the provision for income tax as
reported for continuing operations was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Tax provision at U.S. statutory rate
|
|
$
|
1,385
|
|
|
$
|
(1,517
|
)
|
|
$
|
1,771
|
|
Tax effect of:
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax-exempt investment income
|
|
|
(242
|
)
|
|
|
(288
|
)
|
|
|
(254
|
)
|
State and local income tax
|
|
|
9
|
|
|
|
17
|
|
|
|
2
|
|
Prior year tax
|
|
|
59
|
|
|
|
(26
|
)
|
|
|
53
|
|
Tax credits
|
|
|
(82
|
)
|
|
|
(87
|
)
|
|
|
(58
|
)
|
Foreign tax rate differential and change in valuation allowance
|
|
|
26
|
|
|
|
(118
|
)
|
|
|
65
|
|
Other, net
|
|
|
26
|
|
|
|
4
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
$
|
1,181
|
|
|
$
|
(2,015
|
)
|
|
$
|
1,580
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-161
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Deferred income tax represents the tax effect of the differences
between the book and tax basis of assets and liabilities. Net
deferred income tax assets and liabilities consisted of the
following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Deferred income tax assets:
|
|
|
|
|
|
|
|
|
Policyholder liabilities and receivables
|
|
$
|
5,169
|
|
|
$
|
3,929
|
|
Net operating loss carryforwards
|
|
|
1,400
|
|
|
|
871
|
|
Employee benefits
|
|
|
664
|
|
|
|
661
|
|
Capital loss carryforwards
|
|
|
408
|
|
|
|
551
|
|
Tax credit carryforwards
|
|
|
459
|
|
|
|
401
|
|
Net unrealized investment losses
|
|
|
|
|
|
|
816
|
|
Litigation-related and government mandated
|
|
|
227
|
|
|
|
240
|
|
Other
|
|
|
331
|
|
|
|
276
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,658
|
|
|
|
7,745
|
|
Less: Valuation allowance
|
|
|
261
|
|
|
|
217
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,397
|
|
|
|
7,528
|
|
|
|
|
|
|
|
|
|
|
Deferred income tax liabilities:
|
|
|
|
|
|
|
|
|
Investments, including derivatives
|
|
|
1,253
|
|
|
|
1,434
|
|
Intangibles
|
|
|
3,068
|
|
|
|
334
|
|
Net unrealized investment gains
|
|
|
1,490
|
|
|
|
|
|
DAC
|
|
|
4,342
|
|
|
|
4,439
|
|
Other
|
|
|
125
|
|
|
|
93
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,278
|
|
|
|
6,300
|
|
|
|
|
|
|
|
|
|
|
Net deferred income tax asset (liability)
|
|
$
|
(1,881
|
)
|
|
$
|
1,228
|
|
|
|
|
|
|
|
|
|
|
Domestic net operating loss carryforwards of $2,181 million
at December 31, 2010 will expire beginning in 2020. State
net operating loss carryforwards of $123 million at
December 31, 2010 will expire beginning in 2011. Foreign
net operating loss carryforwards of $2,132 million at
December 31, 2010 were generated in various foreign
countries with expiration periods of five years to indefinite
expiration. Domestic capital loss carryforwards of
$1,130 million at December 31, 2010 will expire
beginning in 2011. Foreign capital loss carryforwards of
$35 million at December 31, 2010 will expire beginning
in 2014. Tax credit carryforwards were $459 million at
December 31, 2010.
The Company has recorded a valuation allowance related to tax
benefits of certain state and foreign net operating and capital
loss carryforwards and certain foreign unrealized losses. The
valuation allowance reflects managements assessment, based
on available information, that it is more likely than not that
the deferred income tax asset for certain foreign net operating
and capital loss carryforwards and certain foreign unrealized
losses will not be realized. The tax benefit will be recognized
when management believes that it is more likely than not that
these deferred income tax assets are realizable. In 2010, the
Company recorded an overall increase to the deferred tax
valuation allowance of $44 million, comprised of a decrease
of $2 million related to certain foreign unrealized losses,
an increase of $18 million related to certain foreign
capital loss carryforwards, an increase of $28 million
related to certain state and foreign net operating loss
carryforwards.
The Company has not provided U.S. deferred taxes on
cumulative earnings of certain
non-U.S. affiliates
and associated companies that have been reinvested indefinitely.
These earnings relate to ongoing operations and have
F-162
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
been reinvested in active
non-U.S. business
operations. The Company does not intend to repatriate these
earnings to fund U.S. operations. Deferred taxes are
provided for earnings of
non-U.S. affiliates
and associated companies when the Company plans to remit those
earnings. At December 31, 2010, the Company has not made a
provision for U.S. taxes on approximately
$1,045 million of the excess of the amount for financial
reporting over the tax basis of investments in foreign
subsidiaries that are essentially permanent in duration. It is
not practicable to estimate the amount of deferred tax liability
related to investments in these foreign subsidiaries.
The Company files income tax returns with the U.S. federal
government and various state and local jurisdictions, as well as
foreign jurisdictions. The Company is under continuous
examination by the IRS and other tax authorities in
jurisdictions in which the Company has significant business
operations. The income tax years under examination vary by
jurisdiction. With a few exceptions, the Company is no longer
subject to U.S. federal, state and local, or foreign income
tax examinations by tax authorities for years prior to 2000. In
early 2009, the Company and the IRS completed and substantially
settled the audit years of 2000 to 2002. A few issues not
settled have been escalated to the next level, IRS Appeals. In
April 2010, the IRS exam of the current audit cycle, years 2003
to 2006 began.
The Companys liability for unrecognized tax benefits may
decrease in the next 12 months pending the outcome of
remaining issues, tax-exempt income and tax credits associated
with the 2000 to 2002 IRS audit. A reasonable estimate of the
decrease cannot be made at this time. However, the Company
continues to believe that the ultimate resolution of the issues
will not result in a material change to its consolidated
financial statements, although the resolution of income tax
matters could impact the Companys effective tax rate for a
particular future period.
The Company classifies interest accrued related to unrecognized
tax benefits in interest expense, included within other
expenses, while penalties are included in income tax expense.
At December 31, 2010, the Companys total amount of
unrecognized tax benefits was $810 million and the total
amount of unrecognized tax benefits that would affect the
effective tax rate, if recognized, was $536 million. The
total amount of unrecognized tax benefits increased by
$37 million from December 31, 2009 primarily due to
increases for tax positions of prior years offset by reductions
for tax positions of prior years and settlements reached with
the IRS. The increases for tax positions of prior years included
$169 million from the acquisition of American Life.
Settlements with tax authorities amounted to $59 million,
all of which was reclassified to current and deferred income tax
payable, as applicable, with $3 million paid in 2010.
At December 31, 2009, the Companys total amount of
unrecognized tax benefits was $773 million and the total
amount of unrecognized tax benefits that would affect the
effective tax rate, if recognized, was $583 million. The
total amount of unrecognized tax benefits increased by
$7 million from December 31, 2008 primarily due to
additions for tax positions of the current and prior years
offset by settlements reached with the IRS. Settlements with tax
authorities amounted to $46 million, of which
$44 million was reclassified to current income tax payable
and paid in 2009 and $2 million reduced current income tax
expense.
At December 31, 2008, the Companys total amount of
unrecognized tax benefits was $766 million and the total
amount of unrecognized tax benefits that would affect the
effective tax rate, if recognized, was $567 million. The
total amount of unrecognized tax benefits decreased by
$74 million from December 31, 2007 primarily due to
settlements reached with the IRS with respect to certain
significant issues involving demutualization, leasing and tax
credits offset by additions for tax positions of the current
year. As a result of the settlements, items within the liability
for unrecognized tax benefits, in the amount of
$153 million, were reclassified to current and deferred
income tax payable, as applicable, of which $20 million was
paid in 2008 and $133 million was paid in 2009.
F-163
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
A reconciliation of the beginning and ending amount of
unrecognized tax benefits was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Balance at January 1,
|
|
$
|
773
|
|
|
$
|
766
|
|
|
$
|
840
|
|
Additions for tax positions of prior years
|
|
|
186
|
|
|
|
43
|
|
|
|
11
|
|
Reductions for tax positions of prior years
|
|
|
(84
|
)
|
|
|
(33
|
)
|
|
|
(51
|
)
|
Additions for tax positions of current year
|
|
|
13
|
|
|
|
52
|
|
|
|
147
|
|
Reductions for tax positions of current year
|
|
|
(8
|
)
|
|
|
(9
|
)
|
|
|
(22
|
)
|
Settlements with tax authorities
|
|
|
(59
|
)
|
|
|
(46
|
)
|
|
|
(153
|
)
|
Lapses of statutes of limitations
|
|
|
(11
|
)
|
|
|
|
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
810
|
|
|
$
|
773
|
|
|
$
|
766
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
During the year ended December 31, 2010, the Company
recognized $39 million in interest expense associated with
the liability for unrecognized tax benefits. At
December 31, 2010, the Company had $221 million of
accrued interest associated with the liability for unrecognized
tax benefits. The $23 million increase from
December 31, 2009 in accrued interest associated with the
liability for unrecognized tax benefits resulted primarily from
an increase of $20 million from the acquisition of American
Life, along with an increase of $39 million of interest
expense and a $36 million decrease primarily resulting from
the aforementioned IRS settlements. Of the $36 million
decrease, $18 million has been reclassified to current
income tax payable, of which $2 million was paid in 2010.
The remaining $18 million reduced interest expense.
During the year ended December 31, 2009, the Company
recognized $44 million in interest expense associated with
the liability for unrecognized tax benefits. At
December 31, 2009, the Company had $198 million of
accrued interest associated with the liability for unrecognized
tax benefits. The $22 million increase from
December 31, 2008 in accrued interest associated with the
liability for unrecognized tax benefits resulted from an
increase of $44 million of interest expense and a
$22 million decrease primarily resulting from the
aforementioned IRS settlements. Of the $22 million
decrease, $20 million was reclassified to current income
tax payable and was paid in 2009. The remaining $2 million
reduced interest expense.
During the year ended December 31, 2008, the Company
recognized $37 million in interest expense associated with
the liability for unrecognized tax benefits. At
December 31, 2008, the Company had $176 million of
accrued interest associated with the liability for unrecognized
tax benefits. The $42 million decrease from
December 31, 2007 in accrued interest associated with the
liability for unrecognized tax benefits resulted from an
increase of $37 million of interest expense and a
$79 million decrease primarily resulting from the
aforementioned IRS settlements. Of the $79 million
decrease, $78 million was reclassified to current income
tax payable in 2008, with $7 million and $71 million
paid in 2008 and 2009, respectively. The remaining
$1 million reduced interest expense.
The U.S. Treasury Department and the IRS have indicated
that they intend to address through regulations the methodology
to be followed in determining the dividends received deduction
(DRD), related to variable life insurance and
annuity contracts. The DRD reduces the amount of dividend income
subject to tax and is a significant component of the difference
between the actual tax expense and expected amount determined
using the federal statutory tax rate of 35%. Any regulations
that the IRS ultimately proposes for issuance in this area will
be subject to public notice and comment, at which time insurance
companies and other interested parties will have the opportunity
to raise legal and practical questions about the content, scope
and application of such regulations. As a result, the ultimate
timing and substance of any such regulations are unknown at this
time. For the years ended December 31, 2010 and 2009, the
Company recognized an income tax benefit of $87 million and
$216 million, respectively, related to the separate account
DRD. The 2010 benefit included an expense of $57 million
related to a
F-164
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
true-up of
the 2009 tax return. The 2009 benefit included a benefit of
$33 million related to a true up of the 2008 tax return.
|
|
16.
|
Contingencies,
Commitments and Guarantees
|
Contingencies
Litigation
The Company is a defendant in a large number of litigation
matters. In some of the matters, very large
and/or
indeterminate amounts, including punitive and treble damages,
are sought. Modern pleading practice in the United States
permits considerable variation in the assertion of monetary
damages or other relief. Jurisdictions may permit claimants not
to specify the monetary damages sought or may permit claimants
to state only that the amount sought is sufficient to invoke the
jurisdiction of the trial court. In addition, jurisdictions may
permit plaintiffs to allege monetary damages in amounts well
exceeding reasonably possible verdicts in the jurisdiction for
similar matters. This variability in pleadings, together with
the actual experience of the Company in litigating or resolving
through settlement numerous claims over an extended period of
time, demonstrates to management that the monetary relief which
may be specified in a lawsuit or claim bears little relevance to
its merits or disposition value.
Due to the vagaries of litigation, the outcome of a litigation
matter and the amount or range of potential loss at particular
points in time may normally be difficult to ascertain.
Uncertainties can include how fact finders will evaluate
documentary evidence and the credibility and effectiveness of
witness testimony, and how trial and appellate courts will apply
the law in the context of the pleadings or evidence presented,
whether by motion practice, or at trial or on appeal.
Disposition valuations are also subject to the uncertainty of
how opposing parties and their counsel will themselves view the
relevant evidence and applicable law.
On a quarterly and annual basis, the Company reviews relevant
information with respect to litigation and contingencies to be
reflected in the Companys consolidated financial
statements. The review includes senior legal and financial
personnel. Estimates of possible losses or ranges of loss for
particular matters cannot in the ordinary course be made with a
reasonable degree of certainty. Liabilities are established when
it is probable that a loss has been incurred and the amount of
the loss can be reasonably estimated. Liabilities have been
established for a number of the matters noted below. It is
possible that some of the matters could require the Company to
pay damages or make other expenditures or establish accruals in
amounts that could not be estimated at December 31, 2010.
Asbestos-Related
Claims
MLIC is and has been a defendant in a large number of
asbestos-related suits filed primarily in state courts. These
suits principally allege that the plaintiff or plaintiffs
suffered personal injury resulting from exposure to asbestos and
seek both actual and punitive damages. MLIC has never engaged in
the business of manufacturing, producing, distributing or
selling asbestos or asbestos-containing products nor has MLIC
issued liability or workers compensation insurance to
companies in the business of manufacturing, producing,
distributing or selling asbestos or asbestos-containing
products. The lawsuits principally have focused on allegations
with respect to certain research, publication and other
activities of one or more of MLICs employees during the
period from the 1920s through approximately the
1950s and allege that MLIC learned or should have learned
of certain health risks posed by asbestos and, among other
things, improperly publicized or failed to disclose those health
risks. MLIC believes that it should not have legal liability in
these cases. The outcome of most asbestos litigation matters,
however, is uncertain and can be impacted by numerous variables,
including differences in legal rulings in various jurisdictions,
the nature of the alleged injury and factors unrelated to the
ultimate legal merit of the claims asserted against MLIC. MLIC
employs a number of resolution strategies to manage its asbestos
loss exposure, including seeking resolution of pending
litigation by judicial rulings and settling individual or groups
of claims or lawsuits under appropriate circumstances.
F-165
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Claims asserted against MLIC have included negligence,
intentional tort and conspiracy concerning the health risks
associated with asbestos. MLICs defenses (beyond denial of
certain factual allegations) include that: (i) MLIC owed no
duty to the plaintiffs it had no special relationship
with the plaintiffs and did not manufacture, produce, distribute
or sell the asbestos products that allegedly injured plaintiffs;
(ii) plaintiffs did not rely on any actions of MLIC;
(iii) MLICs conduct was not the cause of the
plaintiffs injuries; (iv) plaintiffs exposure
occurred after the dangers of asbestos were known; and
(v) the applicable time with respect to filing suit has
expired. During the course of the litigation, certain trial
courts have granted motions dismissing claims against MLIC,
while other trial courts have denied MLICs motions to
dismiss. There can be no assurance that MLIC will receive
favorable decisions on motions in the future. While most cases
brought to date have settled, MLIC intends to continue to defend
aggressively against claims based on asbestos exposure,
including defending claims at trials.
The approximate total number of asbestos personal injury claims
pending against MLIC as of the dates indicated, the approximate
number of new claims during the years ended on those dates and
the approximate total settlement payments made to resolve
asbestos personal injury claims at or during those years are set
forth in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions, except number of claims)
|
|
|
Asbestos personal injury claims at year end
|
|
|
68,513
|
|
|
|
68,804
|
|
|
|
74,027
|
|
Number of new claims during the year
|
|
|
5,670
|
|
|
|
3,910
|
|
|
|
5,063
|
|
Settlement payments during the year (1)
|
|
$
|
34.9
|
|
|
$
|
37.6
|
|
|
$
|
99.0
|
|
|
|
|
(1) |
|
Settlement payments represent payments made by MLIC during the
year in connection with settlements made in that year and in
prior years. Amounts do not include MLICs attorneys
fees and expenses and do not reflect amounts received from
insurance carriers. |
In 2007, MLIC received approximately 7,161 new claims, ending
the year with a total of approximately 79,717 claims, and paid
approximately $28.2 million for settlements reached in 2007
and prior years. In 2006, MLIC received approximately 7,870 new
claims, ending the year with a total of approximately 87,070
claims, and paid approximately $35.5 million for
settlements reached in 2006 and prior years. In 2005, MLIC
received approximately 18,500 new claims, ending the year with a
total of approximately 100,250 claims, and paid approximately
$74.3 million for settlements reached in 2005 and prior
years. In 2004, MLIC received approximately 23,900 new claims,
ending the year with a total of approximately 108,000 claims,
and paid approximately $85.5 million for settlements
reached in 2004 and prior years. In 2003, MLIC received
approximately 58,750 new claims, ending the year with a total of
approximately 111,700 claims, and paid approximately
$84.2 million for settlements reached in 2003 and prior
years. The number of asbestos cases that may be brought, the
aggregate amount of any liability that MLIC may incur, and the
total amount paid in settlements in any given year are uncertain
and may vary significantly from year to year.
The ability of MLIC to estimate its ultimate asbestos exposure
is subject to considerable uncertainty, and the conditions
impacting its liability can be dynamic and subject to change.
The availability of reliable data is limited and it is difficult
to predict with any certainty the numerous variables that can
affect liability estimates, including the number of future
claims, the cost to resolve claims, the disease mix and severity
of disease in pending and future claims, the impact of the
number of new claims filed in a particular jurisdiction and
variations in the law in the jurisdictions in which claims are
filed, the possible impact of tort reform efforts, the
willingness of courts to allow plaintiffs to pursue claims
against MLIC when exposure to asbestos took place after the
dangers of asbestos exposure were well known, and the impact of
any possible future adverse verdicts and their amounts.
The ability to make estimates regarding ultimate asbestos
exposure declines significantly as the estimates relate to years
further in the future. In the Companys judgment, there is
a future point after which losses cease to be probable and
reasonably estimable. It is reasonably possible that the
Companys total exposure to asbestos claims
F-166
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
may be materially greater than the asbestos liability currently
accrued and that future charges to income may be necessary.
While the potential future charges could be material in the
particular quarterly or annual periods in which they are
recorded, based on information currently known by management,
management does not believe any such charges are likely to have
a material adverse effect on the Companys financial
position.
During 1998, MLIC paid $878 million in premiums for excess
insurance policies for asbestos-related claims. The excess
insurance policies for asbestos-related claims provided for
recovery of losses up to $1.5 billion in excess of a
$400 million self-insured retention. The Companys
initial option to commute the excess insurance policies for
asbestos-related claims would have arisen at the end of 2008. On
September 29, 2008, MLIC entered into agreements commuting
the excess insurance policies at September 30, 2008. As a
result of the commutation of the policies, MLIC received cash
and securities totaling $632 million. Of this total, MLIC
received $115 million in fixed maturity securities on
September 26, 2008, $200 million in cash on
October 29, 2008, and $317 million in cash on
January 29, 2009. MLIC recognized a loss on commutation of
the policies in the amount of $35.3 million during 2008.
In the years prior to commutation, the excess insurance policies
for asbestos-related claims were subject to annual and per claim
sublimits. Amounts exceeding the sublimits during 2007, 2006 and
2005 were approximately $16 million, $8 million and
$0, respectively. Amounts were recoverable under the policies
annually with respect to claims paid during the prior calendar
year. Each asbestos-related policy contained an experience fund
and a reference fund that provided for payments to MLIC at the
commutation date if the reference fund was greater than zero at
commutation or pro rata reductions from time to time in the loss
reimbursements to MLIC if the cumulative return on the reference
fund was less than the return specified in the experience fund.
The return in the reference fund was tied to performance of the
S&P 500 Index and the Lehman Brothers Aggregate Bond Index.
A claim with respect to the prior year was made under the excess
insurance policies in each year from 2003 through 2008 for the
amounts paid with respect to asbestos litigation in excess of
the retention. The foregone loss reimbursements were
approximately $62.2 million with respect to claims for the
period of 2002 through 2007. Because the policies were commuted
at September 30, 2008, there will be no claims under the
policies or forgone loss reimbursements with respect to payments
made in 2008 and thereafter.
The Company believes adequate provision has been made in its
consolidated financial statements for all probable and
reasonably estimable losses for asbestos-related claims.
MLICs recorded asbestos liability is based on its
estimation of the following elements, as informed by the facts
presently known to it, its understanding of current law and its
past experiences: (i) the probable and reasonably estimable
liability for asbestos claims already asserted against MLIC,
including claims settled but not yet paid; (ii) the
probable and reasonably estimable liability for asbestos claims
not yet asserted against MLIC, but which MLIC believes are
reasonably probable of assertion; and (iii) the legal
defense costs associated with the foregoing claims. Significant
assumptions underlying MLICs analysis of the adequacy of
its recorded liability with respect to asbestos litigation
include: (i) the number of future claims; (ii) the
cost to resolve claims; and (iii) the cost to defend claims.
MLIC reevaluates on a quarterly and annual basis its exposure
from asbestos litigation, including studying its claims
experience, reviewing external literature regarding asbestos
claims experience in the United States, assessing relevant
trends impacting asbestos liability and considering numerous
variables that can affect its asbestos liability exposure on an
overall or per claim basis. These variables include bankruptcies
of other companies involved in asbestos litigation, legislative
and judicial developments, the number of pending claims
involving serious disease, the number of new claims filed
against it and other defendants and the jurisdictions in which
claims are pending. As previously disclosed, in 2002 MLIC
increased its recorded liability for asbestos-related claims by
$402 million from approximately $820 million to
$1,225 million. Based upon its regular reevaluation of its
exposure from asbestos litigation, MLIC has updated its
liability analysis for asbestos-related claims through
December 31, 2010.
F-167
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Regulatory
Matters
The Company receives and responds to subpoenas or other
inquiries from state regulators, including state insurance
commissioners; state attorneys general or other state
governmental authorities; federal regulators, including the SEC;
federal governmental authorities, including congressional
committees; and the Financial Industry Regulatory Authority
(FINRA) seeking a broad range of information. The
issues involved in information requests and regulatory matters
vary widely. The Company cooperates in these inquiries.
Attorneys general from 50 states and several state banking
and mortgage regulators announced a multistate joint
investigation of mortgage servicers to determine whether
inaccurate affidavits or other documents were submitted in
support of foreclosure proceedings. MetLife Bank, and
specifically its mortgage servicing department within MetLife
Home Loans, received requests for information from some of these
state attorneys general and other regulators. Also, the Acting
Comptroller of the Currency disclosed in testimony before
Congress that 14 mortgage servicing businesses affiliated with
banking organizations, including that of MetLife Bank, have been
the subject of an intra-agency confidential horizontal
examination of mortgage servicing and foreclosure
activities. The Acting Comptroller also testified that federal
banking regulators expect to issue administrative enforcement
orders to such businesses and to seek civil money penalties. The
Acting Comptrollers testimony also indicated that other
federal agencies, including the Department of Justice and the
Federal Trade Commission, were examining potential actions with
respect to such businesses. MetLife is cooperating with its
regulators in connection with their review of these matters but
cannot predict the outcome of these matters. It is possible that
additional state or federal regulators or legislative bodies may
pursue similar investigations or make related inquiries.
Management believes that the Companys financial statements
as a whole will not be materially affected by the MetLife Bank
regulatory matters.
United States of America v. EME Homer City Generation,
L.P., et al. (W.D. Pa., filed January 4,
2011). On January 4, 2011, the United States
commenced a civil action in United States District Court for the
Western District of Pennsylvania against EME Homer City
Generation L.P. (EME Homer City), Homer City OL6
LLC, and other defendants regarding the operations of the Homer
City Generating Station, an electricity generating facility.
Homer City OL6 LLC, an entity owned by MLIC, is a passive
investor with a noncontrolling interest in the electricity
generating facility, which is solely operated by the lessee, EME
Homer City. The complaint seeks injunctive relief and assessment
of civil penalties for alleged violations of the federal Clean
Air Act and Pennsylvanias State Implementation Plan. The
alleged violations were the subject of Notices of Violations
(NOVs) that the Environmental Protection Agency
(EPA) issued to EME Homer City, Homer City OL6 LLC,
and others in June 2008 and May 2010. On January 7, 2011,
the United States District Court for the Western District of
Pennsylvania granted the motion by the Pennsylvania Department
of Environmental Protection and the State of New York to
intervene in the lawsuit as additional plaintiffs. On
January 7, 2011, two plaintiffs filed a putative class
action titled Scott Jackson and Maria Jackson v. EME
Homer City Generation L.P., et. al. in the United States
District Court for the Western District of Pennsylvania on
behalf of a putative class of persons who have allegedly
incurred damage to their persons
and/or
property because of the violations alleged in the action brought
by the United States. Homer City OL6 LLC is a defendant in this
action. EME Homer City has acknowledged its obligation to
indemnify Homer City OL6 LLC for any claims relating to the NOVs.
In the Matter of Chemform, Inc. Site, Pompano Beach, Broward
County, Florida. In July 2010, the EPA advised
MLIC that it believed payments were due under two settlement
agreements, known as Administrative Orders on
Consent, that New England Mutual Life Insurance Company
(New England Mutual) signed in 1989 and 1992 with
respect to the cleanup of a Superfund site in Florida (the
Chemform Site). The EPA originally contacted MLIC
(as successor to New England Mutual) and a third party in 2001,
and advised that they owed additional
clean-up
costs for the Chemform Site. The matter was not resolved at that
time. The EPA is requesting payment of an amount under
$1 million from MLIC and a third party for past costs and
for future environmental testing costs at the Chemform Site.
Regulatory authorities in a small number of states and FINRA,
and occasionally the SEC, have had investigations or inquiries
relating to sales of individual life insurance policies or
annuities or other products
F-168
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
by MLIC, MICC, New England Life Insurance Company and GALIC, and
the four Company broker-dealers, which are MetLife Securities,
Inc. (MSI), New England Securities Corporation,
Walnut Street Securities, Inc. and Tower Square Securities, Inc.
These investigations often focus on the conduct of particular
financial services representatives and the sale of unregistered
or unsuitable products or the misuse of client assets. Over the
past several years, these and a number of investigations by
other regulatory authorities were resolved for monetary payments
and certain other relief, including restitution payments. The
Company may continue to resolve investigations in a similar
manner. The Company believes adequate provision has been made in
its consolidated financial statements for all probable and
reasonably estimable losses for these sales practices-related
investigations or inquiries.
Retained
Asset Account Matters
The New York Attorney General announced on July 29, 2010
that his office had launched a major fraud investigation into
the life insurance industry for practices related to the use of
retained asset accounts as a settlement option for death
benefits and that subpoenas requesting comprehensive data
related to retained asset accounts had been served on MetLife
and other insurance carriers. The Company received the subpoena
on July 30, 2010. The Company also has received requests
for documents and information from U.S. congressional
committees and members as well as various state regulatory
bodies, including the New York Insurance Department. It is
possible that other state and federal regulators or legislative
bodies may pursue similar investigations or make related
inquiries. Management cannot predict what effect any such
investigations might have on the Companys earnings or the
availability of the Companys retained asset account known
as the Total Control Account (TCA), but management
believes that the Companys consolidated financial
statements taken as a whole would not be materially affected.
Management believes that any allegations that information about
the TCA is not adequately disclosed or that the accounts are
fraudulent or otherwise violate state or federal laws are
without merit.
MLIC is a defendant in lawsuits related to the TCA. The lawsuits
include claims of breach of contract, breach of a common law
fiduciary duty or a quasi-fiduciary duty such as a confidential
or special relationship, or breach of a fiduciary duty under the
Employee Retirement Income Security Act of 1974
(ERISA).
Clark, et al. v. Metropolitan Life Insurance Company (D.
Nev., filed March 28, 2008). This putative
class action lawsuit alleges breach of contract and breach of a
common law fiduciary
and/or
quasi-fiduciary duty arising from use of the TCA to pay life
insurance policy death benefits. As damages, plaintiffs seek
disgorgement of the difference between the interest paid to the
account holders and the investment earnings on the assets
backing the accounts. In March 2009, the court granted in part
and denied in part MLICs motion to dismiss,
dismissing the fiduciary duty and unjust enrichment claims but
allowing a breach of contract claim and a special or
confidential relationship claim to go forward. On
September 9, 2010, the court granted MLICs motion for
summary judgment. On September 20, 2010, plaintiff filed a
Notice of Appeal to the United States Court of Appeals for the
Ninth Circuit.
Faber, et al. v. Metropolitan Life Insurance Company
(S.D.N.Y., filed December 4, 2008). This
putative class action lawsuit alleges that MLICs use of
the TCA as the settlement option under group life insurance
policies violates MLICs fiduciary duties under ERISA. As
damages, plaintiffs seek disgorgement of the difference between
the interest paid to the account holders and the investment
earnings on the assets backing the accounts. On October 23,
2009, the court granted MLICs motion to dismiss with
prejudice. On November 24, 2009, plaintiffs filed a Notice
of Appeal to the United States Court of Appeals for the Second
Circuit.
Keife, et al. v. Metropolitan Life Insurance Company (D.
Nev., filed in state court on July 30, 2010 and removed to
federal court on September 7, 2010). This putative class
action lawsuit raises a breach of contract claim arising from
MLICs use of the TCA to pay life insurance benefits under
the Federal Employees Group Life Insurance program. As
damages, plaintiffs seek disgorgement of the difference between
the interest paid to the account holders and the investment
earnings on the assets backing the accounts. In September 2010,
plaintiffs filed a motion for class certification of the breach
of contract claim, which the court has stayed. On
November 22, 2010, MLIC filed a motion to dismiss.
F-169
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Other
U.S. Litigation
Travelers Ins. Co., et al. v. Banc of America Securities
LLC (S.D.N.Y., filed December 13, 2001). On
January 6, 2009, after a jury trial, the district
court entered a judgment in favor of The Travelers Insurance
Company, now known as MICC, in the amount of approximately
$42 million in connection with securities and common law
claims against the defendant. On May 14, 2009, the district
court issued an opinion and order denying the defendants
post judgment motion seeking a judgment in its favor or, in the
alternative, a new trial. On July 20, 2010, the United
States Court of Appeals for the Second Circuit issued an order
affirming the district courts judgment in favor of MICC
and the district courts order denying defendants
post-trial motions. On October 14, 2010, the Second Circuit
issued an order denying defendants petition for rehearing
of its appeal. On October 20, 2010, the defendant paid MICC
approximately $42 million, which represents the judgment
amount due to MICC. This lawsuit is now fully resolved.
Roberts, et al. v. Tishman Speyer Properties, et al.
(Sup. Ct., N.Y. County, filed January 22, 2007). This
lawsuit was filed by a putative class of market rate tenants at
Stuyvesant Town and Peter Cooper Village against parties
including Metropolitan Tower Life Insurance Company
(MTL) and Metropolitan Insurance and Annuity
Company. Metropolitan Insurance and Annuity Company has merged
into MTL and no longer exists as a separate entity. These
tenants claim that MTL, as former owner, and the current owner
improperly deregulated apartments while receiving J-51 tax
abatements. The lawsuit seeks declaratory relief and damages for
rent overcharges. Although the tenants allege over
$200 million in damages in the complaint, MTL strongly
disputes the tenants damages amounts. In October 2009, the
New York State Court of Appeals issued an opinion denying
MTLs motion to dismiss the complaint. The lawsuit has
returned to the trial court where MTL continues to vigorously
defend against the claims. The Company believes adequate
provision has been made in its consolidated financial statements
for all probable and reasonably estimable losses for this
lawsuit. It is reasonably possible that the Companys total
exposure may be greater than the liability currently accrued and
that future charges to income may be necessary. Management
believes that the Companys financial statements as a whole
will not be materially affected by any such future charges.
Thomas, et al. v. Metropolitan Life Ins. Co., et al. (W.D.
Okla., filed January 31, 2007). A putative
class action complaint was filed against MLIC and MSI.
Plaintiffs asserted legal theories of violations of the federal
securities laws and violations of state laws with respect to the
sale of certain proprietary products by the Companys
agency distribution group. Plaintiffs sought rescission,
compensatory damages, interest, punitive damages and
attorneys fees and expenses. In August 2009, the district
court granted defendants motion for summary judgment. On
February 2, 2011, the United States Court of Appeals for
the Tenth Circuit affirmed the judgment of the district court
granting MLICs and MSIs summary judgment motion.
Sales Practices Claims. Over the past several
years, the Company has faced numerous claims, including class
action lawsuits, alleging improper marketing or sales of
individual life insurance policies, annuities, mutual funds or
other products. Some of the current cases seek substantial
damages, including punitive and treble damages and
attorneys fees. The Company continues to vigorously defend
against the claims in these matters. The Company believes
adequate provision has been made in its consolidated financial
statements for all probable and reasonably estimable losses for
sales practices matters.
International
Litigation
Sun Life Assurance Company of Canada v. Metropolitan
Life Ins. Co. (Super. Ct., Ontario, October
2006). In 2006, Sun Life Assurance Company of
Canada (Sun Life), as successor to the purchaser of
MLICs Canadian operations, filed this lawsuit in Toronto,
seeking a declaration that MLIC remains liable for market
conduct claims related to certain individual life
insurance policies sold by MLIC and that have been transferred
to Sun Life. Sun Life had asked that the court require MLIC to
indemnify Sun Life for these claims pursuant to indemnity
provisions in the sale agreement for the sale of MLICs
Canadian operations entered into in June of 1998. In January
2010, the court found that Sun Life had given timely notice of
its claim for indemnification but, because it found
F-170
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
that Sun Life had not yet incurred an indemnifiable loss,
granted MLICs motion for summary judgment. Both parties
appealed. In September 2010, Sun Life notified MLIC that a
purported class action lawsuit was filed against Sun Life in
Toronto, Kang v. Sun Life Assurance Co. (Super. Ct.,
Ontario, September 2010), alleging sales practices claims
regarding the same individual policies sold by MLIC and
transferred to Sun Life. Sun Life contends that MLIC is
obligated to indemnify Sun Life for some or all of the claims in
this lawsuit. MLIC is currently not a party to the
Kang v. Sun Life lawsuit.
Italy Fund Redemption Suspension Complaints and
Litigation. As a result of suspension of
withdrawals and diminution in value in certain funds offered
within certain unit-linked policies sold by the Italian branch
of Alico Life International, Ltd. (ALIL), a number
of policyholders invested in those funds have either commenced
or threatened litigation against ALIL, alleging
misrepresentation, inadequate disclosures and other related
claims. These policyholders contacted ALIL beginning in July
2009 alleging that the funds operated at variance to the
published prospectus and that prospectus risk disclosures were
allegedly wrong, unclear, and misleading. The limited number of
lawsuits that have been filed to date have either been resolved
or are proceeding through litigation. In March 2010, ALIL
learned that the public prosecutor in Milan had opened a formal
investigation into the actions of ALIL employees, as well as of
employees of ALILs major distributor, based upon a
policyholder complaint. The complaint filed by the policyholder
has now been withdrawn. ALIL is cooperating with the Italian and
Irish regulatory authorities, which have jurisdiction in
connection with this matter. The Stock Purchase Agreement
includes a provision pursuant to which the Holding Company and
certain related parties may seek indemnification for liabilities
in excess of an agreed upon amount arising out of certain
specified policyholder claims and governmental investigations in
connection with the above-mentioned unit-linked policies. See
also Indemnification Assets and Contingent
Consideration in Note 2.
Summary
Putative or certified class action litigation and other
litigation and claims and assessments against the Company, in
addition to those discussed previously and those otherwise
provided for in the Companys consolidated financial
statements, have arisen in the course of the Companys
business, including, but not limited to, in connection with its
activities as an insurer, mortgage lending bank, employer,
investor, investment advisor and taxpayer. Further, state
insurance regulatory authorities and other federal and state
authorities regularly make inquiries and conduct investigations
concerning the Companys compliance with applicable
insurance and other laws and regulations.
It is not possible to predict the ultimate outcome or provide
reasonable ranges of potential losses of all pending
investigations and legal proceedings. In some of the matters
referred to previously, very large
and/or
indeterminate amounts, including punitive and treble damages,
are sought. Although in light of these considerations it is
possible that an adverse outcome in certain cases could have a
material adverse effect upon the Companys financial
position, based on information currently known by the
Companys management, in its opinion, the outcomes of such
pending investigations and legal proceedings are not likely to
have such an effect. However, given the large
and/or
indeterminate amounts sought in certain of these matters and the
inherent unpredictability of litigation, it is possible that an
adverse outcome in certain matters could, from time to time,
have a material adverse effect on the Companys
consolidated net income or cash flows in particular quarterly or
annual periods.
Insolvency
Assessments
Most of the jurisdictions in which the Company is admitted to
transact business require insurers doing business within the
jurisdiction to participate in guaranty associations, which are
organized to pay contractual benefits owed pursuant to insurance
policies issued by impaired, insolvent or failed insurers. These
associations levy assessments, up to prescribed limits, on all
member insurers in a particular state on the basis of the
proportionate share of the premiums written by member insurers
in the lines of business in which the impaired, insolvent or
failed insurer engaged. Some states permit member insurers to
recover assessments paid through full or partial premium tax
F-171
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
offsets. In addition, Japan has established a Policyholder
Protection Commission as a contingency to protect policyholders
against the insolvency of life insurance companies in Japan
through assessments to companies licensed to provide life
insurance.
Assets and liabilities held for insolvency assessments were as
follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Other Assets:
|
|
|
|
|
|
|
|
|
Premium tax offset for future undiscounted assessments
|
|
$
|
55
|
|
|
$
|
54
|
|
Premium tax offsets currently available for paid assessments
|
|
|
8
|
|
|
|
9
|
|
Receivable for reimbursement of paid assessments (1)
|
|
|
6
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
69
|
|
|
$
|
67
|
|
|
|
|
|
|
|
|
|
|
Other Liabilities:
|
|
|
|
|
|
|
|
|
Insolvency assessments
|
|
$
|
94
|
|
|
$
|
86
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Company holds a receivable from the seller of a prior
acquisition in accordance with the purchase agreement. |
Assessments levied against the Company were $4 million,
$2 million and $2 million for the years ended
December 31, 2010, 2009 and 2008, respectively.
Argentina
The Argentine economic, regulatory and legal environment,
including interpretations of laws and regulations by regulators
and courts, is uncertain. Potential legal or governmental
actions related to pension reform, fiduciary responsibilities,
performance guarantees and tax rulings could adversely affect
the results of the Company.
In 2007, pension reform legislation in Argentina was enacted
which relieved the Company of its obligation to provide death
and disability policy coverages and resulted in the elimination
of related insurance liabilities. The reform reinstituted the
governments pension plan system and allowed for pension
participants to transfer their future contributions to the
government pension plan system.
Although it no longer received compensation, the Company
continued to be responsible for managing the funds of those
participants that transferred to the government system. This
change resulted in the establishment of a liability for future
servicing obligations and the elimination of the Companys
obligations under death and disability policy coverages. During
2008, the future servicing obligation was reduced by
$23 million, net of income tax, when information regarding
the level of participation in the government pension plan became
fully available.
In September 2008, the Argentine Supreme Court ruled against the
validity of the 2002 Pesification Law enacted by the Argentine
government. This ruling applied to certain social security
pension annuity contractholders that had filed a lawsuit against
the 2002 Pesification Law. The annuity contracts impacted by
this ruling, which were deemed peso denominated under the 2002
Pesification Law, are now considered to be U.S. dollar
denominated obligations of the Company. The applicable
contingent liabilities were then adjusted and refined to be
consistent with this ruling. The impact of the refinements
resulting from the change in these contingent liabilities and
the associated future policyholder benefits was an increase to
net income of $34 million, net of income tax, during the
year ended December 31, 2008.
In October 2008, the Argentine government announced its
intention to nationalize private pensions and, in December 2008,
the Argentine government nationalized the private pension system
seizing the underlying investments of participants which were
being managed by the Company. With this action, the
Companys
F-172
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
pension business in Argentina ceased to exist and the Company
eliminated certain assets and liabilities held in connection
with the pension business. Deferred acquisition costs, deferred
tax assets, and liabilities primarily the liability
for future servicing obligation referred to above
were eliminated and the Company incurred severance costs
associated with the termination of employees. The impact of the
elimination of assets and liabilities and the incurral of
severance costs was an increase to net income of
$6 million, net of income tax, during the year ended
December 31, 2008.
In March 2009, in light of market developments resulting from
the Supreme Court ruling contrary to the Pesification Law and
the implementation by the Company of a program to allow the
contractholders that had not filed a lawsuit to convert to
U.S. dollars the social security annuity contracts
denominated in pesos by the Pesification Law, the Company
further reduced the outstanding contingent liabilities by
$108 million, net of income tax, which was partially offset
by the establishment of contingent liabilities from the
implementation of the program to convert these contracts to
U.S. dollars of $13 million, net of income tax,
resulting in a decrease to net loss of $95 million, net of
income tax, for the year ended December 31, 2009.
Further governmental or legal actions are possible in Argentina.
Such actions may impact the level of existing liabilities or may
create additional obligations or benefits to the Companys
operations in Argentina. Management has made its best estimate
of its obligations based upon information currently available;
however, further governmental or legal actions could result in
changes in obligations which could materially impact the amounts
presented within the consolidated financial statements.
Commitments
Leases
In accordance with industry practice, certain of the
Companys income from lease agreements with retail tenants
are contingent upon the level of the tenants revenues.
Additionally, the Company, as lessee, has entered into various
lease and sublease agreements for office space, information
technology and other equipment. Future minimum rental and
sublease income, and minimum gross rental payments relating to
these lease agreements are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
|
|
|
Rental
|
|
Sublease
|
|
Rental
|
|
|
Income
|
|
Income
|
|
Payments
|
|
|
(In millions)
|
|
2011
|
|
$
|
444
|
|
|
$
|
18
|
|
|
$
|
366
|
|
2012
|
|
$
|
375
|
|
|
$
|
17
|
|
|
$
|
280
|
|
2013
|
|
$
|
331
|
|
|
$
|
16
|
|
|
$
|
237
|
|
2014
|
|
$
|
286
|
|
|
$
|
10
|
|
|
$
|
167
|
|
2015
|
|
$
|
236
|
|
|
$
|
6
|
|
|
$
|
136
|
|
Thereafter
|
|
$
|
724
|
|
|
$
|
44
|
|
|
$
|
965
|
|
During 2008, the Company moved certain of its operations in New
York from Long Island City, Queens to Manhattan. As a result of
this movement of operations and current market conditions, which
precluded the Companys immediate and complete sublet of
all unused space in both Long Island City and Manhattan, the
Company incurred a lease impairment charge of $38 million
which is included within other expenses in Banking,
Corporate & Other. The impairment charge was
determined based upon the present value of the gross rental
payments less sublease income discounted at a risk-adjusted rate
over the remaining lease terms which range from
15-20 years.
The Company has made assumptions with respect to the timing and
amount of future sublease income in the determination of this
impairment charge. During 2009, pending sublease deals were
impacted by the further decline of market conditions, which
resulted in an additional lease impairment charge of
$52 million. See Note 19
F-173
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
for discussion of $28 million of such charges related to
restructuring. Additional impairment charges could be incurred
should market conditions deteriorate further or last for a
period significantly longer than anticipated.
Commitments
to Fund Partnership Investments
The Company makes commitments to fund partnership investments in
the normal course of business. The amounts of these unfunded
commitments were $3.8 billion and $4.1 billion at
December 31, 2010 and 2009, respectively. The Company
anticipates that these amounts will be invested in partnerships
over the next five years.
Mortgage
Loan Commitments
The Company has issued interest rate lock commitments on certain
residential mortgage loan applications totaling
$2.5 billion and $2.7 billion at December 31,
2010 and 2009, respectively. The Company intends to sell the
majority of these originated residential mortgage loans.
Interest rate lock commitments to fund mortgage loans that will
be
held-for-sale
are considered derivatives and their estimated fair value and
notional amounts are included within interest rate forwards in
Note 4.
The Company also commits to lend funds under certain other
mortgage loan commitments that will be
held-for-investment.
The amounts of these mortgage loan commitments were
$3.8 billion and $2.2 billion at December 31,
2010 and 2009, respectively.
Commitments
to Fund Bank Credit Facilities, Bridge Loans and Private
Corporate Bond Investments
The Company commits to lend funds under bank credit facilities,
bridge loans and private corporate bond investments. The amounts
of these unfunded commitments were $2.4 billion and
$1.3 billion at December 31, 2010 and 2009,
respectively.
Guarantees
In the normal course of its business, the Company has provided
certain indemnities, guarantees and commitments to third parties
pursuant to which it may be required to make payments now or in
the future. In the context of acquisition, disposition,
investment and other transactions, the Company has provided
indemnities and guarantees, including those related to tax,
environmental and other specific liabilities and other
indemnities and guarantees that are triggered by, among other
things, breaches of representations, warranties or covenants
provided by the Company. In addition, in the normal course of
business, the Company provides indemnifications to
counterparties in contracts with triggers similar to the
foregoing, as well as for certain other liabilities, such as
third-party lawsuits. These obligations are often subject to
time limitations that vary in duration, including contractual
limitations and those that arise by operation of law, such as
applicable statutes of limitation. In some cases, the maximum
potential obligation under the indemnities and guarantees is
subject to a contractual limitation ranging from less than
$1 million to $800 million, with a cumulative maximum
of $1.6 billion, while in other cases such limitations are
not specified or applicable. Since certain of these obligations
are not subject to limitations, the Company does not believe
that it is possible to determine the maximum potential amount
that could become due under these guarantees in the future.
Management believes that it is unlikely the Company will have to
make any material payments under these indemnities, guarantees,
or commitments.
In addition, the Company indemnifies its directors and officers
as provided in its charters and by-laws. Also, the Company
indemnifies its agents for liabilities incurred as a result of
their representation of the Companys interests. Since
these indemnities are generally not subject to limitation with
respect to duration or amount, the Company does not believe that
it is possible to determine the maximum potential amount that
could become due under these indemnities in the future.
The Company has also guaranteed minimum investment returns on
certain international retirement funds in accordance with local
laws. Since these guarantees are not subject to limitation with
respect to duration or amount,
F-174
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
the Company does not believe that it is possible to determine
the maximum potential amount that could become due under these
guarantees in the future.
During the year ended December 31, 2010, the Company did
not record any additional liabilities for indemnities,
guarantees and commitments. The Companys recorded
liabilities were $5 million at both December 31, 2010
and 2009, for indemnities, guarantees and commitments.
|
|
17.
|
Employee
Benefit Plans
|
Pension
and Other Postretirement Benefit Plans
The Subsidiaries sponsor
and/or
administer various qualified and non-qualified defined benefit
pension plans and other postretirement employee benefit plans
covering employees and sales representatives who meet specified
eligibility requirements. Pension benefits are provided
utilizing either a traditional formula or cash balance formula.
The traditional formula provides benefits that are primarily
based upon years of credited service and final average earnings.
The cash balance formula primarily utilizes hypothetical or
notional accounts which credit participants with benefits equal
to a percentage of eligible pay, as well as earnings credits,
determined annually based upon the average annual rate of
interest on
30-year
U.S. Treasury securities, for each account balance. At
December 31, 2010, the majority of active participants were
accruing benefits under the cash balance formula; however,
approximately 90% of the Subsidiaries obligations result
from benefits calculated with the traditional formula. The
U.S. non-qualified pension plans provide supplemental
benefits in excess of limits applicable to a qualified plan.
The Subsidiaries also provide certain postemployment benefits
and certain postretirement medical and life insurance benefits
for retired employees. Employees of the Subsidiaries who were
hired prior to 2003 (or, in certain cases, rehired during or
after 2003) and meet age and service criteria while working
for one of the Subsidiaries may become eligible for these other
postretirement benefits, at various levels, in accordance with
the applicable plans. Virtually all retirees, or their
beneficiaries, contribute a portion of the total costs of
postretirement medical benefits. Employees hired after 2003 are
not eligible for any employer subsidy for postretirement medical
benefits.
In connection with the Acquisition, domestic American Life
employees who became employees of certain Subsidiaries
(including those who remained employees of companies acquired in
the Acquisition) were credited with service recognized by AIG
for purposes of determining eligibility under the pension plans
with respect to benefits earned under the pension plans
subsequent to the closing date of the Acquisition.
Additionally, in connection with the Acquisition, the Company
acquired certain pension plans sponsored by American Life. As of
the end of the year, these plans had liabilities of
approximately $595 million and assets of approximately
$97 million.
Measurement dates used for all of the Subsidiaries defined
benefit pension and other postretirement benefit plans
correspond with the fiscal year ends of sponsoring Subsidiaries,
which are December 31 for most Subsidiaries and November 30 for
American Life.
F-175
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Obligations,
Funded Status and Net Periodic Benefit Costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
Pension
|
|
|
Postretirement
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Change in benefit obligations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit obligations at beginning of year
|
|
$
|
6,649
|
|
|
$
|
6,041
|
|
|
$
|
1,847
|
|
|
$
|
1,632
|
|
Service costs
|
|
|
180
|
|
|
|
170
|
|
|
|
17
|
|
|
|
22
|
|
Interest costs
|
|
|
399
|
|
|
|
395
|
|
|
|
113
|
|
|
|
125
|
|
Plan participants contributions
|
|
|
|
|
|
|
|
|
|
|
34
|
|
|
|
30
|
|
Net actuarial (gains) losses
|
|
|
271
|
|
|
|
421
|
|
|
|
73
|
|
|
|
351
|
|
Acquisition, settlements and curtailments
|
|
|
639
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
Change in benefits
|
|
|
1
|
|
|
|
(6
|
)
|
|
|
(80
|
)
|
|
|
(167
|
)
|
Prescription drug subsidy
|
|
|
|
|
|
|
|
|
|
|
12
|
|
|
|
12
|
|
Benefits paid
|
|
|
(420
|
)
|
|
|
(384
|
)
|
|
|
(154
|
)
|
|
|
(158
|
)
|
Transfers
|
|
|
|
|
|
|
|
|
|
|
(17
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit obligations at end of year
|
|
|
7,719
|
|
|
|
6,649
|
|
|
|
1,845
|
|
|
|
1,847
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in plan assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at beginning of year
|
|
|
5,770
|
|
|
|
5,559
|
|
|
|
1,121
|
|
|
|
1,011
|
|
Actual return on plan assets
|
|
|
716
|
|
|
|
525
|
|
|
|
102
|
|
|
|
137
|
|
Acquisition and settlements
|
|
|
97
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan participants contributions
|
|
|
|
|
|
|
|
|
|
|
34
|
|
|
|
2
|
|
Employer contributions
|
|
|
325
|
|
|
|
70
|
|
|
|
95
|
|
|
|
4
|
|
Benefits paid
|
|
|
(420
|
)
|
|
|
(384
|
)
|
|
|
(140
|
)
|
|
|
(33
|
)
|
Transfers
|
|
|
|
|
|
|
|
|
|
|
(12
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at end of year
|
|
|
6,488
|
|
|
|
5,770
|
|
|
|
1,200
|
|
|
|
1,121
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funded status at end of year
|
|
$
|
(1,231
|
)
|
|
$
|
(879
|
)
|
|
$
|
(645
|
)
|
|
$
|
(726
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts recognized in the consolidated balance sheets consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets
|
|
$
|
112
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Other liabilities
|
|
|
(1,343
|
)
|
|
|
(879
|
)
|
|
|
(645
|
)
|
|
|
(726
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net amount recognized
|
|
$
|
(1,231
|
)
|
|
$
|
(879
|
)
|
|
$
|
(645
|
)
|
|
$
|
(726
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive (income) loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net actuarial losses
|
|
$
|
2,092
|
|
|
$
|
2,267
|
|
|
$
|
400
|
|
|
$
|
388
|
|
Prior service costs (credit)
|
|
|
20
|
|
|
|
25
|
|
|
|
(285
|
)
|
|
|
(288
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive (income) loss
|
|
|
2,112
|
|
|
|
2,292
|
|
|
|
115
|
|
|
|
100
|
|
Deferred income tax (benefit)
|
|
|
(738
|
)
|
|
|
(811
|
)
|
|
|
(40
|
)
|
|
|
(36
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive (income) loss, net of income tax
|
|
$
|
1,374
|
|
|
$
|
1,481
|
|
|
$
|
75
|
|
|
$
|
64
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-176
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The aggregate projected benefit obligation and aggregate fair
value of plan assets for the pension benefit plans were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Qualified Plans
|
|
|
Non-Qualified Plans
|
|
|
Total
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2010
|
|
|
2009
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
Aggregate fair value of plan assets
|
|
$
|
6,484
|
|
|
$
|
5,770
|
|
|
$
|
4
|
|
|
$
|
|
|
|
$
|
6,488
|
|
|
$
|
5,770
|
|
Aggregate projected benefit obligations
|
|
|
6,835
|
|
|
|
5,862
|
|
|
|
884
|
|
|
|
787
|
|
|
|
7,719
|
|
|
|
6,649
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Over (under) funded
|
|
$
|
(351
|
)
|
|
$
|
(92
|
)
|
|
$
|
(880
|
)
|
|
$
|
(787
|
)
|
|
$
|
(1,231
|
)
|
|
$
|
(879
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accumulated benefit obligations for all defined benefit
pension plans were $7,320 million and $6,321 million
at December 31, 2010 and 2009, respectively.
The aggregate pension accumulated benefit obligation and
aggregate fair value of plan assets for pension benefit plans
with accumulated benefit obligations in excess of plan assets
was as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In millions)
|
|
|
Projected benefit obligations
|
|
$
|
1,436
|
|
|
$
|
798
|
|
Accumulated benefit obligations
|
|
$
|
1,307
|
|
|
$
|
714
|
|
Fair value of plan assets
|
|
$
|
106
|
|
|
$
|
1
|
|
Information for pension and other postretirement benefit plans
with a projected benefit obligation in excess of plan assets
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
Pension
|
|
|
Postretirement
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Projected benefit obligations
|
|
$
|
1,803
|
|
|
$
|
6,580
|
|
|
$
|
1,845
|
|
|
$
|
1,847
|
|
Fair value of plan assets
|
|
$
|
461
|
|
|
$
|
5,700
|
|
|
$
|
1,200
|
|
|
$
|
1,121
|
|
Net periodic pension costs and net periodic other postretirement
benefit plan costs are comprised of the following:
|
|
|
|
i)
|
Service Costs Service costs are the increase in the
projected (expected) pension benefit obligation resulting from
benefits payable to employees of the Subsidiaries on service
rendered during the current year.
|
|
|
ii)
|
Interest Costs on the Liability Interest costs are
the time value adjustment on the projected (expected) pension
benefit obligation at the end of each year.
|
|
|
iii)
|
Settlement and Curtailment Costs The aggregate
amount of net gains (losses) recognized in net periodic benefit
costs due to settlements and curtailments. Settlements result
from actions that relieve/eliminate the plans
responsibility for benefit obligations or risks associated with
the obligations or assets used for the settlement. Curtailments
result from an event that significantly reduces/eliminates plan
participants expected years of future services or benefit
accruals.
|
|
|
iv)
|
Expected Return on Plan Assets Expected return on
plan assets is the assumed return earned by the accumulated
pension and other postretirement fund assets in a particular
year.
|
F-177
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
v)
|
Amortization of Net Actuarial Gains (Losses)
Actuarial gains and losses result from differences between the
actual experience and the expected experience on pension and
other postretirement plan assets or projected (expected) pension
benefit obligation during a particular period. These gains and
losses are accumulated and, to the extent they exceed 10% of the
greater of the PBO or the fair value of plan assets, the excess
is amortized into pension and other postretirement benefit costs
over the expected service years of the employees.
|
|
|
vi)
|
Amortization of Prior Service Costs These costs
relate to the recognition of increases or decreases in pension
and other postretirement benefit obligation due to amendments in
plans or initiation of new plans. These increases or decreases
in obligation are recognized in accumulated other comprehensive
income (loss) at the time of the amendment. These costs are then
amortized to pension and other postretirement benefit costs over
the expected service years of the employees affected by the
change.
|
The components of net periodic benefit costs and other changes
in plan assets and benefit obligations recognized in other
comprehensive income (loss) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
Pension
|
|
|
Postretirement
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
Net Periodic Benefit Costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service costs
|
|
$
|
180
|
|
|
$
|
170
|
|
|
$
|
164
|
|
|
$
|
17
|
|
|
$
|
22
|
|
|
$
|
21
|
|
Interest costs
|
|
|
399
|
|
|
|
395
|
|
|
|
379
|
|
|
|
113
|
|
|
|
125
|
|
|
|
103
|
|
Settlement and curtailment costs
|
|
|
8
|
|
|
|
17
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
Expected return on plan assets
|
|
|
(450
|
)
|
|
|
(439
|
)
|
|
|
(517
|
)
|
|
|
(79
|
)
|
|
|
(72
|
)
|
|
|
(86
|
)
|
Amortization of net actuarial (gains) losses
|
|
|
196
|
|
|
|
227
|
|
|
|
24
|
|
|
|
38
|
|
|
|
42
|
|
|
|
(1
|
)
|
Amortization of prior service costs (credit)
|
|
|
7
|
|
|
|
10
|
|
|
|
15
|
|
|
|
(83
|
)
|
|
|
(36
|
)
|
|
|
(37
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit costs
|
|
|
340
|
|
|
|
380
|
|
|
|
65
|
|
|
|
7
|
|
|
|
81
|
|
|
|
|
|
Net periodic benefit costs of subsidiary at date of disposal
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net periodic benefit costs
|
|
|
340
|
|
|
|
380
|
|
|
|
66
|
|
|
|
7
|
|
|
|
81
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Changes in Plan Assets and Benefit Obligations Recognized
in Other Comprehensive Income (Loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net actuarial (gains) losses
|
|
|
22
|
|
|
|
310
|
|
|
|
1,561
|
|
|
|
50
|
|
|
|
283
|
|
|
|
259
|
|
Prior service costs (credit)
|
|
|
1
|
|
|
|
(10
|
)
|
|
|
(19
|
)
|
|
|
(80
|
)
|
|
|
(167
|
)
|
|
|
36
|
|
Amortization of net actuarial gains (losses)
|
|
|
(196
|
)
|
|
|
(227
|
)
|
|
|
(24
|
)
|
|
|
(38
|
)
|
|
|
(42
|
)
|
|
|
1
|
|
Amortization of prior service (costs) credit
|
|
|
(7
|
)
|
|
|
(10
|
)
|
|
|
(15
|
)
|
|
|
83
|
|
|
|
36
|
|
|
|
37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total recognized in other comprehensive income (loss)
|
|
|
(180
|
)
|
|
|
63
|
|
|
|
1,503
|
|
|
|
15
|
|
|
|
110
|
|
|
|
333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total recognized in net periodic benefit costs and other
comprehensive income (loss)
|
|
$
|
160
|
|
|
$
|
443
|
|
|
$
|
1,569
|
|
|
$
|
22
|
|
|
$
|
191
|
|
|
$
|
333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2010, included within other
comprehensive income (loss) were other changes in plan assets
and benefit obligations associated with pension benefits of
($180) million and other postretirement benefits of
$15 million for an aggregate reduction in other
comprehensive income (loss) of ($165) million before income
tax and ($96) million, net of income tax.
F-178
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The estimated net actuarial (gains) losses and prior service
costs (credit) for the pension plans that will be amortized from
accumulated other comprehensive income (loss) into net periodic
benefit costs over the next year are $176 million and
$5 million, respectively.
The estimated net actuarial (gains) losses and prior service
costs (credit) for the defined benefit other postretirement
benefit plans that will be amortized from accumulated other
comprehensive income (loss) into net periodic benefit costs over
the next year are $34 million and ($108) million,
respectively.
The Medicare Modernization Act of 2003 created various subsidies
for sponsors of retiree drug programs. Two common ways of
providing subsidies were the Retiree Drug Subsidy
(RDS) and Medicare Part D Prescription Drug
Plans (PDP). From 2006 through 2010, the Company
applied for and received the RDS each year. The RDS program
provides the subsidy through cash payments made by Medicare to
the Company, resulting in smaller net claims paid by the
Company. A summary of the reduction to the APBO and the related
reduction to the components of net periodic other postretirement
benefits plan costs resulting from receipt of the RDS is
presented below. As of January 1, 2011, as a result of
changes made under the Patient Protection and Affordable Care
Act of 2010, the Company will no longer apply for the RDS.
Instead it has joined PDP and will indirectly receive Medicare
subsidies in the form of smaller gross benefit payments for
prescription drug coverage.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Cumulative reduction in other postretirement benefits
obligations:
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1,
|
|
$
|
247
|
|
|
$
|
317
|
|
|
$
|
299
|
|
Service costs
|
|
|
3
|
|
|
|
2
|
|
|
|
5
|
|
Interest costs
|
|
|
16
|
|
|
|
16
|
|
|
|
20
|
|
Net actuarial gains (losses)
|
|
|
(255
|
)
|
|
|
(76
|
)
|
|
|
3
|
|
Prescription drug subsidy
|
|
|
(11
|
)
|
|
|
(12
|
)
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
|
|
|
$
|
247
|
|
|
$
|
317
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Reduction in net periodic other postretirement benefit costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
Service costs
|
|
$
|
3
|
|
|
$
|
2
|
|
|
$
|
5
|
|
Interest costs
|
|
|
16
|
|
|
|
16
|
|
|
|
20
|
|
Amortization of net actuarial gains (losses)
|
|
|
10
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total reduction in net periodic benefit costs
|
|
$
|
29
|
|
|
$
|
29
|
|
|
$
|
25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company received subsidies of $8 million,
$12 million and $12 million for the years ended
December 31, 2010, 2009 and 2008, respectively.
F-179
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Assumptions
Assumptions used in determining benefit obligations were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
Pension
|
|
Postretirement
|
|
|
Benefits
|
|
Benefits
|
|
|
December 31,
|
|
|
2010
|
|
2009
|
|
2010
|
|
2009
|
|
Weighted average discount rate
|
|
5.80%
|
|
6.25%
|
|
5.80%
|
|
6.25%
|
Rate of compensation increase
|
|
3.5%-7.5%
|
|
2.0%-7.5%
|
|
N/A
|
|
N/A
|
Assumptions used in determining net periodic benefit costs were
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
Pension
|
|
Postretirement
|
|
|
Benefits
|
|
Benefits
|
|
|
December 31,
|
|
|
2010
|
|
2009
|
|
2008
|
|
2010
|
|
2009
|
|
2008
|
|
Weighted average discount rate
|
|
6.25%
|
|
6.60%
|
|
6.65%
|
|
6.25%
|
|
6.60%
|
|
6.65%
|
Weighted average expected rate of return on plan assets
|
|
8.00%
|
|
8.25%
|
|
8.25%
|
|
7.20%
|
|
7.36%
|
|
7.33%
|
Rate of compensation increase
|
|
3.5%-7.5%
|
|
3.5%-7.5%
|
|
3.5%-8%
|
|
N/A
|
|
N/A
|
|
N/A
|
The weighted average discount rate for most plans is determined
annually based on the yield, measured on a yield to worst basis,
of a hypothetical portfolio constructed of high quality debt
instruments available on the valuation date, which would provide
the necessary future cash flows to pay the aggregate projected
benefit obligation when due.
The weighted average expected rate of return on plan assets is
based on anticipated performance of the various asset sectors in
which the plans invest, weighted by target allocation
percentages. Anticipated future performance is based on
long-term historical returns of the plan assets by sector,
adjusted for the Subsidiaries long-term expectations on
the performance of the markets. While the precise expected
return derived using this approach will fluctuate from year to
year, the policy of most of the Subsidiaries is to hold
this long-term assumption constant as long as it remains within
reasonable tolerance from the derived rate.
The weighted average expected return on plan assets for use in
that plans valuation in 2011 is currently anticipated to
be 7.25% for pension benefits and postretirement medical
benefits and 5.25% for postretirement life benefits.
The assumed healthcare costs trend rates used in measuring the
APBO and net periodic benefit costs were as follows:
|
|
|
|
|
|
|
December 31,
|
|
|
2010
|
|
2009
|
|
Pre-and Post-Medicare eligible claims
|
|
7.8% in 2011, gradually decreasing each year until 2083 reaching
the ultimate rate of 4.4%.
|
|
8.2% in 2010, gradually decreasing each year until 2079 reaching
the ultimate rate of 4.1%.
|
F-180
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Assumed healthcare costs trend rates may have a significant
effect on the amounts reported for healthcare plans. A
one-percentage point change in assumed healthcare costs trend
rates would have the following effects:
|
|
|
|
|
|
|
|
|
|
|
One Percent
|
|
|
One Percent
|
|
|
|
Increase
|
|
|
Decrease
|
|
|
|
(In millions)
|
|
|
Effect on total of service and interest costs components
|
|
$
|
8
|
|
|
$
|
(8
|
)
|
Effect of accumulated postretirement benefit obligations
|
|
$
|
86
|
|
|
$
|
(104
|
)
|
Plan
Assets
Most Subsidiaries have issued group annuity and life insurance
contracts supporting the pension and other postretirement
benefit plans assets, which are invested primarily in separate
accounts.
The underlying assets of the separate accounts are principally
comprised of cash and cash equivalents, short-term investments,
fixed maturity and equity securities, mutual funds, real estate,
private equity investments and hedge funds investments.
The comparative presentation of the 2009 plan assets has been
realigned to conform to the 2010 presentation to disclose the
estimated fair value of the underlying assets of each separate
account at the security level.
F-181
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The pension and postretirement plan assets and liabilities
measured at estimated fair value on a recurring basis were
determined as described below. These estimated fair values and
their corresponding placement in the fair value hierarchy are
summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
Pension
|
|
|
Postretirement
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
|
Fair Value Measurements at
|
|
|
|
|
|
Fair Value Measurements at
|
|
|
|
|
|
|
Reporting Date Using
|
|
|
|
|
|
Reporting Date Using
|
|
|
|
|
|
|
Quoted
|
|
|
|
|
|
|
|
|
|
|
|
Quoted
|
|
|
|
|
|
|
|
|
|
|
|
|
Prices
|
|
|
|
|
|
|
|
|
|
|
|
Prices
|
|
|
|
|
|
|
|
|
|
|
|
|
In Active
|
|
|
|
|
|
|
|
|
|
|
|
In Active
|
|
|
|
|
|
|
|
|
|
|
|
|
Markets
|
|
|
|
|
|
|
|
|
|
|
|
Markets
|
|
|
|
|
|
|
|
|
|
|
|
|
for
|
|
|
Significant
|
|
|
|
|
|
|
|
|
for
|
|
|
Significant
|
|
|
|
|
|
|
|
|
|
Identical
|
|
|
Other
|
|
|
Significant
|
|
|
Total
|
|
|
Identical
|
|
|
Other
|
|
|
Significant
|
|
|
Total
|
|
|
|
Assets and
|
|
|
Observable
|
|
|
Unobservable
|
|
|
Estimated
|
|
|
Assets and
|
|
|
Observable
|
|
|
Unobservable
|
|
|
Estimated
|
|
|
|
Liabilities
|
|
|
Inputs
|
|
|
Inputs
|
|
|
Fair
|
|
|
Liabilities
|
|
|
Inputs
|
|
|
Inputs
|
|
|
Fair
|
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
Value
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
$
|
|
|
|
$
|
1,528
|
|
|
$
|
49
|
|
|
$
|
1,577
|
|
|
$
|
|
|
|
$
|
67
|
|
|
$
|
4
|
|
|
$
|
71
|
|
Federal agencies
|
|
|
|
|
|
|
175
|
|
|
|
|
|
|
|
175
|
|
|
|
|
|
|
|
15
|
|
|
|
|
|
|
|
15
|
|
Foreign bonds
|
|
|
1
|
|
|
|
222
|
|
|
|
4
|
|
|
|
227
|
|
|
|
|
|
|
|
19
|
|
|
|
|
|
|
|
19
|
|
Municipals
|
|
|
|
|
|
|
137
|
|
|
|
|
|
|
|
137
|
|
|
|
|
|
|
|
37
|
|
|
|
1
|
|
|
|
38
|
|
Preferred stocks
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government bonds
|
|
|
650
|
|
|
|
136
|
|
|
|
|
|
|
|
786
|
|
|
|
82
|
|
|
|
|
|
|
|
|
|
|
|
82
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
|
651
|
|
|
|
2,202
|
|
|
|
53
|
|
|
|
2,906
|
|
|
|
82
|
|
|
|
138
|
|
|
|
5
|
|
|
|
225
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock domestic
|
|
|
1,410
|
|
|
|
93
|
|
|
|
240
|
|
|
|
1,743
|
|
|
|
359
|
|
|
|
3
|
|
|
|
|
|
|
|
362
|
|
Common stock foreign
|
|
|
469
|
|
|
|
35
|
|
|
|
|
|
|
|
504
|
|
|
|
77
|
|
|
|
|
|
|
|
|
|
|
|
77
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
|
1,879
|
|
|
|
128
|
|
|
|
240
|
|
|
|
2,247
|
|
|
|
436
|
|
|
|
3
|
|
|
|
|
|
|
|
439
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market securities
|
|
|
200
|
|
|
|
100
|
|
|
|
|
|
|
|
300
|
|
|
|
1
|
|
|
|
1
|
|
|
|
|
|
|
|
2
|
|
Pass-through securities
|
|
|
|
|
|
|
321
|
|
|
|
2
|
|
|
|
323
|
|
|
|
|
|
|
|
73
|
|
|
|
6
|
|
|
|
79
|
|
Derivative securities
|
|
|
3
|
|
|
|
(5
|
)
|
|
|
11
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term investments
|
|
|
(9
|
)
|
|
|
105
|
|
|
|
|
|
|
|
96
|
|
|
|
8
|
|
|
|
443
|
|
|
|
|
|
|
|
451
|
|
Other invested assets
|
|
|
16
|
|
|
|
63
|
|
|
|
471
|
|
|
|
550
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other receivables
|
|
|
|
|
|
|
39
|
|
|
|
|
|
|
|
39
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
3
|
|
Securities receivable
|
|
|
|
|
|
|
70
|
|
|
|
|
|
|
|
70
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
2
|
|
Real estate
|
|
|
|
|
|
|
|
|
|
|
8
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
2,740
|
|
|
$
|
3,023
|
|
|
$
|
785
|
|
|
$
|
6,548
|
|
|
$
|
527
|
|
|
$
|
663
|
|
|
$
|
11
|
|
|
$
|
1,201
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities payable
|
|
$
|
|
|
|
$
|
60
|
|
|
$
|
|
|
|
$
|
60
|
|
|
$
|
|
|
|
$
|
1
|
|
|
$
|
|
|
|
$
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
|
|
|
$
|
60
|
|
|
$
|
|
|
|
$
|
60
|
|
|
$
|
|
|
|
$
|
1
|
|
|
$
|
|
|
|
$
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets and liabilities
|
|
$
|
2,740
|
|
|
$
|
2,963
|
|
|
$
|
785
|
|
|
$
|
6,488
|
|
|
$
|
527
|
|
|
$
|
662
|
|
|
$
|
11
|
|
|
$
|
1,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-182
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
|
|
|
|
Other
|
|
|
|
Pension
|
|
|
Postretirement
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
|
Fair Value Measurements at
|
|
|
|
|
|
Fair Value Measurements at
|
|
|
|
|
|
|
Reporting Date Using
|
|
|
|
|
|
Reporting Date Using
|
|
|
|
|
|
|
Quoted
|
|
|
|
|
|
|
|
|
|
|
|
Quoted
|
|
|
|
|
|
|
|
|
|
|
|
|
Prices
|
|
|
|
|
|
|
|
|
|
|
|
Prices
|
|
|
|
|
|
|
|
|
|
|
|
|
In Active
|
|
|
|
|
|
|
|
|
|
|
|
In Active
|
|
|
|
|
|
|
|
|
|
|
|
|
Markets
|
|
|
Significant
|
|
|
|
|
|
|
|
|
Markets
|
|
|
Significant
|
|
|
|
|
|
|
|
|
|
for
|
|
|
Other
|
|
|
Significant
|
|
|
Total
|
|
|
for
|
|
|
Other
|
|
|
Significant
|
|
|
Total
|
|
|
|
Identical
|
|
|
Observable
|
|
|
Unobservable
|
|
|
Estimated
|
|
|
Identical
|
|
|
Observable
|
|
|
Unobservable
|
|
|
Estimated
|
|
|
|
Assets
|
|
|
Inputs
|
|
|
Inputs
|
|
|
Fair
|
|
|
Assets
|
|
|
Inputs
|
|
|
Inputs
|
|
|
Fair
|
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
Value
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
$
|
|
|
|
$
|
1,458
|
|
|
$
|
68
|
|
|
$
|
1,526
|
|
|
$
|
|
|
|
$
|
48
|
|
|
$
|
|
|
|
$
|
48
|
|
Federal agencies
|
|
|
(41
|
)
|
|
|
140
|
|
|
|
|
|
|
|
99
|
|
|
|
|
|
|
|
30
|
|
|
|
|
|
|
|
30
|
|
Foreign bonds
|
|
|
1
|
|
|
|
195
|
|
|
|
5
|
|
|
|
201
|
|
|
|
|
|
|
|
6
|
|
|
|
|
|
|
|
6
|
|
Municipals
|
|
|
|
|
|
|
56
|
|
|
|
|
|
|
|
56
|
|
|
|
|
|
|
|
21
|
|
|
|
|
|
|
|
21
|
|
Preferred stocks
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government bonds
|
|
|
319
|
|
|
|
50
|
|
|
|
|
|
|
|
369
|
|
|
|
45
|
|
|
|
|
|
|
|
|
|
|
|
45
|
|
U.S. treasury notes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
|
279
|
|
|
|
1,901
|
|
|
|
73
|
|
|
|
2,253
|
|
|
|
57
|
|
|
|
105
|
|
|
|
|
|
|
|
162
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock domestic
|
|
|
1,565
|
|
|
|
238
|
|
|
|
241
|
|
|
|
2,044
|
|
|
|
342
|
|
|
|
6
|
|
|
|
|
|
|
|
348
|
|
Common stock foreign
|
|
|
393
|
|
|
|
|
|
|
|
|
|
|
|
393
|
|
|
|
72
|
|
|
|
|
|
|
|
|
|
|
|
72
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
|
1,958
|
|
|
|
238
|
|
|
|
241
|
|
|
|
2,437
|
|
|
|
414
|
|
|
|
6
|
|
|
|
|
|
|
|
420
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market securities
|
|
|
72
|
|
|
|
56
|
|
|
|
|
|
|
|
128
|
|
|
|
12
|
|
|
|
1
|
|
|
|
|
|
|
|
13
|
|
Pass-through securities
|
|
|
1
|
|
|
|
376
|
|
|
|
69
|
|
|
|
446
|
|
|
|
|
|
|
|
75
|
|
|
|
9
|
|
|
|
84
|
|
Derivative securities
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term investments
|
|
|
2
|
|
|
|
115
|
|
|
|
|
|
|
|
117
|
|
|
|
|
|
|
|
442
|
|
|
|
|
|
|
|
442
|
|
Other invested assets
|
|
|
13
|
|
|
|
|
|
|
|
373
|
|
|
|
386
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
2,328
|
|
|
$
|
2,686
|
|
|
$
|
756
|
|
|
$
|
5,770
|
|
|
$
|
483
|
|
|
$
|
629
|
|
|
$
|
9
|
|
|
$
|
1,121
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The pension and other postretirement benefit plan assets are
categorized into the three-level fair value hierarchy, as
defined in Note 1, based upon the priority of the inputs to
the respective valuation technique. The following summarizes the
types of assets included within the three-level fair value
hierarchy presented in the table above.
|
|
|
|
Level 1
|
This category includes investments in liquid securities, such as
cash, short-term money market and bank time deposits, expected
to mature within a year.
|
|
|
Level 2
|
This category includes certain separate accounts that are
primarily invested in liquid and readily marketable securities.
The estimated fair value of such separate account is based upon
reported NAV provided by fund managers and this value represents
the amount at which transfers into and out of the respective
separate account are effected. These separate accounts provide
reasonable levels of price transparency and can be corroborated
through observable market data.
|
Certain separate accounts are invested in investment
partnerships designated as hedge funds. The values for these
separate accounts is determined monthly based on the NAV of the
underlying hedge fund investment. Additionally, such hedge funds
generally contain lock out or other waiting period provisions
for redemption requests to be filled. While the reporting and
redemption restrictions may
F-183
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
limit the frequency of trading activity in separate accounts
invested in hedge funds, the reported NAV, and thus the
referenced value of the separate account, provides a reasonable
level of price transparency that can be corroborated through
observable market data. Directly held investments are primarily
invested in U.S. and foreign government and corporate
securities.
|
|
|
|
Level 3
|
This category includes separate accounts that are invested in
real estate and private equity investments that provide little
or no price transparency due to the infrequency with which the
underlying assets trade and generally require additional time to
liquidate in an orderly manner. Accordingly, the values for
separate accounts invested in these alternative asset classes
are based on inputs that cannot be readily derived from or
corroborated by observable market data.
|
A rollforward of all pension and other postretirement benefit
plan assets measured at estimated fair value on a recurring
basis using significant unobservable (Level 3) inputs
is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Realized/Unrealized
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gains (Losses) included in:
|
|
|
Purchases,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
Sales,
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance,
|
|
|
|
|
|
Comprehensive
|
|
|
Issuances and
|
|
|
Transfer Into
|
|
|
Transfer Out
|
|
|
Balance,
|
|
|
|
January 1,
|
|
|
Earnings
|
|
|
Income (Loss)
|
|
|
Settlements
|
|
|
Level 3
|
|
|
of Level 3
|
|
|
December 31,
|
|
|
|
(In millions)
|
|
|
Year Ended December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
$
|
68
|
|
|
$
|
|
|
|
$
|
7
|
|
|
$
|
(17
|
)
|
|
$
|
4
|
|
|
$
|
(13
|
)
|
|
$
|
49
|
|
Foreign bonds
|
|
|
5
|
|
|
|
|
|
|
|
1
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
|
73
|
|
|
|
|
|
|
|
8
|
|
|
|
(19
|
)
|
|
|
4
|
|
|
|
(13
|
)
|
|
|
53
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock domestic
|
|
|
241
|
|
|
|
|
|
|
|
(2
|
)
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
240
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
|
241
|
|
|
|
|
|
|
|
(2
|
)
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
240
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pass-through securities
|
|
|
69
|
|
|
|
(11
|
)
|
|
|
14
|
|
|
|
(71
|
)
|
|
|
2
|
|
|
|
(1
|
)
|
|
|
2
|
|
Derivative securities (1)
|
|
|
|
|
|
|
3
|
|
|
|
(3
|
)
|
|
|
(1
|
)
|
|
|
12
|
|
|
|
|
|
|
|
11
|
|
Other invested assets
|
|
|
373
|
|
|
|
78
|
|
|
|
(4
|
)
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
471
|
|
Real estate (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8
|
|
|
|
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total pension assets
|
|
$
|
756
|
|
|
$
|
70
|
|
|
$
|
13
|
|
|
$
|
(66
|
)
|
|
$
|
26
|
|
|
$
|
(14
|
)
|
|
$
|
785
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other postretirement:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
$
|
|
|
|
$
|
|
|
|
$
|
1
|
|
|
$
|
|
|
|
$
|
3
|
|
|
$
|
|
|
|
$
|
4
|
|
Municipals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pass-through securities
|
|
|
9
|
|
|
|
(4
|
)
|
|
|
1
|
|
|
|
(1
|
)
|
|
|
1
|
|
|
|
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other postretirement assets
|
|
$
|
9
|
|
|
$
|
(4
|
)
|
|
$
|
2
|
|
|
$
|
(1
|
)
|
|
$
|
5
|
|
|
$
|
|
|
|
$
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
765
|
|
|
$
|
66
|
|
|
$
|
15
|
|
|
$
|
(67
|
)
|
|
$
|
31
|
|
|
$
|
(14
|
)
|
|
$
|
796
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Derivative securities and real estate transfers into
Level 3 are due to the Acquisition and are not related to
the changes in Level 3 classification at the security level. |
F-184
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Realized/Unrealized
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gains (Losses) included in:
|
|
|
Purchases,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
Sales,
|
|
|
Transfer Into
|
|
|
|
|
|
|
Balance,
|
|
|
|
|
|
Comprehensive
|
|
|
Issuances and
|
|
|
and/or Out
|
|
|
Balance,
|
|
|
|
January 1,
|
|
|
Earnings
|
|
|
Income (Loss)
|
|
|
Settlements
|
|
|
of Level 3
|
|
|
December 31,
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
$
|
57
|
|
|
$
|
(5
|
)
|
|
$
|
21
|
|
|
$
|
(3
|
)
|
|
$
|
(2
|
)
|
|
$
|
68
|
|
Foreign bonds
|
|
|
4
|
|
|
|
(1
|
)
|
|
|
5
|
|
|
|
(3
|
)
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
|
61
|
|
|
|
(6
|
)
|
|
|
26
|
|
|
|
(6
|
)
|
|
|
(2
|
)
|
|
|
73
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock domestic
|
|
|
460
|
|
|
|
|
|
|
|
(232
|
)
|
|
|
13
|
|
|
|
|
|
|
|
241
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
|
460
|
|
|
|
|
|
|
|
(232
|
)
|
|
|
13
|
|
|
|
|
|
|
|
241
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pass-through securities
|
|
|
80
|
|
|
|
(2
|
)
|
|
|
8
|
|
|
|
(24
|
)
|
|
|
7
|
|
|
|
69
|
|
Derivative securities
|
|
|
40
|
|
|
|
36
|
|
|
|
(39
|
)
|
|
|
(37
|
)
|
|
|
|
|
|
|
|
|
Other invested assets
|
|
|
392
|
|
|
|
4
|
|
|
|
(59
|
)
|
|
|
36
|
|
|
|
|
|
|
|
373
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total pension assets
|
|
$
|
1,033
|
|
|
$
|
32
|
|
|
$
|
(296
|
)
|
|
$
|
(18
|
)
|
|
$
|
5
|
|
|
$
|
756
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other postretirement:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pass-through securities
|
|
$
|
13
|
|
|
$
|
(17
|
)
|
|
$
|
17
|
|
|
$
|
(4
|
)
|
|
$
|
|
|
|
$
|
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other postretirement assets
|
|
$
|
13
|
|
|
$
|
(17
|
)
|
|
$
|
17
|
|
|
$
|
(4
|
)
|
|
$
|
|
|
|
$
|
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
1,046
|
|
|
$
|
15
|
|
|
$
|
(279
|
)
|
|
$
|
(22
|
)
|
|
$
|
5
|
|
|
$
|
765
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The U.S. Subsidiaries provide employees with benefits under
various ERISA benefit plans. These include qualified pension
plans, postretirement medical plans and certain retiree life
insurance coverage. The assets of the Subsidiaries
qualified pension plans are held in insurance group annuity
contracts, and the vast majority of the assets of the
postretirement medical plan and backing the retiree life
coverage are held in insurance contracts. All of these contracts
are issued by Company insurance affiliates, and the assets under
the contracts are held in insurance separate accounts that have
been established by the Company. The insurance contract provider
engages investment management firms (Managers) to
serve as
sub-advisors
for the separate accounts based on the specific investment needs
and requests identified by the plan fiduciary. These Managers
have portfolio management discretion over the purchasing and
selling of securities and other investment assets pursuant to
the respective investment management agreements and guidelines
established for each insurance separate account. The assets of
the qualified pension plans and postretirement medical plans
(the Invested Plans) are well diversified across
multiple asset categories and across a number of different
Managers, with the intent of minimizing risk concentrations
within any given asset category or with any given Manager.
The Invested Plans, other than those held in participant
directed investment accounts, are managed in accordance with
investment policies consistent with the longer-term nature of
related benefit obligations and within prudent risk parameters.
Specifically, investment policies are oriented toward
(i) maximizing the Invested Plans funded status;
(ii) minimizing the volatility of the Invested Plans
funded status; (iii) generating asset returns that exceed
liability increases; and (iv) targeting rates of return in
excess of a custom benchmark and industry standards over
appropriate reference time periods. These goals are expected to
be met through identifying appropriate and
F-185
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
diversified asset classes and allocations, ensuring adequate
liquidity to pay benefits and expenses when due and controlling
the costs of administering and managing the Invested Plans
investments. Independent investment consultants are periodically
used to evaluate the investment risk of Invested Plans
assets relative to liabilities, analyze the economic and
portfolio impact of various asset allocations and management
strategies and to recommend asset allocations.
Certain foreign subsidiaries sponsor defined benefit plans that
cover employees and sales representatives who meet specified
eligibility requirements. Pension benefits are provided
utilizing either a traditional formula or cash balance formula,
similar to the U.S. plans discussed above. The investment
objectives are also similar, subject to local regulations.
Generally, these international pension plans invest directly in
high quality equity and fixed maturity securities. The assets of
the foreign pension plans are comprised of cash and cash
equivalents, equity and fixed maturity securities, real estate
and hedge fund investments.
Derivative contracts may be used to reduce investment risk, to
manage duration and to replicate the risk/return profile of an
asset or asset class. Derivatives may not be used to leverage a
portfolio in any manner, such as to magnify exposure to an
asset, asset class, interest rates or any other financial
variable. Derivatives are also prohibited for use in creating
exposures to securities, currencies, indices or any other
financial variable that are otherwise restricted.
The tables below summarize the actual weighted average
allocation by major asset class for the Invested Plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actual Allocation
|
|
|
|
Defined Benefit Plan
|
|
|
Postretirement Medical
|
|
|
Postretirement Life
|
|
|
Year Ended December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Class:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities (target range)
|
|
|
50% to 80
|
%
|
|
|
20% to 50
|
%
|
|
|
|
|
Corporate
|
|
|
24
|
%
|
|
|
9
|
%
|
|
|
|
|
Federal agency
|
|
|
3
|
|
|
|
2
|
|
|
|
|
|
Foreign bonds
|
|
|
3
|
|
|
|
3
|
|
|
|
|
|
Municipals
|
|
|
2
|
|
|
|
5
|
|
|
|
|
|
U.S. government bonds
|
|
|
12
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
|
44
|
%
|
|
|
30
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities (target range)
|
|
|
0% to 40
|
%
|
|
|
50% to 80
|
%
|
|
|
|
|
Common stock domestic
|
|
|
27
|
%
|
|
|
48
|
%
|
|
|
|
|
Common stock foreign
|
|
|
8
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
|
35
|
%
|
|
|
58
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market securities
|
|
|
5
|
%
|
|
|
|
|
|
|
|
|
Pass-through securities
|
|
|
5
|
|
|
|
10
|
|
|
|
|
|
Short-term investments
|
|
|
1
|
|
|
|
1
|
|
|
|
100
|
%
|
Other invested assets
|
|
|
8
|
|
|
|
|
|
|
|
|
|
Other receivables
|
|
|
1
|
|
|
|
1
|
|
|
|
|
|
Securities receivable
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-186
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actual Allocation
|
|
|
|
Defined Benefit Plan
|
|
|
Postretirement Medical
|
|
|
Postretirement Life
|
|
|
Year Ended December 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Class:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities (target range)
|
|
|
35% to 55%
|
|
|
|
10% to 40%
|
|
|
|
|
|
Corporate
|
|
|
26%
|
|
|
|
7%
|
|
|
|
|
|
Federal agency
|
|
|
2
|
|
|
|
4
|
|
|
|
|
|
Foreign bonds
|
|
|
4
|
|
|
|
1
|
|
|
|
|
|
Municipals
|
|
|
1
|
|
|
|
3
|
|
|
|
|
|
U.S. government bonds
|
|
|
6
|
|
|
|
7
|
|
|
|
|
|
U.S. treasury notes
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
|
39%
|
|
|
|
24%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities (target range)
|
|
|
25% to 45%
|
|
|
|
50% to 80%
|
|
|
|
|
|
Common stock domestic
|
|
|
35%
|
|
|
|
51%
|
|
|
|
|
|
Common stock foreign
|
|
|
7
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
|
42%
|
|
|
|
62%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market securities
|
|
|
2%
|
|
|
|
2%
|
|
|
|
|
|
Pass-through securities
|
|
|
8
|
|
|
|
12
|
|
|
|
|
|
Short-term investments
|
|
|
2
|
|
|
|
|
|
|
|
100
|
%
|
Other invested assets
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
100%
|
|
|
|
100%
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The target ranges in the tables above are forward-looking.
Expected
Future Contributions and Benefit Payments
It is the Subsidiaries practice to make contributions to
the qualified pension plan to comply with minimum funding
requirements of ERISA. In accordance with such practice, no
contributions were required for both of the years ended
December 31, 2010 and 2009. No contributions will be
required for 2011. The Subsidiaries made discretionary
contributions of $255 million to the qualified pension plan
during the year ended December 31, 2010. The Subsidiaries
made no discretionary contributions to the qualified pension
plan during the year ended December 31, 2009. The
Subsidiaries expect to make additional discretionary
contributions to the qualified pension plan of $175 million
in 2011.
Benefit payments due under the non-qualified pension plans are
primarily funded from the Subsidiaries general assets as
they become due under the provision of the plans. These payments
totaled $70 million and $57 million for the years
ended December 31, 2010 and 2009, respectively. These
payments are expected to be at approximately the same level in
2011.
Postretirement benefits, other than those provided under
qualified pension plans, are either: (i) not vested under
law; (ii) a non-funded obligation of the Subsidiaries; or
(iii) both. Current regulations do not require funding for
these benefits. The Subsidiaries use their general assets, net
of participants contributions, to pay postretirement
medical claims as they come due in lieu of utilizing any plan
assets. Total payments equaled $154 million and
$158 million for the years ended December 31, 2010 and
2009, respectively.
The Subsidiaries expect to make contributions of
$120 million, net of participants contributions,
towards benefit obligations (other than those under qualified
pension plans) in 2011. As noted previously, the Subsidiaries
F-187
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
no longer expect to receive the RDS under the Medicare
Modernization Act of 2003 to partially offset payment of such
benefits. Instead, the gross benefit payments that will be made
under the PDP will already reflect subsidies.
Gross benefit payments for the next ten years, which reflect
expected future service where appropriate, are expected to be as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
Pension
|
|
|
Postretirement
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
|
(In millions)
|
|
|
2011
|
|
$
|
446
|
|
|
$
|
120
|
|
2012
|
|
$
|
454
|
|
|
$
|
121
|
|
2013
|
|
$
|
463
|
|
|
$
|
122
|
|
2014
|
|
$
|
486
|
|
|
$
|
123
|
|
2015
|
|
$
|
500
|
|
|
$
|
124
|
|
2016-2020
|
|
$
|
2,789
|
|
|
$
|
631
|
|
Additional
Information
As previously discussed, most of the assets of the pension and
other postretirement benefit plans are held in group annuity and
life insurance contracts issued by the Subsidiaries. Total
revenues from these contracts recognized in the consolidated
statements of operations were $46 million, $45 million
and $42 million for the years ended December 31, 2010,
2009 and 2008, respectively, and included policy charges and net
investment income from investments backing the contracts and
administrative fees. Total investment income (loss), including
realized and unrealized gains (losses), credited to the account
balances was $767 million, $725 million and
($1,090) million for the years ended December 31,
2010, 2009 and 2008, respectively. The terms of these contracts
are consistent in all material respects with those the
Subsidiaries offer to unaffiliated parties that are similarly
situated.
Savings
and Investment Plans
The Subsidiaries sponsor savings and investment plans for
substantially all Company employees under which a portion of
employee contributions are matched. The Subsidiaries contributed
$86 million, $93 million and $70 million for the
years ended December 31, 2010, 2009 and 2008, respectively.
Preferred
Stock
There are 200,000,000 authorized shares of preferred stock, of
which 6,857,000 shares were designated for issuance of
convertible preferred stock in connection with the financing of
the Acquisition. See Convertible Preferred
Stock below.
The Holding Company has outstanding 24 million shares of
Floating Rate Non-Cumulative Preferred Stock, Series A (the
Series A preferred shares) with a
$0.01 par value per share, and a liquidation preference of
$25 per share, for aggregate proceeds of $600 million.
The Holding Company has outstanding 60 million shares of
6.50% Non-Cumulative Preferred Stock, Series B (the
Series B preferred shares), with a
$0.01 par value per share, and a liquidation preference of
$25 per share, for aggregate proceeds of $1.5 billion.
The Series A and Series B preferred shares (the
Preferred Shares) rank senior to the Convertible
Preferred Stock and the common stock with respect to dividends
and liquidation rights. Dividends on the Preferred Shares are
not cumulative. Holders of the Preferred Shares will be entitled
to receive dividend payments only when, as and if
F-188
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
declared by the Holding Companys Board of Directors or a
duly authorized committee of the Board. If dividends are
declared on the Series A preferred shares, they will be
payable quarterly, in arrears, at an annual rate of the greater
of: (i) 1.00% above
3-month
LIBOR on the related LIBOR determination date; or
(ii) 4.00%. Any dividends declared on the Series B
preferred shares will be payable quarterly, in arrears, at an
annual fixed rate of 6.50%. Accordingly, in the event that
dividends are not declared on the Preferred Shares for payment
on any dividend payment date, then those dividends will cease to
accrue and be payable. If a dividend is not declared before the
dividend payment date, the Holding Company has no obligation to
pay dividends accrued for that dividend period whether or not
dividends are declared and paid in future periods. No dividends
may, however, be paid or declared on the Holding Companys
common stock or any other securities ranking junior
to the Preferred Shares unless the full dividends
for the latest completed dividend period on all Preferred
Shares, and any parity stock, have been declared and paid or
provided for.
The Holding Company is prohibited from declaring dividends on
the Preferred Shares if it fails to meet specified capital
adequacy, net income and equity levels. In addition, under
Federal Reserve Bank of New York Board policy, the Holding
Company may not be able to pay dividends if it does not earn
sufficient operating income.
The Preferred Shares do not have voting rights except in certain
circumstances where the dividends have not been paid for an
equivalent of six or more dividend payment periods whether or
not those periods are consecutive. Under such circumstances, the
holders of the Preferred Shares have certain voting rights with
respect to members of the Board of Directors of the Holding
Company.
The Preferred Shares are not subject to any mandatory
redemption, sinking fund, retirement fund, purchase fund or
similar provisions. The Preferred Shares are redeemable at the
Holding Companys option in whole or in part, at a
redemption price of $25 per Preferred Share, plus declared and
unpaid dividends.
In December 2008, the Holding Company entered into an RCC
related to the Preferred Shares. As a part of the RCC, the
Holding Company agreed that it will not repay, redeem or
purchase the Preferred Shares on or before December 31,
2018, unless such repayment, redemption or purchase is made from
the proceeds of the issuance of certain capital securities. The
RCC is for the benefit of holders of one or more series of its
indebtedness as designated from time to time by the Holding
Company. The RCC will terminate upon the occurrence of certain
events, including the date on which there are no series of
outstanding eligible debt securities.
In connection with the offering of the Preferred Shares, the
Holding Company incurred $57 million of issuance costs
which have been recorded as a reduction of additional paid-in
capital.
F-189
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Information on the declaration, record and payment dates, as
well as per share and aggregate dividend amounts, for the
Preferred Shares is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend
|
|
|
|
|
|
|
|
Series A
|
|
|
Series A
|
|
|
Series B
|
|
|
Series B
|
|
Declaration Date
|
|
Record Date
|
|
Payment Date
|
|
Per Share
|
|
|
Aggregate
|
|
|
Per Share
|
|
|
Aggregate
|
|
|
|
|
|
|
|
(In millions, except per share data)
|
|
|
November 15, 2010
|
|
November 30, 2010
|
|
December 15, 2010
|
|
$
|
0.2527777
|
|
|
$
|
7
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
August 16, 2010
|
|
August 31, 2010
|
|
September 15, 2010
|
|
$
|
0.2555555
|
|
|
|
6
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
May 17, 2010
|
|
May 31, 2010
|
|
June 15, 2010
|
|
$
|
0.2555555
|
|
|
|
7
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
March 5, 2010
|
|
February 28, 2010
|
|
March 15, 2010
|
|
$
|
0.2500000
|
|
|
|
6
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
26
|
|
|
|
|
|
|
$
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 16, 2009
|
|
November 30, 2009
|
|
December 15, 2009
|
|
$
|
0.2527777
|
|
|
$
|
7
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
August 17, 2009
|
|
August 31, 2009
|
|
September 15, 2009
|
|
$
|
0.2555555
|
|
|
|
6
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
May 15, 2009
|
|
May 31, 2009
|
|
June 15, 2009
|
|
$
|
0.2555555
|
|
|
|
7
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
March 5, 2009
|
|
February 28, 2009
|
|
March 16, 2009
|
|
$
|
0.2500000
|
|
|
|
6
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
26
|
|
|
|
|
|
|
$
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 17, 2008
|
|
November 30, 2008
|
|
December 15, 2008
|
|
$
|
0.2527777
|
|
|
$
|
7
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
August 15, 2008
|
|
August 31, 2008
|
|
September 15, 2008
|
|
$
|
0.2555555
|
|
|
|
6
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
May 15, 2008
|
|
May 31, 2008
|
|
June 16, 2008
|
|
$
|
0.2555555
|
|
|
|
7
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
March 5, 2008
|
|
February 29, 2008
|
|
March 17, 2008
|
|
$
|
0.3785745
|
|
|
|
9
|
|
|
$
|
0.4062500
|
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
29
|
|
|
|
|
|
|
$
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Note 24 for information on subsequent dividends
declared.
Convertible
Preferred Stock
In connection with the financing of the Acquisition (see
Note 2) in November 2010, the Holding Company issued
to ALICO Holdings 6,857,000 shares of Convertible Preferred
Stock with a $0.01 par value per share, a liquidation
preference of $0.01 per share and a fair value of
$2,805 million.
The Convertible Preferred Stock will convert into
68,570,000 shares of the Holding Companys common
stock (subject to anti-dilution adjustments) upon a favorable
vote of the Holding Companys common stockholders. If the
Company (i) pays a dividend or makes another distribution
on common stock to all holders of common stock payable, in whole
or in part, in shares of common stock; (ii) subdivides or
splits the outstanding shares of common stock into a greater
number of shares; or (iii) combines or reclassifies the
outstanding shares of common stock into a smaller number of
shares, then the conversion rate will be adjusted by multiplying
the conversion rate by the number of shares of common stock
which a person who owns only one share of common stock
immediately before the record date or effective date of the
applicable event would own immediately after giving effect to
such dividend, distribution, subdivision, split, combination or
reclassification. If a favorable vote of its common stockholders
is not obtained by the first anniversary of the Acquisition
Date, then the Company must pay ALICO Holdings approximately
$300 million and use reasonable efforts to list the
preferred stock on NYSE. The Convertible Preferred Stock ranks
senior to the common stock with respect to dividends and
liquidation rights, and holders of the Convertible Preferred
Stock will be entitled to receive dividend payments only when,
as and if declared by the Holding Companys Board of
Directors. Under the terms of the Convertible Preferred Stock,
the Board will declare a dividend payment or other distribution
on the Convertible Preferred Stock on an as-converted basis at
any time and with the same terms as any dividend or other
distribution declared on MetLife, Inc.s common stock. No
distribution is payable on the Convertible Preferred Stock
unless there is a concurrent distribution on the MetLife, Inc.
common stock.
F-190
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The Convertible Preferred Stock does not have voting rights
except in certain circumstances when the Convertible Preferred
Stock is listed on the same exchange on which MetLife,
Inc.s common stock is listed, and where the dividends have
not been paid notwithstanding payment of dividends on MetLife,
Inc.s common stock for an equivalent of six or more
dividend payment periods whether or not those periods are
consecutive. Under such circumstances, the holders of the
Convertible Preferred Stock have certain voting rights with
respect to members of the Board of Directors of the Holding
Company. The Convertible Preferred Stock is not redeemable and
is not subject to any sinking fund, retirement fund, purchase
fund or similar provisions.
For purposes of the earnings per common share calculation, the
Convertible Preferred Stock is assumed converted into shares of
common stock for both basic and diluted weighted average shares.
See Note 20.
Common
Stock
Issuances
In connection with the financing of the Acquisition (see
Note 2) in November 2010, the Holding Company issued
to ALICO Holdings 78,239,712 new shares of its common stock at
$40.90 per share with a fair value of $3,200 million.
In anticipation of the Acquisition (see Note 2), in August
2010, the Holding Company issued 86,250,000 new shares of its
common stock at $42.00 per share for gross proceeds of
$3,623 million. In connection with the offering of common
stock, the Holding Company incurred $94 million of issuance
costs which have been recorded as a reduction of additional
paid-in capital.
In February 2009, the Holding Company delivered
24,343,154 shares of newly issued common stock for
$1,035 million, and in August 2008 the Holding Company
delivered 20,244,549 shares of its common stock from
treasury stock also for $1,035 million. Each issuance was
made in connection with the initial settlement of the stock
purchase contracts issued as part of the common equity units
sold in June 2005, as described in Note 14.
In October 2008, the Holding Company issued
86,250,000 shares of its common stock at a price of $26.50
per share for gross proceeds of $2,286 million. Of the
shares issued, 75,000,000 shares, with a value of
$4,040 million were issued from treasury stock for
consideration of $1,988 million. In connection with the
offering of common stock, the Holding Company incurred
$60 million of issuance costs which have been recorded as a
reduction of additional paid-in capital.
During the years ended December 31, 2010, 2009 and 2008,
332,121 shares, 861,586 shares and
2,271,188 shares of common stock were issued from treasury
stock for $18 million, $46 million and
$118 million, respectively, to satisfy various stock option
exercises and other stock-based awards. During the year ended
December 31, 2010, 2,182,174 new shares of common stock
were issued for $74 million to satisfy various stock option
exercises and other stock-based awards. There were no new shares
of common stock issued to satisfy the various stock option
exercises and other stock-based awards during both of the years
ended December 31, 2009 and 2008.
Repurchase
Programs
At January 1, 2008, the Company had $511 million
remaining under its September 2007 stock repurchase program
authorization. In both January and April 2008, the
Companys Board of Directors authorized additional
$1.0 billion common stock repurchase programs. During the
year ended December 31, 2008, the Company repurchased
19,716,418 shares under accelerated share repurchase
programs and 1,550,000 shares under open market repurchases
for $1,162 million and $88 million, respectively.
During the years ended December 31, 2010 and 2009, the
Company did not repurchase any shares. At December 31,
2010, the Company had $1,261 million remaining under its
January and April 2008 stock repurchase program authorizations.
F-191
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Under these authorizations, the Holding Company may purchase its
common stock from the MetLife Policyholder Trust, in the open
market (including pursuant to the terms of a pre-set trading
plan meeting the requirements of
Rule 10b5-1
under the Exchange Act) and in privately negotiated
transactions. Any future common stock repurchases will be
dependent upon several factors, including the Companys
capital position, its liquidity, its financial strength and
credit ratings, general market conditions and the market price
of MetLife, Inc.s common stock compared to
managements assessment of the stocks underlying
value and applicable regulatory, legal and accounting factors.
Whether or not to purchase any common stock and the size and
timing of any such purchases will be determined in the
Companys complete discretion.
Other
In September 2008, in connection with the split-off of RGA as
described in Note 2, the Holding Company received from
MetLife, Inc. stockholders 23,093,689 shares of MetLife,
Inc.s common stock with a fair market value of
$1,318 million and, in exchange, delivered
29,243,539 shares of RGA Class B common stock with a
net book value of $1,716 million resulting in a loss on
disposition, including transaction costs, of $458 million.
Dividends
The table below presents declaration, record and payment dates,
as well as per share and aggregate dividend amounts, for the
common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend
|
|
|
|
|
|
|
Per Share
|
|
Aggregate
|
|
|
|
|
|
|
(In millions, except
|
Declaration Date
|
|
Record Date
|
|
Payment Date
|
|
per share data)
|
|
October 26, 2010
|
|
November 9, 2010
|
|
December 14, 2010
|
|
$
|
0.74
|
|
|
$
|
784
|
(1)
|
October 29, 2009
|
|
November 9, 2009
|
|
December 14, 2009
|
|
$
|
0.74
|
|
|
$
|
610
|
|
October 28, 2008
|
|
November 10, 2008
|
|
December 15, 2008
|
|
$
|
0.74
|
|
|
$
|
592
|
|
|
|
|
(1) |
|
Includes dividends on Convertible Preferred Stock (see above). |
Stock-Based
Compensation Plans
Description
of Plans for Employees and Agents General
Terms
The MetLife, Inc. 2000 Stock Incentive Plan, as amended (the
2000 Stock Plan) authorized the granting of awards
to employees and agents in the form of options to buy shares of
MetLife, Inc. common stock (Stock Options) that
either qualify as incentive Stock Options under
Section 422A of the Code or are non-qualified. By
December 31, 2009 all awards under the 2000 Stock Plan had
either vested or been forfeited. No awards were made under the
2000 Stock Plan in 2010.
Under the MetLife, Inc. 2005 Stock and Incentive Compensation
Plan (the 2005 Stock Plan), awards granted to
employees and agents may be in the form of Stock Options, Stock
Appreciation Rights, Restricted Stock or Restricted Stock Units,
Performance Shares or Performance Share Units, Cash-Based Awards
and Stock-Based Awards (each as defined in the 2005 Stock Plan
with reference to MetLife, Inc. common stock).
The aggregate number of shares authorized for issuance under the
2005 Stock Plan is 68,000,000, plus those shares available but
not utilized under the 2000 Stock Plan and those shares utilized
under the 2000 Stock Plan that are recovered due to forfeiture
of Stock Options. Each share issued under the 2005 Stock Plan in
connection with a Stock Option or Stock Appreciation Right
reduces the number of shares remaining for issuance under that
plan by one, and each share issued under the 2005 Stock Plan in
connection with awards other than Stock Options or Stock
Appreciation Rights reduces the number of shares remaining for
issuance under that plan by 1.179 shares. At
December 31, 2010, the aggregate number of shares remaining
available for issuance pursuant to the 2005 Stock
F-192
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Plan was 40,477,451. Stock Option exercises and other awards
settled in shares are satisfied through the issuance of shares
held in treasury by the Company or by the issuance of new shares.
Compensation expense related to awards under the 2005 Stock Plan
is recognized based on the number of awards expected to vest,
which represents the awards granted less expected forfeitures
over the life of the award, as estimated at the date of grant.
Unless a material deviation from the assumed forfeiture rate is
observed during the term in which the awards are expensed, any
adjustment necessary to reflect differences in actual experience
is recognized in the period the award becomes payable or
exercisable.
Compensation expense related to awards under the 2005 Stock Plan
is principally related to the issuance of Stock Options,
Performance Shares and Restricted Stock Units. The majority of
the awards granted each year under the 2005 Stock Plan are made
in the first quarter of each year.
Description
of Plans for Directors General Terms
The MetLife, Inc. 2000 Directors Stock Plan, as amended
(the 2000 Directors Stock Plan) authorized the
granting of awards in the form of MetLife, Inc. common stock,
non-qualified Stock Options, or a combination of the foregoing
to non-management Directors of MetLife, Inc. As of
December 31, 2009, all awards under the 2000 Directors
Stock Plan had either vested or been forfeited. No awards were
made under the 2000 Directors Stock Plan in 2010.
Under the MetLife, Inc. 2005 Non-Management Director Stock
Compensation Plan (the 2005 Directors Stock
Plan), awards granted may be in the form of non-qualified
Stock Options, Stock Appreciation Rights, Restricted Stock or
Restricted Stock Units, or Stock-Based Awards (each as
defined in the 2005 Directors Stock Plan with reference to
MetLife, Inc. common stock) to non-management Directors of
MetLife, Inc. The number of shares authorized for issuance under
the 2005 Directors Stock Plan is 2,000,000. There were no
shares carried forward from the 2000 Directors Stock Plan
to the 2005 Directors Stock Plan. At December 31,
2010, the aggregate number of shares remaining available for
issuance pursuant to the 2005 Directors Stock Plan was
1,808,114. Stock Option exercises and other awards settled in
shares are satisfied through the issuance of shares held in
treasury by the Company or by the issuance of new shares.
Compensation expense related to awards under the
2005 Directors Plan is recognized based on the number of
shares awarded. The Stock-Based Awards granted under the
2005 Directors Plan have vested immediately. The majority
of the awards granted each year under the 2005 Directors
Stock Plan are made in the second quarter of each year.
Compensation
Expense Related to Stock-Based Compensation
The components of compensation expense related to stock-based
compensation, excluding the insignificant compensation expense
related to the 2005 Directors Stock Plan, is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Stock Options
|
|
$
|
45
|
|
|
$
|
55
|
|
|
$
|
51
|
|
Performance Shares (1)
|
|
|
29
|
|
|
|
11
|
|
|
|
70
|
|
Restricted Stock Units
|
|
|
10
|
|
|
|
3
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total compensation expenses related to the Incentive Plans
|
|
$
|
84
|
|
|
$
|
69
|
|
|
$
|
123
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax benefits
|
|
$
|
29
|
|
|
$
|
24
|
|
|
$
|
43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Performance Shares expected to vest and the related compensation
expenses may be further adjusted by the performance factor most
likely to be achieved, as estimated by management, at the end of
the performance period. |
F-193
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following table presents the total unrecognized compensation
expense related to stock-based compensation and the expected
weighted average period over which these expenses will be
recognized at:
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
|
Weighted Average
|
|
|
Expense
|
|
Period
|
|
|
(In millions)
|
|
(Years)
|
|
Stock Options
|
|
$
|
39
|
|
|
|
1.73
|
|
Performance Shares
|
|
$
|
30
|
|
|
|
1.74
|
|
Restricted Stock Units
|
|
$
|
14
|
|
|
|
1.87
|
|
Stock
Options
Stock Options are the contingent right of award holders to
purchase shares of MetLife, Inc. common stock at a stated price
for a limited time. All Stock Options have an exercise price
equal to the closing price of MetLife, Inc. common stock
reported on the NYSE on the date of grant, and have a maximum
term of ten years. The vast majority of Stock Options granted
have become or will become exercisable at a rate of one-third of
each award on each of the first three anniversaries of the grant
date. Other Stock Options have become or will become exercisable
on the third anniversary of the grant date. Vesting is subject
to continued service, except for employees who are retirement
eligible and in certain other limited circumstances.
A summary of the activity related to Stock Options for the year
ended December 31, 2010 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining
|
|
|
Aggregate
|
|
|
|
Shares Under
|
|
|
Weighted Average
|
|
|
Contractual
|
|
|
Intrinsic
|
|
|
|
Option
|
|
|
Exercise Price
|
|
|
Term
|
|
|
Value (1)
|
|
|
|
|
|
|
|
|
|
(Years)
|
|
|
(In millions)
|
|
|
Outstanding at January 1, 2010
|
|
|
30,152,405
|
|
|
$
|
38.51
|
|
|
|
5.50
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted (2)
|
|
|
4,683,144
|
|
|
$
|
35.06
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(1,742,003
|
)
|
|
$
|
29.74
|
|
|
|
|
|
|
|
|
|
Expired
|
|
|
(154,947
|
)
|
|
$
|
47.78
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
(236,268
|
)
|
|
$
|
34.64
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2010
|
|
|
32,702,331
|
|
|
$
|
38.47
|
|
|
|
5.30
|
|
|
$
|
195
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate number of stock options expected to vest at
December 31, 2010
|
|
|
31,930,964
|
|
|
$
|
38.62
|
|
|
|
5.21
|
|
|
$
|
186
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31, 2010
|
|
|
23,405,998
|
|
|
$
|
40.43
|
|
|
|
4.00
|
|
|
$
|
94
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The aggregate intrinsic value was computed using the closing
share price on December 31, 2010 of $44.44 and
December 31, 2009 of $35.35, as applicable. |
|
(2) |
|
The total fair value on the date of the grant was
$53 million. |
The fair value of Stock Options is estimated on the date of
grant using a binomial lattice model. Significant assumptions
used in the Companys binomial lattice model, which are
further described below, include: expected volatility of the
price of MetLife, Inc. common stock; risk-free rate of return;
expected dividend yield on MetLife, Inc. common stock; exercise
multiple; and the post-vesting termination rate.
Expected volatility is based upon an analysis of historical
prices of MetLife, Inc. common stock and call options on that
common stock traded on the open market. The Company uses a
weighted-average of the implied volatility for publicly-traded
call options with the longest remaining maturity nearest to the
money as of each
F-194
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
valuation date and the historical volatility, calculated using
monthly closing prices of MetLife, Inc.s common stock. The
Company chose a monthly measurement interval for historical
volatility as it believes this better depicts the nature of
employee option exercise decisions being based on longer-term
trends in the price of the underlying shares rather than on
daily price movements.
The binomial lattice model used by the Company incorporates
different risk-free rates based on the imputed forward rates for
U.S. Treasury Strips for each year over the contractual
term of the option. The table below presents the full range of
rates that were used for options granted during the respective
periods.
Dividend yield is determined based on historical dividend
distributions compared to the price of the underlying common
stock as of the valuation date and held constant over the life
of the Stock Option.
The binomial lattice model used by the Company incorporates the
contractual term of the Stock Options and then factors in
expected exercise behavior and a post-vesting termination rate,
or the rate at which vested options are exercised or expire
prematurely due to termination of employment, to derive an
expected life. Exercise behavior in the binomial lattice model
used by the Company is expressed using an exercise multiple,
which reflects the ratio of exercise price to the strike price
of Stock Options granted at which holders of the Stock Options
are expected to exercise. The exercise multiple is derived from
actual historical exercise activity. The post-vesting
termination rate is determined from actual historical exercise
experience and expiration activity under the Incentive Plans.
The following table presents the weighted average assumptions,
with the exception of risk-free rate, which is expressed as a
range, used to determine the fair value of Stock Options issued:
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2010
|
|
2009
|
|
2008
|
|
Dividend yield
|
|
2.11%
|
|
3.15%
|
|
1.21%
|
Risk-free rate of return
|
|
0.35%-5.88%
|
|
0.73%-6.67%
|
|
1.91%-7.21%
|
Expected volatility
|
|
34.41%
|
|
44.39%
|
|
24.85%
|
Exercise multiple
|
|
1.75
|
|
1.76
|
|
1.73
|
Post-vesting termination rate
|
|
3.64%
|
|
3.70%
|
|
3.05%
|
Contractual term (years)
|
|
10
|
|
10
|
|
10
|
Expected life (years)
|
|
7
|
|
6
|
|
6
|
Weighted average exercise price of stock options granted
|
|
$35.06
|
|
$23.61
|
|
$59.48
|
Weighted average fair value of stock options granted
|
|
$11.29
|
|
$8.37
|
|
$17.51
|
The following table presents a summary of Stock Option exercise
activity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2010
|
|
2009
|
|
2008
|
|
|
(In millions)
|
|
Total intrinsic value of stock options exercised
|
|
$
|
22
|
|
|
$
|
1
|
|
|
$
|
36
|
|
Cash received from exercise of stock options
|
|
$
|
52
|
|
|
$
|
8
|
|
|
$
|
45
|
|
Tax benefit realized from stock options exercised
|
|
$
|
8
|
|
|
$
|
|
|
|
$
|
13
|
|
Performance
Shares
Performance Shares are units that, if they vest, are multiplied
by a performance factor to produce a number of final Performance
Shares which are payable in shares of MetLife, Inc. common
stock. Performance Shares are accounted for as equity awards,
but are not credited with dividend-equivalents for actual
dividends paid on MetLife, Inc. common stock during the
performance period. Accordingly, the estimated fair value of
Performance Shares is based upon the closing price of MetLife,
Inc. common stock on the date of grant, reduced by the present
value of estimated dividends to be paid on that stock during the
performance period.
F-195
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Performance Share awards normally vest in their entirety at the
end of the three-year performance period. Vesting is subject to
continued service, except for employees who are retirement
eligible and in certain other limited circumstances. Vested
Performance Shares are multiplied by a performance factor of 0.0
to 2.0 based largely on MetLife, Inc.s performance in
change in annual net operating earnings and total shareholder
return over the applicable three-year performance period
compared to the performance of its competitors. A performance
factor of 0.94 was applied for the January 1,
2007 December 31, 2009 performance period.
The following table presents a summary of Performance Share
activity for the year ended December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
Performance
|
|
|
Grant Date
|
|
|
|
Shares
|
|
|
Fair Value
|
|
|
Outstanding at January 1, 2010
|
|
|
3,493,435
|
|
|
$
|
38.43
|
|
Granted (1)
|
|
|
1,528,065
|
|
|
$
|
32.24
|
|
Forfeited
|
|
|
(58,176
|
)
|
|
$
|
30.06
|
|
Payable (2)
|
|
|
(807,750
|
)
|
|
$
|
60.83
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2010
|
|
|
4,155,574
|
|
|
$
|
31.91
|
|
|
|
|
|
|
|
|
|
|
Performance Shares expected to vest at December 31, 2010
|
|
|
3,972,769
|
|
|
$
|
33.40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The total fair value on the date of the grant was
$49 million. |
|
(2) |
|
Includes both shares paid and shares deferred for later payment. |
Performance Share amounts above represent aggregate initial
target awards and do not reflect potential increases or
decreases resulting from the performance factor determined after
the end of the respective performance periods. At
December 31, 2010, the three year performance period for
the 2008 Performance Share grants was completed, but the
performance factor has not yet been calculated. Included in the
immediately preceding table are 824,825 outstanding Performance
Shares to which the performance factor will be applied.
Restricted
Stock Units
Restricted Stock Units are units that, if they vest, are payable
in shares of MetLife, Inc. common stock. Restricted Stock Units
are accounted for as equity awards, but are not credited with
dividend-equivalents for actual dividends paid on MetLife, Inc.
common stock during the performance period. Accordingly, the
estimated fair value of Restricted Stock Units is based upon the
closing price of MetLife, Inc. common stock on the date of
grant, reduced by the present value of estimated dividends to be
paid on that stock during the performance period.
The vast majority of Restricted Stock Units normally vest in
their entirety on the third anniversary of their grant date.
Other Restricted Stock Units normally vest in their entirety on
the fifth anniversary of their grant date. Vesting is subject to
continued service, except for employees who are retirement
eligible and in certain other limited circumstances.
F-196
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following table presents a summary of Restricted Stock Unit
activity for the year ended December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
Restricted Stock
|
|
|
Grant Date
|
|
|
|
Units
|
|
|
Fair Value
|
|
|
Outstanding at January 1, 2010
|
|
|
393,362
|
|
|
$
|
28.05
|
|
Granted (1)
|
|
|
607,200
|
|
|
$
|
32.32
|
|
Forfeited
|
|
|
(31,275
|
)
|
|
$
|
27.31
|
|
Payable (2)
|
|
|
(32,115
|
)
|
|
$
|
63.32
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2010
|
|
|
937,172
|
|
|
$
|
29.63
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Units expected to vest at December 31, 2010
|
|
|
937,172
|
|
|
$
|
29.63
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The total fair value on the date of the grant was
$20 million. |
|
(2) |
|
Includes both shares paid and shares deferred for later payment. |
Statutory
Equity and Income
Except for American Life, each insurance companys state of
domicile imposes minimum risk-based capital (RBC)
requirements that were developed by the NAIC. The formulas for
determining the amount of RBC specify various weighting factors
that are applied to financial balances or various levels of
activity based on the perceived degree of risk. Regulatory
compliance is determined by a ratio of total adjusted capital,
as defined by the NAIC, to authorized control level RBC, as
defined by the NAIC. Companies below specific trigger points or
ratios are classified within certain levels, each of which
requires specified corrective action. Each of the Holding
Companys U.S. insurance subsidiaries exceeded the
minimum RBC requirements for all periods presented herein.
American Life does not write business in Delaware or any other
domestic state and, as such, is exempt from RBC by Delaware law.
American Life operations are regulated by applicable authorities
of the countries in which the company operates and are subject
to capital and solvency requirements in those countries.
The NAIC has adopted the Codification of Statutory Accounting
Principles (Statutory Codification). Statutory
Codification is intended to standardize regulatory accounting
and reporting to state insurance departments. However, statutory
accounting principles continue to be established by individual
state laws and permitted practices. The New York Insurance
Department (the Department) has adopted Statutory
Codification with certain modifications for the preparation of
statutory financial statements of insurance companies domiciled
in New York. Modifications by the various state insurance
departments may impact the effect of Statutory Codification on
the statutory capital and surplus of the Holding Companys
U.S. insurance subsidiaries.
Statutory accounting principles differ from GAAP primarily by
charging policy acquisition costs to expense as incurred,
establishing future policy benefit liabilities using different
actuarial assumptions, reporting surplus notes as surplus
instead of debt and valuing securities on a different basis.
In addition, certain assets are not admitted under statutory
accounting principles and are charged directly to surplus. The
most significant assets not admitted by the Company are net
deferred income tax assets resulting from temporary differences
between statutory accounting principles basis and tax basis not
expected to reverse and become recoverable within three years.
Further, statutory accounting principles do not give recognition
to purchase accounting adjustments.
Statutory net income (loss) of MLIC, a New York domiciled
insurer, was $2,066 million, $1,221 million and
($338) million for the years ended December 31, 2010,
2009 and 2008, respectively. Statutory capital and surplus, to
be filed with the Department, was $13.2 billion and
$12.6 billion at December 31, 2010 and 2009,
respectively.
F-197
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Statutory net income of American Life, a Delaware domiciled
insurer, of approximately $800 million will be reported in
the Statutory Annual Statement for the year ended
December 31, 2010. Statutory capital and surplus, to be
filed with the Delaware Insurance Department was approximately
$4.0 billion at December 31, 2010.
Statutory net income of MICC, a Connecticut domiciled insurer,
was $668 million, $81 million and $242 million
for the years ended December 31, 2010, 2009 and 2008,
respectively. Statutory capital and surplus, to be filed with
the Connecticut Insurance Department, was $5.1 billion and
$4.9 billion at December 31, 2010 and 2009,
respectively.
Statutory net income of Metropolitan Property and Casualty
Insurance Company (MPC), a Rhode Island domiciled
insurer, was $273 million, $266 million and
$308 million for the years ended December 31, 2010,
2009 and 2008, respectively. Statutory capital and surplus, to
be filed with the Insurance Department of Rhode Island, was
$1.8 billion at both December 31, 2010 and 2009.
Statutory net income of MTL, a Delaware domiciled insurer, was
$151 million, $57 million and $212 million for
the years ended December 31, 2010, 2009 and 2008,
respectively. Statutory capital and surplus, to be filed with
the Delaware Insurance Department was $805 million and
$867 million at December 31, 2010 and 2009,
respectively.
Dividend
Restrictions
The table below sets forth the dividends permitted to be paid by
the respective insurance subsidiary without insurance regulatory
approval and the respective dividends paid:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2011
|
|
|
2010
|
|
|
2009
|
|
|
|
Permitted w/o
|
|
|
|
|
|
Permitted w/o
|
|
|
|
|
|
Permitted w/o
|
|
Company
|
|
Approval (1)
|
|
|
Paid (2)
|
|
|
Approval (3)
|
|
|
Paid (2)
|
|
|
Approval (3)
|
|
|
|
(In millions)
|
|
|
Metropolitan Life Insurance Company
|
|
$
|
1,321
|
|
|
$
|
631
|
(4)
|
|
$
|
1,262
|
|
|
$
|
|
|
|
$
|
552
|
|
American Life Insurance Company (5)
|
|
$
|
661
|
|
|
$
|
|
|
|
$
|
511
|
|
|
|
N/A
|
|
|
|
N/A
|
|
MetLife Insurance Company of Connecticut
|
|
$
|
517
|
|
|
$
|
330
|
|
|
$
|
659
|
|
|
$
|
|
|
|
$
|
714
|
|
Metropolitan Property and Casualty Insurance Company
|
|
$
|
|
|
|
$
|
260
|
|
|
$
|
|
|
|
$
|
300
|
|
|
$
|
9
|
|
Metropolitan Tower Life Insurance Company
|
|
$
|
80
|
|
|
$
|
569
|
(6)
|
|
$
|
93
|
|
|
$
|
|
|
|
$
|
88
|
|
|
|
|
(1) |
|
Reflects dividend amounts that may be paid during 2011 without
prior regulatory approval. However, because dividend tests may
be based on dividends previously paid over rolling
12-month
periods, if paid before a specified date during 2011, some or
all of such dividends may require regulatory approval. |
|
(2) |
|
All amounts paid, including those requiring regulatory approval. |
|
(3) |
|
Reflects dividend amounts that could have been paid during the
relevant year without prior regulatory approval. |
|
(4) |
|
Includes securities transferred to the Holding Company of
$399 million. |
|
(5) |
|
Reflects approximate dividends permitted to be paid and the
respective dividends paid since the Acquisition Date. See
Note 2. |
|
(6) |
|
Includes shares of an affiliate distributed to the Holding
Company as an in-kind dividend of $475 million. |
In addition to the amounts presented in the table above, for the
years ended December 31, 2010 and 2009, cash dividends in
the aggregate amount of $0 and $215 million, respectively,
were paid to the Holding Company.
Under New York State Insurance Law, MLIC is permitted, without
prior insurance regulatory clearance, to pay stockholder
dividends to the Holding Company as long as the aggregate amount
of all such dividends in any calendar year does not exceed the
lesser of: (i) 10% of its surplus to policyholders as of
the end of the immediately
F-198
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
preceding calendar year; or (ii) its statutory net gain
from operations for the immediately preceding calendar year
(excluding realized capital gains). MLIC will be permitted to
pay a dividend to the Holding Company in excess of the lesser of
such two amounts only if it files notice of its intention to
declare such a dividend and the amount thereof with the
Superintendent and the Superintendent does not disapprove the
dividend within 30 days of its filing. Under New York State
Insurance Law, the Superintendent has broad discretion in
determining whether the financial condition of a stock life
insurance company would support the payment of such dividends to
its shareholders.
Under Delaware State Insurance Law, each of American Life and
MTL is permitted, without prior insurance regulatory clearance,
to pay a stockholder dividend to the Holding Company as long as
the amount of the dividend when aggregated with all other
dividends in the preceding 12 months does not exceed the
greater of: (i) 10% of its surplus to policyholders as of
the end of the immediately preceding calendar year; or
(ii) its statutory net gain from operations for the
immediately preceding calendar year (excluding realized capital
gains). Each of American Life and MTL will be permitted to pay a
dividend to the Holding Company in excess of the greater of such
two amounts only if it files notice of the declaration of such a
dividend and the amount thereof with the Delaware Commissioner
of Insurance (the Delaware Commissioner) and the
Delaware Commissioner either approves the distribution of the
dividend or does not disapprove the distribution within
30 days of its filing. In addition, any dividend that
exceeds earned surplus (defined as unassigned funds) as of the
last filed annual statutory statement requires insurance
regulatory approval. Under Delaware State Insurance Law, the
Delaware Commissioner has broad discretion in determining
whether the financial condition of a stock life insurance
company would support the payment of such dividends to its
shareholders.
Under Connecticut State Insurance Law, MICC is permitted,
without prior insurance regulatory clearance, to pay stockholder
dividends to its stockholders as long as the amount of such
dividends, when aggregated with all other dividends in the
preceding 12 months, does not exceed the greater of:
(i) 10% of its surplus to policyholders as of the end of
the immediately preceding calendar year; or (ii) its
statutory net gain from operations for the immediately preceding
calendar year. MICC will be permitted to pay a dividend in
excess of the greater of such two amounts only if it files
notice of its declaration of such a dividend and the amount
thereof with the Connecticut Commissioner of Insurance (the
Connecticut Commissioner) and the Connecticut
Commissioner does not disapprove the payment within 30 days
after notice. In addition, any dividend that exceeds earned
surplus (unassigned funds, reduced by 25% of unrealized
appreciation in value or revaluation of assets or unrealized
profits on investments) as of the last filed annual statutory
statement requires insurance regulatory approval. Under
Connecticut State Insurance Law, the Connecticut Commissioner
has broad discretion in determining whether the financial
condition of a stock life insurance company would support the
payment of such dividends to its shareholders.
Under Rhode Island State Insurance Law, MPC is permitted,
without prior insurance regulatory clearance, to pay a
stockholder dividend to the Holding Company as long as the
aggregate amount of all such dividends in any twelve-month
period does not exceed the lesser of: (i) 10% of its
surplus to policyholders as of the end of the immediately
preceding calendar year; or (ii) net income, not including
realized capital gains, for the immediately preceding calendar
year, which may include carry forward net income from the second
and third preceding calendar years excluding realized capital
gains and less dividends paid in the second and immediately
preceding calendar years. MPC will be permitted to pay a
dividend to the Holding Company in excess of the lesser of such
two amounts only if it files notice of its intention to declare
such a dividend and the amount thereof with the Rhode Island
Commissioner of Insurance (the Rhode Island
Commissioner) and the Rhode Island Commissioner does not
disapprove the distribution within 30 days of its filing.
Under Rhode Island State Insurance Code, the Rhode Island
Commissioner has broad discretion in determining whether the
financial condition of a stock property and casualty insurance
company would support the payment of such dividends to its
shareholders.
F-199
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Other
Comprehensive Income (Loss)
The following table sets forth the reclassification adjustments
required for the years ended December 31, 2010, 2009 and
2008 in other comprehensive income (loss) that are included as
part of net income for the current year that have been reported
as a part of other comprehensive income (loss) in the current or
prior year:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Holding gains (losses) on investments arising during the year
|
|
$
|
10,092
|
|
|
$
|
18,548
|
|
|
$
|
(26,650
|
)
|
Income tax effect of holding gains (losses)
|
|
|
(3,516
|
)
|
|
|
(6,243
|
)
|
|
|
8,989
|
|
Reclassification adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Recognized holding (gains) losses included in current year income
|
|
|
(143
|
)
|
|
|
1,954
|
|
|
|
2,040
|
|
Amortization of premiums and accretion of discounts associated
with investments
|
|
|
(590
|
)
|
|
|
(490
|
)
|
|
|
(926
|
)
|
Income tax effect
|
|
|
255
|
|
|
|
(493
|
)
|
|
|
(377
|
)
|
Allocation of holding (gains) losses on investments relating to
other policyholder amounts
|
|
|
(2,813
|
)
|
|
|
(2,979
|
)
|
|
|
4,809
|
|
Income tax effect of allocation of holding (gains) losses to
other policyholder amounts
|
|
|
980
|
|
|
|
1,002
|
|
|
|
(1,621
|
)
|
Unrealized investment loss of subsidiary at date of sale
|
|
|
|
|
|
|
|
|
|
|
131
|
|
Deferred income tax on unrealized investment loss of subsidiary
at date of sale
|
|
|
|
|
|
|
|
|
|
|
(60
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized investment gains (losses), net of income tax
|
|
|
4,265
|
|
|
|
11,299
|
|
|
|
(13,665
|
)
|
Foreign currency translation adjustments, net of income tax
|
|
|
(350
|
)
|
|
|
63
|
|
|
|
(700
|
)
|
Defined benefit plans adjustment, net of income tax
|
|
|
96
|
|
|
|
(102
|
)
|
|
|
(1,199
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss)
|
|
|
4,011
|
|
|
|
11,260
|
|
|
|
(15,564
|
)
|
Other comprehensive income (loss) attributable to noncontrolling
interests
|
|
|
(5
|
)
|
|
|
11
|
|
|
|
(10
|
)
|
Other comprehensive income (loss) attributable to noncontrolling
interests of subsidiary at date of disposal
|
|
|
|
|
|
|
|
|
|
|
150
|
|
Foreign currency translation adjustments attributable to
noncontrolling interests of subsidiary at date of disposal
|
|
|
|
|
|
|
|
|
|
|
107
|
|
Defined benefit plans adjustment attributable to noncontrolling
interests of subsidiary at date of disposal
|
|
|
|
|
|
|
|
|
|
|
(4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) attributable to MetLife, Inc.,
excluding cumulative effect of change in accounting principle
|
|
|
4,006
|
|
|
|
11,271
|
|
|
|
(15,321
|
)
|
Cumulative effect of change in accounting principle, net of
income tax of $27 million, $40 million and $0 (see
Note 1)
|
|
|
52
|
|
|
|
(76
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) attributable to MetLife,
Inc.
|
|
$
|
4,058
|
|
|
$
|
11,195
|
|
|
$
|
(15,321
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-200
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Information on other expenses was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Compensation
|
|
$
|
3,584
|
|
|
$
|
3,402
|
|
|
$
|
3,299
|
|
Pension, postretirement & postemployment benefit costs
|
|
|
380
|
|
|
|
452
|
|
|
|
120
|
|
Commissions
|
|
|
3,646
|
|
|
|
3,433
|
|
|
|
3,384
|
|
Volume-related costs
|
|
|
379
|
|
|
|
407
|
|
|
|
354
|
|
Interest credited to bank deposits
|
|
|
137
|
|
|
|
163
|
|
|
|
166
|
|
Capitalization of DAC
|
|
|
(3,343
|
)
|
|
|
(3,019
|
)
|
|
|
(3,092
|
)
|
Amortization of DAC and VOBA
|
|
|
2,801
|
|
|
|
1,307
|
|
|
|
3,489
|
|
Interest expense on debt and debt issue costs
|
|
|
1,550
|
|
|
|
1,044
|
|
|
|
1,051
|
|
Premium taxes, licenses & fees
|
|
|
514
|
|
|
|
527
|
|
|
|
471
|
|
Professional services
|
|
|
1,104
|
|
|
|
902
|
|
|
|
949
|
|
Rent, net of sublease income
|
|
|
307
|
|
|
|
385
|
|
|
|
373
|
|
Other
|
|
|
1,744
|
|
|
|
1,553
|
|
|
|
1,383
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other expenses
|
|
$
|
12,803
|
|
|
$
|
10,556
|
|
|
$
|
11,947
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capitalization
of DAC and Amortization of DAC and VOBA
See Note 6 for DAC and VOBA by segment and a rollforward of
each including impacts of capitalization and amortization. See
also Note 10 for a description of the DAC amortization
impact associated with the closed block. Amortization of DAC and
VOBA includes amortization of negative VOBA related to the
Acquisition of $64 million for the year ended
December 31, 2010. Negative VOBA is recorded in other
policy-related balances (see Note 2) and therefore,
the amortization of negative VOBA is an offset to the VOBA
amortization in Note 6.
Interest
Expense on Debt and Debt Issue Costs
See Notes 11, 12, 13 and 14 for attribution of interest
expense by debt issuance. Interest expense on debt and debt
issue costs includes interest expense related to CSEs of
$411 million for the year ended December 31, 2010, and
$0 for both of the years ended December 31, 2009 and 2008.
See Note 3.
Lease
Impairments
See Note 16 for description of lease impairments included
within other expenses.
Costs
Related to the Acquisition
See Note 2 for transaction costs and integration-related
expenses related to the Acquisition which were included in other
expenses.
Restructuring
Charges
In September 2008, the Company began an enterprise-wide cost
reduction and revenue enhancement initiative which is expected
to be fully implemented by December 31, 2011. This
initiative is focused on reducing complexity, leveraging scale,
increasing productivity and improving the effectiveness of the
Companys operations, as well as providing a foundation for
future growth. These restructuring costs were included in
F-201
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
other expenses. As the expenses relate to an enterprise-wide
initiative, they were incurred within Banking,
Corporate & Other. Estimated restructuring costs may
change as management continues to execute its restructuring
plans. Restructuring charges associated with this
enterprise-wide initiative were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Balance at January 1,
|
|
$
|
36
|
|
|
$
|
86
|
|
|
$
|
|
|
Severance charges
|
|
|
17
|
|
|
|
84
|
|
|
|
109
|
|
Change in severance charge estimates
|
|
|
(1
|
)
|
|
|
(8
|
)
|
|
|
(8
|
)
|
Cash payments
|
|
|
(45
|
)
|
|
|
(126
|
)
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
7
|
|
|
$
|
36
|
|
|
$
|
86
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring charges incurred in current period
|
|
$
|
16
|
|
|
$
|
76
|
|
|
$
|
101
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total restructuring charges incurred since inception of program
|
|
$
|
193
|
|
|
$
|
177
|
|
|
$
|
101
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the years ended December 31, 2010, 2009 and 2008, the
change in severance charge estimates of ($1) million,
($8) million and ($8) million, respectively, was due
to changes in estimates for variable incentive compensation,
COBRA benefits, employee outplacement services and for employees
whose severance status changed.
In addition to the above charges, the Company has recognized
lease charges of $28 million associated with the
consolidation of office space since the inception of the
initiative.
Management anticipates further restructuring charges, including
severance, lease and asset impairments, will be incurred during
the year ending December 31, 2011. However, such
restructuring plans were not sufficiently developed to enable
the Company to make an estimate of such restructuring charges at
December 31, 2010.
See Note 2 for discussion of restructuring charges related
to the Acquisition.
F-202
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
20.
|
Earnings
Per Common Share
|
The following table presents the weighted average shares used in
calculating basic earnings per common share and those used in
calculating diluted earnings per common share for each income
category presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions, except share and per share data)
|
|
|
Weighted Average Shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common stock outstanding for basic earnings per
common share (1)
|
|
|
882,436,532
|
|
|
|
818,462,150
|
|
|
|
735,184,337
|
|
Incremental common shares from assumed:
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock purchase contracts underlying common equity units (2)
|
|
|
|
|
|
|
|
|
|
|
2,043,553
|
|
Exercise or issuance of stock-based awards (3)
|
|
|
7,131,346
|
|
|
|
|
|
|
|
7,557,540
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common stock outstanding for diluted earnings
per common share(1)
|
|
|
889,567,878
|
|
|
|
818,462,150
|
|
|
|
744,785,430
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (Loss) from Continuing Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income tax
|
|
$
|
2,777
|
|
|
$
|
(2,319
|
)
|
|
$
|
3,479
|
|
Less: Income (loss) from continuing operations, net of income
tax, attributable to noncontrolling interests
|
|
|
(4
|
)
|
|
|
(32
|
)
|
|
|
(25
|
)
|
Less: Preferred stock dividends
|
|
|
122
|
|
|
|
122
|
|
|
|
125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income tax,
available to MetLife, Inc.s common shareholders
|
|
$
|
2,659
|
|
|
$
|
(2,409
|
)
|
|
$
|
3,379
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
3.01
|
|
|
$
|
(2.94
|
)
|
|
$
|
4.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
2.99
|
|
|
$
|
(2.94
|
)
|
|
$
|
4.54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (Loss) from Discontinued Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations, net of income tax
|
|
$
|
9
|
|
|
$
|
41
|
|
|
$
|
(201
|
)
|
Less: Income (loss) from discontinued operations, net of income
tax, attributable to noncontrolling interests
|
|
|
|
|
|
|
|
|
|
|
94
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations, net of income tax,
available to MetLife, Inc.s common shareholders
|
|
$
|
9
|
|
|
$
|
41
|
|
|
$
|
(295
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.01
|
|
|
$
|
0.05
|
|
|
$
|
(0.41
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
0.01
|
|
|
$
|
0.05
|
|
|
$
|
(0.40
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (Loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
2,786
|
|
|
$
|
(2,278
|
)
|
|
$
|
3,278
|
|
Less: Net income (loss) attributable to noncontrolling interests
|
|
|
(4
|
)
|
|
|
(32
|
)
|
|
|
69
|
|
Less: Preferred stock dividends
|
|
|
122
|
|
|
|
122
|
|
|
|
125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.s common
shareholders
|
|
$
|
2,668
|
|
|
$
|
(2,368
|
)
|
|
$
|
3,084
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
3.02
|
|
|
$
|
(2.89
|
)
|
|
$
|
4.19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
3.00
|
|
|
$
|
(2.89
|
)
|
|
$
|
4.14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
For purposes of the earnings per common share calculation, the
Convertible Preferred Stock is assumed converted into shares of
common stock for both basic and diluted weighted average shares.
See Note 18 for a description of the Convertible Preferred
Stock. |
|
(2) |
|
See Note 14 for a description of the Companys common
equity units. |
F-203
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
(3) |
|
For the year ended December 31, 2009, 4,213,700 shares
related to the assumed exercise or issuance of stock-based
awards have been excluded from the calculation of diluted
earnings per common share as these assumed shares are
anti-dilutive. |
|
|
21.
|
Quarterly
Results of Operations (Unaudited)
|
The unaudited quarterly results of operations for 2010 and 2009
are summarized in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
June 30,
|
|
|
September 30,
|
|
|
December 31,
|
|
|
|
(In millions, except per share data)
|
|
|
2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
$
|
13,190
|
|
|
$
|
14,245
|
|
|
$
|
12,444
|
|
|
$
|
12,838
|
|
Total expenses
|
|
$
|
11,999
|
|
|
$
|
11,875
|
|
|
$
|
12,051
|
|
|
$
|
12,834
|
|
Income (loss) from continuing operations, net of income tax
|
|
$
|
833
|
|
|
$
|
1,540
|
|
|
$
|
322
|
|
|
$
|
82
|
|
Income (loss) from discontinued operations, net of income tax
|
|
$
|
1
|
|
|
$
|
7
|
|
|
$
|
(2
|
)
|
|
$
|
3
|
|
Net income (loss)
|
|
$
|
834
|
|
|
$
|
1,547
|
|
|
$
|
320
|
|
|
$
|
85
|
|
Less: Net income (loss) attributable to noncontrolling interests
|
|
$
|
(1
|
)
|
|
$
|
(10
|
)
|
|
$
|
4
|
|
|
$
|
3
|
|
Net income (loss) attributable to MetLife, Inc.
|
|
$
|
835
|
|
|
$
|
1,557
|
|
|
$
|
316
|
|
|
$
|
82
|
|
Less: Preferred stock dividends
|
|
$
|
30
|
|
|
$
|
31
|
|
|
$
|
30
|
|
|
$
|
31
|
|
Net income (loss) available to MetLife, Inc.s common
shareholders
|
|
$
|
805
|
|
|
$
|
1,526
|
|
|
$
|
286
|
|
|
$
|
51
|
|
Basic earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income tax,
available to MetLife, Inc.s common shareholders
|
|
$
|
0.98
|
|
|
$
|
1.84
|
|
|
$
|
0.33
|
|
|
$
|
0.05
|
|
Income (loss) from discontinued operations, net of income tax,
attributable to MetLife, Inc.
|
|
$
|
|
|
|
$
|
0.01
|
|
|
$
|
|
|
|
$
|
|
|
Net income (loss) attributable to MetLife, Inc.
|
|
$
|
1.02
|
|
|
$
|
1.90
|
|
|
$
|
0.36
|
|
|
$
|
0.08
|
|
Net income (loss) available to MetLife, Inc.s common
shareholders
|
|
$
|
0.98
|
|
|
$
|
1.85
|
|
|
$
|
0.33
|
|
|
$
|
0.05
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income tax,
available to MetLife, Inc.s common shareholders
|
|
$
|
0.97
|
|
|
$
|
1.83
|
|
|
$
|
0.32
|
|
|
$
|
0.05
|
|
Income (loss) from discontinued operations, net of income tax,
attributable to MetLife, Inc.
|
|
$
|
|
|
|
$
|
0.01
|
|
|
$
|
|
|
|
$
|
|
|
Net income (loss) attributable to MetLife, Inc.
|
|
$
|
1.01
|
|
|
$
|
1.87
|
|
|
$
|
0.36
|
|
|
$
|
0.08
|
|
Net income (loss) available to MetLife, Inc.s common
shareholders
|
|
$
|
0.97
|
|
|
$
|
1.84
|
|
|
$
|
0.32
|
|
|
$
|
0.05
|
|
2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
$
|
10,214
|
|
|
$
|
8,264
|
|
|
$
|
10,238
|
|
|
$
|
12,341
|
|
Total expenses
|
|
$
|
11,176
|
|
|
$
|
10,640
|
|
|
$
|
11,413
|
|
|
$
|
12,162
|
|
Income (loss) from continuing operations, net of income tax
|
|
$
|
(585
|
)
|
|
$
|
(1,420
|
)
|
|
$
|
(624
|
)
|
|
$
|
310
|
|
Income (loss) from discontinued operations, net of income tax
|
|
$
|
37
|
|
|
$
|
2
|
|
|
$
|
(1
|
)
|
|
$
|
3
|
|
Net income (loss)
|
|
$
|
(548
|
)
|
|
$
|
(1,418
|
)
|
|
$
|
(625
|
)
|
|
$
|
313
|
|
Less: Net income (loss) attributable to noncontrolling interests
|
|
$
|
(4
|
)
|
|
$
|
(16
|
)
|
|
$
|
(5
|
)
|
|
$
|
(7
|
)
|
Net income (loss) attributable to MetLife, Inc.
|
|
$
|
(544
|
)
|
|
$
|
(1,402
|
)
|
|
$
|
(620
|
)
|
|
$
|
320
|
|
Less: Preferred stock dividends
|
|
$
|
30
|
|
|
$
|
31
|
|
|
$
|
30
|
|
|
$
|
31
|
|
Net income (loss) available to MetLife, Inc.s common
shareholders
|
|
$
|
(574
|
)
|
|
$
|
(1,433
|
)
|
|
$
|
(650
|
)
|
|
$
|
289
|
|
Basic earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income tax,
available to MetLife, Inc.s common shareholders
|
|
$
|
(0.76
|
)
|
|
$
|
(1.74
|
)
|
|
$
|
(0.79
|
)
|
|
$
|
0.35
|
|
Income (loss) from discontinued operations, net of income tax,
attributable to MetLife, Inc.
|
|
$
|
0.05
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Net income (loss) attributable to MetLife, Inc.
|
|
$
|
(0.67
|
)
|
|
$
|
(1.71
|
)
|
|
$
|
(0.75
|
)
|
|
$
|
0.39
|
|
Net income (loss) available to MetLife, Inc.s common
shareholders
|
|
$
|
(0.71
|
)
|
|
$
|
(1.74
|
)
|
|
$
|
(0.79
|
)
|
|
$
|
0.35
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income tax,
available to MetLife, Inc.s common shareholders
|
|
$
|
(0.76
|
)
|
|
$
|
(1.74
|
)
|
|
$
|
(0.79
|
)
|
|
$
|
0.35
|
|
Income (loss) from discontinued operations, net of income tax,
attributable to MetLife, Inc.
|
|
$
|
0.05
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Net income (loss) attributable to MetLife, Inc.
|
|
$
|
(0.67
|
)
|
|
$
|
(1.71
|
)
|
|
$
|
(0.75
|
)
|
|
$
|
0.39
|
|
Net income (loss) available to MetLife, Inc.s common
shareholders
|
|
$
|
(0.71
|
)
|
|
$
|
(1.74
|
)
|
|
$
|
(0.79
|
)
|
|
$
|
0.35
|
|
F-204
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
22.
|
Business
Segment Information
|
MetLife is organized into five segments: Insurance Products,
Retirement Products, Corporate Benefit Funding and
Auto & Home (collectively,
U.S. Business) and International. The assets
and liabilities of ALICO as of November 30, 2010 and the
operating results of ALICO from the Acquisition Date through
November 30, 2010 are included in the International
segment. In addition, the Company reports certain of its results
of operations in Banking, Corporate & Other, which
includes MetLife Bank and other business activities. For
reporting purposes beginning in 2011, our
non-U.S. Business
results will be presented within two separate segments: Japan
and Other International Regions.
Insurance Products offers a broad range of protection products
and services to individuals and corporations, as well as other
institutions and their respective employees, and is organized
into three distinct businesses: Group Life, Individual Life and
Non-Medical Health. Group Life insurance products and services
include variable life, universal life and term life products.
Individual Life insurance products and services include variable
life, universal life, term life and whole life products.
Non-Medical Health products and services include dental
insurance, short- and long-term disability, long-term care and
other insurance products. Retirement Products offers asset
accumulation and income products, including a wide variety of
annuities. Corporate Benefit Funding offers pension risk
solutions, structured settlements, stable value and investment
products and other benefit funding products. Auto &
Home provides personal lines property and casualty insurance,
including private passenger automobile, homeowners and personal
excess liability insurance. In the fourth quarter of 2010,
management realigned certain income annuity products within the
Companys segments to better conform to the way it manages
and assesses its business and began reporting such product
results in the Retirement Products segment, previously reported
in the Corporate Benefit Funding segment. Accordingly, prior
period results for these segments have been adjusted by
$29 million and $13 million of operating losses, net
of $15 million and $8 million of income tax benefits,
for the years ended December 31, 2009 and 2008,
respectively, to reflect such product reclassifications.
International provides life insurance, accident and health
insurance, credit insurance, annuities, endowments and
retirement & savings products to both individuals and
groups.
Banking, Corporate & Other contains the excess capital
not allocated to the segments, the results of operations of
MetLife Bank, various
start-up
entities and run-off entities, as well as interest expense
related to the majority of the Companys outstanding debt
and expenses associated with certain legal proceedings and
income tax audit issues. Banking, Corporate & Other
also includes the elimination of intersegment amounts, which
generally relate to intersegment loans, which bear interest
rates commensurate with related borrowings.
Operating earnings is the measure of segment profit or loss the
Company uses to evaluate segment performance and allocate
resources. Consistent with GAAP accounting guidance for segment
reporting, it is the Companys measure of segment
performance reported below. Operating earnings does not equate
to income (loss) from continuing operations, net of income tax
or net income (loss) as determined in accordance with GAAP and
should not be viewed as a substitute for those GAAP measures.
The Company believes the presentation of operating earnings
herein as the Company measures it for management purposes
enhances the understanding of its performance by highlighting
the results from operations and the underlying profitability
drivers of the businesses.
Operating earnings is defined as operating revenues less
operating expenses, net of income tax.
Operating revenues is defined as GAAP revenues (i) less net
investment gains (losses) and net derivative gains (losses);
(ii) less amortization of unearned revenue related to net
investment gains (losses) and net derivative gains (losses);
(iii) plus scheduled periodic settlement payments on
derivatives that are hedges of investments but do not qualify
for hedge accounting treatment; (iv) plus income from
discontinued real estate operations; (v) less net
investment income related to contractholder-directed unit-linked
investments; and (vi) plus, for operating joint ventures
reported under the equity method of accounting, the
aforementioned adjustments, those identified in the definition
of operating expenses and changes in fair value of hedges of
operating joint venture liabilities, all net of income tax.
F-205
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Operating expenses is defined as GAAP expenses (i) less
changes in policyholder benefits associated with asset value
fluctuations related to experience-rated contractholder
liabilities and certain inflation-indexed liabilities;
(ii) less costs related to business combinations (since
January 1, 2009) and noncontrolling interests;
(iii) less amortization of DAC and VOBA and changes in the
policyholder dividend obligation related to net investment gains
(losses) and net derivative gains (losses); (iv) less
interest credited to policyholder account balances related to
contractholder-directed unit-linked investments; and
(v) plus scheduled periodic settlement payments on
derivatives that are hedges of policyholder account balances but
do not qualify for hedge accounting treatment.
In addition, operating revenues and operating expenses do not
reflect the consolidation of certain securitization entities
that are VIEs as required under GAAP.
Set forth in the tables below is certain financial information
with respect to the Companys segments, as well as Banking,
Corporate & Other for the years ended
December 31, 2010, 2009 and 2008 and at December 31,
2010 and 2009. The accounting policies of the segments are the
same as those of the Company, except for the method of capital
allocation and the accounting for gains (losses) from
intercompany sales, which are eliminated in consolidation.
Economic capital is an internally developed risk capital model,
the purpose of which is to measure the risk in the business and
to provide a basis upon which capital is deployed. The economic
capital model accounts for the unique and specific nature of the
risks inherent in the Companys businesses. As a part of
the economic capital process, a portion of net investment income
is credited to the segments based on the level of allocated
equity. The Company allocates certain non-recurring items, such
as expenses associated with certain legal proceedings, to
Banking, Corporate & Other.
F-206
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Earnings
|
|
|
|
|
|
|
|
|
|
U.S. Business
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
|
|
|
Banking,
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance
|
|
|
Retirement
|
|
|
Benefit
|
|
|
Auto
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
Total
|
|
Year Ended December 31, 2010
|
|
Products
|
|
|
Products
|
|
|
Funding
|
|
|
& Home
|
|
|
Total
|
|
|
International
|
|
|
& Other
|
|
|
Total
|
|
|
Adjustments
|
|
|
Consolidated
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
17,200
|
|
|
$
|
875
|
|
|
$
|
1,938
|
|
|
$
|
2,923
|
|
|
$
|
22,936
|
|
|
$
|
4,447
|
|
|
$
|
11
|
|
|
$
|
27,394
|
|
|
$
|
|
|
|
$
|
27,394
|
|
Universal life and investment-type product policy fees
|
|
|
2,247
|
|
|
|
2,234
|
|
|
|
226
|
|
|
|
|
|
|
|
4,707
|
|
|
|
1,329
|
|
|
|
|
|
|
|
6,036
|
|
|
|
1
|
|
|
|
6,037
|
|
Net investment income
|
|
|
6,068
|
|
|
|
3,395
|
|
|
|
4,954
|
|
|
|
209
|
|
|
|
14,626
|
|
|
|
1,703
|
|
|
|
992
|
|
|
|
17,321
|
|
|
|
294
|
|
|
|
17,615
|
|
Other revenues
|
|
|
761
|
|
|
|
220
|
|
|
|
246
|
|
|
|
22
|
|
|
|
1,249
|
|
|
|
35
|
|
|
|
1,044
|
|
|
|
2,328
|
|
|
|
|
|
|
|
2,328
|
|
Net investment gains (losses)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(392
|
)
|
|
|
(392
|
)
|
Net derivative gains (losses)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(265
|
)
|
|
|
(265
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
26,276
|
|
|
|
6,724
|
|
|
|
7,364
|
|
|
|
3,154
|
|
|
|
43,518
|
|
|
|
7,514
|
|
|
|
2,047
|
|
|
|
53,079
|
|
|
|
(362
|
)
|
|
|
52,717
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims and policyholder dividends
|
|
|
19,075
|
|
|
|
1,879
|
|
|
|
4,041
|
|
|
|
2,021
|
|
|
|
27,016
|
|
|
|
3,723
|
|
|
|
(14
|
)
|
|
|
30,725
|
|
|
|
306
|
|
|
|
31,031
|
|
Interest credited to policyholder account balances
|
|
|
963
|
|
|
|
1,612
|
|
|
|
1,445
|
|
|
|
|
|
|
|
4,020
|
|
|
|
683
|
|
|
|
|
|
|
|
4,703
|
|
|
|
222
|
|
|
|
4,925
|
|
Interest credited to bank deposits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
137
|
|
|
|
137
|
|
|
|
|
|
|
|
137
|
|
Capitalization of DAC
|
|
|
(841
|
)
|
|
|
(1,067
|
)
|
|
|
(19
|
)
|
|
|
(448
|
)
|
|
|
(2,375
|
)
|
|
|
(968
|
)
|
|
|
|
|
|
|
(3,343
|
)
|
|
|
|
|
|
|
(3,343
|
)
|
Amortization of DAC and VOBA
|
|
|
966
|
|
|
|
724
|
|
|
|
16
|
|
|
|
439
|
|
|
|
2,145
|
|
|
|
537
|
|
|
|
1
|
|
|
|
2,683
|
|
|
|
118
|
|
|
|
2,801
|
|
Interest expense on debt
|
|
|
1
|
|
|
|
3
|
|
|
|
6
|
|
|
|
|
|
|
|
10
|
|
|
|
3
|
|
|
|
1,126
|
|
|
|
1,139
|
|
|
|
411
|
|
|
|
1,550
|
|
Other expenses
|
|
|
4,080
|
|
|
|
2,437
|
|
|
|
460
|
|
|
|
769
|
|
|
|
7,746
|
|
|
|
2,538
|
|
|
|
1,155
|
|
|
|
11,439
|
|
|
|
219
|
|
|
|
11,658
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
24,244
|
|
|
|
5,588
|
|
|
|
5,949
|
|
|
|
2,781
|
|
|
|
38,562
|
|
|
|
6,516
|
|
|
|
2,405
|
|
|
|
47,483
|
|
|
|
1,276
|
|
|
|
48,759
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
711
|
|
|
|
397
|
|
|
|
495
|
|
|
|
73
|
|
|
|
1,676
|
|
|
|
206
|
|
|
|
(300
|
)
|
|
|
1,582
|
|
|
|
(401
|
)
|
|
|
1,181
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
1,321
|
|
|
$
|
739
|
|
|
$
|
920
|
|
|
$
|
300
|
|
|
$
|
3,280
|
|
|
$
|
792
|
|
|
$
|
(58
|
)
|
|
|
4,014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(362
|
)
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,276
|
)
|
|
|
|
|
|
|
|
|
Provision for income tax (expense) benefit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
401
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income
tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,777
|
|
|
|
|
|
|
$
|
2,777
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Business
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
|
|
|
Banking,
|
|
|
|
|
|
|
Insurance
|
|
|
Retirement
|
|
|
Benefit
|
|
|
Auto
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
At December 31, 2010:
|
|
Products
|
|
|
Products
|
|
|
Funding
|
|
|
& Home
|
|
|
Total
|
|
|
International
|
|
|
& Other
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Total assets
|
|
$
|
141,366
|
|
|
$
|
177,056
|
|
|
$
|
172,918
|
|
|
$
|
5,541
|
|
|
$
|
496,881
|
|
|
$
|
164,995
|
|
|
$
|
69,030
|
|
|
$
|
730,906
|
|
Separate account assets
|
|
$
|
9,567
|
|
|
$
|
107,335
|
|
|
$
|
56,571
|
|
|
$
|
|
|
|
$
|
173,473
|
|
|
$
|
9,864
|
|
|
$
|
|
|
|
$
|
183,337
|
|
Separate account liabilities
|
|
$
|
9,567
|
|
|
$
|
107,335
|
|
|
$
|
56,571
|
|
|
$
|
|
|
|
$
|
173,473
|
|
|
$
|
9,864
|
|
|
$
|
|
|
|
$
|
183,337
|
|
F-207
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Earnings
|
|
|
|
|
|
|
|
|
|
U.S. Business
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
|
|
|
Banking,
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance
|
|
|
Retirement
|
|
|
Benefit
|
|
|
Auto
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
Total
|
|
Year Ended December 31, 2009
|
|
Products
|
|
|
Products
|
|
|
Funding
|
|
|
& Home
|
|
|
Total
|
|
|
International
|
|
|
& Other
|
|
|
Total
|
|
|
Adjustments
|
|
|
Consolidated
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
17,168
|
|
|
$
|
920
|
|
|
$
|
2,264
|
|
|
$
|
2,902
|
|
|
$
|
23,254
|
|
|
$
|
3,187
|
|
|
$
|
19
|
|
|
$
|
26,460
|
|
|
$
|
|
|
|
$
|
26,460
|
|
Universal life and investment-type product policy fees
|
|
|
2,281
|
|
|
|
1,712
|
|
|
|
176
|
|
|
|
|
|
|
|
4,169
|
|
|
|
1,061
|
|
|
|
|
|
|
|
5,230
|
|
|
|
(27
|
)
|
|
|
5,203
|
|
Net investment income
|
|
|
5,614
|
|
|
|
3,098
|
|
|
|
4,527
|
|
|
|
180
|
|
|
|
13,419
|
|
|
|
1,193
|
|
|
|
477
|
|
|
|
15,089
|
|
|
|
(252
|
)
|
|
|
14,837
|
|
Other revenues
|
|
|
779
|
|
|
|
173
|
|
|
|
238
|
|
|
|
33
|
|
|
|
1,223
|
|
|
|
14
|
|
|
|
1,092
|
|
|
|
2,329
|
|
|
|
|
|
|
|
2,329
|
|
Net investment gains (losses)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,906
|
)
|
|
|
(2,906
|
)
|
Net derivative gains (losses)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,866
|
)
|
|
|
(4,866
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
25,842
|
|
|
|
5,903
|
|
|
|
7,205
|
|
|
|
3,115
|
|
|
|
42,065
|
|
|
|
5,455
|
|
|
|
1,588
|
|
|
|
49,108
|
|
|
|
(8,051
|
)
|
|
|
41,057
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims and policyholder dividends
|
|
|
19,111
|
|
|
|
1,950
|
|
|
|
4,245
|
|
|
|
1,932
|
|
|
|
27,238
|
|
|
|
2,660
|
|
|
|
4
|
|
|
|
29,902
|
|
|
|
84
|
|
|
|
29,986
|
|
Interest credited to policyholder account balances
|
|
|
952
|
|
|
|
1,688
|
|
|
|
1,632
|
|
|
|
|
|
|
|
4,272
|
|
|
|
581
|
|
|
|
|
|
|
|
4,853
|
|
|
|
(4
|
)
|
|
|
4,849
|
|
Interest credited to bank deposits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
163
|
|
|
|
163
|
|
|
|
|
|
|
|
163
|
|
Capitalization of DAC
|
|
|
(873
|
)
|
|
|
(1,067
|
)
|
|
|
(14
|
)
|
|
|
(435
|
)
|
|
|
(2,389
|
)
|
|
|
(630
|
)
|
|
|
|
|
|
|
(3,019
|
)
|
|
|
|
|
|
|
(3,019
|
)
|
Amortization of DAC and VOBA
|
|
|
725
|
|
|
|
424
|
|
|
|
15
|
|
|
|
436
|
|
|
|
1,600
|
|
|
|
415
|
|
|
|
3
|
|
|
|
2,018
|
|
|
|
(711
|
)
|
|
|
1,307
|
|
Interest expense on debt
|
|
|
6
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
9
|
|
|
|
8
|
|
|
|
1,027
|
|
|
|
1,044
|
|
|
|
|
|
|
|
1,044
|
|
Other expenses
|
|
|
4,206
|
|
|
|
2,433
|
|
|
|
456
|
|
|
|
764
|
|
|
|
7,859
|
|
|
|
1,797
|
|
|
|
1,336
|
|
|
|
10,992
|
|
|
|
69
|
|
|
|
11,061
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
24,127
|
|
|
|
5,428
|
|
|
|
6,337
|
|
|
|
2,697
|
|
|
|
38,589
|
|
|
|
4,831
|
|
|
|
2,533
|
|
|
|
45,953
|
|
|
|
(562
|
)
|
|
|
45,391
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
573
|
|
|
|
167
|
|
|
|
288
|
|
|
|
96
|
|
|
|
1,124
|
|
|
|
161
|
|
|
|
(617
|
)
|
|
|
668
|
|
|
|
(2,683
|
)
|
|
|
(2,015
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
1,142
|
|
|
$
|
308
|
|
|
$
|
580
|
|
|
$
|
322
|
|
|
$
|
2,352
|
|
|
$
|
463
|
|
|
$
|
(328
|
)
|
|
|
2,487
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8,051
|
)
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
562
|
|
|
|
|
|
|
|
|
|
Provision for income tax (expense) benefit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,683
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income
tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(2,319
|
)
|
|
|
|
|
|
$
|
(2,319
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Business
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
Banking,
|
|
|
|
|
Insurance
|
|
Retirement
|
|
Benefit
|
|
Auto
|
|
|
|
|
|
Corporate
|
|
|
At December 31, 2009:
|
|
Products
|
|
Products
|
|
Funding
|
|
& Home
|
|
Total
|
|
International
|
|
& Other
|
|
Total
|
|
|
(In millions)
|
|
Total assets
|
|
$
|
132,720
|
|
|
$
|
154,228
|
|
|
$
|
153,795
|
|
|
$
|
5,517
|
|
|
$
|
446,260
|
|
|
$
|
33,923
|
|
|
$
|
59,131
|
|
|
$
|
539,314
|
|
Separate account assets
|
|
$
|
8,838
|
|
|
$
|
87,157
|
|
|
$
|
45,688
|
|
|
$
|
|
|
|
$
|
141,683
|
|
|
$
|
7,358
|
|
|
$
|
|
|
|
$
|
149,041
|
|
Separate account liabilities
|
|
$
|
8,838
|
|
|
$
|
87,157
|
|
|
$
|
45,688
|
|
|
$
|
|
|
|
$
|
141,683
|
|
|
$
|
7,358
|
|
|
$
|
|
|
|
$
|
149,041
|
|
F-208
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Earnings
|
|
|
|
|
|
|
|
|
|
U.S. Business
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
Auto
|
|
|
|
|
|
|
|
|
Banking,
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance
|
|
|
Retirement
|
|
|
Benefit
|
|
|
&
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
Total
|
|
Year Ended December 31, 2008
|
|
Products
|
|
|
Products
|
|
|
Funding
|
|
|
Home
|
|
|
Total
|
|
|
International
|
|
|
& Other
|
|
|
Total
|
|
|
Adjustments
|
|
|
Consolidated
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
16,402
|
|
|
$
|
696
|
|
|
$
|
2,348
|
|
|
$
|
2,971
|
|
|
$
|
22,417
|
|
|
$
|
3,470
|
|
|
$
|
27
|
|
|
$
|
25,914
|
|
|
$
|
|
|
|
$
|
25,914
|
|
Universal life and investment-type product policy fees
|
|
|
2,171
|
|
|
|
1,870
|
|
|
|
227
|
|
|
|
|
|
|
|
4,268
|
|
|
|
1,095
|
|
|
|
|
|
|
|
5,363
|
|
|
|
18
|
|
|
|
5,381
|
|
Net investment income
|
|
|
5,787
|
|
|
|
2,624
|
|
|
|
5,615
|
|
|
|
186
|
|
|
|
14,212
|
|
|
|
1,180
|
|
|
|
808
|
|
|
|
16,200
|
|
|
|
89
|
|
|
|
16,289
|
|
Other revenues
|
|
|
819
|
|
|
|
169
|
|
|
|
358
|
|
|
|
38
|
|
|
|
1,384
|
|
|
|
18
|
|
|
|
184
|
|
|
|
1,586
|
|
|
|
|
|
|
|
1,586
|
|
Net investment gains (losses)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,098
|
)
|
|
|
(2,098
|
)
|
Net derivative gains (losses)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,910
|
|
|
|
3,910
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
25,179
|
|
|
|
5,359
|
|
|
|
8,548
|
|
|
|
3,195
|
|
|
|
42,281
|
|
|
|
5,763
|
|
|
|
1,019
|
|
|
|
49,063
|
|
|
|
1,919
|
|
|
|
50,982
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims and policyholder dividends
|
|
|
18,183
|
|
|
|
1,271
|
|
|
|
4,398
|
|
|
|
1,924
|
|
|
|
25,776
|
|
|
|
3,185
|
|
|
|
46
|
|
|
|
29,007
|
|
|
|
181
|
|
|
|
29,188
|
|
Interest credited to policyholder account balances
|
|
|
930
|
|
|
|
1,338
|
|
|
|
2,297
|
|
|
|
|
|
|
|
4,565
|
|
|
|
171
|
|
|
|
7
|
|
|
|
4,743
|
|
|
|
45
|
|
|
|
4,788
|
|
Interest credited to bank deposits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
166
|
|
|
|
166
|
|
|
|
|
|
|
|
166
|
|
Capitalization of DAC
|
|
|
(849
|
)
|
|
|
(980
|
)
|
|
|
(18
|
)
|
|
|
(444
|
)
|
|
|
(2,291
|
)
|
|
|
(798
|
)
|
|
|
(3
|
)
|
|
|
(3,092
|
)
|
|
|
|
|
|
|
(3,092
|
)
|
Amortization of DAC and VOBA
|
|
|
743
|
|
|
|
1,356
|
|
|
|
29
|
|
|
|
454
|
|
|
|
2,582
|
|
|
|
381
|
|
|
|
5
|
|
|
|
2,968
|
|
|
|
521
|
|
|
|
3,489
|
|
Interest expense on debt
|
|
|
5
|
|
|
|
2
|
|
|
|
2
|
|
|
|
|
|
|
|
9
|
|
|
|
9
|
|
|
|
1,033
|
|
|
|
1,051
|
|
|
|
|
|
|
|
1,051
|
|
Other expenses
|
|
|
4,196
|
|
|
|
2,101
|
|
|
|
440
|
|
|
|
794
|
|
|
|
7,531
|
|
|
|
2,079
|
|
|
|
699
|
|
|
|
10,309
|
|
|
|
24
|
|
|
|
10,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
23,208
|
|
|
|
5,088
|
|
|
|
7,148
|
|
|
|
2,728
|
|
|
|
38,172
|
|
|
|
5,027
|
|
|
|
1,953
|
|
|
|
45,152
|
|
|
|
771
|
|
|
|
45,923
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax expense (benefit)
|
|
|
661
|
|
|
|
91
|
|
|
|
474
|
|
|
|
104
|
|
|
|
1,330
|
|
|
|
257
|
|
|
|
(495
|
)
|
|
|
1,092
|
|
|
|
488
|
|
|
|
1,580
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
$
|
1,310
|
|
|
$
|
180
|
|
|
$
|
926
|
|
|
$
|
363
|
|
|
$
|
2,779
|
|
|
$
|
479
|
|
|
$
|
(439
|
)
|
|
|
2,819
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,919
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(771
|
)
|
|
|
|
|
|
|
|
|
Provision for income tax (expense) benefit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(488
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income
tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,479
|
|
|
|
|
|
|
$
|
3,479
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income is based upon the actual results of each
segments specifically identifiable asset portfolio
adjusted for allocated equity. Other costs are allocated to each
of the segments based upon: (i) a review of the nature of
such costs; (ii) time studies analyzing the amount of
employee compensation costs incurred by each segment; and
(iii) cost estimates included in the Companys product
pricing.
Operating revenues derived from any customer did not exceed 10%
of consolidated operating revenues for the years ended
December 31, 2010, 2009 and 2008. Operating revenues from
U.S. operations were $44.9 billion, $42.8 billion
and $42.9 billion for the years ended December 31,
2010, 2009 and 2008, respectively, which represented 85%, 87%
and 87%, respectively, of consolidated operating revenues.
F-209
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
23.
|
Discontinued
Operations
|
Real
Estate
The Company actively manages its real estate portfolio with the
objective of maximizing earnings through selective acquisitions
and dispositions. Income related to real estate classified as
held-for-sale
or sold is presented in discontinued operations. These assets
are carried at the lower of depreciated cost or estimated fair
value less expected disposition costs. Income from discontinued
real estate operations, net of income tax, was $3 million,
$11 million and $13 million for the years ended
December 31, 2010, 2009 and 2008, respectively.
The carrying value of real estate related to discontinued
operations was $8 million and $55 million at
December 31, 2010 and 2009, respectively.
Operations
Texas
Life Insurance Company
During the fourth quarter of 2008, the Holding Company entered
into an agreement to sell its wholly-owned subsidiary, Cova, the
parent company of Texas Life, to a third-party and the sale
occurred in March 2009. See Note 2. The following table
presents the amounts related to the operations of Cova that have
been reflected as discontinued operations in the consolidated
statements of operations:
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Total revenues
|
|
$
|
25
|
|
|
$
|
134
|
|
Total expenses
|
|
|
19
|
|
|
|
119
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income tax
|
|
|
6
|
|
|
|
15
|
|
Provision for income tax
|
|
|
2
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
Income from operations of discontinued operations, net of income
tax
|
|
|
4
|
|
|
|
11
|
|
Gain on disposal, net of income tax
|
|
|
28
|
|
|
|
37
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations, net of income tax
|
|
$
|
32
|
|
|
$
|
48
|
|
|
|
|
|
|
|
|
|
|
F-210
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Reinsurance
Group of America, Incorporated
As more fully described in Note 2, the Company completed a
tax-free split-off of its majority-owned subsidiary, RGA in
September 2008. The following table presents the amounts related
to the operations of RGA that have been reflected as
discontinued operations in the consolidated statements of
operations:
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31, 2008
|
|
|
|
(In millions)
|
|
|
Total revenues
|
|
$
|
3,952
|
|
Total expenses
|
|
|
3,796
|
|
|
|
|
|
|
Income before provision for income tax
|
|
|
156
|
|
Provision for income tax
|
|
|
53
|
|
|
|
|
|
|
Income from discontinued operations, net of income tax,
available to MetLife, Inc.s common shareholders
|
|
|
103
|
|
Income from discontinued operations, net of income tax,
attributable to noncontrolling interests
|
|
|
94
|
|
Loss on disposal, net of income tax
|
|
|
(458
|
)
|
|
|
|
|
|
Income (loss) from discontinued operations, net of income tax
|
|
$
|
(261
|
)
|
|
|
|
|
|
The operations of RGA included direct policies and reinsurance
agreements with MetLife and some of its subsidiaries. These
agreements are generally terminable by either party upon
90 days written notice with respect to future new business.
Agreements related to existing business generally are not
terminable, unless the underlying policies terminate or are
recaptured. These direct policies and reinsurance agreements do
not constitute significant continuing involvement by the Company
with RGA. Included in continuing operations in the
Companys consolidated statements of operations are amounts
related to these transactions, including ceded amounts that
reduced premiums and fees by $158 million and ceded amounts
that reduced policyholder benefits and claims by
$136 million for the year ended December 31, 2008 that
have not been eliminated as these transactions have continued
after the RGA disposition.
Dividends
On February 18, 2011, the Holding Company announced
dividends of $0.2500000 per share, for a total of
$6 million, on its Series A preferred shares, and
$0.4062500 per share, for a total of $24 million, on its
Series B preferred shares, subject to the final
confirmation that it has met the financial tests specified in
the Series A and Series B preferred shares, which the
Company anticipates will be made on or about March 7, 2011. Both
dividends will be payable March 15, 2011 to shareholders of
record as of February 28, 2011.
Credit
Facility
On February 1, 2011, the Holding Company entered into a
committed facility with a third-party bank to provide letters of
credit for the benefit of Missouri Reinsurance (Barbados) Inc.
(MoRe), a captive reinsurance subsidiary, to address
its short-term solvency needs based on guidance from the
regulator. This one-year facility provides for the issuance of
letters of credit in amounts up to $350 million. Under the
facility, a letter of credit for $250 million was issued on
February 2, 2011 and increased to $295 million on
February 23, 2011, which management believes satisfies
MoRes solvency requirements.
F-211
Schedule I
Consolidated Summary of Investments
MetLife,
Inc.
Schedule I
Consolidated
Summary of Investments
Other Than Investments in Related Parties
December 31, 2010
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount at
|
|
|
|
Cost or
|
|
|
Estimated
|
|
|
Which Shown on
|
|
Type of Investments
|
|
Amortized Cost (1)
|
|
|
Fair Value
|
|
|
Balance Sheet
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Bonds:
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign government securities
|
|
$
|
42,154
|
|
|
$
|
43,400
|
|
|
$
|
43,400
|
|
U.S. Treasury, agency and government guaranteed securities
|
|
|
32,469
|
|
|
|
33,304
|
|
|
|
33,304
|
|
Public utilities
|
|
|
11,416
|
|
|
|
12,040
|
|
|
|
12,040
|
|
State and political subdivision securities
|
|
|
10,476
|
|
|
|
10,129
|
|
|
|
10,129
|
|
All other corporate bonds
|
|
|
138,873
|
|
|
|
143,851
|
|
|
|
143,851
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total bonds
|
|
|
235,388
|
|
|
|
242,724
|
|
|
|
242,724
|
|
Mortgage-backed and asset-backed securities
|
|
|
79,406
|
|
|
|
79,698
|
|
|
|
79,698
|
|
Redeemable preferred stock
|
|
|
5,208
|
|
|
|
4,855
|
|
|
|
4,855
|
|
Other fixed maturity securities
|
|
|
6
|
|
|
|
7
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
|
320,008
|
|
|
|
327,284
|
|
|
|
327,284
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading and other securities
|
|
|
18,263
|
|
|
|
18,589
|
|
|
|
18,589
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial, miscellaneous and all other
|
|
|
2,036
|
|
|
|
2,167
|
|
|
|
2,167
|
|
Banks, trust and insurance companies
|
|
|
18
|
|
|
|
19
|
|
|
|
19
|
|
Public utilities
|
|
|
6
|
|
|
|
8
|
|
|
|
8
|
|
Non-redeemable preferred stock
|
|
|
1,565
|
|
|
|
1,412
|
|
|
|
1,412
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
|
3,625
|
|
|
|
3,606
|
|
|
|
3,606
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-for-investment
|
|
|
59,055
|
|
|
|
|
|
|
|
59,055
|
|
Held-for-sale
|
|
|
3,321
|
|
|
|
|
|
|
|
3,321
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans, net
|
|
|
62,376
|
|
|
|
|
|
|
|
62,376
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policy loans
|
|
|
11,914
|
|
|
|
|
|
|
|
11,914
|
|
Real estate and real estate joint ventures
|
|
|
7,878
|
|
|
|
|
|
|
|
7,878
|
|
Real estate acquired in satisfaction of debt
|
|
|
152
|
|
|
|
|
|
|
|
152
|
|
Other limited partnership interests
|
|
|
6,416
|
|
|
|
|
|
|
|
6,416
|
|
Short-term investments
|
|
|
9,387
|
|
|
|
|
|
|
|
9,387
|
|
Other invested assets
|
|
|
15,430
|
|
|
|
|
|
|
|
15,430
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investments
|
|
$
|
455,449
|
|
|
|
|
|
|
$
|
463,032
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Companys trading and other securities portfolio is
mainly comprised of fixed maturity and equity securities,
including mutual funds, and to a lesser extent, short-term
investments and cash and cash equivalents. Cost or amortized
cost for fixed maturity securities and mortgage loans
held-for-investment
represents original cost reduced by repayments, valuation
allowances and impairments from
other-than-temporary
declines in estimated fair value that are charged to earnings
and adjusted for amortization of premiums or discounts; for
equity securities, cost represents original cost reduced by
impairments from
other-than-temporary
declines in estimated fair value; for real estate, cost
represents original cost reduced by impairments and adjusted for
valuation allowances and depreciation; for real estate joint
ventures and other limited partnership interests cost represents
original cost reduced for
other-than-temporary
impairments or original cost adjusted for equity in earnings and
distributions. |
F-212
Schedule II
MetLife,
Inc.
Schedule II
Condensed
Financial Information of Registrant
December 31, 2010 and 2009
(In millions, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Condensed Balance Sheets
|
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
Investments:
|
|
|
|
|
|
|
|
|
Fixed maturity securities
available-for-sale,
at estimated fair value (amortized cost: $2,691 and $3,173,
respectively)
|
|
$
|
2,740
|
|
|
$
|
3,187
|
|
Equity securities
available-for-sale,
at estimated fair value (cost: $18 and $20, respectively)
|
|
|
15
|
|
|
|
17
|
|
Short-term investments, principally at estimated fair value
|
|
|
33
|
|
|
|
303
|
|
Other invested assets, at estimated fair value
|
|
|
114
|
|
|
|
37
|
|
|
|
|
|
|
|
|
|
|
Total investments
|
|
|
2,902
|
|
|
|
3,544
|
|
Cash and cash equivalents
|
|
|
624
|
|
|
|
679
|
|
Accrued investment income
|
|
|
42
|
|
|
|
36
|
|
Investment in subsidiaries
|
|
|
65,832
|
|
|
|
42,997
|
|
Loans to subsidiaries
|
|
|
1,275
|
|
|
|
1,575
|
|
Receivables from subsidiaries
|
|
|
73
|
|
|
|
11
|
|
Other assets
|
|
|
1,320
|
|
|
|
991
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
72,068
|
|
|
$
|
49,833
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders Equity
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
Payables for collateral under securities loaned and other
transactions
|
|
$
|
660
|
|
|
$
|
427
|
|
Long-term debt unaffiliated
|
|
|
16,258
|
|
|
|
10,458
|
|
Long-term debt affiliated
|
|
|
665
|
|
|
|
500
|
|
Collateral financing arrangements
|
|
|
2,797
|
|
|
|
2,797
|
|
Junior subordinated debt securities
|
|
|
1,748
|
|
|
|
1,748
|
|
Other liabilities
|
|
|
1,315
|
|
|
|
782
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
23,443
|
|
|
$
|
16,712
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity
|
|
|
|
|
|
|
|
|
Preferred stock, par value $0.01 per share;
200,000,000 shares authorized:
|
|
|
|
|
|
|
|
|
Preferred stock, 84,000,000 shares issued and outstanding;
$2,100 aggregate liquidation preference
|
|
|
1
|
|
|
|
1
|
|
Convertible preferred stock, 6,857,000 shares issued and
outstanding at December 31, 2010
|
|
|
|
|
|
|
|
|
Common stock, par value $0.01 per share;
3,000,000,000 shares authorized; 989,031,704 and
822,359,818 shares issued at December 31, 2010 and
2009, respectively; 985,837,817 and 818,833,810 shares
outstanding at December 31, 2010 and 2009, respectively
|
|
|
10
|
|
|
|
8
|
|
Additional paid-in capital
|
|
|
26,423
|
|
|
|
16,859
|
|
Retained earnings
|
|
|
21,363
|
|
|
|
19,501
|
|
Treasury stock, at cost; 3,193,887 and 3,526,008 shares at
December 31, 2010 and 2009, respectively
|
|
|
(172
|
)
|
|
|
(190
|
)
|
Accumulated other comprehensive income (loss)
|
|
|
1,000
|
|
|
|
(3,058
|
)
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
48,625
|
|
|
|
33,121
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$
|
72,068
|
|
|
$
|
49,833
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the condensed financial
information.
F-213
MetLife,
Inc.
Schedule II
Condensed
Financial Information of Registrant (Continued)
For the Years Ended December 31, 2010, 2009 and 2008
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Condensed Statements of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in earnings of subsidiaries
|
|
$
|
3,441
|
|
|
$
|
(1,811
|
)
|
|
$
|
3,666
|
|
Net investment income
|
|
|
144
|
|
|
|
153
|
|
|
|
167
|
|
Other income
|
|
|
144
|
|
|
|
155
|
|
|
|
149
|
|
Net investment gains (losses):
|
|
|
|
|
|
|
|
|
|
|
|
|
Other-than-temporary
impairments on fixed maturity securities
|
|
|
|
|
|
|
(23
|
)
|
|
|
(12
|
)
|
Other net investment gains (losses)
|
|
|
31
|
|
|
|
(85
|
)
|
|
|
139
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net investment gains (losses)
|
|
|
31
|
|
|
|
(108
|
)
|
|
|
127
|
|
Net derivative gains (losses)
|
|
|
(81
|
)
|
|
|
199
|
|
|
|
(399
|
)
|
Interest expense
|
|
|
(882
|
)
|
|
|
(776
|
)
|
|
|
(736
|
)
|
Other expenses
|
|
|
(319
|
)
|
|
|
(202
|
)
|
|
|
(89
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before provision for income tax
|
|
|
2,478
|
|
|
|
(2,390
|
)
|
|
|
2,885
|
|
Provision for income tax benefit
|
|
|
(312
|
)
|
|
|
(144
|
)
|
|
|
(324
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
2,790
|
|
|
|
(2,246
|
)
|
|
|
3,209
|
|
Less: Preferred stock dividends
|
|
|
122
|
|
|
|
122
|
|
|
|
125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to common shareholders
|
|
$
|
2,668
|
|
|
$
|
(2,368
|
)
|
|
$
|
3,084
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the condensed financial
information.
F-214
MetLife,
Inc.
Schedule II
Condensed
Financial Information of Registrant (Continued)
For the Years Ended December 31, 2010, 2009 and 2008
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Condensed Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
2,790
|
|
|
$
|
(2,246
|
)
|
|
$
|
3,209
|
|
Earnings of subsidiaries
|
|
|
(3,441
|
)
|
|
|
1,811
|
|
|
|
(3,666
|
)
|
Dividends from subsidiaries
|
|
|
916
|
|
|
|
515
|
|
|
|
1,148
|
|
Other, net
|
|
|
376
|
|
|
|
(458
|
)
|
|
|
509
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities
|
|
|
641
|
|
|
|
(378
|
)
|
|
|
1,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales of fixed maturity securities
|
|
|
7,422
|
|
|
|
1,005
|
|
|
|
3,970
|
|
Purchases of fixed maturity securities
|
|
|
(6,542
|
)
|
|
|
(3,002
|
)
|
|
|
(2,983
|
)
|
Sales of equity securities
|
|
|
5
|
|
|
|
|
|
|
|
|
|
Purchases of equity securities
|
|
|
|
|
|
|
(3
|
)
|
|
|
(1
|
)
|
Cash received in connection with freestanding derivatives
|
|
|
200
|
|
|
|
239
|
|
|
|
613
|
|
Cash paid in connection with freestanding derivatives
|
|
|
(450
|
)
|
|
|
(496
|
)
|
|
|
(315
|
)
|
Sales of businesses
|
|
|
|
|
|
|
130
|
|
|
|
|
|
Disposal of subsidiary
|
|
|
|
|
|
|
(19
|
)
|
|
|
(43
|
)
|
Purchases of businesses
|
|
|
(7,196
|
)
|
|
|
|
|
|
|
(202
|
)
|
Expense paid on behalf of subsidiaries
|
|
|
(72
|
)
|
|
|
(69
|
)
|
|
|
|
|
Repayments of loans to subsidiaries
|
|
|
300
|
|
|
|
|
|
|
|
400
|
|
Investment in preferred stock of subsidiary
|
|
|
(50
|
)
|
|
|
(75
|
)
|
|
|
|
|
Returns of capital from subsidiaries
|
|
|
54
|
|
|
|
|
|
|
|
|
|
Capital contributions to subsidiaries
|
|
|
(374
|
)
|
|
|
(876
|
)
|
|
|
(1,284
|
)
|
Net change in short-term investments
|
|
|
271
|
|
|
|
772
|
|
|
|
(1,073
|
)
|
Other, net
|
|
|
(35
|
)
|
|
|
186
|
|
|
|
(241
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(6,467
|
)
|
|
|
(2,208
|
)
|
|
|
(1,159
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in payables for collateral under securities loaned
and other transactions
|
|
|
233
|
|
|
|
84
|
|
|
|
(471
|
)
|
Net change in short-term debt
|
|
|
|
|
|
|
(300
|
)
|
|
|
(10
|
)
|
Long-term debt issued
|
|
|
2,987
|
|
|
|
1,647
|
|
|
|
|
|
Long-term debt paid
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash received in connection with collateral financing
arrangements
|
|
|
|
|
|
|
775
|
|
|
|
|
|
Cash paid in connection with collateral financing arrangements
|
|
|
|
|
|
|
(400
|
)
|
|
|
(800
|
)
|
Junior subordinated debt securities issued
|
|
|
|
|
|
|
500
|
|
|
|
|
|
Debt issuance costs
|
|
|
(14
|
)
|
|
|
(30
|
)
|
|
|
(8
|
)
|
Stock options exercised
|
|
|
5
|
|
|
|
8
|
|
|
|
45
|
|
Common stock issued, net of issuance costs
|
|
|
3,576
|
|
|
|
|
|
|
|
290
|
|
Common stock issued to settle stock forward contracts
|
|
|
|
|
|
|
1,035
|
|
|
|
|
|
Treasury stock acquired in connection with share repurchase
agreements
|
|
|
|
|
|
|
|
|
|
|
(1,250
|
)
|
Treasury stock issued in connection with common stock issuance,
net of issuance costs
|
|
|
|
|
|
|
|
|
|
|
1,936
|
|
Treasury stock issued to settle stock forward contracts
|
|
|
|
|
|
|
|
|
|
|
1,035
|
|
Dividends on preferred stock
|
|
|
(122
|
)
|
|
|
(122
|
)
|
|
|
(125
|
)
|
Dividends on common stock
|
|
|
(784
|
)
|
|
|
(610
|
)
|
|
|
(592
|
)
|
Other, net
|
|
|
(110
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
5,771
|
|
|
|
2,587
|
|
|
|
50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents
|
|
|
(55
|
)
|
|
|
1
|
|
|
|
91
|
|
Cash and cash equivalents, beginning of year
|
|
|
679
|
|
|
|
678
|
|
|
|
587
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of year
|
|
$
|
624
|
|
|
$
|
679
|
|
|
$
|
678
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-215
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash paid (received) during the year for:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
$
|
808
|
|
|
$
|
704
|
|
|
$
|
696
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax
|
|
$
|
(474
|
)
|
|
$
|
104
|
|
|
$
|
(249
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash transactions during the year:
|
|
|
|
|
|
|
|
|
|
|
|
|
Business acquisition:
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets acquired
|
|
$
|
125,689
|
|
|
$
|
|
|
|
$
|
|
|
Liabilities assumed
|
|
|
(109,267
|
)
|
|
|
|
|
|
|
|
|
Redeemable and non-redeemable noncontrolling interests assumed
|
|
|
(130
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net assets acquired
|
|
|
16,292
|
|
|
|
|
|
|
|
|
|
Cash paid, excluding transaction costs of $88, $0 and $0,
respectively
|
|
|
(7,196
|
)
|
|
|
|
|
|
|
|
|
Other purchase price adjustments
|
|
|
98
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities issued
|
|
$
|
9,194
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disposal of subsidiary:
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in subsidiary disposed
|
|
$
|
|
|
|
$
|
|
|
|
$
|
1,716
|
|
Transaction costs, including cash paid of $0, $19 and $43,
respectively
|
|
|
|
|
|
|
2
|
|
|
|
60
|
|
Treasury stock received in common stock exchange
|
|
|
|
|
|
|
|
|
|
|
(1,318
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on disposal of subsidiary
|
|
$
|
|
|
|
$
|
2
|
|
|
$
|
458
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remarketing of debt securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities redeemed
|
|
$
|
|
|
|
$
|
32
|
|
|
$
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt issued
|
|
$
|
|
|
|
$
|
1,035
|
|
|
$
|
1,035
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Junior subordinated debt securities redeemed
|
|
$
|
|
|
|
$
|
1,067
|
|
|
$
|
1,067
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contribution of goodwill to subsidiaries
|
|
$
|
|
|
|
$
|
|
|
|
$
|
22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contribution of other intangible assets to subsidiaries, net of
deferred income tax
|
|
$
|
|
|
|
$
|
|
|
|
$
|
97
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of collateral financing arrangements
|
|
$
|
|
|
|
$
|
105
|
|
|
$
|
310
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends from subsidiaries
|
|
$
|
874
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital contribution to subsidiary
|
|
$
|
|
|
|
$
|
105
|
|
|
$
|
310
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of interest expense to subsidiary
|
|
$
|
30
|
|
|
$
|
44
|
|
|
$
|
107
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of interest income to subsidiary
|
|
$
|
46
|
|
|
$
|
56
|
|
|
$
|
110
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of loan to subsidiary via transfer of fixed maturity
securities
|
|
$
|
|
|
|
$
|
300
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the condensed financial
information.
F-216
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial Information of Registrant
The condensed financial information of MetLife, Inc. (the
Holding Company or the Registrant)
should be read in conjunction with the consolidated financial
statements of MetLife, Inc. and its subsidiaries and the notes
thereto (the Consolidated Financial Statements).
These condensed unconsolidated financial statements reflect the
results of operations, financial position and cash flows for the
Holding Company. Investments in subsidiaries are accounted for
using the equity method of accounting.
The preparation of these condensed unconsolidated financial
statements in conformity with accounting principles generally
accepted in the United States of America (GAAP)
requires management to adopt accounting policies and make
certain estimates and assumptions. The most important of these
estimates and assumptions relate to the fair value measurements,
the accounting for goodwill and identifiable intangible assets
and the provision for potential losses that may arise from
litigation and regulatory proceedings and tax audits, which may
affect the amounts reported in the condensed unconsolidated
financial statements and accompanying notes. Actual results
could differ from these estimates.
On November 1, 2010, the Holding Company acquired all of
the issued and outstanding capital stock of American Life
Insurance Company (American Life) and Delaware
American Life Insurance Company (collectively,
ALICO). For further information on the
$16.4 billion purchase price including cash, common stock,
convertible preferred stock and common equity units, as well as
on the capital raised in anticipation of the acquisition, see
Notes 2, 11, 14 and 18 of the Notes to the Consolidated
Financial Statements.
The Holding Company lends funds, as necessary, to its
subsidiaries, some of which are regulated, to meet their capital
requirements. Such loans are included in loans to subsidiaries
and consisted of the following at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
Maturity
|
|
December 31,
|
|
Subsidiaries
|
|
Rate
|
|
Date
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Metropolitan Life Insurance Company
|
|
6-month LIBOR + 1.80%
|
|
December 31, 2011
|
|
$
|
775
|
|
|
$
|
775
|
|
Metropolitan Life Insurance Company
|
|
6-month LIBOR + 1.80%
|
|
December 31, 2011
|
|
|
|
|
|
|
300
|
|
Metropolitan Life Insurance Company
|
|
7.13%
|
|
December 15, 2032
|
|
|
400
|
|
|
|
400
|
|
Metropolitan Life Insurance Company
|
|
7.13%
|
|
January 15, 2033
|
|
|
100
|
|
|
|
100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
$
|
1,275
|
|
|
$
|
1,575
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In December 2009, the $700 million surplus note issued to
the Holding Company by Metropolitan Life Insurance Company
(MLIC) was renewed and increased to
$775 million, extending the maturity to December 31,
2011 with an interest rate of
6-month
LIBOR + 1.80%.
In December 2009, MLIC issued a surplus note to the Holding
Company for $300 million maturing in 2011 with an interest
rate of
6-month
LIBOR + 1.80%. MLIC received securities in exchange for the
surplus note. On December 29, 2010, MLIC repaid the
$300 million surplus note to the Holding Company in cash.
In June 2008, MetLife Investors USA Insurance Company repaid the
$400 million surplus note with an interest rate of 7.35% to
the Holding Company.
Interest income earned on loans to subsidiaries of
$63 million, $50 million and $81 million for the
years ended December 31, 2010, 2009 and 2008, respectively,
is included in net investment income.
F-217
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial Information of
Registrant (Continued)
Payments of interest and principal on surplus notes, which are
subordinate to all other obligations of the issuing company, may
be made only with the prior approval of the insurance department
of the state of domicile.
|
|
4.
|
Long-term
and Short-term Debt
|
Long-term
Debt
Long-term debt outstanding is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rates
|
|
|
|
|
December 31,
|
|
|
|
Range
|
|
Weighted Average
|
|
Maturity
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Senior notes unaffiliated
|
|
0.61%-7.72%
|
|
5.58%
|
|
|
2011-2045
|
|
|
$
|
16,258
|
|
|
$
|
10,458
|
|
Senior notes affiliated (1)
|
|
5.00%-6.82%
|
|
5.62%
|
|
|
2011-2020
|
|
|
|
165
|
|
|
|
|
|
Other affiliated debt
|
|
0.95%-1.23%
|
|
1.04%
|
|
|
2015-2016
|
|
|
|
500
|
|
|
|
500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
$
|
16,923
|
|
|
$
|
10,958
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Consists of affiliated senior notes associated with bonds held
by ALICO. |
The aggregate maturities of long-term debt at December 31,
2010 for the next five years and thereafter are
$751 million in 2011, $797 million in 2012,
$749 million in 2013, $1,350 million in 2014,
$1,284 million in 2015 and $11,992 million thereafter.
Short-term
Debt
There was no short-term debt outstanding at both
December 31, 2010 and 2009. During the years ended
December 31, 2009 and 2008, the weighted average interest
rate on short-term debt was 1.25% and 2.5%, respectively. During
the year ended December 31, 2009, the average daily balance
on short-term debt was $5 million, and the average days
outstanding was 6 days. There was no short-term debt
activity in 2010.
Interest
Expense
Interest expense is comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In millions)
|
|
|
Short-term debt
|
|
$
|
|
|
|
$
|
|
|
|
$
|
10
|
|
Long-term debt unaffiliated
|
|
|
689
|
|
|
|
589
|
|
|
|
412
|
|
Long-term debt affiliated
|
|
|
15
|
|
|
|
16
|
|
|
|
28
|
|
Collateral financing arrangements
|
|
|
44
|
|
|
|
59
|
|
|
|
121
|
|
Junior subordinated debt securities
|
|
|
134
|
|
|
|
112
|
|
|
|
164
|
|
Stock purchase contracts
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total interest expense
|
|
$
|
882
|
|
|
$
|
776
|
|
|
$
|
736
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Holding Company is party to various capital support
commitments and guarantees with certain of its subsidiaries and
a corporation in which it owns 50% of the equity. Under these
arrangements, the Holding Company
F-218
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial Information of
Registrant (Continued)
has agreed to cause each such entity to meet specified capital
and surplus levels or has guaranteed certain contractual
obligations.
In November 2010, the Holding Company guaranteed the obligations
of Exeter Reassurance Company Ltd. (Exeter) in an
aggregate amount up to $1.0 billion, under a reinsurance
agreement with MetLife Europe Limited (MEL), under
which Exeter reinsures the guaranteed living benefits and
guaranteed death benefits associated with certain unit-linked
annuity contracts issued by MEL.
In January 2010, the Holding Company guaranteed the obligations
of its subsidiary, Missouri Reinsurance (Barbados) Inc.
(MoRe), under a retrocession agreement with RGA
Reinsurance (Barbados) Inc., pursuant to which MoRe retrocedes
certain group term life insurance issued by MLIC.
In December 2009, the Holding Company, in connection with
MetLife Reinsurance Company of Vermonts (MRV)
reinsurance of certain universal life and term life insurance
risks, committed to the Vermont Department of Banking,
Insurance, Securities and Health Care Administration to
take necessary action to cause the third protected cell of MRV
to maintain total adjusted capital equal to or greater than 200%
of such protected cells authorized control level
risk-based capital (RBC), as defined in state
insurance statutes. See Note 11 of the Notes to the
Consolidated Financial Statements.
The Holding Company, in connection with MRVs reinsurance
of certain universal life and term life insurance risks,
committed to the Vermont Department of Banking, Insurance,
Securities and Health Care Administration to take necessary
action to cause each of the two initial protected cells of MRV
to maintain total adjusted capital equal to or greater than 200%
of such protected cells authorized control level RBC,
as defined in state insurance statutes. See Note 11 of the
Notes to the Consolidated Financial Statements.
The Holding Company, in connection with the collateral financing
arrangement associated with MetLife Reinsurance Company of
Charlestons (MRC) reinsurance of a portion of
the liabilities associated with the closed block, committed to
the South Carolina Department of Insurance to make capital
contributions, if necessary, to MRC so that MRC may at all times
maintain its total adjusted capital at a level of not less than
200% of the company action level RBC, as defined in state
insurance statutes as in effect on the date of determination or
December 31, 2007, whichever calculation produces the
greater capital requirement, or as otherwise required by the
South Carolina Department of Insurance. See Note 12 of the
Notes to the Consolidated Financial Statements.
The Holding Company, in connection with the collateral financing
arrangement associated with MetLife Reinsurance Company of South
Carolinas (MRSC) reinsurance of universal life
secondary guarantees, committed to the South Carolina Department
of Insurance to take necessary action to cause MRSC to maintain
total adjusted capital equal to the greater of $250,000 or 100%
of MRSCs authorized control level RBC, as defined in
state insurance statutes. See Note 12 of the Notes to the
Consolidated Financial Statements.
The Holding Company has net worth maintenance agreements with
two of its insurance subsidiaries, MetLife Investors Insurance
Company and First MetLife Investors Insurance Company. Under
these agreements, as subsequently amended, the Holding Company
agreed, without limitation as to the amount, to cause each of
these subsidiaries to have a minimum capital and surplus of
$10 million, total adjusted capital at a level not less
than 150% of the company action level RBC, as defined by
state insurance statutes, and liquidity necessary to enable it
to meet its current obligations on a timely basis.
The Holding Company has a net worth maintenance agreement with
Mitsui Sumitomo MetLife Insurance Company Limited (MSI
MetLife), an investment in Japan of which the Holding
Company owns 50% of the equity. Under the agreement, the Holding
Company agreed, without limitation as to amount, to cause MSI
MetLife to have the amount of capital and surplus necessary for
MSI MetLife to maintain a solvency ratio of at least 400%, as
calculated in accordance with the Insurance Business Law of
Japan, and to make such loans to MSI MetLife as may be necessary
to ensure that MSI MetLife has sufficient cash or other liquid
assets to meet its payment
F-219
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial Information of
Registrant (Continued)
obligations as they fall due. As described in Note 2 of the
Notes to the Consolidated Financial Statements, the Holding
Company reached an agreement to sell its 50% interest in MSI
MetLife to a third-party. Upon the close of such sale, the
Holding Companys obligations under the net worth
maintenance agreement will terminate.
The Holding Company has guaranteed the obligations of its
subsidiary, Exeter, under a reinsurance agreement with MSI
MetLife under which Exeter reinsures variable annuities written
by MSI MetLife. This guarantee will remain in place until such
time as the reinsurance agreement between Exeter and MSI MetLife
is terminated, notwithstanding any prior disposition of the
Holding Companys interest in MSI MetLife as described in
Note 2 of the Notes to the Consolidated Financial
Statements.
The Holding Company also guarantees the obligations of a number
of its subsidiaries under credit facilities with third-party
banks. See Note 11 of the Notes to the Consolidated
Financial Statements.
F-220
Schedule III
MetLife,
Inc.
Schedule III
Consolidated
Supplementary Insurance Information
December 31, 2010, 2009 and 2008
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future Policy Benefits,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Policy-Related
|
|
|
|
|
|
|
|
|
|
|
|
|
DAC
|
|
|
Balances and
|
|
|
Policyholder
|
|
|
Policyholder
|
|
|
|
|
|
|
and
|
|
|
Policyholder Dividend
|
|
|
Account
|
|
|
Dividends
|
|
|
Unearned
|
|
Segment
|
|
VOBA
|
|
|
Obligation
|
|
|
Balances
|
|
|
Payable
|
|
|
Revenue (1)
|
|
|
2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Business:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance Products
|
|
$
|
9,080
|
|
|
$
|
79,643
|
|
|
$
|
29,407
|
|
|
$
|
722
|
|
|
$
|
988
|
|
Retirement Products
|
|
|
5,800
|
|
|
|
8,975
|
|
|
|
46,517
|
|
|
|
|
|
|
|
103
|
|
Corporate Benefit Funding
|
|
|
75
|
|
|
|
39,371
|
|
|
|
57,773
|
|
|
|
|
|
|
|
53
|
|
Auto & Home
|
|
|
190
|
|
|
|
3,207
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Business
|
|
|
15,145
|
|
|
|
131,196
|
|
|
|
133,697
|
|
|
|
722
|
|
|
|
1,144
|
|
International
|
|
|
12,159
|
|
|
|
52,638
|
|
|
|
77,281
|
|
|
|
108
|
|
|
|
975
|
|
Banking, Corporate & Other
|
|
|
3
|
|
|
|
6,221
|
|
|
|
42
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
27,307
|
|
|
$
|
190,055
|
|
|
$
|
211,020
|
|
|
$
|
830
|
|
|
$
|
2,119
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Business:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance Products
|
|
$
|
10,103
|
|
|
$
|
76,948
|
|
|
$
|
28,118
|
|
|
$
|
761
|
|
|
$
|
1,123
|
|
Retirement Products
|
|
|
6,024
|
|
|
|
8,348
|
|
|
|
46,855
|
|
|
|
|
|
|
|
79
|
|
Corporate Benefit Funding
|
|
|
74
|
|
|
|
37,574
|
|
|
|
55,522
|
|
|
|
|
|
|
|
62
|
|
Auto & Home
|
|
|
181
|
|
|
|
3,156
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Business
|
|
|
16,382
|
|
|
|
126,026
|
|
|
|
130,495
|
|
|
|
761
|
|
|
|
1,264
|
|
International
|
|
|
2,870
|
|
|
|
12,467
|
|
|
|
8,128
|
|
|
|
|
|
|
|
805
|
|
Banking, Corporate & Other
|
|
|
4
|
|
|
|
5,832
|
|
|
|
50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
19,256
|
|
|
$
|
144,325
|
|
|
$
|
138,673
|
|
|
$
|
761
|
|
|
$
|
2,069
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Business:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance Products
|
|
$
|
11,555
|
|
|
$
|
74,515
|
|
|
$
|
26,510
|
|
|
$
|
1,023
|
|
|
$
|
1,213
|
|
Retirement Products
|
|
|
5,889
|
|
|
|
7,924
|
|
|
|
44,316
|
|
|
|
|
|
|
|
54
|
|
Corporate Benefit Funding
|
|
|
74
|
|
|
|
36,763
|
|
|
|
66,375
|
|
|
|
|
|
|
|
73
|
|
Auto & Home
|
|
|
183
|
|
|
|
3,126
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Business
|
|
|
17,701
|
|
|
|
122,328
|
|
|
|
137,201
|
|
|
|
1,023
|
|
|
|
1,340
|
|
International
|
|
|
2,436
|
|
|
|
10,468
|
|
|
|
5,654
|
|
|
|
|
|
|
|
583
|
|
Banking, Corporate & Other
|
|
|
7
|
|
|
|
5,521
|
|
|
|
66
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
20,144
|
|
|
$
|
138,317
|
|
|
$
|
142,921
|
|
|
$
|
1,023
|
|
|
$
|
1,923
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Amounts are included within the future policy benefits, other
policy-related balances and policyholder dividend obligation
column. |
F-221
MetLife,
Inc.
Schedule III (Continued)
Consolidated
Supplementary Insurance Information
December 31, 2010, 2009 and 2008
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of
|
|
|
|
|
|
|
|
|
|
Premium
|
|
|
Net
|
|
|
Policyholder
|
|
|
DAC and VOBA
|
|
|
Other
|
|
|
|
|
|
|
Revenue and
|
|
|
Investment
|
|
|
Benefits and
|
|
|
Charged to
|
|
|
Operating
|
|
|
Premiums Written
|
|
Segment
|
|
Policy Charges
|
|
|
Income
|
|
|
Interest Credited
|
|
|
Other Expenses
|
|
|
Expenses (1)
|
|
|
(Excluding Life)
|
|
|
2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Business:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance Products
|
|
$
|
19,448
|
|
|
$
|
5,924
|
|
|
$
|
18,568
|
|
|
$
|
1,056
|
|
|
$
|
4,714
|
|
|
$
|
5,899
|
|
Retirement Products
|
|
|
3,109
|
|
|
|
3,147
|
|
|
|
3,491
|
|
|
|
759
|
|
|
|
1,372
|
|
|
|
|
|
Corporate Benefit Funding
|
|
|
2,164
|
|
|
|
5,147
|
|
|
|
5,539
|
|
|
|
16
|
|
|
|
444
|
|
|
|
|
|
Auto & Home
|
|
|
2,923
|
|
|
|
209
|
|
|
|
2,021
|
|
|
|
439
|
|
|
|
321
|
|
|
|
2,970
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Business
|
|
|
27,644
|
|
|
|
14,427
|
|
|
|
29,619
|
|
|
|
2,270
|
|
|
|
6,851
|
|
|
|
8,869
|
|
International
|
|
|
5,776
|
|
|
|
1,747
|
|
|
|
4,865
|
|
|
|
530
|
|
|
|
1,592
|
|
|
|
1,183
|
|
Banking, Corporate & Other
|
|
|
11
|
|
|
|
1,441
|
|
|
|
(14
|
)
|
|
|
1
|
|
|
|
3,045
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
33,431
|
|
|
$
|
17,615
|
|
|
$
|
34,470
|
|
|
$
|
2,801
|
|
|
$
|
11,488
|
|
|
$
|
10,052
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Business:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance Products
|
|
$
|
19,422
|
|
|
$
|
5,540
|
|
|
$
|
18,431
|
|
|
$
|
753
|
|
|
$
|
4,981
|
|
|
$
|
5,936
|
|
Retirement Products
|
|
|
2,632
|
|
|
|
2,879
|
|
|
|
3,638
|
|
|
|
(315
|
)
|
|
|
1,367
|
|
|
|
|
|
Corporate Benefit Funding
|
|
|
2,440
|
|
|
|
4,715
|
|
|
|
5,942
|
|
|
|
15
|
|
|
|
443
|
|
|
|
|
|
Auto & Home
|
|
|
2,902
|
|
|
|
180
|
|
|
|
1,930
|
|
|
|
436
|
|
|
|
331
|
|
|
|
2,898
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Business
|
|
|
27,396
|
|
|
|
13,314
|
|
|
|
29,941
|
|
|
|
889
|
|
|
|
7,122
|
|
|
|
8,834
|
|
International
|
|
|
4,248
|
|
|
|
1,024
|
|
|
|
3,240
|
|
|
|
415
|
|
|
|
1,213
|
|
|
|
645
|
|
Banking, Corporate & Other
|
|
|
19
|
|
|
|
499
|
|
|
|
4
|
|
|
|
3
|
|
|
|
2,564
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
31,663
|
|
|
$
|
14,837
|
|
|
$
|
33,185
|
|
|
$
|
1,307
|
|
|
$
|
10,899
|
|
|
$
|
9,479
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Business:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance Products
|
|
$
|
18,591
|
|
|
$
|
5,786
|
|
|
$
|
17,640
|
|
|
$
|
687
|
|
|
$
|
5,091
|
|
|
$
|
5,594
|
|
Retirement Products
|
|
|
2,566
|
|
|
|
2,579
|
|
|
|
2,609
|
|
|
|
1,933
|
|
|
|
1,123
|
|
|
|
|
|
Corporate Benefit Funding
|
|
|
2,575
|
|
|
|
5,668
|
|
|
|
6,666
|
|
|
|
29
|
|
|
|
424
|
|
|
|
|
|
Auto & Home
|
|
|
2,971
|
|
|
|
186
|
|
|
|
1,919
|
|
|
|
454
|
|
|
|
355
|
|
|
|
2,949
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Business
|
|
|
26,703
|
|
|
|
14,219
|
|
|
|
28,834
|
|
|
|
3,103
|
|
|
|
6,993
|
|
|
|
8,543
|
|
International
|
|
|
4,565
|
|
|
|
1,249
|
|
|
|
3,338
|
|
|
|
381
|
|
|
|
1,325
|
|
|
|
846
|
|
Banking, Corporate & Other
|
|
|
27
|
|
|
|
821
|
|
|
|
53
|
|
|
|
5
|
|
|
|
1,891
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
31,295
|
|
|
$
|
16,289
|
|
|
$
|
32,225
|
|
|
$
|
3,489
|
|
|
$
|
10,209
|
|
|
$
|
9,389
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes other expenses and policyholder dividends, excluding
amortization of deferred policy acquisition costs
(DAC) and value of business acquired
(VOBA), charged to other expenses. |
F-222
Schedule IV
MetLife,
Inc.
Schedule IV
Consolidated
Reinsurance
December 31, 2010, 2009 and 2008
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Amount
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assumed
|
|
|
|
Gross Amount
|
|
|
Ceded
|
|
|
Assumed
|
|
|
Net Amount
|
|
|
to Net
|
|
|
2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance in-force
|
|
$
|
4,208,692
|
|
|
$
|
743,438
|
|
|
$
|
628,879
|
|
|
$
|
4,094,133
|
|
|
|
15.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premium
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance
|
|
$
|
17,576
|
|
|
$
|
1,472
|
|
|
$
|
1,183
|
|
|
$
|
17,287
|
|
|
|
6.8
|
%
|
Accident and health
|
|
|
7,349
|
|
|
|
365
|
|
|
|
189
|
|
|
|
7,173
|
|
|
|
2.6
|
%
|
Property and casualty insurance
|
|
|
2,998
|
|
|
|
69
|
|
|
|
5
|
|
|
|
2,934
|
|
|
|
0.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total insurance premium
|
|
$
|
27,923
|
|
|
$
|
1,906
|
|
|
$
|
1,377
|
|
|
$
|
27,394
|
|
|
|
5.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance in-force
|
|
$
|
3,800,380
|
|
|
$
|
715,405
|
|
|
$
|
740,196
|
|
|
$
|
3,825,171
|
|
|
|
19.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premium
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance
|
|
$
|
17,594
|
|
|
$
|
1,816
|
|
|
$
|
1,223
|
|
|
$
|
17,001
|
|
|
|
7.2
|
%
|
Accident and health
|
|
|
6,897
|
|
|
|
430
|
|
|
|
79
|
|
|
|
6,546
|
|
|
|
1.2
|
%
|
Property and casualty insurance
|
|
|
2,981
|
|
|
|
79
|
|
|
|
11
|
|
|
|
2,913
|
|
|
|
0.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total insurance premium
|
|
$
|
27,472
|
|
|
$
|
2,325
|
|
|
$
|
1,313
|
|
|
$
|
26,460
|
|
|
|
5.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance in-force
|
|
$
|
3,697,999
|
|
|
$
|
715,741
|
|
|
$
|
684,281
|
|
|
$
|
3,666,539
|
|
|
|
18.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premium
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance
|
|
$
|
17,252
|
|
|
$
|
2,066
|
|
|
$
|
1,224
|
|
|
$
|
16,410
|
|
|
|
7.5
|
%
|
Accident and health
|
|
|
6,741
|
|
|
|
444
|
|
|
|
226
|
|
|
|
6,523
|
|
|
|
3.5
|
%
|
Property and casualty insurance
|
|
|
3,065
|
|
|
|
100
|
|
|
|
16
|
|
|
|
2,981
|
|
|
|
0.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total insurance premium
|
|
$
|
27,058
|
|
|
$
|
2,610
|
|
|
$
|
1,466
|
|
|
$
|
25,914
|
|
|
|
5.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-223
|
|
Item 9.
|
Changes
in and Disagreements With Accountants on Accounting and
Financial Disclosure
|
None.
|
|
Item 9A.
|
Controls
and Procedures
|
Management, with the participation of the Chief Executive
Officer and Chief Financial Officer, has evaluated the
effectiveness of the design and operation of the Companys
disclosure controls and procedures as defined in Exchange Act
Rule 13a-15(e)
as of the end of the period covered by this report. Based on
that evaluation, the Chief Executive Officer and Chief Financial
Officer have concluded that these disclosure controls and
procedures are effective.
Managements
Annual Report on Internal Control Over Financial
Reporting
Management of MetLife, Inc. and subsidiaries is responsible for
establishing and maintaining adequate internal control over
financial reporting. In fulfilling this responsibility,
estimates and judgments by management are required to assess the
expected benefits and related costs of control procedures. The
objectives of internal control include providing management with
reasonable, but not absolute, assurance that assets are
safeguarded against loss from unauthorized use or disposition,
and that transactions are executed in accordance with
managements authorization and recorded properly to permit
the preparation of consolidated financial statements in
conformity with accounting principles generally accepted in the
United States of America (GAAP).
Management has documented and evaluated the effectiveness of the
internal control of the Company at December 31, 2010
pertaining to financial reporting in accordance with the
criteria established in Internal Control Integrated
Framework issued by the Committee of Sponsoring Organizations of
the Treadway Commission.
On November 1, 2010, the Holding Company acquired all of
the issued and outstanding capital stock of American Life
Insurance Company and Delaware American Life Insurance Company
(collectively, ALICO). As allowed under the
U.S. Securities and Exchange Commission (the
SEC) guidance, managements assessment of and
conclusion regarding the design and effectiveness of internal
control over financial reporting excluded the internal control
over financial reporting of ALICO, which is relevant to the
Companys 2010 consolidated financial statements as of and
for the year ended December 31, 2010. ALICO represents 17%
of total assets, and 2% of total revenues of MetLife, Inc. as of
and for the year ended December 31, 2010. The financial
reporting systems of ALICO have not yet been integrated into the
Companys financial reporting systems and, as such, the
Company did not have the practical ability to perform an
assessment of ALICOs internal control over financial
reporting in time for this current year-end. Management expects
to complete the process of integrating ALICOs internal
control over financial reporting over the course of 2011. The
ALICO acquisition represents a material change in internal
control over financial reporting as defined in Exchange Act
Rule 13a-15(f)
during the quarter ended December 31, 2010.
In the opinion of management, MetLife, Inc. maintained effective
internal control over financial reporting at December 31,
2010.
Deloitte & Touche LLP, an independent registered
public accounting firm, has audited the consolidated financial
statements and consolidated financial statement schedules
included in the Annual Report on
Form 10-K
for the year ended December 31, 2010. The Report of the
Independent Registered Public Accounting Firm on their audit of
the consolidated financial statements and consolidated financial
statement schedules is included at
page F-1.
Attestation
Report of the Companys Registered Public Accounting
Firm
The Companys independent registered public accounting
firm, Deloitte & Touche LLP, has issued their
attestation report on managements internal control over
financial reporting which is set forth below.
192
Report of
Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders of
MetLife, Inc.:
We have audited the internal control over financial reporting of
MetLife, Inc. and subsidiaries (the Company) as of
December 31, 2010, based on criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission. As described in Managements Annual Report on
Internal Control Over Financial Reporting, management excluded
from its assessment the internal control over financial
reporting at ALICO, acquired on November 1, 2010, as the
financial reporting systems of ALICO have not yet been
integrated into the Companys financial reporting systems
and, as such, the Company did not have the practical ability to
perform an assessment of ALICOs internal control over
financial reporting in time for this current year-end. ALICO
represents 17% of total assets and 2% of total revenues of the
Company as of and for the year ended December 31, 2010.
Accordingly, our audit did not include the internal control over
financial reporting at ALICO. The Companys management is
responsible for maintaining effective internal control over
financial reporting and for its assessment of the effectiveness
of internal control over financial reporting, included in the
accompanying Managements Annual Report on Internal Control
Over Financial Reporting. Our responsibility is to express an
opinion on the Companys internal control over financial
reporting based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, assessing the risk
that a material weakness exists, testing and evaluating the
design and operating effectiveness of internal control based on
the assessed risk, and performing such other procedures as we
considered necessary in the circumstances. We believe that our
audit provides a reasonable basis for our opinion.
A companys internal control over financial reporting is a
process designed by, or under the supervision of, the
companys principal executive and principal financial
officers, or persons performing similar functions, and effected
by the companys board of directors, management, and other
personnel to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of the inherent limitations of internal control over
financial reporting, including the possibility of collusion or
improper management override of controls, material misstatements
due to error or fraud may not be prevented or detected on a
timely basis. Also, projections of any evaluation of the
effectiveness of the internal control over financial reporting
to future periods are subject to the risk that the controls may
become inadequate because of changes in conditions, or that the
degree of compliance with the policies or procedures may
deteriorate.
In our opinion, the Company maintained, in all material
respects, effective internal control over financial reporting as
of December 31, 2010, based on the criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission.
We have also audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
consolidated financial statements and financial statement
schedules of the Company as of and for the year ended
December 31, 2010, and our report dated February 24, 2011
expressed an unqualified opinion on those consolidated financial
statements and financial statement schedules.
/s/ DELOITTE &
TOUCHE LLP
DELOITTE &
TOUCHE LLP
New York, New York
February 24, 2011
193
|
|
Item 9B.
|
Other
Information
|
None.
194
Part III
|
|
Item 10.
|
Directors,
Executive Officers and Corporate Governance
|
The information called for by this Item pertaining to Directors
is incorporated herein by reference to the sections entitled
Proposal 1 Election of Directors,
Corporate Governance Information About the
Board of Directors, Corporate Governance
Board Committees, Corporate Governance
Membership on Board Committees and Security
Ownership of Directors and Executive Officers
Section 16(a) Beneficial Ownership Reporting
Compliance in MetLife, Inc.s definitive proxy
statement for the Annual Meeting of Shareholders to be held on
April 26, 2011, to be filed by MetLife, Inc. with the SEC
pursuant to Regulation 14A within 120 days after the
year ended December 31, 2010 (the 2011 Proxy
Statement).
The information called for by this Item pertaining to Executive
Officers appears in Part I Item 1.
Business Executive Officers of the Registrant
and Security Ownership of Directors and Executive
Officers Section 16(a) Beneficial Ownership
Reporting Compliance in the 2011 Proxy Statement.
The Company has adopted the MetLife Financial Management Code of
Professional Conduct (the Financial Management
Code), a code of ethics as defined under the
rules of the SEC, that applies to the Holding Companys
Chief Executive Officer, Chief Financial Officer, Chief
Accounting Officer and all professionals in finance and
finance-related departments. In addition, the Company has
adopted the Directors Code of Business Conduct and Ethics
(the Directors Code) which applies to all
members of the Holding Companys Board of Directors,
including the Chief Executive Officer, and the Employee Code of
Business Conduct and Ethics (together with the Financial
Management Code and the Directors Code, collectively, the
Ethics Codes), which applies to all employees of the
Company, including the Holding Companys Chief Executive
Officer, Chief Financial Officer and Chief Accounting Officer.
The Ethics Codes are available on the Companys website at
http://www.metlife.com/about/corporate-profile/corporate-governance/corporate-conduct/index.html.
The Company intends to satisfy its disclosure obligations under
Item 5.05 of
Form 8-K
by posting information about amendments to, or waivers from a
provision of, the Ethics Codes that apply to the Holding
Companys Chief Executive Officer, Chief Financial Officer
and Chief Accounting Officer on the Companys website at
the address given above.
|
|
Item 11.
|
Executive
Compensation
|
The information called for by this Item is incorporated herein
by reference to the sections entitled Corporate
Governance Board Committees, Corporate
Governance Compensation of Non-Management
Directors, Compensation Committee Report,
Compensation Discussion and Analysis, Summary
Compensation Table, Grants of Plan-Based Awards in
2010, Outstanding Equity Awards at 2010 Fiscal
Year-End, Option Exercises and Stock Vested in
2010, Pension Benefits, Nonqualified
Deferred Compensation and Potential Payments Upon
Termination or
Change-in-Control
in the 2011 Proxy Statement.
|
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters
|
The information called for by this Item pertaining to ownership
of the Holding Companys common stock is incorporated
herein by reference to the sections entitled Security
Ownership of Directors and Executive Officers and
Security Ownership of Certain Beneficial Owners in
the 2011 Proxy Statement. The following table provides
195
information, at December 31, 2010, regarding the securities
authorized for issuance under the Holding Companys equity
compensation plans:
Equity
Compensation Plan Information at December 31,
2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
|
|
|
Remaining Available for
|
|
|
|
|
|
|
Future Issuance Under
|
|
|
Number of Securities to
|
|
Weighted-average
|
|
Equity Compensation
|
|
|
be Issued upon Exercise
|
|
Exercise Price of
|
|
Plans (Excluding
|
|
|
of Outstanding Options,
|
|
Outstanding Options,
|
|
Securities Reflected
|
|
|
Warrants and Rights (2)
|
|
Warrants and Rights (3)
|
|
in Column (a))
(4)
|
Plan Category
|
|
(a)
|
|
(b)
|
|
(c)
|
|
Equity compensation plans approved by security holders (1)
|
|
|
44,703,216
|
|
|
$
|
38.47
|
|
|
|
42,285,559
|
|
Equity compensation plans not approved by security holders
|
|
|
None
|
|
|
|
|
|
|
|
None
|
|
Total
|
|
|
44,703,216
|
|
|
$
|
38.47
|
|
|
|
42,285,559
|
|
|
|
|
(1) |
|
Includes the MetLife, Inc. 2000 Stock Incentive Plan (the
2000 Stock Plan) and the MetLife, Inc.
2000 Directors Stock Plan (the 2000 Directors
Stock Plan) each of which was approved by Metropolitan
Life Insurance Company (MLIC), the sole shareholder
of the Holding Company at the time of approval. The
policyholders of MLIC entitled to vote on its plan of
reorganization (the Plan of Reorganization) approved
the Plan of Reorganization, which included both the 2000 Stock
Plan and the 2000 Directors Stock Plan. The policyholders
entitled to so vote received a summary description of each plan,
including the applicable limits on the number of shares of
common stock of the Holding Company (Shares)
available for issuance under each plan. Also includes the
MetLife, Inc. 2005 Stock and Incentive Compensation Plan (the
2005 Stock Plan) and the MetLife, Inc. 2005
Non-Management Director Stock Compensation Plan (the
2005 Directors Stock Plan), which were approved
by Holding Company security holders. |
|
(2) |
|
As of December 31, 2010, awards of Stock Options remained
outstanding under the 2000 Stock Plan and 2000 Directors
Stock Plan, and awards of Stock Options, Performance Shares, and
Restricted Stock Units (each as defined in the 2005 Stock Plan)
remained outstanding under the 2005 Stock Plan. In addition, as
of December 31, 2010, a number of Shares that had vested
and become payable from any awards under any plan, but had been
deferred, remained deferred and unpaid (Deferred
Shares). |
|
|
|
Under the award agreements that apply to the Performance Share
awards made under the 2005 Stock Plan as of December 31,
2010, Shares are payable to eligible award recipients following
the conclusion of the performance period. The number of shares
payable is determined by multiplying the number of performance
shares by a performance factor (from 0% to 200%) based on the
performance of the Holding Company with respect to:
(i) change in annual net operating earnings per share; and
(ii) proportionate total shareholder return, as defined, as
a percentile of the performance of other companies in the
Fortune
500®
companies in the Standard & Poors Insurance
Index, with such exceptions as the Holding Company Compensation
Committee has determined, with regard to the performance period.
With respect to Performance Share awards made in 2010, no
Performance Shares will be payable unless the Holding Company
generates positive net income for either the third year of the
performance period or for the performance period as a whole. In
addition, with respect to Performance Share awards made in 2009
and 2010, the performance factor will be multiplied by 0.75 if
the Holding Companys total shareholder return with regard
to the performance period is zero percent or less. |
|
|
|
Under the award agreements that apply to the Restricted Stock
Unit awards made under the 2005 Stock Plan as of
December 31, 2010, Shares equal to the number of Restricted
Stock Units awarded are normally payable to eligible award
recipients on the third or later anniversary of the date the
Restricted Stock Units were granted. |
|
(3) |
|
Column (b) reflects the weighted average exercise price of
all Stock Options under any plan that, as of December 31,
2010, had been granted but not forfeited, expired, or exercised.
Performance Shares, Restricted Stock Units, and Deferred Shares
are not included in determining the weighted average in column
(b) because they have no exercise price. |
196
|
|
|
(4) |
|
The aggregate number of Shares available for issuance under the
2005 Stock Plan is 68,000,000. In addition,
6,099,881 Shares that were available but had not been
utilized under the 2000 Stock Plan became available for issuance
under the 2005 Stock Plan at the time the 2005 Stock Plan became
effective. At December 31, 2010, 6,957,603 additional
Shares recovered due to forfeiture or expiration of awards under
the 2000 Stock Plan, or that, under the Plan of Reorganization,
would otherwise have reduced the number of Shares available for
issuance under the 2000 Stock Plan, from the time the 2005 Stock
Plan became effective to December 31, 2010, were also
available for issuance under the 2005 Stock Plan. The aggregate
number of Shares available for issuance under the
2005 Directors Stock Plan is 2,000,000. |
|
|
|
Each Share issued under the 2005 Stock Plan in connection with
awards other than Stock Options or Stock Appreciation Rights
(including Shares payable on account of Performance Shares,
Restricted Stock Units, and Stock-Based Awards) reduces the
number of Shares remaining for issuance under the 2005 Stock
Plan by 1.179 Shares. Each Share issued under the 2005
Stock Plan in connection with a Stock Option or Stock
Appreciation Right reduces the number of Shares remaining for
issuance under the 2005 Stock Plan by 1.0. |
|
|
|
As of December 31, 2010, all Stock-Based awards made under
the 2005 Directors Stock Plan have been immediately vested.
Share awards to Directors under the 2000 Directors Stock
Plan were made under a separate Share award authorization under
that plan, and have not reduced the number of Shares remaining
available for issuance under any plan as of December 31,
2010. |
|
|
|
Under the 2005 Stock Plan, awards may be in the form of Stock
Options, Stock Appreciation Rights, Restricted Stock or
Restricted Stock Units, Performance Shares or Performance Share
Units, Cash-Based Awards, and Stock-Based Awards (each as
defined in the 2005 Stock Plan). Under the MetLife, Inc. 2005
Non-Management Director Stock Compensation Plan (the
2005 Directors Stock Plan), awards granted may
be in the form of non-qualified Stock Options, Stock
Appreciation Rights, Restricted Stock or Restricted Stock Units,
or Stock-Based Awards (each as defined in the
2005 Directors Stock Plan). Under both the 2005 Stock Plan
and the 2005 Directors Stock Plan, in the event of a
corporate event or transaction (including, but not limited to, a
change in the Shares or the capitalization of the Holding
Company) such as a merger, consolidation, reorganization,
recapitalization, separation, stock dividend, extraordinary
dividend, stock split, reverse stock split, split up, spin-off,
or other distribution of stock or property of the Holding
Company, combination of securities, exchange of securities,
dividend in kind, or other like change in capital structure or
distribution (other than normal cash dividends) to shareholders
of the Holding Company, or any similar corporate event or
transaction, the appropriate committee of the Board of Directors
of the Holding Company (each, a Committee), in order
to prevent dilution or enlargement of participants rights
under the applicable plan, shall in its sole discretion
substitute or adjust, as applicable, the number and kind of
Shares that may be issued under that plan and shall adjust the
number and kind of Shares subject to outstanding awards. Any
Shares related to awards under either plan which:
(i) terminate by expiration, forfeiture, cancellation, or
otherwise without the issuance of Shares; (ii) are settled
in cash either in lieu of Shares or otherwise; or (iii) are
exchanged with the appropriate Committees permission for
awards not involving Shares, are available again for grant under
the applicable plan. If the option price of any Stock Option
granted under either plan or the tax withholding requirements
with respect to any award granted under either plan are
satisfied by tendering Shares to the Holding Company (by either
actual delivery or by attestation), or if a Stock Appreciation
Right is exercised, only the number of Shares issued, net of the
Shares tendered, if any, will be deemed delivered for purposes
of determining the maximum number of Shares available for
issuance under that plan. The maximum number of Shares available
for issuance under either plan shall not be reduced to reflect
any dividends or dividend equivalents that are reinvested into
additional Shares or credited as additional Restricted Stock,
Restricted Stock Units, or Stock-Based Awards. |
197
|
|
Item 13.
|
Certain
Relationships and Related Transactions, and Director
Independence
|
The information called for by this Item is incorporated herein
by reference to the sections entitled Corporate
Governance Procedures for Reviewing Related Person
Transactions, Corporate Governance
Related Person Transactions and Corporate
Governance Information About the Board of
Directors Responsibilities, Independence and
Composition of the Board of Directors in the 2011 Proxy
Statement.
|
|
Item 14.
|
Principal
Accountant Fees and Services
|
The information called for by this item is incorporated herein
by reference to the section entitled
Proposal 4 Ratification of Appointment of
the Independent Auditor in the 2011 Proxy Statement.
198
Part IV
|
|
Item 15.
|
Exhibits
and Financial Statement Schedules
|
The following documents are filed as part of this report:
1. Financial Statements
The financial statements are listed in the Index to Consolidated
Financial Statements and Schedules on page 191.
2. Financial Statement Schedules
The financial statement schedules are listed in the Index to
Consolidated Financial Statements and Schedules on page 191.
3. Exhibits
The exhibits are listed in the Exhibit Index which begins
on
page E-1.
199
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
February 24, 2011
METLIFE, INC.
|
|
|
|
By
|
/s/ C.
Robert Henrikson
|
Name: C. Robert Henrikson
|
|
|
|
Title:
|
Chairman of the Board, President
|
and Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed below by the following persons
on behalf of the registrant and in the capacities and on the
dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Sylvia
Mathews Burwell
Sylvia
Mathews Burwell
|
|
Director
|
|
February 24, 2011
|
|
|
|
|
|
Eduardo
Castro-Wright
|
|
Director
|
|
|
|
|
|
|
|
/s/ Cheryl
W. Grisé
Cheryl
W. Grisé
|
|
Director
|
|
February 24, 2011
|
|
|
|
|
|
/s/ R.
Glenn Hubbard
R.
Glenn Hubbard
|
|
Director
|
|
February 24, 2011
|
|
|
|
|
|
/s/ John
M. Keane
John
M. Keane
|
|
Director
|
|
February 24, 2011
|
|
|
|
|
|
/s/ Alfred
F. Kelly, Jr.
Alfred
F. Kelly, Jr.
|
|
Director
|
|
February 24, 2011
|
|
|
|
|
|
/s/ James
M. Kilts
James
M. Kilts
|
|
Director
|
|
February 24, 2011
|
|
|
|
|
|
/s/ Catherine
R. Kinney
Catherine
R. Kinney
|
|
Director
|
|
February 24, 2011
|
|
|
|
|
|
/s/ Hugh
B. Price
Hugh
B. Price
|
|
Director
|
|
February 24, 2011
|
|
|
|
|
|
/s/ David
Satcher, M.D.
David
Satcher, M.D.
|
|
Director
|
|
February 24, 2011
|
200
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Kenton
J. Sicchitano
Kenton
J. Sicchitano
|
|
Director
|
|
February 24, 2011
|
|
|
|
|
|
/s/ Lulu
C. Wang
Lulu
C. Wang
|
|
Director
|
|
February 24, 2011
|
|
|
|
|
|
/s/ C.
Robert Henrikson
C.
Robert Henrikson
|
|
Chairman of the Board, President and Chief Executive Officer
(Principal Executive Officer)
|
|
February 24, 2011
|
|
|
|
|
|
/s/ William
J. Wheeler
William
J. Wheeler
|
|
Executive Vice President and Chief Financial Officer (Principal
Financial Officer)
|
|
February 24, 2011
|
|
|
|
|
|
/s/ Peter
M. Carlson
Peter
M. Carlson
|
|
Executive Vice President, Finance Operations and Chief
Accounting Officer (Principal Accounting Officer)
|
|
February 24, 2011
|
201
Exhibit Index
(Note Regarding Reliance on Statements in Our
Contracts: In reviewing the agreements included
as exhibits to this Annual Report on
Form 10-K,
please remember that they are included to provide you with
information regarding their terms and are not intended to
provide any other factual or disclosure information about
MetLife, Inc., its subsidiaries or the other parties to the
agreements. The agreements contain representations and
warranties by each of the parties to the applicable agreement.
These representations and warranties have been made solely for
the benefit of the other parties to the applicable agreement and
(i) should not in all instances be treated as categorical
statements of fact, but rather as a way of allocating the risk
to one of the parties if those statements prove to be
inaccurate; (ii) have been qualified by disclosures that
were made to the other party in connection with the negotiation
of the applicable agreement, which disclosures are not
necessarily reflected in the agreement; (iii) may apply
standards of materiality in a way that is different from what
may be viewed as material to investors; and (iv) were made
only as of the date of the applicable agreement or such other
date or dates as may be specified in the agreement and are
subject to more recent developments. Accordingly, these
representations and warranties may not describe the actual state
of affairs as of the date they were made or at any other time.
Additional information about us may be found elsewhere in this
Annual Report on
Form 10-K
and MetLife, Inc.s other public filings, which are
available without charge through the SECs website at
www.sec.gov.)
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
2.1
|
|
Plan of Reorganization (Incorporated by reference to
Exhibit 2.1 to MetLife, Inc.s Registration Statement
on
Form S-1
(No. 333-91517)
(the
S-1
Registration Statement)).
|
|
|
2.2
|
|
Amendment to Plan of Reorganization dated as of March 9,
2000 (Incorporated by reference to Exhibit 2.2 to the
S-1
Registration Statement).
|
|
|
2.3
|
|
Acquisition Agreement between MetLife, Inc. and Citigroup Inc.,
dated as of January 31, 2005 (Incorporated by reference to
Exhibit 2.3 to MetLife, Inc.s Annual Report on
Form 10-K
for the fiscal year ended December 31, 2009 (the 2009
Annual Report)).
|
|
|
2.4
|
|
Stock Purchase Agreement, dated as of March 7, 2010, by and
among MetLife, Inc., ALICO Holdings LLC (ALICO
Holdings) and American International Group, Inc.
(AIG) (Incorporated by reference to Exhibit 2.1
to MetLife, Inc. Current Report on
Form 8-K
dated May 7, 2010 (the May 7, 2010
Form 8-K)).
|
|
|
2.5
|
|
Amendment dated October 28, 2010 among MetLife, Inc., ALICO
Holdings and AIG amending the Stock Purchase Agreement, dated as
of March 7, 2010 by and among MetLife, Inc., ALICO Holdings
and AIG (the Stock Purchase Agreement) (Incorporated
by reference to Exhibit 2.1 to MetLife, Inc.s Current
Report on
Form 8-K
dated October 27, 2010 (the October 27, 2010
Form 8-K)).
|
|
|
2.6
|
|
Amendment dated October 29, 2010 among MetLife, Inc., ALICO
Holdings and AIG amending the Stock Purchase Agreement
(Incorporated by reference to Exhibit 2.2 to the
October 27, 2010
Form 8-K).
|
|
|
3.1
|
|
Amended and Restated Certificate of Incorporation of MetLife,
Inc. (Incorporated by reference to Exhibit 3.1 to MetLife,
Inc.s Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006 (the 2006
Annual Report)).
|
|
|
3.2
|
|
Certificate of Designation, Preferences and Rights of
Series A Junior Participating Preferred Stock of MetLife,
Inc., filed with the Secretary of State of Delaware on
April 7, 2000 (Incorporated by reference to
Exhibit 3.2 to the 2006 Annual Report).
|
|
|
3.3
|
|
Certificate of Designations of Floating Rate Non-Cumulative
Preferred Stock, Series A, of MetLife, Inc., filed with the
Secretary of State of Delaware on June 10, 2005
(Incorporated by reference to Exhibit 99.5 to MetLife,
Inc.s Registration Statement on
Form 8-A
filed on June 10, 2005).
|
|
|
3.4
|
|
Certificate of Designations of 6.50% Non-Cumulative Preferred
Stock, Series B, of MetLife, Inc., filed with the Secretary
of State of Delaware on June 14, 2005 (Incorporated by
reference to Exhibit 99.5 to MetLife, Inc.s
Registration Statement on
Form 8-A
filed on June 15, 2005).
|
|
|
3.5
|
|
Certificate of Designations of Series B Contingent
Convertible Junior Participating Non-Cumulative Perpetual
Preferred Stock, filed with the Secretary of State of Delaware
on October 27, 2010 (Incorporated by reference to
Exhibit 3.1 to MetLife, Inc.s Current Report on
Form 8-K
dated October 27, 2010).
|
|
|
E-1
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
3.6
|
|
MetLife, Inc. Amended and Restated By-Laws effective
January 26, 2010.
|
|
|
4.1(a)
|
|
Indenture dated as of November 9, 2001 between MetLife,
Inc. and Bank One Trust Company, N.A. (predecessor to The
Bank of New York Trust Company, N.A.) relating to Senior
Debt Securities (Incorporated by reference to
Exhibit 4.1(a) to the 2006 Annual Report).
|
|
|
4.1(b)
|
|
Form of Indenture for Senior Debt Securities between MetLife,
Inc. and one or more banking institutions to be qualified as
Trustee pursuant to Section 305(b)(2) of the
Trust Indenture Act of 1939 (Included in
Exhibit 4.1(a) incorporated by reference to
Exhibit 4.1(a) to the 2006 Annual Report, except for the
name of the trustee).
|
|
|
4.2
|
|
Second Supplemental Indenture dated as of November 27, 2001
between MetLife, Inc. and Bank One Trust Company, N.A.
(predecessor to The Bank of New York Trust Company, N.A.)
relating to the 6.125% Senior Notes due December 1,
2011(Incorporated by reference to Exhibit 4.3 to the 2006
Annual Report).
|
|
|
4.3
|
|
Third Supplemental Indenture dated as of December 10, 2002
between MetLife, Inc. and Bank One Trust Company, N.A.
(predecessor to The Bank of New York Trust Company, N.A.)
relating to the 5.375% Senior Notes due December 15,
2012 (Incorporated by reference to Exhibit 4.3 to MetLife,
Inc.s Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007 (the 2007
Annual Report)).
|
|
|
4.4
|
|
Fourth Supplemental Indenture dated as of December 10, 2002
between MetLife, Inc. and Bank One Trust Company, N.A.
(predecessor to The Bank of New York Trust Company, N.A.)
relating to the 6.50% Senior Notes due December 15,
2032 (Incorporated by reference to Exhibit 4.4 to the 2007
Annual Report).
|
|
|
4.5
|
|
Fifth Supplemental Indenture dated as of November 21, 2003
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.) relating to the 5.875% Senior
Notes due November 21, 2033 (Incorporated by reference to
Exhibit 4.5 to MetLife, Inc.s Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008 (the 2008
Annual Report)).
|
|
|
4.6
|
|
Sixth Supplemental Indenture dated as of November 24, 2003
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.) relating to the 5.00% Senior
Notes due November 24, 2013 (Incorporated by reference to
Exhibit 4.6 to the 2008 Annual Report).
|
|
|
4.7
|
|
Seventh Supplemental Indenture dated as of June 3, 2004
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as trustee, relating to the
5.50% Senior Notes due June 15, 2014 (Incorporated by
reference to Exhibit 4.7 to the 2009 Annual Report).
|
|
|
4.8
|
|
Eighth Supplemental Indenture dated as of June 3, 2004
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as trustee, relating to the
6.375% Senior Notes due June 15, 2034 (Incorporated by
reference to Exhibit 4.8 to the 2009 Annual Report).
|
|
|
4.9
|
|
Ninth Supplemental Indenture dated as of July 23, 2004
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as trustee, relating to the
5.50% Senior Notes due June 15, 2014 (Incorporated by
reference to Exhibit 4.9 to the 2009 Annual Report).
|
|
|
4.10
|
|
Tenth Supplemental Indenture dated as of July 23, 2004
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as trustee, relating to the
6.375% Senior Notes due June 15, 2034 (Incorporated by
reference to Exhibit 4.10 to the 2009 Annual Report).
|
|
|
4.11
|
|
Eleventh Supplemental Indenture dated as of December 9,
2004 between MetLife, Inc. and J.P. Morgan
Trust Company, National Association (predecessor to The
Bank of New York Trust Company, N.A.), as trustee, relating
to the 5.375% Senior Notes due December 9, 2024
(Incorporated by reference to Exhibit 4.11 to the 2009
Annual Report).
|
|
|
4.12
|
|
Twelfth Supplemental Indenture dated as of June 23, 2005
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as trustee, relating to the
5.00% Senior Notes due June 15, 2015.
|
|
|
4.13
|
|
Thirteenth Supplemental Indenture dated as of June 23, 2005
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as trustee, relating to the
5.70% Senior Notes due June 15, 2035.
|
|
|
E-2
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
4.14
|
|
Fourteenth Supplemental Indenture dated as of June 29, 2005
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as trustee, relating to the
5.25% Senior Notes due June 29, 2020.
|
|
|
4.15
|
|
Fifteenth Supplemental Indenture, dated May 29, 2009,
between MetLife, Inc. and The Bank of New York Mellon
Trust Company, N.A. (as successor in interest to
J.P. Morgan Trust Company, National Association (as
successor to Bank One Trust Company, N.A.)), as trustee,
relating to the 6.75% Senior Notes due June 1, 2016
(Incorporated by reference to Exhibit 4.1 to MetLife,
Inc.s Current Report on
Form 8-K
dated May 29, 2009 (the May 2009
Form 8-K)).
|
|
|
4.16
|
|
Sixteenth Supplemental Indenture, dated August 6, 2010
between the MetLife, Inc. and The Bank of New York Mellon
Trust Company, N.A. (as successor in interest to
J.P. Morgan Trust Company, National Association (as
successor to Bank One Trust Company, N.A.)), as trustee,
relating to the 2014 Senior Notes (Incorporated by reference to
Exhibit 4.1 to MetLife, Inc.s Current Report on
Form 8-K
dated August 6, 2010 (the August 6, 2010
Form 8-K)).
|
|
|
4.17
|
|
Seventeenth Supplemental Indenture, dated August 6, 2010,
between MetLife, Inc. and The Bank of New York Mellon
Trust Company, N.A. (as successor to Bank One
Trust Company, N.A.)), as trustee, relating to the 2021
Senior Notes (Incorporated by reference to Exhibit 4.2 to
the August 6, 2010
Form 8-K).
|
|
|
4.18
|
|
Eighteenth Supplemental Indenture dated August 6, 2010,
between MetLife, Inc. and The Bank of New York Mellon
Trust Company, N.A. (as successor in interest to
J.P. Morgan Trust Company, National Association (as
successor to Bank One Trust Company, N.A.)), as trustee,
relating to the 2041 Senior Notes (Incorporated by reference to
Exhibit 4.3 to the August 6, 2010
Form 8-K).
|
|
|
4.19
|
|
Nineteenth Supplemental Indenture dated August 6, 2010,
between MetLife, Inc. and The Bank of New York Mellon
Trust Company, N.A. (as successor in interest to
J.P. Morgan Trust Company, National Association (as
successor to Bank One Trust Company, N.A.)), as trustee,
relating to the Floating Rate Senior Notes (Incorporated by
reference to Exhibit 4.4 to the August 6, 2010
Form 8-K).
|
|
|
4.20
|
|
Twentieth Supplemental Indenture dated as of November 1,
2010 between MetLife, Inc. and The Bank of New York Mellon
Trust Company, N.A., as trustee, supplementing the
Indenture dated as of November 9, 2001, between MetLife,
Inc. and The Bank of New York Mellon Trust Company, N.A.
(as successor in interest to J.P. Morgan Trust Company
National Association (as successor to Bank One
Trust Company, N.A.)), as Trustee (such Indenture dated
November 9, 2001, the Original Indenture)
(Incorporated by reference to Exhibit 4.5 to the
October 27, 2010
Form 8-K).
|
|
|
4.21
|
|
Twenty-First Supplemental Indenture dated as of November 1,
2010 between MetLife, Inc. and The Bank of New York Mellon
Trust Company, N.A., supplementing the Original Indenture
(Incorporated by reference to Exhibit 4.6 to the
October 27, 2010
Form 8-K).
|
|
|
4.22
|
|
Twenty-Second Supplemental Indenture dated as of
November 1, 2010 between MetLife, Inc. and The Bank of New
York Mellon Trust Company, N.A., supplementing the Original
Indenture (Incorporated by reference to Exhibit 4.7 to the
October 27, 2010
Form 8-K).
|
|
|
4.23
|
|
Form of 6.125% Senior Note due December 1, 2011
(Included in Exhibit 4.2 incorporated by reference to
Exhibit 4.3 to the 2006 Annual Report).
|
|
|
4.24
|
|
Form of 5.375% Senior Note due December 15, 2012
(Included in Exhibit 4.3 incorporated by reference to
Exhibit 4.3 to the 2007 Annual Report).
|
|
|
4.25
|
|
Form of 6.50% Senior Note due December 15, 2032
(Included in Exhibit 4.4 incorporated by reference to
Exhibit 4.4 to the 2007 Annual Report).
|
|
|
4.26
|
|
Form of 5.875% Senior Note due November 21, 2033
(Included in Exhibit 4.5 incorporated by reference to
Exhibit 4.5 to the 2008 Annual Report).
|
|
|
4.27
|
|
Form of 5.00% Senior Note due November 24, 2013
(Included in Exhibit 4.6 incorporated by reference to
Exhibit 4.6 to the 2008 Annual Report).
|
|
|
4.28
|
|
Form of 5.50% Senior Note due June 15, 2014 (Included
in Exhibit 4.7 incorporated by reference to
Exhibit 4.7 to the 2009 Annual Report).
|
|
|
4.29
|
|
Form of 6.375% Senior Note due June 15, 2034 (Included
in Exhibit 4.8 incorporated by reference to
Exhibit 4.8 to the 2009 Annual Report).
|
|
|
4.30
|
|
Form of 5.50% Senior Note due June 15, 2014 (Included
in Exhibit 4.9 incorporated by reference to
Exhibit 4.9 to the 2009 Annual Report).
|
|
|
4.31
|
|
Form of 6.375% Senior Note due June 15, 2034 (Included
in Exhibit 4.10 incorporated by reference to
Exhibit 4.10 to the 2009 Annual Report).
|
|
|
E-3
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
4.32
|
|
Form of 5.375% Senior Note due December 9, 2024
(Included in Exhibit 4.11 incorporated by reference to
Exhibit 4.11 to the 2009 Annual Report).
|
|
|
4.33
|
|
Form of 5.00% Senior Note due June 15, 2015 (Included
in Exhibit 4.12).
|
|
|
4.34
|
|
Form of 5.70% Senior Note due June 15, 2035 (Included
in Exhibit 4.13).
|
|
|
4.35
|
|
Form of 5.25% Senior Note due June 29, 2020 (Included
in Exhibit 4.14).
|
|
|
4.36
|
|
Form of 6.75% Senior Note due June 1, 2016 (Included
in Exhibit 4.15 incorporated by reference to
Exhibit 4.1 to the May 2009
Form 8-K).
|
|
|
4.37
|
|
Form of 2014 Senior Note (Included in Exhibit 4.16
incorporated by reference to Exhibit 4.1 to the
August 6, 2010
Form 8-K).
|
|
|
4.38
|
|
Form of 2021 Senior Note (Included in Exhibit 4.17
incorporated by reference to Exhibit 4.2 to the
August 6, 2010
Form 8-K).
|
|
|
4.39
|
|
Form of 2041 Senior Note (Included in Exhibit 4.18
incorporated by reference to Exhibit 4.3 to the
August 6, 2010
Form 8-K).
|
|
|
4.40
|
|
Floating Rate Senior Note (Included in Exhibit 4.19
incorporated by reference to Exhibit 4.4 to the
August 6, 2010
Form 8-K).
|
|
|
4.41(a)
|
|
Indenture dated as of June 21, 2005 between MetLife, Inc.
and J.P. Morgan Trust Company, National Association
(predecessor to The Bank of New York Trust Company, N.A.)
relating to Subordinated Debt Securities (the Subordinated
Indenture).
|
|
|
4.41(b)
|
|
Form of Indenture for Subordinated Debt Securities between
MetLife, Inc. and one or more banking institutions to be
qualified as Trustee pursuant to Section 305(b)(2) of the
Trust Indenture Act of 1939 (Incorporated by reference to
Exhibit 4.41(a), except for the name of the trustee).
|
|
|
4.42
|
|
First Supplemental Indenture dated as of June 21, 2005 to
the Subordinated Indenture between MetLife, Inc. and
J.P. Morgan Trust Company, National Association.
|
|
|
4.43
|
|
Second Supplemental Indenture dated as of June 21, 2005 to
the Subordinated Indenture between MetLife, Inc. and
J.P. Morgan Trust Company, National Association
(predecessor to The Bank of New York Trust Company, N.A.).
|
|
|
4.44
|
|
Third Supplemental Indenture dated as of December 21, 2006
to the Subordinated Indenture between MetLife, Inc. and The Bank
of New York Trust Company, N.A. (as successor to
J.P. Morgan Trust Company, National Association)
(Incorporated by reference to Exhibit 4.1 to MetLife,
Inc.s Current Report on
Form 8-K
dated December 22, 2006 (the December 2006
Form 8-K)).
|
|
|
4.45
|
|
Sixth Supplemental Indenture dated as of August 7, 2008 to
the Subordinated Indenture between MetLife, Inc. and The Bank of
New York Mellon Trust Company, N.A. (as successor in
interest to J.P. Morgan Trust Company, National
Association), as trustee (Incorporated by reference to
Exhibit 4.1 to MetLife, Inc.s Current Report on
Form 8-K
dated August 8, 2008).
|
|
|
4.46
|
|
Seventh Supplemental Indenture dated February 6, 2009 for
the Subordinated Indenture between MetLife, Inc. and The Bank of
New York Mellon Trust Company, N.A. (as successor in
interest to J.P. Morgan Trust Company, National
Association), as trustee (Incorporated by reference to
Exhibit 4.1 to MetLife, Inc.s Current Report on
Form 8-K
dated February 9, 2009).
|
|
|
4.47
|
|
Eighth Supplemental Indenture dated July 8, 2009 to the
Subordinated Indenture between MetLife, Inc. and The Bank of New
York Mellon Trust Company, N.A. (as successor in interest
to J.P. Morgan Trust Company, National Association),
as trustee (Incorporated by reference to Exhibit 4.1 to
MetLife, Inc.s Current Report on
Form 8-K
dated July 8, 2009 (the July 2009
Form 8-K)).
|
|
|
4.48
|
|
Form of Series A Debenture (Included in Exhibit 4.42).
|
|
|
4.49
|
|
Form of Series B Debenture (Included in Exhibit 4.43).
|
|
|
4.50
|
|
Form of junior subordinated debenture (Included in
Exhibit 4.44 incorporated by reference to Exhibit 4.1
to the December 2006
Form 8-K).
|
|
|
4.51
|
|
Form of security certificate representing MetLife, Inc.s
6.817% Senior Debt Securities, Series A, due 2018
(Incorporated by reference to Exhibit 4.1 to MetLife,
Inc.s Current Report on
Form 8-K
dated August 15, 2008).
|
|
|
4.52
|
|
Form of security certificate representing MetLife, Inc.s
7.717% Senior Debt Securities, Series B, due 2019
(Incorporated by reference to Exhibit 4.1 to MetLife
Inc.s Current Report on
Form 8-K
dated February 18, 2009).
|
|
|
E-4
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
4.53
|
|
Form of security certificate representing MetLife, Inc.s
10.750%
Fixed-to-Floating
Rate Junior Subordinated Debentures due 2069 (Included in
Exhibit 4.47 incorporated by reference to Exhibit 4.1
to the July 2009
Form 8-K).
|
|
|
4.54
|
|
Certificate of Trust of MetLife Capital Trust III
(Incorporated by reference to Exhibit 4.7 to MetLife,
Inc.s, MetLife Capital Trust IIs and MetLife
Capital Trust IIIs Registration Statement on
Form S-3
(Nos.
333-61282,
333-61282-01
and
333-61282-02)
(the 2001
S-3
Registration Statement)).
|
|
|
4.55
|
|
Certificate of Amendment to Certificate of Trust of MetLife
Capital Trust III (Incorporated by reference to
Exhibit 4.6 to MetLife, Inc.s., MetLife Capital
Trust IIs and MetLife Capital Trust IIIs
Registration Statement on
Form S-3
(Nos.
333-112073,
333-112073-01
and
333-112073-02)
(the 2004
S-3
Registration Statement)).
|
|
|
4.56
|
|
Certificate of Trust of MetLife Capital Trust V
(Incorporated by reference to Exhibit 4.3 to MetLife,
Inc.s, MetLife Capital Trust Vs, MetLife
Capital Trust VIs, MetLife Capital
Trust VIIs, MetLife Capital Trust VIIIs
and MetLife Capital Trust IXs Registration Statement
on
Form S-3
(Nos.
333-147180,
333-147180-01,
333-147180-02,
333-147180-03,
333-147180-04
and
333-147180-05)
(the 2007
S-3
Registration Statement)).
|
|
|
4.57
|
|
Certificate of Trust of MetLife Capital Trust VI
(Incorporated by reference to Exhibit 4.4 to the 2007
S-3
Registration Statement).
|
|
|
4.58
|
|
Certificate of Trust of MetLife Capital Trust VII
(Incorporated by reference to Exhibit 4.5 to the 2007
S-3
Registration Statement).
|
|
|
4.59
|
|
Certificate of Trust of MetLife Capital Trust VIII
(Incorporated by reference to Exhibit 4.6 to the 2007
S-3
Registration Statement).
|
|
|
4.60
|
|
Certificate of Trust of MetLife Capital Trust IX
(Incorporated by reference to Exhibit 4.7 to the 2007
S-3
Registration Statement).
|
|
|
4.61
|
|
Amended and Restated Declaration of Trust of MetLife Capital
Trust III dated as of June 21, 2005.
|
|
|
4.62
|
|
Declaration of Trust of MetLife Capital Trust V
(Incorporated by reference to Exhibit 4.8 to the 2007
S-3
Registration Statement).
|
|
|
4.63
|
|
Declaration of Trust of MetLife Capital Trust VI
(Incorporated by reference to Exhibit 4.9 to the 2007
S-3
Registration Statement).
|
|
|
4.64
|
|
Declaration of Trust of MetLife Capital Trust VII
(Incorporated by reference to Exhibit 4.10 to the 2007
S-3
Registration Statement).
|
|
|
4.65
|
|
Declaration of Trust of MetLife Capital Trust VIII
(Incorporated by reference to Exhibit 4.11 to the 2007
S-3
Registration Statement).
|
|
|
4.66
|
|
Declaration of Trust of MetLife Capital Trust IX
(Incorporated by reference to Exhibit 4.12 to the 2007
S-3
Registration Statement).
|
|
|
4.67
|
|
Form of Amended and Restated Declaration of Trust (substantially
identical, except for names and dates, for MetLife Capital
Trust V, MetLife Capital Trust VI, MetLife Capital
Trust VII, MetLife Capital Trust VIII and MetLife
Capital Trust IX) (Incorporated by reference to
Exhibit 4.13 to the 2007
S-3
Registration Statement).
|
|
|
4.68
|
|
Form of Trust Preferred Security Certificate (substantially
identical, except for names and dates, for MetLife Capital
Trust V, MetLife Capital Trust VI, MetLife Capital
Trust VII, MetLife Capital Trust VIII and MetLife
Capital Trust IX) (Included in Exhibit 4.67
incorporated by reference to Exhibit 4.13 to the 2007
S-3
Registration Statement).
|
|
|
4.69
|
|
Guarantee Agreement dated June 21, 2005 by and between
MetLife, Inc., as Guarantor, and J.P. Morgan
Trust Company, National Association (predecessor to The
Bank of New York Trust Company, N.A.), as Guarantee
Trustee, relating to MetLife Capital Trust III.
|
|
|
4.70
|
|
Form of Trust Preferred Securities Guarantee Agreement
(substantially identical, except for names and dates, for
MetLife Capital Trust V, MetLife Capital Trust VI,
MetLife Capital Trust VII, MetLife Capital Trust VIII
and MetLife Capital Trust IX) (Incorporated by reference to
Exhibit 4.15 to the 2007
S-3
Registration Statement).
|
|
|
4.71
|
|
Form of Common Securities Guarantee Agreement (substantially
identical, except for names and dates, for MetLife Capital
Trust V, MetLife Capital Trust VI, MetLife Capital
Trust VII, MetLife Capital Trust VIII and MetLife
Capital Trust IX) (Incorporated by reference to
Exhibit 4.16 to the 2007
S-3
Registration Statement).
|
|
|
E-5
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
4.72
|
|
Removal and Appointment of Trustees of MetLife Capital
Trust III (Incorporated by reference to Exhibit 4.10
to the 2004
S-3
Registration Statement).
|
|
|
4.73
|
|
Form of Certificate for Common Stock, par value $0.01 per share
(Incorporated by reference to Exhibit 4.1 to the
S-1
Registration Statement).
|
|
|
4.74
|
|
Rights Agreement dated as of April 4, 2000 (expired on
April 4, 2010) between MetLife, Inc. and ChaseMellon
Shareholder Services, L.L.C. (predecessor to Mellon Investor
Services LLC) (Incorporated by reference to Exhibit 4.48 to
the 2006 Annual Report).
|
|
|
4.75
|
|
Certificate of Designation, Preferences and Rights of
Series A Junior Participating Preferred Stock of MetLife,
Inc., filed with the Secretary of State of Delaware on
April 7, 2000 (See Exhibit 3.2 above).
|
|
|
4.76
|
|
Form of Right Certificate (Included as Exhibit B of
Exhibit 4.74 incorporated by reference to Exhibit 4.48
to the 2006 Annual Report).
|
|
|
4.77
|
|
Form of Warrant Agreement (Incorporated by reference to
Exhibit 4.21 to the 2007
S-3
Registration Statement)**.
|
|
|
4.78
|
|
Form of Deposit Agreement (Incorporated by reference to
Exhibit 4.22 to the 2007
S-3
Registration Statement)**.
|
|
|
4.79
|
|
Form of Depositary Receipt (Included in Exhibit 4.78
incorporated by reference to Exhibit 4.22 to the 2007
S-3
Registration Statement)**.
|
|
|
4.80
|
|
Form of Purchase Contract Agreement (Incorporated by reference
to Exhibit 4.24 to the 2007
S-3
Registration Statement)**.
|
|
|
4.81
|
|
Form of Pledge Agreement (Incorporated by reference to
Exhibit 4.25 to the 2007
S-3
Registration Statement)**.
|
|
|
4.82
|
|
Form of Unit Agreement (Incorporated by reference to
Exhibit 4.26 to the 2007
S-3
Registration Statement)**.
|
|
|
4.83
|
|
Stock Purchase Contract Agreement dated June 21, 2005
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as Stock Purchase Contract Agent.
|
|
|
4.84
|
|
Form of Normal Common Equity Unit Certificate (Included in
Exhibit 4.83).
|
|
|
4.85
|
|
Form of Stripped Common Equity Unit Certificate (Included in
Exhibit 4.83).
|
|
|
4.86
|
|
Pledge Agreement dated as of June 21, 2005 among MetLife,
Inc., JP Morgan Chase Bank, National Association (predecessor to
The Bank of New York Trust Company, N.A.), as Collateral
Agent, Custodial Agent and Securities Intermediary, and
J.P. Morgan Trust Company, National Association
(predecessor to The Bank of New York Trust Company, N.A.),
as Stock Purchase Contract Agent.
|
|
|
4.87
|
|
Certificate of Designations of Floating Rate Non-Cumulative
Preferred Stock, Series A, of MetLife, Inc., filed with the
Secretary of State of Delaware on June 10, 2005 (See
Exhibit 3.3 above).
|
|
|
4.88
|
|
Form of Stock Certificate, Floating Rate Non-Cumulative
Preferred Stock, Series A, of MetLife, Inc. (Incorporated
by reference to Exhibit 99.6 to MetLife, Inc.s
Registration Statement on Form 8-A filed on June 10, 2005).
|
|
|
4.89
|
|
Certificate of Designations of 6.50% Non-Cumulative Preferred
Stock, Series B, of MetLife, Inc., filed with the Secretary
of State of Delaware on June 14, 2005 (See Exhibit 3.4
above).
|
|
|
4.90
|
|
Form of Stock Certificate, 6.50% Non-Cumulative Preferred Stock,
Series B, of MetLife, Inc. (Incorporated by reference to
Exhibit 99.6 to MetLife, Inc.s Registration Statement on
Form 8-A filed on June 15, 2005).
|
|
|
4.91
|
|
Replacement Capital Covenant, dated as of December 21, 2006
(Incorporated by reference to Exhibit 4.2 to the December
2006
Form 8-K).
|
|
|
4.92
|
|
Replacement Capital Covenant, dated as of December 12, 2007
(Incorporated by reference to Exhibit 4.2 to MetLife,
Inc.s Current Report on
Form 8-K
dated December 12, 2007).
|
|
|
4.93
|
|
Replacement Capital Covenant, dated as of April 8, 2008
(Incorporated by reference to Exhibit 4.2 to MetLife,
Inc.s Current Report on
Form 8-K
dated April 8, 2008).
|
|
|
4.94
|
|
Replacement Capital Covenant, dated as of December 30, 2008
(Incorporated by reference to Exhibit 4.1 to MetLife,
Inc.s Current Report on
Form 8-K
dated December 30, 2008 (the December 2008
Form 8-K)).
|
|
|
E-6
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
4.95
|
|
Replacement Capital Covenant, dated as of July 8, 2009
(Incorporated by reference to Exhibit 4.2 to the July 2009
Form 8-K).
|
|
|
4.96
|
|
Investor Rights Agreement dated as of November 1, 2010
among MetLife, Inc., ALICO Holdings and AIG (Incorporated by
reference to Exhibit 4.1 to the
Form 8-K
dated October 27, 2010).
|
|
|
4.97
|
|
Stock Purchase Contract Agreement dated as of November 1,
2010 among MetLife, Inc. and Deutsche Bank Trust Company
Americas, as Stock Purchase Contract Agent. (Incorporated by
reference to Exhibit 4.2 to the
Form 8-K
dated October 27, 2010).
|
|
|
4.98
|
|
Indemnification Collateral Account Security and Control
Agreement dated as of November 1, 2010 among MetLife, Inc.,
ALICO Holdings, Deutsche Bank Trust Company Americas, as
Securities Intermediary, Pledge Collateral Agent and Stock
Purchase Contract Agent, and AIG (Incorporated by reference to
Exhibit 4.3 to the
Form 8-K
dated October 27, 2010).
|
|
|
4.99
|
|
Pledge Agreement dated as of November 1, 2010 among
MetLife, Inc. and Deutsche Bank Trust Company America as
Collateral Agent, Custodial Agent, Securities Intermediary and
Stock Purchase Contract Agent (Incorporated by reference to
Exhibit 4.4 to the
Form 8-K
dated October 27, 2010).
|
|
|
4.100
|
|
Form of Transition Services Agreement between MetLife, Inc. and
AIG (Included in Exhibit 2.4 incorporated by reference to
Exhibit 2.1 to May 7, 2010
Form 8-K).
|
|
|
4.101
|
|
Form of Special Asset Protection Agreement by and among MetLife,
Inc., AIG and ALICO Holdings (Included in Exhibit 2.4
incorporated by reference to Exhibit 2.1 to May 7,
2010
Form 8-K).
|
|
|
4.102
|
|
Form of Hold Harmless Agreement by and among MetLife, Inc., AIG,
ALICO Holdings and National Union Fire Insurance Company of
Pittsburgh, Pa. (Included in Exhibit 2.4 incorporated by
reference to Exhibit 2.1 to May 7, 2010
Form 8-K).
|
|
|
10.1
|
|
MetLife Executive Severance Plan (effective as of
December 17, 2007) (Incorporated by reference to
Exhibit 10.2 to MetLife, Inc.s Current Report on
Form 8-K
dated December 13, 2007)*.
|
|
|
10.2
|
|
MetLife Executive Severance Plan (as amended and restated
effective June 14, 2010) (Incorporated by reference to
Exhibit 10.1 to MetLife, Inc.s Current Report on
Form 8-K
dated December 21, 2009 (the December 2009
Form 8-K))*.
|
|
|
10.3
|
|
Separation Agreement, Waiver and General Release dated as of
February 27, 2009 between Ruth A. Fattori and MetLife
Group, Inc. (Incorporated by reference to Exhibit 10.1 to
MetLife, Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2009)*.
|
|
|
10.4
|
|
Separation Agreement, Waiver and General Release dated
August 17, 2009 between Lisa M. Weber and MetLife Group,
Inc. (Incorporated by reference to Exhibit 10.1 to MetLife,
Inc.s Current Report on
Form 8-K
dated September 3, 2009).*
|
|
|
10.5
|
|
Employment Agreement, effective as of April 30, 2010, by
and between James L. Lipscomb and MetLife, Inc. (Incorporated by
reference to Exhibit 10.1 to MetLife, Inc.s Quarterly
Report on
Form 10-Q
dated June 30, 2010)*.
|
|
|
10.6
|
|
MetLife, Inc. 2000 Stock Incentive Plan, as amended and restated
March 28, 2000 (Incorporated by reference to
Exhibit 10.7 to the
S-1
Registration Statement)*.
|
|
|
10.7
|
|
MetLife, Inc. 2000 Stock Incentive Plan, as amended, effective
February 8, 2002 (Incorporated by reference to
Exhibit 10.13 to the 2007 Annual Report)*.
|
|
|
10.8
|
|
Form of Management Stock Option Agreement under the MetLife,
Inc. 2000 Stock Incentive Plan (Incorporated by reference to
Exhibit 10.4 to the 2008 Annual Report)*.
|
|
|
10.9
|
|
Form of Management Stock Option Agreement under the 2005 SIC
Plan (effective December 15, 2009) (Incorporated by
reference to Exhibit 10.3 to the December 2009
Form 8-K)*.
|
|
|
10.10
|
|
MetLife, Inc. 2000 Directors Stock Plan, as amended and
restated March 28, 2000 (Incorporated by reference to
Exhibit 10.8 to the
S-1
Registration Statement)*.
|
|
|
10.11
|
|
MetLife, Inc. 2000 Directors Stock Plan, as amended
effective February 8, 2002 (Incorporated by reference to
Exhibit 10.17 to the 2007 Annual Report)*.
|
|
|
10.12
|
|
Form of Director Stock Option Agreement under the MetLife, Inc.
2000 Directors Stock Plan (Incorporated by reference to
Exhibit 10.7 to the 2008 Annual Report)*.
|
|
|
10.13
|
|
MetLife, Inc. 2005 Stock and Incentive Compensation Plan,
effective April 15, 2005 (the 2005 SIC Plan)
(Incorporated by reference to Exhibit 10.12 to the 2009
Annual Report)*.
|
|
|
10.14
|
|
MetLife, Inc. 2005 Non-Management Director Stock Compensation
Plan, effective April 15, 2005 (Incorporated by reference
to Exhibit 10.13 to the 2009 Annual Report)*.
|
|
|
E-7
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
10.15
|
|
Form of Management Stock Option Agreement under the 2005 SIC
Plan (Incorporated by reference to Exhibit 10.14 to the
2009 Annual Report)*.
|
|
|
10.16
|
|
Form of Management Stock Option Agreement under the 2005 SIC
Plan (effective as of April 25, 2007) (Incorporated by
reference to Exhibit 10.4 to MetLife, Inc.s Quarterly
Report on
Form 10-Q
for the quarter ended March 31, 2007 (the First
Quarter 2007
10-Q))*.
|
|
|
10.17
|
|
Amendment to Stock Option Agreements under the 2005 SIC Plan
(effective as of April 25, 2007) (Incorporated by reference
to Exhibit 10.1 to the First Quarter 2007
10-Q)*.
|
|
|
10.18
|
|
Form of Management Restricted Stock Unit Agreement under the
2005 SIC Plan*.
|
|
|
10.19
|
|
Amendment to Management Restricted Stock Unit Agreement under
the 2005 SIC Plan (effective December 31, 2005)*.
|
|
|
10.20
|
|
Form of Management Restricted Stock Unit Agreement under the
2005 SIC Plan (effective December 31, 2005)*.
|
|
|
10.21
|
|
Form of Management Restricted Stock Unit Agreement under the
2005 SIC Plan (effective as of April 25, 2007)
(Incorporated by reference to Exhibit 10.6 to the First
Quarter 2007
10-Q)*.
|
|
|
10.22
|
|
Amendment to Restricted Stock Unit Agreements under the 2005 SIC
Plan (effective as of April 25, 2007) (Incorporated by
reference to Exhibit 10.3 to the First Quarter 2007
10-Q)*.
|
|
|
10.23
|
|
Form of Management Restricted Stock Unit Agreement under the
2005 SIC Plan (effective December 11, 2007) (Incorporated
by reference to Exhibit 10.5 to MetLife, Inc.s
Current Report on
Form 8-K
dated December 13, 2007 (the December 13, 2007
Form 8-K))*.
|
|
|
10.24
|
|
Amendment to Restricted Stock Unit Agreements under the 2005 SIC
Plan (effective as of December 31, 2007) (Incorporated by
reference to Exhibit 10.29 to the 2007 Annual Report)*.
|
|
|
10.25
|
|
Form of Management Restricted Stock Unit Agreement under the
2005 SIC Plan (effective December 15, 2009) (Incorporated
by reference to Exhibit 10.4 to the December 2009
Form 8-K)*.
|
|
|
10.26
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (effective January 27, 2009) (Incorporated by
reference to Exhibit 10.1 to MetLife, Inc.s Current
Report on
Form 8-K
dated January 30, 2009)*.
|
|
|
10.27
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (effective February 24, 2009) (Incorporated by
reference to Exhibit 10.1 to MetLife, Inc.s Current
Report on
Form 8-K
dated March 13, 2009)*.
|
|
|
10.28
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (effective December 15, 2009) (Incorporated by
reference to Exhibit 10.2 to the December 2009
Form 8-K)*.
|
|
|
10.29
|
|
Clarification of Management Performance Share Agreement under
the 2005 SIC Plan*.
|
|
|
10.30
|
|
Amendment to Management Performance Share Agreement under the
2005 SIC Plan (effective December 31, 2005)*.
|
|
|
10.31
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (effective December 31, 2005)*.
|
|
|
10.32
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (effective February 27, 2007) (Incorporated by
reference to Exhibit 10.27 to the 2006 Annual Report)*.
|
|
|
10.33
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (effective as of April 25, 2007) (Incorporated by
reference to Exhibit 10.5 to the First Quarter 2007
10-Q)*.
|
|
|
10.34
|
|
Amendment to Management Performance Share Agreements under the
2005 SIC Plan (effective as of April 25, 2007)
(Incorporated by reference to Exhibit 10.2 to the First
Quarter 2007
10-Q)*.
|
|
|
10.35
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (effective December 11, 2007) (Incorporated by
reference to Exhibit 10.4 to the December 13, 2007
Form 8-K)*.
|
|
|
10.36
|
|
Amendment to Management Performance Share Agreements under the
2005 SIC Plan (effective as of December 31, 2007)
(Incorporated by reference to Exhibit 10.3 to the
December 13, 2007
Form 8-K)*.
|
|
|
10.37
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (effective February 21, 2010) (Incorporated by
reference to Exhibit 10.1 to MetLife, Inc.s Current
Report on
Form 8-K
dated February 18, 2010)*.
|
|
|
10.38
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (effective December 14, 2010) (Incorporated by
reference to Exhibit 10.1 to MetLife, Inc.s Current
Report on
Form 8-K
dated December 14, 2010)*.
|
|
|
E-8
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
10.39
|
|
MetLife Policyholder Trust Agreement (Incorporated by
reference to Exhibit 10.12 to the
S-1
Registration Statement).
|
|
|
10.40
|
|
Amendment to MetLife Policyholder Trust Agreement
(Incorporated by reference to Exhibit 3.2 to the MetLife
Policyholder Trusts Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007).
|
|
|
10.41
|
|
Five-Year $3,000,000,000 Credit Agreement, dated as of
June 20, 2007, among MetLife, Inc. and MetLife Funding,
Inc., as borrowers, and other parties signatory thereto
(Incorporated by reference to Exhibit 10.1 to MetLife,
Inc.s Current Report on
Form 8-K
dated June 25, 2007).
|
|
|
10.42
|
|
Amended and Restated $2,850,000 Five-Year Credit Agreement,
dated as of June 20, 2007 and amended and restated as of
December 23, 2008, among MetLife, Inc. and MetLife Funding,
Inc., as borrowers, and other parties signatory thereto
(Incorporated by reference to Exhibit 10.1 to the December
2008
Form 8-K).
|
|
|
10.43
|
|
Three-Year Credit Agreement, dated as of October 15, 2010,
among MetLife, Inc. and MetLife Funding, Inc., as borrowers, and
the other parties signatory thereto (Incorporated by reference
to Exhibit 10.1 to MetLife, Inc.s Current Report on
Form 8-K
dated October 15, 2010).
|
|
|
10.44
|
|
364-Day
Credit Agreement, dated as of October 15, 2010, among
MetLife, Inc. and MetLife Funding, Inc., as borrowers, and the
other parties signatory thereto (Incorporated by reference to
Exhibit 10.2 to MetLife, Inc.s Current Report on
Form 8-K
dated October 15, 2010).
|
|
|
10.45
|
|
Amended and Restated $2,850,000 Five-Year Credit Agreement,
dated as of June 20, 2007 and amended and restated as of
December 23, 2008, among MetLife, Inc. and MetLife Funding,
Inc., as borrowers, and other parties signatory thereto
(Incorporated by reference to Exhibit 10.1 to the December
2008
Form 8-K).
|
|
|
10.46
|
|
Amended and Restated Commitment Letter for $5.0 Billion Senior
Credit Facility, dated March 16, 2010 among MetLife, Inc.
and the various lenders named therein (Incorporated by reference
to Exhibit 10.3 to MetLife, Inc.s Quarterly Report on
Form 10-Q
dated March 31, 2010).
|
|
|
10.47
|
|
MetLife Annual Variable Incentive Plan (AVIP)
(Incorporated by reference to Exhibit 10.41 to the 2009
Annual Report)*.
|
|
|
10.48
|
|
Amendment Number One to the AVIP*.
|
|
|
10.49
|
|
Resolutions of the MetLife, Inc. Board of Directors (adopted
December 11, 2007) regarding the selection of
performance measures for 2008 awards under the AVIP
(Incorporated by reference to Exhibit 10.54 to the 2007
Annual Report)*.
|
|
|
10.50
|
|
Resolutions of the MetLife, Inc. Board of Directors (adopted
January 27, 2009) regarding the selection of
performance measures for 2009 awards under the AVIP
(Incorporated by reference to Exhibit 10.1 to MetLife,
Inc.s Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2009)*.
|
|
|
10.51
|
|
Resolutions of the MetLife, Inc. Board of Directors (adopted
February 18, 2010) regarding the selection of
performance measures for 2010 awards under the MetLife Annual
Variable Incentive Plan (Incorporated by reference to
Exhibit 10.1 to MetLife, Inc.s Quarterly Report on
Form 10-Q
dated March 31, 2010)*.
|
|
|
10.52
|
|
Resolutions of MetLife, Inc. Board of Directors (adopted
December 14, 2010) regarding the selection of
performance measures for 2011 under the MetLife Annual Variable
Incentive Plan.
|
|
|
10.53
|
|
Metropolitan Life Auxiliary Savings and Investment Plan (as
amended and restated, effective January 1, 2008)
(Incorporated by reference to Exhibit 10.57 to the 2007
Annual Report)*.
|
|
|
10.54
|
|
Amendment 1 to the Metropolitan Life Auxiliary Savings and
Investment Plan (as amended and restated, effective
January 1, 2008) (Incorporated by reference to
Exhibit 10.46 to the 2009 Annual Report)*.
|
|
|
10.55
|
|
Amendment Number Two to the Metropolitan Life Auxiliary Savings
and Investment Plan (Amended and Restated Effective
January 1, 2008)*.
|
|
|
10.56
|
|
MetLife Deferred Compensation Plan for Officers, as amended and
restated, effective November 1, 2003 (Incorporated by
reference to Exhibit 10.41 to the 2008 Annual Report)*.
|
|
|
10.57
|
|
Amendment Number One to the MetLife Deferred Compensation Plan
for Officers, dated May 4, 2005*.
|
|
|
10.58
|
|
Amendment Number Two to The MetLife Deferred Compensation Plan
for Officers, effective December 14, 2005*.
|
|
|
E-9
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
10.59
|
|
Amendment Number Three to The MetLife Deferred Compensation Plan
for Officers (as amended and restated as of November 1,
2003, effective February 26, 2007) (Incorporated by
reference to Exhibit 10.48 to the 2006 Annual Report)*.
|
|
|
10.60
|
|
MetLife Leadership Deferred Compensation Plan, dated
November 2, 2006 (as amended and restated effective with
respect to salary and cash incentive compensation,
January 1, 2005, and with respect to stock compensation,
April 15, 2005) (Incorporated by reference to
Exhibit 10.3 to MetLife, Inc.s Quarterly Report on
Form 10-Q
for the quarter ended September 30, 2006 (the Third
Quarter 2006
10-Q))*.
|
|
|
10.61
|
|
Amendment Number One to The MetLife Leadership Deferred
Compensation Plan, dated December 13, 2007 (effective as of
December 31, 2007) (Incorporated by reference to
Exhibit 10.63 to the 2007 Annual Report)*.
|
|
|
10.62
|
|
Amendment Number Two to The MetLife Leadership Deferred
Compensation Plan, dated December 11, 2008 (effective
December 31, 2008) (Incorporated by reference to
Exhibit 10.47 to the 2008 Annual Report)*.
|
|
|
10.63
|
|
Amendment Number Three to The MetLife Leadership Deferred
Compensation Plan, dated December 11, 2009 (effective
January 1, 2010) (Incorporated by reference to
Exhibit 10.54 to the 2009 Annual Report)*.
|
|
|
10.64
|
|
Amendment Number Four to The MetLife Leadership Deferred
Compensation Plan, dated December 11, 2009 (effective
December 31, 2009) (Incorporated by reference to
Exhibit 10.55 to the 2009 Annual Report)*.
|
|
|
10.65
|
|
Amendment Number Five to The MetLife Leadership Deferred
Compensation Plan, dated December 11, 2009 (effective
January 1, 2011)*.
|
|
|
10.66
|
|
MetLife Deferred Compensation Plan for Outside Directors
(effective December 9, 2003) (Incorporated by reference to
Exhibit 10.48 to the 2008 Annual Report)*.
|
|
|
10.67
|
|
Amendment Number One to The MetLife Deferred Compensation Plan
for Outside Directors (as amended and restated as of December,
2003, effective February 26, 2007) (Incorporated by
reference to Exhibit 10.51 to the 2006 Annual Report)*.
|
|
|
10.68
|
|
MetLife Non-Management Director Deferred Compensation Plan,
dated November 2, 2006 (as amended and restated, effective
January 1, 2005) (Incorporated by reference to
Exhibit 10.4 to the Third Quarter 2006
10-Q)*.
|
|
|
10.69
|
|
Amendment Number One to The MetLife Non-Management Director
Deferred Compensation Plan (as amended and restated as of
December, 2006, effective February 26, 2007) (Incorporated
by reference to Exhibit 10.53 to the 2006 Annual Report)*.
|
|
|
10.70
|
|
MetLife Non-Management Director Deferred Compensation Plan,
dated December 5, 2007 (as amended and restated, effective
January 1, 2005) (Incorporated by reference to
Exhibit 10.68 to the 2007 Annual Report)*.
|
|
|
10.71
|
|
The MetLife Non-Management Director Deferred Compensation Plan,
dated December 9, 2008 (as amended and restated effective
January 1, 2005) (Incorporated by reference to
Exhibit 10.53 to the 2008 Annual Report)*.
|
|
|
10.72
|
|
MetLife, Inc. Director Indemnity Plan (dated and effective
July 22, 2008) (Incorporated by reference to
Exhibit 10.1 to MetLife, Inc.s Current Report on
Form 8-K
dated July 25, 2008)*.
|
|
|
10.73
|
|
MetLife Auxiliary Pension Plan dated August 7, 2006 (as
amended and restated, effective June 30, 2006)
(Incorporated by reference to Exhibit 10.3 to MetLife,
Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2006 (the Second
Quarter 2006
10-Q))*.
|
|
|
10.74
|
|
MetLife Auxiliary Pension Plan dated December 21, 2006
(amending and restating Part I thereof, effective
January 1, 2007) (Incorporated by reference to
Exhibit 10.57 to the 2006 Annual Report)*.
|
|
|
10.75
|
|
MetLife Auxiliary Pension Plan dated December 21, 2007
(amending and restating Part I thereof, effective
January 1, 2008) (Incorporated by reference to
Exhibit 10.1 to MetLife, Inc.s Current Report on
Form 8-K
dated December 28, 2007)*.
|
|
|
10.76
|
|
Amendment #1 to the MetLife Auxiliary Pension Plan (as amended
and restated effective January 1, 2008) dated
October 24, 2008 (effective October 1, 2008)
(Incorporated by reference to Exhibit 10.58 to the 2008
Annual Report)*.
|
|
|
10.77
|
|
Amendment Number Two to the MetLife Auxiliary Pension Plan (as
amended and restated effective January 1, 2008) dated
December 12, 2008 (effective December 31, 2008)
(Incorporated by reference to Exhibit 10.59 to the 2008
Annual Report)*.
|
|
|
E-10
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
10.78
|
|
Amendment Number Three to the MetLife Auxiliary Pension Plan (as
amended and restated effective January 1, 2008) dated
March 25, 2009 (effective January 1, 2009)
(Incorporated by reference to Exhibit 10.1 to MetLife,
Inc.s Current Report on
Form 8-K
dated March 31, 2009)*.
|
|
|
10.79
|
|
Amendment Number Four to the MetLife Auxiliary Pension Plan (as
amended and restated effective January 1, 2008) (effective
January 1, 2010) (Incorporated by reference to
Exhibit 10.5 to the December 2009
Form 8-K)*.
|
|
|
10.80
|
|
Amendment Number Five to the MetLife Auxiliary Pension Plan (as
amended and restated effective January 1, 2008) (effective
January 1, 2010).
|
|
|
10.81
|
|
MetLife Plan for Transition Assistance for Officers, dated
January 7, 2000, as amended (the MPTA)
(Incorporated by reference to Exhibit 10.70 to the 2009
Annual Report)*.
|
|
|
10.82
|
|
Amendment Number Ten to the MPTA, dated January 26, 2005*.
|
|
|
10.83
|
|
Amendment Number Eleven to the MPTA, dated February 28,
2006*.
|
|
|
10.84
|
|
Amendment Number Twelve to the MPTA, dated August 7, 2006
(Incorporated by reference to Exhibit 10.1 to the Second
Quarter 2006
10-Q)*.
|
|
|
10.85
|
|
Amendment Number Thirteen to the MPTA, dated August 7, 2006
(Incorporated by reference to Exhibit 10.2 to the Second
Quarter 2006
10-Q)*.
|
|
|
10.86
|
|
Amendment Number Fourteen to the MPTA, dated January 26,
2007 (Incorporated by reference to Exhibit 10.63 to the
2006 Annual Report)*.
|
|
|
10.87
|
|
Amendment Number Fifteen to the MPTA, dated June 1, 2007
(Incorporated by reference to Exhibit 10.2 to MetLife,
Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2007)*.
|
|
|
10.88
|
|
Amendment Number Sixteen to the MPTA, dated December 12,
2007 (Incorporated by reference to Exhibit 10.81 to the
2007 Annual Report)*.
|
|
|
10.89
|
|
Amendment Number Seventeen to the MPTA, dated June 3, 2008
(Incorporated by reference to Exhibit 10.1 to MetLife,
Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2008)*.
|
|
|
10.90
|
|
Amendment Number Eighteen to the MPTA, dated August 13,
2008 (Incorporated by reference to Exhibit 10.69 to the
2008 Annual Report)*.
|
|
|
10.91
|
|
Amendment Number Nineteen to the MPTA, dated December 8,
2008 (Incorporated by reference to Exhibit 10.70 to the
2008 Annual Report)*.
|
|
|
10.92
|
|
Amendment Number Twenty to the MPTA, dated December 16,
2008 (Incorporated by reference to Exhibit 10.71 to the
2008 Annual Report)*.
|
|
|
10.93
|
|
Amendment Number Twenty-One to the MPTA, dated December 18,
2008 (Incorporated by reference to Exhibit 10.72 to the
2008 Annual Report)*.
|
|
|
10.94
|
|
Amendment Number Twenty-Two to the MPTA, dated December 21,
2009 (Incorporated by reference to Exhibit 10.41 to the
2009 Annual Report)*.
|
|
|
10.95
|
|
MetLife Plan for Transition Assistance for Officers, dated
December 28, 2009 (as amended and restated, effective
January 1, 2010) (Incorporated by reference to
Exhibit 10.41 to the 2009 Annual Report)*.
|
|
|
10.96
|
|
Amendment Number One to the MetLife Plan for Transition
Assistance for Officers (as amended and restated effective
January 1, 2010)*.
|
|
|
10.97
|
|
One Madison Avenue Purchase and Sale Agreement, dated as of
March 29, 2005, between Metropolitan Life Insurance
Company, as Seller, and 1 Madison Venture LLC and Column
Financial, Inc., collectively, as Purchaser.
|
|
|
10.98
|
|
MetLife Building, 200 Park Avenue, New York, NY Purchase and
Sale Agreement, dated as of April 1, 2005, between
Metropolitan Tower Life Insurance Company, as Seller, and
Tishman Speyer Development, L.L.C., as Purchaser.
|
|
|
10.99
|
|
Stuyvesant Town, New York, New York, Purchase and Sale Agreement
between Metropolitan Tower Life Insurance Company, as Seller,
and Tishman Speyer Development Corp., as Purchaser, dated as of
October 17, 2006 (Incorporated by reference to
Exhibit 10.1 to the Third Quarter 2006
10-Q).
|
|
|
10.100
|
|
Peter Cooper Village, New York, New York, Purchase and Sale
Agreement between Metropolitan Tower Life Insurance Company, as
Seller, and Tishman Speyer Development Corp., as Purchaser,
dated as of October 17, 2006 (Incorporated by reference to
Exhibit 10.2 to the Third Quarter 2006
10-Q).
|
|
|
10.101
|
|
International Distribution Agreement dated as of July 1,
2005 between MetLife, Inc. and Citigroup Inc.
|
|
|
10.102
|
|
Domestic Distribution Agreement dated as of July 1, 2005
between MetLife, Inc. and Citigroup Inc.
|
|
|
E-11
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
12.1
|
|
Statement re: Computation of Ratios of Earnings to Fixed Charges.
|
|
|
21.1
|
|
Subsidiaries of the Registrant.
|
|
|
23.1
|
|
Consent of Deloitte & Touche LLP.
|
|
|
31.1
|
|
Certification of Chief Executive Officer pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
31.2
|
|
Certification of Chief Financial Officer pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.1
|
|
Certification of Chief Executive Officer pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.2
|
|
Certification of Chief Financial Officer pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document.
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document.
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
|
* |
|
Indicates management contracts or compensatory plans or
arrangements. |
|
** |
|
Indicates document to be filed as an exhibit to a Current Report
on
Form 8-K
or Quarterly Report on
Form 10-Q
pursuant to Item 601 of
Regulation S-K
and incorporated herein by reference. |
E-12